1	The	DT	O	the	det	4	SENT_1	[p1l383t81r428b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l447t83r532b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l551t83r739b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l759t83r938b109],
5	of	IN	O	of	_	0	SENT_1	[p1l958t81r986b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l998t83r1198b102],

1	l	NN	O	l	_	0	SENT_2	[p1l90t184r93b303],
2	REVIEW	NNP	O	REVIEW	nn	3	SENT_2	[p1l605t234r779b260],
3	ARTICLE	NN	O	article	dep	1	SENT_2	[p1l790t234r977b260],
4	l	NN	O	l	tmod	3	SENT_2	[p1l1488t184r1491b303],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_3	[p1l558t378r801b401],
2	OF	IN	O	of	_	0	SENT_3	[p1l816t378r862b401],
3	DISEASE	NN	O	disease	prep_of	1	SENT_3	[p1l879t378r1025b401],

1	Leukotrienes	NNS	O	leukotriene	_	0	SENT_4	[p1l595t455r984b510],

1	Marc	NNP	PERSON	Marc	nn	2	SENT_5	[p1l249t581r333b609],
2	Peters-Golden	NNP	PERSON	Peters-Golden	_	0	SENT_5	[p1l348t578r597b615],
3	,	,	O	,	_	0	SENT_5	[p1l348t578r597b615],
4	M.D.	NNP	O	M.D.	conj_and	2	SENT_5	[p1l614t581r704b615],
5	,	,	O	,	_	0	SENT_5	[p1l614t581r704b615],
6	and	CC	O	and	_	0	SENT_5	[p1l719t578r779b609],
7	William	NNP	PERSON	William	nn	13	SENT_5	[p1l792t578r920b609],
8	R.	NNP	PERSON	R.	nn	13	SENT_5	[p1l937t581r965b609],
9	Henderson	NNP	PERSON	Henderson	nn	13	SENT_5	[p1l982t578r1236b618],
10	,	,	O	,	_	0	SENT_5	[p1l982t578r1236b618],
11	Jr.	NNP	O	Jr.	appos	13	SENT_5	[p1l982t578r1236b618],
12	,	,	O	,	_	0	SENT_5	[p1l982t578r1236b618],
13	M.D.	NNP	O	M.D.	conj_and	2	SENT_5	[p1l1253t581r1333b609],

1	conjugated	VBN	O	conjugate	_	0	SENT_6	[p1l188t741r369b780],
2	double	JJ	O	double	amod	3	SENT_6	[p1l380t741r491b771],
3	bonds	NNS	O	bond	nsubj	4	SENT_6	[p1l503t741r613b776],
4	)	VBP	O	)	ccomp	1	SENT_6	[p1l503t741r613b776],
5	comprise	VBP	O	comprise	dep	1	SENT_6	[p1l627t741r780b779],
6	a	DT	O	a	det	7	SENT_6	[p1l791t751r808b771],
7	family	NN	O	family	dobj	5	SENT_6	[p1l818t740r925b779],
8	of	IN	O	of	_	0	SENT_6	[p1l935t740r974b771],
9	products	NNS	O	product	prep_of	7	SENT_6	[p1l977t741r1123b779],
10	of	IN	O	of	_	0	SENT_6	[p1l1135t740r1174b771],
11	the	DT	O	the	det	14	SENT_6	[p1l1178t741r1230b771],
12	5	CD	NUMBER	5	num	14	SENT_6	[p1l1242t741r1490b780],
13	—	NN	O	—	nn	14	SENT_6	[p1l1242t741r1490b780],
14	lipoxygenase	NN	O	lipoxygenase	prep_of	9	SENT_6	[p1l1242t741r1490b780],
15	pathway	NN	O	pathway	nsubj	1	SENT_6	[p1l187t791r324b829],
16	of	IN	O	of	_	0	SENT_6	[p1l334t790r373b821],
17	arachidonic	JJ	O	arachidonic	amod	19	SENT_6	[p1l376t791r568b821],
18	acid	NN	O	acid	nn	19	SENT_6	[p1l579t791r644b821],
19	metabolism	NN	O	metabolism	prep_of	15	SENT_6	[p1l655t791r858b821],
20	.	.	O	.	_	0	SENT_6	[p1l655t791r858b821],

1	The	DT	O	the	det	2	SENT_7	[p1l870t791r931b821],
2	cysteinyl	NN	O	cysteinyl	nsubj	3	SENT_7	[p1l943t791r1083b829],
3	leukotrienes	VBZ	O	leukotriene	dep	57	SENT_7	[p1l1093t791r1294b821],
4	C4	NN	O	c4	dobj	3	SENT_7	[p1l1306t793r1353b831],
5	,	,	O	,	_	0	SENT_7	[p1l1306t793r1353b831],
6	D4	NN	O	d4	dobj	3	SENT_7	[p1l1365t793r1415b831],
7	,	,	O	,	_	0	SENT_7	[p1l1365t793r1415b831],
8	and	CC	O	and	_	0	SENT_7	[p1l1428t791r1490b821],
9	E	NN	O	e	dobj	3	SENT_7	[p1l91t843r111b871],
10	4	CD	NUMBER	4	num	11	SENT_7	[p1l113t866r127b881],
11	account	NN	O	account	nsubj	43	SENT_7	[p1l141t847r272b871],
12	for	IN	O	for	_	0	SENT_7	[p1l284t840r332b871],
13	the	DT	O	the	det	15	SENT_7	[p1l346t841r397b871],
14	biologic	JJ	O	biologic	amod	15	SENT_7	[p1l412t841r544b880],
15	activity	NN	O	activity	prep_for	11	SENT_7	[p1l558t841r679b879],
16	that	WDT	O	that	nsubjpass	19	SENT_7	[p1l691t841r758b871],
17	was	VBD	O	be	auxpass	19	SENT_7	[p1l769t851r832b871],
18	previously	RB	DATE	previously	advmod	19	SENT_7	[p1l847t841r1017b879],
19	termed	VBN	O	term	rcmod	15	SENT_7	[p1l1030t841r1148b871],
20	“	CD	NUMBER	“	num	22	SENT_7	[p1l1163t841r1405b880],
21	slow-reacting	JJ	O	slow-reacting	amod	22	SENT_7	[p1l1163t841r1405b880],
22	substance	NN	O	substance	dobj	19	SENT_7	[p1l1419t841r1489b871, p1l92t897r195b921],
23	of	IN	O	of	_	0	SENT_7	[p1l207t890r245b921],
24	anaphylaxis	NN	O	anaphylaxi	prep_of	22	SENT_7	[p1l250t891r467b929],
25	,	,	O	,	_	0	SENT_7	[p1l250t891r467b929],
26	”	NN	O	”	prep_of	22	SENT_7	[p1l250t891r467b929],
27	and	CC	O	and	_	0	SENT_7	[p1l480t891r541b921],
28	the	DT	O	the	det	29	SENT_7	[p1l553t891r603b921],
29	efficacy	NN	O	efficacy	prep_of	22	SENT_7	[p1l615t890r743b929],
30	of	IN	O	of	_	0	SENT_7	[p1l753t890r792b921],
31	antagonists	NNS	O	antagonist	prep_of	22	SENT_7	[p1l796t891r986b930],
32	to	TO	O	to	_	0	SENT_7	[p1l998t897r1030b921],
33	type	NN	O	type	nn	36	SENT_7	[p1l1042t897r1111b929],
34	1	CD	NUMBER	1	num	36	SENT_7	[p1l1124t893r1141b921],
35	cysteinyl	NN	O	cysteinyl	nn	36	SENT_7	[p1l1153t891r1293b929],
36	leukotriene	NN	O	leukotriene	prep_to	19	SENT_7	[p1l1304t891r1489b921],
37	receptor	NN	O	receptor	nn	40	SENT_7	[p1l91t947r230b979],
38	(	CD	NUMBER	(	num	40	SENT_7	[p1l244t943r377b981],
39	CysLT1	NN	O	cyslt1	nn	40	SENT_7	[p1l244t943r377b981],
40	)	NN	O	)	npadvmod	19	SENT_7	[p1l244t943r377b981],
41	in	IN	O	in	_	0	SENT_7	[p1l392t941r425b971],
42	asthma	NN	O	asthma	prep_in	19	SENT_7	[p1l438t941r562b971],
43	validates	VBZ	O	validate	rcmod	4	SENT_7	[p1l574t941r720b971],
44	the	DT	O	the	det	45	SENT_7	[p1l735t941r786b971],
45	importance	NN	O	importance	dobj	43	SENT_7	[p1l800t941r992b979],
46	of	IN	O	of	_	0	SENT_7	[p1l1007t940r1046b971],
47	cysteinyl	NN	O	cysteinyl	nn	48	SENT_7	[p1l1053t941r1196b979],
48	leukotrienes	NNS	O	leukotriene	prep_of	45	SENT_7	[p1l1209t941r1414b971],
49	and	CC	O	and	_	0	SENT_7	[p1l1428t941r1490b971],
50	CysLT1	NN	O	cyslt1	dobj	43	SENT_7	[p1l92t993r202b1031],
51	in	IN	O	in	_	0	SENT_7	[p1l216t991r248b1021],
52	this	DT	O	this	det	54	SENT_7	[p1l262t991r322b1021],
53	disease	NN	O	disease	nn	54	SENT_7	[p1l338t991r480b1021],
54	}	NN	O	}	prep_in	50	SENT_7	[p1l338t991r480b1021],
55	This	DT	O	this	det	56	SENT_7	[p1l492t991r564b1021],
56	article	NN	O	article	nsubj	57	SENT_7	[p1l578t991r680b1021],
57	reviews	VBZ	O	review	_	0	SENT_7	[p1l694t991r815b1021],
58	both	CC	O	both	preconj	60	SENT_7	[p1l830t991r905b1021],
59	established	JJ	O	established	amod	60	SENT_7	[p1l920t991r1103b1021],
60	understanding	NN	O	understanding	dobj	57	SENT_7	[p1l1117t991r1359b1030],
61	and	CC	O	and	_	0	SENT_7	[p1l1371t991r1431b1021],
62	recent	JJ	O	recent	amod	63	SENT_7	[p1l1445t1001r1489b1021, p1l92t1047r161b1070],
63	advances	NNS	O	advance	dobj	57	SENT_7	[p1l172t1040r321b1071],
64	in	IN	O	in	_	0	SENT_7	[p1l335t1040r367b1070],
65	our	PRP$	O	we	poss	66	SENT_7	[p1l381t1050r437b1071],
66	knowledge	NN	O	knowledge	prep_in	57	SENT_7	[p1l449t1040r630b1079],
67	about	IN	O	about	_	0	SENT_7	[p1l643t1040r738b1071],
68	leukotrienes	NNS	O	leukotriene	prep_about	66	SENT_7	[p1l749t1040r964b1071],
69	.	.	O	.	_	0	SENT_7	[p1l749t1040r964b1071],

1	I	PRP	O	I	nsubj	2	SENT_8	[p1l111t694r132b820],
2	EUKOTRIEN	VBP	O	eukotrien	_	0	SENT_8	[p1l189t699r392b721],
3	ES	NN	O	e	dobj	2	SENT_8	[p1l395t699r431b721],
4	(	CD	NUMBER	(	number	5	SENT_8	[p1l442t693r605b728],
5	“	CD	NUMBER	“	num	6	SENT_8	[p1l442t693r605b728],
6	LEUKO	NNP	O	LEUKO	dep	3	SENT_8	[p1l442t693r605b728],
7	,	,	O	,	_	0	SENT_8	[p1l442t693r605b728],
8	”	CD	NUMBER	”	appos	3	SENT_8	[p1l442t693r605b728],
9	FROM	IN	O	from	_	0	SENT_8	[p1l615t699r712b721],
10	WHITE	JJ	O	white	amod	12	SENT_8	[p1l720t699r837b721],
11	BLOOD	NN	O	blood	nn	12	SENT_8	[p1l847t699r963b721],
12	CELLS	NNS	O	cell	prep_from	8	SENT_8	[p1l972t699r1080b727],
13	;	:	O	;	_	0	SENT_8	[p1l972t699r1080b727],
14	AND	CC	O	and	_	0	SENT_8	[p1l1088t699r1165b721],
15	“	JJ	O	“	amod	16	SENT_8	[p1l1175t699r1364b728],
16	TRIENES	NN	O	triene	conj_and	3	SENT_8	[p1l1175t699r1364b728],
17	,	,	O	,	_	0	SENT_8	[p1l1175t699r1364b728],
18	”	CD	NUMBER	”	number	19	SENT_8	[p1l1175t699r1364b728],
19	THREE	CD	NUMBER	three	appos	16	SENT_8	[p1l1372t699r1489b721],

1	SYNTHESIS	NN	O	synthesis	_	0	SENT_9	[p1l457t1155r694b1179],
2	OF	IN	O	of	_	0	SENT_9	[p1l715t1155r766b1179],
3	LEUKOTRIENES	NN	O	leukotriene	prep_of	1	SENT_9	[p1l786t1155r1124b1179],

1	The	DT	O	the	det	2	SENT_10	[p1l90t1240r152b1270],
2	synthesis	NN	O	synthesis	nsubjpass	10	SENT_10	[p1l164t1240r313b1279],
3	of	IN	O	of	_	0	SENT_10	[p1l326t1239r364b1271],
4	leukotrienes	NNS	O	leukotriene	prep_of	2	SENT_10	[p1l368t1240r569b1271],
5	from	IN	O	from	_	0	SENT_10	[p1l581t1239r662b1271],
6	substrate	JJ	O	substrate	amod	8	SENT_10	[p1l674t1240r822b1271],
7	arachidonic	JJ	O	arachidonic	amod	8	SENT_10	[p1l834t1240r1025b1271],
8	acid	NN	O	acid	prep_from	4	SENT_10	[p1l1036t1240r1101b1271],
9	is	VBZ	O	be	auxpass	10	SENT_10	[p1l1113t1240r1138b1270],
10	initiated	VBN	O	initiate	_	0	SENT_10	[p1l1150t1240r1287b1270],
11	by	IN	O	by	_	0	SENT_10	[p1l1298t1240r1336b1279],
12	5lipoxygenase	NN	O	5lipoxygenase	agent	10	SENT_10	[p1l1347t1240r1489b1279, p1l91t1299r205b1328],
13	in	IN	O	in	_	0	SENT_10	[p1l216t1289r249b1319],
14	concert	NN	O	concert	prep_in	12	SENT_10	[p1l260t1296r384b1320],
15	with	IN	O	with	_	0	SENT_10	[p1l392t1289r468b1320],
16	5	CD	NUMBER	5	num	18	SENT_10	[p1l480t1289r916b1328],
17	—	NN	O	—	nn	18	SENT_10	[p1l480t1289r916b1328],
18	lipoxygenase	NN	O	lipoxygenase	nsubj	20	SENT_10	[p1l480t1289r916b1328],
19	—	CD	NUMBER	—	dep	18	SENT_10	[p1l480t1289r916b1328],
20	activating	VBG	O	activate	prepc_with	10	SENT_10	[p1l480t1289r916b1328],
21	protein	NN	O	protein	nn	24	SENT_10	[p1l925t1289r1046b1328],
22	(	CD	NUMBER	(	num	24	SENT_10	[p1l1059t1291r1185b1324],
23	FLAP	NN	O	flap	nn	24	SENT_10	[p1l1059t1291r1185b1324],
24	)	NN	O	)	dobj	20	SENT_10	[p1l1059t1291r1185b1324],
25	2	CD	NUMBER	2	number	26	SENT_10	[p1l1059t1291r1185b1324],
26	(	CD	NUMBER	(	num	27	SENT_10	[p1l1198t1289r1268b1328],
27	Fig	NN	O	fig	dep	24	SENT_10	[p1l1198t1289r1268b1328],
28	.	.	O	.	_	0	SENT_10	[p1l1198t1289r1268b1328],

1	1	CD	NUMBER	1	_	0	SENT_11	[p1l1283t1291r1320b1324],
2	)	NN	O	)	dep	1	SENT_11	[p1l1283t1291r1320b1324],
3	.	.	O	.	_	0	SENT_11	[p1l1283t1291r1320b1324],

1	Although	IN	O	although	mark	5	SENT_12	[p1l1332t1289r1490b1328],
2	FLAP	NN	O	flap	nsubj	5	SENT_12	[p1l91t1341r179b1369],
3	does	VBZ	O	do	aux	5	SENT_12	[p1l193t1339r267b1369],
4	not	RB	O	not	neg	5	SENT_12	[p1l282t1345r337b1369],
5	have	VB	O	have	advcl	10	SENT_12	[p1l349t1339r423b1370],
6	enzymatic	JJ	O	enzymatic	amod	7	SENT_12	[p1l437t1339r608b1378],
7	activity	NN	O	activity	dobj	5	SENT_12	[p1l621t1339r747b1378],
8	,	,	O	,	_	0	SENT_12	[p1l621t1339r747b1378],
9	it	PRP	O	it	nsubj	10	SENT_12	[p1l762t1339r785b1369],
10	enhances	VBZ	O	enhance	_	0	SENT_12	[p1l797t1339r953b1369],
11	the	DT	O	the	det	12	SENT_12	[p1l967t1339r1019b1369],
12	ability	NN	O	ability	nsubj	16	SENT_12	[p1l1032t1339r1137b1378],
13	of	IN	O	of	_	0	SENT_12	[p1l1150t1338r1189b1369],
14	5-lipoxygenase	NN	O	5-lipoxygenase	prep_of	12	SENT_12	[p1l1196t1339r1443b1378],
15	to	TO	O	to	aux	16	SENT_12	[p1l1457t1345r1489b1369],
16	interact	VB	O	interact	xcomp	10	SENT_12	[p1l91t1388r219b1418],
17	with	IN	O	with	_	0	SENT_12	[p1l229t1388r305b1419],
18	its	PRP$	O	its	poss	19	SENT_12	[p1l318t1388r356b1418],
19	substrate	NN	O	substrate	prep_with	16	SENT_12	[p1l371t1388r531b1419],
20	.	.	O	.	_	0	SENT_12	[p1l371t1388r531b1419],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_13	[p1l546t1388r746b1419],
2	A4	NN	O	a4	dep	7	SENT_13	[p1l758t1391r797b1429],
3	(	CD	NUMBER	(	num	5	SENT_13	[p1l812t1390r913b1429],
4	LTA4	NN	O	lta4	nn	5	SENT_13	[p1l812t1390r913b1429],
5	)	NN	O	)	dep	2	SENT_13	[p1l812t1390r913b1429],
6	is	VBZ	O	be	auxpass	7	SENT_13	[p1l928t1389r953b1418],
7	converted	VBN	O	convert	_	0	SENT_13	[p1l968t1388r1129b1419],
8	by	IN	O	by	_	0	SENT_13	[p1l1143t1388r1181b1427],
9	LTA4	NN	O	lta4	nn	10	SENT_13	[p1l1191t1390r1272b1429],
10	hydrolase	NN	O	hydrolase	agent	7	SENT_13	[p1l1284t1388r1444b1427],
11	to	TO	O	to	_	0	SENT_13	[p1l1457t1394r1489b1419],
12	leukotriene	NN	O	leukotriene	nn	13	SENT_13	[p1l91t1437r276b1468],
13	B4	NN	O	b4	prep_to	7	SENT_13	[p1l286t1440r323b1478],
14	(	CD	NUMBER	(	num	17	SENT_13	[p1l336t1439r410b1472],
15	LTB	NN	O	ltb	nn	17	SENT_13	[p1l336t1439r410b1472],
16	4	CD	NUMBER	4	num	17	SENT_13	[p1l412t1440r444b1478],
17	)	NN	O	)	nsubjpass	7	SENT_13	[p1l412t1440r444b1478],
18	,	,	O	,	_	0	SENT_13	[p1l412t1440r444b1478],
19	or	CC	O	or	_	0	SENT_13	[p1l457t1447r491b1468],
20	it	PRP	O	it	nsubjpass	23	SENT_13	[p1l501t1437r523b1467],
21	can	MD	O	can	aux	23	SENT_13	[p1l532t1447r589b1467],
22	be	VB	O	be	auxpass	23	SENT_13	[p1l600t1437r638b1468],
23	conjugated	VBN	O	conjugate	conj_or	7	SENT_13	[p1l649t1437r826b1476],
24	with	IN	O	with	_	0	SENT_13	[p1l835t1437r910b1468],
25	reduced	VBN	O	reduce	amod	26	SENT_13	[p1l921t1437r1049b1468],
26	glutathione	NN	O	glutathione	prep_with	23	SENT_13	[p1l1060t1437r1247b1476],
27	by	IN	O	by	_	0	SENT_13	[p1l1258t1437r1296b1476],
28	leukotriene	NN	O	leukotriene	nn	29	SENT_13	[p1l1304t1437r1490b1468],
29	C4	NN	O	c4	prep_by	26	SENT_13	[p1l92t1488r130b1527],
30	(	CD	NUMBER	(	num	31	SENT_13	[p1l144t1488r221b1521],
31	LTC	NN	ORGANIZATION	ltc	amod	29	SENT_13	[p1l144t1488r221b1521],
32	4	CD	NUMBER	4	num	34	SENT_13	[p1l223t1489r247b1527],
33	)	NN	O	)	nn	34	SENT_13	[p1l223t1489r247b1527],
34	synthase	NN	O	synthase	dep	31	SENT_13	[p1l262t1486r407b1525],
35	to	TO	O	to	aux	36	SENT_13	[p1l420t1492r452b1517],
36	yield	VB	O	yield	infmod	34	SENT_13	[p1l464t1486r542b1525],
37	LTC	NNP	ORGANIZATION	LTC	dobj	36	SENT_13	[p1l555t1488r620b1517],
38	4	CD	NUMBER	4	num	37	SENT_13	[p1l622t1511r645b1527],
39	.	.	O	.	_	0	SENT_13	[p1l622t1511r645b1527],

1	LTB	NN	O	ltb	nsubjpass	7	SENT_14	[p1l660t1488r724b1516],
2	4	CD	NUMBER	4	num	1	SENT_14	[p1l726t1511r740b1527],
3	and	CC	O	and	_	0	SENT_14	[p1l753t1486r814b1517],
4	LTC	NNP	ORGANIZATION	LTC	nsubjpass	7	SENT_14	[p1l826t1488r892b1517],
5	4	CD	NUMBER	4	num	4	SENT_14	[p1l894t1511r908b1527],
6	are	VBP	O	be	auxpass	7	SENT_14	[p1l920t1496r970b1516],
7	exported	VBN	O	export	dep	21	SENT_14	[p1l984t1486r1130b1525],
8	from	IN	O	from	_	0	SENT_14	[p1l1143t1486r1225b1517],
9	the	DT	O	the	det	10	SENT_14	[p1l1238t1486r1289b1516],
10	cell	NN	O	cell	prep_from	7	SENT_14	[p1l1303t1486r1359b1516],
11	by	IN	O	by	_	0	SENT_14	[p1l1372t1486r1410b1525],
12	specific	JJ	O	specific	amod	14	SENT_14	[p1l1422t1496r1489b1525, p1l92t1535r163b1565],
13	transporter	NN	O	transporter	nn	14	SENT_14	[p1l177t1541r367b1574],
14	proteins	NNS	O	protein	agent	7	SENT_14	[p1l380t1535r527b1574],
15	;	:	O	;	_	0	SENT_14	[p1l380t1535r527b1574],
16	the	DT	O	the	det	18	SENT_14	[p1l542t1535r594b1565],
17	released	VBN	O	release	amod	18	SENT_14	[p1l608t1535r744b1566],
18	LTC	NN	ORGANIZATION	ltc	dep	14	SENT_14	[p1l757t1537r822b1566],
19	4	CD	NUMBER	4	amod	18	SENT_14	[p1l825t1560r838b1576],
20	is	VBZ	O	be	auxpass	21	SENT_14	[p1l852t1535r877b1565],
21	converted	VBN	O	convert	_	0	SENT_14	[p1l892t1535r1054b1566],
22	to	TO	O	to	_	0	SENT_14	[p1l1068t1541r1100b1566],
23	leukotriene	NN	O	leukotriene	nn	24	SENT_14	[p1l1114t1535r1302b1566],
24	D4	NN	O	d4	prep_to	21	SENT_14	[p1l1316t1538r1357b1576],
25	(	CD	NUMBER	(	num	27	SENT_14	[p1l1373t1537r1488b1576],
26	LTD4	NN	O	ltd4	nn	27	SENT_14	[p1l1373t1537r1488b1576],
27	)	NN	O	)	tmod	21	SENT_14	[p1l1373t1537r1488b1576],
28	,	,	O	,	_	0	SENT_14	[p1l1373t1537r1488b1576],
29	which	WDT	O	which	nsubj	30	SENT_14	[p1l90t1584r192b1615],
30	undergoes	VBZ	O	undergo	rcmod	27	SENT_14	[p1l206t1584r379b1623],
31	conversion	NN	O	conversion	dobj	30	SENT_14	[p1l394t1584r573b1615],
32	to	TO	O	to	_	0	SENT_14	[p1l587t1591r619b1615],
33	leukotriene	NN	O	leukotriene	nn	36	SENT_14	[p1l633t1584r822b1615],
34	E4	NN	O	e4	nn	36	SENT_14	[p1l835t1587r872b1625],
35	(	NN	O	(	nn	36	SENT_14	[p1l887t1586r961b1619],
36	LTE	NN	O	lte	prep_to	30	SENT_14	[p1l887t1586r961b1619],
37	4	CD	NUMBER	4	num	38	SENT_14	[p1l963t1587r987b1625],
38	)	NN	O	)	nsubjpass	21	SENT_14	[p1l963t1587r987b1625],
39	by	IN	O	by	_	0	SENT_14	[p1l1003t1584r1041b1623],
40	sequential	JJ	O	sequential	amod	43	SENT_14	[p1l1054t1584r1225b1623],
41	amino	NN	O	amino	nn	43	SENT_14	[p1l1238t1584r1345b1615],
42	acid	NN	O	acid	nn	43	SENT_14	[p1l1359t1584r1426b1615],
43	hydrolysis	NN	O	hydrolysis	agent	21	SENT_14	[p1l1440t1584r1489b1623, p1l92t1633r229b1672],
44	.	.	O	.	_	0	SENT_14	[p1l1440t1584r1489b1623, p1l92t1633r229b1672],

1	The	DT	O	the	det	2	SENT_15	[p1l242t1633r305b1663],
2	capacity	NN	O	capacity	nsubjpass	12	SENT_15	[p1l318t1633r453b1672],
3	to	TO	O	to	aux	4	SENT_15	[p1l464t1639r496b1664],
4	generate	VB	O	generate	infmod	2	SENT_15	[p1l508t1640r650b1672],
5	large	JJ	O	large	amod	7	SENT_15	[p1l662t1633r745b1672],
6	amounts	NNS	O	amount	nn	7	SENT_15	[p1l758t1639r903b1664],
7	ofleukotrienes	NNS	O	ofleukotriene	dobj	4	SENT_15	[p1l917t1633r1166b1664],
8	from	IN	O	from	_	0	SENT_15	[p1l1179t1633r1261b1664],
9	arachidonate	NN	O	arachidonate	prep_from	4	SENT_15	[p1l1273t1633r1489b1664],
10	is	VBZ	O	be	auxpass	12	SENT_15	[p1l91t1682r117b1712],
11	largely	RB	O	largely	advmod	12	SENT_15	[p1l131t1682r244b1721],
12	confined	VBN	O	confine	_	0	SENT_15	[p1l257t1682r406b1713],
13	to	TO	O	to	_	0	SENT_15	[p1l421t1688r452b1713],
14	leukocytes	NNS	O	leukocyte	prep_to	12	SENT_15	[p1l467t1682r652b1721],
15	;	:	O	;	_	0	SENT_15	[p1l467t1682r652b1721],
16	however	RB	O	however	advmod	14	SENT_15	[p1l667t1682r813b1719],
17	,	,	O	,	_	0	SENT_15	[p1l667t1682r813b1719],
18	the	DT	O	the	det	19	SENT_15	[p1l829t1682r881b1712],
19	amounts	NNS	O	amount	prep_to	12	SENT_15	[p1l895t1688r1041b1713],
20	of	IN	O	of	_	0	SENT_15	[p1l1056t1682r1095b1713],
21	LTB	NN	O	ltb	prep_of	19	SENT_15	[p1l1102t1684r1166b1712],
22	4	CD	NUMBER	4	num	21	SENT_15	[p1l1168t1707r1182b1723],
23	and	CC	O	and	_	0	SENT_15	[p1l1196t1682r1257b1713],
24	cysteinyl	NN	O	cysteinyl	nn	25	SENT_15	[p1l1272t1682r1415b1721],
25	leukotrienes	NNS	O	leukotriene	conj_and	14	SENT_15	[p1l1428t1682r1489b1713, p1l91t1731r245b1762],
26	that	WDT	O	that	dobj	31	SENT_15	[p1l262t1731r329b1761],
27	various	JJ	O	various	amod	28	SENT_15	[p1l342t1731r462b1762],
28	types	NNS	O	type	nsubj	31	SENT_15	[p1l479t1738r566b1770],
29	of	IN	O	of	_	0	SENT_15	[p1l583t1731r622b1762],
30	leukocytes	NNS	O	leukocyte	prep_of	28	SENT_15	[p1l631t1731r806b1770],
31	produce	VBP	O	produce	ccomp	12	SENT_15	[p1l822t1731r956b1770],
32	depend	VB	O	depend	dep	31	SENT_15	[p1l973t1731r1094b1770],
33	on	IN	O	on	_	0	SENT_15	[p1l1110t1741r1151b1762],
34	the	DT	O	the	det	38	SENT_15	[p1l1168t1731r1219b1761],
35	distal	JJ	O	distal	amod	38	SENT_15	[p1l1236t1731r1328b1762],
36	enzymes	NNS	O	enzyme	nn	38	SENT_15	[p1l1344t1741r1489b1770],
37	LTA4	NN	O	lta4	nn	38	SENT_15	[p1l91t1782r171b1821],
38	hydrolase	NN	O	hydrolase	prep_on	32	SENT_15	[p1l184t1780r344b1819],
39	and	CC	O	and	_	0	SENT_15	[p1l357t1780r418b1811],
40	LTC	NN	ORGANIZATION	ltc	nn	42	SENT_15	[p1l431t1782r496b1811],
41	4	CD	NUMBER	4	num	42	SENT_15	[p1l498t1805r512b1821],
42	synthase	NN	O	synthase	prep_on	32	SENT_15	[p1l526t1780r680b1819],
43	,	,	O	,	_	0	SENT_15	[p1l526t1780r680b1819],
44	respectively	RB	O	respectively	advmod	38	SENT_15	[p1l695t1780r890b1819],
45	(	CD	NUMBER	(	num	46	SENT_15	[p1l903t1780r1003b1815],
46	Table	NNP	O	Table	dep	38	SENT_15	[p1l903t1780r1003b1815],
47	1	CD	NUMBER	1	num	46	SENT_15	[p1l1018t1782r1035b1810],
48	and	CC	O	and	_	0	SENT_15	[p1l1049t1780r1110b1811],
49	Glossary	JJ	O	glossary	amod	50	SENT_15	[p1l1123t1780r1289b1819],
50	)	NN	O	)	conj_and	46	SENT_15	[p1l1123t1780r1289b1819],
51	.	.	O	.	_	0	SENT_15	[p1l1123t1780r1289b1819],

1	Although	IN	O	although	mark	7	SENT_16	[p1l140t1829r295b1868],
2	nonleukocyte	JJ	O	nonleukocyte	amod	3	SENT_16	[p1l310t1829r530b1868],
3	cells	NNS	O	cell	nsubj	7	SENT_16	[p1l544t1829r615b1859],
4	generally	RB	O	generally	advmod	7	SENT_16	[p1l631t1829r780b1868],
5	do	VBP	O	do	aux	7	SENT_16	[p1l793t1829r833b1860],
6	not	RB	O	not	neg	7	SENT_16	[p1l848t1836r903b1860],
7	have	VB	O	have	advcl	30	SENT_16	[p1l915t1829r987b1860],
8	sufficient	JJ	O	sufficient	amod	11	SENT_16	[p1l1002t1829r1159b1860],
9	5	CD	NUMBER	5	tmod	8	SENT_16	[p1l1172t1829r1414b1868],
10	—	NN	O	—	nn	11	SENT_16	[p1l1172t1829r1414b1868],
11	lipoxygenase	NN	O	lipoxygenase	dobj	7	SENT_16	[p1l1172t1829r1414b1868],
12	and	CC	O	and	_	0	SENT_16	[p1l1428t1829r1490b1860],
13	FLAP	NN	O	flap	dobj	7	SENT_16	[p1l91t1881r177b1908],
14	to	TO	O	to	aux	15	SENT_16	[p1l188t1885r219b1909],
15	synthesize	VB	O	synthesize	infmod	13	SENT_16	[p1l232t1878r399b1917],
16	appreciable	JJ	O	appreciable	amod	17	SENT_16	[p1l411t1878r592b1917],
17	amounts	NNS	O	amount	dobj	15	SENT_16	[p1l604t1885r744b1909],
18	of	IN	O	of	_	0	SENT_16	[p1l758t1878r796b1909],
19	leukotrienes	NNS	O	leukotriene	prep_of	17	SENT_16	[p1l800t1878r996b1909],
20	from	IN	O	from	_	0	SENT_16	[p1l1009t1878r1089b1909],
21	arachidonate	NN	O	arachidonate	prep_from	15	SENT_16	[p1l1100t1878r1316b1915],
22	,	,	O	,	_	0	SENT_16	[p1l1100t1878r1316b1915],
23	such	JJ	O	such	amod	24	SENT_16	[p1l1331t1878r1403b1909],
24	cells	NNS	O	cell	nsubj	30	SENT_16	[p1l1416t1878r1489b1908],
25	expressing	VBG	O	express	partmod	24	SENT_16	[p1l92t1927r263b1966],
26	distal	JJ	O	distal	amod	28	SENT_16	[p1l275t1927r363b1958],
27	LTA4-metabolizing	NN	O	lta4-metabolizing	nn	28	SENT_16	[p1l375t1927r679b1968],
28	enzymes	NNS	O	enzyme	dobj	25	SENT_16	[p1l691t1937r830b1966],
29	can	MD	O	can	aux	30	SENT_16	[p1l844t1937r900b1957],
30	take	VB	O	take	_	0	SENT_16	[p1l913t1927r980b1958],
31	up	RP	O	up	prt	30	SENT_16	[p1l993t1937r1032b1966],
32	leukocyte	NN	O	leukocyte	nn	33	SENT_16	[p1l1045t1927r1326b1966],
33	—	NN	O	—	dobj	30	SENT_16	[p1l1045t1927r1326b1966],
34	derived	VBN	O	derive	partmod	33	SENT_16	[p1l1045t1927r1326b1966],
35	LTA4	NN	O	lta4	dobj	34	SENT_16	[p1l1338t1929r1416b1968],
36	and	CC	O	and	_	0	SENT_16	[p1l1428t1927r1490b1958],
37	metabolize	VBZ	O	metabolize	conj_and	30	SENT_16	[p1l91t1976r269b2007],
38	it	PRP	O	it	dobj	37	SENT_16	[p1l284t1976r306b2006],
39	into	IN	O	into	_	0	SENT_16	[p1l319t1976r383b2007],
40	bioactive	JJ	O	bioactive	amod	41	SENT_16	[p1l399t1976r538b2007],
41	leukotrienes	NNS	O	leukotriene	prep_into	37	SENT_16	[p1l553t1976r758b2013],
42	,	,	O	,	_	0	SENT_16	[p1l553t1976r758b2013],
43	a	DT	O	a	det	44	SENT_16	[p1l775t1986r792b2006],
44	process	NN	O	process	appos	41	SENT_16	[p1l807t1986r927b2015],
45	that	WDT	O	that	nsubjpass	47	SENT_16	[p1l943t1976r1008b2006],
46	is	VBZ	O	be	auxpass	47	SENT_16	[p1l1020t1976r1045b2006],
47	termed	VBN	O	term	rcmod	44	SENT_16	[p1l1062t1976r1175b2007],
48	“	JJ	O	“	amod	50	SENT_16	[p1l1192t1976r1410b2007],
49	transcellular	JJ	O	transcellular	amod	50	SENT_16	[p1l1192t1976r1410b2007],
50	biosynthesis	NN	O	biosynthesis	dobj	47	SENT_16	[p1l1425t1976r1489b2007, p1l92t2025r278b2064],
51	.	.	O	.	_	0	SENT_16	[p1l1425t1976r1489b2007, p1l92t2025r278b2064],

1	”	NN	O	”	nsubj	53	SENT_17	[p1l1425t1976r1489b2007, p1l92t2025r278b2064],
2	3	CD	NUMBER	3	num	1	SENT_17	[p1l1425t1976r1489b2007, p1l92t2025r278b2064],
3	The	DT	O	the	det	4	SENT_17	[p1l291t2025r352b2055],
4	interaction	NN	O	interaction	nsubj	12	SENT_17	[p1l365t2025r543b2056],
5	between	IN	O	between	_	0	SENT_17	[p1l555t2025r692b2056],
6	neutrophils	NNS	O	neutrophil	prep_between	4	SENT_17	[p1l705t2025r893b2064],
7	and	CC	O	and	_	0	SENT_17	[p1l906t2025r967b2056],
8	endothelial	JJ	O	endothelial	amod	9	SENT_17	[p1l980t2025r1164b2056],
9	cells	NNS	O	cell	prep_between	4	SENT_17	[p1l1177t2025r1248b2055],
10	is	VBZ	O	be	cop	12	SENT_17	[p1l1261t2025r1286b2055],
11	an	DT	O	a	det	12	SENT_17	[p1l1300t2035r1339b2055],
12	example	NN	O	example	rcmod	1	SENT_17	[p1l1352t2025r1489b2064],
13	of	IN	O	of	_	0	SENT_17	[p1l92t2074r130b2105],
14	this	DT	O	this	det	15	SENT_17	[p1l136t2074r195b2104],
15	phenomenon	NN	O	phenomenon	prep_of	12	SENT_17	[p1l208t2074r429b2113],
16	:	:	O	:	_	0	SENT_17	[p1l208t2074r429b2113],
17	a	DT	O	a	det	18	SENT_17	[p1l443t2084r461b2104],
18	neutrophil	NN	O	neutrophil	nsubj	19	SENT_17	[p1l473t2074r641b2113],
19	(	VBD	O	(	parataxis	12	SENT_17	[p1l656t2074r715b2109],
20	the	DT	O	the	det	23	SENT_17	[p1l656t2074r715b2109],
21	donor	NN	O	donor	nn	23	SENT_17	[p1l728t2074r823b2105],
22	cell	NN	O	cell	nn	23	SENT_17	[p1l835t2074r899b2109],
23	)	NN	O	)	dobj	19	SENT_17	[p1l835t2074r899b2109],
24	containing	VBG	O	contain	xcomp	19	SENT_17	[p1l915t2075r1090b2113],
25	5	CD	NUMBER	5	num	27	SENT_17	[p1l1102t2074r1339b2113],
26	—	NN	O	—	nn	27	SENT_17	[p1l1102t2074r1339b2113],
27	lipoxygenase	NN	O	lipoxygenase	nsubj	28	SENT_17	[p1l1102t2074r1339b2113],
28	provides	VBZ	O	provide	ccomp	24	SENT_17	[p1l1351t2074r1489b2113],
29	LTA4	NN	O	lta4	dobj	28	SENT_17	[p1l91t2125r170b2164],
30	to	TO	O	to	_	0	SENT_17	[p1l186t2129r218b2154],
31	the	DT	O	the	det	34	SENT_17	[p1l235t2123r286b2153],
32	endothelial	JJ	O	endothelial	amod	34	SENT_17	[p1l303t2123r487b2154],
33	cell	NN	O	cell	nn	34	SENT_17	[p1l503t2123r559b2153],
34	(	NN	O	(	prep_to	28	SENT_17	[p1l577t2123r637b2158],
35	the	DT	O	the	det	38	SENT_17	[p1l577t2123r637b2158],
36	acceptor	NN	O	acceptor	nn	38	SENT_17	[p1l654t2130r792b2162],
37	cell	NN	O	cell	nn	38	SENT_17	[p1l808t2123r883b2160],
38	)	NN	O	)	tmod	19	SENT_17	[p1l808t2123r883b2160],
39	,	,	O	,	_	0	SENT_17	[p1l808t2123r883b2160],
40	which	WDT	O	which	nsubj	41	SENT_17	[p1l900t2123r1000b2154],
41	lacks	VBZ	O	lack	rcmod	38	SENT_17	[p1l1016t2123r1098b2154],
42	5	CD	NUMBER	5	num	44	SENT_17	[p1l1116t2123r1358b2162],
43	—	NN	O	—	nn	44	SENT_17	[p1l1116t2123r1358b2162],
44	lipoxygenase	NN	O	lipoxygenase	nsubj	46	SENT_17	[p1l1116t2123r1358b2162],
45	but	CC	O	but	_	0	SENT_17	[p1l1375t2123r1429b2154],
46	expresses	VBZ	O	express	ccomp	41	SENT_17	[p1l1444t2133r1489b2153, p1l91t2182r210b2211],
47	LTC	NNP	ORGANIZATION	LTC	nsubj	49	SENT_17	[p1l224t2174r288b2203],
48	4	CD	NUMBER	4	num	49	SENT_17	[p1l290t2197r304b2213],
49	synthase	NN	O	synthase	xcomp	46	SENT_17	[p1l318t2172r460b2211],
50	and	CC	O	and	_	0	SENT_17	[p1l474t2172r534b2203],
51	can	MD	O	can	conj_and	46	SENT_17	[p1l548t2182r605b2202],
52	thereby	RB	O	thereby	advmod	53	SENT_17	[p1l619t2172r740b2211],
53	metabolize	VBZ	O	metabolize	_	0	SENT_17	[p1l752t2172r934b2203],
54	the	DT	O	the	det	56	SENT_17	[p1l948t2172r999b2202],
55	donated	VBN	O	donate	amod	56	SENT_17	[p1l1013t2172r1144b2203],
56	LTA4	NN	O	lta4	dobj	53	SENT_17	[p1l1157t2174r1236b2213],
57	to	TO	O	to	_	0	SENT_17	[p1l1250t2178r1281b2203],
58	LTC4	NN	O	ltc4	prep_to	53	SENT_17	[p1l1295t2174r1384b2213],
59	.	.	O	.	_	0	SENT_17	[p1l1295t2174r1384b2213],

1	Products	NNPS	O	Products	nsubjpass	24	SENT_18	[p1l1399t2172r1489b2203, p1l91t2227r157b2252],
2	of	IN	O	of	_	0	SENT_18	[p1l174t2221r212b2252],
3	the	DT	O	the	det	5	SENT_18	[p1l222t2221r272b2251],
4	5-lipoxygenase	NN	O	5-lipoxygenase	nn	5	SENT_18	[p1l290t2221r532b2260],
5	pathway	NN	O	pathway	prep_of	1	SENT_18	[p1l547t2221r685b2260],
6	besides	IN	O	besides	_	0	SENT_18	[p1l700t2221r818b2252],
7	leukotrienes	NN	O	leukotriene	prep_besides	5	SENT_18	[p1l834t2221r1035b2252],
8	(	CD	NUMBER	(	number	9	SENT_18	[p1l1054t2221r1490b2260],
9	5	CD	NUMBER	5	dep	5	SENT_18	[p1l1054t2221r1490b2260],
10	—	NN	O	—	nn	12	SENT_18	[p1l1054t2221r1490b2260],
11	hydroxyeicosatetraenoic	JJ	O	hydroxyeicosatetraenoic	amod	12	SENT_18	[p1l1054t2221r1490b2260],
12	acid	NN	O	acid	dep	9	SENT_18	[p1l91t2270r165b2307],
13	,	,	O	,	_	0	SENT_18	[p1l91t2270r165b2307],
14	5-oxo	JJ	O	5-oxo	amod	15	SENT_18	[p1l182t2270r550b2301],
15	—	NN	O	—	appos	5	SENT_18	[p1l182t2270r550b2301],
16	eicosatetraenoic	JJ	O	eicosatetraenoic	amod	18	SENT_18	[p1l182t2270r550b2301],
17	acid	NN	O	acid	nn	18	SENT_18	[p1l564t2270r654b2307],
18	,4	NN	O	,4	dep	15	SENT_18	[p1l564t2270r654b2307],
19	and	CC	O	and	_	0	SENT_18	[p1l668t2270r728b2301],
20	lipoxins5	NN	O	lipoxins5	nn	21	SENT_18	[p1l742t2270r896b2309],
21	)	NN	O	)	conj_and	18	SENT_18	[p1l742t2270r896b2309],
22	are	VBP	O	be	auxpass	24	SENT_18	[p1l912t2280r962b2300],
23	not	RB	O	not	neg	24	SENT_18	[p1l976t2276r1031b2301],
24	considered	VBN	O	consider	_	0	SENT_18	[p1l1044t2270r1220b2301],
25	in	IN	O	in	_	0	SENT_18	[p1l1234t2271r1266b2300],
26	this	DT	O	this	det	27	SENT_18	[p1l1280t2270r1341b2300],
27	review	NN	O	review	prep_in	24	SENT_18	[p1l1356t2270r1470b2301],
28	.	.	O	.	_	0	SENT_18	[p1l1356t2270r1470b2301],

1	The	DT	O	the	det	2	SENT_19	[p1l140t2319r203b2349],
2	output	NN	O	output	nsubjpass	9	SENT_19	[p1l219t2325r329b2358],
3	of	IN	O	of	_	0	SENT_19	[p1l342t2319r381b2350],
4	the	DT	O	the	det	7	SENT_19	[p1l390t2319r441b2349],
5	leukotriene	NN	O	leukotriene	nn	7	SENT_19	[p1l456t2319r645b2350],
6	synthetic	JJ	O	synthetic	amod	7	SENT_19	[p1l661t2319r812b2358],
7	pathway	NN	O	pathway	prep_of	2	SENT_19	[p1l826t2319r967b2358],
8	is	VBZ	O	be	auxpass	9	SENT_19	[p1l980t2320r1006b2349],
9	regulated	VBN	O	regulate	_	0	SENT_19	[p1l1022t2319r1180b2358],
10	by	IN	O	by	_	0	SENT_19	[p1l1195t2319r1233b2358],
11	the	DT	O	the	det	12	SENT_19	[p1l1247t2319r1299b2349],
12	amount	NN	O	amount	agent	9	SENT_19	[p1l1314t2326r1444b2350],
13	of	IN	O	of	_	0	SENT_19	[p1l1458t2319r1497b2350],
14	free	JJ	O	free	amod	15	SENT_19	[p1l91t2368r154b2399],
15	arachidonate	NN	O	arachidonate	prep_of	12	SENT_19	[p1l168t2368r384b2399],
16	that	WDT	O	that	rel	82	SENT_19	[p1l398t2368r465b2399],
17	phospholipase	NN	O	phospholipase	nn	19	SENT_19	[p1l476t2368r719b2407],
18	A2	NN	O	a2	nn	19	SENT_19	[p1l731t2371r771b2409],
19	releases	NNS	O	release	dep	28	SENT_19	[p1l785t2368r915b2399],
20	from	IN	O	from	_	0	SENT_19	[p1l930t2368r1012b2399],
21	cell	NN	O	cell	nn	24	SENT_19	[p1l1026t2368r1274b2399],
22	—	NN	O	—	nn	24	SENT_19	[p1l1026t2368r1274b2399],
23	membrane	NN	O	membrane	nn	24	SENT_19	[p1l1026t2368r1274b2399],
24	phospholip	NN	O	phospholip	prep_from	19	SENT_19	[p1l1288t2368r1489b2407],
25	—	CD	NUMBER	—	num	26	SENT_19	[p1l1288t2368r1489b2407],
26	ids	NNS	O	id	dep	28	SENT_19	[p1l91t2418r183b2455],
27	,6	CD	NUMBER	,6	num	28	SENT_19	[p1l91t2418r183b2455],
28	»	NN	O	»	dep	31	SENT_19	[p1l91t2418r183b2455],
29	7	CD	NUMBER	7	dep	28	SENT_19	[p1l91t2418r183b2455],
30	the	DT	O	the	det	31	SENT_19	[p1l199t2418r250b2448],
31	level	NN	O	level	dep	49	SENT_19	[p1l265t2418r337b2449],
32	of	IN	O	of	_	0	SENT_19	[p1l353t2418r391b2449],
33	each	DT	O	each	prep_of	31	SENT_19	[p1l400t2418r473b2448],
34	of	IN	O	of	_	0	SENT_19	[p1l489t2418r528b2449],
35	the	DT	O	the	det	36	SENT_19	[p1l536t2418r587b2448],
36	proteins	NNS	O	protein	prep_of	33	SENT_19	[p1l602t2418r737b2457],
37	in	IN	O	in	_	0	SENT_19	[p1l753t2418r785b2448],
38	the	DT	O	the	det	42	SENT_19	[p1l801t2418r851b2448],
39	5	CD	NUMBER	5	num	42	SENT_19	[p1l868t2418r1110b2457],
40	—	NN	O	—	nn	42	SENT_19	[p1l868t2418r1110b2457],
41	lipoxygenase	NN	O	lipoxygenase	nn	42	SENT_19	[p1l868t2418r1110b2457],
42	pathway	NN	O	pathway	prep_in	36	SENT_19	[p1l1125t2418r1268b2457],
43	,	,	O	,	_	0	SENT_19	[p1l1125t2418r1268b2457],
44	the	DT	O	the	det	46	SENT_19	[p1l1285t2418r1336b2448],
45	catalytic	JJ	O	catalytic	amod	46	SENT_19	[p1l1352t2418r1490b2457],
46	activity	NN	O	activity	appos	36	SENT_19	[p1l91t2467r206b2506],
47	per	IN	O	per	_	0	SENT_19	[p1l214t2477r267b2506],
48	enzyme	NN	O	enzyme	prep_per	46	SENT_19	[p1l276t2477r400b2506],
49	molecule	NN	O	molecule	dep	58	SENT_19	[p1l411t2467r555b2498],
50	(	CD	NUMBER	(	num	49	SENT_19	[p1l567t2470r639b2506],
51	e.g.	FW	O	e.g.	nsubj	58	SENT_19	[p1l567t2470r639b2506],
52	,	,	O	,	_	0	SENT_19	[p1l567t2470r639b2506],
53	modulated	VBN	O	modulate	partmod	51	SENT_19	[p1l652t2467r824b2498],
54	by	IN	O	by	_	0	SENT_19	[p1l835t2467r872b2506],
55	protein	NN	O	protein	nn	57	SENT_19	[p1l880t2467r996b2506],
56	kinase	NN	O	kinase	nn	57	SENT_19	[p1l1006t2467r1264b2498],
57	—	NN	O	—	agent	53	SENT_19	[p1l1006t2467r1264b2498],
58	directed	VBD	O	direct	dep	82	SENT_19	[p1l1006t2467r1264b2498],
59	phosphoryla	NN	O	phosphorylum	nn	61	SENT_19	[p1l1273t2467r1489b2506],
60	—	NN	O	—	nn	61	SENT_19	[p1l1273t2467r1489b2506],
61	tions	NNS	O	tion	nsubj	62	SENT_19	[p1l92t2516r190b2553],
62	)	VBP	O	)	ccomp	58	SENT_19	[p1l92t2516r190b2553],
63	,	,	O	,	_	0	SENT_19	[p1l92t2516r190b2553],
64	and	CC	O	and	_	0	SENT_19	[p1l207t2516r268b2547],
65	the	DT	O	the	det	66	SENT_19	[p1l284t2516r335b2546],
66	availability	NN	O	availability	nsubj	70	SENT_19	[p1l351t2516r529b2555],
67	of	IN	O	of	_	0	SENT_19	[p1l544t2516r582b2547],
68	small	JJ	O	small	amod	69	SENT_19	[p1l591t2516r681b2546],
69	molecules	NNS	O	molecule	prep_of	66	SENT_19	[p1l696t2516r860b2547],
70	(	VBP	O	(	conj_and	58	SENT_19	[p1l878t2519r952b2555],
71	e.g.	FW	O	e.g.	dobj	70	SENT_19	[p1l878t2519r952b2555],
72	,	,	O	,	_	0	SENT_19	[p1l878t2519r952b2555],
73	ATP	NN	ORGANIZATION	atp	nsubj	82	SENT_19	[p1l968t2518r1042b2553],
74	,	,	O	,	_	0	SENT_19	[p1l968t2518r1042b2553],
75	nitric	JJ	O	nitric	amod	77	SENT_19	[p1l1060t2516r1147b2546],
76	oxide	NN	O	oxide	nn	77	SENT_19	[p1l1163t2516r1272b2553],
77	,9	NN	O	,9	nsubj	82	SENT_19	[p1l1163t2516r1272b2553],
78	and	CC	O	and	_	0	SENT_19	[p1l1288t2516r1349b2547],
79	reactive	JJ	O	reactive	amod	81	SENT_19	[p1l1365t2517r1490b2547],
80	oxygen	NN	O	oxygen	nn	81	SENT_19	[p1l92t2575r208b2604],
81	intermediates	NNS	O	intermediate	conj_and	73	SENT_19	[p1l223t2565r463b2600],
82	)	VBP	O	)	rcmod	12	SENT_19	[p1l223t2565r463b2600],
83	that	IN	O	that	complm	84	SENT_19	[p1l480t2565r548b2595],
84	modulate	VBP	O	modulate	ccomp	82	SENT_19	[p1l561t2565r718b2596],
85	5	CD	NUMBER	5	number	86	SENT_19	[p1l734t2565r981b2604],
86	—	CD	NUMBER	—	num	88	SENT_19	[p1l734t2565r981b2604],
87	lipoxygenase	NN	O	lipoxygenase	nn	88	SENT_19	[p1l734t2565r981b2604],
88	activity	NN	O	activity	dobj	84	SENT_19	[p1l996t2565r1122b2604],
89	.	.	O	.	_	0	SENT_19	[p1l996t2565r1122b2604],

1	Another	DT	O	another	det	2	SENT_20	[p1l140t2614r276b2645],
2	variable	NN	O	variable	nsubj	10	SENT_20	[p1l285t2614r412b2645],
3	that	WDT	O	that	nsubj	4	SENT_20	[p1l424t2614r490b2644],
4	influences	VBZ	O	influence	rcmod	2	SENT_20	[p1l499t2614r669b2645],
5	leukotriene	NN	O	leukotriene	nn	6	SENT_20	[p1l681t2614r866b2645],
6	synthesis	NN	O	synthesis	dobj	4	SENT_20	[p1l878t2614r1027b2653],
7	is	VBZ	O	be	cop	10	SENT_20	[p1l1039t2614r1065b2644],
8	the	DT	O	the	det	10	SENT_20	[p1l1077t2614r1128b2644],
9	intracellular	JJ	O	intracellular	amod	10	SENT_20	[p1l1140t2614r1340b2645],
10	localization	NN	O	localization	_	0	SENT_20	[p1l1350t2614r1489b2645, p1l92t2663r155b2694],
11	of	IN	O	of	_	0	SENT_20	[p1l168t2663r206b2694],
12	5	CD	NUMBER	5	number	13	SENT_20	[p1l212t2663r457b2702],
13	—	CD	NUMBER	—	num	14	SENT_20	[p1l212t2663r457b2702],
14	lipoxygenase	NN	O	lipoxygenase	prep_of	10	SENT_20	[p1l212t2663r457b2702],
15	.	.	O	.	_	0	SENT_20	[p1l212t2663r457b2702],

1	In	IN	O	in	_	0	SENT_21	[p1l471t2666r505b2693],
2	resting	VBG	O	rest	amod	3	SENT_21	[p1l518t2663r630b2702],
3	leukocytes	NNS	O	leukocyte	prep_in	8	SENT_21	[p1l641t2663r818b2702],
4	,	,	O	,	_	0	SENT_21	[p1l641t2663r818b2702],
5	this	DT	O	this	det	6	SENT_21	[p1l832t2663r892b2693],
6	enzyme	NN	O	enzyme	nsubj	8	SENT_21	[p1l906t2673r1030b2702],
7	can	MD	O	can	aux	8	SENT_21	[p1l1043t2673r1099b2693],
8	reside	VB	O	reside	_	0	SENT_21	[p1l1111t2663r1205b2694],
9	in	IN	O	in	_	0	SENT_21	[p1l1217t2663r1249b2693],
10	the	DT	O	the	det	11	SENT_21	[p1l1261t2663r1311b2693],
11	cytoplasm	NN	O	cytoplasm	prep_in	8	SENT_21	[p1l1324t2663r1490b2702],
12	or	CC	O	or	_	0	SENT_21	[p1l92t2722r126b2743],
13	the	DT	O	the	det	14	SENT_21	[p1l139t2712r191b2742],
14	nucleoplasm	NN	O	nucleoplasm	conj_or	11	SENT_21	[p1l204t2712r424b2751],
15	,	,	O	,	_	0	SENT_21	[p1l204t2712r424b2751],
16	and	CC	O	and	_	0	SENT_21	[p1l439t2712r501b2743],
17	it	PRP	O	it	nsubj	18	SENT_21	[p1l514t2712r537b2742],
18	shuttles	VBZ	O	shuttle	conj_and	8	SENT_21	[p1l549t2712r678b2743],
19	between	IN	O	between	_	0	SENT_21	[p1l693t2712r832b2743],
20	them	PRP	O	they	prep_between	18	SENT_21	[p1l845t2712r931b2742],
21	by	IN	O	by	_	0	SENT_21	[p1l945t2712r983b2751],
22	regulated	VBN	O	regulate	amod	24	SENT_21	[p1l994t2712r1152b2751],
23	nuclear	JJ	O	nuclear	amod	24	SENT_21	[p1l1166t2712r1289b2743],
24	import	NN	O	import	prep_by	18	SENT_21	[p1l1301t2713r1417b2751],
25	and	CC	O	and	advmod	24	SENT_21	[p1l1429t2712r1490b2743],

1	N	NN	O	n	nn	2	SENT_22	[p1l410t2820r424b2835],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_22	[p1l438t2820r516b2842],
3	MED	VBD	O	med	_	0	SENT_22	[p1l531t2820r583b2835],
4	{	CD	NUMBER	{	num	5	SENT_22	[p1l593t2814r667b2842],
5	]	NN	O	]	dobj	3	SENT_22	[p1l593t2814r667b2842],
6	+	CC	O	+	_	0	SENT_22	[p1l593t2814r667b2842],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	dobj	3	SENT_22	[p1l699t2820r901b2842],
8	NOVEMBER	NNP	DATE	NOVEMBER	poss	7	SENT_22	[p1l938t2820r1173b2841],
9	'	POS	O	'	_	0	SENT_22	[p1l938t2820r1173b2841],
10	I	PRP	O	I	nsubj	11	SENT_22	[p1l938t2820r1173b2841],
11	,2007	VBP	O	,2007	rcmod	5	SENT_22	[p1l938t2820r1173b2841],

1	The	DT	O	the	det	4	SENT_23	[p1l750t2877r801b2901],
2	New	NNP	O	New	nn	4	SENT_23	[p1l810t2878r872b2901],
3	England	NNP	O	England	nn	4	SENT_23	[p1l881t2877r992b2908],
4	Journal	NNP	O	Journal	_	0	SENT_23	[p1l1001t2877r1098b2901],
5	of	IN	O	of	_	0	SENT_23	[p1l1108t2877r1137b2901],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_23	[p1l1143t2877r1268b2901],

1	From	IN	O	from	_	0	SENT_24	[p1l1531t699r1596b721],
2	the	DT	O	the	det	4	SENT_24	[p1l1605t697r1646b721],
3	Division	NNP	O	Division	nn	4	SENT_24	[p1l1657t699r1760b721],
4	ofPulmonary	NNP	O	ofPulmonary	pobj	1	SENT_24	[p1l1771t697r1946b728],
5	and	CC	O	and	_	0	SENT_24	[p1l1954t697r2000b721],
6	Critical	JJ	O	critical	amod	8	SENT_24	[p1l2011t699r2065b721, p1l1530t735r1571b758],
7	Care	NN	O	care	nn	8	SENT_24	[p1l1583t736r1641b758],
8	Medicine	NN	O	medicine	conj_and	4	SENT_24	[p1l1654t735r1780b762],
9	,	,	O	,	_	0	SENT_24	[p1l1654t735r1780b762],
10	Department	NNP	O	Department	appos	8	SENT_24	[p1l1793t737r1952b765],
11	of	IN	O	of	prep	10	SENT_24	[p1l1962t734r2065b758, p1l1531t772r1564b796],
12	|	CD	NUMBER	|	num	14	SENT_24	[p1l1962t734r2065b758, p1l1531t772r1564b796],
13	nternal	JJ	O	nternal	amod	14	SENT_24	[p1l1962t734r2065b758, p1l1531t772r1564b796],
14	Medicine	NN	O	medicine	dep	11	SENT_24	[p1l1573t772r1692b800],
15	,	,	O	,	_	0	SENT_24	[p1l1573t772r1692b800],
16	UniversityofMichigan	NNP	O	UniversityofMichigan	nn	18	SENT_24	[p1l1700t772r1970b803],
17	Health	NNP	O	Health	nn	18	SENT_24	[p1l1979t772r2063b796],
18	System	NNP	O	System	appos	14	SENT_24	[p1l1530t811r1630b840],
19	,	,	O	,	_	0	SENT_24	[p1l1530t811r1630b840],
20	Ann	NNP	PERSON	Ann	nn	23	SENT_24	[p1l1649t811r1700b833],
21	Arbor	NNP	PERSON	Arbor	nn	23	SENT_24	[p1l1720t810r1795b833],
22	(	NNP	O	(	nn	23	SENT_24	[p1l1815t811r1939b841],
23	M.P.	NNP	LOCATION	M.P.	appos	14	SENT_24	[p1l1815t811r1939b841],
24	-	:	O	-	_	0	SENT_24	[p1l1815t811r1939b841],
25	(	NN	O	(	dep	14	SENT_24	[p1l1815t811r1939b841],
26	3	CD	NUMBER	3	dep	25	SENT_24	[p1l1815t811r1939b841],
27	.	.	O	.	_	0	SENT_24	[p1l1815t811r1939b841],
28	)	SYM	O	)	dep	10	SENT_24	[p1l1815t811r1939b841],

1	;	:	O	;	_	0	SENT_25	[p1l1815t811r1939b841],
2	and	CC	O	and	_	0	SENT_25	[p1l1959t810r2005b833],
3	the	DT	O	the	det	4	SENT_25	[p1l2024t810r2065b833],
4	Center	NNP	O	Center	_	0	SENT_25	[p1l1530t849r1616b871],
5	for	IN	O	for	_	0	SENT_25	[p1l1625t847r1661b871],
6	Allergy	NNP	O	Allergy	prep_for	4	SENT_25	[p1l1670t847r1761b878],
7	and	CC	O	and	_	0	SENT_25	[p1l1771t847r1817b871],
8	Inflammation	NN	O	inflammation	conj_and	4	SENT_25	[p1l1831t847r2015b875],
9	,	,	O	,	_	0	SENT_25	[p1l1831t847r2015b875],
10	Division	NNP	O	Division	nn	11	SENT_25	[p1l2029t849r2065b870, p1l1529t887r1604b908],
11	ofAllergy	NNP	O	ofAllergy	appos	8	SENT_25	[p1l1614t884r1736b916],
12	and	CC	O	and	_	0	SENT_25	[p1l1745t885r1790b908],
13	Infectious	JJ	O	infectious	amod	14	SENT_25	[p1l1803t884r1931b908],
14	Diseases	NNS	O	disease	conj_and	4	SENT_25	[p1l1942t887r2063b912],
15	,	,	O	,	_	0	SENT_25	[p1l1942t887r2063b912],
16	Department	NNP	ORGANIZATION	Department	appos	14	SENT_25	[p1l1531t924r1690b953],
17	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1706t922r1734b946],
18	Medicine	NNP	ORGANIZATION	Medicine	nn	20	SENT_25	[p1l1749t922r1874b950],
19	,	,	O	,	_	0	SENT_25	[p1l1749t922r1874b950],
20	University	NNP	ORGANIZATION	University	prep_of	16	SENT_25	[p1l1894t924r2025b953],
21	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l2041t922r2069b946],
22	Washington	NNP	ORGANIZATION	Washington	nn	26	SENT_25	[p1l1528t960r1687b991],
23	,	,	O	,	_	0	SENT_25	[p1l1528t960r1687b991],
24	Seattle	NNP	LOCATION	Seattle	appos	26	SENT_25	[p1l1698t960r1783b983],
25	(	CD	NUMBER	(	num	26	SENT_25	[p1l1795t962r1910b991],
26	W.R.H.	NNP	O	W.R.H.	prep_of	4	SENT_25	[p1l1795t962r1910b991],
27	)	CD	NUMBER	)	dep	26	SENT_25	[p1l1795t962r1910b991],
28	.	.	O	.	_	0	SENT_25	[p1l1795t962r1910b991],

1	Address	NN	O	address	nsubj	2	SENT_26	[p1l1919t960r2021b983],
2	reprint	VB	O	reprint	_	0	SENT_26	[p1l2033t968r2065b983, p1l1531t999r1590b1028],
3	requests	NNS	O	request	dobj	2	SENT_26	[p1l1600t1002r1708b1028],
4	to	TO	O	to	_	0	SENT_26	[p1l1717t1002r1742b1021],
5	Dr.	NNP	O	Dr.	nn	6	SENT_26	[p1l1754t999r1788b1021],
6	Peters	NNP	PERSON	Peters	prep_to	2	SENT_26	[p1l1801t997r1982b1021],
7	.	.	O	.	_	0	SENT_26	[p1l1801t997r1982b1021],

1	—	NN	O	—	_	0	SENT_27	[p1l1801t997r1982b1021],
2	.	.	O	.	_	0	SENT_27	[p1l1801t997r1982b1021],

1	Go	VB	O	go	_	0	SENT_28	[p1l1801t997r1982b1021],
2	|	NN	O	|	nn	3	SENT_28	[p1l1801t997r1982b1021],
3	den	NN	O	den	dobj	1	SENT_28	[p1l1801t997r1982b1021],
4	at	IN	O	at	_	0	SENT_28	[p1l1993t1002r2016b1021],
5	the	DT	O	the	det	6	SENT_28	[p1l2024t997r2065b1021],
6	Division	NN	O	division	prep_at	1	SENT_28	[p1l1531t1036r1635b1058],
7	of	IN	O	of	_	0	SENT_28	[p1l1649t1034r1677b1058],
8	Pulmonary	JJ	O	pulmonary	amod	11	SENT_28	[p1l1688t1034r1829b1065],
9	and	CC	O	and	_	0	SENT_28	[p1l1842t1034r1887b1058],
10	Critical	JJ	O	critical	amod	11	SENT_28	[p1l1902t1034r1992b1058],
11	Care	NN	O	care	prep_of	6	SENT_28	[p1l2007t1036r2065b1058],
12	Medicine	NN	O	medicine	rcmod	11	SENT_28	[p1l1531t1072r1657b1099],
13	,	,	O	,	_	0	SENT_28	[p1l1531t1072r1657b1099],
14	Department	NNP	O	Department	nn	16	SENT_28	[p1l1672t1074r1830b1102],
15	oflnternal	JJ	O	oflnternal	amod	16	SENT_28	[p1l1842t1071r1976b1095],
16	Medicine	NN	O	medicine	appos	12	SENT_28	[p1l1992t1072r2065b1095, p1l1529t1111r1589b1137],
17	,	,	O	,	_	0	SENT_28	[p1l1992t1072r2065b1095, p1l1529t1111r1589b1137],
18	University	NNP	ORGANIZATION	University	appos	12	SENT_28	[p1l1604t1111r1734b1140],
19	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1746t1109r1774b1133],
20	Michigan	NNP	ORGANIZATION	Michigan	nn	22	SENT_28	[p1l1783t1109r1901b1140],
21	Health	NNP	ORGANIZATION	Health	nn	22	SENT_28	[p1l1917t1109r2001b1133],
22	System	NNP	ORGANIZATION	System	prep_of	18	SENT_28	[p1l2015t1111r2065b1140, p1l1528t1151r1585b1174],
23	,	,	O	,	_	0	SENT_28	[p1l2015t1111r2065b1140, p1l1528t1151r1585b1174],
24	6301	CD	NUMBER	6301	num	26	SENT_28	[p1l1595t1148r1652b1170],
25	MSRB	NNP	O	MSRB	nn	26	SENT_28	[p1l1664t1148r1739b1170],
26	III	NNP	O	III	appos	12	SENT_28	[p1l1750t1148r1780b1174],
27	,	,	O	,	_	0	SENT_28	[p1l1750t1148r1780b1174],
28	1150	CD	DATE	1150	appos	12	SENT_28	[p1l1791t1148r1849b1170],
29	W.	NNP	ORGANIZATION	W.	nn	32	SENT_28	[p1l1856t1148r1887b1170],
30	Medical	NNP	ORGANIZATION	Medical	nn	32	SENT_28	[p1l1899t1146r1997b1170],
31	Center	NNP	ORGANIZATION	Center	nn	32	SENT_28	[p1l2006t1148r2065b1170, p1l1528t1189r1564b1208],
32	Dr.	NNP	ORGANIZATION	Dr.	dep	28	SENT_28	[p1l1577t1186r1620b1212],
33	,	,	O	,	_	0	SENT_28	[p1l1577t1186r1620b1212],
34	Ann	NNP	PERSON	Ann	nn	35	SENT_28	[p1l1632t1186r1683b1207],
35	Arbor	NNP	PERSON	Arbor	appos	12	SENT_28	[p1l1695t1184r1775b1212],
36	,	,	O	,	_	0	SENT_28	[p1l1695t1184r1775b1212],
37	MI	NNP	LOCATION	MI	appos	12	SENT_28	[p1l1790t1186r1820b1207],
38	48109-5642	CD	NUMBER	48109-5642	num	37	SENT_28	[p1l1834t1186r1992b1212],
39	,	,	O	,	_	0	SENT_28	[p1l1834t1186r1992b1212],
40	or	CC	O	or	_	0	SENT_28	[p1l2005t1192r2031b1208],
41	at	IN	O	at	_	0	SENT_28	[p1l2042t1189r2065b1208],
42	petersm@umich.edu	NN	O	petersm@umich.edu	conj_or	6	SENT_28	[p1l1531t1221r1816b1252],
43	.	.	O	.	_	0	SENT_28	[p1l1531t1221r1816b1252],

1	N	NN	MISC	n	nn	3	SENT_29	[p1l1531t1298r1549b1319],
2	Englj	NNP	MISC	Englj	nn	3	SENT_29	[p1l1562t1296r1630b1327],
3	Med	NNP	O	Med	_	0	SENT_29	[p1l1644t1296r1699b1319],
4	2007	CD	DATE	2007	num	3	SENT_29	[p1l1709t1297r1941b1323],
5	;	:	O	;	_	0	SENT_29	[p1l1709t1297r1941b1323],
6	357:1841	CD	NUMBER	357:1841	number	7	SENT_29	[p1l1709t1297r1941b1323],
7	-54	CD	NUMBER	-54	dep	3	SENT_29	[p1l1709t1297r1941b1323],
8	.	.	O	.	_	0	SENT_29	[p1l1709t1297r1941b1323],

1	Copyright	NN	O	copyright	_	0	SENT_30	[p1l1530t1337r1623b1362],
2	©	CD	NUMBER	©	num	6	SENT_30	[p1l1632t1339r1653b1360],
3	2007	CD	DATE	2007	num	6	SENT_30	[p1l1663t1338r1714b1356],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_30	[p1l1721t1337r1861b1356],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_30	[p1l1870t1337r1947b1356],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_30	[p1l1955t1338r2027b1362],
7	.	.	O	.	_	0	SENT_30	[p1l1955t1338r2027b1362],

1	Downloaded	VBN	O	download	_	0	SENT_31	[p1l192t2918r362b2941],
2	from	IN	O	from	_	0	SENT_31	[p1l371t2918r435b2941],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_31	[p1l444t2918r562b2948],
4	at	IN	O	at	_	0	SENT_31	[p1l572t2922r595b2941],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_31	[p1l604t2918r787b2941],
6	on	IN	O	on	_	0	SENT_31	[p1l796t2925r828b2941],
7	January	NNP	DATE	January	prep_on	1	SENT_31	[p1l837t2918r940b2948],
8	5	CD	DATE	5	num	7	SENT_31	[p1l950t2918r972b2946],
9	,	,	DATE	,	_	0	SENT_31	[p1l950t2918r972b2946],
10	2014	CD	DATE	2014	num	7	SENT_31	[p1l983t2918r1055b2941],
11	.	.	O	.	_	0	SENT_31	[p1l983t2918r1055b2941],

1	For	IN	O	for	_	0	SENT_32	[p1l1066t2918r1112b2941],
2	personal	JJ	O	personal	amod	3	SENT_32	[p1l1120t2918r1233b2948],
3	use	NN	O	use	pobj	1	SENT_32	[p1l1242t2925r1285b2941],
4	only	RB	O	only	advmod	3	SENT_32	[p1l1295t2918r1360b2948],
5	.	.	O	.	_	0	SENT_32	[p1l1295t2918r1360b2948],

1	No	DT	O	no	det	3	SENT_33	[p1l1371t2918r1410b2941],
2	other	JJ	O	other	amod	3	SENT_33	[p1l1420t2918r1488b2941],
3	uses	NNS	O	use	_	0	SENT_33	[p1l1497t2925r1553b2941],
4	without	IN	O	without	_	0	SENT_33	[p1l1563t2918r1664b2941],
5	permission	NN	O	permission	prep_without	3	SENT_33	[p1l1672t2918r1825b2948],
6	.	.	O	.	_	0	SENT_33	[p1l1672t2918r1825b2948],

1	Copyright	NN	O	copyright	_	0	SENT_34	[p1l542t2959r677b2990],
2	©	CD	NUMBER	©	num	6	SENT_34	[p1l686t2959r709b2983],
3	2007	CD	DATE	2007	num	6	SENT_34	[p1l720t2959r784b2983],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_34	[p1l794t2959r985b2983],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_34	[p1l995t2959r1103b2983],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_34	[p1l1114t2959r1218b2990],
7	.	.	O	.	_	0	SENT_34	[p1l1114t2959r1218b2990],

1	All	DT	O	all	det	2	SENT_35	[p1l1230t2959r1271b2983],
2	rights	NNS	O	rights	nsubj	3	SENT_35	[p1l1280t2959r1355b2990],
3	reserved	VBN	O	reserve	_	0	SENT_35	[p1l1364t2959r1483b2983],
4	.	.	O	.	_	0	SENT_35	[p1l1364t2959r1483b2983],

1	The	DT	O	the	det	4	SENT_36	[p1l672t3065r717b3086],
2	NEW	NNP	O	NEW	nn	4	SENT_36	[p1l736t3067r821b3086],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_36	[p1l840t3067r1029b3086],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_36	[p1l1048t3067r1228b3093],
5	of	IN	O	of	_	0	SENT_36	[p1l1247t3065r1276b3092],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_36	[p1l1288t3067r1487b3086],

1	export	NN	O	export	nn	2	SENT_37	[p1l10t3305r280b3388],
2	processes	NNS	O	process	_	0	SENT_37	[p1l318t3314r740b3388],
3	.	.	O	.	_	0	SENT_37	[p1l318t3314r740b3388],

1	When	WRB	O	when	advmod	6	SENT_38	[p1l786t3288r1036b3366],
2	5	CD	NUMBER	5	num	4	SENT_38	[p1l1081t3288r1697b3389],
3	—	NN	O	—	nn	4	SENT_38	[p1l1081t3288r1697b3389],
4	lipoxygenase	NN	O	lipoxygenase	nsubjpass	6	SENT_38	[p1l1081t3288r1697b3389],
5	is	VBZ	O	be	auxpass	6	SENT_38	[p1l1741t3289r1805b3366],
6	activated	VBN	O	activate	advcl	9	SENT_38	[p1l1851t3289r2148b3367, p1l10t3416r129b3512],
7	,	,	O	,	_	0	SENT_38	[p1l1851t3289r2148b3367, p1l10t3416r129b3512],
8	it	PRP	O	it	nsubj	9	SENT_38	[p1l166t3417r224b3494],
9	relocates	VBZ	O	relocate	_	0	SENT_38	[p1l251t3416r624b3495],
10	to	TO	O	to	_	0	SENT_38	[p1l658t3433r739b3495],
11	the	DT	O	the	det	12	SENT_38	[p1l773t3416r904b3494],
12	outer	JJ	O	outer	prep_to	9	SENT_38	[p1l937t3433r1157b3495],
13	or	CC	O	or	_	0	SENT_38	[p1l1186t3442r1275b3495],
14	inner	JJ	O	inner	amod	16	SENT_38	[p1l1302t3417r1529b3494],
15	nuclear	JJ	O	nuclear	amod	16	SENT_38	[p1l1557t3416r1871b3495],
16	membrane	NN	O	membrane	conj_or	12	SENT_38	[p1l1899t3442r2148b3494, p1l10t3545r339b3625],
17	.	.	O	.	_	0	SENT_38	[p1l1899t3442r2148b3494, p1l10t3545r339b3625],

1	”	NN	O	”	_	0	SENT_39	[p1l1899t3442r2148b3494, p1l10t3545r339b3625],

1	The	DT	O	the	det	2	SENT_40	[p1l366t3545r525b3624],
2	movement	NN	O	movement	nsubjpass	16	SENT_40	[p1l555t3562r994b3625],
3	of	IN	O	of	_	0	SENT_40	[p1l1020t3544r1119b3625],
4	5	CD	NUMBER	5	number	5	SENT_40	[p1l1133t3545r1748b3647],
5	—	CD	NUMBER	—	num	6	SENT_40	[p1l1133t3545r1748b3647],
6	lipoxygenase	NN	O	lipoxygenase	prep_of	2	SENT_40	[p1l1133t3545r1748b3647],
7	from	IN	O	from	_	0	SENT_40	[p1l1779t3544r1985b3625],
8	the	DT	O	the	det	9	SENT_40	[p1l2015t3545r2149b3624],
9	nucleoplasm	NN	O	nucleoplasm	prep_from	6	SENT_40	[p1l10t3674r535b3774],
10	to	TO	O	to	_	0	SENT_40	[p1l570t3691r651b3753],
11	the	DT	O	the	det	14	SENT_40	[p1l687t3674r816b3752],
12	inner	JJ	O	inner	amod	14	SENT_40	[p1l851t3675r1074b3752],
13	nuclear	JJ	O	nuclear	amod	14	SENT_40	[p1l1105t3674r1412b3753],
14	membrane	NN	O	membrane	prep_to	9	SENT_40	[p1l1443t3674r1893b3753],
15	is	VBZ	O	be	auxpass	16	SENT_40	[p1l1927t3675r1991b3752],
16	associated	VBN	O	associate	_	0	SENT_40	[p1l2028t3700r2148b3752, p2l11t22r365b102],

1	with	IN	O	with	_	0	SENT_41	[p2l400t22r597b102],
2	a	DT	O	a	det	4	SENT_41	[p2l636t48r681b101],
3	maximal	JJ	O	maximal	amod	4	SENT_41	[p2l719t22r1105b101],
4	synthesis	NN	O	synthesis	pobj	1	SENT_41	[p2l1146t22r1543b123],
5	of	IN	O	of	_	0	SENT_41	[p2l1585t21r1686b102],
6	LTB	NN	O	ltb	prep_of	4	SENT_41	[p2l1705t29r1872b101],
7	4.11	CD	NUMBER	4.11	num	6	SENT_41	[p2l1878t27r2016b128],

1	Heritable	JJ	O	heritable	amod	2	SENT_42	[p2l139t150r521b229],
2	deﬁciencies	NNS	O	deﬁciencies	nsubj	11	SENT_42	[p2l558t149r1041b229],
3	of	IN	O	of	_	0	SENT_42	[p2l1081t149r1179b229],
4	enzymes	NNS	O	enzyme	prep_of	2	SENT_42	[p2l1198t176r1560b250],
5	in	IN	O	in	_	0	SENT_42	[p2l1599t151r1681b228],
6	the	DT	O	the	det	9	SENT_42	[p2l1718t150r1847b228],
7	leukotriene	NN	O	leukotriene	nn	9	SENT_42	[p2l1883t150r2148b230, p2l10t280r258b357],
8	synthetic	JJ	O	synthetic	amod	9	SENT_42	[p2l296t279r688b379],
9	pathway	NN	O	pathway	prep_in	4	SENT_42	[p2l722t279r1086b379],
10	are	VBP	O	be	cop	11	SENT_42	[p2l1117t305r1247b357],
11	rare	JJ	O	rare	dep	53	SENT_42	[p2l1283t284r1555b375],
12	,	,	O	,	_	0	SENT_42	[p2l1283t284r1555b375],
13	”	JJ	O	”	acomp	11	SENT_42	[p2l1283t284r1555b375],
14	but	CC	O	but	_	0	SENT_42	[p2l1592t279r1733b358],
15	there	EX	O	there	expl	16	SENT_42	[p2l1764t279r1983b357],
16	are	VBP	O	be	dep	53	SENT_42	[p2l2019t305r2149b357],
17	allelic	JJ	O	allelic	amod	18	SENT_42	[p2l9t408r252b487],
18	Variants	NNS	O	variant	nsubj	16	SENT_42	[p2l277t409r608b488],
19	of	IN	O	of	_	0	SENT_42	[p2l641t407r740b488],
20	the	DT	O	the	det	24	SENT_42	[p2l752t408r881b487],
21	coding	NN	O	coding	nn	24	SENT_42	[p2l913t408r1201b510],
22	and	CC	O	and	_	0	SENT_42	[p2l1228t408r1383b488],
23	promoter	NN	O	promoter	nn	24	SENT_42	[p2l1411t425r1804b509],
24	regions	NNS	O	region	prep_of	18	SENT_42	[p2l1832t409r2147b510],
25	of	IN	O	of	_	0	SENT_42	[p2l11t536r111b617],
26	the	DT	O	the	det	27	SENT_42	[p2l140t537r274b616],
27	genes	NNS	O	gene	prep_of	24	SENT_42	[p2l321t563r564b639],
28	for	IN	O	for	_	0	SENT_42	[p2l613t536r738b617],
29	5	CD	NUMBER	5	number	30	SENT_42	[p2l784t537r1529b639],
30	—	CD	NUMBER	—	num	31	SENT_42	[p2l784t537r1529b639],
31	lipoxygenase	NN	O	lipoxygenase	prep_for	16	SENT_42	[p2l784t537r1529b639],
32	,13	CD	NUMBER	,13	num	33	SENT_42	[p2l784t537r1529b639],
33	FLAP	NN	O	flap	dep	31	SENT_42	[p2l1576t542r1897b634],
34	,	,	O	,	_	0	SENT_42	[p2l1576t542r1897b634],
35	“	CD	NUMBER	“	num	37	SENT_42	[p2l1576t542r1897b634],
36	LTA4	NN	O	lta4	nn	37	SENT_42	[p2l1942t544r2150b644],
37	hydrolase	NN	O	hydrolase	prep_for	16	SENT_42	[p2l10t666r524b767],
38	,15	CD	NUMBER	,15	dep	37	SENT_42	[p2l10t666r524b767],
39	and	CC	O	and	_	0	SENT_42	[p2l568t666r727b746],
40	LT	JJ	O	lt	amod	42	SENT_42	[p2l768t672r877b744],
41	C4	NN	O	c4	nn	42	SENT_42	[p2l880t672r979b773],
42	synthase	NN	O	synthase	prep_for	16	SENT_42	[p2l1022t666r1499b767],
43	.16	CD	NUMBER	.16	dep	42	SENT_42	[p2l1022t666r1499b767],
44	Moreover	RB	O	moreover	advmod	16	SENT_42	[p2l1539t674r1967b763],
45	,	,	O	,	_	0	SENT_42	[p2l1539t674r1967b763],
46	the	DT	O	the	det	47	SENT_42	[p2l2015t666r2149b745],
47	transcription	NN	O	transcription	nsubj	16	SENT_42	[p2l10t796r577b896],
48	of	IN	O	of	_	0	SENT_42	[p2l616t794r717b875],
49	these	DT	O	these	det	50	SENT_42	[p2l737t795r962b874],
50	genes	NNS	O	gene	prep_of	47	SENT_42	[p2l999t821r1243b897],
51	can	MD	O	can	aux	53	SENT_42	[p2l1283t821r1434b874],
52	be	VB	O	be	auxpass	53	SENT_42	[p2l1472t795r1569b875],
53	regulated	VBN	O	regulate	_	0	SENT_42	[p2l1607t795r2017b897],
54	by	IN	O	by	_	0	SENT_42	[p2l2055t795r2154b896],
55	cytol	NN	O	cytol	agent	53	SENT_42	[p2l10t924r626b1025],
56	<	JJR	O	<	amod	55	SENT_42	[p2l10t924r626b1025],
57	ines	CD	NUMBER	ines	number	58	SENT_42	[p2l10t924r626b1025],
58	,17	CD	NUMBER	,17	num	59	SENT_42	[p2l10t924r626b1025],
59	’18	CD	NUMBER	’18	nsubjpass	53	SENT_42	[p2l10t924r626b1025],
60	transforming	VBG	O	transform	partmod	59	SENT_42	[p2l693t923r1291b1026],
61	growth	NN	O	growth	nn	63	SENT_42	[p2l1353t924r1676b1026],
62	factor	NN	O	factor	nn	63	SENT_42	[p2l1742t923r2000b1004],
63	B	NN	O	b	dobj	60	SENT_42	[p2l2058t928r2143b1025],
64	,	,	O	,	_	0	SENT_42	[p2l2058t928r2143b1025],
65	leptin	NN	O	leptin	conj_and	63	SENT_42	[p2l8t1053r283b1154],
66	,	,	O	,	_	0	SENT_42	[p2l8t1053r283b1154],
67	endothelin	NN	O	endothelin	conj_and	63	SENT_42	[p2l329t1053r820b1149],
68	,	,	O	,	_	0	SENT_42	[p2l329t1053r820b1149],
69	Vitamin	NN	O	vitamin	nn	70	SENT_42	[p2l861t1054r1199b1133],
70	D3	NN	O	d3	conj_and	63	SENT_42	[p2l1237t1059r1370b1161],
71	,	,	O	,	_	0	SENT_42	[p2l1237t1059r1370b1161],
72	endotoxin	NN	O	endotoxin	conj_and	63	SENT_42	[p2l1416t1053r1950b1149],
73	,19	CD	NUMBER	,19	num	72	SENT_42	[p2l1416t1053r1950b1149],
74	and	CC	O	and	_	0	SENT_42	[p2l1990t1053r2149b1132],
75	corticosteroids	NNS	O	corticosteroid	conj_and	63	SENT_42	[p2l10t1182r678b1262],
76	.	.	O	.	_	0	SENT_42	[p2l10t1182r678b1262],

1	Expression	NN	O	expression	nsubjpass	12	SENT_43	[p2l717t1183r1191b1283],
2	of	IN	O	of	_	0	SENT_43	[p2l1226t1181r1326b1262],
3	LTC4	NN	O	ltc4	nn	4	SENT_43	[p2l1341t1188r1552b1289],
4	synthase	NN	O	synthase	prep_of	1	SENT_43	[p2l1588t1182r1988b1283],
5	,	,	O	,	_	0	SENT_43	[p2l1588t1182r1988b1283],
6	for	IN	O	for	_	0	SENT_43	[p2l2028t1181r2152b1262],
7	example	NN	O	example	prep_for	1	SENT_43	[p2l10t1311r400b1411],
8	,	,	O	,	_	0	SENT_43	[p2l10t1311r400b1411],
9	is	VBZ	O	be	auxpass	12	SENT_43	[p2l444t1312r512b1389],
10	up	RB	O	up	advmod	12	SENT_43	[p2l553t1311r1119b1412],
11	—	RB	O	—	advmod	12	SENT_43	[p2l553t1311r1119b1412],
12	regulated	VBN	O	regulate	_	0	SENT_43	[p2l553t1311r1119b1412],
13	by	IN	O	by	_	0	SENT_43	[p2l1159t1311r1258b1411],
14	interleul	NN	O	interleul	agent	12	SENT_43	[p2l1292t1311r1949b1390],
15	<	JJR	O	<	amod	14	SENT_43	[p2l1292t1311r1949b1390],
16	in	IN	O	in	_	0	SENT_43	[p2l1292t1311r1949b1390],
17	—	CD	NUMBER	—	num	18	SENT_43	[p2l1292t1311r1949b1390],
18	418	CD	NUMBER	418	prep_in	15	SENT_43	[p2l1292t1311r1949b1390],
19	and	CC	O	and	_	0	SENT_43	[p2l1988t1311r2149b1390],
20	down	RB	O	down	advmod	12	SENT_43	[p2l10t1439r696b1540],
21	—	RB	O	—	advmod	22	SENT_43	[p2l10t1439r696b1540],
22	regulated	VBN	O	regulate	conj_and	12	SENT_43	[p2l10t1439r696b1540],
23	by	IN	O	by	_	0	SENT_43	[p2l736t1439r834b1539],
24	endotoxin	NN	O	endotoxin	prep_by	22	SENT_43	[p2l870t1439r1404b1518],
25	.19	CD	NUMBER	.19	num	24	SENT_43	[p2l870t1439r1404b1518],

1	LEUKOTRIENE	NN	O	leukotriene	nn	2	SENT_44	[p2l318t1736r1134b1797],
2	RECEPTORS	NNS	O	receptor	_	0	SENT_44	[p2l1189t1736r1841b1796],

1	Leukotrienes	NNPS	O	Leukotrienes	nsubj	2	SENT_45	[p2l8t1955r569b2035],
2	act	VBP	O	act	ccomp	39	SENT_45	[p2l609t1972r735b2034],
3	by	IN	O	by	_	0	SENT_45	[p2l768t1955r866b2056],
4	binding	VBG	O	bind	prep_by	2	SENT_45	[p2l900t1955r1240b2057],
5	to	TO	O	to	_	0	SENT_45	[p2l1276t1972r1357b2035],
6	specific	JJ	O	specific	amod	10	SENT_45	[p2l1398t1954r1730b2056],
7	heptahe	NN	O	heptahe	nn	10	SENT_45	[p2l1768t1955r2148b2056],
8	—	NN	O	—	nn	10	SENT_45	[p2l1768t1955r2148b2056],
9	lical	JJ	O	lical	amod	10	SENT_45	[p2l8t2083r190b2161],
10	receptors	NNS	O	receptor	prep_to	4	SENT_45	[p2l224t2100r623b2183],
11	of	IN	O	of	_	0	SENT_45	[p2l661t2082r762b2162],
12	the	DT	O	the	det	14	SENT_45	[p2l778t2083r912b2161],
13	rhodopsin	NN	O	rhodopsin	nn	14	SENT_45	[p2l947t2083r1391b2183],
14	class	NN	O	class	prep_of	4	SENT_45	[p2l1426t2083r1631b2161],
15	that	WDT	O	that	nsubj	17	SENT_45	[p2l1668t2083r1842b2161],
16	are	VBP	O	be	cop	17	SENT_45	[p2l1871t2109r2001b2161],
17	located	JJ	O	located	rcmod	14	SENT_45	[p2l2035t2083r2148b2162, p2l10t2211r232b2290],
18	on	IN	O	on	_	0	SENT_45	[p2l261t2237r366b2290],
19	the	DT	O	the	det	22	SENT_45	[p2l395t2211r526b2289],
20	outer	JJ	O	outer	amod	22	SENT_45	[p2l556t2228r775b2291],
21	plasma	NN	O	plasma	nn	22	SENT_45	[p2l799t2211r1106b2311],
22	membrane	NN	O	membrane	prep_on	17	SENT_45	[p2l1132t2211r1590b2290],
23	of	IN	O	of	_	0	SENT_45	[p2l1618t2210r1718b2290],
24	structural	JJ	O	structural	amod	28	SENT_45	[p2l1729t2211r2150b2291],
25	and	CC	O	and	_	0	SENT_45	[p2l10t2340r170b2420],
26	inflammatory	JJ	O	inflammatory	conj_and	24	SENT_45	[p2l203t2339r831b2441],
27	cells	NNS	O	cell	nn	28	SENT_45	[p2l860t2340r1261b2420],
28	.2	NN	NUMBER	.2	prep_of	22	SENT_45	[p2l860t2340r1261b2420],
29	°	CD	NUMBER	°	num	30	SENT_45	[p2l860t2340r1261b2420],
30	v21	NN	O	v21	npadvmod	31	SENT_45	[p2l860t2340r1261b2420],
31	Once	RB	DATE	once	advmod	32	SENT_45	[p2l1294t2346r1516b2420],
32	ligated	VBN	O	ligate	partmod	22	SENT_45	[p2l1549t2340r1850b2442],
33	by	IN	O	by	_	0	SENT_45	[p2l1884t2340r1983b2441],
34	the	DT	O	the	det	35	SENT_45	[p2l2013t2340r2149b2419],
35	leukotriene	NN	O	leukotriene	agent	32	SENT_45	[p2l11t2469r524b2565],
36	,	,	O	,	_	0	SENT_45	[p2l11t2469r524b2565],
37	these	DT	O	these	det	38	SENT_45	[p2l567t2469r792b2547],
38	receptors	NNS	O	receptor	nsubj	39	SENT_45	[p2l829t2486r1228b2569],
39	interact	VBP	O	interact	_	0	SENT_45	[p2l1266t2470r1598b2547],
40	with	IN	O	with	_	0	SENT_45	[p2l1626t2469r1822b2549],
41	G	NN	O	g	nn	42	SENT_45	[p2l1860t2475r1930b2548],
42	proteins	NNS	O	protein	prep_with	39	SENT_45	[p2l1967t2495r2147b2569, p2l12t2599r218b2676],
43	in	IN	O	in	_	0	SENT_45	[p2l248t2599r332b2676],
44	the	DT	O	the	det	45	SENT_45	[p2l361t2598r494b2677],
45	cytoplasm	NN	O	cytoplasm	prep_in	42	SENT_45	[p2l524t2598r990b2698],
46	,	,	O	,	_	0	SENT_45	[p2l524t2598r990b2698],
47	thereby	RB	O	thereby	advmod	42	SENT_45	[p2l1024t2598r1346b2698],
48	eliciting	VBG	O	elicit	amod	49	SENT_45	[p2l1370t2598r1724b2699],
49	increases	NNS	O	increase	dep	42	SENT_45	[p2l1748t2599r2146b2676],
50	in	IN	O	in	_	0	SENT_45	[p2l11t2728r95b2805],
51	intracellular	JJ	O	intracellular	amod	52	SENT_45	[p2l137t2727r670b2806],
52	calcium	NN	O	calcium	prep_in	49	SENT_45	[p2l709t2727r1047b2806],
53	and	CC	O	and	_	0	SENT_45	[p2l1088t2727r1247b2806],
54	reductions	NNS	O	reduction	conj_and	52	SENT_45	[p2l1288t2727r1743b2806],
55	in	IN	O	in	_	0	SENT_45	[p2l1785t2728r1870b2805],
56	intracellular	JJ	O	intracellular	amod	58	SENT_45	[p2l1910t2728r2147b2805, p2l12t2855r336b2934],
57	cyclic	JJ	O	cyclic	amod	58	SENT_45	[p2l370t2855r605b2955],
58	AMP	NN	O	amp	prep_in	49	SENT_45	[p2l638t2861r863b2934],
59	.	.	O	.	_	0	SENT_45	[p2l638t2861r863b2934],

1	These	DT	O	these	det	3	SENT_46	[p2l902t2855r1156b2934],
2	proximal	JJ	O	proximal	amod	3	SENT_46	[p2l1191t2855r1585b2955],
3	signals	NNS	O	signal	nsubj	4	SENT_46	[p2l1622t2855r1924b2956],
4	activate	VBP	O	activate	_	0	SENT_46	[p2l1962t2856r2147b2933, p2l7t3000r177b3062],
5	downstream	JJ	O	downstream	amod	7	SENT_46	[p2l230t2983r773b3063],
6	kinase	NN	O	kinase	nn	7	SENT_46	[p2l825t2983r1107b3063],
7	cascades	NNS	O	cascade	dobj	4	SENT_46	[p2l1160t2983r1533b3062],
8	in	IN	O	in	_	0	SENT_46	[p2l1587t2984r1670b3061],
9	ways	NNS	O	way	prep_in	4	SENT_46	[p2l1718t3009r1925b3083],
10	that	WDT	O	that	nsubj	11	SENT_46	[p2l1980t2983r2153b3061],
11	alter	VBP	O	alter	rcmod	9	SENT_46	[p2l11t3112r206b3191],
12	Various	JJ	O	various	amod	14	SENT_46	[p2l228t3113r541b3192],
13	cellular	JJ	O	cellular	amod	14	SENT_46	[p2l573t3112r897b3192],
14	activities	NNS	O	activity	dobj	11	SENT_46	[p2l923t3113r1328b3209],
15	,	,	O	,	_	0	SENT_46	[p2l923t3113r1328b3209],
16	ranging	VBG	O	range	partmod	11	SENT_46	[p2l1363t3113r1707b3214],
17	from	IN	O	from	_	0	SENT_46	[p2l1733t3111r1945b3192],
18	motility	NN	O	motility	prep_from	16	SENT_46	[p2l1975t3138r2147b3192, p2l12t3241r216b3341],
19	to	TO	O	to	_	0	SENT_46	[p2l263t3258r345b3320],
20	transcriptional	JJ	O	transcriptional	amod	21	SENT_46	[p2l398t3241r1045b3341],
21	activation	NN	O	activation	prep_to	16	SENT_46	[p2l1095t3242r1538b3320],
22	.	.	O	.	_	0	SENT_46	[p2l1095t3242r1538b3320],

1	Table	NNP	O	Table	nsubj	3	SENT_47	[p2l1591t3241r1822b3320],
2	1	CD	NUMBER	1	num	1	SENT_47	[p2l1876t3247r1921b3319],
3	lists	VBZ	O	list	_	0	SENT_47	[p2l1971t3241r2145b3319],
4	the	DT	O	the	det	6	SENT_47	[p2l12t3369r146b3447],
5	major	JJ	O	major	amod	6	SENT_47	[p2l185t3370r437b3469],
6	types	NNS	O	type	dobj	3	SENT_47	[p2l473t3386r698b3469],
7	of	IN	O	of	_	0	SENT_47	[p2l740t3368r841b3448],
8	cells	NNS	O	cell	prep_of	6	SENT_47	[p2l862t3369r1051b3447],
9	that	WDT	O	that	nsubj	10	SENT_47	[p2l1092t3369r1265b3447],
10	express	VBP	O	express	rcmod	8	SENT_47	[p2l1300t3395r1618b3469],
11	leukotriene	NN	O	leukotriene	nn	12	SENT_47	[p2l1658t3369r2148b3449],
12	receptors	NNS	O	receptor	dobj	10	SENT_47	[p2l12t3515r435b3598],
13	.	.	O	.	_	0	SENT_47	[p2l12t3515r435b3598],

1	Type	NN	O	type	nn	4	SENT_48	[p2l138t3633r340b3727],
2	1	CD	NUMBER	1	num	4	SENT_48	[p2l366t3633r411b3705],
3	cysteinyl	NN	O	cysteinyl	nn	4	SENT_48	[p2l435t3627r806b3727],
4	leukotriene	NN	O	leukotriene	_	0	SENT_48	[p2l827t3627r1317b3707],
5	receptor	NN	O	receptor	nn	7	SENT_48	[p2l1341t3644r1699b3728],
6	(	NN	O	(	nn	7	SENT_48	[p2l1724t3633r2148b3731],
7	CysLT1	NN	O	cyslt1	dep	4	SENT_48	[p2l1724t3633r2148b3731],
8	)	CD	NUMBER	)	number	9	SENT_48	[p2l1724t3633r2148b3731],
9	22	CD	NUMBER	22	dep	7	SENT_48	[p2l1724t3633r2148b3731],

1	mediates	VBZ	O	mediate	_	0	SENT_49	[p3l12t19r399b98],
2	sustained	JJ	O	sustained	amod	3	SENT_49	[p3l448t19r861b98],
3	bronchoconstriction	NN	O	bronchoconstriction	dobj	1	SENT_49	[p3l907t19r1815b115],
4	,	,	O	,	_	0	SENT_49	[p3l907t19r1815b115],
5	mucus	NN	O	mucus	nn	6	SENT_49	[p3l1866t45r2146b98],
6	secretion	NN	O	secretion	dobj	1	SENT_49	[p3l13t149r428b244],
7	,	,	O	,	_	0	SENT_49	[p3l13t149r428b244],
8	and	CC	O	and	_	0	SENT_49	[p3l488t148r647b227],
9	edema	NN	O	edema	dobj	1	SENT_49	[p3l703t148r985b227],
10	in	IN	O	in	_	0	SENT_49	[p3l1038t149r1122b226],
11	the	DT	O	the	det	12	SENT_49	[p3l1178t148r1311b226],
12	airways	NNS	O	airway	prep_in	9	SENT_49	[p3l1366t149r1718b248],
13	.	.	O	.	_	0	SENT_49	[p3l1366t149r1718b248],

1	Selective	JJ	O	selective	amod	2	SENT_50	[p3l1781t148r2148b228],
2	antagonists	NNS	O	antagonist	nsubj	14	SENT_50	[p3l11t278r515b379],
3	of	IN	O	of	_	0	SENT_50	[p3l562t276r663b356],
4	CysLT	NN	O	cyslt	prep_of	2	SENT_50	[p3l688t283r981b381],
5	,	,	O	,	_	0	SENT_50	[p3l688t283r981b381],
6	that	WDT	O	that	nsubjpass	8	SENT_50	[p3l1025t277r1199b355],
7	are	VBP	O	be	auxpass	8	SENT_50	[p3l1238t303r1368b356],
8	approved	VBN	O	approve	rcmod	4	SENT_50	[p3l1412t277r1804b378],
9	for	IN	O	for	_	0	SENT_50	[p3l1848t276r1972b356],
10	the	DT	O	the	det	11	SENT_50	[p3l2014t277r2148b356],
11	treatment	NN	O	treatment	prep_for	8	SENT_50	[p3l12t422r439b483],
12	of	IN	O	of	_	0	SENT_50	[p3l478t404r578b484],
13	asthma	NN	O	asthma	prep_of	11	SENT_50	[p3l603t405r925b483],
14	block	VBP	O	block	_	0	SENT_50	[p3l968t405r1204b485],
15	the	DT	O	the	det	18	SENT_50	[p3l1244t405r1377b483],
16	proasthmatic	JJ	O	proasthmatic	amod	18	SENT_50	[p3l1419t405r1999b505],
17	effects	NNS	O	effect	nn	18	SENT_50	[p3l2042t404r2147b483, p3l12t533r211b613],
18	ofCysLT1	NN	O	ofcyslt1	nsubj	20	SENT_50	[p3l247t533r653b638],
19	(	CD	NUMBER	(	num	20	SENT_50	[p3l690t535r872b636],
20	Fig	NN	O	fig	xcomp	14	SENT_50	[p3l690t535r872b636],
21	.	.	O	.	_	0	SENT_50	[p3l690t535r872b636],

1	1	CD	NUMBER	1	_	0	SENT_51	[p3l913t540r1009b625],
2	)	NN	O	)	dep	1	SENT_51	[p3l913t540r1009b625],
3	.	.	O	.	_	0	SENT_51	[p3l913t540r1009b625],

1	Experiments	NNS	O	experiment	nsubj	26	SENT_52	[p3l1046t535r1591b635],
2	in	IN	O	in	_	0	SENT_52	[p3l1625t535r1709b612],
3	mice	NNS	O	mouse	prep_in	1	SENT_52	[p3l1742t535r1947b613],
4	that	WDT	O	that	nsubj	6	SENT_52	[p3l1980t534r2153b612],
5	are	VBP	O	be	cop	6	SENT_52	[p3l12t688r141b740],
6	deficient	JJ	O	deficient	rcmod	3	SENT_52	[p3l191t661r571b741],
7	in	IN	O	in	_	0	SENT_52	[p3l614t663r698b740],
8	type	NN	O	type	nn	11	SENT_52	[p3l747t679r929b762],
9	2	CD	NUMBER	2	num	11	SENT_52	[p3l978t668r1026b740],
10	cysteinyl	NN	O	cysteinyl	nn	11	SENT_52	[p3l1077t662r1447b762],
11	leukotriene	NN	O	leukotriene	prep_in	6	SENT_52	[p3l1495t662r1984b742],
12	receptor	NN	O	receptor	nn	14	SENT_52	[p3l2033t688r2147b740, p3l12t808r285b891],
13	(	NN	O	(	nn	14	SENT_52	[p3l337t797r760b895],
14	CysLT2	NN	O	cyslt2	nsubj	25	SENT_52	[p3l337t797r760b895],
15	)	CD	NUMBER	)	num	16	SENT_52	[p3l337t797r760b895],
16	23	CD	NUMBER	23	nsubj	19	SENT_52	[p3l337t797r760b895],
17	or	CC	O	or	_	0	SENT_52	[p3l813t817r902b870],
18	that	DT	O	that	nsubj	19	SENT_52	[p3l950t791r1124b869],
19	overexpress	VBP	O	overexpress	rcmod	14	SENT_52	[p3l1169t817r1669b892],
20	CysLT	NN	O	cyslt	dobj	19	SENT_52	[p3l1722t797r2014b895],
21	,	,	O	,	_	0	SENT_52	[p3l1722t797r2014b895],
22	in	IN	O	in	_	0	SENT_52	[p3l2064t792r2148b869],
23	the	DT	O	the	det	24	SENT_52	[p3l12t920r146b998],
24	lungs	NNS	O	lung	prep_in	19	SENT_52	[p3l189t920r501b1022],
25	“	VBP	O	“	rcmod	11	SENT_52	[p3l189t920r501b1022],
26	indicate	VBP	O	indicate	_	0	SENT_52	[p3l543t920r886b999],
27	that	IN	O	that	complm	32	SENT_52	[p3l930t920r1103b998],
28	CysLT	NN	O	cyslt	nsubj	38	SENT_52	[p3l1141t926r1434b1024],
29	,	,	O	,	_	0	SENT_52	[p3l1141t926r1434b1024],
30	does	VBZ	O	do	aux	32	SENT_52	[p3l1478t920r1673b999],
31	not	RB	O	not	neg	32	SENT_52	[p3l1718t937r1861b999],
32	mediate	VB	O	mediate	ccomp	26	SENT_52	[p3l1900t920r2147b999, p3l11t1066r133b1127],
33	bronchoconstriction	NN	O	bronchoconstriction	dobj	32	SENT_52	[p3l181t1049r1066b1128],
34	but	CC	O	but	_	0	SENT_52	[p3l1113t1049r1274b1145],
35	,	,	O	,	_	0	SENT_52	[p3l1113t1049r1274b1145],
36	rather	RB	O	rather	dep	32	SENT_52	[p3l1326t1049r1606b1145],
37	,	,	O	,	_	0	SENT_52	[p3l1326t1049r1606b1145],
38	contributes	VBZ	O	contribute	ccomp	26	SENT_52	[p3l1659t1049r2146b1128],
39	to	TO	O	to	_	0	SENT_52	[p3l12t1194r94b1256],
40	inﬂammation	NN	O	inﬂammation	prep_to	38	SENT_52	[p3l134t1176r769b1273],
41	,	,	O	,	_	0	SENT_52	[p3l134t1176r769b1273],
42	vascular	JJ	O	vascular	amod	43	SENT_52	[p3l809t1177r1169b1257],
43	permeability	NN	O	permeability	prep_to	38	SENT_52	[p3l1204t1177r1769b1277],
44	,	,	O	,	_	0	SENT_52	[p3l1204t1177r1769b1277],
45	and	CC	O	and	_	0	SENT_52	[p3l1814t1177r1973b1256],
46	tissue	NN	O	tissue	nn	47	SENT_52	[p3l2012t1178r2147b1255, p3l13t1333r149b1386],
47	ﬁbrosis	NN	O	ﬁbrosis	prep_to	38	SENT_52	[p3l182t1305r525b1386],
48	.	.	O	.	_	0	SENT_52	[p3l182t1305r525b1386],

1	There	EX	O	there	expl	2	SENT_53	[p3l560t1306r802b1385],
2	are	VBP	O	be	_	0	SENT_53	[p3l835t1332r963b1385],
3	no	DT	O	no	det	6	SENT_53	[p3l995t1332r1100b1386],
4	known	JJ	O	known	amod	6	SENT_53	[p3l1134t1306r1429b1386],
5	speciﬁc	NN	O	speciﬁc	nn	6	SENT_53	[p3l1463t1305r1787b1407],
6	antagonists	NNS	O	antagonist	nsubj	2	SENT_53	[p3l1819t1323r2147b1408, p3l12t1436r211b1513],
7	of	IN	O	of	_	0	SENT_53	[p3l247t1434r346b1514],
8	CysLT	NN	O	cyslt	prep_of	6	SENT_53	[p3l361t1441r617b1535],
9	.	.	O	.	_	0	SENT_53	[p3l657t1499r672b1514],

1	Certain	JJ	O	certain	amod	3	SENT_54	[p3l710t1436r1026b1514],
2	reported	VBN	O	report	amod	3	SENT_54	[p3l1059t1435r1420b1536],
3	actions	NNS	O	action	nsubjpass	10	SENT_54	[p3l1452t1436r1752b1514],
4	of	IN	O	of	_	0	SENT_54	[p3l1788t1434r1888b1514],
5	cysteinyl	NN	O	cysteinyl	nn	6	SENT_54	[p3l1903t1452r2147b1535, p3l11t1564r161b1664],
6	leukotrienes	NNS	O	leukotriene	prep_of	3	SENT_54	[p3l189t1564r698b1644],
7	are	VBP	O	be	auxpass	10	SENT_54	[p3l729t1590r855b1642],
8	not	RB	O	not	neg	10	SENT_54	[p3l884t1581r1024b1643],
9	readily	RB	O	readily	advmod	10	SENT_54	[p3l1048t1564r1329b1664],
10	explained	VBN	O	explain	_	0	SENT_54	[p3l1356t1564r1756b1664],
11	by	IN	O	by	prep	10	SENT_54	[p3l1787t1564r1882b1664],
12	either	CC	O	either	advmod	10	SENT_54	[p3l1908t1564r2151b1642],

1	Glossary	JJ	O	glossary	_	0	SENT_55	[p3l1162t1748r1282b1781],

1	BLT	NNP	O	BLT	nsubj	13	SENT_56	[p3l399t1833r470b1861],
2	,	,	O	,	_	0	SENT_56	[p3l399t1833r470b1861],
3	:	:	O	:	_	0	SENT_56	[p3l399t1833r470b1861],
4	B	NN	O	b	nn	6	SENT_56	[p3l482t1833r497b1855],
5	leukotriene	NN	O	leukotriene	nn	6	SENT_56	[p3l509t1830r659b1856],
6	receptor	NN	O	receptor	appos	1	SENT_56	[p3l671t1835r783b1863],
7	1	CD	NUMBER	1	dep	6	SENT_56	[p3l794t1833r813b1860],
8	,	,	O	,	_	0	SENT_56	[p3l794t1833r813b1860],
9	a	DT	O	a	det	11	SENT_56	[p3l825t1839r837b1856],
10	G	NN	O	g	nn	11	SENT_56	[p3l848t1832r868b1856],
11	protein	NN	O	protein	appos	6	SENT_56	[p3l881t1830r1102b1863],
12	—	CD	NUMBER	—	dep	11	SENT_56	[p3l881t1830r1102b1863],
13	coupled	VBN	O	couple	_	0	SENT_56	[p3l881t1830r1102b1863],
14	receptor	NN	O	receptor	dobj	13	SENT_56	[p3l1115t1835r1227b1863],
15	recognizing	VBG	O	recognize	partmod	14	SENT_56	[p3l1237t1833r1396b1864],
16	leukotriene	NN	O	leukotriene	nn	17	SENT_56	[p3l1406t1830r1557b1856],
17	B4	NN	O	b4	dobj	15	SENT_56	[p3l1569t1833r1597b1863],
18	with	IN	O	with	_	0	SENT_56	[p3l1606t1830r1662b1856],
19	high	JJ	O	high	amod	20	SENT_56	[p3l1674t1830r1730b1864],
20	affinity	NN	O	affinity	prep_with	15	SENT_56	[p3l1742t1830r1840b1863],
21	.	.	O	.	_	0	SENT_56	[p3l1742t1830r1840b1863],

1	BLT2	NN	O	blt2	_	0	SENT_57	[p3l399t1890r470b1919],
2	:	:	O	:	_	0	SENT_57	[p3l399t1890r470b1919],
3	B	NN	O	b	nn	5	SENT_57	[p3l482t1890r497b1913],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_57	[p3l509t1888r659b1913],
5	receptor	NN	O	receptor	dep	1	SENT_57	[p3l671t1893r783b1921],
6	2	CD	NUMBER	2	dep	5	SENT_57	[p3l792t1890r813b1918],
7	,	,	O	,	_	0	SENT_57	[p3l792t1890r813b1918],
8	a	DT	O	a	det	13	SENT_57	[p3l825t1897r837b1913],
9	G	NN	O	g	nn	13	SENT_57	[p3l848t1890r868b1913],
10	protein	NN	O	protein	nn	13	SENT_57	[p3l881t1888r1102b1921],
11	—	CD	NUMBER	—	num	13	SENT_57	[p3l881t1888r1102b1921],
12	coupled	VBN	O	couple	amod	13	SENT_57	[p3l881t1888r1102b1921],
13	receptor	NN	O	receptor	appos	5	SENT_57	[p3l1115t1893r1227b1921],
14	recognizing	VBG	O	recognize	partmod	13	SENT_57	[p3l1237t1890r1396b1921],
15	leukotriene	NN	O	leukotriene	nn	16	SENT_57	[p3l1406t1888r1557b1913],
16	B4	NN	O	b4	dobj	14	SENT_57	[p3l1569t1890r1597b1920],
17	and	CC	O	and	_	0	SENT_57	[p3l1607t1888r1655b1913],
18	a	DT	O	a	det	22	SENT_57	[p3l1667t1897r1679b1913],
19	variety	NN	O	variety	nn	22	SENT_57	[p3l1689t1890r1778b1921],
20	ofother	NN	O	ofother	nn	22	SENT_57	[p3l1787t1888r1894b1913],
21	lipoxygenase	NN	O	lipoxygenase	nn	22	SENT_57	[p3l1904t1888r2039b1921, p3l448t1934r492b1951],
22	metabolites	NNS	O	metabolite	dobj	14	SENT_57	[p3l503t1926r661b1951],
23	ofarachidonic	JJ	O	ofarachidonic	amod	24	SENT_57	[p3l672t1925r866b1951],
24	acid	NN	O	acid	dep	22	SENT_57	[p3l876t1926r928b1951],
25	with	IN	O	with	_	0	SENT_57	[p3l939t1926r995b1951],
26	low	JJ	O	low	amod	27	SENT_57	[p3l1007t1926r1053b1951],
27	affinity	NN	O	affinity	prep_with	14	SENT_57	[p3l1062t1925r1160b1959],
28	.	.	O	.	_	0	SENT_57	[p3l1062t1925r1160b1959],

1	CysLT1	NN	O	cyslt1	_	0	SENT_58	[p3l397t1985r500b2016],
2	:	:	O	:	_	0	SENT_58	[p3l397t1985r500b2016],
3	Cysteinyl	NN	O	cysteinyl	nn	5	SENT_58	[p3l510t1983r629b2016],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_58	[p3l641t1983r792b2008],
5	receptor	NN	O	receptor	dep	1	SENT_58	[p3l803t1988r915b2016],
6	1	CD	NUMBER	1	dep	5	SENT_58	[p3l926t1986r946b2013],
7	,	,	O	,	_	0	SENT_58	[p3l926t1986r946b2013],
8	a	DT	O	a	det	13	SENT_58	[p3l957t1992r970b2008],
9	G	NN	O	g	nn	13	SENT_58	[p3l981t1985r1000b2008],
10	protein	NN	O	protein	nn	13	SENT_58	[p3l1013t1983r1234b2016],
11	—	CD	NUMBER	—	num	13	SENT_58	[p3l1013t1983r1234b2016],
12	coupled	JJ	O	coupled	amod	13	SENT_58	[p3l1013t1983r1234b2016],
13	receptor	NN	O	receptor	appos	5	SENT_58	[p3l1247t1988r1359b2016],
14	that	WDT	O	that	nsubj	15	SENT_58	[p3l1367t1983r1421b2008],
15	recognizes	VBZ	O	recognize	rcmod	13	SENT_58	[p3l1432t1986r1576b2016],
16	cysteinyl	NN	O	cysteinyl	nn	17	SENT_58	[p3l1587t1983r1700b2016],
17	leukotrienes	NNS	O	leukotriene	dobj	15	SENT_58	[p3l1713t1983r1877b2008],
18	in	IN	O	in	_	0	SENT_58	[p3l1889t1986r1911b2008],
19	a	DT	O	a	det	23	SENT_58	[p3l1922t1992r1935b2008],
20	descending	VBG	O	descend	amod	23	SENT_58	[p3l1946t1983r1986b2008, p3l448t2021r571b2054],
21	order	NN	O	order	nn	23	SENT_58	[p3l580t2021r652b2046],
22	ofaffinity	NN	O	ofaffinity	nn	23	SENT_58	[p3l662t2020r788b2054],
23	(	NN	O	(	prep_in	17	SENT_58	[p3l800t2020r868b2054],
24	first	RB	ORDINAL	first	amod	13	SENT_58	[p3l800t2020r868b2054],
25	,	,	O	,	_	0	SENT_58	[p3l800t2020r868b2054],
26	Ieukotriene	NN	O	ieukotriene	nn	27	SENT_58	[p3l881t2021r1031b2046],
27	D4	NN	O	d4	appos	13	SENT_58	[p3l1043t2023r1082b2053],
28	;	:	O	;	_	0	SENT_58	[p3l1043t2023r1082b2053],
29	second	JJ	ORDINAL	second	dep	27	SENT_58	[p3l1094t2021r1198b2050],
30	,	,	O	,	_	0	SENT_58	[p3l1094t2021r1198b2050],
31	either	CC	O	either	preconj	33	SENT_58	[p3l1209t2021r1286b2046],
32	Ieukotriene	NNP	O	Ieukotriene	nn	33	SENT_58	[p3l1297t2021r1447b2046],
33	C4	NN	O	c4	appos	13	SENT_58	[p3l1457t2023r1488b2053],
34	or	CC	O	or	_	0	SENT_58	[p3l1497t2030r1525b2046],
35	Ieukotriene	NN	O	ieukotriene	nn	37	SENT_58	[p3l1535t2021r1686b2046],
36	E4	NN	O	e4	nn	37	SENT_58	[p3l1698t2023r1743b2054],
37	)	NN	O	)	conj_or	33	SENT_58	[p3l1698t2023r1743b2054],
38	;	:	O	;	_	0	SENT_58	[p3l1698t2023r1743b2054],
39	the	DT	O	the	det	42	SENT_58	[p3l1753t2021r1796b2046],
40	target	NN	O	target	nn	42	SENT_58	[p3l1805t2026r1884b2054],
41	ofantileukotriene	NN	O	ofantileukotriene	nn	42	SENT_58	[p3l1894t2020r2030b2046, p3l449t2058r557b2083],
42	agents	NNS	O	agent	dep	13	SENT_58	[p3l568t2063r656b2091],
43	such	JJ	O	such	_	0	SENT_58	[p3l668t2058r729b2083],
44	as	IN	O	as	_	0	SENT_58	[p3l741t2067r768b2083],
45	montelukast	NN	O	montelukast	prep_such_as	42	SENT_58	[p3l780t2058r956b2088],
46	,	,	O	,	_	0	SENT_58	[p3l780t2058r956b2088],
47	zaﬁrlukast	NN	O	zaﬁrlukast	prep_such_as	42	SENT_58	[p3l967t2058r1114b2088],
48	,	,	O	,	_	0	SENT_58	[p3l967t2058r1114b2088],
49	and	CC	O	and	_	0	SENT_58	[p3l1126t2058r1174b2083],
50	pranlukast	NN	O	pranlukast	prep_such_as	42	SENT_58	[p3l1187t2058r1336b2091],
51	.	.	O	.	_	0	SENT_58	[p3l1187t2058r1336b2091],

1	CysLT2	NN	O	cyslt2	_	0	SENT_59	[p3l397t2118r500b2149],
2	:	:	O	:	_	0	SENT_59	[p3l397t2118r500b2149],
3	Cysteinyl	NN	O	cysteinyl	nn	5	SENT_59	[p3l510t2116r629b2149],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_59	[p3l641t2116r792b2141],
5	receptor	NN	O	receptor	dep	1	SENT_59	[p3l803t2121r915b2149],
6	2	CD	NUMBER	2	dep	5	SENT_59	[p3l924t2118r946b2146],
7	,	,	O	,	_	0	SENT_59	[p3l924t2118r946b2146],
8	a	DT	O	a	det	13	SENT_59	[p3l957t2125r970b2141],
9	G	NN	O	g	nn	13	SENT_59	[p3l981t2118r1000b2141],
10	protein	NN	O	protein	nn	13	SENT_59	[p3l1013t2116r1235b2149],
11	—	CD	NUMBER	—	num	13	SENT_59	[p3l1013t2116r1235b2149],
12	coupled	JJ	O	coupled	amod	13	SENT_59	[p3l1013t2116r1235b2149],
13	receptor	NN	O	receptor	appos	1	SENT_59	[p3l1247t2121r1359b2149],
14	that	WDT	O	that	nsubj	15	SENT_59	[p3l1367t2116r1421b2141],
15	recognizes	VBZ	O	recognize	rcmod	13	SENT_59	[p3l1432t2118r1576b2149],
16	cysteinyl	NN	O	cysteinyl	nn	17	SENT_59	[p3l1587t2116r1700b2149],
17	leukotrienes	NNS	O	leukotriene	dobj	15	SENT_59	[p3l1713t2116r1877b2141],
18	in	IN	O	in	_	0	SENT_59	[p3l1889t2118r1911b2141],
19	a	DT	O	a	prep_in	17	SENT_59	[p3l1922t2125r1935b2141],
20	descending	VBG	O	descend	amod	19	SENT_59	[p3l1946t2116r1986b2141, p3l448t2153r571b2187],

1	order	NN	O	order	_	0	SENT_60	[p3l580t2153r653b2179],
2	of	IN	O	of	_	0	SENT_60	[p3l662t2153r691b2179],
3	affinity	NN	O	affinity	nn	5	SENT_60	[p3l697t2153r788b2186],
4	(	CD	NUMBER	(	num	5	SENT_60	[p3l800t2153r868b2186],
5	ﬁrst	NN	O	ﬁrst	prep_of	1	SENT_60	[p3l800t2153r868b2186],
6	,	,	O	,	_	0	SENT_60	[p3l800t2153r868b2186],
7	either	CC	O	either	preconj	5	SENT_60	[p3l880t2153r957b2179],
8	Ieukotriene	NNP	O	Ieukotriene	nn	9	SENT_60	[p3l968t2153r1118b2179],
9	C4	NN	O	c4	conj	5	SENT_60	[p3l1128t2155r1159b2186],
10	or	CC	O	or	_	0	SENT_60	[p3l1168t2162r1196b2179],
11	Ieukotriene	NN	O	ieukotriene	nn	12	SENT_60	[p3l1206t2153r1357b2179],
12	D4	NN	O	d4	conj	5	SENT_60	[p3l1376t2156r1415b2186],
13	;	:	O	;	_	0	SENT_60	[p3l1376t2156r1415b2186],
14	second	JJ	ORDINAL	second	dep	1	SENT_60	[p3l1427t2153r1531b2183],
15	,	,	O	,	_	0	SENT_60	[p3l1427t2153r1531b2183],
16	Ieukotriene	JJ	O	ieukotriene	amod	18	SENT_60	[p3l1543t2153r1693b2179],
17	E4	NN	O	e4	nn	18	SENT_60	[p3l1706t2155r1751b2186],
18	)	NN	O	)	appos	14	SENT_60	[p3l1706t2155r1751b2186],
19	.	.	O	.	_	0	SENT_60	[p3l1706t2155r1751b2186],

1	Cysteinyl	JJ	O	cysteinyl	amod	2	SENT_61	[p3l397t2211r519b2244],
2	leukotrienes	NNS	O	leukotriene	_	0	SENT_61	[p3l530t2211r704b2236],
3	:	:	O	:	_	0	SENT_61	[p3l530t2211r704b2236],
4	Class	NNP	O	Class	nsubj	5	SENT_61	[p3l714t2211r785b2236],
5	includes	VBZ	O	include	ccomp	18	SENT_61	[p3l797t2211r908b2236],
6	Ieukotriene	NNP	O	Ieukotriene	nn	7	SENT_61	[p3l920t2211r1071b2236],
7	C4	NN	O	c4	dobj	5	SENT_61	[p3l1081t2213r1118b2243],
8	,	,	O	,	_	0	SENT_61	[p3l1081t2213r1118b2243],
9	Ieukotriene	NN	O	ieukotriene	nn	10	SENT_61	[p3l1131t2211r1281b2236],
10	D4	NN	O	d4	dobj	5	SENT_61	[p3l1293t2213r1332b2243],
11	,	,	O	,	_	0	SENT_61	[p3l1293t2213r1332b2243],
12	and	CC	O	and	_	0	SENT_61	[p3l1344t2211r1392b2236],
13	Ieukotriene	NNP	O	Ieukotriene	nn	14	SENT_61	[p3l1404t2211r1555b2236],
14	E4	NN	O	e4	conj_and	7	SENT_61	[p3l1567t2213r1600b2243],
15	,	,	O	,	_	0	SENT_61	[p3l1567t2213r1600b2243],
16	all	DT	O	all	det	17	SENT_61	[p3l1612t2211r1639b2236],
17	ofwhich	JJ	O	ofwhich	nsubj	18	SENT_61	[p3l1651t2211r1763b2236],
18	contain	VBP	O	contain	dep	2	SENT_61	[p3l1774t2213r1874b2236],
19	the	DT	O	the	det	22	SENT_61	[p3l1884t2211r1927b2236],
20	amino	NN	O	amino	nn	22	SENT_61	[p3l1937t2213r2023b2236],
21	acid	NN	O	acid	nn	22	SENT_61	[p3l448t2249r501b2274],
22	cysteine	NN	O	cysteine	dobj	18	SENT_61	[p3l512t2251r621b2282],
23	conjugated	VBN	O	conjugate	partmod	22	SENT_61	[p3l631t2249r781b2282],
24	to	TO	O	to	_	0	SENT_61	[p3l791t2253r818b2274],
25	the	DT	O	the	det	27	SENT_61	[p3l827t2249r870b2274],
26	lipid	NN	O	lipid	nn	27	SENT_61	[p3l881t2249r937b2281],
27	backbone	NN	O	backbone	prep_to	23	SENT_61	[p3l949t2249r1085b2274],
28	.	.	O	.	_	0	SENT_61	[p3l949t2249r1085b2274],

1	5-Lipoxygenase	NN	O	5-lipoxygenase	_	0	SENT_62	[p3l398t2307r616b2339],
2	:	:	O	:	_	0	SENT_62	[p3l398t2307r616b2339],
3	The	DT	O	the	det	4	SENT_62	[p3l625t2306r675b2331],
4	enzyme	NN	O	enzyme	dep	1	SENT_62	[p3l685t2315r790b2339],
5	that	WDT	O	that	nsubj	6	SENT_62	[p3l799t2306r852b2331],
6	initiates	VBZ	O	initiate	rcmod	4	SENT_62	[p3l863t2309r968b2331],
7	Ieukotriene	NN	MISC	ieukotriene	nn	8	SENT_62	[p3l981t2306r1131b2331],
8	synthesis	NN	O	synthesis	dobj	6	SENT_62	[p3l1141t2306r1266b2339],
9	from	IN	O	from	_	0	SENT_62	[p3l1276t2306r1340b2331],
10	arachidonic	JJ	O	arachidonic	amod	11	SENT_62	[p3l1352t2306r1510b2331],
11	acid	NN	O	acid	prep_from	6	SENT_62	[p3l1520t2306r1582b2331],
12	.	.	O	.	_	0	SENT_62	[p3l1520t2306r1582b2331],

1	FLAP	NN	O	flap	_	0	SENT_63	[p3l399t2366r476b2389],
2	:	:	O	:	_	0	SENT_63	[p3l399t2366r476b2389],
3	5-Lipoxygenase	NN	O	5-lipoxygenase	dep	1	SENT_63	[p3l486t2366r845b2397],
4	—	CD	NUMBER	—	num	3	SENT_63	[p3l486t2366r845b2397],
5	activating	VBG	O	activate	partmod	3	SENT_63	[p3l486t2366r845b2397],
6	protein	NN	O	protein	dobj	5	SENT_63	[p3l856t2366r959b2397],
7	,	,	O	,	_	0	SENT_63	[p3l856t2366r959b2397],
8	a	DT	O	a	det	10	SENT_63	[p3l970t2373r983b2389],
9	helper	NN	O	helper	nn	10	SENT_63	[p3l995t2364r1079b2397],
10	protein	NN	O	protein	appos	6	SENT_63	[p3l1089t2366r1183b2397],
11	for	IN	O	for	_	0	SENT_63	[p3l1194t2364r1232b2389],
12	5-lipoxygenase	NN	O	5-lipoxygenase	prep_for	10	SENT_63	[p3l1242t2364r1441b2397],
13	that	WDT	O	that	nsubj	21	SENT_63	[p3l1450t2364r1503b2389],
14	is	VBZ	O	be	auxpass	15	SENT_63	[p3l1514t2366r1533b2389],
15	thought	VBN	O	think	rcmod	10	SENT_63	[p3l1543t2364r1651b2397],
16	to	TO	O	to	aux	17	SENT_63	[p3l1659t2369r1686b2389],
17	bind	VB	O	bind	xcomp	15	SENT_63	[p3l1697t2364r1754b2389],
18	arachidonic	JJ	O	arachidonic	amod	19	SENT_63	[p3l1766t2364r1925b2389],
19	acid	NN	O	acid	dobj	17	SENT_63	[p3l1935t2364r1987b2389],
20	and	CC	O	and	_	0	SENT_63	[p3l448t2401r496b2427],
21	present	JJ	DATE	present	rcmod	10	SENT_63	[p3l509t2406r609b2434],
22	it	PRP	O	it	dep	21	SENT_63	[p3l620t2404r636b2427],
23	to	TO	O	to	_	0	SENT_63	[p3l644t2406r671b2427],
24	5-lipoxygenase	NN	O	5-lipoxygenase	prep_to	21	SENT_63	[p3l681t2401r881b2435],
25	to	TO	O	to	aux	26	SENT_63	[p3l890t2406r916b2427],
26	facilitate	VB	O	facilitate	xcomp	5	SENT_63	[p3l926t2401r1041b2427],
27	its	PRP$	O	its	poss	29	SENT_63	[p3l1052t2404r1081b2427],
28	catalytic	JJ	O	catalytic	amod	29	SENT_63	[p3l1092t2401r1202b2434],
29	function	NN	O	function	dobj	26	SENT_63	[p3l1211t2401r1331b2427],
30	.	.	O	.	_	0	SENT_63	[p3l1211t2401r1331b2427],

1	LTA4	NN	O	lta4	_	0	SENT_64	[p3l399t2461r470b2491],
2	:	:	O	:	_	0	SENT_64	[p3l399t2461r470b2491],
3	Leukotriene	NN	O	leukotriene	nn	4	SENT_64	[p3l483t2459r641b2484],
4	A4	NN	O	a4	dep	1	SENT_64	[p3l649t2461r688b2491],
5	,	,	O	,	_	0	SENT_64	[p3l649t2461r688b2491],
6	the	DT	O	the	det	10	SENT_64	[p3l698t2459r741b2484],
7	unstable	JJ	O	unstable	amod	10	SENT_64	[p3l752t2459r867b2484],
8	product	NN	O	product	nn	10	SENT_64	[p3l878t2459r983b2492],
9	of5-lipoxygenase	NN	O	of5-lipoxygenase	nn	10	SENT_64	[p3l993t2459r1227b2492],
10	action	NN	O	action	appos	1	SENT_64	[p3l1238t2462r1319b2484],
11	on	IN	O	on	_	0	SENT_64	[p3l1330t2468r1362b2484],
12	substrate	JJ	O	substrate	amod	14	SENT_64	[p3l1374t2459r1500b2484],
13	arachidonic	JJ	O	arachidonic	amod	14	SENT_64	[p3l1511t2459r1669b2484],
14	acid	NN	O	acid	prep_on	10	SENT_64	[p3l1679t2459r1732b2484],
15	and	CC	O	and	_	0	SENT_64	[p3l1744t2459r1792b2484],
16	the	DT	O	the	det	18	SENT_64	[p3l1802t2459r1845b2484],
17	precursor	NN	O	precursor	nn	18	SENT_64	[p3l1856t2468r1986b2492],
18	ofthe	NN	O	ofthe	prep_on	10	SENT_64	[p3l448t2496r524b2522],
19	bioactive	JJ	O	bioactive	amod	21	SENT_64	[p3l535t2497r655b2522],
20	leukotriene	NN	O	leukotriene	nn	21	SENT_64	[p3l666t2497r817b2522],
21	B4	NN	O	b4	dep	1	SENT_64	[p3l829t2499r857b2529],
22	and	CC	O	and	_	0	SENT_64	[p3l867t2497r915b2522],
23	cysteinyl	NN	O	cysteinyl	nn	24	SENT_64	[p3l926t2497r1039b2530],
24	leukotrienes	NNS	O	leukotriene	conj_and	21	SENT_64	[p3l1052t2497r1225b2522],
25	.	.	O	.	_	0	SENT_64	[p3l1052t2497r1225b2522],

1	LTA4	NN	O	lta4	nn	2	SENT_65	[p3l399t2557r463b2586],
2	hydrolase	NN	O	hydrolase	_	0	SENT_65	[p3l473t2554r611b2587],
3	:	:	O	:	_	0	SENT_65	[p3l473t2554r611b2587],
4	Leukotriene	NN	O	leukotriene	nn	6	SENT_65	[p3l623t2554r781b2579],
5	A4	NN	O	a4	nn	6	SENT_65	[p3l790t2556r822b2586],
6	hydrolase	NN	O	hydrolase	dep	2	SENT_65	[p3l832t2554r969b2587],
7	,	,	O	,	_	0	SENT_65	[p3l832t2554r969b2587],
8	an	DT	O	a	det	9	SENT_65	[p3l981t2563r1010b2579],
9	enzyme	NN	O	enzyme	appos	6	SENT_65	[p3l1022t2563r1126b2587],
10	that	WDT	O	that	nsubj	11	SENT_65	[p3l1135t2554r1189b2579],
11	hydrolyzes	VBZ	O	hydrolyze	rcmod	9	SENT_65	[p3l1199t2554r1341b2587],
12	Ieukotriene	NNP	O	Ieukotriene	nn	13	SENT_65	[p3l1353t2554r1503b2579],
13	A4	NN	O	a4	dobj	11	SENT_65	[p3l1512t2556r1544b2586],
14	to	TO	O	to	_	0	SENT_65	[p3l1552t2559r1579b2579],
15	leukotriene	NN	O	leukotriene	nn	16	SENT_65	[p3l1590t2554r1741b2579],
16	B4	NN	O	b4	prep_to	11	SENT_65	[p3l1753t2557r1788b2586],
17	.	.	O	.	_	0	SENT_65	[p3l1753t2557r1788b2586],

1	LTB4	NN	O	ltb4	_	0	SENT_66	[p3l399t2614r470b2644],
2	:	:	O	:	_	0	SENT_66	[p3l399t2614r470b2644],
3	Leukotriene	NN	O	leukotriene	nn	4	SENT_66	[p3l482t2612r640b2637],
4	B4	NN	O	b4	dep	1	SENT_66	[p3l652t2614r687b2644],
5	,	,	O	,	_	0	SENT_66	[p3l652t2614r687b2644],
6	a	DT	O	a	det	12	SENT_66	[p3l699t2621r712b2637],
7	product	NN	O	product	nn	12	SENT_66	[p3l724t2612r829b2645],
8	ofthe	NN	O	ofthe	nn	12	SENT_66	[p3l838t2612r915b2637],
9	action	NN	O	action	nn	12	SENT_66	[p3l925t2614r1006b2637],
10	ofleukotriene	NN	O	ofleukotriene	nn	12	SENT_66	[p3l1018t2612r1204b2637],
11	A4	NN	O	a4	nn	12	SENT_66	[p3l1213t2614r1245b2644],
12	hydrolase	NN	O	hydrolase	dep	1	SENT_66	[p3l1255t2612r1385b2645],
13	on	IN	O	on	_	0	SENT_66	[p3l1395t2621r1427b2637],
14	Ieukotriene	NNP	O	Ieukotriene	nn	15	SENT_66	[p3l1439t2612r1590b2637],
15	A4	NN	O	a4	prep_on	12	SENT_66	[p3l1599t2614r1630b2644],
16	and	CC	O	and	_	0	SENT_66	[p3l1640t2612r1688b2637],
17	a	DT	O	a	det	20	SENT_66	[p3l1700t2621r1712b2637],
18	potent	JJ	O	potent	amod	20	SENT_66	[p3l1725t2617r1812b2645],
19	leukocyte	NN	O	leukocyte	nn	20	SENT_66	[p3l1822t2612r1948b2645],
20	chemoattractant	NN	O	chemoattractant	conj_and	4	SENT_66	[p3l1958t2612r2013b2637, p3l449t2654r625b2675],

1	and	CC	O	and	_	0	SENT_67	[p3l635t2649r683b2675],
2	activator	NN	O	activator	dep	1	SENT_67	[p3l694t2652r818b2675],
3	.	.	O	.	_	0	SENT_67	[p3l694t2652r818b2675],

1	LTC4	NN	O	ltc4	_	0	SENT_68	[p3l399t2709r471b2739],
2	:	:	O	:	_	0	SENT_68	[p3l399t2709r471b2739],
3	Leukotriene	NN	O	leukotriene	nn	4	SENT_68	[p3l483t2707r641b2732],
4	C4	NN	O	c4	dep	1	SENT_68	[p3l651t2709r688b2739],
5	,	,	O	,	_	0	SENT_68	[p3l651t2709r688b2739],
6	a	DT	O	a	det	12	SENT_68	[p3l700t2716r713b2732],
7	product	NN	O	product	nn	12	SENT_68	[p3l725t2707r830b2740],
8	ofthe	NN	O	ofthe	nn	12	SENT_68	[p3l839t2707r916b2732],
9	action	NN	O	action	nn	12	SENT_68	[p3l926t2709r1007b2732],
10	ofleukotriene	NN	O	ofleukotriene	nn	12	SENT_68	[p3l1018t2707r1205b2732],
11	C4	NN	O	c4	nn	12	SENT_68	[p3l1215t2709r1246b2739],
12	synthase	NN	O	synthase	appos	4	SENT_68	[p3l1256t2707r1374b2740],
13	on	IN	O	on	_	0	SENT_68	[p3l1384t2716r1416b2732],
14	Ieukotriene	NNP	O	Ieukotriene	nn	15	SENT_68	[p3l1429t2707r1579b2732],
15	A4	NN	O	a4	prep_on	12	SENT_68	[p3l1588t2709r1620b2739],
16	and	CC	O	and	_	0	SENT_68	[p3l1630t2707r1678b2732],
17	a	DT	O	a	det	19	SENT_68	[p3l1690t2716r1702b2732],
18	precursor	NN	O	precursor	nn	19	SENT_68	[p3l1714t2716r1845b2740],
19	ofthe	NN	O	ofthe	conj_and	12	SENT_68	[p3l1853t2707r1930b2732],
20	other	JJ	O	other	amod	22	SENT_68	[p3l1940t2707r2011b2732],
21	cysteinyl	NN	O	cysteinyl	nn	22	SENT_68	[p3l448t2745r561b2778],
22	leukotrienes	NNS	O	leukotriene	dep	19	SENT_68	[p3l574t2745r746b2770],
23	.	.	O	.	_	0	SENT_68	[p3l574t2745r746b2770],

1	LTC4	NN	O	ltc4	nn	2	SENT_69	[p3l399t2804r462b2834],
2	synthase	NN	O	synthase	_	0	SENT_69	[p3l470t2802r596b2835],
3	:	:	O	:	_	0	SENT_69	[p3l470t2802r596b2835],
4	Leukotriene	NN	O	leukotriene	nn	6	SENT_69	[p3l608t2802r763b2827],
5	C4	NN	O	c4	nn	6	SENT_69	[p3l772t2804r803b2834],
6	synthase	NN	O	synthase	dep	2	SENT_69	[p3l812t2802r935b2835],
7	,	,	O	,	_	0	SENT_69	[p3l812t2802r935b2835],
8	an	DT	O	a	det	9	SENT_69	[p3l946t2811r975b2827],
9	enzyme	NN	O	enzyme	appos	6	SENT_69	[p3l986t2811r1089b2835],
10	that	WDT	O	that	nsubj	11	SENT_69	[p3l1097t2802r1150b2827],
11	conjugates	VBZ	O	conjugate	rcmod	9	SENT_69	[p3l1158t2805r1303b2835],
12	glutathione	NN	O	glutathione	dobj	11	SENT_69	[p3l1313t2802r1465b2835],
13	to	TO	O	to	_	0	SENT_69	[p3l1473t2807r1499b2827],
14	Ieukotriene	NNP	O	Ieukotriene	nn	15	SENT_69	[p3l1510t2802r1657b2827],
15	A4	NN	O	a4	prep_to	11	SENT_69	[p3l1665t2804r1697b2834],
16	to	TO	O	to	aux	17	SENT_69	[p3l1704t2807r1731b2827],
17	form	VB	O	form	xcomp	11	SENT_69	[p3l1740t2802r1802b2827],
18	Ieukotriene	NNP	O	Ieukotriene	nn	19	SENT_69	[p3l1814t2802r1961b2827],
19	C4	NN	O	c4	dobj	17	SENT_69	[p3l1971t2804r2008b2834],
20	.	.	O	.	_	0	SENT_69	[p3l1971t2804r2008b2834],

1	LTD4	NN	O	ltd4	_	0	SENT_70	[p3l399t2862r474b2892],
2	:	:	O	:	_	0	SENT_70	[p3l399t2862r474b2892],
3	Leukotriene	NN	O	leukotriene	nn	4	SENT_70	[p3l486t2860r644b2885],
4	D4	NN	O	d4	conj_and	1	SENT_70	[p3l656t2862r695b2892],
5	,	,	O	,	_	0	SENT_70	[p3l656t2862r695b2892],
6	a	DT	O	a	det	9	SENT_70	[p3l707t2869r720b2885],
7	metabolite	NN	O	metabolite	nn	9	SENT_70	[p3l732t2860r876b2885],
8	ofleukotriene	NN	O	ofleukotriene	nn	9	SENT_70	[p3l886t2860r1072b2885],
9	C4	NN	O	c4	conj_and	1	SENT_70	[p3l1082t2862r1113b2892],
10	and	CC	O	and	_	0	SENT_70	[p3l1123t2860r1171b2885],
11	the	DT	O	the	det	16	SENT_70	[p3l1181t2860r1224b2885],
12	most	RBS	O	most	advmod	13	SENT_70	[p3l1235t2865r1303b2885],
13	potent	JJ	O	potent	amod	16	SENT_70	[p3l1314t2865r1401b2893],
14	ofthe	NN	O	ofthe	nn	16	SENT_70	[p3l1411t2860r1487b2885],
15	cysteinyl	NN	O	cysteinyl	nn	16	SENT_70	[p3l1497t2860r1610b2893],
16	leukotrienes	NNS	O	leukotriene	conj_and	1	SENT_70	[p3l1623t2860r1787b2885],
17	in	IN	O	in	_	0	SENT_70	[p3l1799t2862r1821b2885],
18	contracting	NN	O	contracting	nn	19	SENT_70	[p3l1832t2862r1987b2893],
19	airway	NN	O	airway	prep_in	16	SENT_70	[p3l1997t2862r2039b2885, p3l447t2906r498b2930],
20	smooth	JJ	O	smooth	amod	21	SENT_70	[p3l508t2897r610b2923],
21	muscle	NN	O	muscle	dep	1	SENT_70	[p3l623t2897r719b2923],
22	by	IN	O	by	_	0	SENT_70	[p3l730t2897r758b2930],
23	ligation	NN	O	ligation	prep_by	21	SENT_70	[p3l769t2897r867b2931],
24	of	IN	O	of	_	0	SENT_70	[p3l879t2897r908b2923],
25	CysLT1	NN	O	cyslt1	prep_of	23	SENT_70	[p3l914t2899r1014b2930],
26	.	.	O	.	_	0	SENT_70	[p3l914t2899r1014b2930],

1	LTE4	NN	O	lte4	_	0	SENT_71	[p3l399t2957r468b2987],
2	:	:	O	:	_	0	SENT_71	[p3l399t2957r468b2987],
3	Leukotriene	NN	O	leukotriene	nn	4	SENT_71	[p3l481t2955r639b2980],
4	E4	NN	O	e4	dep	1	SENT_71	[p3l651t2957r684b2987],
5	,	,	O	,	_	0	SENT_71	[p3l651t2957r684b2987],
6	a	DT	O	a	det	9	SENT_71	[p3l696t2964r708b2980],
7	metabolite	NN	O	metabolite	nn	9	SENT_71	[p3l720t2955r864b2980],
8	ofleukotriene	NN	O	ofleukotriene	nn	9	SENT_71	[p3l874t2955r1060b2980],
9	D4	NN	O	d4	appos	4	SENT_71	[p3l1073t2957r1105b2987],
10	and	CC	O	and	_	0	SENT_71	[p3l1115t2955r1163b2980],
11	end	NN	O	end	nn	12	SENT_71	[p3l1174t2955r1222b2980],
12	product	NN	O	product	conj_and	9	SENT_71	[p3l1235t2955r1340b2988],
13	ofall	NN	O	ofall	nn	15	SENT_71	[p3l1350t2955r1413b2980],
14	cysteinyl	NN	O	cysteinyl	nn	15	SENT_71	[p3l1424t2955r1537b2988],
15	leukotrienes	NNS	O	leukotriene	dep	9	SENT_71	[p3l1550t2955r1714b2980],
16	that	WDT	O	that	nsubjpass	19	SENT_71	[p3l1724t2955r1778b2980],
17	can	MD	O	can	aux	19	SENT_71	[p3l1787t2964r1832b2980],
18	be	VB	O	be	auxpass	19	SENT_71	[p3l1845t2955r1875b2980],
19	measured	VBN	O	measure	rcmod	4	SENT_71	[p3l1886t2955r2018b2980],
20	in	IN	O	in	_	0	SENT_71	[p3l449t2995r470b3017],
21	the	DT	O	the	det	22	SENT_71	[p3l481t2993r523b3018],
22	urine	NN	O	urine	prep_in	19	SENT_71	[p3l535t2995r610b3018],
23	.	.	O	.	_	0	SENT_71	[p3l535t2995r610b3018],

1	Rhodopsin	NNP	O	Rhodopsin	_	0	SENT_72	[p3l399t3050r552b3083],
2	:	:	O	:	_	0	SENT_72	[p3l399t3050r552b3083],
3	A	NNP	O	A	nn	5	SENT_72	[p3l562t3052r581b3075],
4	retinal	JJ	O	retinal	amod	5	SENT_72	[p3l592t3050r674b3075],
5	photoreceptor	NN	O	photoreceptor	dep	1	SENT_72	[p3l687t3050r881b3083],
6	that	WDT	O	that	nsubj	12	SENT_72	[p3l889t3050r942b3075],
7	is	VBZ	O	be	cop	12	SENT_72	[p3l953t3053r972b3075],
8	the	DT	O	the	det	12	SENT_72	[p3l982t3050r1024b3075],
9	prototypic	JJ	O	prototypic	amod	12	SENT_72	[p3l1035t3053r1172b3083],
10	heptahelical	JJ	O	heptahelical	amod	12	SENT_72	[p3l1183t3050r1344b3083],
11	G	NN	O	g	nn	12	SENT_72	[p3l1356t3052r1375b3075],
12	protein	NN	O	protein	rcmod	5	SENT_72	[p3l1388t3050r1610b3083],
13	—	CD	NUMBER	—	dep	12	SENT_72	[p3l1388t3050r1610b3083],
14	coupled	VBN	O	couple	partmod	12	SENT_72	[p3l1388t3050r1610b3083],
15	receptor	NN	O	receptor	dobj	14	SENT_72	[p3l1623t3055r1735b3083],
16	and	CC	O	and	_	0	SENT_72	[p3l1744t3050r1792b3075],
17	that	IN	O	that	dep	21	SENT_72	[p3l1802t3050r1856b3075],
18	resembles	VBZ	O	resemble	cop	21	SENT_72	[p3l1867t3050r2004b3075],
19	a	DT	O	a	det	21	SENT_72	[p3l2015t3059r2028b3075],
20	leukotriene	NN	O	leukotriene	nn	21	SENT_72	[p3l449t3088r599b3113],
21	receptor	NN	O	receptor	rcmod	5	SENT_72	[p3l610t3093r729b3121],
22	.	.	O	.	_	0	SENT_72	[p3l610t3093r729b3121],

1	1842	CD	DATE	1842	num	4	SENT_73	[p3l93t3223r169b3245],
2	N	NN	O	n	nn	4	SENT_73	[p3l841t3233r855b3248],
3	ENGLJ	NN	O	englj	nn	4	SENT_73	[p3l870t3233r948b3255],
4	MED	NN	O	med	_	0	SENT_73	[p3l962t3233r1014b3248],
5	357	CD	NUMBER	357	num	7	SENT_73	[p3l1025t3227r1098b3255],
6	;	:	O	;	_	0	SENT_73	[p3l1025t3227r1098b3255],
7	18	CD	NUMBER	18	dep	4	SENT_73	[p3l1025t3227r1098b3255],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_73	[p3l1131t3233r1332b3255],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_73	[p3l1369t3233r1504b3249],
10	1	CD	DATE	1	num	9	SENT_73	[p3l1515t3233r1531b3253],
11	,	,	DATE	,	_	0	SENT_73	[p3l1515t3233r1531b3253],
12	2007	CD	DATE	2007	num	9	SENT_73	[p3l1542t3233r1605b3254],

1	The	DT	O	the	det	4	SENT_74	[p3l879t3266r930b3290],
2	New	NNP	O	New	nn	4	SENT_74	[p3l939t3267r1001b3290],
3	England	NNP	O	England	nn	4	SENT_74	[p3l1010t3266r1121b3297],
4	Journal	NNP	O	Journal	_	0	SENT_74	[p3l1130t3266r1227b3290],
5	of	IN	O	of	_	0	SENT_74	[p3l1237t3266r1266b3290],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_74	[p3l1273t3266r1398b3290],

1	Downloaded	VBN	O	download	_	0	SENT_75	[p3l321t3307r491b3330],
2	from	IN	O	from	_	0	SENT_75	[p3l500t3307r565b3330],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_75	[p3l573t3307r692b3337],
4	at	IN	O	at	_	0	SENT_75	[p3l702t3311r725b3330],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_75	[p3l733t3307r916b3330],
6	on	IN	O	on	_	0	SENT_75	[p3l925t3314r958b3330],
7	January	NNP	DATE	January	prep_on	1	SENT_75	[p3l966t3307r1069b3337],
8	5	CD	DATE	5	num	7	SENT_75	[p3l1079t3307r1102b3334],
9	,	,	DATE	,	_	0	SENT_75	[p3l1079t3307r1102b3334],
10	2014	CD	DATE	2014	num	7	SENT_75	[p3l1112t3307r1184b3330],
11	.	.	O	.	_	0	SENT_75	[p3l1112t3307r1184b3330],

1	For	IN	O	for	_	0	SENT_76	[p3l1195t3307r1242b3330],
2	personal	JJ	O	personal	amod	3	SENT_76	[p3l1250t3307r1362b3337],
3	use	NN	O	use	pobj	1	SENT_76	[p3l1371t3314r1415b3330],
4	only	RB	O	only	advmod	3	SENT_76	[p3l1424t3307r1489b3337],
5	.	.	O	.	_	0	SENT_76	[p3l1424t3307r1489b3337],

1	No	DT	O	no	det	3	SENT_77	[p3l1500t3307r1539b3330],
2	other	JJ	O	other	amod	3	SENT_77	[p3l1549t3307r1617b3330],
3	uses	NNS	O	use	_	0	SENT_77	[p3l1626t3314r1682b3330],
4	without	IN	O	without	_	0	SENT_77	[p3l1692t3307r1793b3330],
5	permission	NN	O	permission	prep_without	3	SENT_77	[p3l1801t3307r1954b3337],
6	.	.	O	.	_	0	SENT_77	[p3l1801t3307r1954b3337],

1	Copyright	NN	O	copyright	_	0	SENT_78	[p3l672t3348r806b3379],
2	©	CD	NUMBER	©	num	6	SENT_78	[p3l815t3348r839b3372],
3	2007	CD	DATE	2007	num	6	SENT_78	[p3l849t3348r913b3372],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_78	[p3l923t3348r1114b3372],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_78	[p3l1124t3348r1232b3372],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_78	[p3l1243t3348r1348b3379],
7	.	.	O	.	_	0	SENT_78	[p3l1243t3348r1348b3379],

1	All	DT	O	all	det	2	SENT_79	[p3l1359t3348r1400b3372],
2	rights	NNS	O	rights	nsubj	3	SENT_79	[p3l1409t3348r1484b3379],
3	reserved	VBN	O	reserve	_	0	SENT_79	[p3l1494t3348r1612b3372],
4	.	.	O	.	_	0	SENT_79	[p3l1494t3348r1612b3372],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_80	[p3l866t3454r1091b3472],
2	OF	IN	O	of	_	0	SENT_80	[p3l1106t3454r1146b3472],
3	DISEASE	NN	O	disease	prep_of	1	SENT_80	[p3l1160t3454r1294b3472],

1	CysLT	NNP	O	CysLT	nsubj	6	SENT_81	[p3l8t3674r305b3771],
2	,	,	O	,	_	0	SENT_81	[p3l8t3674r305b3771],
3	or	CC	O	or	_	0	SENT_81	[p3l348t3693r437b3746],
4	CysLT2	NN	O	cyslt2	nsubj	6	SENT_81	[p3l476t3674r799b3771],
5	,	,	O	,	_	0	SENT_81	[p3l476t3674r799b3771],
6	raising	VBG	O	raise	_	0	SENT_81	[p3l847t3668r1154b3769],
7	the	DT	O	the	det	8	SENT_81	[p3l1194t3667r1330b3745],
8	possibility	NN	O	possibility	dobj	6	SENT_81	[p3l1370t3667r1835b3767],
9	of	IN	O	of	_	0	SENT_81	[p3l1873t3666r1974b3746],
10	the	DT	O	the	det	11	SENT_81	[p3l1998t3667r2133b3745],
11	presence	NN	O	presence	prep_of	8	SENT_81	[p4l7t46r391b120],
12	of	IN	O	of	_	0	SENT_81	[p4l431t19r532b99],
13	CysLT1	NN	O	cyslt1	prep_of	11	SENT_81	[p4l553t27r1209b124],
14	.	.	O	.	_	0	SENT_81	[p4l553t27r1209b124],

1	—	NN	O	—	_	0	SENT_82	[p4l553t27r1209b124],
2	.	.	O	.	_	0	SENT_82	[p4l553t27r1209b124],

1	CysLT2	NN	O	cyslt2	nn	2	SENT_83	[p4l553t27r1209b124],
2	heterodimers	NNS	O	heterodimer	nsubjpass	13	SENT_83	[p4l1249t20r1833b99],
3	or	CC	O	or	_	0	SENT_83	[p4l1875t46r1965b99],
4	additional	JJ	O	additional	amod	5	SENT_83	[p4l2001t20r2132b99, p4l9t149r353b227],
5	receptors	NNS	O	receptor	nsubjpass	13	SENT_83	[p4l410t155r920b248],
6	.25	CD	NUMBER	.25	num	8	SENT_83	[p4l410t155r920b248],
7	One	CD	NUMBER	one	num	8	SENT_83	[p4l980t155r1155b227],
8	candidate	NN	O	candidate	dep	5	SENT_83	[p4l1213t149r1640b227],
9	is	VBZ	O	be	auxpass	13	SENT_83	[p4l1696t150r1763b226],
10	G	NN	O	g	nn	11	SENT_83	[p4l1823t155r1893b227],
11	protein	NN	O	protein	attr	13	SENT_83	[p4l1949t174r2132b248, p4l9t277r580b376],
12	—	CD	NUMBER	—	num	11	SENT_83	[p4l1949t174r2132b248, p4l9t277r580b376],
13	coupled	VBN	O	couple	_	0	SENT_83	[p4l1949t174r2132b248, p4l9t277r580b376],
14	receptor	NN	O	receptor	dobj	13	SENT_83	[p4l618t294r982b376],
15	17	CD	NUMBER	17	number	16	SENT_83	[p4l1020t283r1115b355],
16	(	CD	NUMBER	(	num	18	SENT_83	[p4l1159t283r1537b372],
17	GPR17	NN	O	gpr17	nn	18	SENT_83	[p4l1159t283r1537b372],
18	)	NN	O	)	dep	14	SENT_83	[p4l1159t283r1537b372],
19	,	,	O	,	_	0	SENT_83	[p4l1159t283r1537b372],
20	a	DT	O	a	det	23	SENT_83	[p4l1580t303r1624b354],
21	dual-uracil	JJ	O	dual-uracil	amod	23	SENT_83	[p4l1661t277r2134b356],
22	nucleotide	NN	O	nucleotide	nn	23	SENT_83	[p4l8t405r867b504],
23	—	NN	O	—	appos	14	SENT_83	[p4l8t405r867b504],
24	cysteinyl	NN	O	cysteinyl	nn	26	SENT_83	[p4l8t405r867b504],
25	leukotriene	NN	O	leukotriene	nn	26	SENT_83	[p4l899t405r1375b484],
26	receptor	NN	O	receptor	dep	23	SENT_83	[p4l1409t409r1851b504],
27	.	.	O	.	_	0	SENT_83	[p4l1409t409r1851b504],

1	“	NN	O	“	nn	4	SENT_84	[p4l1409t409r1851b504],
2	B	NN	O	b	nn	4	SENT_84	[p4l1885t411r1940b482],
3	leukotriene	NN	O	leukotriene	nn	4	SENT_84	[p4l1975t405r2132b484, p4l8t533r356b613],
4	receptor	NN	O	receptor	nsubj	43	SENT_84	[p4l394t550r743b633],
5	1	CD	NUMBER	1	number	6	SENT_84	[p4l783t540r827b611],
6	(	CD	NUMBER	(	num	8	SENT_84	[p4l872t540r1119b637],
7	BLT1	NN	O	blt1	nn	8	SENT_84	[p4l872t540r1119b637],
8	)	NN	O	)	nsubj	12	SENT_84	[p4l872t540r1119b637],
9	is	VBZ	O	be	cop	12	SENT_84	[p4l1163t534r1228b611],
10	the	DT	O	the	det	12	SENT_84	[p4l1270t533r1400b611],
11	high-affinity	JJ	O	high-affinity	amod	12	SENT_84	[p4l1439t532r1984b635],
12	receptor	NN	O	receptor	rcmod	4	SENT_84	[p4l2019t559r2132b611, p4l9t679r280b762],
13	for	IN	O	for	_	0	SENT_84	[p4l313t661r436b741],
14	LT	NN	O	lt	nn	15	SENT_84	[p4l468t668r577b739],
15	B	NN	O	b	prep_for	12	SENT_84	[p4l578t669r633b740],
16	4	CD	NUMBER	4	num	15	SENT_84	[p4l639t727r674b767],
17	that	WDT	O	that	nsubj	18	SENT_84	[p4l710t662r883b740],
18	mediates	VBZ	O	mediate	rcmod	12	SENT_84	[p4l913t662r1298b741],
19	most	RBS	O	most	dobj	18	SENT_84	[p4l1336t679r1574b758],
20	,	,	O	,	_	0	SENT_84	[p4l1336t679r1574b758],
21	if	IN	O	if	mark	22	SENT_84	[p4l1614t661r1691b740],
22	not	RB	O	not	dep	19	SENT_84	[p4l1709t679r1852b741],
23	all	DT	O	all	dep	22	SENT_84	[p4l1882t662r2010b758],
24	,	,	O	,	_	0	SENT_84	[p4l1882t662r2010b758],
25	of	IN	O	of	_	0	SENT_84	[p4l2052t661r2152b741],
26	its	PRP$	O	its	poss	27	SENT_84	[p4l8t790r102b867],
27	chemoattractant	NN	O	chemoattractant	prep_of	19	SENT_84	[p4l137t789r819b868],
28	and	CC	O	and	_	0	SENT_84	[p4l845t789r999b868],
29	proinflammatory	JJ	O	proinflammatory	amod	35	SENT_84	[p4l1030t788r1758b889],
30	action	NN	O	action	nn	35	SENT_84	[p4l1785t790r2134b868],
31	.2	NN	NUMBER	.2	nn	35	SENT_84	[p4l1785t790r2134b868],
32	°	NN	O	°	nn	35	SENT_84	[p4l1785t790r2134b868],
33	B	NN	O	b	nn	35	SENT_84	[p4l7t925r63b996],
34	leukotriene	NN	O	leukotriene	nn	35	SENT_84	[p4l100t918r575b998],
35	receptor	NN	O	receptor	conj_and	19	SENT_84	[p4l612t935r961b1018],
36	2	CD	NUMBER	2	number	37	SENT_84	[p4l995t925r1041b996],
37	(	CD	NUMBER	(	num	39	SENT_84	[p4l1083t925r1332b1022],
38	BLT2	NN	O	blt2	nn	39	SENT_84	[p4l1083t925r1332b1022],
39	)	NN	O	)	dep	35	SENT_84	[p4l1083t925r1332b1022],
40	is	VBZ	O	be	cop	43	SENT_84	[p4l1372t919r1437b996],
41	a	DT	O	a	det	43	SENT_84	[p4l1475t944r1519b996],
42	lower-affinity	JJ	O	lower-affinity	amod	43	SENT_84	[p4l1553t917r2138b1018],
43	receptor	NN	O	receptor	_	0	SENT_84	[p4l8t1064r357b1147],
44	for	IN	O	for	_	0	SENT_84	[p4l387t1046r508b1126],
45	LTB4	NN	O	ltb4	prep_for	43	SENT_84	[p4l536t1054r740b1152],
46	that	WDT	O	that	nsubj	48	SENT_84	[p4l773t1047r942b1125],
47	also	RB	O	also	advmod	48	SENT_84	[p4l969t1047r1137b1126],
48	binds	VBZ	O	bind	rcmod	43	SENT_84	[p4l1173t1047r1402b1126],
49	other	JJ	O	other	amod	50	SENT_84	[p4l1438t1047r1661b1126],
50	lipoXygen	NN	O	lipoxygen	dobj	48	SENT_84	[p4l1690t1047r2132b1148],
51	—	CD	NUMBER	—	num	53	SENT_84	[p4l1690t1047r2132b1148],
52	ase	NN	O	ase	nn	53	SENT_84	[p4l8t1201r142b1253],
53	products	NNS	O	product	dep	50	SENT_84	[p4l175t1175r575b1275],
54	;	:	O	;	_	0	SENT_84	[p4l175t1175r575b1275],
55	little	JJ	O	little	nsubjpass	57	SENT_84	[p4l613t1175r810b1253],
56	is	VBZ	O	be	auxpass	57	SENT_84	[p4l845t1176r911b1253],
57	known	VBN	O	know	parataxis	43	SENT_84	[p4l947t1175r1245b1254],
58	about	IN	O	about	_	0	SENT_84	[p4l1279t1175r1523b1254],
59	its	PRP$	O	its	poss	61	SENT_84	[p4l1551t1176r1651b1253],
60	physiological	JJ	O	physiological	amod	61	SENT_84	[p4l1686t1175r2132b1276, p4l8t1303r157b1381],
61	function	NN	O	function	prep_about	57	SENT_84	[p4l197t1302r587b1382],
62	.	.	O	.	_	0	SENT_84	[p4l197t1302r587b1382],

1	The	DT	O	the	det	2	SENT_85	[p4l137t1431r299b1509],
2	expression	NN	O	expression	nsubjpass	7	SENT_85	[p4l332t1432r793b1531],
3	of	IN	O	of	_	0	SENT_85	[p4l826t1430r927b1510],
4	CysLT1	NN	O	cyslt1	prep_of	2	SENT_85	[p4l941t1438r1233b1535],
5	can	MD	O	can	aux	7	SENT_85	[p4l1266t1457r1416b1509],
6	be	VB	O	be	auxpass	7	SENT_85	[p4l1449t1431r1547b1510],
7	influenced	VBN	O	influence	_	0	SENT_85	[p4l1579t1430r2043b1511],
8	at	IN	O	at	_	0	SENT_85	[p4l2075t1448r2154b1509],
9	the	DT	O	the	det	11	SENT_85	[p4l10t1560r141b1638],
10	transcriptional	JJ	O	transcriptional	amod	11	SENT_85	[p4l179t1560r804b1660],
11	level	NN	O	level	prep_at	7	SENT_85	[p4l839t1560r1023b1639],
12	by	IN	O	by	_	0	SENT_85	[p4l1060t1560r1157b1660],
13	type	NN	O	type	nn	16	SENT_85	[p4l1189t1577r1367b1660],
14	2	CD	NUMBER	2	num	16	SENT_85	[p4l1405t1566r1452b1638],
15	helper	NN	O	helper	nn	16	SENT_85	[p4l1490t1560r1752b1660],
16	T	NN	O	t	agent	7	SENT_85	[p4l1783t1566r1845b1638],
17	(	CD	NUMBER	(	num	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
18	Th2	NN	O	th2	nn	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
19	)	NN	O	)	nn	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
20	cell	NN	O	cell	nn	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
21	—	NN	O	—	nn	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
22	type	NN	O	type	nn	23	SENT_85	[p4l1883t1560r2148b1651, p4l11t1688r412b1788],
23	cytokines	NNS	O	cytokine	dep	16	SENT_85	[p4l466t1688r994b1788],
24	.	.	O	.	_	0	SENT_85	[p4l466t1688r994b1788],

1	”	NN	O	”	nsubj	5	SENT_86	[p4l466t1688r994b1788],
2	This	DT	O	this	det	3	SENT_86	[p4l1044t1688r1237b1766],
3	effect	NN	O	effect	npadvmod	4	SENT_86	[p4l1293t1687r1543b1766],
4	probably	RB	O	probably	advmod	5	SENT_86	[p4l1590t1688r1979b1788],
5	explains	VBZ	O	explain	_	0	SENT_86	[p4l2028t1714r2148b1766, p4l8t1817r277b1917],
6	Why	WRB	O	why	advmod	9	SENT_86	[p4l321t1817r502b1917],
7	CysLT1	NN	O	cyslt1	nsubjpass	9	SENT_86	[p4l543t1823r841b1921],
8	is	VBZ	O	be	auxpass	9	SENT_86	[p4l885t1818r953b1895],
9	overexpressed	VBN	O	overexpress	dep	5	SENT_86	[p4l1002t1817r1621b1917],
10	in	IN	O	in	_	0	SENT_86	[p4l1666t1818r1751b1895],
11	patients	NNS	O	patient	prep_in	9	SENT_86	[p4l1795t1818r2148b1917],
12	with	IN	O	with	_	0	SENT_86	[p4l6t1947r206b2026],
13	asthma	NN	O	asthma	prep_with	11	SENT_86	[p4l246t1947r569b2025],
14	or	CC	O	or	_	0	SENT_86	[p4l607t1973r696b2026],
15	chronic	JJ	O	chronic	amod	16	SENT_86	[p4l733t1947r1059b2026],
16	rhinosinusitis	NN	O	rhinosinusitis	prep_in	9	SENT_86	[p4l1097t1947r1696b2026],
17	who	WP	O	who	nsubj	18	SENT_86	[p4l1734t1947r1918b2026],
18	have	VBP	O	have	rcmod	16	SENT_86	[p4l1958t1947r2149b2026],
19	aspirin	NN	O	aspirin	nn	20	SENT_86	[p4l10t2075r311b2174],
20	sensitivity	NN	O	sensitivity	dobj	18	SENT_86	[p4l352t2075r788b2174],
21	and	CC	O	and	_	0	SENT_86	[p4l821t2074r980b2153],
22	Why	WRB	O	why	dep	5	SENT_86	[p4l1015t2074r1193b2174],
23	levels	NNS	O	level	dep	22	SENT_86	[p4l1227t2074r1459b2154],
24	of	IN	O	of	_	0	SENT_86	[p4l1500t2073r1600b2153],
25	the	DT	O	the	det	27	SENT_86	[p4l1621t2074r1755b2152],
26	receptor	NN	O	receptor	nn	27	SENT_86	[p4l1794t2091r2153b2174],
27	return	NN	O	return	prep_of	23	SENT_86	[p4l10t2219r281b2282],
28	to	TO	O	to	_	0	SENT_86	[p4l322t2219r404b2281],
29	normal	JJ	O	normal	amod	32	SENT_86	[p4l445t2202r760b2281],
30	after	IN	O	after	_	0	SENT_86	[p4l799t2201r1003b2280],
31	aspirin	NN	O	aspirin	prep_after	29	SENT_86	[p4l1039t2203r1341b2302],
32	desensitization	NN	O	desensitization	prep_to	27	SENT_86	[p4l1382t2202r2142b2281],
33	.	.	O	.	_	0	SENT_86	[p4l1382t2202r2142b2281],

1	”	NN	O	”	npadvmod	15	SENT_87	[p4l1382t2202r2142b2281],
2	In	IN	O	in	_	0	SENT_87	[p4l139t2338r228b2408],
3	addition	NN	O	addition	_	0	SENT_87	[p4l272t2330r632b2409],
4	to	TO	O	to	_	0	SENT_87	[p4l676t2347r758b2409],
5	the	DT	O	the	det	6	SENT_87	[p4l804t2330r938b2408],
6	actions	NNS	O	action	prep_in_addition_to	15	SENT_87	[p4l981t2331r1288b2409],
7	of	IN	O	of	_	0	SENT_87	[p4l1336t2329r1437b2409],
8	cysteinyl	NN	O	cysteinyl	nn	9	SENT_87	[p4l1463t2330r1834b2430],
9	leukotrienes	NNS	O	leukotriene	prep_of	6	SENT_87	[p4l1877t2330r2148b2410, p4l10t2460r307b2538],
10	in	IN	O	in	_	0	SENT_87	[p4l346t2460r431b2537],
11	the	DT	O	the	det	12	SENT_87	[p4l469t2459r605b2538],
12	airway	NN	O	airway	prep_in	9	SENT_87	[p4l642t2460r951b2560],
13	,	,	O	,	_	0	SENT_87	[p4l642t2460r951b2560],
14	they	PRP	O	they	nsubj	15	SENT_87	[p4l994t2459r1182b2560],
15	join	VBP	O	join	_	0	SENT_87	[p4l1201t2460r1381b2560],
16	LTB4	NN	O	ltb4	dobj	15	SENT_87	[p4l1417t2465r1628b2565],
17	in	IN	O	in	_	0	SENT_87	[p4l1664t2460r1750b2537],
18	exerting	VBG	O	exert	prepc_in	15	SENT_87	[p4l1787t2460r2153b2561],
19	other	JJ	O	other	amod	21	SENT_87	[p4l11t2588r231b2668],
20	biologic	JJ	O	biologic	amod	21	SENT_87	[p4l266t2588r595b2690],
21	actions	NNS	O	action	dobj	18	SENT_87	[p4l630t2589r946b2668],
22	.	.	O	.	_	0	SENT_87	[p4l630t2589r946b2668],

1	Some	DT	O	some	nsubj	12	SENT_88	[p4l991t2595r1217b2668],
2	of	IN	O	of	_	0	SENT_88	[p4l1254t2587r1353b2668],
3	the	DT	O	the	det	4	SENT_88	[p4l1370t2588r1500b2667],
4	actions	NNS	O	action	prep_of	1	SENT_88	[p4l1536t2589r1830b2668],
5	of	IN	O	of	_	0	SENT_88	[p4l1869t2587r1967b2668],
6	cysteinyl	NN	O	cysteinyl	nn	7	SENT_88	[p4l1986t2615r2148b2689, p4l11t2718r247b2818],
7	leukotrienes	NNS	O	leukotriene	prep_of	4	SENT_88	[p4l281t2718r815b2797],
8	and	CC	O	and	_	0	SENT_88	[p4l852t2718r1011b2797],
9	LTB4	NN	O	ltb4	prep_of	4	SENT_88	[p4l1047t2724r1254b2823],
10	are	VBP	O	be	cop	12	SENT_88	[p4l1290t2744r1420b2796],
11	distinctive	JJ	O	distinctive	amod	12	SENT_88	[p4l1457t2718r1906b2797],
12	(	NN	O	(	_	0	SENT_88	[p4l1947t2725r2144b2819],
13	e.g.	FW	O	e.g.	dep	12	SENT_88	[p4l1947t2725r2144b2819],
14	,	,	O	,	_	0	SENT_88	[p4l1947t2725r2144b2819],
15	smooth	JJ	O	smooth	amod	18	SENT_88	[p4l12t2847r690b2927],
16	—	NN	O	—	nn	18	SENT_88	[p4l12t2847r690b2927],
17	muscle	NN	O	muscle	nn	18	SENT_88	[p4l12t2847r690b2927],
18	contraction	NN	O	contraction	appos	12	SENT_88	[p4l737t2848r1244b2927],
19	for	IN	O	for	_	0	SENT_88	[p4l1290t2846r1416b2927],
20	the	DT	O	the	det	21	SENT_88	[p4l1460t2847r1595b2926],
21	former	JJ	O	former	prep_for	18	SENT_88	[p4l1642t2846r1946b2927],
22	and	CC	O	and	cc	21	SENT_88	[p4l1989t2847r2150b2927],

1	Stimuli	NNS	O	stimulus	_	0	SENT_89	[p5l153t70r250b97],

1	Antigen	NN	O	antigen	nn	3	SENT_90	[p5l151t114r244b143],
2	Immune	JJ	O	immune	amod	3	SENT_90	[p5l153t148r254b169],
3	complex	NN	O	complex	_	0	SENT_90	[p5l263t146r364b175],
4	Cross-linked	JJ	O	cross-linked	amod	8	SENT_90	[p5l153t180r300b203],
5	lgE	NNP	O	lgE	nn	8	SENT_90	[p5l311t181r347b209],
6	Microbe	NNP	O	Microbe	nn	8	SENT_90	[p5l153t212r252b236],
7	Complement	NNP	O	Complement	nn	8	SENT_90	[p5l152t246r310b275],
8	Cytokine	NN	O	cytokine	dep	3	SENT_90	[p5l152t280r256b309],
9	Osmotic	JJ	O	osmotic	amod	11	SENT_90	[p5l153t314r256b336],
10	challenge	NN	O	challenge	nn	11	SENT_90	[p5l263t312r378b343],
11	Pollutant	NN	O	pollutant	dep	3	SENT_90	[p5l153t346r261b370],

1	Montelukast	NNP	O	Montelukast	nn	4	SENT_91	[p5l911t714r1082b747],
2	V	NNP	O	V	nn	4	SENT_91	[p5l1105t732r1108b734],
3	Zaﬁrlukast	NNP	O	Zaﬁrlukast	nn	4	SENT_91	[p5l909t748r1056b772],
4	Pranlukast	NNP	O	Pranlukast	_	0	SENT_91	[p5l911t780r1056b806],

1	/	:	O	/	punct	3	SENT_92	[p5l1459t882r1508b958],
2	'	''	O	'	_	0	SENT_92	[p5l1459t882r1508b958],
3	D	NN	O	d	_	0	SENT_92	[p5l1614t884r1738b962],
4	‘	CD	NUMBER	‘	num	3	SENT_92	[p5l1614t884r1738b962],
5	e	SYM	O	e	dep	6	SENT_92	[p5l1614t884r1738b962],
6	§	CD	NUMBER	§	dep	7	SENT_92	[p5l1614t884r1738b962],
7	eased	VBD	O	ease	dep	3	SENT_92	[p5l1614t884r1738b962],
8	p	NN	O	p	nn	10	SENT_92	[p5l782t976r802b988],
9	*	CD	NUMBER	*	num	10	SENT_92	[p5l782t976r802b988],
10	G	NN	O	g	nn	15	SENT_92	[p5l811t962r826b974],
11	*	CD	NUMBER	*	num	12	SENT_92	[p5l811t962r826b974],
12	T	NN	O	t	dep	10	SENT_92	[p5l838t948r858b958],
13	«‘	CD	NUMBER	«‘	number	14	SENT_92	[p5l1021t974r1055b986],
14	”	NN	O	”	amod	15	SENT_92	[p5l1021t974r1055b986],
15	r	NN	O	r	dobj	7	SENT_92	[p5l1021t974r1055b986],
16	-	:	O	-	_	0	SENT_92	[p5l1021t974r1055b986],
17	3	CD	DATE	3	dep	3	SENT_92	[p5l1097t954r1104b958],
18	Increased	VBN	O	increase	partmod	17	SENT_92	[p5l1381t962r1504b986],
19	Caz	NNP	O	Caz	dep	22	SENT_92	[p5l1513t958r1576b986],
20	"	``	O	"	punct	22	SENT_92	[p5l1513t958r1576b986],
21	(	CD	NUMBER	(	num	22	SENT_92	[p5l1639t972r1712b996],
22	AMI	NNP	O	AMI	dep	18	SENT_92	[p5l1639t972r1712b996],
23	:	:	O	:	_	0	SENT_92	[p5l1639t972r1712b996],
24	*	CD	NUMBER	*	num	25	SENT_92	[p5l751t1000r758b1008],
25	*	NN	O	*	dep	22	SENT_92	[p5l771t988r794b1000],
26	,	,	O	,	_	0	SENT_92	[p5l806t992r809b994],
27	E	NN	O	e	appos	22	SENT_92	[p5l827t988r850b1010],
28	3	CD	NUMBER	3	num	27	SENT_92	[p5l983t986r1019b1000],
29	,	,	O	,	_	0	SENT_92	[p5l983t986r1019b1000],
30	.	.	O	.	_	0	SENT_92	[p5l983t986r1019b1000],

1	.	.	O	.	_	0	SENT_93	[p5l729t1020r732b1022],

1	P	NN	O	p	_	0	SENT_94	[p5l752t1024r766b1036],
2	/	:	O	/	punct	3	SENT_94	[p5l835t1038r872b1051],
3	7	CD	NUMBER	7	dep	1	SENT_94	[p5l835t1038r872b1051],
4	f	LS	O	f	dep	3	SENT_94	[p5l883t976r1004b1033],
5	,	,	O	,	_	0	SENT_94	[p5l883t976r1004b1033],
6	_	NN	O	_	appos	3	SENT_94	[p5l883t976r1004b1033],
7	.	.	O	.	_	0	SENT_94	[p5l883t976r1004b1033],

1	%	NN	O	%	_	0	SENT_95	[p5l883t976r1004b1033],
2	_	SYM	O	_	dep	1	SENT_95	[p5l883t976r1004b1033],

1	Transgo	FW	O	transgo	nn	4	SENT_96	[p5l359t1008r460b1037],
2	\	FW	O	\	nn	4	SENT_96	[p5l467t1024r470b1028],
3	i	FW	O	i	nn	4	SENT_96	[p5l477t1020r478b1023],
4	’	FW	O	’	_	0	SENT_96	[p5l487t1012r490b1013],
5	E	NN	O	e	dep	4	SENT_96	[p5l1011t1006r1024b1028],
6	/	:	O	/	punct	4	SENT_96	[p5l1631t1002r1680b1066],

1	Gq	NNP	O	Gq	_	0	SENT_97	[p5l1507t1065r1542b1094],
2	Gi	NN	O	gi	dep	1	SENT_97	[p5l1595t1065r1622b1088],

1	Figure	NNP	O	Figure	_	0	SENT_98	[p5l123t1302r207b1335],
2	1	CD	NUMBER	1	dep	1	SENT_98	[p5l219t1304r241b1327],
3	.	.	O	.	_	0	SENT_98	[p5l219t1304r241b1327],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_99	[p5l254t1302r416b1327],
2	Synthesis	NN	O	synthesis	_	0	SENT_99	[p5l426t1302r566b1335],
3	,	,	O	,	_	0	SENT_99	[p5l426t1302r566b1335],
4	Receptors	NNS	O	receptor	appos	2	SENT_99	[p5l579t1304r724b1334],
5	,	,	O	,	_	0	SENT_99	[p5l579t1304r724b1334],
6	and	CC	O	and	_	0	SENT_99	[p5l735t1302r785b1327],
7	Signaling	NN	O	signaling	conj_and	4	SENT_99	[p5l796t1302r932b1335],
8	.	.	O	.	_	0	SENT_99	[p5l796t1302r932b1335],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_100	[p5l123t1352r285b1377],
2	synthesis	NN	O	synthesis	nsubjpass	5	SENT_100	[p5l297t1352r424b1385],
3	can	MD	O	can	aux	5	SENT_100	[p5l436t1361r482b1377],
4	be	VB	O	be	auxpass	5	SENT_100	[p5l496t1352r527b1377],
5	activated	VBN	O	activate	_	0	SENT_100	[p5l538t1352r662b1377],
6	in	IN	O	in	_	0	SENT_100	[p5l675t1354r697b1377],
7	a	DT	O	a	det	9	SENT_100	[p5l710t1361r723b1377],
8	cell	NN	O	cell	nn	9	SENT_100	[p5l735t1352r779b1377],
9	(	NN	O	(	prep_in	5	SENT_100	[p5l794t1354r859b1385],
10	e.g.	FW	O	e.g.	dep	9	SENT_100	[p5l794t1354r859b1385],
11	,	,	O	,	_	0	SENT_100	[p5l794t1354r859b1385],
12	a	DT	O	a	det	14	SENT_100	[p5l872t1361r884b1377],
13	leukocyte	NN	O	leukocyte	nn	14	SENT_100	[p5l898t1352r1036b1385],
14	)	NN	O	)	appos	9	SENT_100	[p5l898t1352r1036b1385],
15	by	IN	O	by	_	0	SENT_100	[p5l1052t1352r1081b1385],
16	a	DT	O	a	det	17	SENT_100	[p5l1092t1361r1104b1377],
17	variety	NN	O	variety	agent	5	SENT_100	[p5l1115t1354r1208b1385],
18	of	IN	O	of	_	0	SENT_100	[p5l1218t1352r1248b1377],
19	stimuli	NNS	O	stimulus	prep_of	17	SENT_100	[p5l1255t1352r1357b1377],
20	.	.	O	.	_	0	SENT_100	[p5l1255t1352r1357b1377],

1	The	DT	O	the	det	3	SENT_101	[p5l1369t1352r1420b1377],
2	enzymatic	JJ	O	enzymatic	amod	3	SENT_101	[p5l1431t1354r1573b1385],
3	machinery	NN	O	machinery	_	0	SENT_101	[p5l1585t1352r1730b1385],
4	for	IN	O	for	_	0	SENT_101	[p5l120t1393r159b1419],
5	phospholipase	NN	O	phospholipase	nn	6	SENT_101	[p5l171t1393r373b1426],
6	A2	NN	O	a2	prep_for	3	SENT_101	[p5l383t1395r416b1425],
7	(	CD	NUMBER	(	num	9	SENT_101	[p5l427t1393r666b1427],
8	PLA2	NN	O	pla2	nn	9	SENT_101	[p5l427t1393r666b1427],
9	)	NN	O	)	dep	6	SENT_101	[p5l427t1393r666b1427],
10	.	.	O	.	_	0	SENT_101	[p5l427t1393r666b1427],

1	—	NN	O	—	_	0	SENT_102	[p5l427t1393r666b1427],
2	.	.	O	.	_	0	SENT_102	[p5l427t1393r666b1427],

1	cata	NN	O	ca	nn	2	SENT_103	[p5l427t1393r666b1427],
2	|	NN	O	|	nsubj	3	SENT_103	[p5l427t1393r666b1427],
3	yzed	VBD	O	yze	_	0	SENT_103	[p5l427t1393r666b1427],
4	arachidonate	NN	O	arachidonate	nn	5	SENT_103	[p5l679t1393r859b1419],
5	hydrolysis	NN	O	hydrolysis	nsubj	10	SENT_103	[p5l871t1393r1007b1427],
6	and	CC	O	and	_	0	SENT_103	[p5l1019t1393r1068b1419],
7	leukotriene	NN	O	leukotriene	nn	8	SENT_103	[p5l1082t1393r1236b1419],
8	synthesis	NN	O	synthesis	nsubj	10	SENT_103	[p5l1247t1393r1375b1426],
9	is	VBZ	O	be	cop	10	SENT_103	[p5l1388t1396r1407b1419],
10	localized	JJ	O	localized	conj_or	10	SENT_103	[p5l1420t1393r1540b1419],
11	primarily	RB	O	primarily	advmod	10	SENT_103	[p5l1554t1394r1676b1427],
12	at	IN	O	at	_	0	SENT_103	[p5l1687t1398r1712b1419],
13	or	CC	O	or	_	0	SENT_103	[p5l1722t1402r1751b1419],
14	near	IN	O	near	_	0	SENT_103	[p5l122t1444r182b1460],
15	the	DT	O	the	det	17	SENT_103	[p5l191t1435r235b1460],
16	nuclear	JJ	O	nuclear	amod	17	SENT_103	[p5l247t1435r348b1460],
17	membrane	NN	O	membrane	prep_at	10	SENT_103	[p5l360t1435r517b1465],
18	,	,	O	,	_	0	SENT_103	[p5l360t1435r517b1465],
19	necessitating	VBG	O	necessitate	xcomp	3	SENT_103	[p5l531t1437r713b1468],
20	that	IN	O	that	complm	33	SENT_103	[p5l723t1435r778b1460],
21	leukotriene	NN	O	leukotriene	nn	22	SENT_103	[p5l790t1435r943b1460],
22	B4	NN	O	b4	nsubjpass	33	SENT_103	[p5l957t1437r986b1467],
23	(	CD	NUMBER	(	num	25	SENT_103	[p5l1000t1437r1082b1468],
24	LTB4	NN	O	ltb4	nn	25	SENT_103	[p5l1000t1437r1082b1468],
25	)	NN	O	)	dep	22	SENT_103	[p5l1000t1437r1082b1468],
26	and	CC	O	and	_	0	SENT_103	[p5l1097t1435r1146b1460],
27	leukotriene	NN	O	leukotriene	nn	28	SENT_103	[p5l1160t1435r1313b1460],
28	C4	NN	O	c4	conj_and	22	SENT_103	[p5l1325t1437r1357b1467],
29	(	CD	NUMBER	(	num	30	SENT_103	[p5l1370t1437r1453b1468],
30	LTC4	NN	O	ltc4	dep	28	SENT_103	[p5l1370t1437r1453b1468],
31	)	CD	NUMBER	)	dep	28	SENT_103	[p5l1370t1437r1453b1468],
32	be	VB	O	be	auxpass	33	SENT_103	[p5l1469t1435r1499b1460],
33	transported	VBN	O	transport	ccomp	19	SENT_103	[p5l1510t1435r1673b1468],
34	by	IN	O	by	_	0	SENT_103	[p5l1687t1435r1715b1468],
35	carrier	NN	O	carrier	nn	36	SENT_103	[p5l121t1479r211b1502],
36	proteins	NNS	O	protein	agent	33	SENT_103	[p5l223t1479r334b1510],
37	out	IN	O	out	_	0	SENT_103	[p5l346t1482r391b1502],
38	ofthe	NN	O	ofthe	nn	39	SENT_103	[p5l402t1477r481b1502],
39	cell	NN	O	cell	prep_out	33	SENT_103	[p5l492t1477r545b1507],
40	;	:	O	;	_	0	SENT_103	[p5l492t1477r545b1507],
41	the	DT	O	the	det	43	SENT_103	[p5l556t1477r600b1502],
42	LTC4	NN	O	ltc4	nn	43	SENT_103	[p5l613t1479r676b1509],
43	transporter	NN	O	transporter	nsubj	47	SENT_103	[p5l685t1482r844b1510],
44	is	VBZ	O	be	cop	47	SENT_103	[p5l856t1479r875b1502],
45	multidrug	JJ	O	multidrug	amod	47	SENT_103	[p5l888t1477r1024b1510],
46	resistance	NN	O	resistance	nn	47	SENT_103	[p5l1037t1479r1175b1502],
47	protein	NN	O	protein	parataxis	3	SENT_103	[p5l1188t1479r1284b1510],
48	1	CD	NUMBER	1	dep	47	SENT_103	[p5l1298t1479r1318b1507],
49	;	:	O	;	_	0	SENT_103	[p5l1298t1479r1318b1507],
50	the	DT	O	the	det	52	SENT_103	[p5l1329t1477r1373b1502],
51	LTB4	NN	O	ltb4	nn	52	SENT_103	[p5l1386t1479r1449b1509],
52	transporter	NN	O	transporter	nsubj	54	SENT_103	[p5l1459t1482r1618b1510],
53	is	VBZ	O	be	cop	54	SENT_103	[p5l1629t1479r1648b1502],
54	unknown	JJ	O	unknown	parataxis	3	SENT_103	[p5l1661t1486r1704b1502, p5l122t1518r220b1544],
55	.	.	O	.	_	0	SENT_103	[p5l1661t1486r1704b1502, p5l122t1518r220b1544],

1	In	IN	O	in	_	0	SENT_104	[p5l234t1521r256b1543],
2	the	DT	O	the	det	4	SENT_104	[p5l268t1519r312b1544],
3	extracellular	JJ	O	extracellular	amod	4	SENT_104	[p5l323t1518r492b1544],
4	milieu	NN	O	milieu	prep_in	8	SENT_104	[p5l504t1518r595b1548],
5	,	,	O	,	_	0	SENT_104	[p5l504t1518r595b1548],
6	LTC4	NN	O	ltc4	nsubjpass	8	SENT_104	[p5l610t1520r673b1551],
7	is	VBZ	O	be	auxpass	8	SENT_104	[p5l685t1521r704b1544],
8	converted	VBN	O	convert	_	0	SENT_104	[p5l716t1519r852b1544],
9	to	TO	O	to	_	0	SENT_104	[p5l864t1523r891b1544],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_104	[p5l903t1518r1057b1544],
11	D4	NN	O	d4	prep_to	8	SENT_104	[p5l1071t1521r1103b1551],
12	(	CD	NUMBER	(	num	13	SENT_104	[p5l1117t1521r1203b1552],
13	LTD	NN	O	ltd	dobj	8	SENT_104	[p5l1117t1521r1203b1552],
14	,	,	O	,	_	0	SENT_104	[p5l1117t1521r1203b1552],
15	,	,	O	,	_	0	SENT_104	[p5l1117t1521r1203b1552],
16	)	NN	O	)	dep	24	SENT_104	[p5l1117t1521r1203b1552],
17	and	CC	O	and	_	0	SENT_104	[p5l1217t1518r1266b1544],
18	LTD4	NN	O	ltd4	dep	24	SENT_104	[p5l1281t1521r1346b1551],
19	to	TO	O	to	_	0	SENT_104	[p5l1356t1523r1383b1544],
20	leukotriene	NN	O	leukotriene	nn	21	SENT_104	[p5l1396t1518r1550b1544],
21	E4	NN	O	e4	prep_to	16	SENT_104	[p5l1563t1521r1591b1551],
22	(	CD	NUMBER	(	num	24	SENT_104	[p5l1604t1521r1695b1552],
23	LTE4	NN	O	lte4	nn	24	SENT_104	[p5l1604t1521r1695b1552],
24	)	NN	O	)	ccomp	8	SENT_104	[p5l1604t1521r1695b1552],
25	.	.	O	.	_	0	SENT_104	[p5l1604t1521r1695b1552],

1	Collectively	RB	O	collectively	advmod	5	SENT_105	[p5l1707t1518r1761b1544, p5l122t1560r238b1593],
2	,	,	O	,	_	0	SENT_105	[p5l1707t1518r1761b1544, p5l122t1560r238b1593],
3	these	DT	O	these	det	4	SENT_105	[p5l250t1560r324b1585],
4	molecules	NNS	O	molecule	nsubj	5	SENT_105	[p5l337t1560r477b1585],
5	make	VBP	O	make	_	0	SENT_105	[p5l490t1560r562b1585],
6	up	RP	O	up	prt	5	SENT_105	[p5l575t1569r607b1593],
7	the	DT	O	the	det	9	SENT_105	[p5l618t1560r661b1585],
8	cysteinyl	NN	O	cysteinyl	nn	9	SENT_105	[p5l673t1560r790b1593],
9	leukotrienes	NNS	O	leukotriene	dobj	5	SENT_105	[p5l804t1560r980b1585],
10	.	.	O	.	_	0	SENT_105	[p5l804t1560r980b1585],

1	Leukotrienes	NNPS	O	Leukotrienes	nsubj	2	SENT_106	[p5l995t1560r1171b1585],
2	act	VBP	O	act	_	0	SENT_106	[p5l1184t1565r1224b1585],
3	on	IN	O	on	_	0	SENT_106	[p5l1235t1569r1267b1585],
4	target	NN	O	target	nn	5	SENT_106	[p5l1279t1565r1361b1593],
5	cells	NNS	O	cell	prep_on	2	SENT_106	[p5l1372t1560r1440b1590],
6	,	,	O	,	_	0	SENT_106	[p5l1372t1560r1440b1590],
7	which	WDT	O	which	nsubj	10	SENT_106	[p5l1451t1560r1531b1585],
8	may	MD	O	may	aux	10	SENT_106	[p5l1545t1569r1600b1593],
9	be	VB	O	be	cop	10	SENT_106	[p5l1612t1560r1642b1585],
10	leukocytes	NNS	O	leukocyte	rcmod	5	SENT_106	[p5l1655t1560r1738b1585, p5l121t1607r199b1635],
11	,	,	O	,	_	0	SENT_106	[p5l1655t1560r1738b1585, p5l121t1607r199b1635],
12	epithelial	JJ	O	epithelial	amod	13	SENT_106	[p5l212t1602r337b1635],
13	cells	NNS	O	cell	conj_or	10	SENT_106	[p5l350t1602r417b1632],
14	,	,	O	,	_	0	SENT_106	[p5l350t1602r417b1632],
15	smooth-muscle	JJ	O	smooth-muscle	amod	16	SENT_106	[p5l431t1602r648b1627],
16	cells	NNS	O	cell	rcmod	5	SENT_106	[p5l659t1602r727b1632],
17	,	,	O	,	_	0	SENT_106	[p5l659t1602r727b1632],
18	or	CC	O	or	_	0	SENT_106	[p5l739t1611r768b1627],
19	endothelial	JJ	O	endothelial	amod	20	SENT_106	[p5l778t1602r931b1627],
20	cells	NNS	O	cell	rcmod	5	SENT_106	[p5l944t1602r1012b1632],
21	,	,	O	,	_	0	SENT_106	[p5l944t1602r1012b1632],
22	by	IN	O	by	_	0	SENT_106	[p5l1025t1602r1054b1635],
23	interacting	VBG	O	interact	prepc_by	10	SENT_106	[p5l1066t1604r1215b1635],
24	with	IN	O	with	_	0	SENT_106	[p5l1224t1602r1282b1627],
25	one	CD	NUMBER	one	prep_with	23	SENT_106	[p5l1294t1611r1344b1627],
26	or	CC	O	or	_	0	SENT_106	[p5l1356t1611r1384b1627],
27	both	DT	O	both	det	28	SENT_106	[p5l1396t1602r1455b1627],
28	classes	NNS	O	class	nsubj	29	SENT_106	[p5l1468t1602r1565b1627],
29	oftheir	VBP	O	oftheir	conj_or	2	SENT_106	[p5l1577t1602r1677b1627],
30	cognate	JJ	O	cognate	amod	31	SENT_106	[p5l121t1648r230b1677],
31	receptors	NNS	O	receptor	dobj	29	SENT_106	[p5l242t1648r379b1676],
32	.	.	O	.	_	0	SENT_106	[p5l242t1648r379b1676],

1	B	NN	O	b	nn	3	SENT_107	[p5l394t1646r408b1668],
2	leukotriene	NN	O	leukotriene	nn	3	SENT_107	[p5l421t1643r575b1669],
3	receptor	NN	O	receptor	nsubj	42	SENT_107	[p5l588t1648r703b1676],
4	1	CD	NUMBER	1	number	5	SENT_107	[p5l715t1646r726b1668],
5	(	CD	NUMBER	(	num	7	SENT_107	[p5l742t1646r820b1677],
6	BLT1	NN	O	blt1	nn	7	SENT_107	[p5l742t1646r820b1677],
7	)	NN	O	)	nsubjpass	9	SENT_107	[p5l742t1646r820b1677],
8	is	VBZ	O	be	auxpass	9	SENT_107	[p5l835t1646r854b1669],
9	expressed	VBN	O	express	rcmod	3	SENT_107	[p5l867t1643r1003b1676],
10	primarily	RB	O	primarily	advmod	9	SENT_107	[p5l1017t1643r1140b1677],
11	on	IN	O	on	_	0	SENT_107	[p5l1150t1652r1183b1669],
12	leukocytes	NNS	O	leukocyte	prep_on	9	SENT_107	[p5l1197t1643r1341b1677],
13	and	CC	O	and	_	0	SENT_107	[p5l1354t1643r1403b1669],
14	is	VBZ	O	be	cop	17	SENT_107	[p5l1416t1646r1435b1669],
15	a	DT	O	a	det	17	SENT_107	[p5l1448t1652r1461b1669],
16	high-affinity	JJ	O	high-affinity	amod	17	SENT_107	[p5l1474t1643r1642b1677],
17	receptor	NN	O	receptor	rcmod	3	SENT_107	[p5l1654t1652r1737b1676, p5l120t1690r165b1715],
18	,	,	O	,	_	0	SENT_107	[p5l1654t1652r1737b1676, p5l120t1690r165b1715],
19	whereas	IN	O	whereas	mark	28	SENT_107	[p5l176t1685r290b1710],
20	B	NN	O	b	nn	22	SENT_107	[p5l304t1687r319b1710],
21	leukotriene	NN	O	leukotriene	nn	22	SENT_107	[p5l332t1685r486b1710],
22	receptor	NN	O	receptor	nsubjpass	28	SENT_107	[p5l499t1690r613b1718],
23	2	CD	NUMBER	2	number	24	SENT_107	[p5l624t1687r638b1710],
24	(	CD	NUMBER	(	dep	22	SENT_107	[p5l652t1687r732b1718],
25	BLT2	NN	O	blt2	nn	26	SENT_107	[p5l652t1687r732b1718],
26	)	NN	O	)	dep	22	SENT_107	[p5l652t1687r732b1718],
27	is	VBZ	O	be	auxpass	28	SENT_107	[p5l747t1687r767b1710],
28	expressed	VBN	O	express	dep	3	SENT_107	[p5l779t1685r915b1718],
29	more	JJR	O	more	dobj	28	SENT_107	[p5l929t1694r1000b1710],
30	ubiquitously	RB	O	ubiquitously	advmod	28	SENT_107	[p5l1012t1685r1188b1718],
31	,	,	O	,	_	0	SENT_107	[p5l1012t1685r1188b1718],
32	has	VBZ	O	have	_	0	SENT_107	[p5l1201t1685r1246b1710],
33	a	DT	O	a	det	36	SENT_107	[p5l1259t1694r1272b1710],
34	somewhat	RB	O	somewhat	advmod	35	SENT_107	[p5l1284t1685r1427b1710],
35	lower	JJR	O	lower	amod	36	SENT_107	[p5l1439t1685r1513b1710],
36	affinity	NN	O	affinity	dobj	32	SENT_107	[p5l1524t1685r1621b1718],
37	for	IN	O	for	_	0	SENT_107	[p5l1631t1685r1669b1710],
38	LTB4	NN	O	ltb4	prep_for	36	SENT_107	[p5l1682t1687r1752b1717],
39	,	,	O	,	_	0	SENT_107	[p5l1682t1687r1752b1717],
40	and	CC	O	and	_	0	SENT_107	[p5l121t1727r170b1752],
41	can	MD	O	can	aux	42	SENT_107	[p5l183t1736r229b1752],
42	bind	VB	O	bind	conj_and	32	SENT_107	[p5l243t1727r301b1752],
43	other	JJ	O	other	amod	44	SENT_107	[p5l313t1727r387b1752],
44	lipids	NNS	O	lipid	dobj	42	SENT_107	[p5l398t1727r479b1760],
45	.	.	O	.	_	0	SENT_107	[p5l398t1727r479b1760],

1	The	DT	O	the	det	5	SENT_108	[p5l490t1727r542b1752],
2	two	CD	NUMBER	two	num	5	SENT_108	[p5l552t1732r603b1752],
3	cysteinyl	NN	O	cysteinyl	nn	5	SENT_108	[p5l614t1727r731b1760],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_108	[p5l745t1727r899b1752],
5	receptors	NNS	O	receptor	nsubj	6	SENT_108	[p5l912t1732r1040b1760],
6	have	VBP	O	have	_	0	SENT_108	[p5l1053t1727r1114b1752],
7	a	DT	O	a	det	9	SENT_108	[p5l1126t1736r1139b1752],
8	broad	JJ	O	broad	amod	9	SENT_108	[p5l1152t1727r1228b1752],
9	distribution	NN	O	distribution	dobj	6	SENT_108	[p5l1241t1727r1411b1752],
10	.	.	O	.	_	0	SENT_108	[p5l1241t1727r1411b1752],

1	All	DT	O	all	det	3	SENT_109	[p5l1422t1727r1456b1752],
2	leukotriene	NN	O	leukotriene	nn	3	SENT_109	[p5l1470t1727r1624b1752],
3	receptors	NNS	O	receptor	nsubj	4	SENT_109	[p5l1637t1736r1721b1760, p5l120t1773r173b1794],
4	activate	VBP	O	activate	_	0	SENT_109	[p5l186t1771r292b1794],
5	the	DT	O	the	det	9	SENT_109	[p5l302t1769r346b1794],
6	Gq	NNP	MISC	Gq	nn	9	SENT_109	[p5l357t1770r395b1801],
7	class	NN	O	class	nn	9	SENT_109	[p5l407t1768r473b1794],
8	ofG	NN	O	ofg	nn	9	SENT_109	[p5l485t1768r542b1794],
9	proteins	NNS	O	protein	dobj	4	SENT_109	[p5l556t1771r676b1801],
10	,	,	O	,	_	0	SENT_109	[p5l556t1771r676b1801],
11	resulting	VBG	O	result	partmod	4	SENT_109	[p5l690t1768r810b1802],
12	in	IN	O	in	_	0	SENT_109	[p5l822t1771r844b1793],
13	increased	VBN	O	increase	amod	15	SENT_109	[p5l858t1768r988b1794],
14	intracellular	JJ	O	intracellular	amod	15	SENT_109	[p5l1002t1768r1166b1794],
15	calcium	NN	O	calcium	prep_in	11	SENT_109	[p5l1176t1768r1291b1798],
16	,	,	O	,	_	0	SENT_109	[p5l1176t1768r1291b1798],
17	the	DT	O	the	det	19	SENT_109	[p5l1303t1768r1346b1794],
18	Gi	NN	MISC	gi	nn	19	SENT_109	[p5l1358t1770r1386b1794],
19	class	NN	O	class	appos	15	SENT_109	[p5l1398t1769r1473b1798],
20	,	,	O	,	_	0	SENT_109	[p5l1398t1769r1473b1798],
21	resulting	VBG	O	result	partmod	15	SENT_109	[p5l1487t1768r1607b1802],
22	in	IN	O	in	_	0	SENT_109	[p5l1619t1771r1641b1793],
23	decreased	VBN	O	decrease	amod	26	SENT_109	[p5l1654t1769r1696b1794, p5l121t1810r226b1835],
24	intracellular	JJ	O	intracellular	amod	26	SENT_109	[p5l239t1810r403b1835],
25	cyclic	JJ	O	cyclic	amod	26	SENT_109	[p5l414t1810r489b1843],
26	AMP	NN	O	amp	prep_in	21	SENT_109	[p5l498t1812r565b1835],
27	(	CD	NUMBER	(	num	30	SENT_109	[p5l579t1812r649b1843],
28	CAM	NNP	O	CAM	nn	30	SENT_109	[p5l579t1812r649b1843],
29	P	NN	O	p	nn	30	SENT_109	[p5l656t1812r689b1843],
30	)	NN	O	)	dobj	11	SENT_109	[p5l656t1812r689b1843],
31	,	,	O	,	_	0	SENT_109	[p5l656t1812r689b1843],
32	or	CC	O	or	_	0	SENT_109	[p5l701t1819r730b1835],
33	both	DT	O	both	dobj	11	SENT_109	[p5l741t1810r810b1835],
34	.	.	O	.	_	0	SENT_109	[p5l741t1810r810b1835],

1	These	DT	O	these	det	2	SENT_110	[p5l821t1810r904b1835],
2	effects	NNS	O	effect	nsubj	10	SENT_110	[p5l915t1810r1016b1840],
3	,	,	O	,	_	0	SENT_110	[p5l915t1810r1016b1840],
4	which	WDT	O	which	nsubj	5	SENT_110	[p5l1028t1810r1108b1835],
5	activate	VBP	O	activate	rcmod	2	SENT_110	[p5l1121t1812r1227b1835],
6	downstream	JJ	O	downstream	amod	8	SENT_110	[p5l1238t1810r1410b1835],
7	protein	NN	O	protein	nn	8	SENT_110	[p5l1424t1812r1520b1843],
8	kinases	NNS	O	kinase	dobj	5	SENT_110	[p5l1534t1810r1642b1840],
9	,	,	O	,	_	0	SENT_110	[p5l1534t1810r1642b1840],
10	culminate	VBP	O	culminate	_	0	SENT_110	[p5l1655t1810r1740b1835, p5l122t1857r179b1877],
11	in	IN	O	in	_	0	SENT_110	[p5l192t1854r214b1877],
12	myriad	JJ	O	myriad	amod	13	SENT_110	[p5l228t1852r319b1885],
13	cellular	JJ	O	cellular	prep_in	10	SENT_110	[p5l332t1852r432b1877],
14	and	CC	O	and	_	0	SENT_110	[p5l443t1852r491b1877],
15	tissue	NN	O	tissue	nn	16	SENT_110	[p5l503t1854r584b1877],
16	responses	NNS	O	response	conj_and	13	SENT_110	[p5l597t1861r745b1885],
17	.	.	O	.	_	0	SENT_110	[p5l597t1861r745b1885],

1	The	DT	O	the	det	2	SENT_111	[p5l756t1852r807b1877],
2	sites	NNS	O	site	nsubj	8	SENT_111	[p5l819t1854r881b1877],
3	of	IN	O	of	_	0	SENT_111	[p5l893t1852r923b1877],
4	action	NN	O	action	prep_of	2	SENT_111	[p5l930t1854r1013b1877],
5	of	IN	O	of	_	0	SENT_111	[p5l1026t1852r1056b1877],
6	antileukotriene	JJ	O	antileukotriene	amod	7	SENT_111	[p5l1063t1852r1271b1877],
7	drugs	NNS	O	drug	prep_of	4	SENT_111	[p5l1282t1852r1360b1885],
8	(	VBP	O	(	_	0	SENT_111	[p5l1375t1852r1590b1885],
9	5-lipoxygenase	NN	O	5-lipoxygenase	nn	12	SENT_111	[p5l1375t1852r1590b1885],
10	[	CD	NUMBER	[	num	12	SENT_111	[p5l1602t1854r1685b1885],
11	5-LO	NN	O	5-lo	nn	12	SENT_111	[p5l1602t1854r1685b1885],
12	]	NN	O	]	nsubjpass	26	SENT_111	[p5l1602t1854r1685b1885],
13	for	IN	O	for	_	0	SENT_111	[p5l1697t1852r1735b1877],
14	zileuton	NN	O	zileuton	prep_for	12	SENT_111	[p5l121t1894r231b1919],
15	and	CC	O	and	_	0	SENT_111	[p5l244t1893r292b1919],
16	CysLT1	NN	O	cyslt1	prep_for	12	SENT_111	[p5l305t1895r394b1927],
17	for	IN	O	for	_	0	SENT_111	[p5l405t1893r444b1919],
18	montelukast	NN	O	montelukast	nn	20	SENT_111	[p5l455t1893r635b1923],
19	,	,	O	,	_	0	SENT_111	[p5l455t1893r635b1923],
20	zafirlukast	NN	O	zafirlukast	prep_for	14	SENT_111	[p5l648t1893r801b1923],
21	,	,	O	,	_	0	SENT_111	[p5l648t1893r801b1923],
22	and	CC	O	and	_	0	SENT_111	[p5l814t1893r862b1919],
23	pranlukast	NN	O	pranlukast	nn	24	SENT_111	[p5l876t1893r1030b1927],
24	)	NN	O	)	conj_and	20	SENT_111	[p5l876t1893r1030b1927],
25	are	VBP	O	be	auxpass	26	SENT_111	[p5l1045t1902r1085b1919],
26	shown	VBN	O	show	ccomp	8	SENT_111	[p5l1097t1893r1194b1919],
27	.	.	O	.	_	0	SENT_111	[p5l1097t1893r1194b1919],

1	FLAP	NN	O	flap	nsubj	2	SENT_112	[p5l1209t1895r1279b1918],
2	denotes	VBZ	O	denote	_	0	SENT_112	[p5l1290t1893r1400b1919],
3	5	CD	NUMBER	5	num	5	SENT_112	[p5l1412t1893r1739b1927, p5l122t1938r163b1968],
4	|	NN	O	|	nn	5	SENT_112	[p5l1412t1893r1739b1927, p5l122t1938r163b1968],
5	ipoxygenase	NN	O	ipoxygenase	dobj	2	SENT_112	[p5l1412t1893r1739b1927, p5l122t1938r163b1968],
6	—	NN	O	—	nn	8	SENT_112	[p5l1412t1893r1739b1927, p5l122t1938r163b1968],
7	activatmg	NN	O	activatmg	nn	8	SENT_112	[p5l1412t1893r1739b1927, p5l122t1938r163b1968],
8	protein	NN	O	protein	dep	5	SENT_112	[p5l175t1937r280b1968],
9	.	.	O	.	_	0	SENT_112	[p5l175t1937r280b1968],

1	N	NN	O	n	nn	3	SENT_113	[p5l546t2087r561b2103],
2	ENGLJ	NN	O	englj	nn	3	SENT_113	[p5l576t2087r656b2110],
3	MED	NN	O	med	_	0	SENT_113	[p5l671t2087r724b2103],
4	357	CD	NUMBER	357	num	6	SENT_113	[p5l734t2081r810b2110],
5	;	:	O	;	_	0	SENT_113	[p5l734t2081r810b2110],
6	18	CD	NUMBER	18	dep	3	SENT_113	[p5l734t2081r810b2110],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_113	[p5l843t2087r1050b2110],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	6	SENT_113	[p5l1088t2087r1227b2104],
9	1	CD	DATE	1	num	8	SENT_113	[p5l1238t2087r1254b2108],
10	,	,	DATE	,	_	0	SENT_113	[p5l1238t2087r1254b2108],
11	2007	CD	DATE	2007	num	8	SENT_113	[p5l1266t2087r1330b2109],
12	1843	CD	DATE	1843	dep	3	SENT_113	[p5l1991t2077r2066b2100],

1	The	DT	O	the	det	4	SENT_114	[p5l753t2121r804b2144],
2	New	NNP	O	New	nn	4	SENT_114	[p5l813t2121r875b2144],
3	England	NNP	O	England	nn	4	SENT_114	[p5l884t2121r995b2151],
4	Journal	NNP	O	Journal	_	0	SENT_114	[p5l1003t2121r1101b2144],
5	of	IN	O	of	_	0	SENT_114	[p5l1110t2121r1139b2144],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_114	[p5l1146t2121r1271b2144],

1	Downloaded	VBN	O	download	_	0	SENT_115	[p5l195t2161r365b2184],
2	from	IN	O	from	_	0	SENT_115	[p5l374t2161r438b2184],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_115	[p5l447t2161r565b2191],
4	at	IN	O	at	_	0	SENT_115	[p5l575t2164r598b2184],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_115	[p5l607t2161r789b2185],
6	on	IN	O	on	_	0	SENT_115	[p5l799t2168r831b2184],
7	January	NNP	DATE	January	prep_on	1	SENT_115	[p5l840t2161r943b2191],
8	5	CD	DATE	5	num	7	SENT_115	[p5l953t2161r975b2189],
9	,	,	DATE	,	_	0	SENT_115	[p5l953t2161r975b2189],
10	2014	CD	DATE	2014	num	7	SENT_115	[p5l986t2161r1058b2185],
11	.	.	O	.	_	0	SENT_115	[p5l986t2161r1058b2185],

1	For	IN	O	for	_	0	SENT_116	[p5l1069t2161r1115b2184],
2	personal	JJ	O	personal	amod	3	SENT_116	[p5l1123t2161r1236b2191],
3	use	NN	O	use	pobj	1	SENT_116	[p5l1245t2168r1288b2184],
4	only	RB	O	only	advmod	3	SENT_116	[p5l1298t2161r1363b2191],
5	.	.	O	.	_	0	SENT_116	[p5l1298t2161r1363b2191],

1	No	DT	O	no	det	3	SENT_117	[p5l1373t2161r1413b2184],
2	other	JJ	O	other	amod	3	SENT_117	[p5l1423t2161r1491b2184],
3	uses	NNS	O	use	_	0	SENT_117	[p5l1499t2168r1555b2184],
4	without	IN	O	without	_	0	SENT_117	[p5l1565t2161r1667b2184],
5	permission	NN	O	permission	prep_without	3	SENT_117	[p5l1675t2161r1827b2191],
6	.	.	O	.	_	0	SENT_117	[p5l1675t2161r1827b2191],

1	Copyright	NN	O	copyright	_	0	SENT_118	[p5l545t2202r680b2233],
2	©	CD	NUMBER	©	num	6	SENT_118	[p5l689t2202r712b2226],
3	2007	CD	DATE	2007	num	6	SENT_118	[p5l722t2202r787b2226],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_118	[p5l797t2202r988b2226],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_118	[p5l998t2202r1106b2226],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_118	[p5l1116t2202r1221b2233],
7	.	.	O	.	_	0	SENT_118	[p5l1116t2202r1221b2233],

1	All	DT	O	all	det	2	SENT_119	[p5l1232t2202r1274b2226],
2	rights	NNS	O	rights	nsubj	3	SENT_119	[p5l1283t2202r1357b2233],
3	reserved	VBN	O	reserve	_	0	SENT_119	[p5l1367t2202r1486b2226],
4	.	.	O	.	_	0	SENT_119	[p5l1367t2202r1486b2226],

1	The	DT	O	the	det	4	SENT_120	[p5l672t2308r717b2329],
2	NEW	NNP	O	NEW	nn	4	SENT_120	[p5l736t2310r821b2329],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_120	[p5l840t2310r1029b2329],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_120	[p5l1048t2310r1228b2336],
5	of	IN	O	of	_	0	SENT_120	[p5l1247t2308r1276b2335],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_120	[p5l1287t2310r1487b2329],

1	Table	NNP	O	Table	_	0	SENT_121	[p6l59t130r200b178],
2	1	CD	NUMBER	1	dep	1	SENT_121	[p6l220t134r261b178],
3	.	.	O	.	_	0	SENT_121	[p6l220t134r261b178],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_122	[p6l284t130r589b178],
2	Synthesis	NN	O	synthesis	_	0	SENT_122	[p6l605t130r856b193],
3	and	CC	O	and	_	0	SENT_122	[p6l875t130r969b178],
4	Receptor	NN	O	receptor	nn	5	SENT_122	[p6l992t134r1222b192],
5	Expression	NN	O	expression	conj_and	2	SENT_122	[p6l1241t131r1522b192],
6	in	IN	O	in	_	0	SENT_122	[p6l1544t131r1588b177],
7	Leukocyte	NN	O	leukocyte	nn	8	SENT_122	[p6l1612t130r1870b193],
8	Subgroups	NNS	O	subgroup	prep_in	2	SENT_122	[p6l59t209r392b272],
9	.	.	O	.	_	0	SENT_122	[p6l59t209r392b272],

1	*	NN	O	*	_	0	SENT_123	[p6l59t209r392b272],

1	Relative	JJ	O	relative	_	0	SENT_124	[p6l806t352r1008b400],

1	Type	NN	O	type	_	0	SENT_125	[p6l58t428r184b487],
2	of	IN	O	of	_	0	SENT_125	[p6l203t423r263b472],
3	Cell	NN	O	cell	prep_of	1	SENT_125	[p6l272t424r367b472],
4	Synthetic	JJ	O	synthetic	amod	7	SENT_125	[p6l662t424r905b487],
5	Capacity	NN	O	capacity	nn	7	SENT_125	[p6l925t425r1149b487],
6	Receptor	NN	O	receptor	nn	7	SENT_125	[p6l1405t428r1634b486],
7	Expression	NN	O	expression	dep	1	SENT_125	[p6l1656t425r1937b486],

1	Cysteinyl	NN	O	cysteinyl	_	0	SENT_126	[p6l862t534r1089b598],

1	LTB4	NN	O	ltb4	nn	2	SENT_127	[p6l640t611r760b668],
2	Leukotrienes	NNS	O	leukotriene	_	0	SENT_127	[p6l814t606r1143b654],
3	BLT1	NN	O	blt1	nn	6	SENT_127	[p6l1263t611r1380b666],
4	BLT2	NN	O	blt2	nn	6	SENT_127	[p6l1486t611r1606b666],
5	CysLT1	NN	O	cyslt1	nn	6	SENT_127	[p6l1687t610r1864b669],
6	CysLT2	NN	O	cyslt2	dep	2	SENT_127	[p6l1925t610r2103b669],

1	Neutrophil	NN	O	neutrophil	_	0	SENT_128	[p6l65t717r342b779],
2	+	CC	O	+	dep	5	SENT_128	[p6l646t733r748b764],
3	+	CC	O	+	_	0	SENT_128	[p6l646t733r748b764],
4	+	CC	O	+	_	0	SENT_128	[p6l646t733r748b764],
5	—	NN	O	—	rcmod	1	SENT_128	[p6l963t747r991b751],
6	+	CC	O	+	_	0	SENT_128	[p6l1305t733r1336b764],
7	+	CC	O	+	cc	8	SENT_128	[p6l1528t733r1559b764],
8	J_r	NN	O	j_r	rcmod	1	SENT_128	[p6l1760t733r1791b764],
9	Macrophage	NN	O	macrophage	dep	8	SENT_128	[p6l65t827r388b891],
10	or	CC	O	or	_	0	SENT_128	[p6l408t844r461b875],
11	+	CC	O	+	nsubj	13	SENT_128	[p6l664t844r730b875],
12	+	CC	O	+	_	0	SENT_128	[p6l664t844r730b875],
13	+	CC	O	+	conj_or	5	SENT_128	[p6l943t844r1010b874],
14	+	CC	O	+	xcomp	13	SENT_128	[p6l943t844r1010b874],
15	+	CC	O	+	_	0	SENT_128	[p6l1305t844r1336b874],
16	+	CC	O	+	conj_or	5	SENT_128	[p6l1528t844r1559b874],
17	+	CC	O	+	xcomp	16	SENT_128	[p6l1760t844r1791b874],

1	monocyte	NN	O	monocyte	_	0	SENT_129	[p6l159t908r413b962],

1	Eosinophil	NN	O	eosinophil	nn	4	SENT_130	[p6l65t1009r335b1072],
2	Basophil	NN	O	basophil	nn	4	SENT_130	[p6l65t1120r284b1182],
3	Mast	NN	O	mast	nn	4	SENT_130	[p6l65t1235r192b1278],
4	cell	NN	O	cell	_	0	SENT_130	[p6l210t1231r292b1278],

1	B	NN	O	b	nn	3	SENT_131	[p6l65t1346r92b1388],
2	lymphocyte	NN	O	lymphocyte	nn	3	SENT_131	[p6l116t1341r411b1404],
3	CD4	NN	O	cd4	_	0	SENT_131	[p6l61t1455r172b1499],
4	T	NN	O	t	nn	8	SENT_131	[p6l189t1456r223b1499],
5	lymphocyte	NN	O	lymphocyte	nn	8	SENT_131	[p6l243t1451r538b1515],
6	CD8	NN	O	cd8	nn	8	SENT_131	[p6l61t1565r171b1610],
7	T	NN	O	t	nn	8	SENT_131	[p6l189t1566r223b1609],
8	lymphocyte	NN	O	lymphocyte	dep	3	SENT_131	[p6l243t1562r538b1625],
9	Dendritic	JJ	MISC	dendritic	amod	10	SENT_131	[p6l65t1672r303b1721],
10	cell	NN	O	cell	dep	3	SENT_131	[p6l321t1673r403b1721],

1	Hematopoietic	JJ	MISC	hematopoietic	amod	2	SENT_132	[p6l65t1787r453b1845],
2	progenitor	NN	O	progenitor	_	0	SENT_132	[p6l474t1800r575b1845, p6l157t1859r342b1918],

1	cell	NN	O	cell	_	0	SENT_133	[p6l360t1855r441b1903],

1	7	CD	NUMBER	7	dep	8	SENT_134	[p6l9t2022r38b2050],
2	'	''	O	'	_	0	SENT_134	[p6l9t2022r38b2050],
3	‘	CD	NUMBER	‘	num	6	SENT_134	[p6l9t2022r38b2050],
4	Relative	JJ	O	relative	amod	6	SENT_134	[p6l62t2018r260b2066],
5	synthetic	JJ	O	synthetic	amod	6	SENT_134	[p6l284t2018r516b2080],
6	capacity	NN	O	capacity	nsubjpass	8	SENT_134	[p6l537t2022r748b2080],
7	is	VBZ	O	be	auxpass	8	SENT_134	[p6l770t2022r806b2065],
8	expressed	VBN	O	express	_	0	SENT_134	[p6l830t2018r1086b2080],
9	by	IN	O	by	_	0	SENT_134	[p6l1113t2018r1168b2080],
10	the	DT	O	the	det	11	SENT_134	[p6l1186t2018r1268b2065],
11	number	NN	O	number	agent	8	SENT_134	[p6l1292t2017r1496b2066],
12	of	IN	O	of	_	0	SENT_134	[p6l1516t2017r1572b2066],
13	plus	CC	O	plus	_	0	SENT_134	[p6l1588t2017r1693b2080],
14	(	NN	O	(	prep_of	11	SENT_134	[p6l1722t2021r1788b2080],
15	+	CC	O	+	_	0	SENT_134	[p6l1722t2021r1788b2080],
16	)	NN	O	)	nn	17	SENT_134	[p6l1722t2021r1788b2080],
17	signs	NNS	O	sign	prep_of	11	SENT_134	[p6l1816t2022r1965b2081],
18	;	:	O	;	_	0	SENT_134	[p6l1816t2022r1965b2081],
19	a	DT	O	a	dep	14	SENT_134	[p6l1990t2034r2014b2065],
20	minus	CC	O	minus	prep	11	SENT_134	[p6l2040t2022r2120b2065, p6l60t2106r149b2138],
21	sign	NN	O	sign	nn	22	SENT_134	[p6l174t2094r277b2153],
22	(	NN	O	(	dep	20	SENT_134	[p6l308t2094r368b2152],
23	.	.	O	.	_	0	SENT_134	[p6l308t2094r368b2152],

1	—	NN	O	—	_	0	SENT_135	[p6l308t2094r368b2152],
2	.	.	O	.	_	0	SENT_135	[p6l308t2094r368b2152],
3	)	SYM	O	)	dep	1	SENT_135	[p6l308t2094r368b2152],

1	denotes	VBZ	O	denote	_	0	SENT_136	[p6l396t2090r601b2138],
2	no	DT	O	no	amod	6	SENT_136	[p6l628t2107r689b2138],
3	or	CC	O	or	_	0	SENT_136	[p6l711t2107r764b2137],
4	negligible	JJ	O	negligible	amod	6	SENT_136	[p6l787t2090r1035b2153],
5	synthetic	JJ	O	synthetic	amod	6	SENT_136	[p6l1058t2090r1291b2152],
6	capacity	NN	O	capacity	dobj	1	SENT_136	[p6l1312t2094r1535b2152],
7	.	.	O	.	_	0	SENT_136	[p6l1312t2094r1535b2152],

1	Receptor	NN	O	receptor	nn	2	SENT_137	[p6l1563t2094r1793b2152],
2	expression	NN	O	expression	nsubjpass	4	SENT_137	[p6l1813t2094r2089b2152],
3	is	VBZ	O	be	auxpass	4	SENT_137	[p6l60t2165r96b2209],
4	classified	VBN	O	classify	_	0	SENT_137	[p6l120t2160r357b2209],
5	as	IN	O	as	_	0	SENT_137	[p6l383t2177r435b2209],
6	positive	JJ	O	positive	amod	7	SENT_137	[p6l461t2165r661b2223],
7	(	NN	O	(	prep_as	4	SENT_137	[p6l689t2165r774b2223],
8	+	CC	O	+	_	0	SENT_137	[p6l689t2165r774b2223],
9	)	NN	O	)	conj_+	7	SENT_137	[p6l689t2165r774b2223],
10	,	,	O	,	_	0	SENT_137	[p6l689t2165r774b2223],
11	negative	JJ	O	negative	amod	12	SENT_137	[p6l801t2165r1016b2224],
12	(	NN	O	(	appos	9	SENT_137	[p6l1044t2165r1123b2223],
13	.	.	O	.	_	0	SENT_137	[p6l1044t2165r1123b2223],

1	—	NN	O	—	_	0	SENT_138	[p6l1044t2165r1123b2223],
2	.	.	O	.	_	0	SENT_138	[p6l1044t2165r1123b2223],
3	)	SYM	O	)	dep	1	SENT_138	[p6l1044t2165r1123b2223],

1	,	,	O	,	_	0	SENT_139	[p6l1044t2165r1123b2223],
2	minimal	JJ	O	minimal	amod	3	SENT_139	[p6l1150t2161r1361b2208],
3	(	NN	O	(	_	0	SENT_139	[p6l1391t2165r1476b2223],
4	1	CD	NUMBER	1	num	5	SENT_139	[p6l1391t2165r1476b2223],
5	)	NN	O	)	dep	3	SENT_139	[p6l1391t2165r1476b2223],
6	,	,	O	,	_	0	SENT_139	[p6l1391t2165r1476b2223],
7	or	CC	O	or	cc	8	SENT_139	[p6l1501t2178r1554b2209],
8	not	RB	O	not	advmod	3	SENT_139	[p6l1577t2170r1659b2209],
9	determined	VBN	O	determine	partmod	3	SENT_139	[p6l1680t2161r1978b2209],
10	(	CD	NUMBER	(	num	12	SENT_139	[p6l63t2236r207b2294],
11	ND	NN	O	nd	nn	12	SENT_139	[p6l63t2236r207b2294],
12	)	NN	O	)	dobj	9	SENT_139	[p6l63t2236r207b2294],
13	.	.	O	.	_	0	SENT_139	[p6l63t2236r207b2294],

1	With	IN	O	with	_	0	SENT_140	[p6l229t2232r349b2280],
2	respect	NN	O	respect	_	0	SENT_140	[p6l377t2241r563b2294],
3	to	TO	O	to	_	0	SENT_140	[p6l583t2241r633b2279],
4	cells	NNS	O	cell	prep_with_respect_to	20	SENT_140	[p6l656t2232r767b2280],
5	for	IN	O	for	_	0	SENT_140	[p6l790t2231r862b2279],
6	which	WDT	O	which	rel	8	SENT_140	[p6l880t2232r1030b2280],
7	discrepancies	NNS	O	discrepancy	nsubj	8	SENT_140	[p6l1055t2232r1410b2294],
8	exist	VBP	O	exist	rcmod	4	SENT_140	[p6l1434t2236r1550b2279],
9	in	IN	O	in	_	0	SENT_140	[p6l1573t2236r1614b2279],
10	reports	NNS	O	report	prep_in	8	SENT_140	[p6l1642t2241r1823b2294],
11	on	IN	O	on	_	0	SENT_140	[p6l1847t2248r1908b2279],
12	leukotriene	NN	O	leukotriene	nn	13	SENT_140	[p6l1936t2232r2089b2280, p6l56t2307r205b2351],
13	synthesis	NN	O	synthesis	prep_on	10	SENT_140	[p6l228t2303r467b2365],
14	or	CC	O	or	_	0	SENT_140	[p6l491t2320r544b2350],
15	receptor	NN	O	receptor	nn	16	SENT_140	[p6l567t2312r781b2365],
16	expression	NN	O	expression	conj_or	13	SENT_140	[p6l801t2307r1094b2365],
17	,	,	O	,	_	0	SENT_140	[p6l801t2307r1094b2365],
18	the	DT	O	the	det	19	SENT_140	[p6l1117t2303r1198b2350],
19	table	NN	O	table	nsubj	20	SENT_140	[p6l1218t2303r1345b2351],
20	lists	VBZ	O	list	_	0	SENT_140	[p6l1369t2303r1469b2351],
21	the	DT	O	the	det	24	SENT_140	[p6l1490t2303r1572b2350],
22	best	JJS	O	best	dep	23	SENT_140	[p6l1596t2303r1702b2351],
23	available	JJ	O	available	amod	24	SENT_140	[p6l1724t2303r1949b2351],
24	information	NN	O	information	dobj	20	SENT_140	[p6l1973t2302r2108b2350, p6l60t2378r239b2422],
25	taken	VBN	O	take	partmod	24	SENT_140	[p6l262t2374r401b2422],
26	from	IN	O	from	_	0	SENT_140	[p6l425t2373r546b2421],
27	primary	JJ	O	primary	amod	28	SENT_140	[p6l573t2378r772b2436],
28	cells	NNS	O	cell	prep_from	25	SENT_140	[p6l793t2374r919b2430],
29	,	,	O	,	_	0	SENT_140	[p6l793t2374r919b2430],
30	particularly	RB	O	particularly	advmod	24	SENT_140	[p6l946t2374r1234b2436],
31	those	DT	O	those	dep	24	SENT_140	[p6l1253t2374r1397b2422],
32	that	WDT	O	that	nsubj	34	SENT_140	[p6l1417t2374r1520b2422],
33	are	VBP	O	be	cop	34	SENT_140	[p6l1541t2390r1618b2422],
34	human	JJ	O	human	rcmod	31	SENT_140	[p6l1642t2374r1821b2422],
35	in	IN	O	in	_	0	SENT_140	[p6l1848t2378r1889b2421],
36	origin	NN	O	origin	prep_in	34	SENT_140	[p6l1914t2378r2077b2437],
37	.	.	O	.	_	0	SENT_140	[p6l1914t2378r2077b2437],

1	neutrophil	NN	O	neutrophil	nn	2	SENT_141	[p6l561t2640r905b2714],
2	chemotaxis	NN	O	chemotaxi	nsubj	19	SENT_141	[p6l943t2640r1315b2699],
3	for	IN	O	for	_	0	SENT_141	[p6l1355t2639r1448b2699],
4	the	DT	O	the	det	6	SENT_141	[p6l1484t2640r1584b2698],
5	latter	JJ	O	latter	amod	6	SENT_141	[p6l1621t2640r1831b2711],
6	)	NN	O	)	prep_for	2	SENT_141	[p6l1621t2640r1831b2711],
7	,	,	O	,	_	0	SENT_141	[p6l1621t2640r1831b2711],
8	Whereas	IN	O	whereas	mark	11	SENT_141	[p6l1870t2640r2136b2699],
9	other	JJ	O	other	amod	10	SENT_141	[p6l561t2735r724b2794],
10	actions	NNS	O	action	nsubj	11	SENT_141	[p6l741t2736r958b2794],
11	(	VBP	O	(	advcl	19	SENT_141	[p6l983t2740r1120b2810],
12	e.g.	FW	O	e.g.	dobj	11	SENT_141	[p6l983t2740r1120b2810],
13	,	,	O	,	_	0	SENT_141	[p6l983t2740r1120b2810],
14	promotion	NN	O	promotion	nsubj	19	SENT_141	[p6l1143t2736r1472b2809],
15	of	IN	O	of	_	0	SENT_141	[p6l1492t2734r1565b2794],
16	allergic	JJ	O	allergic	amod	18	SENT_141	[p6l1570t2735r1795b2810],
17	responses	NNS	O	response	nn	18	SENT_141	[p6l1814t2740r2134b2809],
18	)	NN	O	)	prep_of	14	SENT_141	[p6l1814t2740r2134b2809],
19	are	VBP	O	be	_	0	SENT_141	[p6l560t2849r655b2888],
20	not	RB	O	not	neg	19	SENT_141	[p6l678t2842r797b2889],
21	.	.	O	.	_	0	SENT_141	[p6l678t2842r797b2889],

1	Leukotrienes	NNS	O	leukotriene	nsubj	2	SENT_142	[p6l823t2830r1228b2889],
2	promote	VBP	O	promote	_	0	SENT_142	[p6l1253t2842r1519b2904],
3	the	DT	O	the	det	4	SENT_142	[p6l1542t2830r1639b2888],
4	movement	NN	O	movement	dobj	2	SENT_142	[p6l1663t2842r1992b2889],
5	into	IN	O	into	_	0	SENT_142	[p6l2011t2831r2137b2889],
6	tissues	NNS	O	tissue	prep_into	2	SENT_142	[p6l561t2926r776b2984],
7	and	CC	O	and	_	0	SENT_142	[p6l801t2925r919b2984],
8	function	NN	O	function	prep_into	2	SENT_142	[p6l944t2924r1216b2984],
9	of	IN	O	of	_	0	SENT_142	[p6l1242t2924r1316b2984],
10	virtually	RB	O	virtually	advmod	12	SENT_142	[p6l1324t2925r1594b2999],
11	all	DT	O	all	det	12	SENT_142	[p6l1615t2925r1693b2983],
12	subgroups	NNS	O	subgroup	prep_of	8	SENT_142	[p6l1719t2925r2051b3000],
13	of	IN	O	of	_	0	SENT_142	[p6l2078t2924r2152b2984],
14	leul	NN	O	leul	prep_of	12	SENT_142	[p6l560t3020r1006b3094],
15	2	CD	NUMBER	2	number	16	SENT_142	[p6l560t3020r1006b3094],
16	(	CD	NUMBER	(	num	17	SENT_142	[p6l1034t3021r1161b3095],
17	Fig	NN	O	fig	dep	8	SENT_142	[p6l1034t3021r1161b3095],
18	.	.	O	.	_	0	SENT_142	[p6l1034t3021r1161b3095],

1	2	CD	NUMBER	2	num	2	SENT_143	[p6l1189t3024r1260b3088],
2	)	CD	NUMBER	)	_	0	SENT_143	[p6l1189t3024r1260b3088],
3	.	.	O	.	_	0	SENT_143	[p6l1189t3024r1260b3088],

1	Also	RB	O	also	advmod	5	SENT_144	[p6l1284t3020r1422b3079],
2	important	JJ	O	important	advmod	5	SENT_144	[p6l1446t3021r1761b3094],
3	is	VBZ	O	be	cop	5	SENT_144	[p6l1780t3021r1827b3078],
4	their	PRP$	O	they	poss	5	SENT_144	[p6l1853t3020r1998b3078],
5	role	NN	O	role	_	0	SENT_144	[p6l2019t3020r2138b3079],
6	in	IN	O	in	_	0	SENT_144	[p6l560t3116r622b3173],
7	amplifying	VBG	O	amplify	prepc_in	5	SENT_144	[p6l647t3114r1001b3190],
8	inflammatory	JJ	O	inflammatory	amod	9	SENT_144	[p6l1024t3114r1477b3189],
9	responses	NNS	O	response	dobj	7	SENT_144	[p6l1500t3134r1814b3189],
10	mediated	VBN	O	mediate	partmod	9	SENT_144	[p6l1841t3115r2138b3174],
11	by	IN	O	by	_	0	SENT_144	[p6l561t3210r631b3284],
12	Th2	NN	O	th2	nn	13	SENT_144	[p6l649t3210r771b3268],
13	cells	NNS	O	cell	agent	10	SENT_144	[p6l796t3210r1067b3269],
14	.33	CD	NUMBER	.33	nsubj	5	SENT_144	[p6l796t3210r1067b3269],
15	‘	CD	NUMBER	‘	number	16	SENT_144	[p6l796t3210r1067b3269],
16	35	CD	NUMBER	35	num	18	SENT_144	[p6l796t3210r1067b3269],
17	The	DT	O	the	det	18	SENT_144	[p6l1091t3210r1207b3268],
18	ability	NN	O	ability	nsubj	34	SENT_144	[p6l1230t3210r1422b3284],
19	of	IN	O	of	_	0	SENT_144	[p6l1442t3209r1514b3269],
20	a	DT	O	a	det	22	SENT_144	[p6l1523t3229r1556b3268],
21	CysLT1	NN	O	cyslt1	nn	22	SENT_144	[p6l1578t3214r1786b3287],
22	antagonist	NN	O	antagonist	prep_of	18	SENT_144	[p6l1809t3211r2142b3285],
23	to	TO	O	to	aux	24	SENT_144	[p6l561t3317r622b3364],
24	reduce	VB	O	reduce	infmod	18	SENT_144	[p6l658t3305r870b3364],
25	serum	NN	O	serum	nn	26	SENT_144	[p6l906t3324r1109b3364],
26	levels	NNS	O	level	dobj	24	SENT_144	[p6l1143t3305r1318b3364],
27	of	IN	O	of	_	0	SENT_144	[p6l1355t3304r1430b3364],
28	IgE	NN	O	ige	prep_of	26	SENT_144	[p6l1449t3310r1555b3380],
29	in	IN	O	in	_	0	SENT_144	[p6l1591t3306r1654b3363],
30	children	NNS	O	child	prep_in	24	SENT_144	[p6l1689t3305r1959b3364],
31	with	IN	O	with	_	0	SENT_144	[p6l1990t3305r2138b3364],
32	asthma	NN	O	asthma	prep_with	30	SENT_144	[p6l560t3400r790b3458],
33	is	VBZ	O	be	cop	34	SENT_144	[p6l815t3401r862b3458],
34	indicative	JJ	O	indicative	rcmod	14	SENT_144	[p6l890t3400r1183b3459],
35	of	IN	O	of	_	0	SENT_144	[p6l1211t3399r1283b3459],
36	the	DT	O	the	det	37	SENT_144	[p6l1297t3400r1392b3458],
37	effects	NNS	O	effect	prep_of	14	SENT_144	[p6l1420t3399r1619b3458],
38	of	IN	O	of	_	0	SENT_144	[p6l1648t3399r1721b3459],
39	cysteinyl	NN	O	cysteinyl	nn	40	SENT_144	[p6l1734t3400r1995b3474],
40	leukotrienes	NNS	O	leukotriene	prep_of	37	SENT_144	[p6l2021t3400r2137b3459, p6l561t3495r855b3554],
41	on	IN	O	on	_	0	SENT_144	[p6l887t3514r966b3554],
42	systemic	JJ	O	systemic	amod	44	SENT_144	[p6l996t3496r1269b3569],
43	immune	JJ	O	immune	amod	44	SENT_144	[p6l1297t3496r1565b3554],
44	responses.-36	NN	O	responses.-36	prep_on	40	SENT_144	[p6l1595t3498r1986b3569],

1	BLOCKADE	NN	O	blockade	_	0	SENT_145	[p6l740t3743r1182b3788],
2	OF	IN	O	of	_	0	SENT_145	[p6l1221t3743r1319b3787],
3	LEUKOTRIENE	NN	O	leukotriene	prep_of	1	SENT_145	[p6l1359t3743r1960b3788],

1	SYNTHESIS	NN	O	synthesis	_	0	SENT_146	[p7l695t24r1148b68],
2	AND	CC	O	and	cc	3	SENT_146	[p7l1185t24r1362b68],
3	LEUKOTRIENE	NN	O	leukotriene	dep	1	SENT_146	[p7l1404t24r2005b69],

1	RECEPTORS	NNS	O	receptor	_	0	SENT_147	[p7l1109t102r1590b146],

1	Commonly	RB	O	commonly	advmod	2	SENT_148	[p7l561t275r906b349],
2	used	VBN	O	use	amod	4	SENT_148	[p7l924t275r1066b334],
3	antiinﬂammatory	JJ	O	antiinﬂammatory	amod	4	SENT_148	[p7l1087t274r1644b349],
4	medications	NNS	O	medication	nsubj	8	SENT_148	[p7l1663t275r2036b334],
5	do	VBP	O	do	aux	8	SENT_148	[p7l2061t275r2137b334],
6	not	RB	O	not	neg	8	SENT_148	[p7l561t382r667b429],
7	predictably	RB	O	predictably	advmod	8	SENT_148	[p7l692t370r1050b444],
8	interfere	VB	O	interfere	_	0	SENT_148	[p7l1075t369r1348b428],
9	with	IN	O	with	_	0	SENT_148	[p7l1374t370r1520b429],
10	the	DT	O	the	det	11	SENT_148	[p7l1550t370r1649b428],
11	synthesis	NN	O	synthesis	prep_with	8	SENT_148	[p7l1679t370r1972b444],
12	of	IN	O	of	_	0	SENT_148	[p7l2004t369r2078b429],
13	37	CD	NUMBER	37	prep_of	11	SENT_148	[p7l2087t374r2138b406],
14	or	CC	O	or	_	0	SENT_148	[p7l561t484r626b524],
15	responses	NNS	O	response	conj_or	11	SENT_148	[p7l650t484r959b539],
16	to38	CD	NUMBER	to38	num	17	SENT_148	[p7l987t469r1102b524],
17	leukotrienes	NNS	O	leukotriene	dep	15	SENT_148	[p7l1128t465r1530b524],
18	.	.	O	.	_	0	SENT_148	[p7l1128t465r1530b524],

1	Nonsteroidal	JJ	O	nonsteroidal	amod	3	SENT_149	[p7l1559t465r1966b524],
2	antiinflammatory	JJ	O	antiinflammatory	amod	3	SENT_149	[p7l1992t466r2137b523, p7l560t559r1005b634],
3	drugs	NNS	O	drug	nsubj	6	SENT_149	[p7l1022t560r1200b635],
4	can	MD	O	can	aux	6	SENT_149	[p7l1222t579r1331b618],
5	actually	RB	O	actually	advmod	6	SENT_149	[p7l1351t560r1595b634],
6	increase	VB	O	increase	_	0	SENT_149	[p7l1611t561r1868b618],
7	the	DT	O	the	det	8	SENT_149	[p7l1888t560r1985b618],
8	production	NN	O	production	nsubj	11	SENT_149	[p7l2004t579r2137b634, p7l561t655r797b714],
9	of	IN	O	of	_	0	SENT_149	[p7l824t654r897b713],
10	leul	NN	O	leul	prep_of	8	SENT_149	[p7l909t655r1367b726],
11	<	JJR	O	<	xcomp	6	SENT_149	[p7l909t655r1367b726],
12	otrienes	CD	NUMBER	otrienes	num	13	SENT_149	[p7l909t655r1367b726],
13	,39	CD	NUMBER	,39	nsubj	17	SENT_149	[p7l909t655r1367b726],
14	and	CC	O	and	_	0	SENT_149	[p7l1394t655r1509b714],
15	corticosteroids	NNS	O	corticosteroid	conj_and	13	SENT_149	[p7l1536t655r1999b713],
16	can	MD	O	can	aux	17	SENT_149	[p7l2027t674r2138b713],
17	increase	VB	O	increase	ccomp	11	SENT_149	[p7l560t751r817b808],
18	the	DT	O	the	det	19	SENT_149	[p7l841t750r938b808],
19	expression	NN	O	expression	dobj	17	SENT_149	[p7l963t751r1295b825],
20	of	IN	O	of	_	0	SENT_149	[p7l1320t749r1393b809],
21	BLT1	NN	O	blt1	prep_of	19	SENT_149	[p7l1403t754r1547b827],
22	on	IN	O	on	_	0	SENT_149	[p7l1572t769r1650b809],
23	neutrophils	NNS	O	neutrophil	prep_on	11	SENT_149	[p7l1674t750r2111b825],
24	.4	CD	NUMBER	.4	number	25	SENT_149	[p7l1674t750r2111b825],
25	°	CD	NUMBER	°	num	27	SENT_149	[p7l1674t750r2111b825],
26	CysLT1	NN	O	cyslt1	nn	27	SENT_149	[p7l657t849r876b922],
27	antagonists	NNS	O	antagonist	nsubj	28	SENT_149	[p7l905t846r1285b920],
28	(	VBP	O	(	rcmod	23	SENT_149	[p7l1320t846r1457b920],
29	Fig	NN	O	fig	dobj	28	SENT_149	[p7l1320t846r1457b920],
30	.	.	O	.	_	0	SENT_149	[p7l1320t846r1457b920],

1	1	CD	NUMBER	1	number	2	SENT_150	[p7l1493t849r1546b913],
2	)	CD	NUMBER	)	nsubj	10	SENT_150	[p7l1493t849r1546b913],
3	include	VBP	O	include	dep	2	SENT_150	[p7l1579t845r1815b904],
4	montelukast	NN	O	montelukast	dobj	3	SENT_150	[p7l1845t845r2137b904, p7l561t940r702b1011],
5	,	,	O	,	_	0	SENT_150	[p7l1845t845r2137b904, p7l561t940r702b1011],
6	zafirlukast	NN	O	zafirlukast	dobj	3	SENT_150	[p7l731t939r1078b1011],
7	,	,	O	,	_	0	SENT_150	[p7l731t939r1078b1011],
8	and	CC	O	and	_	0	SENT_150	[p7l1106t940r1221b999],
9	pranlukast	NN	O	pranlukast	conj_and	4	SENT_150	[p7l1245t940r1577b1014],
10	(	VBP	O	(	_	0	SENT_150	[p7l1602t940r1715b1008],
11	the	DT	O	the	det	12	SENT_150	[p7l1602t940r1715b1008],
12	last	JJ	O	last	nsubj	13	SENT_150	[p7l1739t940r1849b998],
13	available	JJ	O	available	xcomp	10	SENT_150	[p7l1869t940r2138b999],
14	only	RB	O	only	advmod	13	SENT_150	[p7l562t1035r694b1109],
15	in	IN	O	in	_	0	SENT_150	[p7l713t1036r773b1093],
16	Japan	NNP	LOCATION	Japan	prep_in	10	SENT_150	[p7l789t1040r998b1109],
17	)	CD	NUMBER	)	num	16	SENT_150	[p7l789t1040r998b1109],
18	.	.	O	.	_	0	SENT_150	[p7l789t1040r998b1109],

1	The	DT	O	the	det	5	SENT_151	[p7l1023t1035r1140b1093],
2	only	JJ	O	only	amod	5	SENT_151	[p7l1163t1035r1295b1109],
3	other	JJ	O	other	amod	5	SENT_151	[p7l1315t1035r1478b1094],
4	antileukotriene	JJ	O	antileukotriene	amod	5	SENT_151	[p7l1498t1035r1965b1094],
5	drug	NN	O	drug	_	0	SENT_151	[p7l1989t1035r2141b1110],
6	that	WDT	O	that	nsubjpass	9	SENT_151	[p7l562t1130r685b1188],
7	has	VBZ	O	have	aux	9	SENT_151	[p7l707t1130r810b1188],
8	been	VBN	O	be	auxpass	9	SENT_151	[p7l839t1130r984b1189],
9	approved	VBN	O	approve	rcmod	5	SENT_151	[p7l1009t1130r1287b1204],
10	by	IN	O	by	_	0	SENT_151	[p7l1313t1130r1384b1204],
11	the	DT	O	the	det	15	SENT_151	[p7l1407t1130r1502b1188],
12	Food	NNP	ORGANIZATION	Food	nn	15	SENT_151	[p7l1528t1130r1682b1189],
13	and	CC	ORGANIZATION	and	_	0	SENT_151	[p7l1707t1130r1822b1189],
14	Drug	NNP	ORGANIZATION	Drug	nn	15	SENT_151	[p7l1846t1135r2006b1205],
15	Administration	NNP	ORGANIZATION	Administration	agent	9	SENT_151	[p7l2026t1130r2137b1189, p7l10t1399r541b1476],

1	(	NN	O	(	nsubj	5	SENT_152	[p7l585t1404r817b1488],
2	FDA	NNP	ORGANIZATION	FDA	dep	1	SENT_152	[p7l585t1404r817b1488],
3	)	CD	NUMBER	)	num	2	SENT_152	[p7l585t1404r817b1488],
4	is	VBZ	O	be	cop	5	SENT_152	[p7l861t1399r926b1475],
5	zileuton	NN	O	zileuton	_	0	SENT_152	[p7l967t1398r1330b1493],
6	,	,	O	,	_	0	SENT_152	[p7l967t1398r1330b1493],
7	which	WDT	O	which	nsubj	9	SENT_152	[p7l1370t1398r1629b1477],
8	directly	RB	O	directly	advmod	9	SENT_152	[p7l1668t1398r1985b1497],
9	inhibits	VBZ	O	inhibit	rcmod	5	SENT_152	[p7l2019t1399r2134b1475, p7l10t1526r250b1605],
10	5-lipoxygenase	NN	O	5-lipoxygenase	dobj	9	SENT_152	[p7l295t1526r959b1627],
11	;	:	O	;	_	0	SENT_152	[p7l295t1526r959b1627],
12	this	DT	O	this	det	13	SENT_152	[p7l1004t1526r1165b1604],
13	effect	NN	O	effect	nsubj	14	SENT_152	[p7l1208t1525r1450b1604],
14	blocks	VBZ	O	block	parataxis	5	SENT_152	[p7l1487t1526r1760b1605],
15	production	NN	O	production	dobj	14	SENT_152	[p7l1803t1526r2134b1626, p7l10t1655r180b1733],
16	of	IN	O	of	_	0	SENT_152	[p7l218t1653r318b1733],
17	cysteinyl	NN	O	cysteinyl	nn	18	SENT_152	[p7l338t1654r706b1754],
18	leukotrienes	NNS	O	leukotriene	prep_of	15	SENT_152	[p7l742t1654r1272b1733],
19	and	CC	O	and	_	0	SENT_152	[p7l1311t1654r1469b1733],
20	LTB4	NN	O	ltb4	conj_and	18	SENT_152	[p7l1504t1660r1735b1760],
21	.	.	O	.	_	0	SENT_152	[p7l1504t1660r1735b1760],

1	Zileuton	NN	O	zileuton	nsubj	2	SENT_153	[p7l1776t1654r2135b1733],
2	inhibits	VBZ	O	inhibit	_	0	SENT_153	[p7l9t1782r347b1861],
3	an	DT	O	a	det	5	SENT_153	[p7l387t1808r491b1860],
4	estimated	VBN	O	estimate	amod	5	SENT_153	[p7l530t1782r961b1861],
5	26	CD	NUMBER	26	dobj	2	SENT_153	[p7l999t1788r1099b1861],
6	to	TO	O	to	_	0	SENT_153	[p7l1138t1799r1221b1861],
7	86	CD	PERCENT	86	num	8	SENT_153	[p7l1260t1787r1447b1861],
8	%	NN	PERCENT	%	prep_to	5	SENT_153	[p7l1260t1787r1447b1861],
9	of	IN	O	of	_	0	SENT_153	[p7l1485t1781r1586b1861],
10	endogenous	JJ	O	endogenous	amod	12	SENT_153	[p7l1606t1782r2133b1883],
11	leukotriene	NN	O	leukotriene	nn	12	SENT_153	[p7l8t1909r474b1989],
12	production	NN	O	production	prep_of	8	SENT_153	[p7l507t1909r1058b2009],
13	.	.	O	.	_	0	SENT_153	[p7l507t1909r1058b2009],

1	“	NN	O	“	nsubjpass	8	SENT_154	[p7l507t1909r1058b2009],
2	The	DT	O	the	det	4	SENT_154	[p7l1090t1909r1246b1987],
3	clinical	JJ	O	clinical	amod	4	SENT_154	[p7l1281t1909r1581b1987],
4	use	NN	O	use	dep	1	SENT_154	[p7l1614t1935r1750b1989],
5	of	IN	O	of	_	0	SENT_154	[p7l1786t1908r1883b1988],
6	zileuton	NN	O	zileuton	prep_of	1	SENT_154	[p7l1899t1909r2134b1989, p7l10t2055r146b2116],
7	is	VBZ	O	be	auxpass	8	SENT_154	[p7l186t2039r249b2115],
8	limited	VBN	O	limit	_	0	SENT_154	[p7l291t2038r588b2116],
9	by	IN	O	by	_	0	SENT_154	[p7l630t2038r724b2137],
10	the	DT	O	the	det	11	SENT_154	[p7l761t2038r890b2116],
11	need	NN	O	need	agent	8	SENT_154	[p7l931t2038r1126b2116],
12	to	TO	O	to	aux	13	SENT_154	[p7l1167t2054r1246b2116],
13	monitor	VB	O	monitor	ccomp	8	SENT_154	[p7l1289t2039r1627b2116],
14	hepatic	JJ	O	hepatic	amod	16	SENT_154	[p7l1665t2038r1963b2137],
15	enzyme	NN	O	enzyme	nn	16	SENT_154	[p7l2004t2064r2134b2116, p7l9t2192r231b2266],
16	levels	NNS	O	level	dobj	13	SENT_154	[p7l260t2166r486b2245],
17	and	CC	O	and	_	0	SENT_154	[p7l517t2166r673b2245],
18	to	TO	O	to	aux	19	SENT_154	[p7l703t2183r784b2245],
19	administer	VB	O	administer	ccomp	8	SENT_154	[p7l815t2166r1276b2245],
20	the	DT	O	the	det	21	SENT_154	[p7l1303t2166r1434b2245],
21	drug	NN	O	drug	dobj	19	SENT_154	[p7l1465t2166r1666b2267],
22	four	CD	NUMBER	four	num	23	SENT_154	[p7l1693t2165r1870b2245],
23	times	NNS	O	time	tmod	19	SENT_154	[p7l1897t2167r2133b2245],
24	daily	RB	SET	daily	advmod	23	SENT_154	[p7l10t2293r221b2393],
25	.	.	O	.	_	0	SENT_154	[p7l10t2293r221b2393],

1	A	DT	O	a	det	4	SENT_155	[p7l253t2301r319b2371],
2	twice-daily	JJ	O	twice-daily	amod	4	SENT_155	[p7l347t2293r802b2393],
3	sustained-release	JJ	O	sustained-release	amod	4	SENT_155	[p7l830t2293r1535b2373],
4	form	NN	O	form	nsubj	9	SENT_155	[p7l1565t2292r1769b2372],
5	of	IN	O	of	_	0	SENT_155	[p7l1800t2292r1898b2372],
6	zileuton	NN	O	zileuton	prep_of	4	SENT_155	[p7l1910t2293r2134b2373, p7l10t2439r152b2500],
7	has	VBZ	O	have	aux	9	SENT_155	[p7l202t2422r349b2499],
8	recently	RB	DATE	recently	advmod	9	SENT_155	[p7l401t2422r749b2521],
9	received	VBN	O	receive	_	0	SENT_155	[p7l795t2422r1148b2501],
10	FDA	NNP	ORGANIZATION	FDA	nn	11	SENT_155	[p7l1197t2428r1384b2499],
11	approval	NN	O	approval	dobj	9	SENT_155	[p7l1431t2422r1829b2521],
12	.	.	O	.	_	0	SENT_155	[p7l1431t2422r1829b2521],

1	Other	JJ	O	other	amod	4	SENT_156	[p7l1885t2422r2138b2500],
2	candidate	NN	O	candidate	nn	4	SENT_156	[p7l10t2550r410b2629],
3	5-lipoxygenase	NN	O	5-lipoxygenase	nn	4	SENT_156	[p7l445t2550r1058b2651],
4	inhibitors	NNS	O	inhibitor	nsubj	6	SENT_156	[p7l1090t2550r1494b2629],
5	also	RB	O	also	advmod	6	SENT_156	[p7l1529t2550r1693b2629],
6	have	VBP	O	have	_	0	SENT_156	[p7l1728t2550r1912b2629],
7	hepatotoxicity	NN	O	hepatotoxicity	dobj	6	SENT_156	[p7l1945t2550r2134b2650, p7l9t2679r476b2777],
8	.	.	O	.	_	0	SENT_156	[p7l1945t2550r2134b2650, p7l9t2679r476b2777],

1	The	DT	O	the	det	3	SENT_157	[p7l512t2678r674b2756],
2	hepatic	JJ	O	hepatic	amod	3	SENT_157	[p7l708t2678r1019b2777],
3	injury	NN	O	injury	nsubj	7	SENT_157	[p7l1051t2679r1306b2777],
4	caused	VBN	O	cause	partmod	3	SENT_157	[p7l1336t2678r1626b2757],
5	by	IN	O	by	_	0	SENT_157	[p7l1661t2678r1758b2777],
6	zileuton	NN	O	zileuton	agent	4	SENT_157	[p7l1787t2678r2135b2757],
7	appears	VBZ	O	appear	_	0	SENT_157	[p7l9t2831r329b2905],
8	to	TO	O	to	aux	13	SENT_157	[p7l365t2822r444b2884],
9	be	VB	O	be	cop	13	SENT_157	[p7l480t2805r574b2884],
10	a	DT	O	a	det	13	SENT_157	[p7l607t2831r651b2883],
11	direct	JJ	O	direct	amod	13	SENT_157	[p7l684t2805r922b2884],
12	toxic	JJ	O	toxic	amod	13	SENT_157	[p7l951t2806r1148b2884],
13	effect	NN	O	effect	xcomp	7	SENT_157	[p7l1182t2804r1413b2883],
14	that	WDT	O	that	nsubj	16	SENT_157	[p7l1442t2805r1608b2883],
15	is	VBZ	O	be	cop	16	SENT_157	[p7l1636t2806r1700b2883],
16	unrelated	JJ	O	unrelated	rcmod	13	SENT_157	[p7l1734t2805r2135b2885],
17	to	TO	O	to	_	0	SENT_157	[p7l10t2951r91b3013],
18	inhibition	NN	O	inhibition	prep_to	16	SENT_157	[p7l132t2934r562b3013],
19	of	IN	O	of	_	0	SENT_157	[p7l603t2933r702b3013],
20	5-lipoXygenase	NN	O	5-lipoxygenase	prep_of	18	SENT_157	[p7l725t2934r1467b3035],
21	.42	CD	NUMBER	.42	num	20	SENT_157	[p7l725t2934r1467b3035],

1	An	DT	O	a	det	3	SENT_158	[p7l135t3070r257b3140],
2	alternative	JJ	O	alternative	amod	3	SENT_158	[p7l291t3062r722b3141],
3	Way	NN	O	way	nsubj	8	SENT_158	[p7l752t3088r917b3162],
4	of	IN	O	of	_	0	SENT_158	[p7l948t3061r1046b3141],
5	blocking	VBG	O	block	prepc_of	3	SENT_158	[p7l1064t3062r1426b3163],
6	leukotriene	NN	O	leukotriene	nn	7	SENT_158	[p7l1458t3062r1923b3141],
7	synthesis	NN	O	synthesis	dobj	5	SENT_158	[p7l1960t3088r2134b3162, p7l10t3189r257b3267],
8	is	VBZ	O	be	_	0	SENT_158	[p7l294t3190r359b3267],
9	to	TO	O	to	aux	10	SENT_158	[p7l396t3206r478b3268],
10	inhibit	VB	O	inhibit	xcomp	8	SENT_158	[p7l513t3189r805b3268],
11	FLAP	NN	O	flap	dobj	10	SENT_158	[p7l833t3196r1074b3268],
12	.	.	O	.	_	0	SENT_158	[p7l833t3196r1074b3268],

1	The	DT	O	the	det	3	SENT_159	[p7l1111t3189r1272b3267],
2	crystal	NN	O	crystal	nn	3	SENT_159	[p7l1308t3189r1592b3289],
3	structure	NN	O	structure	nsubjpass	10	SENT_159	[p7l1628t3206r2018b3269],
4	of	IN	O	of	_	0	SENT_159	[p7l2053t3188r2153b3268],
5	this	DT	O	this	det	6	SENT_159	[p7l10t3318r173b3395],
6	molecule	NN	O	molecule	prep_of	3	SENT_159	[p7l214t3318r608b3397],
7	has	VBZ	O	have	aux	10	SENT_159	[p7l646t3318r793b3395],
8	recently	RB	DATE	recently	advmod	10	SENT_159	[p7l833t3318r1181b3417],
9	been	VBN	O	be	auxpass	10	SENT_159	[p7l1215t3318r1420b3396],
10	reported	VBN	O	report	_	0	SENT_159	[p7l1459t3318r1936b3417],
11	,43	CD	NUMBER	,43	dobj	10	SENT_159	[p7l1459t3318r1936b3417],
12	and	CC	O	and	_	0	SENT_159	[p7l1975t3318r2135b3396],
13	this	DT	O	this	det	14	SENT_159	[p7l10t3446r173b3524],
14	information	NN	O	information	nsubj	16	SENT_159	[p7l231t3445r766b3525],
15	should	MD	O	should	aux	16	SENT_159	[p7l824t3446r1117b3525],
16	prove	VB	O	prove	conj_and	10	SENT_159	[p7l1171t3472r1408b3546],
17	useful	JJ	O	useful	acomp	16	SENT_159	[p7l1464t3445r1735b3525],
18	in	IN	O	in	_	0	SENT_159	[p7l1790t3447r1874b3524],
19	drug	NN	O	drug	nn	20	SENT_159	[p7l1931t3446r2139b3547],
20	design	NN	O	design	prep_in	16	SENT_159	[p7l10t3574r321b3675],
21	.	.	O	.	_	0	SENT_159	[p7l10t3574r321b3675],

1	One	CD	NUMBER	one	num	3	SENT_160	[p7l364t3580r537b3653],
2	FLAP	NN	O	flap	nn	3	SENT_160	[p7l573t3581r804b3652],
3	inhibitor	NN	O	inhibitor	nsubjpass	15	SENT_160	[p7l839t3574r1250b3670],
4	,	,	O	,	_	0	SENT_160	[p7l839t3574r1250b3670],
5	DGO31	NN	O	dgo31	nn	7	SENT_160	[p7l1291t3580r1593b3653],
6	(	NN	O	(	nn	7	SENT_160	[p7l1635t3573r2130b3674],
7	veliflapon	NN	O	veliflapon	appos	3	SENT_160	[p7l1635t3573r2130b3674],
8	,	,	O	,	_	0	SENT_160	[p7l1635t3573r2130b3674],
9	DeCode	NNP	O	DeCode	nn	10	SENT_160	[p7l8t3702r347b3781],
10	Genetics	NNP	O	Genetics	appos	3	SENT_160	[p7l385t3703r808b3798],
11	)	RB	O	)	advmod	10	SENT_160	[p7l385t3703r808b3798],
12	,	,	O	,	_	0	SENT_160	[p7l385t3703r808b3798],
13	is	VBZ	O	be	aux	15	SENT_160	[p7l852t3703r917b3780],
14	being	VBG	O	be	auxpass	15	SENT_160	[p7l958t3702r1200b3803],
15	reformulated	VBN	O	reformulate	_	0	SENT_160	[p7l1234t3701r1798b3781],
16	for	IN	O	for	_	0	SENT_160	[p7l1836t3701r1959b3781],
17	use	NN	O	use	prep_for	15	SENT_160	[p7l1994t3728r2135b3781],
18	in	IN	O	in	_	0	SENT_160	[p8l9t21r91b98],
19	phase	NN	O	phase	nn	21	SENT_160	[p8l125t20r370b120],
20	3	CD	NUMBER	3	num	21	SENT_160	[p8l406t26r450b99],
21	trials	NNS	O	trial	prep_in	17	SENT_160	[p8l489t20r704b98],
22	for	IN	O	for	_	0	SENT_160	[p8l741t19r863b99],
23	the	DT	O	the	det	24	SENT_160	[p8l895t20r1026b98],
24	prevention	NN	O	prevention	prep_for	15	SENT_160	[p8l1060t21r1509b120],
25	of	IN	O	of	_	0	SENT_160	[p8l1545t19r1644b99],
26	myocardial	JJ	O	myocardial	amod	27	SENT_160	[p8l1661t20r2135b120],
27	infarction	NN	O	infarction	prep_of	24	SENT_160	[p8l9t148r472b228],
28	.	.	O	.	_	0	SENT_160	[p8l9t148r472b228],

1	Selective	JJ	O	selective	amod	3	SENT_161	[p8l520t149r894b229],
2	BLT1	NN	O	blt1	nn	3	SENT_161	[p8l933t155r1135b253],
3	antagonists	NNS	O	antagonist	nsubj	23	SENT_161	[p8l1175t150r1687b251],
4	that	WDT	O	that	nsubjpass	7	SENT_161	[p8l1730t149r1906b227],
5	have	VBP	O	have	aux	7	SENT_161	[p8l1941t149r2135b229],
6	been	VBN	O	be	auxpass	7	SENT_161	[p8l10t278r215b356],
7	developed	VBN	O	develop	rcmod	3	SENT_161	[p8l262t278r697b377],
8	up	RP	O	up	prt	7	SENT_161	[p8l743t304r848b377],
9	to	TO	O	to	aux	13	SENT_161	[p8l896t295r979b356],
10	now	RB	DATE	now	advmod	13	SENT_161	[p8l1026t304r1213b357],
11	have	VB	O	have	aux	13	SENT_161	[p8l1255t278r1448b357],
12	been	VBN	O	be	auxpass	13	SENT_161	[p8l1494t278r1700b356],
13	tested	VBN	O	test	xcomp	7	SENT_161	[p8l1746t278r2006b356],
14	in	IN	O	in	_	0	SENT_161	[p8l2051t279r2135b355],
15	animal	NN	O	animal	nn	16	SENT_161	[p8l9t406r301b484],
16	models	NNS	O	model	prep_in	13	SENT_161	[p8l325t406r623b485],
17	of	IN	O	of	_	0	SENT_161	[p8l650t405r748b485],
18	disease	NN	O	disease	prep_of	16	SENT_161	[p8l754t406r1152b502],
19	,44	CD	NUMBER	,44	num	18	SENT_161	[p8l754t406r1152b502],
20	but	CC	O	but	prep	18	SENT_161	[p8l1176t406r1312b485],
21	none	NN	O	none	dep	20	SENT_161	[p8l1331t432r1533b485],
22	have	VBP	O	have	aux	23	SENT_161	[p8l1557t406r1741b485],
23	emerged	VBN	O	emerge	_	0	SENT_161	[p8l1766t406r2135b507],
24	for	IN	O	for	_	0	SENT_161	[p8l10t533r133b613],
25	clinical	JJ	O	clinical	amod	26	SENT_161	[p8l170t534r484b612],
26	use	NN	O	use	prep_for	23	SENT_161	[p8l524t560r687b613],
27	.	.	O	.	_	0	SENT_161	[p8l524t560r687b613],

1	LEUKOTRIENES	NNP	O	LEUKOTRIENES	_	0	SENT_162	[p8l290t830r1161b891],
2	IN	IN	O	in	dep	1	SENT_162	[p8l1218t831r1342b890],
3	DISEASE	NNP	O	DISEASE	pobj	2	SENT_162	[p8l1400t831r1856b890],

1	Leukotrienes	NNS	O	leukotriene	nsubj	2	SENT_163	[p8l8t1049r566b1128],
2	have	VBP	O	have	dep	22	SENT_163	[p8l599t1049r789b1128],
3	a	DT	O	a	det	4	SENT_163	[p8l819t1075r864b1127],
4	multitude	NN	O	multitude	dobj	2	SENT_163	[p8l892t1049r1312b1128],
5	of	IN	O	of	_	0	SENT_163	[p8l1343t1048r1444b1128],
6	biologic	JJ	O	biologic	amod	7	SENT_163	[p8l1456t1049r1798b1150],
7	actions	NNS	O	action	prep_of	4	SENT_163	[p8l1828t1050r2133b1128],
8	(	VBP	O	(	rcmod	4	SENT_163	[p8l15t1177r273b1268],
9	Table	NNP	O	Table	nsubj	11	SENT_163	[p8l15t1177r273b1268],
10	2	CD	NUMBER	2	num	11	SENT_163	[p8l316t1183r390b1268],
11	)	NN	O	)	xcomp	8	SENT_163	[p8l316t1183r390b1268],
12	and	CC	O	and	_	0	SENT_163	[p8l438t1177r595b1256],
13	have	VBP	O	have	aux	15	SENT_163	[p8l638t1177r828b1256],
14	been	VBN	O	be	auxpass	15	SENT_163	[p8l871t1177r1073b1256],
15	suggested	VBN	O	suggest	rcmod	4	SENT_163	[p8l1118t1177r1545b1278],
16	as	IN	O	as	_	0	SENT_163	[p8l1587t1203r1673b1255],
17	factors	NNS	O	factor	prep_as	15	SENT_163	[p8l1717t1176r2007b1256],
18	in	IN	O	in	_	0	SENT_163	[p8l2052t1178r2135b1255],
19	numerous	JJ	O	numerous	amod	21	SENT_163	[p8l10t1330r440b1383],
20	disease	NN	O	disease	nn	21	SENT_163	[p8l471t1304r782b1383],
21	processes	NNS	O	process	prep_in	17	SENT_163	[p8l809t1330r1223b1404],
22	(	VBP	O	(	_	0	SENT_163	[p8l1259t1304r1518b1395],
23	Table	NNP	O	Table	dobj	22	SENT_163	[p8l1259t1304r1518b1395],
24	3	CD	NUMBER	3	num	25	SENT_163	[p8l1547t1310r1644b1395],
25	)	NN	O	)	nsubj	22	SENT_163	[p8l1547t1310r1644b1395],
26	.	.	O	.	_	0	SENT_163	[p8l1547t1310r1644b1395],

1	The	DT	O	the	det	2	SENT_164	[p8l1675t1304r1836b1382],
2	role	NN	O	role	nsubjpass	7	SENT_164	[p8l1865t1304r2024b1383],
3	of	IN	O	of	_	0	SENT_164	[p8l2054t1303r2153b1383],
4	leukotrienes	NNS	O	leukotriene	prep_of	2	SENT_164	[p8l9t1434r538b1513],
5	has	VBZ	O	have	aux	7	SENT_164	[p8l581t1434r724b1512],
6	been	VBN	O	be	auxpass	7	SENT_164	[p8l768t1434r969b1513],
7	validated	VBN	O	validate	_	0	SENT_164	[p8l1005t1434r1395b1513],
8	in	IN	O	in	_	0	SENT_164	[p8l1435t1435r1518b1512],
9	clinical	JJ	O	clinical	amod	10	SENT_164	[p8l1559t1434r1873b1512],
10	trials	NNS	O	trial	prep_in	7	SENT_164	[p8l1913t1434r2133b1512],
11	of	IN	O	of	_	0	SENT_164	[p8l11t1561r111b1641],
12	antileukotriene	JJ	O	antileukotriene	amod	13	SENT_164	[p8l133t1562r792b1641],
13	agents	NNS	O	agent	prep_of	10	SENT_164	[p8l833t1579r1109b1663],
14	for	IN	O	for	_	0	SENT_164	[p8l1152t1561r1276b1641],
15	asthma	NN	O	asthma	prep_for	13	SENT_164	[p8l1313t1562r1633b1640],
16	and	CC	O	and	_	0	SENT_164	[p8l1672t1562r1830b1641],
17	only	RB	O	only	quantmod	19	SENT_164	[p8l1872t1562r2056b1662],
18	a	DT	O	a	quantmod	19	SENT_164	[p8l2092t1588r2137b1640],
19	few	JJ	O	few	conj_and	10	SENT_164	[p8l10t1689r165b1769],
20	of	IN	O	of	_	0	SENT_164	[p8l196t1689r297b1769],
21	the	DT	O	the	det	23	SENT_164	[p8l313t1690r446b1768],
22	other	JJ	O	other	amod	23	SENT_164	[p8l481t1690r710b1769],
23	diseases	NNS	O	disease	prep_of	19	SENT_164	[p8l742t1690r1095b1769],
24	listed	VBN	O	list	partmod	23	SENT_164	[p8l1131t1690r1365b1769],
25	in	IN	O	in	_	0	SENT_164	[p8l1400t1691r1483b1768],
26	Table	NNP	O	Table	prep_in	24	SENT_164	[p8l1514t1690r1745b1769],
27	3	CD	NUMBER	3	num	26	SENT_164	[p8l1781t1696r1850b1769],
28	.	.	O	.	_	0	SENT_164	[p8l1781t1696r1850b1769],

1	ASTHMA	NN	O	asthma	_	0	SENT_165	[p8l8t1949r344b1999],

1	Antileukotriene	NNP	O	Antileukotriene	nn	2	SENT_166	[p8l6t2061r613b2138],
2	Drugs	NNPS	O	Drugs	nsubjpass	36	SENT_166	[p8l653t2068r882b2162],
3	as	IN	O	as	_	0	SENT_166	[p8l914t2088r994b2138],
4	Controller	NNP	O	Controller	nn	5	SENT_166	[p8l1030t2061r1428b2138],
5	Agents	NNPS	O	Agents	prep_as	2	SENT_166	[p8l1450t2066r1719b2162],
6	The	DT	O	the	det	7	SENT_166	[p8l6t2186r170b2264],
7	benefits	NNS	O	benefit	dep	12	SENT_166	[p8l237t2185r591b2265],
8	of	IN	O	of	_	0	SENT_166	[p8l661t2185r762b2265],
9	antileukotriene	JJ	O	antileukotriene	amod	10	SENT_166	[p8l808t2186r1486b2266],
10	therapy	NN	O	therapy	prep_of	7	SENT_166	[p8l1553t2186r1883b2286],
11	(	CD	NUMBER	(	dep	12	SENT_166	[p8l1950t2187r2130b2282],
12	i.e.	FW	O	i.e.	dep	28	SENT_166	[p8l1950t2187r2130b2282],
13	,	,	O	,	_	0	SENT_166	[p8l1950t2187r2130b2282],
14	5	CD	NUMBER	5	number	15	SENT_166	[p8l12t2315r624b2416],
15	—	CD	NUMBER	—	num	17	SENT_166	[p8l12t2315r624b2416],
16	lipoXygenase	NN	O	lipoxygenase	nn	17	SENT_166	[p8l12t2315r624b2416],
17	inhibition	NN	O	inhibition	appos	12	SENT_166	[p8l658t2315r1069b2394],
18	by	IN	O	by	_	0	SENT_166	[p8l1105t2315r1200b2414],
19	zileuton45	NN	O	zileuton45	nn	22	SENT_166	[p8l1230t2315r1629b2394],
20	and	CC	O	and	_	0	SENT_166	[p8l1667t2315r1821b2394],
21	CysLT1	NN	O	cyslt1	conj_and	19	SENT_166	[p8l1856t2321r2135b2418],
22	blockade	NN	O	blockade	prep_by	17	SENT_166	[p8l10t2442r376b2522],
23	by	IN	O	by	_	0	SENT_166	[p8l403t2442r498b2542],
24	montelukast	NN	O	montelukast	prep_by	12	SENT_166	[p8l521t2442r1039b2522],
25	or	CC	O	or	_	0	SENT_166	[p8l1062t2468r1148b2521],
26	zaf1rlul	NN	O	zaf1rlul	prep_by	12	SENT_166	[p8l1172t2441r1803b2533],
27	47	CD	NUMBER	47	num	28	SENT_166	[p8l1172t2441r1803b2533],
28	)	NN	O	)	dep	2	SENT_166	[p8l1172t2441r1803b2533],
29	in	IN	O	in	_	0	SENT_166	[p8l1835t2443r1917b2520],
30	children	NNS	O	child	prep_in	28	SENT_166	[p8l1945t2442r2134b2520, p8l10t2571r204b2649],
31	and	CC	O	and	_	0	SENT_166	[p8l247t2571r405b2649],
32	adults	NNS	O	adult	conj_and	30	SENT_166	[p8l448t2571r705b2650],
33	with	IN	O	with	_	0	SENT_166	[p8l746t2571r942b2650],
34	asthma	NN	O	asthma	prep_with	2	SENT_166	[p8l985t2571r1304b2648],
35	are	VBP	O	be	auxpass	36	SENT_166	[p8l1346t2597r1475b2649],
36	improved	VBN	O	improve	ccomp	40	SENT_166	[p8l1518t2571r1923b2670],
37	pulmonary	JJ	O	pulmonary	amod	38	SENT_166	[p8l1965t2571r2134b2670, p8l10t2724r345b2798],
38	function	NN	O	function	dobj	36	SENT_166	[p8l371t2697r762b2794],
39	,	,	O	,	_	0	SENT_166	[p8l371t2697r762b2794],
40	decreased	VBD	O	decrease	_	0	SENT_166	[p8l799t2698r1223b2777],
41	daytime	JJ	TIME	daytime	amod	44	SENT_166	[p8l1255t2698r1599b2798],
42	and	CC	O	and	_	0	SENT_166	[p8l1630t2698r1788b2777],
43	nocturnal	JJ	O	nocturnal	conj_and	41	SENT_166	[p8l1819t2715r2134b2778, p8l10t2827r145b2905],
44	symptoms	NNS	O	symptom	nsubj	40	SENT_166	[p8l189t2844r666b2927],
45	,	,	O	,	_	0	SENT_166	[p8l189t2844r666b2927],
46	a	DT	O	a	det	48	SENT_166	[p8l715t2853r759b2905],
47	reduced	VBN	O	reduce	amod	48	SENT_166	[p8l802t2827r1145b2906],
48	need	NN	O	need	appos	44	SENT_166	[p8l1189t2827r1394b2906],
49	for	IN	O	for	_	0	SENT_166	[p8l1437t2826r1563b2906],
50	short	JJ	O	short	amod	51	SENT_166	[p8l1605t2827r2139b2928],
51	—	NN	O	—	prep_for	48	SENT_166	[p8l1605t2827r2139b2928],
52	acting	VBG	O	act	partmod	51	SENT_166	[p8l1605t2827r2139b2928],
53	rescue	NN	O	rescue	nn	55	SENT_166	[p8l10t2981r275b3035],
54	B2	NN	O	b2	nn	55	SENT_166	[p8l296t2959r394b3059],
55	agonists	NNS	O	agonist	dobj	52	SENT_166	[p8l420t2956r795b3057],
56	,	,	O	,	_	0	SENT_166	[p8l420t2956r795b3057],
57	fewer	JJR	O	fewer	amod	58	SENT_166	[p8l826t2954r1059b3035],
58	exacerbations	NNS	O	exacerbation	conj_and	51	SENT_166	[p8l1082t2955r1657b3034],
59	of	IN	O	of	_	0	SENT_166	[p8l1686t2954r1785b3034],
60	asthma	NN	O	asthma	prep_of	58	SENT_166	[p8l1791t2955r2130b3051],
61	,	,	O	,	_	0	SENT_166	[p8l1791t2955r2130b3051],
62	and	CC	O	and	_	0	SENT_166	[p8l8t3083r167b3162],
63	an	DT	O	a	det	65	SENT_166	[p8l202t3109r305b3161],
64	increased	VBN	O	increase	amod	65	SENT_166	[p8l340t3083r750b3162],
65	quality	NN	O	quality	conj_and	51	SENT_166	[p8l786t3083r1085b3183],
66	of	IN	O	of	_	0	SENT_166	[p8l1118t3082r1218b3162],
67	life	NN	O	life	prep_of	65	SENT_166	[p8l1234t3082r1394b3162],
68	.	.	O	.	_	0	SENT_166	[p8l1234t3082r1394b3162],

1	Inhaled	VBN	O	inhale	_	0	SENT_167	[p8l1434t3083r1764b3162],
2	corticosteroids	NNS	O	corticosteroid	nsubj	5	SENT_167	[p8l1801t3084r2134b3162, p8l11t3212r351b3290],
3	are	VBP	O	be	cop	5	SENT_167	[p8l408t3238r540b3290],
4	more	RBR	O	more	advmod	5	SENT_167	[p8l594t3238r817b3290],
5	potent	JJ	O	potent	dep	1	SENT_167	[p8l870t3228r1156b3311],
6	than	IN	O	than	_	0	SENT_167	[p8l1206t3212r1407b3289],
7	antileukotriene	JJ	O	antileukotriene	amod	8	SENT_167	[p8l1460t3212r2135b3291],
8	agents48	NN	O	agents48	prep_than	5	SENT_167	[p8l9t3345r372b3441],
9	and	CC	O	and	_	0	SENT_167	[p8l405t3340r563b3419],
10	hence	RB	O	hence	advmod	5	SENT_167	[p8l596t3340r843b3418],
11	are	VBP	O	be	auxpass	12	SENT_167	[p8l876t3366r1005b3418],
12	favored	VBN	O	favor	conj_and	5	SENT_167	[p8l1038t3339r1352b3419],
13	as	IN	O	as	_	0	SENT_167	[p8l1385t3366r1471b3418],
14	first	JJ	ORDINAL	first	amod	17	SENT_167	[p8l1506t3339r1877b3418],
15	—	NN	O	—	nn	17	SENT_167	[p8l1506t3339r1877b3418],
16	line	NN	O	line	nn	17	SENT_167	[p8l1506t3339r1877b3418],
17	treatment	NN	O	treatment	prep_as	12	SENT_167	[p8l1910t3357r2134b3418, p8l10t3484r244b3562],
18	;	:	O	;	_	0	SENT_167	[p8l1910t3357r2134b3418, p8l10t3484r244b3562],
19	however	RB	O	however	advmod	25	SENT_167	[p8l272t3468r633b3563],
20	,	,	O	,	_	0	SENT_167	[p8l272t3468r633b3563],
21	antileukotriene	JJ	O	antileukotriene	amod	22	SENT_167	[p8l662t3468r1292b3547],
22	therapy	NN	O	therapy	nsubjpass	25	SENT_167	[p8l1317t3468r1627b3567],
23	can	MD	O	can	aux	25	SENT_167	[p8l1648t3494r1793b3545],
24	be	VB	O	be	auxpass	25	SENT_167	[p8l1819t3468r1913b3546],
25	used	VBN	O	use	parataxis	5	SENT_167	[p8l1938t3468r2135b3547],
26	initially	RB	O	initially	advmod	25	SENT_167	[p8l9t3596r344b3695],
27	in	IN	O	in	_	0	SENT_167	[p8l376t3597r460b3673],
28	a	DT	O	a	det	29	SENT_167	[p8l497t3622r541b3673],
29	patient	NN	O	patient	prep_in	25	SENT_167	[p8l575t3597r878b3695],
30	who	WP	O	who	nsubj	36	SENT_167	[p8l905t3596r1089b3675],
31	can	MD	O	can	rcmod	29	SENT_167	[p8l1128t3613r1427b3674],
32	not	RB	O	not	neg	31	SENT_167	[p8l1128t3613r1427b3674],
33	or	CC	O	or	_	0	SENT_167	[p8l1460t3622r1549b3674],
34	will	MD	O	will	aux	36	SENT_167	[p8l1578t3596r1743b3675],
35	not	RB	O	not	neg	36	SENT_167	[p8l1780t3613r1923b3674],
36	take	VB	O	take	conj_or	31	SENT_167	[p8l1955t3596r2135b3675],
37	corticosteroids	NNS	O	corticosteroid	iobj	36	SENT_167	[p9l10t21r754b100],
38	.49	CD	NUMBER	.49	num	40	SENT_167	[p9l10t21r754b100],
39	Antileukotriene	JJ	O	antileukotriene	amod	40	SENT_167	[p9l785t21r1464b100],
40	agents	NNS	O	agent	dobj	36	SENT_167	[p9l1498t38r1773b122],
41	have	VBP	O	have	dep	1	SENT_167	[p9l1809t21r1999b100],
42	an	DT	O	a	det	44	SENT_167	[p9l2032t47r2135b99],
43	additive	JJ	O	additive	amod	44	SENT_167	[p9l9t148r344b228],
44	beneﬁt	NN	O	beneﬁt	dobj	41	SENT_167	[p9l384t147r690b227],
45	in	IN	O	in	_	0	SENT_167	[p9l724t149r807b226],
46	patients	NNS	O	patient	prep_in	44	SENT_167	[p9l845t149r1187b248],
47	Whose	WP$	O	whose	poss	48	SENT_167	[p9l1224t148r1500b228],
48	disease	NN	O	disease	nsubjpass	52	SENT_167	[p9l1540t148r1851b227],
49	is	VBZ	O	be	auxpass	52	SENT_167	[p9l1890t149r1956b226],
50	not	RB	O	not	neg	52	SENT_167	[p9l1998t165r2140b227],
51	adequately	RB	O	adequately	advmod	52	SENT_167	[p9l10t277r459b376],
52	controlled	VBN	O	control	rcmod	46	SENT_167	[p9l485t277r913b355],
53	by	IN	O	by	_	0	SENT_167	[p9l944t277r1040b376],
54	inhaled	VBN	O	inhale	agent	52	SENT_167	[p9l1064t277r1382b355],
55	corticosteroids	NNS	O	corticosteroid	dobj	54	SENT_167	[p9l1412t277r2135b372],
56	,5	CD	NUMBER	,5	num	57	SENT_167	[p9l1412t277r2135b372],
57	°	NN	O	°	nsubj	1	SENT_167	[p9l1412t277r2135b372],
58	perhaps	RB	O	perhaps	advmod	59	SENT_167	[p9l8t405r349b505],
59	reflecting	VBG	O	reflect	partmod	57	SENT_167	[p9l382t404r805b506],
60	the	DT	O	the	det	61	SENT_167	[p9l832t405r965b484],
61	inability	NN	O	inability	dobj	59	SENT_167	[p9l995t405r1355b505],
62	of	IN	O	of	_	0	SENT_167	[p9l1382t404r1482b484],
63	corticosteroids	NNS	O	corticosteroid	prep_of	61	SENT_167	[p9l1494t405r2133b484],

1	1844	CD	DATE	1844	num	4	SENT_168	[p9l149t581r225b603],
2	N	NN	O	n	nn	4	SENT_168	[p9l897t591r911b606],
3	ENGLJ	NN	O	englj	nn	4	SENT_168	[p9l926t591r1004b613],
4	MED	NN	O	med	_	0	SENT_168	[p9l1018t591r1070b606],
5	357	CD	NUMBER	357	num	7	SENT_168	[p9l1081t585r1154b613],
6	;	:	O	;	_	0	SENT_168	[p9l1081t585r1154b613],
7	18	CD	NUMBER	18	dep	4	SENT_168	[p9l1081t585r1154b613],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_168	[p9l1187t591r1388b613],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_168	[p9l1425t591r1560b607],
10	1	CD	DATE	1	num	9	SENT_168	[p9l1571t591r1587b611],
11	,	,	DATE	,	_	0	SENT_168	[p9l1571t591r1587b611],
12	2007	CD	DATE	2007	num	9	SENT_168	[p9l1598t591r1661b612],

1	The	DT	O	the	det	4	SENT_169	[p9l935t624r986b648],
2	New	NNP	O	New	nn	4	SENT_169	[p9l995t625r1057b648],
3	England	NNP	O	England	nn	4	SENT_169	[p9l1066t624r1177b655],
4	Joumal	NNP	O	Joumal	_	0	SENT_169	[p9l1186t624r1283b648],
5	of	IN	O	of	_	0	SENT_169	[p9l1293t624r1322b648],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_169	[p9l1329t624r1454b648],

1	Downloaded	VBN	O	download	_	0	SENT_170	[p9l377t665r547b688],
2	from	IN	O	from	_	0	SENT_170	[p9l556t665r621b688],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_170	[p9l629t665r748b695],
4	at	IN	O	at	_	0	SENT_170	[p9l758t669r781b688],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_170	[p9l789t665r972b688],
6	on	IN	O	on	_	0	SENT_170	[p9l981t672r1014b688],
7	January	NNP	DATE	January	prep_on	1	SENT_170	[p9l1022t665r1125b695],
8	5	CD	DATE	5	num	7	SENT_170	[p9l1135t665r1158b692],
9	,	,	DATE	,	_	0	SENT_170	[p9l1135t665r1158b692],
10	2014	CD	DATE	2014	num	7	SENT_170	[p9l1168t665r1241b688],
11	.	.	O	.	_	0	SENT_170	[p9l1168t665r1241b688],

1	For	IN	O	for	_	0	SENT_171	[p9l1251t665r1298b688],
2	personal	JJ	O	personal	amod	3	SENT_171	[p9l1306t665r1418b695],
3	use	NN	O	use	pobj	1	SENT_171	[p9l1427t672r1471b688],
4	only	RB	O	only	advmod	3	SENT_171	[p9l1480t665r1545b695],
5	.	.	O	.	_	0	SENT_171	[p9l1480t665r1545b695],

1	No	DT	O	no	det	3	SENT_172	[p9l1556t665r1595b688],
2	other	JJ	O	other	amod	3	SENT_172	[p9l1605t665r1673b688],
3	uses	NNS	O	use	_	0	SENT_172	[p9l1682t672r1738b688],
4	without	IN	O	without	_	0	SENT_172	[p9l1748t665r1849b688],
5	permission	NN	O	permission	prep_without	3	SENT_172	[p9l1857t665r2010b695],
6	.	.	O	.	_	0	SENT_172	[p9l1857t665r2010b695],

1	Copyright	NN	O	copyright	_	0	SENT_173	[p9l727t706r862b737],
2	©	CD	NUMBER	©	num	6	SENT_173	[p9l871t706r895b730],
3	2007	CD	DATE	2007	num	6	SENT_173	[p9l905t706r969b730],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_173	[p9l979t706r1170b730],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_173	[p9l1180t706r1289b730],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_173	[p9l1299t706r1404b737],
7	.	.	O	.	_	0	SENT_173	[p9l1299t706r1404b737],

1	All	DT	O	all	det	2	SENT_174	[p9l1415t706r1456b730],
2	rights	NNS	O	rights	nsubj	3	SENT_174	[p9l1465t706r1540b737],
3	reserved	VBN	O	reserve	_	0	SENT_174	[p9l1550t706r1668b730],
4	.	.	O	.	_	0	SENT_174	[p9l1550t706r1668b730],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_175	[p9l723t750r949b769],
2	OF	IN	O	of	_	0	SENT_175	[p9l963t750r1003b769],
3	DISEASE	NN	O	disease	prep_of	1	SENT_175	[p9l1018t750r1152b769],

1	Bone	NN	O	bone	nn	2	SENT_176	[p9l206t1007r282b1033],
2	marrow	NN	O	marrow	_	0	SENT_176	[p9l294t1014r412b1033],

1	Increased	VBN	O	increase	amod	2	SENT_177	[p9l427t1239r555b1264],
2	production	NN	O	production	_	0	SENT_177	[p9l569t1239r716b1272],
3	and	CC	O	and	_	0	SENT_177	[p9l728t1239r776b1264],
4	motility	NN	O	motility	nn	5	SENT_177	[p9l426t1272r528b1305],
5	ofCD34	NN	O	ofcd34	conj_and	2	SENT_177	[p9l537t1272r666b1298],
6	+	CC	O	+	_	0	SENT_177	[p9l537t1272r666b1298],
7	progenitors	NNS	O	progenitor	conj_+	5	SENT_177	[p9l678t1275r834b1306],

1	Increased	VBN	O	increase	_	0	SENT_178	[p9l1313t1672r1442b1696],
2	/	:	O	/	punct	4	SENT_178	[p9l1612t1692r1650b1703],
3	G	NN	O	g	nn	4	SENT_178	[p9l1612t1692r1650b1703],
4	^	NN	O	^	dep	8	SENT_178	[p9l1612t1692r1650b1703],
5	+	CC	O	+	_	0	SENT_178	[p9l1612t1692r1650b1703],
6	‘	CD	NUMBER	‘	num	7	SENT_178	[p9l1694t1700r1698b1704],
7	(	NN	O	(	dep	8	SENT_178	[p9l1066t1700r1080b1758],
8	adhesion	NN	O	adhesion	dep	1	SENT_178	[p9l1311t1705r1436b1729],
9	?	.	O	?	_	0	SENT_178	[p9l1484t1716r1518b1727],

1	_	NN	O	_	nn	2	SENT_179	[p9l1484t1716r1518b1727],
2	^	NN	O	^	_	0	SENT_179	[p9l1484t1716r1518b1727],
3	+	CC	O	+	_	0	SENT_179	[p9l1484t1716r1518b1727],
4	V	NN	O	v	conj_+	2	SENT_179	[p9l1617t1704r1620b1706],
5	ྈ	CD	NUMBER	ྈ	num	6	SENT_179	[p9l1647t1716r1668b1726],
6	^	NN	O	^	dep	2	SENT_179	[p9l1647t1716r1668b1726],
7	+	CC	O	+	rcmod	6	SENT_179	[p9l1647t1716r1668b1726],

1	Increased	VBN	O	increase	_	0	SENT_180	[p9l1388t2098r1517b2124],
2	transmigration	NN	O	transmigration	dobj	1	SENT_180	[p9l1385t2134r1588b2165],

1	Increased	VBN	O	increase	_	0	SENT_181	[p9l678t2193r807b2217],
2	activation	NN	O	activation	dobj	1	SENT_181	[p9l676t2227r811b2251],

1	Increased	VBN	O	increase	_	0	SENT_182	[p9l1019t2306r1148b2332],
2	survival	NN	O	survival	dobj	1	SENT_182	[p9l1018t2340r1120b2365],

1	Cells	NNS	O	cell	_	0	SENT_183	[p9l190t2466r250b2489],
2	with	IN	O	with	_	0	SENT_183	[p9l260t2466r314b2489],
3	response	NN	O	response	prep_with	1	SENT_183	[p9l326t2474r441b2496],
4	to	TO	O	to	dep	1	SENT_183	[p9l449t2470r474b2489],
5	LTD4	NN	O	ltd4	pobj	4	SENT_183	[p9l486t2469r551b2497],
6	through	IN	O	through	_	0	SENT_183	[p9l559t2466r660b2497],
7	CysLT1	NN	O	cyslt1	nn	8	SENT_183	[p9l671t2468r760b2497],
8	Cells	NNS	O	cell	prep_through	4	SENT_183	[p9l814t2466r874b2489],
9	with	IN	O	with	_	0	SENT_183	[p9l884t2466r938b2489],
10	response	NN	O	response	prep_with	8	SENT_183	[p9l949t2474r1065b2496],
11	to	TO	O	to	_	0	SENT_183	[p9l1073t2470r1098b2489],
12	LTB4	NN	O	ltb4	prep_to	4	SENT_183	[p9l1109t2469r1171b2497],
13	through	IN	O	through	dep	1	SENT_183	[p9l1179t2466r1280b2497],
14	BLT1	NN	O	blt1	pobj	13	SENT_183	[p9l1292t2469r1352b2497],

1	Neutrophil	NN	O	neutrophil	nn	2	SENT_184	[p9l1158t2578r1284b2607],
2	D	NN	O	d	_	0	SENT_184	[p9l1366t2560r1428b2636],
3	[	CD	NUMBER	[	num	4	SENT_184	[p9l1366t2560r1428b2636],
4	^	NN	O	^	dep	2	SENT_184	[p9l1366t2560r1428b2636],
5	+	CC	O	+	rcmod	4	SENT_184	[p9l1366t2560r1428b2636],

1	Eosinophil	NN	O	eosinophil	_	0	SENT_185	[p9l626t2741r749b2770],

1	Dendritic	JJ	MISC	dendritic	amod	2	SENT_186	[p9l241t2770r351b2793],
2	cell	NN	O	cell	_	0	SENT_186	[p9l359t2770r397b2793],

1	Figure	NN	O	figure	_	0	SENT_187	[p9l123t2959r207b2991],
2	2	CD	NUMBER	2	dep	1	SENT_187	[p9l218t2960r242b2983],
3	.	.	O	.	_	0	SENT_187	[p9l218t2960r242b2983],

1	Leukocyte	NN	O	leukocyte	nn	2	SENT_188	[p9l255t2958r394b2991],
2	Recruitment	NN	O	recruitment	_	0	SENT_188	[p9l406t2959r576b2983],
3	and	CC	O	and	_	0	SENT_188	[p9l586t2958r635b2983],
4	Activation	NN	O	activation	conj_and	2	SENT_188	[p9l646t2959r785b2983],
5	by	IN	O	by	_	0	SENT_188	[p9l798t2958r828b2991],
6	Leukotrienes	NNPS	O	Leukotrienes	prep_by	2	SENT_188	[p9l840t2958r1025b2983],
7	.	.	O	.	_	0	SENT_188	[p9l840t2958r1025b2983],

1	By	IN	O	by	_	0	SENT_189	[p9l123t3010r153b3041],
2	ligating	VBG	O	ligate	prepc_by	17	SENT_189	[p9l165t3008r265b3041],
3	their	PRP$	O	they	poss	6	SENT_189	[p9l274t3008r338b3033],
4	specific	JJ	O	specific	amod	6	SENT_189	[p9l348t3008r453b3041],
5	cognate	JJ	O	cognate	amod	6	SENT_189	[p9l464t3013r571b3041],
6	receptors	NNS	O	receptor	dobj	2	SENT_189	[p9l583t3013r710b3041],
7	(	CD	NUMBER	(	tmod	2	SENT_189	[p9l725t3008r812b3041],
8	which	WDT	O	which	nsubjpass	10	SENT_189	[p9l725t3008r812b3041],
9	are	VBP	O	be	auxpass	10	SENT_189	[p9l825t3017r865b3033],
10	summarized	VBN	O	summarize	rcmod	7	SENT_189	[p9l877t3008r1047b3033],
11	in	IN	O	in	_	0	SENT_189	[p9l1061t3010r1082b3033],
12	Table	NNP	O	Table	prep_in	10	SENT_189	[p9l1093t3008r1166b3033],
13	1	CD	NUMBER	1	number	14	SENT_189	[p9l1179t3010r1208b3041],
14	)	CD	NUMBER	)	dep	12	SENT_189	[p9l1179t3010r1208b3041],
15	,	,	O	,	_	0	SENT_189	[p9l1179t3010r1208b3041],
16	leukotrienes	NNS	O	leukotriene	nsubj	17	SENT_189	[p9l1222t3008r1388b3033],
17	promote	VBP	O	promote	_	0	SENT_189	[p9l1402t3013r1518b3041],
18	the	DT	O	the	det	19	SENT_189	[p9l1528t3008r1571b3033],
19	accumulation	NN	O	accumulation	nsubj	25	SENT_189	[p9l1582t3008r1723b3033, p9l120t3052r172b3075],
20	and	CC	O	and	_	0	SENT_189	[p9l185t3050r233b3075],
21	function	NN	O	function	nsubj	25	SENT_189	[p9l245t3050r359b3075],
22	ofvirtually	RB	O	ofvirtually	advmod	23	SENT_189	[p9l372t3050r516b3083],
23	all	DT	O	all	amod	25	SENT_189	[p9l527t3050r555b3075],
24	subgroups	NNS	O	subgroup	nn	25	SENT_189	[p9l568t3050r712b3083],
25	ofleukocytes	NNS	O	ofleukocyte	xcomp	17	SENT_189	[p9l724t3050r904b3083],
26	at	IN	O	at	_	0	SENT_189	[p9l916t3055r940b3075],
27	sites	NNS	O	site	nn	28	SENT_189	[p9l951t3052r1012b3075],
28	ofinflammation	NN	O	ofinflammation	prep_at	25	SENT_189	[p9l1024t3050r1254b3075],
29	.	.	O	.	_	0	SENT_189	[p9l1024t3050r1254b3075],

1	Such	JJ	O	such	amod	2	SENT_190	[p9l1267t3050r1332b3075],
2	responses	NNS	O	response	nsubj	4	SENT_190	[p9l1346t3059r1483b3083],
3	are	VBP	O	be	cop	4	SENT_190	[p9l1496t3059r1536b3075],
4	important	JJ	O	important	_	0	SENT_190	[p9l1548t3052r1686b3083],
5	in	IN	O	in	_	0	SENT_190	[p9l1698t3052r1719b3075],
6	the	DT	O	the	det	8	SENT_190	[p9l120t3091r163b3117],
7	pathogenesis	NN	O	pathogenesis	nn	8	SENT_190	[p9l176t3091r357b3125],
8	ofdiseases	NNS	O	ofdisease	prep_in	4	SENT_190	[p9l369t3091r528b3121],
9	,	,	O	,	_	0	SENT_190	[p9l369t3091r528b3121],
10	including	VBG	O	include	_	0	SENT_190	[p9l542t3091r668b3125],
11	asthma	NN	O	asthma	prep_including	8	SENT_190	[p9l679t3091r787b3121],
12	,	,	O	,	_	0	SENT_190	[p9l679t3091r787b3121],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_190	[p9l799t3091r999b3117],
14	disease	NN	O	disease	prep_including	8	SENT_190	[p9l1008t3091r1117b3121],
15	,	,	O	,	_	0	SENT_190	[p9l1008t3091r1117b3121],
16	and	CC	O	and	_	0	SENT_190	[p9l1130t3091r1178b3117],
17	cancer	NN	O	cancer	prep_including	8	SENT_190	[p9l1190t3100r1286b3117],
18	.	.	O	.	_	0	SENT_190	[p9l1190t3100r1286b3117],

1	Leukotrienes	NNS	O	leukotriene	nsubj	2	SENT_191	[p9l1300t3091r1474b3117],
2	affect	VBP	O	affect	_	0	SENT_191	[p9l1486t3091r1563b3117],
3	leukocytes	NNS	O	leukocyte	dobj	2	SENT_191	[p9l1575t3091r1718b3124],
4	by	IN	O	by	_	0	SENT_191	[p9l1731t3091r1760b3124],
5	stimulating	VBG	O	stimulate	prepc_by	2	SENT_191	[p9l122t3133r277b3166],
6	the	DT	O	the	det	7	SENT_191	[p9l287t3133r330b3158],
7	growth	NN	O	growth	dobj	5	SENT_191	[p9l341t3133r435b3166],
8	of	IN	O	of	_	0	SENT_191	[p9l448t3133r478b3158],
9	bone	NN	O	bone	nn	11	SENT_191	[p9l485t3133r552b3158],
10	marrow	NN	O	marrow	nn	11	SENT_191	[p9l564t3142r668b3158],
11	CD34	NN	O	cd34	prep_of	7	SENT_191	[p9l679t3135r772b3158],
12	+	CC	O	+	_	0	SENT_191	[p9l679t3135r772b3158],
13	pluripotent	JJ	O	pluripotent	amod	16	SENT_191	[p9l785t3133r937b3166],
14	hematopoietic	JJ	O	hematopoietic	amod	16	SENT_191	[p9l949t3133r1147b3166],
15	stem-cell	NN	O	stem-cell	nn	16	SENT_191	[p9l1158t3133r1282b3158],
16	progenitors	NNS	O	progenitor	conj_+	7	SENT_191	[p9l1295t3136r1452b3166],
17	and	CC	O	and	_	0	SENT_191	[p9l1465t3133r1513b3158],
18	their	PRP$	O	they	poss	20	SENT_191	[p9l1524t3133r1588b3158],
19	subsequent	JJ	O	subsequent	amod	20	SENT_191	[p9l1599t3133r1758b3166],
20	migration	NN	O	migration	conj_+	7	SENT_191	[p9l122t3177r253b3208],
21	into	IN	O	into	_	0	SENT_191	[p9l267t3177r318b3200],
22	the	DT	O	the	det	23	SENT_191	[p9l328t3175r371b3200],
23	bloodstream	NN	O	bloodstream	prep_into	5	SENT_191	[p9l383t3175r565b3200],
24	.	.	O	.	_	0	SENT_191	[p9l383t3175r565b3200],

1	Leukotrienes	NNS	O	leukotriene	nsubj	3	SENT_192	[p9l579t3175r753b3200],
2	also	RB	O	also	advmod	3	SENT_192	[p9l765t3175r819b3200],
3	increase	VBP	O	increase	_	0	SENT_192	[p9l831t3177r943b3200],
4	the	DT	O	the	det	5	SENT_192	[p9l953t3175r996b3200],
5	expression	NN	O	expression	nsubj	9	SENT_192	[p9l1007t3177r1153b3208],
6	of	IN	O	of	_	0	SENT_192	[p9l1165t3175r1195b3200],
7	adhesion	NN	O	adhesion	nn	8	SENT_192	[p9l1202t3175r1325b3200],
8	proteins	NNS	O	protein	prep_of	5	SENT_192	[p9l1338t3177r1449b3208],
9	(	VBP	O	(	ccomp	3	SENT_192	[p9l1463t3175r1574b3208],
10	thereby	RB	O	thereby	advmod	11	SENT_192	[p9l1463t3175r1574b3208],
11	enhancing	VBG	O	enhance	dep	9	SENT_192	[p9l1584t3175r1727b3208],
12	leukocyte	NN	O	leukocyte	nn	13	SENT_192	[p9l122t3216r251b3249],
13	adhesion	NN	O	adhesion	dobj	11	SENT_192	[p9l262t3216r385b3242],
14	to	TO	O	to	_	0	SENT_192	[p9l397t3221r424b3242],
15	the	DT	O	the	det	17	SENT_192	[p9l434t3216r477b3242],
16	microvasculature	NN	O	microvasculature	nn	17	SENT_192	[p9l489t3216r733b3250],
17	)	NN	O	)	prep_to	11	SENT_192	[p9l489t3216r733b3250],
18	and	CC	O	and	_	0	SENT_192	[p9l747t3216r795b3242],
19	promote	VB	O	promote	conj_and	11	SENT_192	[p9l809t3221r925b3249],
20	cell	NN	O	cell	nn	21	SENT_192	[p9l936t3216r979b3242],
21	motility	NN	O	motility	dobj	19	SENT_192	[p9l993t3216r1102b3249],
22	,	,	O	,	_	0	SENT_192	[p9l993t3216r1102b3249],
23	which	WDT	O	which	nsubj	24	SENT_192	[p9l1113t3216r1193b3242],
24	leads	VBZ	O	lead	rcmod	21	SENT_192	[p9l1206t3216r1275b3242],
25	to	TO	O	to	_	0	SENT_192	[p9l1286t3221r1312b3242],
26	transmigration	NN	O	transmigration	prep_to	24	SENT_192	[p9l1323t3219r1526b3250],
27	into	IN	O	into	_	0	SENT_192	[p9l1540t3219r1591b3242],
28	tissues	NNS	O	tissue	prep_into	24	SENT_192	[p9l1601t3219r1704b3242],
29	.	.	O	.	_	0	SENT_192	[p9l1601t3219r1704b3242],

1	Once	RB	DATE	once	advmod	3	SENT_193	[p9l121t3260r193b3283],
2	leukocytes	NNS	O	leukocyte	nsubj	3	SENT_193	[p9l206t3258r349b3291],
3	reach	VBP	O	reach	dep	13	SENT_193	[p9l362t3258r433b3283],
4	the	DT	O	the	det	6	SENT_193	[p9l445t3258r488b3283],
5	inflamed	JJ	O	inflamed	amod	6	SENT_193	[p9l500t3258r620b3283],
6	tissues	NNS	O	tissue	dobj	3	SENT_193	[p9l631t3261r734b3288],
7	,	,	O	,	_	0	SENT_193	[p9l631t3261r734b3288],
8	their	PRP$	O	they	poss	9	SENT_193	[p9l745t3258r809b3283],
9	survival	NN	O	survival	nsubjpass	13	SENT_193	[p9l820t3258r923b3283],
10	and	CC	O	and	_	0	SENT_193	[p9l936t3258r984b3283],
11	activation	NN	O	activation	nsubjpass	13	SENT_193	[p9l997t3261r1129b3283],
12	are	VBP	O	be	auxpass	13	SENT_193	[p9l1142t3267r1182b3283],
13	enhanced	VBN	O	enhance	_	0	SENT_193	[p9l1193t3258r1325b3283],
14	by	IN	O	by	_	0	SENT_193	[p9l1339t3258r1367b3291],
15	leukotrienes	NNS	O	leukotriene	agent	13	SENT_193	[p9l1379t3258r1554b3283],
16	.	.	O	.	_	0	SENT_193	[p9l1379t3258r1554b3283],

1	Through	IN	O	through	_	0	SENT_194	[p9l1564t3258r1681b3291],
2	B	NN	O	b	nn	4	SENT_194	[p9l1695t3260r1710b3283],
3	leukotriene	NN	O	leukotriene	nn	4	SENT_194	[p9l122t3300r274b3325],
4	receptor	NN	O	receptor	prep_through	53	SENT_194	[p9l287t3305r400b3333],
5	1	CD	NUMBER	1	number	6	SENT_194	[p9l412t3302r423b3325],
6	(	CD	NUMBER	(	num	8	SENT_194	[p9l439t3302r526b3336],
7	BLT1	NN	O	blt1	nn	8	SENT_194	[p9l439t3302r526b3336],
8	)	NN	O	)	dep	4	SENT_194	[p9l439t3302r526b3336],
9	,	,	O	,	_	0	SENT_194	[p9l439t3302r526b3336],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_194	[p9l539t3300r692b3325],
11	B4	NN	O	b4	nsubj	53	SENT_194	[p9l705t3302r734b3332],
12	(	CD	NUMBER	(	num	13	SENT_194	[p9l747t3302r829b3333],
13	LTB4	NN	O	ltb4	nsubj	16	SENT_194	[p9l747t3302r829b3333],
14	)	CD	NUMBER	)	dep	13	SENT_194	[p9l747t3302r829b3333],
15	primarily	RB	O	primarily	advmod	16	SENT_194	[p9l844t3300r965b3333],
16	mediates	VBZ	O	mediate	rcmod	11	SENT_194	[p9l977t3300r1100b3325],
17	the	DT	O	the	det	18	SENT_194	[p9l1111t3300r1154b3325],
18	recruitment	NN	O	recruitment	dobj	16	SENT_194	[p9l1167t3302r1328b3325],
19	of	IN	O	of	_	0	SENT_194	[p9l1338t3300r1368b3325],
20	mast	NN	O	mast	nn	21	SENT_194	[p9l1376t3305r1442b3325],
21	cells	NNS	O	cell	prep_of	18	SENT_194	[p9l1453t3300r1520b3330],
22	,	,	O	,	_	0	SENT_194	[p9l1453t3300r1520b3330],
23	neutrophils	NNS	O	neutrophil	conj_or	21	SENT_194	[p9l1534t3300r1697b3333],
24	,	,	O	,	_	0	SENT_194	[p9l1534t3300r1697b3333],
25	monocytes	NNS	O	monocyte	conj_or	21	SENT_194	[p9l122t3346r273b3375],
26	or	CC	O	or	_	0	SENT_194	[p9l285t3350r313b3367],
27	macrophages	NNS	O	macrophage	conj_or	21	SENT_194	[p9l324t3341r516b3375],
28	,	,	O	,	_	0	SENT_194	[p9l324t3341r516b3375],
29	and	CC	O	and	_	0	SENT_194	[p9l529t3342r577b3367],
30	T	NN	O	t	nn	31	SENT_194	[p9l588t3344r606b3366],
31	cells	NNS	O	cell	prep_of	18	SENT_194	[p9l616t3341r683b3371],
32	;	:	O	;	_	0	SENT_194	[p9l616t3341r683b3371],
33	through	IN	O	through	_	0	SENT_194	[p9l694t3341r802b3375],
34	type	NN	O	type	nn	37	SENT_194	[p9l814t3346r872b3374],
35	1	CD	NUMBER	1	num	37	SENT_194	[p9l885t3344r896b3366],
36	cysteinyl	NN	O	cysteinyl	nn	37	SENT_194	[p9l909t3342r1024b3375],
37	leukotriene	NN	O	leukotriene	prep_through	16	SENT_194	[p9l1038t3342r1190b3367],
38	receptor	NN	O	receptor	nn	41	SENT_194	[p9l1202t3346r1316b3374],
39	(	CD	NUMBER	(	num	41	SENT_194	[p9l1329t3343r1444b3377],
40	CysLT1	NN	O	cyslt1	nn	41	SENT_194	[p9l1329t3343r1444b3377],
41	)	NN	O	)	tmod	16	SENT_194	[p9l1329t3343r1444b3377],
42	,	,	O	,	_	0	SENT_194	[p9l1329t3343r1444b3377],
43	cysteinyl	NN	O	cysteinyl	nn	44	SENT_194	[p9l1456t3342r1572b3375],
44	leukotrienes	NNS	O	leukotriene	appos	41	SENT_194	[p9l1586t3341r1760b3371],
45	,	,	O	,	_	0	SENT_194	[p9l1586t3341r1760b3371],
46	including	VBG	O	include	dep	16	SENT_194	[p9l122t3383r248b3416],
47	leukotriene	NN	O	leukotriene	nn	48	SENT_194	[p9l260t3383r412b3408],
48	D4	NN	O	d4	pobj	46	SENT_194	[p9l425t3386r458b3415],
49	(	CD	NUMBER	(	num	51	SENT_194	[p9l467t3385r561b3416],
50	LTD4	NN	O	ltd4	nn	51	SENT_194	[p9l467t3385r561b3416],
51	)	NN	O	)	dep	48	SENT_194	[p9l467t3385r561b3416],
52	,	,	O	,	_	0	SENT_194	[p9l467t3385r561b3416],
53	promote	VBP	O	promote	_	0	SENT_194	[p9l575t3388r691b3416],
54	the	DT	O	the	det	56	SENT_194	[p9l701t3383r744b3408],
55	recruitment	NN	O	recruitment	nn	56	SENT_194	[p9l757t3386r918b3408],
56	ofeosinophils	NNS	O	ofeosinophil	dobj	53	SENT_194	[p9l928t3383r1130b3416],
57	,	,	O	,	_	0	SENT_194	[p9l928t3383r1130b3416],
58	dendritic	JJ	O	dendritic	amod	59	SENT_194	[p9l1142t3383r1265b3408],
59	cells	NNS	O	cell	dobj	53	SENT_194	[p9l1275t3383r1342b3413],
60	,	,	O	,	_	0	SENT_194	[p9l1275t3383r1342b3413],
61	and	CC	O	and	_	0	SENT_194	[p9l1355t3383r1403b3408],
62	T	NN	O	t	nn	63	SENT_194	[p9l1414t3386r1432b3408],
63	cells	NNS	O	cell	dobj	53	SENT_194	[p9l1442t3383r1509b3408],
64	.	.	O	.	_	0	SENT_194	[p9l1442t3383r1509b3408],

1	N	NN	O	n	nn	3	SENT_195	[p9l547t3545r561b3561],
2	ENG	NNP	O	ENG	nn	3	SENT_195	[p9l576t3545r625b3561],
3	L	NNP	O	L	_	0	SENT_195	[p9l632t3545r656b3568],
4	}	CD	NUMBER	}	num	6	SENT_195	[p9l632t3545r656b3568],
5	M	NN	O	m	nn	6	SENT_195	[p9l671t3545r688b3561],
6	ED	NN	O	ed	dep	3	SENT_195	[p9l695t3545r724b3561],
7	357	CD	NUMBER	357	dep	3	SENT_195	[p9l734t3539r810b3568],
8	;	:	O	;	_	0	SENT_195	[p9l734t3539r810b3568],
9	18	CD	NUMBER	18	dep	3	SENT_195	[p9l734t3539r810b3568],
10	WWW	NNP	O	WWW	dep	9	SENT_195	[p9l844t3545r937b3561],
11	.	.	O	.	_	0	SENT_195	[p9l844t3545r937b3561],

1	N	NN	O	n	nn	2	SENT_196	[p9l844t3545r937b3561],
2	E	NN	O	e	_	0	SENT_196	[p9l944t3545r962b3568],
3	)	CD	NUMBER	)	dep	2	SENT_196	[p9l944t3545r962b3568],
4	M.oRG	NNP	O	M.oRG	nn	5	SENT_196	[p9l969t3545r1051b3561],
5	NOVEMBER	NNP	DATE	NOVEMBER	dep	3	SENT_196	[p9l1088t3545r1227b3562],
6	1	CD	DATE	1	num	5	SENT_196	[p9l1238t3545r1255b3566],
7	,	,	DATE	,	_	0	SENT_196	[p9l1238t3545r1255b3566],
8	2007	CD	DATE	2007	num	5	SENT_196	[p9l1266t3545r1331b3567],
9	1345	CD	DATE	1345	dep	2	SENT_196	[p9l1991t3535r2066b3558],

1	The	DT	O	the	det	4	SENT_197	[p9l753t3579r804b3602],
2	New	NNP	O	New	nn	4	SENT_197	[p9l813t3579r875b3602],
3	England	NNP	O	England	nn	4	SENT_197	[p9l884t3579r995b3609],
4	Journal	NNP	O	Journal	_	0	SENT_197	[p9l1003t3579r1101b3602],
5	of	IN	O	of	_	0	SENT_197	[p9l1111t3579r1140b3602],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_197	[p9l1146t3579r1272b3602],

1	Downloaded	VBN	O	download	_	0	SENT_198	[p9l195t3619r365b3642],
2	from	IN	O	from	_	0	SENT_198	[p9l374t3619r438b3642],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_198	[p9l447t3619r565b3649],
4	at	IN	O	at	_	0	SENT_198	[p9l575t3622r598b3642],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_198	[p9l607t3619r790b3642],
6	on	IN	O	on	_	0	SENT_198	[p9l799t3626r831b3642],
7	January	NNP	DATE	January	prep_on	1	SENT_198	[p9l840t3619r943b3649],
8	5	CD	DATE	5	num	7	SENT_198	[p9l953t3619r975b3647],
9	,	,	DATE	,	_	0	SENT_198	[p9l953t3619r975b3647],
10	2014	CD	DATE	2014	num	7	SENT_198	[p9l986t3619r1058b3642],
11	.	.	O	.	_	0	SENT_198	[p9l986t3619r1058b3642],

1	For	IN	O	for	_	0	SENT_199	[p9l1069t3619r1115b3642],
2	personal	JJ	O	personal	amod	3	SENT_199	[p9l1123t3619r1236b3649],
3	use	NN	O	use	pobj	1	SENT_199	[p9l1245t3626r1288b3642],
4	only	RB	O	only	advmod	3	SENT_199	[p9l1298t3619r1363b3649],
5	.	.	O	.	_	0	SENT_199	[p9l1298t3619r1363b3649],

1	No	DT	O	no	det	3	SENT_200	[p9l1374t3619r1413b3642],
2	other	JJ	O	other	amod	3	SENT_200	[p9l1423t3619r1491b3642],
3	uses	NNS	O	use	_	0	SENT_200	[p9l1500t3626r1556b3642],
4	without	IN	O	without	_	0	SENT_200	[p9l1566t3619r1667b3642],
5	permission	NN	O	permission	prep_without	3	SENT_200	[p9l1675t3619r1828b3649],
6	.	.	O	.	_	0	SENT_200	[p9l1675t3619r1828b3649],

1	Copyright	NN	O	copyright	_	0	SENT_201	[p9l545t3660r680b3691],
2	©	CD	NUMBER	©	num	6	SENT_201	[p9l689t3660r712b3684],
3	2007	CD	DATE	2007	num	6	SENT_201	[p9l723t3660r787b3684],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_201	[p9l797t3660r988b3684],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_201	[p9l998t3660r1106b3684],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_201	[p9l1116t3660r1222b3691],
7	.	.	O	.	_	0	SENT_201	[p9l1116t3660r1222b3691],

1	All	DT	O	all	det	2	SENT_202	[p9l1232t3660r1274b3684],
2	rights	NNS	O	rights	nsubj	3	SENT_202	[p9l1283t3660r1358b3691],
3	reserved	VBN	O	reserve	_	0	SENT_202	[p9l1367t3660r1486b3684],
4	.	.	O	.	_	0	SENT_202	[p9l1367t3660r1486b3684],

1	The	DT	O	the	det	4	SENT_203	[p9l815t3703r860b3724],
2	NEW	NNP	O	NEW	nn	4	SENT_203	[p9l879t3705r964b3724],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_203	[p9l983t3705r1171b3724],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_203	[p9l1190t3705r1370b3731],
5	of	IN	O	of	_	0	SENT_203	[p9l1390t3703r1418b3730],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_203	[p9l1430t3705r1629b3724],

1	Table	NNP	O	Table	_	0	SENT_204	[p10l118t71r192b96],
2	2	CD	NUMBER	2	dep	1	SENT_204	[p10l201t74r223b96],
3	.	.	O	.	_	0	SENT_204	[p10l201t74r223b96],

1	Effects	NNS	O	effect	nsubj	10	SENT_205	[p10l235t71r324b96],
2	of	IN	O	of	_	0	SENT_205	[p10l334t71r365b96],
3	Leukotrienes	NNS	O	leukotriene	prep_of	1	SENT_205	[p10l370t71r544b96],
4	on	IN	O	on	_	0	SENT_205	[p10l553t80r586b96],
5	the	DT	O	the	det	7	SENT_205	[p10l595t71r639b96],
6	Biologic	JJ	ORGANIZATION	biologic	amod	7	SENT_205	[p10l650t71r757b104],
7	Actions	NNS	ORGANIZATION	action	prep_on	3	SENT_205	[p10l765t72r868b96],
8	of	IN	ORGANIZATION	of	_	0	SENT_205	[p10l877t71r908b96],
9	Cells	NNS	ORGANIZATION	cell	prep_of	7	SENT_205	[p10l912t71r977b96],
10	Associated	VBN	ORGANIZATION	associate	_	0	SENT_205	[p10l985t71r1133b96],
11	with	IN	O	with	_	0	SENT_205	[p10l1142t71r1200b96],
12	Asthma	NN	O	asthma	prep_with	10	SENT_205	[p10l1210t71r1324b102],
13	,	,	O	,	_	0	SENT_205	[p10l1210t71r1324b102],
14	Cardiovascular	NNP	O	Cardiovascular	nn	15	SENT_205	[p10l1334t71r1538b96],
15	Disease	NNP	O	Disease	ccomp	10	SENT_205	[p10l1548t72r1661b102],
16	,	,	O	,	_	0	SENT_205	[p10l1548t72r1661b102],
17	and	CC	O	and	_	0	SENT_205	[p10l1671t71r1720b96],
18	Cancer	NN	O	cancer	conj_and	15	SENT_205	[p10l1730t73r1850b96],
19	.	.	O	.	_	0	SENT_205	[p10l1730t73r1850b96],
20	"	''	O	"	punct	10	SENT_205	[p10l1730t73r1850b96],
21	"	''	O	"	punct	10	SENT_205	[p10l1730t73r1850b96],

1	Type	NN	O	type	_	0	SENT_206	[p10l118t149r183b179],
2	of	IN	O	of	_	0	SENT_206	[p10l193t146r225b172],
3	Cell	NN	O	cell	nn	7	SENT_206	[p10l229t146r279b172],
4	Asthma	NN	O	asthma	nn	7	SENT_206	[p10l745t146r850b172],
5	Cardiovascular	NNP	O	Cardiovascular	nn	7	SENT_206	[p10l1142t146r1347b172],
6	Disease	NNP	O	Disease	nn	7	SENT_206	[p10l1358t147r1464b172],
7	Cancer	NNP	O	Cancer	prep_of	1	SENT_206	[p10l1759t148r1855b172],

1	Leukocyte	NN	O	leukocyte	nn	2	SENT_207	[p10l121t204r254b237],
2	Increases	NNS	O	increase	_	0	SENT_207	[p10l566t206r692b229],
3	recruitment	NN	O	recruitment	dep	2	SENT_207	[p10l704t206r862b229],
4	of	IN	O	of	_	0	SENT_207	[p10l872t204r902b229],
5	Increases	NNS	O	increase	prep_of	3	SENT_207	[p10l1087t206r1213b229],
6	monocyte	NN	O	monocyte	nn	10	SENT_207	[p10l1225t209r1358b237],
7	and	CC	O	and	_	0	SENT_207	[p10l1368t204r1416b229],
8	Increases	NNS	O	increase	nn	10	SENT_207	[p10l1575t206r1701b229],
9	recruitment	NN	O	recruitment	nn	10	SENT_207	[p10l1713t206r1872b229],
10	ofmonoT	NN	O	ofmonot	dep	2	SENT_207	[p10l1882t204r2005b229, p10l612t244r630b266],

1	ce	NN	O	ce	nsubj	66	SENT_208	[p10l639t242r725b275],
2	|	CD	NUMBER	|	num	4	SENT_208	[p10l639t242r725b275],
3	|	NN	O	|	nn	4	SENT_208	[p10l639t242r725b275],
4	s	NNS	O	s	rcmod	1	SENT_208	[p10l639t242r725b275],
5	,	,	O	,	_	0	SENT_208	[p10l639t242r725b275],
6	]	CD	NUMBER	]	appos	4	SENT_208	[p10l639t242r725b275],
7	"	``	O	"	punct	6	SENT_208	[p10l639t242r725b275],
8	eosinophi	FW	O	eosinophi	nn	10	SENT_208	[p10l743t242r928b275],
9	|	FW	O	|	nn	10	SENT_208	[p10l743t242r928b275],
10	s	NNS	O	s	dep	6	SENT_208	[p10l743t242r928b275],
11	,	,	O	,	_	0	SENT_208	[p10l743t242r928b275],
12	'	''	O	'	_	0	SENT_208	[p10l743t242r928b275],
13	i	FW	O	i	dep	4	SENT_208	[p10l743t242r928b275],
14	'	''	O	'	_	0	SENT_208	[p10l743t242r928b275],
15	T-cell	NN	O	t-cell	nn	16	SENT_208	[p10l1134t242r1205b267],
16	recruitmentj	NN	O	recruitmentj	dep	4	SENT_208	[p10l1218t244r1394b275],
17	:	:	O	:	_	0	SENT_208	[p10l1218t244r1394b275],
18	cytesj	NN	O	cytesj	dep	16	SENT_208	[p10l1623t244r1708b275],
19	:	:	O	:	_	0	SENT_208	[p10l1623t244r1708b275],
20	and	CC	O	and	_	0	SENT_208	[p10l614t279r662b304],
21	mast	NN	O	mast	conj_and	1	SENT_208	[p10l675t284r741b304],
22	ceIIs	NNS	O	ceii	rcmod	21	SENT_208	[p10l750t279r828b312],
23	:	:	O	:	_	0	SENT_208	[p10l750t279r828b312],
24	i	FW	O	i	dep	22	SENT_208	[p10l750t279r828b312],
25	:	:	O	:	_	0	SENT_208	[p10l750t279r828b312],
26	Increases	NNS	O	increase	dep	22	SENT_208	[p10l1087t281r1213b304],
27	differentiation	NN	O	differentiation	dep	26	SENT_208	[p10l1224t279r1415b304],
28	of	IN	O	of	_	0	SENT_208	[p10l1426t279r1456b304],
29	Increases	NNS	O	increase	prep_of	27	SENT_208	[p10l1575t281r1701b304],
30	cytokines	NNS	O	cytokine	rcmod	29	SENT_208	[p10l1712t279r1837b312],
31	or	CC	O	or	_	0	SENT_208	[p10l1848t288r1876b304],
32	chemokines	NNS	O	chemokine	nn	33	SENT_208	[p10l1884t279r2048b304],
33	Increases	NNS	O	increase	conj_or	30	SENT_208	[p10l566t319r692b360],
34	Th2	NN	O	th2	nn	35	SENT_208	[p10l701t317r752b341],
35	responses	NNS	O	response	rcmod	33	SENT_208	[p10l764t325r909b360],
36	,	,	O	,	_	0	SENT_208	[p10l764t325r909b360],
37	cyto	SYM	O	cyto	dep	39	SENT_208	[p10l920t321r983b350],
38	-	:	O	-	_	0	SENT_208	[p10l920t321r983b350],
39	macrophages	NNS	O	macrophage	dep	35	SENT_208	[p10l1136t317r1319b350],
40	or	CC	O	or	_	0	SENT_208	[p10l1330t325r1358b342],
41	foam	NN	O	foam	dep	35	SENT_208	[p10l1366t316r1434b342],
42	and	CC	O	and	_	0	SENT_208	[p10l1624t317r1671b342],
43	reactive	JJ	O	reactive	amod	45	SENT_208	[p10l1684t319r1787b342],
44	oxygen	NN	O	oxygen	nn	45	SENT_208	[p10l1797t325r1889b350],
45	species	NNS	O	species	conj_or	30	SENT_208	[p10l1901t319r2019b350],
46	'	POS	O	'	_	0	SENT_208	[p10l1901t319r2019b350],
47	i	FW	O	i	dep	45	SENT_208	[p10l1901t319r2019b350],
48	'	''	O	'	_	0	SENT_208	[p10l1901t319r2019b350],
49	kines	NNS	O	kine	conj_or	30	SENT_208	[p10l615t354r683b379],
50	or	CC	O	or	_	0	SENT_208	[p10l693t363r721b379],
51	chemokines	NNS	O	chemokine	conj_or	49	SENT_208	[p10l730t354r901b384],
52	,	,	O	,	_	0	SENT_208	[p10l730t354r901b384],
53	and	CC	O	and	advmod	49	SENT_208	[p10l913t354r961b379],
54	re	SYM	O	re	dep	27	SENT_208	[p10l974t363r1006b379],
55	-	:	O	-	_	0	SENT_208	[p10l974t363r1006b379],
56	cellsj	NN	O	cellsj	dep	22	SENT_208	[p10l1135t354r1212b387],
57	:	:	O	:	_	0	SENT_208	[p10l1135t354r1212b387],
58	active	JJ	O	active	amod	60	SENT_208	[p10l614t394r691b417],
59	oxygen	NN	O	oxygen	nn	60	SENT_208	[p10l701t400r793b425],
60	species	NNS	O	species	dep	22	SENT_208	[p10l805t394r922b425],
61	'	POS	O	'	_	0	SENT_208	[p10l805t394r922b425],
62	i	FW	O	i	dep	60	SENT_208	[p10l805t394r922b425],
63	'	''	O	'	_	0	SENT_208	[p10l805t394r922b425],
64	Increases	NNS	O	increase	dep	22	SENT_208	[p10l1087t394r1213b417],
65	chemokines	NNS	O	chemokine	dep	64	SENT_208	[p10l1224t392r1387b417],
66	(	VBP	O	(	_	0	SENT_208	[p10l1401t394r1464b425],
67	e.g.	FW	O	e.g.	dobj	66	SENT_208	[p10l1401t394r1464b425],
68	,	,	O	,	_	0	SENT_208	[p10l1401t394r1464b425],
69	MCP-1	NN	O	mcp-1	nn	72	SENT_208	[p10l1137t431r1225b454],
70	and	CC	O	and	_	0	SENT_208	[p10l1237t429r1285b454],
71	MIP-la	NN	O	mip-la	nn	72	SENT_208	[p10l1298t431r1407b462],
72	)	NN	O	)	conj_and	67	SENT_208	[p10l1298t431r1407b462],
73	and	CC	O	and	_	0	SENT_208	[p10l1421t429r1468b454],
74	proteases	NNS	O	protease	conj_and	67	SENT_208	[p10l1136t469r1285b500],
75	'	POS	O	'	_	0	SENT_208	[p10l1136t469r1285b500],
76	i	FW	O	i	nn	77	SENT_208	[p10l1136t469r1285b500],
77	‘	FW	O	‘	dep	74	SENT_208	[p10l1136t469r1285b500],

1	Dendritic	JJ	O	dendritic	amod	3	SENT_209	[p10l121t524r245b550],
2	cell	NN	O	cell	nn	3	SENT_209	[p10l255t524r298b550],
3	Increases	NNS	O	increase	_	0	SENT_209	[p10l566t527r692b550],
4	cell	NN	O	cell	nn	5	SENT_209	[p10l702t524r745b550],
5	recruitment	NN	O	recruitment	dep	3	SENT_209	[p10l758t527r917b550],
6	and	CC	O	and	_	0	SENT_209	[p10l926t524r974b550],
7	NA	NN	O	na	nn	8	SENT_209	[p10l1275t526r1317b549],
8	NA	NN	O	na	dep	3	SENT_209	[p10l1791t526r1833b549],

1	activationfl	NN	O	activationfl	_	0	SENT_210	[p10l614t562r758b595],

1	Epithelial	JJ	O	epithelial	amod	3	SENT_211	[p10l121t619r243b652],
2	cell	NN	O	cell	nn	3	SENT_211	[p10l255t619r297b645],
3	Increases	NNS	O	increase	_	0	SENT_211	[p10l566t622r692b645],
4	mucus	NN	O	mucus	nn	5	SENT_211	[p10l704t628r793b645],
5	release	NN	O	release	dep	3	SENT_211	[p10l806t619r899b645],
6	and	CC	O	and	_	0	SENT_211	[p10l909t620r957b645],
7	NA	NN	O	na	nn	8	SENT_211	[p10l1275t621r1317b645],
8	NA	NN	O	na	dep	3	SENT_211	[p10l1791t621r1833b645],

1	goblet	NN	O	goblet	nn	2	SENT_212	[p10l614t657r698b690],
2	cellsfl	NNS	O	cellsfl	_	0	SENT_212	[p10l707t657r779b690],

1	Fibroblast	NN	O	fibroblast	nn	4	SENT_213	[p10l121t715r256b740],
2	or	CC	O	or	_	0	SENT_213	[p10l265t724r293b740],
3	myoﬁbroblast	NN	O	myoﬁbroblast	nn	4	SENT_213	[p10l304t714r491b748],
4	Increases	NNS	O	increase	_	0	SENT_213	[p10l566t717r692b740],
5	collagen	NN	O	collagen	nn	6	SENT_213	[p10l702t715r814b748],
6	releasefl	NN	O	releasefl	dep	4	SENT_213	[p10l827t715r933b748],
7	NA	NNP	O	NA	nn	8	SENT_213	[p10l1275t716r1317b740],
8	NA	NNP	O	NA	dep	4	SENT_213	[p10l1791t716r1833b740],

1	Smooth-muscle	JJ	O	smooth-muscle	amod	4	SENT_214	[p10l119t772r335b798],
2	cell	NN	O	cell	nn	4	SENT_214	[p10l345t772r388b798],
3	Increases	NNS	O	increase	nn	4	SENT_214	[p10l566t775r692b798],
4	contractility	NN	O	contractility	_	0	SENT_214	[p10l702t772r862b805],
5	and	CC	O	and	_	0	SENT_214	[p10l872t772r920b798],
6	pro	JJ	O	pro	amod	7	SENT_214	[p10l933t772r1011b805],
7	|	NN	O	|	conj_and	4	SENT_214	[p10l933t772r1011b805],
8	if	IN	O	if	amod	7	SENT_214	[p10l933t772r1011b805],
9	-	:	O	-	_	0	SENT_214	[p10l933t772r1011b805],
10	Increases	NNS	O	increase	dep	4	SENT_214	[p10l1087t775r1213b798],
11	contractility	NN	O	contractility	dep	10	SENT_214	[p10l1224t772r1384b805],
12	and	CC	O	and	_	0	SENT_214	[p10l1394t772r1441b798],
13	NA	NN	O	na	dep	10	SENT_214	[p10l1791t774r1833b797],

1	erationfl	NN	O	erationfl	nn	2	SENT_215	[p10l614t810r721b843],
2	proliferationfl	NN	O	proliferationfl	_	0	SENT_215	[p10l1136t810r1315b843],

1	Endothelial	JJ	O	endothelial	amod	3	SENT_216	[p10l121t868r271b893],
2	cell	NN	O	cell	nn	3	SENT_216	[p10l282t868r325b893],
3	Increases	NNS	O	increase	dep	16	SENT_216	[p10l566t870r692b893],
4	vascular	JJ	O	vascular	amod	6	SENT_216	[p10l702t868r815b893],
5	permeabilityij	NN	O	permeabilityij	nn	6	SENT_216	[p10l825t867r1005b901],
6	Increases	NNS	O	increase	dep	3	SENT_216	[p10l1087t870r1213b893],
7	vascular	JJ	O	vascular	amod	8	SENT_216	[p10l1223t868r1336b893],
8	perme	NN	O	perme	dep	6	SENT_216	[p10l1347t876r1441b900],
9	-	:	O	-	_	0	SENT_216	[p10l1347t876r1441b900],
10	Increases	NNS	O	increase	dep	6	SENT_216	[p10l1575t870r1701b893],
11	vascular	JJ	O	vascular	amod	12	SENT_216	[p10l1711t868r1824b893],
12	permeability	NN	O	permeability	dep	16	SENT_216	[p10l1835t868r2002b901],
13	abilityfl	NN	O	abilityfl	nn	16	SENT_216	[p10l1135t905r1227b938],
14	and	CC	O	and	_	0	SENT_216	[p10l1624t905r1671b930],
15	angiogenesisl	NN	O	angiogenesisl	nn	16	SENT_216	[p10l1683t905r1875b938],
16	Increases	NNS	O	increase	dep	23	SENT_216	[p10l1087t945r1213b968],
17	intimal	JJ	O	intimal	amod	20	SENT_216	[p10l1225t943r1317b968],
18	hyperp	NN	O	hyperp	nn	20	SENT_216	[p10l1330t943r1502b976],
19	|	NN	O	|	nn	20	SENT_216	[p10l1330t943r1502b976],
20	asia	NN	O	asia	dep	16	SENT_216	[p10l1330t943r1502b976],
21	]	CD	NUMBER	]	num	23	SENT_216	[p10l1330t943r1502b976],
22	"	``	O	"	punct	23	SENT_216	[p10l1330t943r1502b976],
23	Increases	NNS	O	increase	_	0	SENT_216	[p10l1087t982r1213b1005],
24	chemokines	NNS	O	chemokine	nsubj	25	SENT_216	[p10l1224t980r1387b1005],
25	(	VBP	O	(	rcmod	23	SENT_216	[p10l1401t982r1464b1013],
26	e.g.	FW	O	e.g.	dobj	25	SENT_216	[p10l1401t982r1464b1013],
27	,	,	O	,	_	0	SENT_216	[p10l1401t982r1464b1013],

1	MIP-2	NN	O	mip-2	_	0	SENT_217	[p10l1137t1020r1247b1051],
2	)	SYM	O	)	dep	1	SENT_217	[p10l1137t1020r1247b1051],
3	-	:	O	-	_	0	SENT_217	[p10l1137t1020r1247b1051],
4	i	FW	O	i	dep	1	SENT_217	[p10l1137t1020r1247b1051],
5	‘	FW	O	‘	dep	4	SENT_217	[p10l1137t1020r1247b1051],

1	Increases	NNS	O	increase	_	0	SENT_218	[p10l1087t1057r1213b1080],
2	thrombosisﬁ	NN	O	thrombosisﬁ	dep	1	SENT_218	[p10l1223t1055r1393b1088],

1	Malignant	JJ	O	malignant	amod	2	SENT_219	[p10l121t1113r258b1146],
2	cell	NN	O	cell	dep	7	SENT_219	[p10l267t1113r310b1138],
3	NA	NNP	O	NA	nn	4	SENT_219	[p10l1275t1114r1317b1138],
4	Increases	NNS	O	increase	dep	2	SENT_219	[p10l1575t1115r1701b1138],
5	proliferation	NN	O	proliferation	dep	7	SENT_219	[p10l1713t1112r1878b1146],
6	(	CD	NUMBER	(	num	5	SENT_219	[p10l1893t1115r1956b1146],
7	e.g.	FW	O	e.g.	_	0	SENT_219	[p10l1893t1115r1956b1146],
8	,	,	O	,	_	0	SENT_219	[p10l1893t1115r1956b1146],
9	kinase	NN	O	kinase	appos	7	SENT_219	[p10l1968t1113r1997b1138, p10l1625t1159r1685b1175],
10	or	CC	O	or	_	0	SENT_219	[p10l1695t1159r1723b1175],
11	B-catenin	NN	O	b-catenin	nn	12	SENT_219	[p10l1730t1152r1859b1182],
12	signaIing	NN	O	signaiing	conj_or	7	SENT_219	[p10l1871t1150r2024b1183],
13	)	NN	O	)	rcmod	12	SENT_219	[p10l1871t1150r2024b1183],
14	1	CD	NUMBER	1	num	13	SENT_219	[p10l1871t1150r2024b1183],
15	'	''	O	'	_	0	SENT_219	[p10l1871t1150r2024b1183],
16	Increases	NNS	O	increase	dobj	13	SENT_219	[p10l1575t1190r1701b1213],
17	transcriptional	JJ	O	transcriptional	amod	20	SENT_219	[p10l1711t1188r1909b1221],
18	activity	NN	O	activity	nn	20	SENT_219	[p10l1921t1190r2015b1221],
19	ofoncogenic	JJ	O	ofoncogenic	amod	20	SENT_219	[p10l1623t1225r1799b1258],
20	genesi	NNS	O	genesus	dep	16	SENT_219	[p10l1808t1228r1905b1258],
21	Increases	NNS	O	increase	nn	22	SENT_219	[p10l1575t1265r1701b1288],
22	expression	NN	O	expression	dep	20	SENT_219	[p10l1712t1265r1856b1296],
23	of	IN	O	of	_	0	SENT_219	[p10l1868t1262r1897b1288],
24	adhesion	NN	O	adhesion	nn	25	SENT_219	[p10l1903t1263r2025b1288],
25	molecuIes1	NN	O	molecuies1	prep_of	13	SENT_219	[p10l1625t1300r1780b1333],
26	'	''	O	'	_	0	SENT_219	[p10l1625t1300r1780b1333],

1	Decreases	VBZ	O	decrease	_	0	SENT_220	[p10l1575t1340r1712b1363],
2	apoptosis	NN	O	apoptosis	nn	3	SENT_220	[p10l1724t1340r1856b1371],
3	(	NN	O	(	dobj	1	SENT_220	[p10l1870t1338r1908b1371],
4	by	IN	O	by	_	0	SENT_220	[p10l1870t1338r1908b1371],
5	increasing	VBG	O	increase	prepc_by	1	SENT_220	[p10l1919t1340r2023b1363, p10l1624t1378r1665b1409],
6	Bcl-2	NN	O	bcl-2	nn	7	SENT_220	[p10l1676t1375r1750b1408],
7	)	NN	O	)	dobj	5	SENT_220	[p10l1676t1375r1750b1408],
8	to	TO	O	to	aux	9	SENT_220	[p10l1761t1380r1788b1400],
9	increase	VB	O	increase	xcomp	5	SENT_220	[p10l1799t1378r1910b1400],
10	tumorcell	NN	O	tumorcell	dobj	9	SENT_220	[p10l1919t1380r2013b1401, p10l1623t1413r1666b1438],
11	survival	NN	O	survival	nsubj	1	SENT_220	[p10l1678t1413r1799b1446],
12	'	''	O	'	_	0	SENT_220	[p10l1678t1413r1799b1446],
13	i	FW	O	i	nn	14	SENT_220	[p10l1678t1413r1799b1446],
14	‘	FW	O	‘	dep	11	SENT_220	[p10l1678t1413r1799b1446],

1	*	NN	O	*	nn	2	SENT_221	[p10l92t1500r107b1514],
2	Th2	NN	O	th2	nsubj	3	SENT_221	[p10l117t1498r168b1523],
3	denotes	VBZ	O	denote	_	0	SENT_221	[p10l180t1498r287b1523],
4	type	NN	O	type	nn	7	SENT_221	[p10l298t1503r355b1531],
5	2	CD	NUMBER	2	num	7	SENT_221	[p10l366t1500r380b1523],
6	helper	NN	O	helper	nn	7	SENT_221	[p10l393t1498r477b1531],
7	T	NN	O	t	dobj	3	SENT_221	[p10l486t1500r504b1523],
8	cell	NN	O	cell	dep	7	SENT_221	[p10l515t1498r566b1527],
9	,	,	O	,	_	0	SENT_221	[p10l515t1498r566b1527],
10	MCP-1	NN	O	mcp-1	nn	12	SENT_221	[p10l581t1500r669b1523],
11	monocyte	NN	O	monocyte	nn	12	SENT_221	[p10l683t1503r815b1531],
12	chemoattractant	NN	O	chemoattractant	dobj	3	SENT_221	[p10l827t1498r1052b1523],
13	protein	NN	O	protein	dep	12	SENT_221	[p10l1065t1500r1159b1531],
14	1	CD	NUMBER	1	num	13	SENT_221	[p10l1174t1500r1193b1527],
15	,	,	O	,	_	0	SENT_221	[p10l1174t1500r1193b1527],
16	MIP-la	JJ	O	mip-la	amod	18	SENT_221	[p10l1208t1500r1307b1523],
17	macrophage	NN	O	macrophage	nn	18	SENT_221	[p10l1321t1498r1489b1531],
18	inﬂammatory	NN	O	inﬂammatory	dobj	3	SENT_221	[p10l1502t1497r1684b1531],
19	protein	NN	O	protein	nn	20	SENT_221	[p10l1696t1500r1790b1531],
20	lac	NN	O	lac	dep	18	SENT_221	[p10l1805t1500r1845b1527],
21	,	,	O	,	_	0	SENT_221	[p10l1805t1500r1845b1527],
22	MIP-2	NN	O	mip-2	nn	23	SENT_221	[p10l1860t1500r1939b1523],
23	macrophage	NN	O	macrophage	dobj	3	SENT_221	[p10l1952t1507r2045b1523, p10l119t1535r199b1569],
24	inﬂammatory	JJ	O	inﬂammatory	amod	25	SENT_221	[p10l212t1535r394b1569],
25	protein	NN	O	protein	dep	23	SENT_221	[p10l406t1538r500b1569],
26	2	CD	NUMBER	2	num	25	SENT_221	[p10l513t1538r535b1565],
27	,	,	O	,	_	0	SENT_221	[p10l513t1538r535b1565],
28	and	CC	O	and	_	0	SENT_221	[p10l548t1535r596b1561],
29	NA	NNP	O	NA	conj_and	7	SENT_221	[p10l611t1537r652b1561],
30	not	RB	O	not	neg	31	SENT_221	[p10l665t1540r708b1561],
31	applicable	JJ	O	applicable	amod	29	SENT_221	[p10l719t1535r864b1569],
32	.	.	O	.	_	0	SENT_221	[p10l719t1535r864b1569],

1	1	CD	NUMBER	1	number	2	SENT_222	[p10l93t1575r108b1606],
2	‘	CD	NUMBER	‘	num	4	SENT_222	[p10l93t1575r108b1606],
3	Biologic	JJ	O	biologic	amod	4	SENT_222	[p10l123t1573r230b1606],
4	action	NN	O	action	nsubj	8	SENT_222	[p10l242t1575r323b1598],
5	is	VBZ	O	be	cop	8	SENT_222	[p10l337t1575r355b1598],
6	most	RBS	O	most	advmod	8	SENT_222	[p10l369t1578r437b1598],
7	closely	RB	O	closely	advmod	8	SENT_222	[p10l448t1573r539b1606],
8	attributable	JJ	O	attributable	_	0	SENT_222	[p10l550t1573r706b1598],
9	to	TO	O	to	_	0	SENT_222	[p10l717t1578r743b1598],
10	both	DT	O	both	det	12	SENT_222	[p10l756t1573r815b1598],
11	leukotriene	NN	O	leukotriene	nn	12	SENT_222	[p10l829t1573r979b1598],
12	B4	NN	O	b4	prep_to	8	SENT_222	[p10l993t1575r1021b1605],
13	and	CC	O	and	_	0	SENT_222	[p10l1032t1573r1080b1598],
14	cysteinyl	NN	O	cysteinyl	nn	15	SENT_222	[p10l1093t1573r1207b1606],
15	leukotrienes	NNS	O	leukotriene	prep_to	8	SENT_222	[p10l1221t1573r1393b1598],
16	.	.	O	.	_	0	SENT_222	[p10l1221t1573r1393b1598],

1	Ii	NN	O	ii	_	0	SENT_223	[p10l93t1612r108b1643],
2	:	:	O	:	_	0	SENT_223	[p10l93t1612r108b1643],
3	Biologic	JJ	O	biologic	amod	4	SENT_223	[p10l123t1610r230b1643],
4	action	NN	O	action	nsubj	8	SENT_223	[p10l242t1612r323b1635],
5	is	VBZ	O	be	cop	8	SENT_223	[p10l337t1612r356b1635],
6	most	RBS	O	most	advmod	8	SENT_223	[p10l369t1615r437b1635],
7	closely	RB	O	closely	advmod	8	SENT_223	[p10l448t1610r539b1643],
8	attributable	JJ	O	attributable	dep	1	SENT_223	[p10l550t1610r706b1635],
9	to	TO	O	to	_	0	SENT_223	[p10l717t1615r743b1635],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_223	[p10l756t1610r907b1635],
11	B4	NN	O	b4	prep_to	8	SENT_223	[p10l920t1612r955b1642],
12	.	.	O	.	_	0	SENT_223	[p10l920t1612r955b1642],

1	§	NN	O	§	nn	3	SENT_224	[p10l92t1646r103b1680],
2	Biologic	JJ	O	biologic	amod	3	SENT_224	[p10l119t1646r227b1680],
3	action	NN	O	action	nsubj	7	SENT_224	[p10l238t1649r319b1672],
4	is	VBZ	O	be	cop	7	SENT_224	[p10l333t1649r352b1672],
5	most	RBS	O	most	advmod	7	SENT_224	[p10l366t1651r434b1672],
6	closely	RB	O	closely	advmod	7	SENT_224	[p10l445t1646r536b1680],
7	attributable	JJ	O	attributable	_	0	SENT_224	[p10l547t1646r703b1672],
8	to	TO	O	to	_	0	SENT_224	[p10l714t1651r740b1672],
9	cysteinyl	NN	O	cysteinyl	nn	10	SENT_224	[p10l752t1646r865b1680],
10	leukotrienes	NNS	O	leukotriene	prep_to	7	SENT_224	[p10l879t1646r1052b1672],
11	.	.	O	.	_	0	SENT_224	[p10l879t1646r1052b1672],

1	to	TO	O	to	aux	2	SENT_225	[p10l12t1919r96b1981],
2	inhibit	VB	O	inhibit	_	0	SENT_225	[p10l148t1902r449b1981],
3	leukotriene	NN	O	leukotriene	nn	4	SENT_225	[p10l495t1902r998b1981],
4	pathways	NNS	O	pathway	dobj	2	SENT_225	[p10l1049t1902r1485b2002],
5	.	.	O	.	_	0	SENT_225	[p10l1049t1902r1485b2002],

1	Although	IN	O	although	mark	2	SENT_226	[p10l1540t1902r1959b2003],
2	the	DT	O	the	_	0	SENT_226	[p10l2011t1902r2148b1980],

1	Weight	NNP	O	Weight	nsubj	24	SENT_227	[p10l7t2030r303b2132],
2	of	IN	O	of	_	0	SENT_227	[p10l338t2029r438b2110],
3	evidence	NN	O	evidence	prep_of	1	SENT_227	[p10l459t2030r826b2110],
4	from	IN	O	from	prep	3	SENT_227	[p10l865t2029r1077b2110],
5	randomized	VBN	O	randomize	partmod	9	SENT_227	[p10l1115t2030r1662b2127],
6	,	,	O	,	_	0	SENT_227	[p10l1115t2030r1662b2127],
7	controlled	JJ	O	controlled	amod	8	SENT_227	[p10l1707t2030r2148b2110],
8	studies	NNS	O	study	nsubj	9	SENT_227	[p10l13t2159r315b2238],
9	indicates	VBZ	O	indicate	dep	4	SENT_227	[p10l357t2159r743b2238],
10	that	IN	O	that	complm	14	SENT_227	[p10l786t2159r960b2237],
11	antileukotriene	JJ	O	antileukotriene	amod	12	SENT_227	[p10l995t2159r1657b2238],
12	agents	NNS	O	agent	nsubj	14	SENT_227	[p10l1697t2176r1975b2260],
13	are	VBP	O	be	cop	14	SENT_227	[p10l2018t2185r2147b2238],
14	inferior	JJ	O	inferior	ccomp	9	SENT_227	[p10l11t2286r332b2366],
15	to	TO	O	to	_	0	SENT_227	[p10l361t2304r442b2366],
16	long	JJ	O	long	amod	17	SENT_227	[p10l474t2287r960b2389],
17	—	NN	O	—	prep_to	14	SENT_227	[p10l474t2287r960b2389],
18	acting	VBG	O	act	partmod	17	SENT_227	[p10l474t2287r960b2389],
19	[	NN	O	[	nn	20	SENT_227	[p10l983t2291r1082b2391],
20	~	NN	O	~	dobj	18	SENT_227	[p10l983t2291r1082b2391],
21	32	CD	NUMBER	32	num	22	SENT_227	[p10l983t2291r1082b2391],
22	agonists	NNS	O	agonist	npadvmod	23	SENT_227	[p10l1114t2288r1467b2389],
23	as	IN	O	as	advmod	18	SENT_227	[p10l1500t2313r1585b2365],
24	add	VBP	O	add	_	0	SENT_227	[p10l1618t2287r1912b2366],
25	—	NN	O	—	dobj	24	SENT_227	[p10l1618t2287r1912b2366],
26	on	IN	O	on	_	0	SENT_227	[p10l1618t2287r1912b2366],
27	therapy	NN	O	therapy	prep_on	25	SENT_227	[p10l1944t2287r2147b2366, p10l11t2442r154b2516],

1	to	TO	O	to	nsubj	2	SENT_228	[p10l180t2433r259b2495],
2	inhaled	VBN	O	inhale	_	0	SENT_228	[p10l291t2416r604b2495],
3	corticosteroids	NNS	O	corticosteroid	dep	2	SENT_228	[p10l635t2416r1247b2495],
4	(	CD	NUMBER	(	npadvmod	5	SENT_228	[p10l1284t2416r1791b2516],
5	particularly	RB	O	particularly	advmod	6	SENT_228	[p10l1284t2416r1791b2516],
6	With	IN	O	with	dep	3	SENT_228	[p10l1813t2416r2003b2496],
7	respect	NN	O	respect	pobj	6	SENT_228	[p10l2033t2442r2147b2494, p10l13t2562r233b2646],

1	to	TO	O	to	_	0	SENT_229	[p10l261t2562r342b2625],
2	improving	VBG	O	improve	amod	4	SENT_229	[p10l375t2546r819b2647],
3	lung	NN	O	lung	nn	4	SENT_229	[p10l847t2545r1039b2647],
4	function	NN	O	function	prep_to	11	SENT_229	[p10l1069t2544r1552b2642],
5	“	CD	NUMBER	“	num	6	SENT_229	[p10l1069t2544r1552b2642],
6	)	NN	O	)	dep	4	SENT_229	[p10l1069t2544r1552b2642],
7	,	,	O	,	_	0	SENT_229	[p10l1069t2544r1552b2642],
8	some	DT	O	some	det	9	SENT_229	[p10l1592t2571r1814b2625],
9	studies	NNS	O	study	nsubj	11	SENT_229	[p10l1848t2545r2146b2625],
10	have	VBP	O	have	aux	11	SENT_229	[p10l12t2674r203b2753],
11	shown	VBN	O	show	_	0	SENT_229	[p10l243t2674r528b2753],
12	that	IN	O	that	complm	15	SENT_229	[p10l566t2674r740b2752],
13	montelukast	NN	O	montelukast	nsubj	15	SENT_229	[p10l774t2674r1316b2753],
14	is	VBZ	O	be	cop	15	SENT_229	[p10l1349t2675r1416b2752],
15	similar	JJ	O	similar	ccomp	11	SENT_229	[p10l1458t2674r1766b2752],
16	to	TO	O	to	_	0	SENT_229	[p10l1803t2691r1885b2753],
17	longacting	VBG	O	longact	prepc_to	15	SENT_229	[p10l1924t2674r2146b2775, p10l11t2803r275b2904],

1	,	,	O	,	_	0	SENT_230	[p10l304t2806r403b2906],
2	B	NN	O	b	dep	6	SENT_230	[p10l304t2806r403b2906],
3	_	NN	O	_	dep	2	SENT_230	[p10l304t2806r403b2906],
4	,	,	O	,	_	0	SENT_230	[p10l304t2806r403b2906],
5	_	NN	O	_	dep	6	SENT_230	[p10l304t2806r403b2906],
6	agonists	NNS	O	agonist	_	0	SENT_230	[p10l440t2803r793b2904],
7	in	IN	O	in	_	0	SENT_230	[p10l831t2803r914b2880],
8	reducing	VBG	O	reduce	prepc_in	6	SENT_230	[p10l951t2802r1324b2904],
9	symptoms	NNS	O	symptom	dobj	8	SENT_230	[p10l1359t2819r1796b2903],
10	and	CC	O	and	_	0	SENT_230	[p10l1835t2802r1992b2881],
11	exacerbations	NNS	O	exacerbation	conj_and	9	SENT_230	[p10l2029t2828r2147b2880, p10l11t2931r506b3010],

1	of	IN	O	of	_	0	SENT_231	[p10l543t2930r644b3010],
2	asthma	NN	O	asthma	pobj	1	SENT_231	[p10l660t2931r1174b3010],
3	.5253	CD	NUMBER	.5253	num	2	SENT_231	[p10l660t2931r1174b3010],

1	Some	DT	O	some	det	2	SENT_232	[p10l144t3065r380b3138],
2	patients	NNS	O	patient	nsubj	8	SENT_232	[p10l429t3060r781b3159],
3	with	IN	O	with	_	0	SENT_232	[p10l829t3059r1029b3139],
4	asthma	NN	O	asthma	prep_with	2	SENT_232	[p10l1078t3059r1405b3137],
5	are	VBP	O	be	cop	8	SENT_232	[p10l1453t3085r1586b3137],
6	particularly	RB	O	particularly	advmod	8	SENT_232	[p10l1635t3059r2152b3159],
7	good	JJ	O	good	amod	8	SENT_232	[p10l12t3188r225b3290],
8	candidates	NNS	O	candidate	_	0	SENT_232	[p10l265t3188r717b3268],
9	for	IN	O	for	_	0	SENT_232	[p10l757t3187r880b3268],
10	antileukotriene	JJ	O	antileukotriene	amod	11	SENT_232	[p10l914t3188r1562b3268],
11	therapy	NN	O	therapy	prep_for	8	SENT_232	[p10l1601t3188r1931b3289],
12	.	.	O	.	_	0	SENT_232	[p10l1601t3188r1931b3289],

1	One	CD	NUMBER	one	num	2	SENT_233	[p10l1975t3194r2148b3268],
2	example	NN	O	example	nsubj	5	SENT_233	[p10l13t3317r371b3417],
3	is	VBZ	O	be	cop	5	SENT_233	[p10l407t3318r473b3395],
4	the	DT	O	the	det	5	SENT_233	[p10l513t3317r647b3395],
5	patient	NN	O	patient	_	0	SENT_233	[p10l683t3318r987b3417],
6	with	IN	O	with	_	0	SENT_233	[p10l1015t3317r1212b3396],
7	allergic	JJ	O	allergic	amod	8	SENT_233	[p10l1248t3317r1568b3418],
8	rhinitis	NN	O	rhinitis	prep_with	5	SENT_233	[p10l1605t3317r1946b3396],
9	.	.	O	.	_	0	SENT_233	[p10l1605t3317r1946b3396],

1	The	DT	O	the	det	3	SENT_234	[p10l1985t3317r2148b3395],
2	nasal	JJ	O	nasal	amod	3	SENT_234	[p10l12t3445r235b3523],
3	congestion	NN	O	congestion	_	0	SENT_234	[p10l269t3446r733b3546],
4	and	CC	O	and	_	0	SENT_234	[p10l766t3445r922b3524],
5	rhinorrhea	NN	O	rhinorrhea	conj_and	3	SENT_234	[p10l957t3445r1413b3524],
6	in	IN	O	in	_	0	SENT_234	[p10l1445t3446r1529b3523],
7	allergic	JJ	O	allergic	amod	8	SENT_234	[p10l1562t3445r1874b3546],
8	rhinitis	NN	O	rhinitis	prep_in	3	SENT_234	[p10l1907t3445r2147b3523, p10l12t3574r109b3651],

1	are	VBP	O	be	auxpass	2	SENT_235	[p10l146t3599r271b3652],
2	reduced	VBN	O	reduce	_	0	SENT_235	[p10l307t3573r633b3652],
3	by	IN	O	by	_	0	SENT_235	[p10l668t3573r764b3673],
4	montelukast	NN	O	montelukast	agent	2	SENT_235	[p10l794t3573r1315b3652],
5	to	TO	O	to	_	0	SENT_235	[p10l1345t3590r1425b3652],
6	a	DT	O	a	det	7	SENT_235	[p10l1461t3599r1505b3651],
7	degree	NN	O	degree	prep_to	2	SENT_235	[p10l1540t3573r1814b3674],
8	similar	JJ	O	similar	amod	7	SENT_235	[p10l1851t3573r2151b3651],
9	to	TO	O	to	_	0	SENT_235	[p10l12t3718r95b3780],
10	that	DT	O	that	prep_to	8	SENT_235	[p10l138t3701r315b3779],
11	with	IN	O	with	_	0	SENT_235	[p10l346t3701r546b3780],
12	antihistamines	NNS	O	antihistamine	prep_with	10	SENT_235	[p10l586t3701r1253b3779],
13	but	CC	O	but	_	0	SENT_235	[p10l1297t3701r1440b3780],
14	inferior	JJ	O	inferior	conj_but	8	SENT_235	[p10l1475t3700r1812b3780],
15	to	TO	O	to	_	0	SENT_235	[p10l1850t3718r1934b3780],
16	that	DT	O	that	prep_to	14	SENT_235	[p10l1976t3701r2153b3779],
17	with	IN	O	with	_	0	SENT_235	[p11l7t31r197b110],
18	topical	JJ	O	topical	amod	19	SENT_235	[p11l235t31r515b131],
19	corticosteroids	NNS	O	corticosteroid	prep_with	16	SENT_235	[p11l553t31r1360b110],
20	.	.	O	.	_	0	SENT_235	[p11l553t31r1360b110],

1	-	:	O	-	_	0	SENT_236	[p11l553t31r1360b110],
2	“	NN	O	“	dep	9	SENT_236	[p11l553t31r1360b110],
3	'56	CD	NUMBER	'56	num	2	SENT_236	[p11l553t31r1360b110],
4	Since	IN	O	since	dep	9	SENT_236	[p11l1401t32r1616b110],
5	allergic	JJ	O	allergic	amod	6	SENT_236	[p11l1653t31r1957b132],
6	rhinitis	NN	O	rhinitis	nsubj	13	SENT_236	[p11l1995t31r2147b109, p11l12t159r192b236],
7	is	VBZ	O	be	cop	9	SENT_236	[p11l225t159r289b236],
8	often	RB	O	often	advmod	9	SENT_236	[p11l324t157r538b237],
9	present	JJ	DATE	present	parataxis	21	SENT_236	[p11l569t175r877b258],
10	with	IN	O	with	_	0	SENT_236	[p11l899t158r1090b238],
11	asthma	NN	O	asthma	prep_with	9	SENT_236	[p11l1120t158r1431b236],
12	and	CC	O	and	_	0	SENT_236	[p11l1460t158r1614b237],
13	complicates	VBZ	O	complicate	parataxis	21	SENT_236	[p11l1647t158r2145b258],
14	its	PRP$	O	its	poss	15	SENT_236	[p11l11t288r106b366],
15	management	NN	O	management	dobj	13	SENT_236	[p11l144t304r714b389],
16	,	,	O	,	_	0	SENT_236	[p11l144t304r714b389],
17	a	DT	O	a	det	19	SENT_236	[p11l755t314r800b366],
18	leukotriene	NN	O	leukotriene	nn	19	SENT_236	[p11l834t287r1301b367],
19	modiﬁer	NN	O	modiﬁer	nsubj	21	SENT_236	[p11l1338t286r1705b367],
20	could	MD	O	could	aux	21	SENT_236	[p11l1739t287r1966b367],
21	improve	VB	O	improve	_	0	SENT_236	[p11l2001t288r2147b365, p11l11t442r247b515],
22	upper	JJ	O	upper	amod	23	SENT_236	[p11l301t442r582b515],
23	—	NN	O	—	dobj	21	SENT_236	[p11l301t442r582b515],
24	and	CC	O	and	_	0	SENT_236	[p11l636t416r797b494],
25	loWer	JJR	O	lower	amod	28	SENT_236	[p11l849t416r1418b515],
26	—	NN	O	—	nn	28	SENT_236	[p11l849t416r1418b515],
27	airway	NN	O	airway	nn	28	SENT_236	[p11l849t416r1418b515],
28	symptoms	NNS	O	symptom	dobj	21	SENT_236	[p11l1469t432r1919b515],
29	and	CC	O	and	_	0	SENT_236	[p11l1974t416r2134b494],
30	signs	NNS	O	sign	dobj	21	SENT_236	[p11l13t545r328b645],
31	.57	CD	NUMBER	.57	dep	30	SENT_236	[p11l13t545r328b645],
32	However	RB	O	however	advmod	21	SENT_236	[p11l362t552r749b640],
33	,	,	O	,	_	0	SENT_236	[p11l362t552r749b640],
34	trials	NNS	O	trial	nsubj	57	SENT_236	[p11l789t544r1003b622],
35	of	IN	O	of	_	0	SENT_236	[p11l1040t543r1139b623],
36	the	DT	O	the	det	37	SENT_236	[p11l1155t544r1286b623],
37	use	NN	O	use	prep_of	34	SENT_236	[p11l1320t570r1458b623],
38	of	IN	O	of	_	0	SENT_236	[p11l1494t543r1592b623],
39	montelukast	NN	O	montelukast	prep_of	37	SENT_236	[p11l1609t544r2139b623],
40	to	TO	O	to	aux	41	SENT_236	[p11l12t689r94b751],
41	reduce	VB	O	reduce	infmod	37	SENT_236	[p11l129t672r409b751],
42	the	DT	O	the	det	43	SENT_236	[p11l443t672r576b751],
43	need	NN	O	need	dobj	41	SENT_236	[p11l610t672r811b751],
44	for	IN	O	for	_	0	SENT_236	[p11l845t671r968b751],
45	other	JJ	O	other	amod	47	SENT_236	[p11l999t672r1227b751],
46	rhinitis	NN	O	rhinitis	nn	47	SENT_236	[p11l1258t672r1572b750],
47	medications	NNS	O	medication	prep_for	43	SENT_236	[p11l1608t672r2133b751],
48	in	IN	O	in	_	0	SENT_236	[p11l12t801r95b878],
49	patients	NNS	O	patient	prep_in	41	SENT_236	[p11l133t801r474b900],
50	with	IN	O	with	_	0	SENT_236	[p11l512t800r707b879],
51	both	DT	O	both	det	52	SENT_236	[p11l747t800r945b879],
52	asthma	NN	O	asthma	prep_with	49	SENT_236	[p11l983t800r1303b878],
53	and	CC	O	and	_	0	SENT_236	[p11l1340t800r1498b879],
54	allergic	JJ	O	allergic	amod	55	SENT_236	[p11l1537t800r1854b901],
55	rhinitis	NN	O	rhinitis	conj_and	52	SENT_236	[p11l1893t800r2133b878, p11l12t929r113b1006],
56	have	VBP	O	have	aux	57	SENT_236	[p11l154t928r344b1007],
57	had	VBN	O	have	dep	21	SENT_236	[p11l384t928r540b1007],
58	divergent	JJ	O	divergent	amod	59	SENT_236	[p11l580t928r981b1029],
59	results	NNS	O	result	dobj	57	SENT_236	[p11l1016t928r1494b1007],
60	.58	CD	NUMBER	.58	num	61	SENT_236	[p11l1016t928r1494b1007],
61	’59	CD	NUMBER	’59	dep	59	SENT_236	[p11l1016t928r1494b1007],

1	Montelukast	NNP	O	Montelukast	nsubj	3	SENT_237	[p11l138t1056r690b1135],
2	also	RB	O	also	advmod	3	SENT_237	[p11l718t1056r892b1135],
3	provides	VBZ	O	provide	_	0	SENT_237	[p11l927t1056r1294b1156],
4	protection	NN	O	protection	nsubj	8	SENT_237	[p11l1329t1057r1784b1156],
5	against	IN	O	against	_	0	SENT_237	[p11l1817t1057r2139b1157],
6	eXercise	NN	O	exercise	nn	7	SENT_237	[p11l12t1184r742b1263],
7	—	NN	O	—	prep_against	4	SENT_237	[p11l12t1184r742b1263],
8	induced	VBD	O	induce	ccomp	3	SENT_237	[p11l12t1184r742b1263],
9	asthma	NN	O	asthma	dobj	8	SENT_237	[p11l786t1184r1134b1263],
10	.	.	O	.	_	0	SENT_237	[p11l786t1184r1134b1263],

1	A	DT	O	a	det	4	SENT_238	[p11l1181t1192r1247b1262],
2	single	JJ	O	single	amod	4	SENT_238	[p11l1290t1184r1548b1285],
3	oral	JJ	O	oral	amod	4	SENT_238	[p11l1594t1184r1763b1263],
4	dose	NN	O	dose	nsubj	9	SENT_238	[p11l1809t1184r2005b1263],
5	of	IN	O	of	_	0	SENT_238	[p11l2051t1183r2152b1263],
6	montelukast	NN	O	montelukast	prep_of	4	SENT_238	[p11l12t1311r540b1390],
7	is	VBZ	O	be	cop	9	SENT_238	[p11l571t1312r635b1389],
8	as	IN	O	as	dep	9	SENT_238	[p11l674t1337r758b1389],
9	effective	JJ	O	effective	_	0	SENT_238	[p11l798t1310r1147b1390],
10	as	IN	O	as	mark	35	SENT_238	[p11l1184t1337r1269b1389],
11	inhaled	VBN	O	inhale	csubjpass	35	SENT_238	[p11l1307t1311r1625b1390],
12	salmeterol	NN	O	salmeterol	dobj	11	SENT_238	[p11l1663t1311r2128b1407],
13	,	,	O	,	_	0	SENT_238	[p11l1663t1311r2128b1407],
14	a	DT	O	a	det	17	SENT_238	[p11l11t1466r55b1518],
15	long-acting	JJ	O	long-acting	amod	17	SENT_238	[p11l86t1440r590b1541],
16	B2	NN	O	b2	nn	17	SENT_238	[p11l616t1444r717b1543],
17	agonist	NN	O	agonist	appos	12	SENT_238	[p11l749t1441r1096b1541],
18	,	,	O	,	_	0	SENT_238	[p11l749t1441r1096b1541],
19	in	IN	O	in	_	0	SENT_238	[p11l1134t1441r1218b1517],
20	preventing	VBG	O	prevent	prepc_in	11	SENT_238	[p11l1250t1441r1723b1541],
21	exerciseinduced	JJ	O	exerciseinduced	amod	22	SENT_238	[p11l1754t1441r2133b1518, p11l11t1568r357b1647],
22	asthma	NN	O	asthma	dobj	20	SENT_238	[p11l398t1568r829b1664],
23	,5	CD	NUMBER	,5	num	24	SENT_238	[p11l398t1568r829b1664],
24	°	NN	O	°	dep	22	SENT_238	[p11l398t1568r829b1664],
25	and	CC	O	and	_	0	SENT_238	[p11l869t1568r1029b1647],
26	its	PRP$	O	its	poss	28	SENT_238	[p11l1070t1569r1171b1646],
27	regular	JJ	O	regular	amod	28	SENT_238	[p11l1214t1568r1535b1669],
28	use	NN	O	use	conj_and	22	SENT_238	[p11l1574t1594r1716b1647],
29	during	IN	O	during	_	0	SENT_238	[p11l1759t1568r2054b1669],
30	a	DT	O	a	det	32	SENT_238	[p11l2091t1594r2136b1646],
31	2-month	JJ	DURATION	2-month	amod	32	SENT_238	[p11l12t1696r365b1774],
32	period	NN	O	period	prep_during	28	SENT_238	[p11l397t1696r665b1795],
33	was	VBD	O	be	auxpass	35	SENT_238	[p11l694t1722r852b1775],
34	not	RB	O	not	neg	35	SENT_238	[p11l888t1713r1027b1774],
35	associated	VBN	O	associate	advcl	9	SENT_238	[p11l1055t1696r1481b1774],
36	with	IN	O	with	_	0	SENT_238	[p11l1511t1696r1700b1775],
37	the	DT	O	the	det	38	SENT_238	[p11l1734t1696r1863b1774],
38	development	NN	O	development	prep_with	35	SENT_238	[p11l1898t1696r2133b1775, p11l12t1840r331b1923],
39	of	IN	O	of	_	0	SENT_238	[p11l358t1822r455b1902],
40	tachyphylaxis	NN	O	tachyphylaxi	prep_of	38	SENT_238	[p11l467t1823r1048b1923],
41	,	,	O	,	_	0	SENT_238	[p11l467t1823r1048b1923],
42	as	IN	O	as	mark	43	SENT_238	[p11l1084t1849r1168b1901],
43	occurs	VBZ	O	occur	advcl	35	SENT_238	[p11l1201t1849r1469b1903],
44	with	IN	O	with	_	0	SENT_238	[p11l1498t1823r1686b1903],
45	the	DT	O	the	det	46	SENT_238	[p11l1717t1823r1846b1901],
46	use	NN	O	use	prep_with	43	SENT_238	[p11l1877t1849r2017b1903],
47	of	IN	O	of	_	0	SENT_238	[p11l2053t1822r2152b1902],
48	salmeterol	NN	O	salmeterol	prep_of	46	SENT_238	[p11l13t1953r566b2032],
49	.61	CD	NUMBER	.61	num	48	SENT_238	[p11l13t1953r566b2032],

1	Antileukotriene	JJ	O	antileukotriene	amod	2	SENT_239	[p11l137t2081r786b2160],
2	agents	NNS	O	agent	nsubj	4	SENT_239	[p11l813t2098r1078b2182],
3	are	VBP	O	be	cop	4	SENT_239	[p11l1106t2107r1231b2159],
4	beneficial	JJ	O	beneficial	_	0	SENT_239	[p11l1258t2080r1662b2160],
5	in	IN	O	in	_	0	SENT_239	[p11l1688t2082r1769b2159],
6	patients	NNS	O	patient	prep_in	4	SENT_239	[p11l1795t2082r2132b2181],
7	With	IN	O	with	_	0	SENT_239	[p11l7t2209r197b2288],
8	aspirin	NN	O	aspirin	npadvmod	10	SENT_239	[p11l223t2210r890b2308],
9	—	CD	NUMBER	—	num	8	SENT_239	[p11l223t2210r890b2308],
10	sensitive	JJ	O	sensitive	amod	11	SENT_239	[p11l223t2210r890b2308],
11	asthma	NN	O	asthma	prep_with	40	SENT_239	[p11l916t2209r1245b2304],
12	,	,	O	,	_	0	SENT_239	[p11l916t2209r1245b2304],
13	a	DT	O	a	det	14	SENT_239	[p11l1277t2235r1322b2287],
14	condition	NN	O	condition	appos	11	SENT_239	[p11l1348t2209r1742b2287],
15	in	IN	O	in	_	0	SENT_239	[p11l1768t2210r1849b2286],
16	which	WDT	O	which	rel	26	SENT_239	[p11l1872t2209r2134b2288],
17	production	NN	O	production	nsubj	26	SENT_239	[p11l11t2337r475b2437],
18	of	IN	O	of	_	0	SENT_239	[p11l517t2336r616b2416],
19	very	RB	O	very	advmod	20	SENT_239	[p11l634t2363r808b2437],
20	high	JJ	O	high	amod	21	SENT_239	[p11l845t2337r1038b2438],
21	levels	NNS	O	level	prep_of	17	SENT_239	[p11l1077t2337r1302b2416],
22	of	IN	O	of	_	0	SENT_239	[p11l1346t2336r1445b2416],
23	cysteinyl	NN	O	cysteinyl	nn	24	SENT_239	[p11l1468t2337r1828b2437],
24	leukotrienes	NNS	O	leukotriene	prep_of	21	SENT_239	[p11l1868t2337r2133b2416, p11l13t2466r301b2544],
25	is	VBZ	O	be	cop	26	SENT_239	[p11l336t2466r402b2543],
26	typical	JJ	O	typical	rcmod	14	SENT_239	[p11l438t2465r920b2565],
27	.52	CD	NUMBER	.52	number	28	SENT_239	[p11l438t2465r920b2565],
28	»	CD	NUMBER	»	dep	26	SENT_239	[p11l438t2465r920b2565],
29	63	CD	NUMBER	63	dep	26	SENT_239	[p11l438t2465r920b2565],
30	However	RB	O	however	advmod	33	SENT_239	[p11l954t2473r1348b2561],
31	,	,	O	,	_	0	SENT_239	[p11l954t2473r1348b2561],
32	even	RB	O	even	advmod	33	SENT_239	[p11l1388t2491r1577b2544],
33	among	IN	O	among	dep	29	SENT_239	[p11l1609t2491r1909b2566],
34	such	JJ	O	such	amod	35	SENT_239	[p11l1940t2465r2134b2544],
35	patients	NNS	O	patient	pobj	33	SENT_239	[p11l11t2594r377b2693],
36	,	,	O	,	_	0	SENT_239	[p11l11t2594r377b2693],
37	the	DT	O	the	det	38	SENT_239	[p11l418t2593r551b2671],
38	drugs	NNS	O	drug	nsubj	40	SENT_239	[p11l588t2593r831b2694],
39	are	VBP	O	be	cop	40	SENT_239	[p11l868t2619r998b2672],
40	inconsistent	JJ	O	inconsistent	rcmod	6	SENT_239	[p11l1032t2594r1560b2672],
41	in	IN	O	in	_	0	SENT_239	[p11l1591t2594r1674b2671],
42	their	PRP$	O	they	poss	43	SENT_239	[p11l1709t2593r1914b2671],
43	abil1846	NN	O	abil1846	prep_in	40	SENT_239	[p11l1946t2593r2133b2672, p11l149t2752r225b2775],

1	N	NN	O	n	nn	3	SENT_240	[p11l897t2763r911b2778],
2	ENGLJ	NN	O	englj	nn	3	SENT_240	[p11l926t2763r1004b2785],
3	MED	NN	O	med	_	0	SENT_240	[p11l1018t2763r1070b2778],
4	;	:	O	;	_	0	SENT_240	[p11l1122t2757r1154b2783],
5	18	CD	NUMBER	18	num	7	SENT_240	[p11l1122t2757r1154b2783],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_240	[p11l1187t2763r1388b2785],
7	NOVEMBERLZOO7	NN	O	novemberlzoo7	dep	3	SENT_240	[p11l1425t2763r1661b2784],

1	The	DT	O	the	det	3	SENT_241	[p11l935t2796r986b2820],
2	New	NNP	O	New	nn	3	SENT_241	[p11l995t2797r1057b2820],
3	n	NN	O	n	_	0	SENT_241	[p11l1087t2804r1103b2820],
4	and	CC	O	and	_	0	SENT_241	[p11l1130t2796r1177b2820],
5	Journal	NNP	O	Journal	conj_and	3	SENT_241	[p11l1186t2796r1283b2820],
6	of	IN	O	of	_	0	SENT_241	[p11l1293t2796r1322b2820],
7	Medicine	NNP	O	Medicine	prep_of	3	SENT_241	[p11l1329t2796r1454b2820],

1	Downloaded	VBN	O	download	_	0	SENT_242	[p11l377t2837r547b2860],
2	from	IN	O	from	_	0	SENT_242	[p11l556t2837r621b2860],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_242	[p11l629t2837r748b2867],
4	at	IN	O	at	_	0	SENT_242	[p11l758t2841r781b2860],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_242	[p11l789t2837r972b2860],
6	on	IN	O	on	_	0	SENT_242	[p11l981t2844r1014b2860],
7	January	NNP	DATE	January	prep_on	1	SENT_242	[p11l1022t2837r1125b2867],
8	5	CD	DATE	5	num	7	SENT_242	[p11l1135t2837r1158b2864],
9	,	,	DATE	,	_	0	SENT_242	[p11l1135t2837r1158b2864],
10	2014	CD	DATE	2014	num	7	SENT_242	[p11l1168t2837r1241b2860],
11	.	.	O	.	_	0	SENT_242	[p11l1168t2837r1241b2860],

1	For	IN	O	for	_	0	SENT_243	[p11l1251t2837r1298b2860],
2	personal	JJ	O	personal	amod	3	SENT_243	[p11l1306t2837r1418b2867],
3	use	NN	O	use	pobj	1	SENT_243	[p11l1427t2844r1471b2860],
4	only	RB	O	only	advmod	3	SENT_243	[p11l1480t2837r1545b2867],
5	.	.	O	.	_	0	SENT_243	[p11l1480t2837r1545b2867],

1	No	DT	O	no	det	3	SENT_244	[p11l1556t2837r1595b2860],
2	other	JJ	O	other	amod	3	SENT_244	[p11l1605t2837r1673b2860],
3	uses	NNS	O	use	_	0	SENT_244	[p11l1682t2844r1738b2860],
4	without	IN	O	without	_	0	SENT_244	[p11l1748t2837r1849b2860],
5	permission	NN	O	permission	prep_without	3	SENT_244	[p11l1857t2837r2010b2867],
6	.	.	O	.	_	0	SENT_244	[p11l1857t2837r2010b2867],

1	Copyright	NN	O	copyright	_	0	SENT_245	[p11l728t2878r862b2909],
2	©	CD	NUMBER	©	num	6	SENT_245	[p11l871t2878r895b2902],
3	2007	CD	DATE	2007	num	6	SENT_245	[p11l905t2878r969b2902],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_245	[p11l979t2878r1170b2902],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_245	[p11l1180t2878r1288b2902],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_245	[p11l1299t2878r1404b2909],
7	.	.	O	.	_	0	SENT_245	[p11l1299t2878r1404b2909],

1	All	DT	O	all	det	2	SENT_246	[p11l1415t2878r1456b2902],
2	rights	NNS	O	rights	nsubj	3	SENT_246	[p11l1465t2878r1540b2909],
3	reserved	VBN	O	reserve	_	0	SENT_246	[p11l1550t2878r1668b2902],
4	.	.	O	.	_	0	SENT_246	[p11l1550t2878r1668b2902],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_247	[p11l866t2984r1091b3003],
2	OF	IN	O	of	_	0	SENT_247	[p11l1106t2984r1146b3003],
3	DISEASE	NN	O	disease	prep_of	1	SENT_247	[p11l1160t2984r1294b3003],

1	ity	NN	O	ity	_	0	SENT_248	[p11l11t3198r118b3297],
2	to	TO	O	to	aux	3	SENT_248	[p11l150t3214r232b3276],
3	attenuate	VB	O	attenuate	dep	1	SENT_248	[p11l269t3214r665b3276],
4	responses	NNS	O	response	dobj	3	SENT_248	[p11l701t3223r1124b3297],
5	to	TO	O	to	_	0	SENT_248	[p11l1164t3214r1245b3276],
6	aspirin	NN	O	aspirin	nn	7	SENT_248	[p11l1282t3198r1581b3297],
7	challenge	NN	O	challenge	prep_to	3	SENT_248	[p11l1618t3197r2134b3298],
8	.	.	O	.	_	0	SENT_248	[p11l1618t3197r2134b3298],

1	“	NN	O	“	nn	2	SENT_249	[p11l1618t3197r2134b3298],
2	Applications	NNS	O	application	nsubj	12	SENT_249	[p11l7t3324r549b3424],
3	of	IN	O	of	_	0	SENT_249	[p11l600t3323r700b3403],
4	antileukotriene	JJ	O	antileukotriene	amod	5	SENT_249	[p11l729t3324r1388b3404],
5	therapy	NN	O	therapy	prep_of	2	SENT_249	[p11l1437t3324r1759b3424],
6	that	WDT	O	that	nsubj	7	SENT_249	[p11l1804t3324r1976b3402],
7	remain	VBP	O	remain	rcmod	5	SENT_249	[p11l2019t3350r2132b3402, p11l11t3454r236b3531],
8	under	IN	O	under	_	0	SENT_249	[p11l286t3453r541b3532],
9	investigation	NN	O	investigation	prep_under	7	SENT_249	[p11l587t3454r1155b3554],
10	are	VBP	O	be	cop	12	SENT_249	[p11l1205t3479r1336b3532],
11	the	DT	O	the	det	12	SENT_249	[p11l1387t3453r1522b3531],
12	treatment	NN	O	treatment	_	0	SENT_249	[p11l1573t3470r2005b3532],
13	of	IN	O	of	_	0	SENT_249	[p11l2051t3452r2152b3532],
14	persistent	JJ	O	persistent	amod	16	SENT_249	[p11l9t3581r435b3680],
15	respiratory	JJ	O	respiratory	amod	16	SENT_249	[p11l479t3581r950b3680],
16	symptoms	NNS	O	symptom	prep_of	12	SENT_249	[p11l995t3597r1438b3680],
17	in	IN	O	in	_	0	SENT_249	[p11l1488t3581r1571b3658],
18	children	NNS	O	child	prep_in	16	SENT_249	[p11l1620t3580r1976b3659],
19	after	IN	O	after	_	0	SENT_249	[p11l2024t3579r2132b3658, p11l12t3725r126b3786],
20	respiratory	JJ	O	respiratory	amod	24	SENT_249	[p11l157t3709r628b3808],
21	syncytial	NN	O	syncytial	nn	24	SENT_249	[p11l659t3708r1039b3808],
22	virus	NN	O	virus	nn	24	SENT_249	[p11l1067t3709r1280b3788],
23	infection	NN	O	infection	nn	24	SENT_249	[p11l1315t3707r1773b3787],
24	“	NN	O	“	prep_after	18	SENT_249	[p11l1315t3707r1773b3787],
25	and	CC	O	and	_	0	SENT_249	[p11l1809t3708r1966b3787],
26	the	DT	O	the	det	27	SENT_249	[p11l2001t3708r2133b3786],
27	treatment	NN	O	treatment	conj_and	18	SENT_249	[p12l12t40r435b102],
28	of	IN	O	of	_	0	SENT_249	[p12l467t22r567b102],
29	acute	JJ	O	acute	amod	31	SENT_249	[p12l585t40r807b102],
30	asthma	NN	O	asthma	nn	31	SENT_249	[p12l843t23r1162b101],
31	exacerbations	NNS	O	exacerbation	prep_of	27	SENT_249	[p12l1197t23r1785b102],
32	in	IN	O	in	_	0	SENT_249	[p12l1823t24r1906b101],
33	children	NNS	O	child	prep_in	31	SENT_249	[p12l1943t23r2132b101, p12l12t152r281b231],
34	“	CD	NUMBER	“	num	33	SENT_249	[p12l1943t23r2132b101, p12l12t152r281b231],
35	and	CC	O	and	_	0	SENT_249	[p12l320t152r478b231],
36	adults	NNS	O	adult	prep_in	31	SENT_249	[p12l516t152r875b231],
37	.67	CD	NUMBER	.67	num	36	SENT_249	[p12l516t152r875b231],

1	Eﬁects	NNS	O	eﬁects	nsubj	10	SENT_250	[p12l16t410r264b513],
2	of	IN	O	of	_	0	SENT_250	[p12l297t410r390b513],
3	Antileukotriene	NNP	O	Antileukotriene	nn	4	SENT_250	[p12l396t411r1003b488],
4	Agents	NNPS	O	Agents	prep_of	1	SENT_250	[p12l1033t417r1302b513],
5	on	IN	O	on	_	0	SENT_250	[p12l1335t439r1428b488],
6	Airway	NNP	O	Airway	nn	9	SENT_250	[p12l1460t415r1735b511],
7	Remodeling	NNP	O	Remodeling	nn	9	SENT_250	[p12l16t539r486b641],
8	Structural	NNP	O	Structural	nn	9	SENT_250	[p12l13t665r424b745],
9	alterations	NNS	O	alteration	prep_on	4	SENT_250	[p12l451t665r884b744],
10	referred	VBD	O	refer	_	0	SENT_250	[p12l914t664r1239b744],
11	to	TO	O	to	prep	10	SENT_250	[p12l1267t682r1346b744],
12	as	IN	O	as	mark	46	SENT_250	[p12l1374t691r1457b743],
13	“	NN	O	“	nn	15	SENT_250	[p12l1491t666r1805b765],
14	airway	NN	O	airway	nn	15	SENT_250	[p12l1491t666r1805b765],
15	remodeling	NN	O	remodeling	nsubj	46	SENT_250	[p12l1828t665r2132b744, p12l12t794r273b895],
16	,	,	O	,	_	0	SENT_250	[p12l1828t665r2132b744, p12l12t794r273b895],
17	”	NN	O	”	appos	15	SENT_250	[p12l1828t665r2132b744, p12l12t794r273b895],
18	consisting	VBG	O	consist	partmod	17	SENT_250	[p12l305t795r732b895],
19	of	IN	O	of	_	0	SENT_250	[p12l756t793r854b873],
20	increases	NNS	O	increase	prep_of	18	SENT_250	[p12l862t795r1239b872],
21	in	IN	O	in	_	0	SENT_250	[p12l1267t795r1349b872],
22	the	DT	O	the	det	23	SENT_250	[p12l1376t794r1504b873],
23	number	NN	O	number	prep_in	20	SENT_250	[p12l1531t794r1858b873],
24	of	IN	O	of	_	0	SENT_250	[p12l1882t793r1980b873],
25	airway	NN	O	airway	nn	27	SENT_250	[p12l1988t795r2132b872, p12l7t948r172b1022],
26	goblet	NN	O	goblet	nn	27	SENT_250	[p12l198t922r461b1023],
27	cells	NNS	O	cell	prep_of	23	SENT_250	[p12l488t922r671b1000],
28	and	CC	O	and	_	0	SENT_250	[p12l703t922r860b1001],
29	smooth	JJ	O	smooth	amod	32	SENT_250	[p12l892t922r1538b1001],
30	—	NN	O	—	nn	32	SENT_250	[p12l892t922r1538b1001],
31	muscle	NN	O	muscle	nn	32	SENT_250	[p12l892t922r1538b1001],
32	mass	NN	O	mass	prep_of	23	SENT_250	[p12l1570t948r1808b1018],
33	,	,	O	,	_	0	SENT_250	[p12l1570t948r1808b1018],
34	as	RB	O	as	_	0	SENT_250	[p12l1844t948r1928b1000],
35	well	RB	O	well	_	0	SENT_250	[p12l1957t922r2134b1001],
36	as	IN	O	as	_	0	SENT_250	[p12l11t1076r96b1128],
37	deposition	NN	O	deposition	prep_in	20	SENT_250	[p12l135t1050r588b1150],
38	of	IN	O	of	_	0	SENT_250	[p12l625t1049r724b1129],
39	subepithelial	JJ	O	subepithelial	amod	42	SENT_250	[p12l743t1050r1298b1150],
40	collagen	NN	O	collagen	nn	42	SENT_250	[p12l1334t1050r1694b1151],
41	(	NN	O	(	nn	42	SENT_250	[p12l1735t1050r1993b1141],
42	Table	NNP	O	Table	prep_of	37	SENT_250	[p12l1735t1050r1993b1141],
43	2	CD	NUMBER	2	number	44	SENT_250	[p12l2029t1056r2128b1146],
44	)	CD	NUMBER	)	num	42	SENT_250	[p12l2029t1056r2128b1146],
45	,	,	O	,	_	0	SENT_250	[p12l2029t1056r2128b1146],
46	contribute	VBP	O	contribute	advcl	10	SENT_250	[p12l12t1178r444b1257],
47	to	TO	O	to	_	0	SENT_250	[p12l475t1195r555b1257],
48	the	DT	O	the	det	50	SENT_250	[p12l586t1178r717b1256],
49	progressive	JJ	O	progressive	amod	50	SENT_250	[p12l746t1179r1224b1279],
50	loss	NN	O	loss	prep_to	46	SENT_250	[p12l1253t1178r1413b1257],
51	of	IN	O	of	_	0	SENT_250	[p12l1445t1177r1544b1257],
52	lung	NN	O	lung	nn	53	SENT_250	[p12l1555t1178r1745b1279],
53	function	NN	O	function	prep_of	50	SENT_250	[p12l1771t1177r2134b1257],
54	in	IN	O	in	_	0	SENT_250	[p12l11t1307r92b1383],
55	patients	NNS	O	patient	prep_in	46	SENT_250	[p12l122t1307r448b1405],
56	with	IN	O	with	_	0	SENT_250	[p12l477t1306r666b1385],
57	chronic	JJ	O	chronic	amod	58	SENT_250	[p12l698t1306r1008b1384],
58	asthma	NN	O	asthma	prep_with	55	SENT_250	[p12l1038t1306r1443b1384],
59	.	.	O	.	_	0	SENT_250	[p12l1038t1306r1443b1384],

1	“	NN	O	“	npadvmod	16	SENT_251	[p12l1038t1306r1443b1384],
2	For	IN	O	for	_	0	SENT_251	[p12l1473t1313r1612b1384],
3	this	DT	O	this	det	4	SENT_251	[p12l1640t1306r1793b1383],
4	reason	NN	O	reason	prep_for	16	SENT_251	[p12l1827t1332r2128b1401],
5	,	,	O	,	_	0	SENT_251	[p12l1827t1332r2128b1401],
6	a	DT	O	a	det	8	SENT_251	[p12l11t1459r55b1511],
7	desirable	JJ	O	desirable	amod	8	SENT_251	[p12l89t1433r472b1512],
8	feature	NN	O	feature	nsubj	16	SENT_251	[p12l507t1432r807b1512],
9	of	IN	O	of	_	0	SENT_251	[p12l843t1432r942b1512],
10	controller	NN	O	controller	nn	11	SENT_251	[p12l960t1433r1382b1512],
11	therapy	NN	O	therapy	prep_of	8	SENT_251	[p12l1414t1433r1736b1533],
12	for	IN	O	for	_	0	SENT_251	[p12l1766t1432r1889b1512],
13	asthma	NN	O	asthma	prep_for	11	SENT_251	[p12l1921t1433r2132b1511, p12l11t1588r144b1640],
14	is	VBZ	O	be	cop	16	SENT_251	[p12l172t1563r238b1640],
15	its	PRP$	O	its	poss	16	SENT_251	[p12l270t1563r369b1640],
16	ability	NN	O	ability	_	0	SENT_251	[p12l402t1562r672b1662],
17	to	TO	O	to	aux	18	SENT_251	[p12l699t1579r780b1641],
18	ameliorate	VB	O	ameliorate	infmod	16	SENT_251	[p12l812t1562r1267b1641],
19	airway	NN	O	airway	nn	20	SENT_251	[p12l1298t1563r1585b1662],
20	remodeling	NN	O	remodeling	dobj	18	SENT_251	[p12l1611t1562r2128b1663],
21	.	.	O	.	_	0	SENT_251	[p12l1611t1562r2128b1663],

1	Airway	NN	O	airway	nn	2	SENT_252	[p12l7t1691r315b1790],
2	remodeling	NN	O	remodeling	nsubj	3	SENT_252	[p12l346t1690r843b1791],
3	appears	VBZ	O	appear	ccomp	26	SENT_252	[p12l875t1716r1207b1790],
4	to	TO	O	to	aux	6	SENT_252	[p12l1245t1707r1327b1769],
5	be	VB	O	be	cop	6	SENT_252	[p12l1364t1690r1461b1769],
6	resistant	JJ	O	resistant	xcomp	3	SENT_252	[p12l1497t1691r1869b1768],
7	to	TO	O	to	aux	8	SENT_252	[p12l1900t1707r1982b1769],
8	inhaled	VBN	O	inhale	xcomp	6	SENT_252	[p12l2018t1691r2132b1768, p12l11t1817r237b1895],
9	corticosteroids	NNS	O	corticosteroid	xcomp	8	SENT_252	[p12l261t1817r967b1895],
10	.69	CD	NUMBER	.69	dep	9	SENT_252	[p12l261t1817r967b1895],
11	However	RB	O	however	advmod	8	SENT_252	[p12l991t1824r1371b1912],
12	,	,	O	,	_	0	SENT_252	[p12l991t1824r1371b1912],
13	in	IN	O	in	_	0	SENT_252	[p12l1400t1818r1480b1894],
14	a	DT	O	a	det	16	SENT_252	[p12l1503t1843r1548b1894],
15	mouse	NN	O	mouse	nn	16	SENT_252	[p12l1570t1842r1843b1896],
16	model	NN	O	model	prep_in	8	SENT_252	[p12l1867t1817r2134b1895],
17	of	IN	O	of	_	0	SENT_252	[p12l12t1943r112b2023],
18	chronic	JJ	O	chronic	amod	20	SENT_252	[p12l126t1944r450b2023],
19	allergic	JJ	O	allergic	amod	20	SENT_252	[p12l480t1944r798b2045],
20	asthma	NN	O	asthma	prep_of	16	SENT_252	[p12l829t1944r1171b2039],
21	,	,	O	,	_	0	SENT_252	[p12l829t1944r1171b2039],
22	CysLT1	NN	O	cyslt1	nn	23	SENT_252	[p12l1208t1950r1498b2047],
23	blockade	NN	O	blockade	nsubj	26	SENT_252	[p12l1530t1944r1910b2023],
24	with	IN	O	with	_	0	SENT_252	[p12l1938t1944r2133b2023],
25	montelukast	NN	O	montelukast	prep_with	23	SENT_252	[p12l11t2072r550b2151],
26	reversed	VBD	O	reverse	_	0	SENT_252	[p12l590t2072r945b2151],
27	all	PDT	O	all	predet	30	SENT_252	[p12l990t2072r1094b2150],
28	the	DT	O	the	det	30	SENT_252	[p12l1140t2072r1273b2150],
29	histologic	JJ	O	histologic	amod	30	SENT_252	[p12l1319t2072r1744b2173],
30	features	NNS	O	feature	dobj	26	SENT_252	[p12l1789t2071r2132b2151],
31	of	IN	O	of	_	0	SENT_252	[p12l12t2199r111b2279],
32	airway	NN	O	airway	nn	33	SENT_252	[p12l120t2201r402b2300],
33	remodeling	NN	O	remodeling	prep_of	30	SENT_252	[p12l426t2200r1005b2301],
34	.7	CD	NUMBER	.7	number	35	SENT_252	[p12l426t2200r1005b2301],
35	°	CD	NUMBER	°	num	36	SENT_252	[p12l426t2200r1005b2301],
36	Myofibroblasts	NNS	O	myofibroblast	nsubjpass	55	SENT_252	[p12l1031t2199r1688b2300],
37	,	,	O	,	_	0	SENT_252	[p12l1031t2199r1688b2300],
38	which	WDT	O	which	nsubj	41	SENT_252	[p12l1717t2200r1976b2279],
39	are	VBP	O	be	cop	41	SENT_252	[p12l2004t2226r2133b2278],
40	mesenchymal	JJ	O	mesenchymal	amod	41	SENT_252	[p12l11t2327r581b2427],
41	cells	NNS	O	cell	rcmod	36	SENT_252	[p12l604t2327r782b2405],
42	with	IN	O	with	_	0	SENT_252	[p12l802t2327r991b2407],
43	features	NNS	O	feature	prep_with	41	SENT_252	[p12l1013t2326r1340b2407],
44	of	IN	O	of	_	0	SENT_252	[p12l1365t2326r1462b2406],
45	both	DT	O	both	det	46	SENT_252	[p12l1467t2327r1658b2406],
46	fibroblasts	NNS	O	fibroblast	prep_of	43	SENT_252	[p12l1680t2326r2131b2406],
47	and	CC	O	and	_	0	SENT_252	[p12l10t2456r166b2534],
48	smooth	JJ	O	smooth	amod	51	SENT_252	[p12l199t2456r846b2535],
49	—	NN	O	—	nn	51	SENT_252	[p12l199t2456r846b2535],
50	muscle	NN	O	muscle	nn	51	SENT_252	[p12l199t2456r846b2535],
51	cells	NNS	O	cell	conj_and	46	SENT_252	[p12l879t2456r1086b2551],
52	,	,	O	,	_	0	SENT_252	[p12l879t2456r1086b2551],
53	have	VBP	O	have	aux	55	SENT_252	[p12l1124t2456r1310b2535],
54	been	VBN	O	be	auxpass	55	SENT_252	[p12l1343t2456r1542b2534],
55	implicated	VBN	O	implicate	rcmod	30	SENT_252	[p12l1574t2456r2018b2555],
56	in	IN	O	in	_	0	SENT_252	[p12l2050t2457r2133b2533],
57	airway	NN	O	airway	nn	58	SENT_252	[p12l10t2585r297b2684],
58	remodeling	NN	O	remodeling	prep_in	55	SENT_252	[p12l323t2584r821b2685],
59	because	IN	O	because	_	0	SENT_252	[p12l849t2584r1185b2663],
60	of	IN	O	of	_	0	SENT_252	[p12l1217t2583r1317b2663],
61	their	PRP$	O	they	poss	63	SENT_252	[p12l1330t2584r1534b2662],
62	high	JJ	O	high	amod	63	SENT_252	[p12l1562t2584r1757b2685],
63	capacity	NN	O	capacity	prep_because_of	55	SENT_252	[p12l1789t2585r2138b2684],
64	for	IN	O	for	_	0	SENT_252	[p12l11t2711r130b2791],
65	collagen	NN	O	collagen	nn	66	SENT_252	[p12l163t2712r508b2813],
66	synthesis	NN	O	synthesis	prep_for	63	SENT_252	[p12l544t2712r942b2812],
67	.	.	O	.	_	0	SENT_252	[p12l544t2712r942b2812],

1	In	IN	O	in	_	0	SENT_253	[p12l982t2720r1069b2790],
2	atopic	JJ	O	atopic	amod	3	SENT_253	[p12l1103t2713r1351b2812],
3	asthma	NN	O	asthma	prep_in	8	SENT_253	[p12l1384t2712r1714b2808],
4	,	,	O	,	_	0	SENT_253	[p12l1384t2712r1714b2808],
5	the	DT	O	the	det	7	SENT_253	[p12l1755t2712r1883b2790],
6	allergen	NN	O	allergen	nn	7	SENT_253	[p12l1917t2712r2132b2791, p12l11t2840r539b2941],
7	—	NN	O	—	nsubj	8	SENT_253	[p12l1917t2712r2132b2791, p12l11t2840r539b2941],
8	induced	VBD	O	induce	_	0	SENT_253	[p12l1917t2712r2132b2791, p12l11t2840r539b2941],
9	increase	NN	O	increase	nsubjpass	22	SENT_253	[p12l568t2841r920b2919],
10	in	IN	O	in	_	0	SENT_253	[p12l950t2841r1033b2918],
11	the	DT	O	the	det	12	SENT_253	[p12l1063t2840r1196b2918],
12	number	NN	O	number	prep_in	9	SENT_253	[p12l1227t2840r1564b2919],
13	of	IN	O	of	_	0	SENT_253	[p12l1592t2839r1692b2919],
14	myof1bro	NN	O	myof1bro	nn	16	SENT_253	[p12l1704t2839r2132b2940],
15	—	NN	O	—	nn	16	SENT_253	[p12l1704t2839r2132b2940],
16	blasts	NNS	O	blast	prep_of	12	SENT_253	[p12l12t2968r252b3046],
17	in	IN	O	in	_	0	SENT_253	[p12l283t2969r365b3045],
18	the	DT	O	the	det	20	SENT_253	[p12l394t2968r524b3046],
19	airway	NN	O	airway	nn	20	SENT_253	[p12l553t2969r834b3067],
20	wall	NN	O	wall	prep_in	16	SENT_253	[p12l854t2968r1033b3047],
21	is	VBZ	O	be	auxpass	22	SENT_253	[p12l1061t2969r1125b3045],
22	limited	VBN	O	limit	ccomp	8	SENT_253	[p12l1155t2968r1457b3046],
23	by	IN	O	by	_	0	SENT_253	[p12l1486t2968r1582b3067],
24	montelukast	NN	O	montelukast	nn	25	SENT_253	[p12l1606t2968r2138b3047],
25	treatment	NN	O	treatment	agent	22	SENT_253	[p12l12t3101r509b3192],
26	,	,	O	,	_	0	SENT_253	[p12l12t3101r509b3192],
27	“	NN	O	“	appos	25	SENT_253	[p12l12t3101r509b3192],
28	but	CC	O	but	_	0	SENT_253	[p12l534t3096r670b3175],
29	whether	IN	O	whether	complm	44	SENT_253	[p12l685t3096r1027b3175],
30	antileukotriene	JJ	O	antileukotriene	amod	31	SENT_253	[p12l1048t3096r1676b3175],
31	drugs	NNS	O	drug	nsubj	44	SENT_253	[p12l1702t3096r1937b3197],
32	pre	JJ	O	pre	amod	34	SENT_253	[p12l1962t3122r2132b3196],
33	—	CD	NUMBER	—	tmod	32	SENT_253	[p12l1962t3122r2132b3196],
34	Vent	NN	O	vent	dep	31	SENT_253	[p12l7t3241r187b3303],
35	or	CC	O	or	_	0	SENT_253	[p12l217t3250r306b3303],
36	ameliorate	VB	O	ameliorate	dep	41	SENT_253	[p12l337t3224r793b3303],
37	airway	NN	O	airway	nn	38	SENT_253	[p12l827t3225r1114b3324],
38	remodeling	NN	O	remodeling	dobj	36	SENT_253	[p12l1144t3224r1642b3325],
39	in	IN	O	in	_	0	SENT_253	[p12l1673t3225r1756b3302],
40	patients	NNS	O	patient	prep_in	36	SENT_253	[p12l1789t3225r2131b3324],
41	with	IN	O	with	nsubj	44	SENT_253	[p12l7t3353r202b3432],
42	asthma	NN	O	asthma	pobj	41	SENT_253	[p12l236t3353r555b3431],
43	is	VBZ	O	be	cop	44	SENT_253	[p12l588t3354r653b3431],
44	unknown	JJ	O	unknown	conj_but	22	SENT_253	[p12l690t3353r1128b3432],
45	.	.	O	.	_	0	SENT_253	[p12l690t3353r1128b3432],

1	Responsiveness	NN	O	responsiveness	_	0	SENT_254	[p12l16t3616r603b3712],
2	to	TO	O	to	_	0	SENT_254	[p12l636t3627r710b3689],
3	Antileukotriene	NNP	O	Antileukotriene	nn	4	SENT_254	[p12l742t3612r1348b3689],
4	Agents	NNPS	O	Agents	prep_to	1	SENT_254	[p12l1379t3617r1648b3714],

1	Since	IN	O	since	mark	3	SENT_255	[p13l13t20r231b97],
2	asthma	NN	O	asthma	nsubj	3	SENT_255	[p13l260t19r573b97],
3	involves	VBZ	O	involve	advcl	10	SENT_255	[p13l600t19r931b98],
4	multiple	JJ	O	multiple	amod	5	SENT_255	[p13l961t19r1310b118],
5	mediators	NNS	O	mediator	dobj	3	SENT_255	[p13l1339t19r1785b114],
6	,	,	O	,	_	0	SENT_255	[p13l1339t19r1785b114],
7	it	PRP	O	it	nsubj	10	SENT_255	[p13l1819t20r1877b97],
8	is	VBZ	O	be	cop	10	SENT_255	[p13l1900t20r1965b97],
9	not	RB	O	not	neg	10	SENT_255	[p13l1996t36r2139b97],
10	surprising	JJ	O	surprising	_	0	SENT_255	[p13l13t148r457b248],
11	that	IN	O	that	complm	27	SENT_255	[p13l493t147r665b225],
12	the	DT	O	the	det	13	SENT_255	[p13l698t147r831b225],
13	efficacy	NN	O	efficacy	nsubj	29	SENT_255	[p13l870t146r1207b247],
14	of	IN	O	of	_	0	SENT_255	[p13l1241t146r1341b226],
15	agents	NNS	O	agent	prep_of	13	SENT_255	[p13l1360t164r1636b248],
16	that	WDT	O	that	nsubj	17	SENT_255	[p13l1677t147r1849b225],
17	target	VBP	O	target	rcmod	15	SENT_255	[p13l1882t164r2138b248],
18	only	RB	O	only	advmod	19	SENT_255	[p13l12t275r199b375],
19	components	NNS	O	component	dobj	17	SENT_255	[p13l229t292r764b375],
20	of	IN	O	of	_	0	SENT_255	[p13l800t274r901b354],
21	the	DT	O	the	det	25	SENT_255	[p13l916t275r1051b354],
22	5	CD	NUMBER	5	num	25	SENT_255	[p13l1086t275r1738b376],
23	—	NN	O	—	nn	25	SENT_255	[p13l1086t275r1738b376],
24	lipoxygenase	NN	O	lipoxygenase	nn	25	SENT_255	[p13l1086t275r1738b376],
25	pathway	NN	O	pathway	prep_of	19	SENT_255	[p13l1770t275r2138b375],
26	is	VBZ	O	be	cop	27	SENT_255	[p13l11t404r77b481],
27	limited	JJ	O	limited	ccomp	10	SENT_255	[p13l114t403r429b481],
28	and	CC	O	and	_	0	SENT_255	[p13l465t403r624b481],
29	variable	JJ	O	variable	ccomp	10	SENT_255	[p13l656t403r1024b482],
30	.	.	O	.	_	0	SENT_255	[p13l656t403r1024b482],

1	Why	WRB	O	why	advmod	5	SENT_256	[p13l1062t403r1262b502],
2	are	VBP	O	be	cop	5	SENT_256	[p13l1293t429r1424b481],
3	antileukotriene	JJ	O	antileukotriene	amod	4	SENT_256	[p13l1459t403r2133b482],
4	drugs	NNS	O	drug	nsubj	10	SENT_256	[p13l12t531r260b632],
5	effective	JJ	O	effective	_	0	SENT_256	[p13l300t530r666b610],
6	in	IN	O	in	_	0	SENT_256	[p13l704t532r789b609],
7	some	DT	O	some	det	8	SENT_256	[p13l827t557r1054b610],
8	patients	NNS	O	patient	prep_in	5	SENT_256	[p13l1091t532r1440b631],
9	and	CC	O	and	_	0	SENT_256	[p13l1479t531r1639b610],
10	ineffective	JJ	O	ineffective	conj_and	5	SENT_256	[p13l1676t530r2133b610],
11	in	IN	O	in	_	0	SENT_256	[p13l10t661r94b737],
12	others	NNS	O	other	prep_in	10	SENT_256	[p13l129t657r435b738],
13	?	.	O	?	_	0	SENT_256	[p13l129t657r435b738],

1	One	CD	NUMBER	one	num	2	SENT_257	[p13l140t793r309b866],
2	explanation	NN	O	explanation	nsubj	9	SENT_257	[p13l340t787r835b887],
3	for	IN	O	for	_	0	SENT_257	[p13l865t786r986b866],
4	the	DT	O	the	det	5	SENT_257	[p13l1013t787r1143b865],
5	efficacy	NN	O	efficacy	prep_for	2	SENT_257	[p13l1173t786r1502b887],
6	of	IN	O	of	_	0	SENT_257	[p13l1528t786r1626b866],
7	these	DT	O	these	det	8	SENT_257	[p13l1638t787r1857b866],
8	drugs	NNS	O	drug	prep_of	5	SENT_257	[p13l1887t787r2131b888],
9	is	VBZ	O	be	_	0	SENT_257	[p13l10t916r75b993],
10	that	IN	O	that	complm	13	SENT_257	[p13l121t915r290b993],
11	CysLT1	NN	O	cyslt1	nn	12	SENT_257	[p13l328t921r613b1018],
12	signaling	NN	O	signaling	nsubj	13	SENT_257	[p13l658t915r1053b1016],
13	contributes	VBZ	O	contribute	ccomp	9	SENT_257	[p13l1094t915r1568b994],
14	to	TO	O	to	aux	15	SENT_257	[p13l1614t932r1694b994],
15	many	JJ	O	many	xcomp	13	SENT_257	[p13l1739t941r1974b1014],
16	as	IN	O	as	_	0	SENT_257	[p13l2013t941r2132b993],
17	—	NN	O	—	nn	18	SENT_257	[p13l2013t941r2132b993],
18	pects	NNS	O	pect	prep_as	15	SENT_257	[p13l10t1060r223b1143],
19	of	IN	O	of	_	0	SENT_257	[p13l261t1042r359b1122],
20	asthma	NN	O	asthma	nn	21	SENT_257	[p13l376t1043r684b1121],
21	pathogenesis	NN	O	pathogenesis	prep_of	18	SENT_257	[p13l717t1043r1257b1144],
22	besides	IN	O	besides	_	0	SENT_257	[p13l1296t1043r1594b1122],
23	constriction	NN	O	constriction	prep_besides	21	SENT_257	[p13l1632t1044r2134b1122],
24	of	IN	O	of	_	0	SENT_257	[p13l12t1169r112b1249],
25	bronchial	JJ	O	bronchial	amod	27	SENT_257	[p13l121t1170r532b1249],
26	smooth	JJ	O	smooth	amod	27	SENT_257	[p13l560t1170r886b1249],
27	muscle	NN	O	muscle	prep_of	23	SENT_257	[p13l912t1170r1235b1249],
28	.	.	O	.	_	0	SENT_257	[p13l912t1170r1235b1249],

1	For	IN	O	for	_	0	SENT_258	[p13l1266t1178r1408b1249],
2	example	NN	O	example	prep_for	5	SENT_258	[p13l1433t1170r1812b1270],
3	,	,	O	,	_	0	SENT_258	[p13l1433t1170r1812b1270],
4	CysLT1	NN	O	cyslt1	nsubj	10	SENT_258	[p13l1844t1176r2134b1273],
5	influences	VBZ	O	influence	_	0	SENT_258	[p13l11t1296r467b1377],
6	systemic	JJ	O	systemic	amod	8	SENT_258	[p13l507t1298r882b1397],
7	immune	JJ	O	immune	amod	8	SENT_258	[p13l917t1298r1283b1376],
8	responses	NNS	O	response	dobj	5	SENT_258	[p13l1319t1323r1751b1397],
9	and	CC	O	and	_	0	SENT_258	[p13l1789t1297r1949b1376],
10	has	VBZ	O	have	conj_and	5	SENT_258	[p13l1985t1297r2132b1375],
11	bidirectional	JJ	O	bidirectional	amod	12	SENT_258	[p13l12t1426r549b1504],
12	interactions	NNS	O	interaction	dobj	10	SENT_258	[p13l587t1427r1085b1504],
13	with	IN	O	with	_	0	SENT_258	[p13l1123t1426r1315b1505],
14	cytokines	NNS	O	cytokine	prep_with	12	SENT_258	[p13l1355t1426r1778b1525],
15	.	.	O	.	_	0	SENT_258	[p13l1355t1426r1778b1525],

1	The	DT	O	the	det	2	SENT_259	[p13l1819t1426r1978b1504],
2	interplay	NN	O	interplay	nsubj	17	SENT_259	[p13l2018t1427r2132b1503, p13l12t1554r306b1653],
3	between	IN	O	between	_	0	SENT_259	[p13l342t1554r700b1633],
4	the	DT	O	the	det	7	SENT_259	[p13l741t1554r874b1632],
5	Th2	NN	O	th2	nn	7	SENT_259	[p13l911t1554r1080b1631],
6	cytokine	NN	O	cytokine	nn	7	SENT_259	[p13l1123t1554r1488b1653],
7	interleul	NN	O	interleul	dep	8	SENT_259	[p13l1528t1554r2130b1633],
8	<	JJR	O	<	prep_between	2	SENT_259	[p13l1528t1554r2130b1633],
9	in	IN	O	in	_	0	SENT_259	[p13l1528t1554r2130b1633],
10	—	CD	NUMBER	—	num	11	SENT_259	[p13l1528t1554r2130b1633],
11	13	CD	NUMBER	13	prep_in	8	SENT_259	[p13l1528t1554r2130b1633],
12	and	CC	O	and	_	0	SENT_259	[p13l11t1681r166b1760],
13	cysteinyl	NN	O	cysteinyl	nn	14	SENT_259	[p13l199t1681r559b1780],
14	leukotrienes	NNS	O	leukotriene	prep_between	2	SENT_259	[p13l590t1681r1106b1760],
15	and	CC	O	and	_	0	SENT_259	[p13l1141t1681r1296b1760],
16	CysLT1	NN	O	cyslt1	conj_and	14	SENT_259	[p13l1328t1687r1613b1784],
17	exemplifies	VBZ	O	exemplify	_	0	SENT_259	[p13l1646t1680r2131b1781],
18	such	JJ	O	such	amod	19	SENT_259	[p13l12t1809r206b1888],
19	relationships	NNS	O	relationship	nsubj	20	SENT_259	[p13l246t1809r804b1909],
20	(	VBP	O	(	ccomp	17	SENT_259	[p13l850t1810r1031b1910],
21	Fig	NN	O	fig	dobj	20	SENT_259	[p13l850t1810r1031b1910],
22	.	.	O	.	_	0	SENT_259	[p13l850t1810r1031b1910],

1	3	CD	NUMBER	3	_	0	SENT_260	[p13l1077t1815r1174b1900],
2	)	NN	O	)	dep	1	SENT_260	[p13l1077t1815r1174b1900],
3	.	.	O	.	_	0	SENT_260	[p13l1077t1815r1174b1900],

1	Variations	NNS	O	variation	nsubj	16	SENT_261	[p13l136t1937r572b2015],
2	in	IN	O	in	_	0	SENT_261	[p13l612t1937r695b2014],
3	responses	NNS	O	response	prep_in	1	SENT_261	[p13l732t1962r1155b2036],
4	of	IN	O	of	_	0	SENT_261	[p13l1195t1935r1295b2015],
5	patients	NNS	O	patient	prep_of	3	SENT_261	[p13l1312t1937r1654b2036],
6	with	IN	O	with	_	0	SENT_261	[p13l1689t1936r1884b2016],
7	asthma	NN	O	asthma	prep_with	5	SENT_261	[p13l1921t1936r2132b2014, p13l11t2091r141b2143],
8	to	TO	O	to	_	0	SENT_261	[p13l175t2082r254b2144],
9	corticosteroids	NNS	O	corticosteroid	prep_to	7	SENT_261	[p13l290t2065r897b2144],
10	and	CC	O	and	_	0	SENT_261	[p13l933t2065r1087b2144],
11	,8	CD	NUMBER	,8	prep_with	5	SENT_261	[p13l1116t2069r1213b2168],
12	,	,	O	,	_	0	SENT_261	[p13l1116t2069r1213b2168],
13	agonists	NNS	O	agonist	appos	11	SENT_261	[p13l1248t2066r1591b2166],
14	were	VBD	O	be	cop	16	SENT_261	[p13l1623t2091r1818b2144],
15	illumi	JJ	O	illumi	amod	16	SENT_261	[p13l1851t2065r2132b2144],
16	—	NN	O	—	_	0	SENT_261	[p13l1851t2065r2132b2144],
17	nated	VBN	O	nate	partmod	16	SENT_261	[p13l11t2193r248b2272],
18	by	IN	O	by	_	0	SENT_261	[p13l280t2193r378b2293],
19	studies	NNS	O	study	agent	17	SENT_261	[p13l407t2193r707b2272],
20	of	IN	O	of	_	0	SENT_261	[p13l742t2192r842b2272],
21	an	DT	O	a	det	23	SENT_261	[p13l855t2219r958b2271],
22	antileukotriene	JJ	O	antileukotriene	amod	23	SENT_261	[p13l990t2193r1648b2272],
23	agent	NN	O	agent	prep_of	19	SENT_261	[p13l1680t2199r2013b2294],
24	.	.	O	.	_	0	SENT_261	[p13l1680t2199r2013b2294],

1	”	NN	O	”	_	0	SENT_262	[p13l1680t2199r2013b2294],
2	In	IN	O	in	dep	1	SENT_262	[p13l2045t2201r2133b2271],
3	randomized	VBN	O	randomize	dep	6	SENT_262	[p13l11t2321r566b2417],
4	,	,	O	,	_	0	SENT_262	[p13l11t2321r566b2417],
5	controlled	VBN	O	control	amod	6	SENT_262	[p13l609t2321r1056b2400],
6	trials	NNS	O	trial	pobj	2	SENT_262	[p13l1093t2321r1318b2399],
7	with	IN	O	with	_	0	SENT_262	[p13l1353t2321r1551b2400],
8	these	DT	O	these	det	9	SENT_262	[p13l1588t2321r1816b2400],
9	drugs	NNS	O	drug	prep_with	6	SENT_262	[p13l1854t2321r2128b2422],
10	,	,	O	,	_	0	SENT_262	[p13l1854t2321r2128b2422],

1	Table	NNP	O	Table	_	0	SENT_263	[p14l59t132r201b180],
2	3	CD	NUMBER	3	dep	1	SENT_263	[p14l218t136r262b180],
3	.	.	O	.	_	0	SENT_263	[p14l218t136r262b180],

1	Diseases	NNS	O	disease	nsubj	3	SENT_264	[p14l285t133r515b180],
2	That	WDT	O	that	nsubj	3	SENT_264	[p14l532t132r652b180],
3	Have	VBP	O	have	_	0	SENT_264	[p14l672t136r806b180],
4	a	DT	O	a	det	6	SENT_264	[p14l823t148r850b180],
5	Possible	JJ	O	possible	amod	6	SENT_264	[p14l872t132r1086b180],
6	Association	NN	O	association	dobj	3	SENT_264	[p14l1102t133r1405b180],
7	with	IN	O	with	_	0	SENT_264	[p14l1424t132r1535b180],
8	Leukotrienes	NNPS	O	Leukotrienes	prep_with	6	SENT_264	[p14l1560t132r1908b180],
9	.	.	O	.	_	0	SENT_264	[p14l1560t132r1908b180],

1	Allergic	JJ	O	allergic	amod	2	SENT_265	[p14l59t285r255b348],
2	diseases	NNS	O	disease	_	0	SENT_265	[p14l273t285r494b333],

1	Asthma	NN	O	asthma	_	0	SENT_266	[p14l155t380r391b428],
2	*	CD	NUMBER	*	num	1	SENT_266	[p14l155t380r391b428],
3	Allergic	JJ	O	allergic	amod	4	SENT_266	[p14l155t475r351b538],
4	rhinitis	NN	O	rhinitis	dep	1	SENT_266	[p14l372t475r584b523],
5	"	''	O	"	punct	4	SENT_266	[p14l372t475r584b523],
6	?	.	O	?	_	0	SENT_266	[p14l372t475r584b523],

1	Rhinosinusitis	NNP	O	Rhinosinusitis	nn	3	SENT_267	[p14l161t569r530b618],
2	Atopic	JJ	O	atopic	amod	3	SENT_267	[p14l155t667r325b727],
3	dermatitis	NN	O	dermatitis	nsubj	7	SENT_267	[p14l343t664r645b727],
4	'	''	O	'	_	0	SENT_267	[p14l343t664r645b727],
5	i	FW	O	i	dep	7	SENT_267	[p14l343t664r645b727],
6	'	''	O	'	_	0	SENT_267	[p14l343t664r645b727],
7	Urticaria'i	NN	O	urticaria'us	_	0	SENT_267	[p14l160t763r417b822],
8	'	''	O	'	_	0	SENT_267	[p14l160t763r417b822],

1	Fibrotic	JJ	MISC	fibrotic	amod	2	SENT_268	[p14l65t854r261b902],
2	diseases	NNS	O	disease	_	0	SENT_268	[p14l279t854r499b902],

1	Airway	NN	O	airway	nn	2	SENT_269	[p14l155t952r329b1012],
2	remodeling	NN	O	remodeling	_	0	SENT_269	[p14l349t949r647b1012],
3	in	IN	O	in	_	0	SENT_269	[p14l667t953r708b996],
4	asthma	NN	O	asthma	nn	6	SENT_269	[p14l731t949r923b997],
5	Bronchiolitis	NN	ORGANIZATION	bronchiolitis	nn	6	SENT_269	[p14l161t1043r488b1091],
6	obliterans	NNS	O	obliteran	prep_in	2	SENT_269	[p14l509t1043r768b1091],
7	after	IN	O	after	_	0	SENT_269	[p14l789t1043r906b1091],
8	lung	NN	O	lung	nn	9	SENT_269	[p14l926t1043r1037b1107],
9	transplantation	NN	O	transplantation	prep_after	6	SENT_269	[p14l1054t1043r1454b1106],
10	Idiopathic	JJ	MISC	idiopathic	amod	12	SENT_269	[p14l161t1138r421b1201],
11	pulmonary	JJ	O	pulmonary	amod	12	SENT_269	[p14l442t1138r723b1201],
12	fibrosiszi	NNS	O	fibrosiszus	dep	2	SENT_269	[p14l739t1137r968b1201],
13	:	:	O	:	_	0	SENT_269	[p14l739t1137r968b1201],
14	Scleroderma	NNP	O	Scleroderma	nn	15	SENT_269	[p14l158t1233r486b1281],
15	Asbestosis	NNP	O	Asbestosis	dep	12	SENT_269	[p14l155t1328r437b1376],

1	Other	JJ	O	other	_	0	SENT_270	[p14l62t1423r213b1471],
2	pulmonary	JJ	O	pulmonary	amod	3	SENT_270	[p14l233t1423r514b1486],
3	syndromes	NNS	O	syndrome	dep	1	SENT_270	[p14l533t1423r818b1486],

1	Acute	JJ	O	acute	amod	2	SENT_271	[p14l155t1521r304b1565],
2	lung	NN	O	lung	_	0	SENT_271	[p14l325t1517r437b1581],
3	injury	NN	O	injury	rcmod	2	SENT_271	[p14l458t1522r601b1581],
4	or	CC	O	or	_	0	SENT_271	[p14l619t1534r672b1565],
5	adult	JJ	O	adult	amod	10	SENT_271	[p14l690t1517r821b1565],
6	respiratory	JJ	O	respiratory	amod	10	SENT_271	[p14l842t1522r1121b1581],
7	distress	NN	O	distress	nn	10	SENT_271	[p14l1139t1517r1341b1565],
8	syndrome	NN	O	syndrome	nn	10	SENT_271	[p14l1363t1517r1621b1580],
9	Viral	JJ	O	viral	amod	10	SENT_271	[p14l155t1612r270b1661],
10	bronchiolitis	NN	O	bronchiolitis	conj_or	3	SENT_271	[p14l295t1612r656b1675],
11	'	''	O	'	_	0	SENT_271	[p14l295t1612r656b1675],
12	i	FW	O	i	dep	10	SENT_271	[p14l295t1612r656b1675],
13	'	''	O	'	_	0	SENT_271	[p14l295t1612r656b1675],
14	Obstructive	JJ	O	obstructive	amod	15	SENT_271	[p14l158t1707r463b1755],
15	sleep	NN	O	sleep	conj_or	3	SENT_271	[p14l483t1707r616b1769],
16	apnea'i	NN	O	apnea'us	dep	15	SENT_271	[p14l637t1711r827b1770],
17	'	''	O	'	_	0	SENT_271	[p14l637t1711r827b1770],
18	Chronic	JJ	O	chronic	amod	21	SENT_271	[p14l158t1802r362b1850],
19	obstructive	JJ	O	obstructive	amod	21	SENT_271	[p14l380t1802r671b1850],
20	pulmonary	JJ	O	pulmonary	amod	21	SENT_271	[p14l693t1802r974b1865],
21	disease'i	NN	O	disease'us	conj_or	3	SENT_271	[p14l991t1802r1257b1865],
22	'	''	O	'	_	0	SENT_271	[p14l991t1802r1257b1865],
23	:	:	O	:	_	0	SENT_271	[p14l991t1802r1257b1865],
24	i	FW	O	i	conj_or	3	SENT_271	[p14l991t1802r1257b1865],
25	:	:	O	:	_	0	SENT_271	[p14l991t1802r1257b1865],
26	Cystic	JJ	MISC	cystic	amod	28	SENT_271	[p14l158t1900r311b1960],
27	ﬁbrosis	NN	O	ﬁbrosis	nn	28	SENT_271	[p14l328t1896r546b1959],
28	§	NN	O	§	conj_or	3	SENT_271	[p14l328t1896r546b1959],
29	and	CC	O	and	_	0	SENT_271	[p14l567t1897r659b1944],
30	other	JJ	O	other	amod	31	SENT_271	[p14l681t1897r819b1945],
31	forms	NNS	O	form	conj_and	3	SENT_271	[p14l835t1896r987b1944],
32	ofbronchiectasis	NN	O	ofbronchiectasis	nn	34	SENT_271	[p14l1008t1896r1454b1944],
33	Bronchopulmonary	JJ	O	bronchopulmonary	amod	34	SENT_271	[p14l161t1991r666b2055],
34	dysplasia	NN	O	dysplasium	dep	2	SENT_271	[p14l684t1991r923b2054],
35	Other	JJ	O	other	amod	38	SENT_271	[p14l62t2086r213b2134],
36	local	JJ	O	local	amod	38	SENT_271	[p14l233t2086r347b2134],
37	inﬂammatory	JJ	O	inﬂammatory	amod	38	SENT_271	[p14l371t2085r721b2149],
38	diseases	NNS	O	disease	dep	34	SENT_271	[p14l739t2086r960b2134],

1	Arthritis	NNP	O	Arthritis	_	0	SENT_272	[p14l155t2181r367b2229],
2	(	CD	NUMBER	(	num	1	SENT_272	[p14l393t2181r654b2244],
3	including	VBG	O	include	partmod	1	SENT_272	[p14l393t2181r654b2244],
4	osteoarthritis	NN	O	osteoarthritis	dobj	3	SENT_272	[p14l673t2181r1021b2229],
5	and	CC	O	and	_	0	SENT_272	[p14l1043t2181r1135b2229],
6	gout	NN	O	gout	nn	8	SENT_272	[p14l1158t2185r1292b2244],
7	)	CD	NUMBER	)	num	8	SENT_272	[p14l1158t2185r1292b2244],
8	Glomerulonephritis	NNP	MISC	Glomerulonephritis	conj_and	4	SENT_272	[p14l158t2276r672b2338],
9	Interstitial	JJ	MISC	interstitial	amod	10	SENT_272	[p14l161t2371r421b2418],
10	cystitis	NN	O	cystitis	dep	8	SENT_272	[p14l443t2375r657b2434],
11	'	''	O	'	_	0	SENT_272	[p14l443t2375r657b2434],
12	i	FW	O	i	dep	8	SENT_272	[p14l443t2375r657b2434],
13	'	''	O	'	_	0	SENT_272	[p14l443t2375r657b2434],
14	Psoriasis	NNP	O	Psoriasis	nn	17	SENT_272	[p14l161t2470r391b2513],
15	Inﬂammatory	NNP	O	Inﬂammatory	nn	17	SENT_272	[p14l161t2559r513b2623],
16	bowel	NN	O	bowel	nn	17	SENT_272	[p14l533t2560r679b2608],
17	diseaseﬂ	NN	O	diseaseﬂ	conj_and	4	SENT_272	[p14l702t2559r931b2622],
18	]	CD	NUMBER	]	num	21	SENT_272	[p14l702t2559r931b2622],
19	Systemic	JJ	O	systemic	amod	21	SENT_272	[p14l62t2658r295b2718],
20	inﬂammatory	JJ	O	inﬂammatory	amod	21	SENT_272	[p14l315t2654r665b2718],
21	diseases	NNS	O	disease	dep	17	SENT_272	[p14l683t2655r904b2703],

1	Rheumatoid	JJ	O	rheumatoid	amod	2	SENT_273	[p14l161t2750r475b2798],
2	arthritis	NN	O	arthritis	_	0	SENT_273	[p14l498t2750r736b2813],
3	'	''	O	'	_	0	SENT_273	[p14l498t2750r736b2813],
4	i	FW	O	i	rcmod	2	SENT_273	[p14l498t2750r736b2813],
5	'	''	O	'	_	0	SENT_273	[p14l498t2750r736b2813],
6	Vasculitides	NNPS	O	Vasculitides	rcmod	4	SENT_273	[p14l155t2844r471b2893],
7	(	CD	NUMBER	(	dep	6	SENT_273	[p14l497t2849r743b2908],
8	systemic	JJ	O	systemic	dep	6	SENT_273	[p14l497t2849r743b2908],
9	lupus	NN	O	lupus	nn	10	SENT_273	[p14l764t2844r903b2907],
10	erythematosus	NN	O	erythematosus	dep	8	SENT_273	[p14l924t2844r1364b2908],
11	,	,	O	,	_	0	SENT_273	[p14l924t2844r1364b2908],
12	'	''	O	'	_	0	SENT_273	[p14l924t2844r1364b2908],
13	i	FW	O	i	dep	2	SENT_273	[p14l924t2844r1364b2908],
14	'	''	O	'	_	0	SENT_273	[p14l924t2844r1364b2908],
15	Churg	NNP	O	Churg	dep	13	SENT_273	[p14l1385t2844r1771b2908],
16	.	.	O	.	_	0	SENT_273	[p14l1385t2844r1771b2908],

1	—	NN	O	—	_	0	SENT_274	[p14l1385t2844r1771b2908],
2	.	.	O	.	_	0	SENT_274	[p14l1385t2844r1771b2908],

1	Strauss	NNP	PERSON	Strauss	_	0	SENT_275	[p14l1385t2844r1771b2908],
2	syndrome	NN	O	syndrome	dep	1	SENT_275	[p14l1793t2844r2065b2908],
3	,	,	O	,	_	0	SENT_275	[p14l1793t2844r2065b2908],

1	Henoch	NNP	PERSON	Henoch	_	0	SENT_276	[p14l258t2917r751b2965],
2	.	.	O	.	_	0	SENT_276	[p14l258t2917r751b2965],

1	—	NN	O	—	_	0	SENT_277	[p14l258t2917r751b2965],
2	.	.	O	.	_	0	SENT_277	[p14l258t2917r751b2965],

1	Schonlein	NNP	O	Schonlein	_	0	SENT_278	[p14l258t2917r751b2965],
2	purpura	NN	O	purpura	nn	3	SENT_278	[p14l777t2921r1000b2980],
3	)	NN	O	)	dep	1	SENT_278	[p14l777t2921r1000b2980],

1	Transplant	NN	O	transplant	nn	2	SENT_279	[p14l155t3011r439b3074],
2	rejection	NN	O	rejection	_	0	SENT_279	[p14l460t3016r681b3075],

1	Cancer	NN	O	cancer	_	0	SENT_280	[p14l62t3110r243b3154],

1	Solid	JJ	O	solid	amod	2	SENT_281	[p14l158t3201r281b3249],
2	tumors	NNS	O	tumor	nsubj	3	SENT_281	[p14l300t3210r486b3249],
3	(	VBP	O	(	_	0	SENT_281	[p14l511t3201r767b3264],
4	including	VBG	O	include	_	0	SENT_281	[p14l511t3201r767b3264],
5	melanoma	NN	O	melanoma	prep_including	3	SENT_281	[p14l787t3201r1072b3258],
6	,	,	O	,	_	0	SENT_281	[p14l787t3201r1072b3258],
7	mesothelioma	NN	O	mesothelioma	prep_including	3	SENT_281	[p14l1095t3201r1475b3258],
8	,	,	O	,	_	0	SENT_281	[p14l1095t3201r1475b3258],
9	and	CC	O	and	_	0	SENT_281	[p14l1497t3201r1588b3249],
10	pancreatic	JJ	O	pancreatic	conj_and	5	SENT_281	[p14l1611t3205r1886b3263],
11	,	,	O	,	_	0	SENT_281	[p14l1611t3205r1886b3263],
12	lung	NN	O	lung	prep_including	3	SENT_281	[p14l1909t3201r2068b3264],
13	,	,	O	,	_	0	SENT_281	[p14l1909t3201r2068b3264],
14	:	:	O	:	_	0	SENT_281	[p14l1909t3201r2068b3264],
15	§	CD	NUMBER	§	conj_and	5	SENT_281	[p14l1909t3201r2068b3264],
16	:	:	O	:	_	0	SENT_281	[p14l1909t3201r2068b3264],

1	esophageal	NN	O	esophageal	nn	3	SENT_282	[p14l253t3273r557b3336],
2	,	,	O	,	_	0	SENT_282	[p14l253t3273r557b3336],
3	prostate	NN	O	prostate	nsubj	8	SENT_282	[p14l580t3282r801b3336],
4	,	,	O	,	_	0	SENT_282	[p14l580t3282r801b3336],
5	and	CC	O	and	_	0	SENT_282	[p14l822t3273r913b3321],
6	colon	NN	O	colon	nn	7	SENT_282	[p14l934t3273r1071b3321],
7	cancers	NNS	O	cancer	nsubj	8	SENT_282	[p14l1092t3277r1303b3336],
8	)	VBP	O	)	_	0	SENT_282	[p14l1092t3277r1303b3336],

1	Leukemias	NNS	O	leukemia	_	0	SENT_283	[p14l161t3368r436b3416],
2	Lymphomas	NNS	O	lymphoma	dep	1	SENT_283	[p14l161t3463r480b3526],

1	Cardiovascular	NNP	O	Cardiovascular	_	0	SENT_284	[p14l62t3557r452b3606],
2	disease	NN	O	disease	dep	1	SENT_284	[p14l469t3557r664b3606],

1	Atherosclerosis	NN	O	atherosclerosis	_	0	SENT_285	[p14l155t3652r597b3715],
2	'	''	O	'	_	0	SENT_285	[p14l155t3652r597b3715],
3	i	FW	O	i	dep	1	SENT_285	[p14l155t3652r597b3715],
4	'	''	O	'	_	0	SENT_285	[p14l155t3652r597b3715],
5	Aortic	JJ	O	aortic	amod	6	SENT_285	[p14l155t3750r312b3795],
6	aneurysm	NN	O	aneurysm	dep	3	SENT_285	[p14l331t3764r583b3810],

1	Sickle	JJ	O	sickle	amod	3	SENT_286	[p15l158t14r305b62],
2	cell	NN	O	cell	nn	3	SENT_286	[p15l325t14r406b62],
3	crisis	NN	O	crisis	_	0	SENT_286	[p15l429t18r562b62],

1	|	NN	O	|	nn	2	SENT_287	[p15l161t108r727b171],
2	schemia	NN	O	schemia	_	0	SENT_287	[p15l161t108r727b171],
3	—	CD	NUMBER	—	num	5	SENT_287	[p15l161t108r727b171],
4	reperfusion	NN	O	reperfusion	nn	5	SENT_287	[p15l161t108r727b171],
5	injury	NN	O	injury	dep	2	SENT_287	[p15l752t113r895b172],
6	Pulmonary	JJ	O	pulmonary	amod	8	SENT_287	[p15l161t203r441b266],
7	arterial	JJ	O	arterial	amod	8	SENT_287	[p15l460t203r637b251],
8	hypertension	NN	O	hypertension	dep	2	SENT_287	[p15l661t203r997b267],

1	Sepsis	NN	MISC	sepsis	_	0	SENT_288	[p15l158t302r323b361],

1	*	NN	O	*	nsubj	24	SENT_289	[p15l9t474r38b501],
2	An	DT	O	a	det	3	SENT_289	[p15l56t472r124b517],
3	association	NN	O	association	nsubjpass	6	SENT_289	[p15l149t474r443b517],
4	has	VBZ	O	have	aux	6	SENT_289	[p15l470t469r555b517],
5	been	VBN	O	be	auxpass	6	SENT_289	[p15l581t469r700b517],
6	established	VBN	O	establish	rcmod	1	SENT_289	[p15l725t469r1020b517],
7	in	IN	O	in	_	0	SENT_289	[p15l1047t474r1088b517],
8	large-scale	JJ	O	large-scale	prep_in	6	SENT_289	[p15l1115t469r1389b533],
9	randomized	VBN	O	randomize	partmod	8	SENT_289	[p15l1414t469r1740b526],
10	,	,	O	,	_	0	SENT_289	[p15l1414t469r1740b526],
11	double-blind	JJ	O	double-blind	amod	15	SENT_289	[p15l1765t469r2109b526],
12	,	,	O	,	_	0	SENT_289	[p15l1765t469r2109b526],
13	placebo-controlled	JJ	O	placebo-controlled	amod	15	SENT_289	[p15l61t542r544b604],
14	clinical	JJ	O	clinical	amod	15	SENT_289	[p15l569t542r746b590],
15	trials	NNS	O	trial	nsubj	24	SENT_289	[p15l769t542r912b598],
16	,	,	O	,	_	0	SENT_289	[p15l769t542r912b598],
17	and	CC	O	and	_	0	SENT_289	[p15l937t542r1029b590],
18	the	DT	O	the	det	22	SENT_289	[p15l1052t542r1134b590],
19	Food	NNP	ORGANIZATION	Food	nn	22	SENT_289	[p15l1160t542r1285b590],
20	and	CC	ORGANIZATION	and	_	0	SENT_289	[p15l1311t542r1402b590],
21	Drug	NNP	ORGANIZATION	Drug	conj_and	19	SENT_289	[p15l1432t546r1558b605],
22	Administration	NNP	ORGANIZATION	Administration	nsubj	24	SENT_289	[p15l1578t542r1971b590],
23	has	VBZ	O	have	aux	24	SENT_289	[p15l1998t542r2083b590],
24	approved	VBN	O	approve	_	0	SENT_289	[p15l59t613r300b675],
25	an	DT	O	a	det	27	SENT_289	[p15l325t629r383b660],
26	antileukotriene	JJ	O	antileukotriene	amod	27	SENT_289	[p15l409t613r800b661],
27	intervention	NN	O	intervention	dobj	24	SENT_289	[p15l824t617r1152b661],
28	.	.	O	.	_	0	SENT_289	[p15l824t617r1152b661],

1	1	CD	NUMBER	1	dep	7	SENT_290	[p15l11t688r41b746],
2	'	''	O	'	_	0	SENT_290	[p15l11t688r41b746],
3	An	DT	O	a	det	4	SENT_290	[p15l56t687r124b731],
4	association	NN	O	association	nsubjpass	7	SENT_290	[p15l149t688r443b732],
5	has	VBZ	O	have	aux	7	SENT_290	[p15l470t684r555b731],
6	been	VBN	O	be	auxpass	7	SENT_290	[p15l581t684r700b732],
7	established	VBN	O	establish	_	0	SENT_290	[p15l725t684r1020b732],
8	in	IN	O	in	_	0	SENT_290	[p15l1047t688r1088b731],
9	small-scale	JJ	O	small-scale	amod	14	SENT_290	[p15l1114t684r1403b732],
10	or	CC	O	or	_	0	SENT_290	[p15l1425t701r1479b731],
11	nonrandomized	JJ	O	nonrandomized	amod	14	SENT_290	[p15l1502t684r1932b740],
12	,	,	O	,	_	0	SENT_290	[p15l1502t684r1932b740],
13	placebo-controlled	JJ	O	placebo-controlled	amod	14	SENT_290	[p15l1959t684r2108b746, p15l60t755r404b803],
14	trials	NNS	O	trial	prep_in	7	SENT_290	[p15l428t755r555b803],
15	indicating	VBG	O	indicate	xcomp	7	SENT_290	[p15l581t755r839b818],
16	that	IN	O	that	complm	19	SENT_290	[p15l858t755r961b803],
17	leukotrienes	NNS	O	leukotriene	nsubj	19	SENT_290	[p15l984t755r1300b803],
18	may	MD	O	may	aux	19	SENT_290	[p15l1326t771r1431b817],
19	play	VB	O	play	ccomp	15	SENT_290	[p15l1455t755r1556b817],
20	a	DT	O	a	det	21	SENT_290	[p15l1577t771r1601b802],
21	role	NN	O	role	dobj	19	SENT_290	[p15l1627t755r1721b803],
22	in	IN	O	in	_	0	SENT_290	[p15l1745t759r1787b802],
23	disease	NN	O	disease	nn	24	SENT_290	[p15l1812t755r2005b803],
24	pathogenesis	NN	O	pathogenesis	prep_in	21	SENT_290	[p15l61t826r422b889],
25	,	,	O	,	_	0	SENT_290	[p15l61t826r422b889],
26	but	CC	O	but	_	0	SENT_290	[p15l448t826r531b874],
27	larger	JJR	O	larger	nsubjpass	32	SENT_290	[p15l554t826r701b889],
28	randomized	VBN	O	randomize	partmod	27	SENT_290	[p15l724t826r1034b874],
29	clinical	JJ	O	clinical	amod	30	SENT_290	[p15l1059t826r1236b874],
30	trials	NNS	O	trial	dobj	28	SENT_290	[p15l1259t826r1387b874],
31	are	VBP	O	be	auxpass	32	SENT_290	[p15l1411t842r1488b874],
32	required	VBN	O	require	conj_but	19	SENT_290	[p15l1513t826r1741b888],
33	.	.	O	.	_	0	SENT_290	[p15l1513t826r1741b888],

1	Ii	NN	O	ii	_	0	SENT_291	[p15l11t901r41b959],
2	:	:	O	:	_	0	SENT_291	[p15l11t901r41b959],
3	Clinical	JJ	O	clinical	amod	4	SENT_291	[p15l58t897r246b945],
4	trials	NNS	O	trial	nsubj	6	SENT_291	[p15l269t897r396b945],
5	are	VBP	O	be	cop	6	SENT_291	[p15l420t913r498b945],
6	ongoing	JJ	O	ongoing	dep	1	SENT_291	[p15l520t901r735b960],
7	or	CC	O	or	_	0	SENT_291	[p15l756t914r810b945],
8	contemplated	JJ	O	contemplated	dep	1	SENT_291	[p15l830t897r1206b959],
9	.	.	O	.	_	0	SENT_291	[p15l830t897r1206b959],

1	§	NN	O	§	nsubj	7	SENT_292	[p15l10t967r30b1030],
2	Adverse	JJ	O	adverse	amod	3	SENT_292	[p15l56t968r265b1016],
3	events	NNS	O	event	nsubj	4	SENT_292	[p15l287t977r453b1016],
4	(	VBP	O	(	parataxis	7	SENT_292	[p15l483t972r604b1031],
5	e.g.	FW	O	e.g.	dobj	4	SENT_292	[p15l483t972r604b1031],
6	,	,	O	,	_	0	SENT_292	[p15l483t972r604b1031],
7	increased	VBD	O	increase	_	0	SENT_292	[p15l631t968r876b1016],
8	infectious	JJ	O	infectious	amod	9	SENT_292	[p15l903t967r1155b1016],
9	exacerbations	NNS	O	exacerbation	nsubj	10	SENT_292	[p15l1179t968r1557b1030],
10	)	VBP	O	)	ccomp	7	SENT_292	[p15l1179t968r1557b1030],
11	that	IN	O	that	complm	19	SENT_292	[p15l1582t968r1685b1016],
12	were	VBD	O	be	auxpass	13	SENT_292	[p15l1704t984r1826b1016],
13	associated	VBN	O	associate	csubjpass	19	SENT_292	[p15l1849t968r2122b1016],
14	with	IN	O	with	_	0	SENT_292	[p15l56t1039r163b1087],
15	antileukotriene	JJ	O	antileukotriene	amod	16	SENT_292	[p15l189t1039r580b1087],
16	therapy	NN	O	therapy	prep_with	13	SENT_292	[p15l601t1039r797b1101],
17	have	VBP	O	have	aux	19	SENT_292	[p15l819t1039r937b1087],
18	been	VBN	O	be	auxpass	19	SENT_292	[p15l961t1039r1080b1087],
19	reported	VBN	O	report	ccomp	10	SENT_292	[p15l1108t1039r1341b1101],
20	.	.	O	.	_	0	SENT_292	[p15l1108t1039r1341b1101],

1	ﬂ	NN	O	ﬂ	nsubj	13	SENT_293	[p15l11t1109r41b1171],
2	]	CD	NUMBER	]	num	3	SENT_293	[p15l11t1109r41b1171],
3	Results	NNS	O	result	amod	1	SENT_293	[p15l62t1110r247b1158],
4	ofa	NN	O	ofa	nn	6	SENT_293	[p15l270t1109r365b1158],
5	clinical	JJ	O	clinical	amod	6	SENT_293	[p15l388t1110r566b1158],
6	trial	NN	O	trial	dep	3	SENT_293	[p15l589t1110r686b1158],
7	involving	VBG	O	involve	dep	6	SENT_293	[p15l713t1110r948b1173],
8	patients	NNS	O	patient	dobj	7	SENT_293	[p15l972t1114r1178b1172],
9	with	IN	O	with	_	0	SENT_293	[p15l1199t1110r1307b1158],
10	ulcerative	JJ	O	ulcerative	amod	11	SENT_293	[p15l1335t1110r1582b1158],
11	colitis	NN	O	colitis	prep_with	7	SENT_293	[p15l1605t1110r1756b1158],
12	were	VBD	O	be	cop	13	SENT_293	[p15l1778t1126r1900b1158],
13	negative	JJ	O	negative	_	0	SENT_293	[p15l61t1185r290b1245],
14	.	.	O	.	_	0	SENT_293	[p15l61t1185r290b1245],

1	N	NN	O	n	nn	3	SENT_294	[p15l496t1375r510b1391],
2	ENGLJ	NN	O	englj	nn	3	SENT_294	[p15l525t1375r605b1398],
3	MED	NN	O	med	_	0	SENT_294	[p15l620t1375r673b1391],
4	357	CD	NUMBER	357	num	6	SENT_294	[p15l683t1369r759b1398],
5	;	:	O	;	_	0	SENT_294	[p15l683t1369r759b1398],
6	18	CD	NUMBER	18	dep	3	SENT_294	[p15l683t1369r759b1398],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_294	[p15l792t1375r999b1398],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	6	SENT_294	[p15l1037t1375r1176b1391],
9	1	CD	DATE	1	num	8	SENT_294	[p15l1187t1375r1203b1396],
10	,	,	O	,	_	0	SENT_294	[p15l1187t1375r1203b1396],
11	2oo7	CD	NUMBER	2oo7	num	8	SENT_294	[p15l1215t1375r1279b1397],
12	1847	CD	DATE	1847	dep	3	SENT_294	[p15l1940t1365r2016b1387],

1	The	DT	O	the	det	4	SENT_295	[p15l702t1409r753b1433],
2	New	NNP	O	New	nn	4	SENT_295	[p15l762t1410r824b1433],
3	England	NNP	O	England	nn	4	SENT_295	[p15l833t1409r944b1440],
4	Journal	NNP	O	Journal	_	0	SENT_295	[p15l952t1409r1050b1433],
5	of	IN	O	of	_	0	SENT_295	[p15l1059t1409r1088b1433],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_295	[p15l1095t1409r1220b1433],

1	Downloaded	VBN	O	download	_	0	SENT_296	[p15l144t1450r314b1473],
2	from	IN	O	from	_	0	SENT_296	[p15l323t1450r387b1473],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_296	[p15l396t1450r514b1480],
4	at	IN	O	at	_	0	SENT_296	[p15l524t1454r547b1473],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_296	[p15l556t1450r738b1473],
6	on	IN	O	on	_	0	SENT_296	[p15l748t1457r780b1473],
7	January	NNP	DATE	January	prep_on	1	SENT_296	[p15l789t1450r892b1480],
8	5	CD	DATE	5	num	7	SENT_296	[p15l902t1450r924b1478],
9	,	,	DATE	,	_	0	SENT_296	[p15l902t1450r924b1478],
10	2014	CD	DATE	2014	num	7	SENT_296	[p15l935t1450r1007b1473],
11	.	.	O	.	_	0	SENT_296	[p15l935t1450r1007b1473],

1	For	IN	O	for	_	0	SENT_297	[p15l1018t1450r1064b1473],
2	personal	JJ	O	personal	amod	3	SENT_297	[p15l1072t1450r1185b1480],
3	use	NN	O	use	pobj	1	SENT_297	[p15l1194t1457r1237b1473],
4	only	RB	O	only	advmod	3	SENT_297	[p15l1247t1450r1312b1480],
5	.	.	O	.	_	0	SENT_297	[p15l1247t1450r1312b1480],

1	No	DT	O	no	det	3	SENT_298	[p15l1322t1450r1362b1473],
2	other	JJ	O	other	amod	3	SENT_298	[p15l1372t1450r1440b1473],
3	uses	NNS	O	use	_	0	SENT_298	[p15l1448t1457r1504b1473],
4	without	IN	O	without	_	0	SENT_298	[p15l1515t1450r1616b1473],
5	permission	NN	O	permission	prep_without	3	SENT_298	[p15l1624t1450r1776b1480],
6	.	.	O	.	_	0	SENT_298	[p15l1624t1450r1776b1480],

1	Copyright	NN	O	copyright	_	0	SENT_299	[p15l494t1491r629b1522],
2	©	CD	NUMBER	©	num	6	SENT_299	[p15l638t1491r661b1515],
3	2007	CD	DATE	2007	num	6	SENT_299	[p15l671t1491r736b1515],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_299	[p15l746t1491r937b1515],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_299	[p15l947t1491r1055b1515],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_299	[p15l1065t1491r1170b1522],
7	.	.	O	.	_	0	SENT_299	[p15l1065t1491r1170b1522],

1	All	DT	O	all	det	2	SENT_300	[p15l1181t1491r1223b1515],
2	rights	NNS	O	rights	nsubj	3	SENT_300	[p15l1232t1491r1306b1522],
3	reserved	VBN	O	reserve	_	0	SENT_300	[p15l1316t1491r1435b1515],
4	.	.	O	.	_	0	SENT_300	[p15l1316t1491r1435b1515],

1	The	DT	O	the	det	4	SENT_301	[p15l672t1597r717b1618],
2	NEW	NNP	O	NEW	nn	4	SENT_301	[p15l736t1599r821b1618],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_301	[p15l840t1599r1029b1618],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_301	[p15l1048t1599r1228b1625],
5	of	IN	O	of	_	0	SENT_301	[p15l1247t1597r1276b1624],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_301	[p15l1288t1599r1487b1618],

1	Leukotriene	NN	O	leukotriene	_	0	SENT_302	[p16l948t248r1358b314],
2	receptor	NN	O	receptor	nn	3	SENT_302	[p16l1390t261r1681b333],
3	Leukotriene	NN	O	leukotriene	dep	1	SENT_302	[p16l948t426r1358b492],

1	Cytokine	NN	O	cytokine	_	0	SENT_303	[p16l837t1580r1141b1666],
2	Cytokine	NN	O	cytokine	nn	3	SENT_303	[p16l518t1755r821b1840],
3	receptor	NN	O	receptor	dep	1	SENT_303	[p16l852t1766r1143b1840],

1	Smooth-musclewcell	JJ	O	smooth-musclewcell	_	0	SENT_304	[p16l550t2385r1250b2467],
2	v	LS	O	v	dep	1	SENT_304	[p16l778t2531r835b2557],

1	Th2	NN	O	th2	nn	2	SENT_305	[p16l290t2982r422b3046],
2	cell	NN	O	cell	_	0	SENT_305	[p16l451t2982r562b3047],
3	kin-13	NN	O	kin-13	nn	4	SENT_305	[p17l495t43r674b130],
4	Jvo	NN	O	jvo	dep	2	SENT_305	[p17l762t6r965b71],
5	+	CC	O	+	_	0	SENT_305	[p17l762t6r965b71],
6	ll	NN	O	ll	dep	2	SENT_305	[p17l1244t6r1281b60],
7	to	TO	O	to	_	0	SENT_305	[p17l1311t76r1347b116],
8	+	CC	O	+	cc	9	SENT_305	[p17l1311t76r1347b116],
9	T	NN	O	t	prep_to	6	SENT_305	[p17l1393t76r1395b79],
10	-	:	O	-	_	0	SENT_305	[p17l1427t46r1457b69],
11	‘	NN	O	‘	dep	9	SENT_305	[p17l1427t46r1457b69],

1	Interleu	FW	O	interleu	_	0	SENT_306	[p17l254t43r484b100],

1	Interleukin-13	NN	O	interleukin-13	_	0	SENT_307	[p17l931t291r1351b349],
2	~	SYM	O	~	dep	1	SENT_307	[p17l1395t321r1399b325],

1	receptor	NN	O	receptor	_	0	SENT_308	[p17l1017t377r1272b441],

1	Eoipﬂil	NN	O	eoipﬂil	_	0	SENT_309	[p17l1522t580r1889b715],

1	Figure	NNP	O	Figure	_	0	SENT_310	[p17l84t806r304b890],
2	3	CD	NUMBER	3	dep	1	SENT_310	[p17l332t810r389b870],
3	.	.	O	.	_	0	SENT_310	[p17l332t810r389b870],

1	Cross-Talk	NN	O	cross-talk	_	0	SENT_311	[p17l419t805r788b870],
2	between	IN	O	between	_	0	SENT_311	[p17l818t805r1116b870],
3	Leukotrienes	NNPS	O	Leukotrienes	prep_between	1	SENT_311	[p17l1153t805r1611b870],
4	and	CC	O	and	_	0	SENT_311	[p17l79t913r206b978],
5	Cytokines	NNS	O	cytokine	prep_between	1	SENT_311	[p17l237t913r609b999],
6	.	.	O	.	_	0	SENT_311	[p17l237t913r609b999],

1	As	IN	O	as	mark	2	SENT_312	[p17l77t1047r164b1108],
2	shown	VBN	O	show	advcl	11	SENT_312	[p17l198t1043r426b1108],
3	in	IN	O	in	_	0	SENT_312	[p17l462t1049r518b1107],
4	Panel	NN	O	panel	nn	5	SENT_312	[p17l558t1043r744b1108],
5	A	NN	O	a	prep_in	2	SENT_312	[p17l775t1047r846b1120],
6	,	,	O	,	_	0	SENT_312	[p17l775t1047r846b1120],
7	Ieukotrienes	NNPS	O	Ieukotrienes	nsubj	11	SENT_312	[p17l883t1043r1320b1108],
8	and	CC	O	and	_	0	SENT_312	[p17l1352t1043r1479b1108],
9	cytokines	NNS	O	cytokine	nsubj	11	SENT_312	[p17l1512t1043r1849b1129],
10	can	MD	O	can	aux	11	SENT_312	[p17l1881t1066r2000b1108],
11	regulate	VB	O	regulate	_	0	SENT_312	[p17l83t1152r369b1237],
12	each	DT	O	each	det	13	SENT_312	[p17l399t1152r558b1216],
13	other	JJ	O	other	dobj	11	SENT_312	[p17l592t1152r795b1216],
14	.	.	O	.	_	0	SENT_312	[p17l592t1152r795b1216],

1	This	DT	O	this	det	2	SENT_313	[p17l826t1152r976b1216],
2	process	NN	O	process	nsubjpass	4	SENT_313	[p17l1011t1174r1282b1236],
3	is	VBZ	O	be	auxpass	4	SENT_313	[p17l1317t1157r1366b1216],
4	shown	VBN	O	show	_	0	SENT_313	[p17l1400t1152r1628b1217],
5	in	IN	O	in	_	0	SENT_313	[p17l1664t1157r1720b1216],
6	Panel	NNP	O	Panel	nn	7	SENT_313	[p17l1760t1152r1946b1216],
7	B.	NNP	O	B.	prep_in	4	SENT_313	[p17l1985t1157r2045b1216],
8	Interleukin-13	NN	O	interleukin-13	nsubj	31	SENT_313	[p17l85t1260r596b1337],
9	,	,	O	,	_	0	SENT_313	[p17l85t1260r596b1337],
10	a	DT	O	a	det	11	SENT_313	[p17l630t1283r662b1325],
11	product	NN	O	product	appos	8	SENT_313	[p17l698t1260r978b1345],
12	derived	VBN	O	derive	partmod	11	SENT_313	[p17l1007t1260r1268b1325],
13	from	IN	O	from	_	0	SENT_313	[p17l1300t1259r1468b1325],
14	type	NN	O	type	nn	17	SENT_313	[p17l1499t1272r1651b1345],
15	2	CD	NUMBER	2	num	17	SENT_313	[p17l1681t1265r1717b1324],
16	helper	NN	O	helper	nn	17	SENT_313	[p17l1751t1260r1976b1345],
17	T	NN	O	t	prep_from	12	SENT_313	[p17l2000t1266r2046b1324],
18	(	CD	NUMBER	(	num	21	SENT_313	[p17l87t1368r271b1453],
19	Th2	NN	O	th2	nn	21	SENT_313	[p17l87t1368r271b1453],
20	)	NN	O	)	nn	21	SENT_313	[p17l87t1368r271b1453],
21	lymphocytes	NNS	O	lymphocyte	dep	11	SENT_313	[p17l311t1368r764b1454],
22	that	WDT	O	that	nsubj	23	SENT_313	[p17l793t1368r934b1433],
23	participates	VBZ	O	participate	rcmod	21	SENT_313	[p17l967t1374r1386b1452],
24	in	IN	O	in	_	0	SENT_313	[p17l1421t1374r1476b1432],
25	the	DT	O	the	det	26	SENT_313	[p17l1508t1368r1620b1433],
26	development	NN	O	development	prep_in	23	SENT_313	[p17l1650t1368r1958b1452, p17l83t1488r266b1541],
27	of	IN	O	of	_	0	SENT_313	[p17l295t1475r372b1541],
28	asthma	NN	O	asthma	prep_of	26	SENT_313	[p17l390t1477r675b1553],
29	,	,	O	,	_	0	SENT_313	[p17l390t1477r675b1553],
30	can	MD	O	can	aux	31	SENT_313	[p17l709t1499r827b1541],
31	up-regulate	VB	O	up-regulate	rcmod	7	SENT_313	[p17l865t1477r1273b1562],
32	both	CC	O	both	preconj	40	SENT_313	[p17l1307t1476r1462b1541],
33	the	DT	O	the	det	40	SENT_313	[p17l1494t1477r1606b1541],
34	leukocyte	NN	O	leukocyte	nn	40	SENT_313	[p17l1639t1476r1976b1562],
35	biosynthesis	NN	O	biosynthesis	nn	40	SENT_313	[p17l83t1585r527b1670],
36	ofleukotriene	NN	O	ofleukotriene	nn	40	SENT_313	[p17l558t1584r1056b1650],
37	D4	NN	O	d4	nn	40	SENT_313	[p17l1092t1591r1176b1667],
38	(	CD	NUMBER	(	num	40	SENT_313	[p17l1212t1590r1434b1670],
39	LTD4	NN	O	ltd4	nn	40	SENT_313	[p17l1212t1590r1434b1670],
40	)	NN	O	)	dobj	31	SENT_313	[p17l1212t1590r1434b1670],
41	and	CC	O	and	_	0	SENT_313	[p17l1473t1585r1598b1650],
42	the	DT	O	the	det	43	SENT_313	[p17l1630t1585r1742b1650],
43	expression	NN	O	expression	conj_and	40	SENT_313	[p17l1772t1608r2027b1669, p17l81t1699r224b1758],
44	of	IN	O	of	_	0	SENT_313	[p17l258t1692r336b1758],
45	cellular	JJ	O	cellular	amod	46	SENT_313	[p17l353t1693r613b1758],
46	type	NN	O	type	prep_of	7	SENT_313	[p17l637t1705r790b1779],
47	1	CD	NUMBER	1	num	50	SENT_313	[p17l824t1699r853b1757],
48	cysteinyl	NN	O	cysteinyl	nn	50	SENT_313	[p17l887t1693r1190b1779],
49	leukotriene	NN	O	leukotriene	nn	50	SENT_313	[p17l1227t1692r1626b1758],
50	receptors	NNS	O	receptor	nsubj	51	SENT_313	[p17l1660t1705r1992b1777],
51	(	VBP	O	(	rcmod	7	SENT_313	[p17l87t1806r388b1887],
52	CysLT1	NN	O	cyslt1	nn	53	SENT_313	[p17l87t1806r388b1887],
53	)	NN	O	)	dobj	51	SENT_313	[p17l87t1806r388b1887],
54	.	.	O	.	_	0	SENT_313	[p17l87t1806r388b1887],

1	Moreover	RB	O	moreover	advmod	5	SENT_314	[p17l427t1807r783b1878],
2	,	,	O	,	_	0	SENT_314	[p17l427t1807r783b1878],
3	LTD4	NN	O	ltd4	nsubj	5	SENT_314	[p17l823t1807r993b1884],
4	can	MD	O	can	aux	5	SENT_314	[p17l1022t1824r1141b1866],
5	up-regulate	VB	O	up-regulate	_	0	SENT_314	[p17l1178t1801r1587b1887],
6	production	NN	O	production	nn	7	SENT_314	[p17l1620t1802r2013b1886],
7	ofinterleukin-13	NN	O	ofinterleukin-13	dobj	5	SENT_314	[p17l80t1908r686b1987],
8	,	,	O	,	_	0	SENT_314	[p17l80t1908r686b1987],
9	as	RB	O	as	_	0	SENT_314	[p17l720t1933r792b1975],
10	well	RB	O	well	_	0	SENT_314	[p17l821t1910r957b1975],
11	as	IN	O	as	_	0	SENT_314	[p17l992t1933r1063b1975],
12	the	DT	O	the	det	13	SENT_314	[p17l1092t1910r1205b1975],
13	expression	NN	O	expression	dobj	5	SENT_314	[p17l1235t1916r1616b1994],
14	of	IN	O	of	_	0	SENT_314	[p17l1650t1908r1728b1975],
15	its	PRP$	O	its	poss	16	SENT_314	[p17l1747t1916r1826b1975],
16	receptor	NN	O	receptor	prep_of	13	SENT_314	[p17l1862t1933r2079b1994, p17l77t2030r193b2083],
17	.	.	O	.	_	0	SENT_314	[p17l1862t1933r2079b1994, p17l77t2030r193b2083],

1	The	DT	O	the	det	4	SENT_315	[p17l223t2018r356b2083],
2	result	NN	O	result	nn	4	SENT_315	[p17l390t2017r587b2083],
3	ofthis	NN	O	ofthi	nn	4	SENT_315	[p17l616t2017r837b2083],
4	cross-talk	NN	O	cross-talk	nsubj	9	SENT_315	[p17l869t2018r1214b2083],
5	is	VBZ	O	be	cop	9	SENT_315	[p17l1245t2024r1294b2083],
6	a	DT	O	a	det	9	SENT_315	[p17l1327t2041r1359b2083],
7	self-perpetuating	JJ	O	self-perpetuating	amod	9	SENT_315	[p17l1392t2017r2010b2104],
8	circuit	NN	O	circuit	nn	9	SENT_315	[p17l80t2132r301b2192],
9	ofinflammation	NN	O	ofinflammation	_	0	SENT_315	[p17l329t2125r910b2191],
10	and	CC	O	and	_	0	SENT_315	[p17l945t2126r1071b2191],
11	smooth-muscle	JJ	O	smooth-muscle	amod	12	SENT_315	[p17l1106t2126r1670b2191],
12	contraction	NN	O	contraction	conj_and	9	SENT_315	[p17l1700t2138r1987b2191, p17l77t2241r214b2300],

1	in	IN	O	in	dep	7	SENT_316	[p17l250t2241r306b2299],
2	which	WDT	O	which	pobj	1	SENT_316	[p17l337t2235r544b2300],
3	interleukin-13	NN	O	interleukin-13	nsubj	7	SENT_316	[p17l581t2235r1067b2300],
4	and	CC	O	and	_	0	SENT_316	[p17l1103t2234r1228b2300],
5	its	PRP$	O	its	poss	6	SENT_316	[p17l1265t2241r1343b2300],
6	receptor	NN	O	receptor	conj_and	3	SENT_316	[p17l1379t2247r1676b2319],
7	mediate	VB	O	mediate	_	0	SENT_316	[p17l1707t2234r1993b2300],
8	some	DT	O	some	det	10	SENT_316	[p17l81t2366r275b2408],
9	ofthe	NN	O	ofthe	nn	10	SENT_316	[p17l304t2342r509b2408],
10	actions	NNS	O	action	dobj	7	SENT_316	[p17l540t2349r798b2408],
11	of	IN	O	of	_	0	SENT_316	[p17l830t2342r908b2408],
12	LTD4	NN	O	ltd4	prep_of	10	SENT_316	[p17l930t2349r1100b2426],
13	and	CC	O	and	_	0	SENT_316	[p17l1130t2342r1256b2408],
14	LTD4	NN	O	ltd4	conj_and	12	SENT_316	[p17l1295t2348r1753b2429],
15	.	.	O	.	_	0	SENT_316	[p17l1295t2348r1753b2429],

1	—	NN	O	—	_	0	SENT_317	[p17l1295t2348r1753b2429],
2	.	.	O	.	_	0	SENT_317	[p17l1295t2348r1753b2429],

1	CysLT1	NN	O	cyslt1	nsubj	2	SENT_318	[p17l1295t2348r1753b2429],
2	mediates	VBZ	O	mediate	_	0	SENT_318	[p17l1789t2342r1989b2408, p17l81t2463r221b2516],
3	some	DT	O	some	det	6	SENT_318	[p17l255t2474r448b2516],
4	ofthe	JJ	O	ofthe	amod	6	SENT_318	[p17l478t2450r683b2516],
5	actions	NNS	O	action	nn	6	SENT_318	[p17l714t2457r971b2516],
6	ofinterleukin-13	NN	O	ofinterleukin-13	dobj	2	SENT_318	[p17l1003t2450r1610b2516],
7	.	.	O	.	_	0	SENT_318	[p17l1003t2450r1610b2516],

1	symptoms	NNS	O	symptom	nsubjpass	3	SENT_319	[p17l13t2850r459b2933],
2	were	VBD	O	be	auxpass	3	SENT_319	[p17l492t2859r695b2912],
3	reduced	VBN	O	reduce	_	0	SENT_319	[p17l731t2833r1071b2912],
4	as	IN	O	as	prep	3	SENT_319	[p17l1105t2859r1191b2911],
5	compared	VBN	O	compare	_	0	SENT_319	[p17l1230t2833r1659b2933],
6	with	IN	O	with	prepc_compared_with	3	SENT_319	[p17l1691t2833r1887b2912],
7	baseline	NN	O	baseline	pobj	3	SENT_319	[p17l1923t2833r2147b2912, p17l11t2961r171b3039],
8	in	IN	O	in	_	0	SENT_319	[p17l212t2962r295b3039],
9	60	CD	NUMBER	60	number	11	SENT_319	[p17l337t2967r437b3040],
10	to	TO	O	to	dep	11	SENT_319	[p17l479t2978r561b3040],
11	80	CD	PERCENT	80	num	12	SENT_319	[p17l604t2966r793b3041],
12	%	NN	PERCENT	%	prep_in	7	SENT_319	[p17l604t2966r793b3041],
13	of	IN	O	of	_	0	SENT_319	[p17l834t2960r934b3040],
14	patients	NNS	O	patient	prep_of	12	SENT_319	[p17l956t2962r1324b3061],
15	,	,	O	,	_	0	SENT_319	[p17l956t2962r1324b3061],
16	whereas	IN	O	whereas	mark	22	SENT_319	[p17l1366t2961r1720b3041],
17	improvements	NNS	O	improvement	nsubjpass	22	SENT_319	[p17l1762t2962r2147b3061, p17l12t3107r274b3169],
18	in	IN	O	in	_	0	SENT_319	[p17l313t3091r397b3168],
19	lung	NN	O	lung	nn	20	SENT_319	[p17l434t3090r629b3192],
20	function	NN	O	function	prep_in	17	SENT_319	[p17l664t3089r1033b3170],
21	were	VBD	O	be	auxpass	22	SENT_319	[p17l1066t3116r1269b3170],
22	noted	VBN	O	note	advcl	3	SENT_319	[p17l1308t3090r1551b3170],
23	in	IN	O	in	_	0	SENT_319	[p17l1588t3091r1672b3168],
24	only	RB	O	only	quantmod	27	SENT_319	[p17l1710t3090r1896b3191],
25	35	CD	NUMBER	35	number	27	SENT_319	[p17l1930t3097r2023b3170],
26	to	TO	O	to	dep	27	SENT_319	[p17l2065t3107r2147b3170],
27	50	CD	PERCENT	50	num	28	SENT_319	[p17l15t3223r201b3297],
28	%	NN	PERCENT	%	prep_in	22	SENT_319	[p17l15t3223r201b3297],
29	of	IN	O	of	_	0	SENT_319	[p17l238t3217r339b3297],
30	such	JJ	O	such	amod	31	SENT_319	[p17l360t3218r555b3298],
31	patients	NNS	O	patient	prep_of	28	SENT_319	[p17l591t3219r1035b3318],
32	.73	CD	NUMBER	.73	tmod	22	SENT_319	[p17l591t3219r1035b3318],
33	This	DT	O	this	det	34	SENT_319	[p17l1071t3218r1261b3296],
34	discordance	NN	O	discordance	nsubj	40	SENT_319	[p17l1302t3218r1822b3297],
35	in	IN	O	in	_	0	SENT_319	[p17l1860t3219r1944b3296],
36	outcome	NN	O	outcome	nn	37	SENT_319	[p17l1983t3235r2147b3298, p17l12t3373r238b3427],
37	measures	NNS	O	measure	prep_in	34	SENT_319	[p17l272t3373r671b3427],
38	may	MD	O	may	aux	40	SENT_319	[p17l708t3373r885b3448],
39	be	VB	O	be	cop	40	SENT_319	[p17l916t3347r1012b3427],
40	due	JJ	O	due	rcmod	32	SENT_319	[p17l1047t3347r1195b3427],
41	to	TO	O	to	_	0	SENT_319	[p17l1229t3364r1310b3427],
42	differences	NNS	O	difference	prep_to	40	SENT_319	[p17l1347t3346r1813b3427],
43	among	IN	O	among	_	0	SENT_319	[p17l1849t3373r2152b3449],
44	patients	NNS	O	patient	prep_among	42	SENT_319	[p17l11t3477r339b3576],
45	in	IN	O	in	_	0	SENT_319	[p17l377t3477r459b3554],
46	leukotriene	NN	O	leukotriene	nn	47	SENT_319	[p17l494t3476r961b3555],
47	biology	NN	O	biology	prep_in	44	SENT_319	[p17l999t3476r1318b3577],
48	,	,	O	,	_	0	SENT_319	[p17l999t3476r1318b3577],
49	genotype	NN	O	genotype	prep_in	44	SENT_319	[p17l1360t3493r1762b3577],
50	,	,	O	,	_	0	SENT_319	[p17l1360t3493r1762b3577],
51	or	CC	O	or	_	0	SENT_319	[p17l1805t3502r1892b3555],
52	clinical	JJ	O	clinical	amod	53	SENT_319	[p17l1926t3476r2147b3554, p17l12t3605r134b3683],
53	characteristics	NNS	O	characteristic	prep_in	44	SENT_319	[p17l174t3605r824b3684],
54	.	.	O	.	_	0	SENT_319	[p17l174t3605r824b3684],

1	After	IN	O	after	dep	121	SENT_320	[p18l138t30r362b109],
2	spontaneous	JJ	O	spontaneous	dep	121	SENT_320	[p18l398t48r945b131],
3	episodes	NNS	O	episode	dep	121	SENT_320	[p18l984t31r1353b131],
4	of	IN	O	of	dep	121	SENT_320	[p18l1393t30r1493b110],
5	bronchospasm	NN	O	bronchospasm	dep	121	SENT_320	[p18l1511t31r2148b131],
6	in	IN	O	in	dep	121	SENT_320	[p18l11t161r97b238],
7	patients	NNS	O	patient	dep	121	SENT_320	[p18l133t161r485b261],
8	with	IN	O	with	dep	121	SENT_320	[p18l521t160r721b240],
9	asthma	NN	O	asthma	dep	121	SENT_320	[p18l758t160r1086b239],
10	or	CC	O	or	dep	121	SENT_320	[p18l1123t186r1213b240],
11	after	IN	O	after	dep	121	SENT_320	[p18l1248t159r1456b239],
12	challenge	NN	O	challenge	dep	121	SENT_320	[p18l1493t160r1914b262],
13	with	IN	O	with	dep	121	SENT_320	[p18l1948t160r2148b240],
14	allergen	NN	O	allergen	dep	121	SENT_320	[p18l11t289r392b390],
15	,	,	O	,	_	0	SENT_320	[p18l11t289r392b390],
16	exercise	NN	O	exercise	dep	121	SENT_320	[p18l443t290r813b385],
17	,	,	O	,	_	0	SENT_320	[p18l443t290r813b385],
18	or	CC	O	or	dep	121	SENT_320	[p18l865t315r955b368],
19	aspirin	NN	O	aspirin	dep	121	SENT_320	[p18l996t290r1304b389],
20	in	IN	O	in	dep	121	SENT_320	[p18l1348t290r1433b367],
21	susceptible	JJ	O	susceptible	dep	121	SENT_320	[p18l1480t289r1969b389],
22	patients	NNS	O	patient	dep	121	SENT_320	[p18l2013t315r2147b389, p18l12t417r276b512],
23	,	,	O	,	_	0	SENT_320	[p18l2013t315r2147b389, p18l12t417r276b512],
24	levels	NNS	O	level	dep	121	SENT_320	[p18l315t416r547b496],
25	of	IN	O	of	dep	121	SENT_320	[p18l585t415r685b495],
26	cysteinyl	NN	O	cysteinyl	dep	121	SENT_320	[p18l703t416r1073b516],
27	leukotrienes	NNS	O	leukotriene	dep	121	SENT_320	[p18l1106t416r1639b495],
28	increase	VBP	O	increase	dep	121	SENT_320	[p18l1675t417r2030b494],
29	in	IN	O	in	dep	121	SENT_320	[p18l2065t417r2148b494],
30	airway	NN	O	airway	dep	121	SENT_320	[p18l12t546r294b646],
31	fluids	NNS	O	fluid	dep	121	SENT_320	[p18l325t544r568b625],
32	and	CC	O	and	dep	121	SENT_320	[p18l604t545r761b625],
33	urine	NN	O	urine	dep	121	SENT_320	[p18l796t546r1199b625],
34	.7475	CD	NUMBER	.7475	dep	121	SENT_320	[p18l796t546r1199b625],
35	Urinary	JJ	O	urinary	dep	121	SENT_320	[p18l1237t546r1566b646],
36	LTE4	NN	O	lte4	dep	121	SENT_320	[p18l1596t552r1819b652],
37	,	,	O	,	_	0	SENT_320	[p18l1596t552r1819b652],
38	a	DT	O	a	dep	121	SENT_320	[p18l1859t572r1904b624],
39	measure	NN	O	measure	dep	121	SENT_320	[p18l1937t571r2147b624, p18l13t699r185b753],
40	of	IN	O	of	dep	121	SENT_320	[p18l224t672r323b752],
41	Whole	JJ	O	whole	dep	121	SENT_320	[p18l338t673r826b773],
42	—	NN	O	—	dep	121	SENT_320	[p18l338t673r826b773],
43	body	NN	O	body	dep	121	SENT_320	[p18l338t673r826b773],
44	synthesis	NN	O	synthesis	dep	121	SENT_320	[p18l861t673r1239b773],
45	of	IN	O	of	dep	121	SENT_320	[p18l1280t672r1379b752],
46	cysteinyl	NN	O	cysteinyl	dep	121	SENT_320	[p18l1399t673r1752b773],
47	leukotrienes	NNS	O	leukotriene	dep	121	SENT_320	[p18l1789t673r2147b753, p18l13t806r293b899],
48	,76	CD	NUMBER	,76	dep	121	SENT_320	[p18l1789t673r2147b753, p18l13t806r293b899],
49	is	VBZ	O	be	dep	121	SENT_320	[p18l329t803r394b881],
50	a	DT	O	a	dep	121	SENT_320	[p18l432t829r477b881],
51	possible	JJ	O	possible	dep	121	SENT_320	[p18l509t802r855b903],
52	predictor	NN	O	predictor	dep	121	SENT_320	[p18l890t802r1279b903],
53	of	IN	O	of	dep	121	SENT_320	[p18l1313t801r1412b882],
54	drug	NN	O	drug	dep	121	SENT_320	[p18l1430t802r1633b904],
55	responsiveness	NN	O	responsiveness	dep	121	SENT_320	[p18l1665t803r2147b903, p18l12t957r222b1028],
56	,	,	O	,	_	0	SENT_320	[p18l1665t803r2147b903, p18l12t957r222b1028],
57	and	CC	O	and	dep	121	SENT_320	[p18l268t931r428b1011],
58	significant	JJ	O	significant	dep	121	SENT_320	[p18l470t930r942b1033],
59	associations	NNS	O	association	dep	121	SENT_320	[p18l977t932r1506b1011],
60	between	IN	O	between	dep	121	SENT_320	[p18l1550t931r1910b1011],
61	high	JJ	O	high	dep	121	SENT_320	[p18l1952t931r2148b1033],
62	urinary	JJ	O	urinary	dep	121	SENT_320	[p18l12t1061r328b1160],
63	LT	NN	O	lt	dep	121	SENT_320	[p18l356t1066r464b1137],
64	E	NN	O	e	dep	121	SENT_320	[p18l464t1068r516b1137],
65	4	CD	NUMBER	4	dep	121	SENT_320	[p18l521t1125r556b1166],
66	levels	NNS	O	level	dep	121	SENT_320	[p18l587t1060r815b1139],
67	and	CC	O	and	dep	121	SENT_320	[p18l849t1060r1006b1139],
68	responsiveness	NN	O	responsiveness	dep	121	SENT_320	[p18l1039t1061r1669b1160],
69	to	TO	O	to	dep	121	SENT_320	[p18l1705t1077r1786b1139],
70	antileukotriene	JJ	O	antileukotriene	dep	121	SENT_320	[p18l1820t1060r2147b1139, p18l12t1188r360b1267],
71	agents	NNS	O	agent	dep	121	SENT_320	[p18l395t1205r667b1289],
72	have	VBP	O	have	dep	121	SENT_320	[p18l703t1188r891b1267],
73	been	VBN	O	be	dep	121	SENT_320	[p18l926t1188r1125b1267],
74	reported	VBN	O	report	dep	121	SENT_320	[p18l1160t1188r1620b1288],
75	.77	CD	NUMBER	.77	dep	121	SENT_320	[p18l1160t1188r1620b1288],
76	Other	JJ	O	other	dep	121	SENT_320	[p18l1654t1188r1900b1267],
77	studies	NNS	O	study	dep	121	SENT_320	[p18l1932t1188r2147b1267, p18l11t1317r145b1412],
78	,	,	O	,	_	0	SENT_320	[p18l1932t1188r2147b1267, p18l11t1317r145b1412],
79	however	RB	O	however	dep	121	SENT_320	[p18l187t1316r556b1412],
80	,	,	O	,	_	0	SENT_320	[p18l187t1316r556b1412],
81	have	VBP	O	have	dep	121	SENT_320	[p18l598t1316r785b1395],
82	shown	VBN	O	show	dep	121	SENT_320	[p18l823t1316r1103b1395],
83	either	CC	O	either	dep	121	SENT_320	[p18l1139t1316r1382b1394],
84	no	DT	O	no	dep	121	SENT_320	[p18l1415t1342r1520b1395],
85	such	JJ	O	such	dep	121	SENT_320	[p18l1559t1316r1751b1395],
86	relationship63	NN	O	relationship63	dep	121	SENT_320	[p18l1787t1316r2147b1395, p18l13t1445r267b1545],
87	or	CC	O	or	dep	121	SENT_320	[p18l309t1471r398b1524],
88	an	DT	O	a	dep	121	SENT_320	[p18l434t1471r538b1523],
89	inverse	JJ	O	inverse	dep	121	SENT_320	[p18l577t1446r878b1524],
90	relationship	NN	O	relationship	dep	121	SENT_320	[p18l918t1445r1535b1545],
91	.78	CD	NUMBER	.78	dep	121	SENT_320	[p18l918t1445r1535b1545],
92	It	PRP	O	it	dep	121	SENT_320	[p18l1575t1453r1640b1523],
93	seems	VBZ	O	seem	dep	121	SENT_320	[p18l1676t1471r1938b1523],
94	that	IN	O	that	dep	121	SENT_320	[p18l1980t1445r2153b1523],
95	technical	JJ	O	technical	dep	121	SENT_320	[p18l12t1574r407b1652],
96	limitations	NNS	O	limitation	dep	121	SENT_320	[p18l438t1574r914b1653],
97	and	CC	O	and	dep	121	SENT_320	[p18l948t1574r1107b1653],
98	spontaneous	JJ	O	spontaneous	dep	121	SENT_320	[p18l1140t1591r1687b1674],
99	variations	NNS	O	variation	dep	121	SENT_320	[p18l1718t1575r2145b1653],
100	in	IN	O	in	dep	121	SENT_320	[p18l11t1704r95b1781],
101	the	DT	O	the	dep	121	SENT_320	[p18l135t1703r269b1782],
102	level	NN	O	level	dep	121	SENT_320	[p18l308t1703r498b1783],
103	of	IN	O	of	dep	121	SENT_320	[p18l538t1702r638b1783],
104	urinary	JJ	O	urinary	dep	121	SENT_320	[p18l660t1704r982b1804],
105	LTE4	NN	O	lte4	dep	121	SENT_320	[p18l1017t1710r1220b1809],
106	reduce	VB	O	reduce	dep	121	SENT_320	[p18l1260t1703r1542b1783],
107	its	PRP$	O	its	dep	121	SENT_320	[p18l1580t1704r1680b1782],
108	value	NN	O	value	dep	121	SENT_320	[p18l1717t1703r1939b1783],
109	as	IN	O	as	dep	121	SENT_320	[p18l1978t1730r2064b1782],
110	a	DT	O	a	dep	121	SENT_320	[p18l2105t1730r2149b1782],
111	robust	JJ	O	robust	dep	121	SENT_320	[p18l12t1831r280b1911],
112	predictor	NN	O	predictor	dep	121	SENT_320	[p18l306t1831r686b1931],
113	of	IN	O	of	dep	121	SENT_320	[p18l718t1830r816b1910],
114	the	DT	O	the	dep	121	SENT_320	[p18l832t1831r961b1909],
115	response	NN	O	response	dep	121	SENT_320	[p18l995t1857r1363b1931],
116	to	TO	O	to	dep	121	SENT_320	[p18l1397t1848r1477b1910],
117	antileukotriene	JJ	O	antileukotriene	dep	121	SENT_320	[p18l1511t1831r2148b1911],
118	therapy	NN	O	therapy	dep	121	SENT_320	[p18l12t1960r324b2060],
119	in	IN	O	in	dep	121	SENT_320	[p18l353t1961r434b2038],
120	individual	JJ	O	individual	dep	121	SENT_320	[p18l468t1960r883b2039],
121	patients	NNS	O	patient	_	0	SENT_320	[p18l916t1961r1267b2060],
122	.	.	O	.	_	0	SENT_320	[p18l916t1961r1267b2060],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_321	[p18l1306t1960r1802b2039],
2	synthesis	NN	O	synthesis	npadvmod	75	SENT_321	[p18l1839t1960r2147b2060, p18l13t2090r123b2167],
3	by	IN	O	by	_	0	SENT_321	[p18l169t2089r267b2189],
4	cultured	VBN	O	culture	prepc_by	75	SENT_321	[p18l307t2089r674b2168],
5	leukocytes	NNS	O	leukocyte	dobj	4	SENT_321	[p18l716t2089r1180b2189],
6	is	VBZ	O	be	cop	17	SENT_321	[p18l1225t2090r1292b2167],
7	also	RB	O	also	advmod	17	SENT_321	[p18l1336t2089r1512b2168],
8	an	DT	O	a	det	10	SENT_321	[p18l1556t2115r1661b2167],
9	unreliable	JJ	O	unreliable	amod	10	SENT_321	[p18l1704t2089r2148b2168],
10	predictor	NN	O	predictor	npadvmod	17	SENT_321	[p18l11t2217r391b2317],
11	of	IN	O	of	_	0	SENT_321	[p18l425t2216r523b2296],
12	the	DT	O	the	det	14	SENT_321	[p18l540t2217r669b2295],
13	clinical	JJ	O	clinical	amod	14	SENT_321	[p18l705t2217r1006b2295],
14	response	NN	O	response	prep_of	10	SENT_321	[p18l1041t2243r1409b2317],
15	to	TO	O	to	_	0	SENT_321	[p18l1445t2234r1525b2296],
16	pranlul	NN	O	pranlul	prep_to	14	SENT_321	[p18l1561t2217r2101b2317],
17	<	JJR	O	<	rcmod	5	SENT_321	[p18l1561t2217r2101b2317],
18	ast	CD	NUMBER	ast	num	19	SENT_321	[p18l1561t2217r2101b2317],
19	.79	CD	NUMBER	.79	npadvmod	48	SENT_321	[p18l1561t2217r2101b2317],
20	In	IN	O	in	_	0	SENT_321	[p18l141t2354r229b2424],
21	patients	NNS	O	patient	prep_in	48	SENT_321	[p18l259t2347r595b2446],
22	with	IN	O	with	_	0	SENT_321	[p18l623t2346r817b2425],
23	asthma	NN	O	asthma	prep_with	21	SENT_321	[p18l848t2346r1164b2424],
24	who	WP	O	who	nsubjpass	26	SENT_321	[p18l1189t2346r1370b2425],
25	were	VBD	O	be	auxpass	26	SENT_321	[p18l1399t2372r1599b2425],
26	treated	VBN	O	treat	rcmod	23	SENT_321	[p18l1631t2346r1925b2425],
27	with	IN	O	with	_	0	SENT_321	[p18l1952t2346r2148b2425],
28	a	DT	O	a	det	32	SENT_321	[p18l11t2501r56b2553],
29	5	CD	NUMBER	5	num	32	SENT_321	[p18l92t2475r720b2576],
30	—	NN	O	—	nn	32	SENT_321	[p18l92t2475r720b2576],
31	lipoxygenase	NN	O	lipoxygenase	nn	32	SENT_321	[p18l92t2475r720b2576],
32	inhibitor	NN	O	inhibitor	prep_with	26	SENT_321	[p18l756t2475r1149b2571],
33	,	,	O	,	_	0	SENT_321	[p18l756t2475r1149b2571],
34	polymorphisms	NNS	O	polymorphism	appos	23	SENT_321	[p18l1189t2475r1858b2575],
35	in	IN	O	in	_	0	SENT_321	[p18l1896t2476r1978b2553],
36	the	DT	O	the	det	37	SENT_321	[p18l2014t2475r2148b2553],
37	promoter	NN	O	promoter	prep_in	34	SENT_321	[p18l11t2620r403b2704],
38	of	IN	O	of	_	0	SENT_321	[p18l435t2602r533b2683],
39	the	DT	O	the	det	43	SENT_321	[p18l550t2603r679b2682],
40	5	CD	NUMBER	5	num	43	SENT_321	[p18l716t2603r1330b2705],
41	—	NN	O	—	nn	43	SENT_321	[p18l716t2603r1330b2705],
42	lipoxygenase	NN	O	lipoxygenase	nn	43	SENT_321	[p18l716t2603r1330b2705],
43	gene	NN	O	gene	prep_of	37	SENT_321	[p18l1365t2629r1559b2705],
44	(	CD	NUMBER	(	num	46	SENT_321	[p18l1598t2609r1909b2695],
45	ALOX5	NN	O	alox5	nn	46	SENT_321	[p18l1598t2609r1909b2695],
46	)	NN	O	)	nsubjpass	48	SENT_321	[p18l1598t2609r1909b2695],
47	were	VBD	O	be	auxpass	48	SENT_321	[p18l1945t2629r2148b2683],
48	associated	VBN	O	associate	ccomp	17	SENT_321	[p18l11t2732r459b2811],
49	with	IN	O	with	_	0	SENT_321	[p18l495t2732r691b2811],
50	diminished	VBN	O	diminish	amod	51	SENT_321	[p18l732t2732r1226b2811],
51	improvement	NN	O	improvement	prep_with	48	SENT_321	[p18l1266t2733r1844b2832],
52	in	IN	O	in	_	0	SENT_321	[p18l1878t2733r1962b2810],
53	airflow	NN	O	airflow	prep_in	4	SENT_321	[p18l2001t2733r2147b2810, p18l12t2860r300b2941],
54	.8	CD	NUMBER	.8	number	55	SENT_321	[p18l2001t2733r2147b2810, p18l12t2860r300b2941],
55	°	CD	NUMBER	°	num	53	SENT_321	[p18l2001t2733r2147b2810, p18l12t2860r300b2941],
56	However	RB	O	however	advmod	4	SENT_321	[p18l342t2869r730b2958],
57	,	,	O	,	_	0	SENT_321	[p18l342t2869r730b2958],
58	since	IN	O	since	mark	62	SENT_321	[p18l779t2862r991b2940],
59	these	DT	O	these	det	61	SENT_321	[p18l1034t2861r1254b2940],
60	genetic	JJ	O	genetic	amod	61	SENT_321	[p18l1296t2862r1600b2963],
61	variants	NNS	O	variant	nsubj	62	SENT_321	[p18l1636t2862r1974b2941],
62	occur	VBP	O	occur	advcl	4	SENT_321	[p18l2019t2887r2147b2941, p18l13t3015r154b3068],
63	in	IN	O	in	_	0	SENT_321	[p18l198t2990r282b3067],
64	less	JJR	O	less	mwe	65	SENT_321	[p18l328t2989r488b3067],
65	than	IN	O	than	quantmod	66	SENT_321	[p18l538t2989r738b3067],
66	10	CD	PERCENT	10	num	67	SENT_321	[p18l789t2994r973b3068],
67	%	NN	PERCENT	%	prep_in	62	SENT_321	[p18l789t2994r973b3068],
68	of	IN	O	of	_	0	SENT_321	[p18l1021t2988r1122b3068],
69	patients	NNS	O	patient	prep_of	67	SENT_321	[p18l1149t2990r1500b3089],
70	with	IN	O	with	_	0	SENT_321	[p18l1545t2989r1745b3069],
71	asthma	NN	O	asthma	prep_with	69	SENT_321	[p18l1792t2989r2142b3085],
72	,	,	O	,	_	0	SENT_321	[p18l1792t2989r2142b3085],
73	they	PRP	O	they	nsubj	75	SENT_321	[p18l12t3117r197b3217],
74	can	MD	O	can	aux	75	SENT_321	[p18l226t3143r376b3195],
75	explain	VB	O	explain	_	0	SENT_321	[p18l409t3117r725b3217],
76	only	RB	O	only	advmod	78	SENT_321	[p18l759t3117r945b3217],
77	a	DT	O	a	det	78	SENT_321	[p18l973t3143r1017b3195],
78	fraction	NN	O	fraction	dobj	75	SENT_321	[p18l1049t3116r1389b3196],
79	of	IN	O	of	_	0	SENT_321	[p18l1422t3116r1523b3196],
80	the	DT	O	the	det	81	SENT_321	[p18l1539t3117r1672b3195],
81	unresponsiveness	NN	O	unresponsiveness	prep_of	78	SENT_321	[p18l1705t3143r2147b3217, p18l13t3246r351b3325],
82	to	TO	O	to	_	0	SENT_321	[p18l390t3262r471b3324],
83	leukotriene	NN	O	leukotriene	nn	84	SENT_321	[p18l507t3245r986b3325],
84	modiﬁers	NNS	O	modiﬁers	prep_to	75	SENT_321	[p18l1022t3244r1460b3324],
85	.	.	O	.	_	0	SENT_321	[p18l1022t3244r1460b3324],

1	By	IN	O	by	dep	5	SENT_322	[p18l1500t3252r1604b3345],
2	contrast	NN	O	contrast	pobj	1	SENT_322	[p18l1636t3262r2003b3341],
3	,	,	O	,	_	0	SENT_322	[p18l1636t3262r2003b3341],
4	an	DT	O	a	det	5	SENT_322	[p18l2044t3271r2148b3323],
5	A	NN	O	a	_	0	SENT_322	[p18l8t3381r281b3454],
6	.	.	O	.	_	0	SENT_322	[p18l8t3381r281b3454],

1	—	NN	O	—	_	0	SENT_323	[p18l8t3381r281b3454],
2	.	.	O	.	_	0	SENT_323	[p18l8t3381r281b3454],

1	to	TO	O	to	_	0	SENT_324	[p18l8t3381r281b3454],
2	.	.	O	.	_	0	SENT_324	[p18l8t3381r281b3454],

1	—	NN	O	—	_	0	SENT_325	[p18l8t3381r281b3454],
2	.	.	O	.	_	0	SENT_325	[p18l8t3381r281b3454],

1	C	NN	O	c	nn	2	SENT_326	[p18l8t3381r281b3454],
2	transversion	NN	O	transversion	nsubj	9	SENT_326	[p18l314t3376r824b3454],
3	in	IN	O	in	_	0	SENT_326	[p18l853t3376r935b3453],
4	the	DT	O	the	det	8	SENT_326	[p18l966t3375r1095b3453],
5	LTC4	NN	O	ltc4	nn	8	SENT_326	[p18l1125t3381r1329b3480],
6	synthase	NN	O	synthase	nn	8	SENT_326	[p18l1361t3375r1721b3475],
7	promoter	NN	O	promoter	nn	8	SENT_326	[p18l1750t3392r2151b3475],
8	region	NN	O	region	prep_in	2	SENT_326	[p18l12t3504r284b3605],
9	occurs	VBZ	O	occur	_	0	SENT_326	[p18l324t3529r599b3583],
10	in	IN	O	in	_	0	SENT_326	[p18l640t3504r724b3581],
11	approximately	RB	O	approximately	quantmod	14	SENT_326	[p18l762t3503r1370b3604],
12	20	CD	NUMBER	20	number	14	SENT_326	[p18l1405t3510r1504b3583],
13	to	TO	O	to	dep	14	SENT_326	[p18l1545t3520r1626b3583],
14	40	CD	PERCENT	40	num	15	SENT_326	[p18l1666t3508r1856b3583],
15	%	NN	PERCENT	%	prep_in	9	SENT_326	[p18l1666t3508r1856b3583],
16	of	IN	O	of	_	0	SENT_326	[p18l1896t3502r1995b3583],
17	patients	NNS	O	patient	prep_of	15	SENT_326	[p18l2015t3529r2147b3604, p18l12t3634r250b3711],
18	with	IN	O	with	_	0	SENT_326	[p18l295t3633r491b3712],
19	asthma	NN	O	asthma	nn	20	SENT_326	[p18l538t3633r933b3711],
20	“	NN	O	“	prep_with	17	SENT_326	[p18l538t3633r933b3711],
21	and	CC	O	and	_	0	SENT_326	[p18l979t3633r1138b3712],
22	is	VBZ	O	be	auxpass	23	SENT_326	[p18l1184t3634r1250b3711],
23	associated	VBN	O	associate	conj_and	9	SENT_326	[p18l1299t3633r1747b3712],
24	with	IN	O	with	_	0	SENT_326	[p18l1788t3633r1985b3712],
25	increased	VBN	O	increase	prep_with	23	SENT_326	[p18l2031t3634r2147b3711, p19l13t31r322b110],

1	synthesis	NN	O	synthesis	_	0	SENT_327	[p19l357t31r736b131],
2	of	IN	O	of	_	0	SENT_327	[p19l773t30r871b110],
3	cysteinyl	NN	O	cysteinyl	nn	4	SENT_327	[p19l887t31r1240b131],
4	leukotrienes	NNS	O	leukotriene	prep_of	1	SENT_327	[p19l1273t31r1803b111],
5	.	.	O	.	_	0	SENT_327	[p19l1273t31r1803b111],

1	A	DT	O	a	det	3	SENT_328	[p19l1839t39r1905b109],
2	positive	JJ	O	positive	amod	3	SENT_328	[p19l1935t32r2147b131, p19l12t162r163b240],
3	relation	NN	O	relation	nsubjpass	17	SENT_328	[p19l204t161r545b240],
4	between	IN	O	between	_	0	SENT_328	[p19l586t161r952b240],
5	this	DT	O	this	det	7	SENT_328	[p19l992t161r1156b239],
6	variant	JJ	O	variant	amod	7	SENT_328	[p19l1195t162r1507b240],
7	allele	NN	O	allele	prep_between	3	SENT_328	[p19l1541t161r1771b239],
8	and	CC	O	and	_	0	SENT_328	[p19l1811t161r1972b240],
9	the	DT	O	the	det	11	SENT_328	[p19l2013t161r2148b239],
10	clinical	JJ	O	clinical	amod	11	SENT_328	[p19l13t289r336b367],
11	response	NN	O	response	conj_and	7	SENT_328	[p19l377t315r768b389],
12	to	TO	O	to	_	0	SENT_328	[p19l810t306r893b368],
13	various	JJ	O	various	amod	15	SENT_328	[p19l931t290r1251b369],
14	CysLT1	NN	O	cyslt1	nn	15	SENT_328	[p19l1294t295r1591b393],
15	antagonists	NNS	O	antagonist	prep_to	11	SENT_328	[p19l1631t290r2145b391],
16	was	VBD	O	be	auxpass	17	SENT_328	[p19l7t444r173b497],
17	reported	VBN	O	report	dep	42	SENT_328	[p19l232t418r608b518],
18	in	IN	O	in	_	0	SENT_328	[p19l665t419r750b496],
19	two	CD	NUMBER	two	num	20	SENT_328	[p19l807t435r968b497],
20	studies3132	NN	O	studies3132	prep_in	17	SENT_328	[p19l1027t418r1515b497],
21	but	CC	O	but	_	0	SENT_328	[p19l1572t418r1714b497],
22	not	RB	O	not	_	0	SENT_328	[p19l1767t435r1912b497],
23	in	IN	O	in	_	0	SENT_328	[p19l1963t419r2048b496],
24	a	DT	O	a	det	26	SENT_328	[p19l2105t444r2149b496],
25	third	JJ	ORDINAL	third	amod	26	SENT_328	[p19l12t547r314b627],
26	.83	NN	NUMBER	.83	prep_in	17	SENT_328	[p19l12t547r314b627],
27	A	DT	O	a	det	29	SENT_328	[p19l346t555r412b625],
28	variant	JJ	O	variant	amod	29	SENT_328	[p19l438t548r730b627],
29	allele	NN	O	allele	dobj	17	SENT_328	[p19l758t547r972b626],
30	in	IN	O	in	_	0	SENT_328	[p19l1005t548r1086b625],
31	the	DT	O	the	det	33	SENT_328	[p19l1120t547r1249b626],
32	coding	VBG	O	code	amod	33	SENT_328	[p19l1283t547r1572b649],
33	region	NN	O	region	prep_in	29	SENT_328	[p19l1601t548r1867b649],
34	of	IN	O	of	_	0	SENT_328	[p19l1901t546r1999b627],
35	the	DT	O	the	det	38	SENT_328	[p19l2014t547r2148b626],
36	gene	NN	O	gene	nn	38	SENT_328	[p19l11t702r208b778],
37	encoding	VBG	O	encode	amod	38	SENT_328	[p19l246t676r642b778],
38	CysLT2	NN	O	cyslt2	prep_of	33	SENT_328	[p19l675t682r963b780],
39	has	VBZ	O	have	aux	42	SENT_328	[p19l1000t676r1143b754],
40	recently	RB	DATE	recently	advmod	42	SENT_328	[p19l1182t676r1517b776],
41	been	VBN	O	be	auxpass	42	SENT_328	[p19l1549t676r1749b755],
42	reported	VBN	O	report	_	0	SENT_328	[p19l1786t676r2148b776],
43	to	TO	O	to	aux	45	SENT_328	[p19l12t822r95b884],
44	be	VB	O	be	auxpass	45	SENT_328	[p19l140t805r237b884],
45	associated	VBN	O	associate	xcomp	42	SENT_328	[p19l279t805r737b884],
46	with	IN	O	with	_	0	SENT_328	[p19l775t805r974b884],
47	an	DT	O	a	det	49	SENT_328	[p19l1016t831r1121b883],
48	enhanced	VBN	O	enhance	amod	49	SENT_328	[p19l1164t805r1588b884],
49	response	NN	O	response	prep_with	45	SENT_328	[p19l1630t831r2021b905],
50	to	TO	O	to	_	0	SENT_328	[p19l2063t822r2147b884],
51	montelul	NN	O	montelul	prep_to	49	SENT_328	[p19l12t934r672b1013],
52	<	JJR	O	<	amod	51	SENT_328	[p19l12t934r672b1013],
53	ast	CD	NUMBER	ast	number	54	SENT_328	[p19l12t934r672b1013],
54	.34	CD	NUMBER	.34	nsubjpass	42	SENT_328	[p19l12t934r672b1013],
55	It	PRP	O	it	nsubj	57	SENT_328	[p19l708t942r774b1012],
56	is	VBZ	O	be	cop	57	SENT_328	[p19l807t935r874b1012],
57	likely	JJ	O	likely	rcmod	54	SENT_328	[p19l914t934r1153b1034],
58	that	IN	O	that	complm	62	SENT_328	[p19l1187t934r1364b1012],
59	these	DT	O	these	det	61	SENT_328	[p19l1398t934r1627b1012],
60	pharmacogenetic	JJ	O	pharmacogenetic	amod	61	SENT_328	[p19l1665t934r2147b1034, p19l12t1064r329b1164],
61	associations	NNS	O	association	nsubj	62	SENT_328	[p19l369t1064r911b1142],
62	vary	VBP	O	vary	ccomp	57	SENT_328	[p19l951t1089r1137b1163],
63	according	VBG	O	accord	_	0	SENT_328	[p19l1174t1063r1613b1164],
64	to	TO	O	to	prepc_according_to	62	SENT_328	[p19l1652t1080r1735b1142],
65	the	DT	O	the	det	67	SENT_328	[p19l1779t1063r1914b1141],
66	geographic	JJ	O	geographic	amod	67	SENT_328	[p19l1957t1089r2147b1164, p19l12t1191r345b1293],
67	origin	NN	O	origin	pobj	62	SENT_328	[p19l383t1192r644b1293],
68	of	IN	O	of	_	0	SENT_328	[p19l683t1190r784b1271],
69	the	DT	O	the	det	70	SENT_328	[p19l804t1191r938b1270],
70	population	NN	O	population	prep_of	67	SENT_328	[p19l975t1191r1450b1292],
71	under	IN	O	under	_	0	SENT_328	[p19l1488t1191r1740b1271],
72	analysis	NN	O	analysis	prep_under	70	SENT_328	[p19l1775t1191r2142b1292],
73	.	.	O	.	_	0	SENT_328	[p19l1775t1191r2142b1292],

1	Since	IN	O	since	mark	10	SENT_329	[p19l15t1320r229b1398],
2	levels	NNS	O	level	nsubjpass	10	SENT_329	[p19l263t1319r485b1399],
3	of	IN	O	of	_	0	SENT_329	[p19l522t1318r620b1398],
4	leukotrienes	NNS	O	leukotriene	prep_of	2	SENT_329	[p19l636t1319r1144b1399],
5	and	CC	O	and	_	0	SENT_329	[p19l1180t1319r1335b1398],
6	their	PRP$	O	they	poss	7	SENT_329	[p19l1370t1319r1566b1397],
7	receptors	NNS	O	receptor	prep_of	2	SENT_329	[p19l1598t1336r1979b1419],
8	are	VBP	O	be	auxpass	10	SENT_329	[p19l2015t1345r2148b1397],
9	greatly	RB	O	greatly	advmod	10	SENT_329	[p19l12t1448r317b1550],
10	influenced	VBN	O	influence	advcl	26	SENT_329	[p19l357t1447r832b1528],
11	by	IN	O	by	_	0	SENT_329	[p19l878t1448r977b1549],
12	substances	NNS	O	substance	agent	10	SENT_329	[p19l1021t1448r1500b1528],
13	such	JJ	O	such	_	0	SENT_329	[p19l1550t1448r1748b1528],
14	as	IN	O	as	_	0	SENT_329	[p19l1793t1475r1881b1527],
15	cytokines	NNS	O	cytokine	prep_such_as	12	SENT_329	[p19l1930t1465r2147b1549, p19l12t1576r265b1672],
16	,	,	O	,	_	0	SENT_329	[p19l1930t1465r2147b1549, p19l12t1576r265b1672],
17	analysis	NN	O	analysis	nsubj	26	SENT_329	[p19l305t1576r647b1676],
18	of	IN	O	of	_	0	SENT_329	[p19l686t1575r786b1655],
19	responsiveness	NN	O	responsiveness	prep_of	17	SENT_329	[p19l803t1577r1447b1676],
20	to	TO	O	to	_	0	SENT_329	[p19l1485t1593r1566b1655],
21	antileukotri	JJ	O	antileukotri	amod	24	SENT_329	[p19l1602t1576r2147b1656],
22	—	NN	O	—	nn	24	SENT_329	[p19l1602t1576r2147b1656],
23	ene	NN	O	ene	nn	24	SENT_329	[p19l12t1731r157b1784],
24	therapy	NN	O	therapy	prep_to	19	SENT_329	[p19l191t1705r516b1806],
25	must	MD	O	must	aux	26	SENT_329	[p19l545t1722r762b1785],
26	take	VB	O	take	_	0	SENT_329	[p19l791t1705r972b1785],
27	into	IN	O	into	_	0	SENT_329	[p19l1005t1706r1176b1785],
28	account	NN	O	account	prep_into	26	SENT_329	[p19l1210t1722r1550b1785],
29	the	DT	O	the	det	30	SENT_329	[p19l1579t1705r1713b1784],
30	genes	NNS	O	gene	dobj	26	SENT_329	[p19l1746t1731r1990b1807],
31	for	IN	O	for	prep	30	SENT_329	[p19l2025t1704r2152b1785],

1	1848	CD	DATE	1848	num	4	SENT_330	[p19l149t1882r224b1904],
2	N	NN	O	n	nn	4	SENT_330	[p19l897t1892r911b1907],
3	ENGLJ	NN	O	englj	nn	4	SENT_330	[p19l926t1892r1004b1914],
4	MED	NN	O	med	_	0	SENT_330	[p19l1018t1892r1070b1907],
5	357	CD	NUMBER	357	num	7	SENT_330	[p19l1081t1886r1154b1914],
6	;	:	O	;	_	0	SENT_330	[p19l1081t1886r1154b1914],
7	18	CD	NUMBER	18	dep	4	SENT_330	[p19l1081t1886r1154b1914],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_330	[p19l1187t1892r1388b1914],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_330	[p19l1425t1892r1560b1908],
10	1	CD	DATE	1	num	9	SENT_330	[p19l1571t1892r1587b1912],
11	,	,	DATE	,	_	0	SENT_330	[p19l1571t1892r1587b1912],
12	2007	CD	DATE	2007	num	9	SENT_330	[p19l1598t1892r1661b1913],

1	The	DT	O	the	det	4	SENT_331	[p19l935t1925r986b1949],
2	New	NNP	O	New	nn	4	SENT_331	[p19l995t1926r1057b1949],
3	England	NNP	O	England	nn	4	SENT_331	[p19l1067t1925r1177b1956],
4	Journal	NNP	O	Journal	_	0	SENT_331	[p19l1186t1925r1283b1949],
5	of	IN	O	of	_	0	SENT_331	[p19l1293t1925r1322b1949],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_331	[p19l1329t1925r1454b1949],

1	Downloaded	VBN	O	download	_	0	SENT_332	[p19l377t1966r547b1989],
2	from	IN	O	from	_	0	SENT_332	[p19l556t1966r621b1989],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_332	[p19l629t1966r747b1996],
4	at	IN	O	at	_	0	SENT_332	[p19l758t1970r781b1989],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_332	[p19l789t1966r972b1989],
6	on	IN	O	on	_	0	SENT_332	[p19l981t1973r1014b1989],
7	January	NNP	DATE	January	prep_on	1	SENT_332	[p19l1022t1966r1125b1996],
8	5	CD	DATE	5	num	7	SENT_332	[p19l1135t1966r1158b1993],
9	,	,	DATE	,	_	0	SENT_332	[p19l1135t1966r1158b1993],
10	2014	CD	DATE	2014	num	7	SENT_332	[p19l1168t1966r1241b1989],
11	.	.	O	.	_	0	SENT_332	[p19l1168t1966r1241b1989],

1	For	IN	O	for	_	0	SENT_333	[p19l1251t1966r1298b1989],
2	personal	JJ	O	personal	amod	3	SENT_333	[p19l1306t1966r1418b1996],
3	use	NN	O	use	pobj	1	SENT_333	[p19l1427t1973r1471b1989],
4	only	RB	O	only	advmod	3	SENT_333	[p19l1480t1966r1545b1996],
5	.	.	O	.	_	0	SENT_333	[p19l1480t1966r1545b1996],

1	No	DT	O	no	det	3	SENT_334	[p19l1556t1966r1595b1989],
2	other	JJ	O	other	amod	3	SENT_334	[p19l1605t1966r1673b1989],
3	uses	NNS	O	use	_	0	SENT_334	[p19l1682t1973r1738b1989],
4	without	IN	O	without	_	0	SENT_334	[p19l1748t1966r1849b1989],
5	permission	NN	O	permission	prep_without	3	SENT_334	[p19l1857t1966r2010b1996],
6	.	.	O	.	_	0	SENT_334	[p19l1857t1966r2010b1996],

1	Copyright	NN	O	copyright	_	0	SENT_335	[p19l728t2007r862b2038],
2	©	CD	NUMBER	©	num	6	SENT_335	[p19l871t2007r895b2031],
3	2007	CD	DATE	2007	num	6	SENT_335	[p19l905t2007r969b2031],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_335	[p19l979t2007r1170b2031],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_335	[p19l1180t2007r1288b2031],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_335	[p19l1299t2007r1404b2038],
7	.	.	O	.	_	0	SENT_335	[p19l1299t2007r1404b2038],

1	All	DT	O	all	det	2	SENT_336	[p19l1415t2007r1456b2031],
2	rights	NNS	O	rights	nsubj	3	SENT_336	[p19l1465t2007r1540b2038],
3	reserved	VBN	O	reserve	_	0	SENT_336	[p19l1549t2007r1668b2031],
4	.	.	O	.	_	0	SENT_336	[p19l1549t2007r1668b2031],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_337	[p19l866t2113r1091b2132],
2	OF	IN	O	of	_	0	SENT_337	[p19l1106t2113r1146b2132],
3	DISEASE	NN	O	disease	prep_of	1	SENT_337	[p19l1160t2113r1294b2132],

1	molecules	NNS	O	molecule	_	0	SENT_338	[p19l10t2327r452b2406],
2	that	WDT	O	that	nsubj	3	SENT_338	[p19l516t2327r694b2405],
3	reside	VBP	O	reside	rcmod	1	SENT_338	[p19l749t2327r1008b2406],
4	outside	IN	O	outside	_	0	SENT_338	[p19l1070t2327r1388b2406],
5	the	DT	O	the	det	7	SENT_338	[p19l1449t2327r1586b2405],
6	leukotriene	NN	O	leukotriene	nn	7	SENT_338	[p19l1646t2327r2149b2406],
7	pathway	NN	O	pathway	prep_outside	3	SENT_338	[p19l8t2455r386b2555],
8	.	.	O	.	_	0	SENT_338	[p19l8t2455r386b2555],

1	Several	JJ	O	several	amod	2	SENT_339	[p19l142t2583r431b2663],
2	characteristics	NNS	O	characteristic	nsubjpass	7	SENT_339	[p19l465t2583r1062b2661],
3	of	IN	O	of	_	0	SENT_339	[p19l1099t2582r1197b2662],
4	patients	NNS	O	patient	prep_of	2	SENT_339	[p19l1211t2584r1541b2683],
5	have	VBP	O	have	aux	7	SENT_339	[p19l1577t2583r1762b2663],
6	been	VBN	O	be	auxpass	7	SENT_339	[p19l1797t2583r1994b2662],
7	associated	VBN	O	associate	_	0	SENT_339	[p19l2028t2609r2148b2661, p19l11t2712r365b2791],
8	with	IN	O	with	_	0	SENT_339	[p19l410t2712r607b2792],
9	responsiveness	NN	O	responsiveness	prep_with	7	SENT_339	[p19l656t2713r1301b2812],
10	to	TO	O	to	_	0	SENT_339	[p19l1353t2729r1435b2791],
11	antileukotriene	JJ	O	antileukotriene	amod	12	SENT_339	[p19l1486t2712r2149b2792],
12	drugs	NNS	O	drug	prep_to	7	SENT_339	[p19l11t2841r275b2943],
13	.	.	O	.	_	0	SENT_339	[p19l11t2841r275b2943],

1	A	DT	O	a	det	2	SENT_340	[p19l310t2849r377b2919],
2	benefit	NN	O	benefit	nsubj	5	SENT_340	[p19l406t2840r707b2921],
3	is	VBZ	O	be	cop	5	SENT_340	[p19l734t2842r799b2920],
4	more	RBR	O	more	advmod	5	SENT_340	[p19l834t2867r1052b2921],
5	likely	JJ	O	likely	_	0	SENT_340	[p19l1082t2841r1312b2942],
6	in	IN	O	in	_	0	SENT_340	[p19l1339t2842r1422b2919],
7	children	NNS	O	child	prep_in	5	SENT_340	[p19l1454t2841r1806b2921],
8	than	IN	O	than	prep	7	SENT_340	[p19l1838t2841r2033b2920],
9	in	IN	O	in	pcomp	8	SENT_340	[p19l2065t2842r2149b2919],
10	adults35	NN	O	adults35	pobj	9	SENT_340	[p19l10t2970r351b3049],
11	and	CC	O	and	_	0	SENT_340	[p19l399t2970r560b3049],
12	in	IN	O	in	conj_and	8	SENT_340	[p19l605t2971r690b3048],
13	younger	JJR	O	younger	amod	14	SENT_340	[p19l733t2996r1092b3071],
14	children	NNS	O	child	pobj	12	SENT_340	[p19l1136t2970r1503b3049],
15	than	IN	O	than	prep	5	SENT_340	[p19l1549t2970r1751b3048],
16	in	IN	O	in	pcomp	15	SENT_340	[p19l1796t2971r1882b3048],
17	older	JJR	O	older	amod	18	SENT_340	[p19l1929t2970r2152b3049],
18	children	NNS	O	child	pobj	16	SENT_340	[p19l11t3097r454b3176],
19	.	.	O	.	_	0	SENT_340	[p19l11t3097r454b3176],

1	“	NN	O	“	nsubj	15	SENT_341	[p19l11t3097r454b3176],
2	Moreover	RB	O	moreover	advmod	4	SENT_341	[p19l482t3105r892b3193],
3	,	,	O	,	_	0	SENT_341	[p19l482t3105r892b3193],
4	acquired	VBD	O	acquire	rcmod	1	SENT_341	[p19l927t3097r1285b3197],
5	factors	NNS	O	factor	nsubj	13	SENT_341	[p19l1315t3096r1594b3176],
6	such	JJ	O	such	_	0	SENT_341	[p19l1628t3097r1816b3177],
7	as	IN	O	as	_	0	SENT_341	[p19l1846t3123r1929b3175],
8	obesity	NN	O	obesity	prep_such_as	5	SENT_341	[p19l1963t3097r2148b3176, p19l11t3227r161b3326],
9	and	CC	O	and	_	0	SENT_341	[p19l189t3226r348b3305],
10	smoking	NN	O	smoking	prep_such_as	5	SENT_341	[p19l383t3226r764b3327],
11	may	MD	O	may	aux	13	SENT_341	[p19l794t3252r974b3326],
12	be	VB	O	be	cop	13	SENT_341	[p19l1003t3226r1101b3305],
13	relevant	JJ	O	relevant	ccomp	4	SENT_341	[p19l1134t3226r1478b3305],
14	in	IN	O	in	prep	13	SENT_341	[p19l1505t3227r1590b3304],
15	understand	VBP	O	understand	_	0	SENT_341	[p19l1622t3226r2148b3305],
16	—	CD	NUMBER	—	dobj	15	SENT_341	[p19l1622t3226r2148b3305],
17	ing	VBG	O	ing	partmod	16	SENT_341	[p19l10t3355r151b3456],
18	the	DT	O	the	det	20	SENT_341	[p19l183t3354r317b3433],
19	clinical	JJ	O	clinical	amod	20	SENT_341	[p19l353t3354r668b3433],
20	effects	NNS	O	effect	dobj	17	SENT_341	[p19l704t3353r988b3433],
21	of	IN	O	of	_	0	SENT_341	[p19l1025t3353r1126b3434],
22	antileukotriene	JJ	O	antileukotriene	amod	23	SENT_341	[p19l1142t3354r1806b3434],
23	agents	NNS	O	agent	prep_of	20	SENT_341	[p19l1840t3371r2144b3456],
24	.	.	O	.	_	0	SENT_341	[p19l1840t3371r2144b3456],

1	Although	IN	O	although	mark	15	SENT_342	[p19l6t3483r409b3585],
2	in	IN	O	in	_	0	SENT_342	[p19l440t3484r523b3561],
3	one	CD	NUMBER	one	num	4	SENT_342	[p19l556t3509r706b3563],
4	study	NN	O	study	prep_in	15	SENT_342	[p19l739t3483r967b3584],
5	the	DT	O	the	det	6	SENT_342	[p19l994t3483r1126b3562],
6	effect	NN	O	effect	nsubj	15	SENT_342	[p19l1158t3482r1397b3562],
7	of	IN	O	of	_	0	SENT_342	[p19l1424t3482r1524b3563],
8	inhaled	VBN	O	inhale	prepc_of	6	SENT_342	[p19l1536t3483r1856b3563],
9	beclo	NN	O	beclo	nn	11	SENT_342	[p19l1889t3483r2148b3563],
10	—	NN	O	—	nn	11	SENT_342	[p19l1889t3483r2148b3563],
11	methasone	NN	O	methasone	dobj	8	SENT_342	[p19l10t3613r486b3692],
12	on	IN	O	on	_	0	SENT_342	[p19l529t3639r636b3692],
13	asthma	NN	O	asthma	nn	14	SENT_342	[p19l677t3613r1000b3691],
14	control	NN	O	control	prep_on	11	SENT_342	[p19l1041t3613r1349b3692],
15	declined	VBD	O	decline	_	0	SENT_342	[p19l1392t3613r1756b3692],
16	with	IN	O	with	_	0	SENT_342	[p19l1794t3613r1991b3692],
17	increasing	VBG	O	increase	prep_with	15	SENT_342	[p19l2033t3614r2148b3691, p20l11t32r382b132],

1	body	NN	O	body	nn	4	SENT_343	[p20l421t31r890b131],
2	—	CD	NUMBER	—	num	4	SENT_343	[p20l421t31r890b131],
3	mass	NN	O	mass	nn	4	SENT_343	[p20l421t31r890b131],
4	index	NN	O	index	nsubjpass	10	SENT_343	[p20l932t31r1196b127],
5	,	,	O	,	_	0	SENT_343	[p20l932t31r1196b127],
6	no	DT	O	no	det	8	SENT_343	[p20l1241t57r1348b110],
7	such	JJ	O	such	amod	8	SENT_343	[p20l1392t31r1590b110],
8	decline	NN	O	decline	appos	4	SENT_343	[p20l1631t31r1946b110],
9	was	VBD	O	be	auxpass	10	SENT_343	[p20l1981t57r2148b110],
10	observed	VBN	O	observe	_	0	SENT_343	[p20l11t159r395b239],
11	for	IN	O	for	_	0	SENT_343	[p20l437t158r561b239],
12	montelukast	NN	O	montelukast	prep_for	10	SENT_343	[p20l601t159r1245b256],
13	,87	CD	NUMBER	,87	num	12	SENT_343	[p20l601t159r1245b256],
14	suggesting	VBG	O	suggest	xcomp	10	SENT_343	[p20l1289t160r1764b261],
15	that	IN	O	that	complm	24	SENT_343	[p20l1804t159r1977b238],
16	the	DT	O	the	det	18	SENT_343	[p20l2015t159r2149b238],
17	relative	JJ	O	relative	amod	18	SENT_343	[p20l10t287r329b367],
18	benefit	NN	O	benefit	nsubj	24	SENT_343	[p20l379t286r694b366],
19	of	IN	O	of	_	0	SENT_343	[p20l739t286r841b366],
20	montelukast	NN	O	montelukast	prep_of	18	SENT_343	[p20l872t287r1426b367],
21	may	MD	O	may	aux	24	SENT_343	[p20l1470t313r1653b387],
22	have	VB	O	have	aux	24	SENT_343	[p20l1698t287r1893b367],
23	been	VBN	O	be	cop	24	SENT_343	[p20l1943t287r2149b366],
24	greater	JJR	O	greater	ccomp	14	SENT_343	[p20l10t433r311b517],
25	in	IN	O	in	_	0	SENT_343	[p20l340t417r422b494],
26	more	JJR	O	more	amod	28	SENT_343	[p20l455t442r673b495],
27	obese	JJ	O	obese	amod	28	SENT_343	[p20l707t416r945b495],
28	patients	NNS	O	patient	prep_in	24	SENT_343	[p20l976t417r1336b516],
29	.	.	O	.	_	0	SENT_343	[p20l976t417r1336b516],

1	Likewise	RB	O	likewise	advmod	8	SENT_344	[p20l1373t416r1768b512],
2	,	,	O	,	_	0	SENT_344	[p20l1373t416r1768b512],
3	patients	NNS	O	patient	nsubj	8	SENT_344	[p20l1805t417r2147b516],
4	with	IN	O	with	_	0	SENT_344	[p20l6t544r202b623],
5	asthma	NN	O	asthma	prep_with	3	SENT_344	[p20l233t544r555b622],
6	who	WP	O	who	nsubj	7	SENT_344	[p20l581t544r765b623],
7	smoked	VBD	O	smoke	rcmod	5	SENT_344	[p20l799t544r1135b623],
8	had	VBD	O	have	dep	15	SENT_344	[p20l1166t544r1323b623],
9	a	DT	O	a	det	11	SENT_344	[p20l1354t570r1399b622],
10	greater	JJR	O	greater	amod	11	SENT_344	[p20l1428t561r1737b645],
11	response	NN	O	response	dobj	8	SENT_344	[p20l1765t570r2149b644],
12	to	TO	O	to	_	0	SENT_344	[p20l10t689r92b751],
13	montelukast	NN	O	montelukast	prep_to	11	SENT_344	[p20l124t672r668b751],
14	than	IN	O	than	advmod	15	SENT_344	[p20l694t672r892b750],
15	did	VBD	O	do	_	0	SENT_344	[p20l924t672r1059b751],
16	their	PRP$	O	they	poss	20	SENT_344	[p20l1091t672r1297b750],
17	nonsmoking	JJ	O	nonsmoking	amod	20	SENT_344	[p20l1324t672r1877b773],
18	coun	NN	O	coun	nn	20	SENT_344	[p20l1906t698r2148b751],
19	—	NN	O	—	nn	20	SENT_344	[p20l1906t698r2148b751],
20	terparts	NNS	O	terpart	dobj	15	SENT_344	[p20l11t805r456b900],
21	.88	CD	NUMBER	.88	nsubj	15	SENT_344	[p20l11t805r456b900],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_345	[p20l15t1060r486b1161],
2	Trials	NNS	O	trial	dep	9	SENT_345	[p20l522t1060r734b1137],
3	of	IN	O	of	_	0	SENT_345	[p20l768t1059r860b1163],
4	Antileukotriene	NNP	O	Antileukotriene	nn	5	SENT_345	[p20l867t1060r1478b1138],
5	Agents	NNPS	O	Agents	prep_of	2	SENT_345	[p20l1509t1066r1780b1163],
6	Since	IN	O	since	dep	9	SENT_345	[p20l12t1189r236b1267],
7	it	PRP	O	it	nsubj	9	SENT_345	[p20l266t1189r325b1266],
8	is	VBZ	O	be	cop	9	SENT_345	[p20l349t1189r415b1266],
9	impossible	JJ	O	impossible	advcl	29	SENT_345	[p20l446t1188r916b1288],
10	to	TO	O	to	aux	11	SENT_345	[p20l946t1205r1028b1267],
11	predict	VB	O	predict	xcomp	9	SENT_345	[p20l1058t1188r1364b1288],
12	responsiveness	NN	O	responsiveness	dobj	11	SENT_345	[p20l1388t1189r2033b1288],
13	to	TO	O	to	_	0	SENT_345	[p20l2065t1205r2148b1267],
14	antileukotriene	JJ	O	antileukotriene	amod	15	SENT_345	[p20l9t1317r673b1397],
15	therapy	NN	O	therapy	prep_to	11	SENT_345	[p20l715t1317r1040b1417],
16	in	IN	O	in	_	0	SENT_345	[p20l1075t1318r1159b1395],
17	an	DT	O	a	det	19	SENT_345	[p20l1200t1343r1304b1395],
18	individual	JJ	O	individual	amod	19	SENT_345	[p20l1344t1317r1779b1396],
19	patient	NN	O	patient	prep_in	15	SENT_345	[p20l1818t1318r2144b1417],
20	,	,	O	,	_	0	SENT_345	[p20l1818t1318r2144b1417],
21	a	DT	O	a	det	23	SENT_345	[p20l9t1472r54b1524],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_345	[p20l82t1446r560b1546],
23	trial	NN	O	trial	nsubj	29	SENT_345	[p20l588t1446r764b1524],
24	in	IN	O	in	_	0	SENT_345	[p20l791t1447r874b1524],
25	the	DT	O	the	det	26	SENT_345	[p20l903t1446r1035b1524],
26	patient	NN	O	patient	prep_in	23	SENT_345	[p20l1063t1447r1361b1546],
27	may	MD	O	may	aux	29	SENT_345	[p20l1384t1472r1563b1546],
28	be	VB	O	be	cop	29	SENT_345	[p20l1587t1446r1683b1525],
29	necessary	JJ	O	necessary	_	0	SENT_345	[p20l1712t1472r2143b1546],
30	.	.	O	.	_	0	SENT_345	[p20l1712t1472r2143b1546],

1	Improvements	NNP	O	Improvements	nsubjpass	13	SENT_346	[p20l8t1582r620b1674],
2	in	IN	O	in	_	0	SENT_346	[p20l653t1575r736b1652],
3	symptoms	NNS	O	symptom	prep_in	1	SENT_346	[p20l769t1591r1208b1674],
4	or	CC	O	or	_	0	SENT_346	[p20l1242t1600r1330b1653],
5	a	DT	O	a	det	7	SENT_346	[p20l1358t1600r1403b1652],
6	reduced	VBN	O	reduce	amod	7	SENT_346	[p20l1433t1574r1765b1654],
7	need	NN	O	need	prep_in	1	SENT_346	[p20l1797t1574r1997b1653],
8	for	IN	O	for	_	0	SENT_346	[p20l2028t1573r2153b1653],
9	rescue	NN	O	rescue	nn	10	SENT_346	[p20l10t1730r282b1783],
10	bronchodilators	NNS	O	bronchodilator	prep_for	7	SENT_346	[p20l318t1704r1011b1783],
11	can	MD	O	can	aux	13	SENT_346	[p20l1048t1730r1198b1782],
12	be	VB	O	be	auxpass	13	SENT_346	[p20l1233t1704r1330b1783],
13	seen	VBN	O	see	_	0	SENT_346	[p20l1366t1730r1556b1783],
14	with	IN	O	with	_	0	SENT_346	[p20l1586t1704r1783b1783],
15	antileukotriene	JJ	O	antileukotriene	amod	16	SENT_346	[p20l1817t1704r2148b1783, p20l10t1831r367b1911],
16	therapy	NN	O	therapy	prep_with	13	SENT_346	[p20l402t1831r728b1931],
17	as	IN	O	as	_	0	SENT_346	[p20l757t1857r843b1909],
18	early	JJ	O	early	prep_as	13	SENT_346	[p20l881t1831r1088b1931],
19	as	IN	O	as	_	0	SENT_346	[p20l1118t1857r1204b1909],
20	the	DT	DURATION	the	det	22	SENT_346	[p20l1241t1831r1375b1909],
21	first	JJ	DURATION	first	amod	22	SENT_346	[p20l1411t1830r1596b1909],
22	day	NN	DURATION	day	prep_as	18	SENT_346	[p20l1627t1831r1775b1931],
23	of	IN	O	of	_	0	SENT_346	[p20l1806t1830r1907b1910],
24	treatment	NN	O	treatment	prep_of	22	SENT_346	[p20l1924t1848r2148b1909, p20l10t1977r253b2056],
25	,	,	O	,	_	0	SENT_346	[p20l1924t1848r2148b1909, p20l10t1977r253b2056],
26	since	IN	O	since	mark	29	SENT_346	[p20l296t1961r513b2038],
27	cysteinyl	NN	O	cysteinyl	nn	28	SENT_346	[p20l549t1960r921b2060],
28	leukotrienes	NNS	O	leukotriene	nsubj	29	SENT_346	[p20l955t1960r1488b2040],
29	increase	VBP	O	increase	advcl	13	SENT_346	[p20l1526t1961r1880b2039],
30	bronchial	JJ	O	bronchial	amod	31	SENT_346	[p20l1917t1960r2148b2039, p20l11t2089r225b2168],
31	tone	NN	O	tone	dobj	29	SENT_346	[p20l272t2093r669b2169],
32	.46	CD	NUMBER	.46	number	33	SENT_346	[p20l272t2093r669b2169],
33	’89	CD	NUMBER	’89	num	34	SENT_346	[p20l272t2093r669b2169],
34	Reductions	NNS	O	reduction	nsubj	45	SENT_346	[p20l716t2089r1209b2174],
35	in	IN	O	in	_	0	SENT_346	[p20l1258t2090r1344b2167],
36	levels	NNS	O	level	prep_in	34	SENT_346	[p20l1390t2089r1628b2169],
37	of	IN	O	of	_	0	SENT_346	[p20l1678t2088r1780b2169],
38	exhaled	VBN	O	exhale	amod	41	SENT_346	[p20l1809t2089r2150b2169],
39	nitric	JJ	O	nitric	amod	41	SENT_346	[p20l10t2219r236b2296],
40	oXide9	NN	O	oxide9	nn	41	SENT_346	[p20l260t2218r560b2297],
41	°	NN	O	°	prep_of	36	SENT_346	[p20l260t2218r560b2297],
42	and	CC	O	and	_	0	SENT_346	[p20l584t2218r741b2297],
43	bronchial	JJ	O	bronchial	amod	44	SENT_346	[p20l765t2218r1170b2297],
44	hyperresponsiveness91	NN	O	hyperresponsiveness91	conj_and	41	SENT_346	[p20l1193t2218r2150b2318],
45	occur	VBP	O	occur	rcmod	31	SENT_346	[p20l11t2374r252b2428],
46	within	IN	O	within	_	0	SENT_346	[p20l276t2348r564b2428],
47	1	CD	DURATION	1	num	48	SENT_346	[p20l600t2355r645b2427],
48	week	NN	NUMBER	week	prep_within	45	SENT_346	[p20l673t2348r898b2428],
49	and	CC	O	and	_	0	SENT_346	[p20l925t2348r1084b2428],
50	2	CD	DURATION	2	num	51	SENT_346	[p20l1116t2355r1163b2427],
51	weeks	NNS	NUMBER	week	conj_and	48	SENT_346	[p20l1193t2348r1456b2428],
52	after	IN	O	after	_	0	SENT_346	[p20l1489t2347r1694b2427],
53	the	DT	O	the	det	54	SENT_346	[p20l1723t2348r1858b2427],
54	initiation	NN	O	initiation	prep_after	45	SENT_346	[p20l1890t2349r2148b2427, p20l11t2477r182b2555],
55	of	IN	O	of	_	0	SENT_346	[p20l222t2475r322b2555],
56	therapy	NN	O	therapy	prep_of	54	SENT_346	[p20l344t2476r689b2576],
57	,	,	O	,	_	0	SENT_346	[p20l344t2476r689b2576],
58	respectively	RB	O	respectively	advmod	45	SENT_346	[p20l737t2476r1268b2576],
59	,	,	O	,	_	0	SENT_346	[p20l737t2476r1268b2576],
60	and	CC	O	and	_	0	SENT_346	[p20l1315t2476r1476b2555],
61	improvements	NNS	O	improvement	nsubj	67	SENT_346	[p20l1517t2477r2147b2576],
62	in	IN	O	in	_	0	SENT_346	[p20l10t2606r95b2683],
63	lung	NN	O	lung	nn	64	SENT_346	[p20l127t2605r325b2707],
64	function	NN	O	function	prep_in	61	SENT_346	[p20l354t2604r732b2685],
65	and	CC	O	and	_	0	SENT_346	[p20l764t2605r925b2685],
66	symptoms	NNS	O	symptom	prep_in	61	SENT_346	[p20l959t2622r1413b2706],
67	occur	VBP	O	occur	conj_and	13	SENT_346	[p20l1449t2631r1694b2685],
68	over	IN	O	over	_	0	SENT_346	[p20l1725t2631r1907b2685],
69	a	DT	O	a	det	70	SENT_346	[p20l1937t2632r1981b2684],
70	period	NN	O	period	prep_over	67	SENT_346	[p20l2012t2631r2148b2706, p20l10t2733r188b2812],
71	of	IN	O	of	_	0	SENT_346	[p20l226t2732r328b2812],
72	weeks	NNS	DURATION	week	prep_of	70	SENT_346	[p20l343t2733r597b2813],
73	or	CC	O	or	_	0	SENT_346	[p20l631t2759r719b2812],
74	months	NNS	DURATION	month	prep_of	70	SENT_346	[p20l747t2733r1251b2812],
75	.5273	CD	NUMBER	.5273	dobj	67	SENT_346	[p20l747t2733r1251b2812],
76	A	DT	O	a	det	78	SENT_346	[p20l1281t2741r1348b2811],
77	trial	NN	O	trial	nn	78	SENT_346	[p20l1376t2733r1547b2811],
78	period	NN	O	period	nsubjpass	85	SENT_346	[p20l1576t2733r1845b2833],
79	of	IN	O	of	_	0	SENT_346	[p20l1877t2732r1975b2812],
80	1	CD	DURATION	1	number	82	SENT_346	[p20l1991t2739r2036b2811],
81	to	TO	DURATION	to	dep	82	SENT_346	[p20l2068t2750r2148b2812],
82	2	CD	DURATION	2	num	83	SENT_346	[p20l10t2869r57b2941],
83	months	NNS	NUMBER	month	prep_of	78	SENT_346	[p20l89t2863r408b2942],
84	is	VBZ	O	be	auxpass	85	SENT_346	[p20l442t2864r508b2941],
85	recommended	VBN	O	recommend	rcmod	75	SENT_346	[p20l545t2863r1190b2942],
86	.	.	O	.	_	0	SENT_346	[p20l545t2863r1190b2942],

1	Montelukast	NNP	O	Montelukast	nsubj	7	SENT_347	[p20l137t2991r682b3071],
2	is	VBZ	O	be	cop	7	SENT_347	[p20l724t2992r790b3069],
3	the	DT	O	the	det	7	SENT_347	[p20l839t2991r974b3069],
4	most	RBS	O	most	advmod	6	SENT_347	[p20l1021t3008r1239b3070],
5	commonly	RB	O	commonly	advmod	6	SENT_347	[p20l1282t2991r1745b3091],
6	used	VBN	O	use	amod	7	SENT_347	[p20l1787t2991r1986b3070],
7	inhibitor	NN	O	inhibitor	_	0	SENT_347	[p20l2032t2992r2148b3069, p20l10t3119r305b3198],
8	of	IN	O	of	_	0	SENT_347	[p20l340t3118r440b3198],
9	the	DT	O	the	det	11	SENT_347	[p20l459t3119r593b3197],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_347	[p20l629t3119r1119b3199],
11	pathway	NN	O	pathway	prep_of	7	SENT_347	[p20l1155t3119r1520b3219],
12	because	IN	O	because	_	0	SENT_347	[p20l1552t3119r1891b3199],
13	of	IN	O	of	dep	27	SENT_347	[p20l1929t3118r2030b3198],
14	its	PRP$	O	its	poss	15	SENT_347	[p20l2047t3120r2147b3197],
15	ease	NN	O	ease	pobj	13	SENT_347	[p20l11t3274r196b3327],
16	of	IN	O	of	_	0	SENT_347	[p20l236t3247r338b3328],
17	use	NN	O	use	prep_of	15	SENT_347	[p20l358t3275r526b3345],
18	,	,	O	,	_	0	SENT_347	[p20l358t3275r526b3345],
19	good	JJ	O	good	amod	21	SENT_347	[p20l571t3248r793b3350],
20	safety	NN	O	safety	nn	21	SENT_347	[p20l833t3247r1093b3349],
21	profile	NN	O	profile	appos	17	SENT_347	[p20l1127t3247r1448b3349],
22	,	,	O	,	_	0	SENT_347	[p20l1127t3247r1448b3349],
23	and	CC	O	and	_	0	SENT_347	[p20l1493t3248r1654b3328],
24	once	RB	DATE	once	dep	27	SENT_347	[p20l1694t3248r2154b3349],
25	—	RB	O	—	advmod	26	SENT_347	[p20l1694t3248r2154b3349],
26	daily	JJ	SET	daily	dep	27	SENT_347	[p20l1694t3248r2154b3349],
27	regimen	NN	O	regimen	prep_because	11	SENT_347	[p20l10t3378r392b3479],
28	.	.	O	.	_	0	SENT_347	[p20l10t3378r392b3479],

1	However	RB	O	however	advmod	8	SENT_348	[p20l432t3385r829b3473],
2	,	,	O	,	_	0	SENT_348	[p20l432t3385r829b3473],
3	use	NN	O	use	nsubj	8	SENT_348	[p20l870t3403r1012b3457],
4	of	IN	O	of	_	0	SENT_348	[p20l1047t3376r1149b3456],
5	this	DT	O	this	det	7	SENT_348	[p20l1165t3377r1326b3455],
6	CysLT1	NN	O	cyslt1	nn	7	SENT_348	[p20l1363t3383r1656b3481],
7	antagonist	NN	O	antagonist	prep_of	3	SENT_348	[p20l1690t3378r2154b3479],
8	ignores	VBZ	O	ignore	_	0	SENT_348	[p20l10t3507r316b3608],
9	possible	JJ	O	possible	amod	10	SENT_348	[p20l351t3506r689b3607],
10	contributions	NNS	O	contribution	dobj	8	SENT_348	[p20l725t3506r1283b3586],
11	of	IN	O	of	_	0	SENT_348	[p20l1319t3505r1418b3585],
12	CysLT2	NN	O	cyslt2	prep_of	10	SENT_348	[p20l1434t3512r1716b3610],
13	to	TO	O	to	_	0	SENT_348	[p20l1752t3523r1832b3585],
14	effects	NNS	O	effect	prep_to	8	SENT_348	[p20l1868t3505r2147b3585],
15	mediated	VBN	O	mediate	partmod	14	SENT_348	[p20l10t3635r412b3714],
16	by	IN	O	by	_	0	SENT_348	[p20l455t3635r553b3735],
17	cysteinyl	NN	O	cysteinyl	nn	18	SENT_348	[p20l592t3635r963b3735],
18	leukotrienes	NNS	O	leukotriene	agent	15	SENT_348	[p20l1005t3635r1563b3715],
19	.	.	O	.	_	0	SENT_348	[p20l1005t3635r1563b3715],

1	Montelukast	NNP	O	Montelukast	nsubj	5	SENT_349	[p20l1609t3635r2154b3715],
2	also	RB	O	also	advmod	5	SENT_349	[p21l10t21r186b100],
3	does	VBZ	O	do	aux	5	SENT_349	[p21l257t21r455b100],
4	not	RB	O	not	neg	5	SENT_349	[p21l527t38r673b100],
5	inhibit	VB	O	inhibit	_	0	SENT_349	[p21l737t21r1037b100],
6	other	JJ	O	other	amod	7	SENT_349	[p21l1102t21r1336b100],
7	products	NNS	O	product	dobj	5	SENT_349	[p21l1401t21r1788b121],
8	of	IN	O	of	_	0	SENT_349	[p21l1860t20r1962b100],
9	the	DT	O	the	det	11	SENT_349	[p21l2013t21r2149b99],
10	5-lipoxygenase	NN	O	5-lipoxygenase	nn	11	SENT_349	[p21l12t150r622b252],
11	pathway	NN	O	pathway	prep_of	7	SENT_349	[p21l649t150r998b251],
12	—	CD	NUMBER	—	tmod	11	SENT_349	[p21l1018t196r1126b203],
13	most	RBS	O	most	advmod	14	SENT_349	[p21l1150t167r1361b230],
14	notably	RB	O	notably	advmod	12	SENT_349	[p21l1384t150r1702b251],
15	,	,	O	,	_	0	SENT_349	[p21l1384t150r1702b251],
16	LTB4	NN	O	ltb4	appos	11	SENT_349	[p21l1734t156r1956b257],
17	.	.	O	.	_	0	SENT_349	[p21l1734t156r1956b257],

1	The	DT	O	the	det	2	SENT_350	[p21l1987t150r2149b229],
2	lack	NN	O	lack	nsubj	10	SENT_350	[p21l9t279r180b359],
3	of	IN	O	of	_	0	SENT_350	[p21l215t278r313b359],
4	an	DT	O	a	det	5	SENT_350	[p21l333t305r435b358],
5	effect	NN	O	effect	prep_of	2	SENT_350	[p21l474t278r707b358],
6	on	IN	O	on	_	0	SENT_350	[p21l742t305r846b359],
7	LTB4	NN	O	ltb4	prep_on	5	SENT_350	[p21l884t286r1085b386],
8	could	MD	O	could	aux	10	SENT_350	[p21l1125t279r1352b359],
9	be	VB	O	be	cop	10	SENT_350	[p21l1392t279r1487b359],
10	important	JJ	O	important	_	0	SENT_350	[p21l1525t280r1971b380],
11	,	,	O	,	_	0	SENT_350	[p21l1525t280r1971b380],
12	because	IN	O	because	mark	20	SENT_350	[p21l2016t279r2148b359, p21l11t434r250b487],
13	this	DT	O	this	det	15	SENT_350	[p21l297t408r462b486],
14	leukocyte	NN	O	leukocyte	nn	15	SENT_350	[p21l509t408r931b508],
15	chemoattractant	NN	O	chemoattractant	nsubjpass	20	SENT_350	[p21l978t408r1711b487],
16	and	CC	O	and	_	0	SENT_350	[p21l1752t408r1913b487],
17	activator	NN	O	activator	nsubjpass	20	SENT_350	[p21l1959t409r2148b486, p21l6t554r229b616],
18	is	VBZ	O	be	auxpass	20	SENT_350	[p21l265t538r331b615],
19	probably	RB	O	probably	advmod	20	SENT_350	[p21l371t537r759b637],
20	involved	VBN	O	involve	advcl	10	SENT_350	[p21l794t537r1156b617],
21	in	IN	O	in	_	0	SENT_350	[p21l1194t538r1279b615],
22	severe	JJ	O	severe	amod	23	SENT_350	[p21l1320t563r1585b616],
23	asthma	NN	O	asthma	prep_in	20	SENT_350	[p21l1624t537r1951b615],
24	and	CC	O	and	_	0	SENT_350	[p21l1989t537r2150b616],
25	asthma	NN	O	asthma	nn	26	SENT_350	[p21l10t666r326b744],
26	exacerbations	NNS	O	exacerbation	conj_and	23	SENT_350	[p21l362t666r965b745],
27	.	.	O	.	_	0	SENT_350	[p21l362t666r965b745],

1	A	DT	O	a	det	5	SENT_351	[p21l1004t674r1071b744],
2	5	CD	NUMBER	5	num	5	SENT_351	[p21l1107t666r1736b767],
3	—	NN	O	—	nn	5	SENT_351	[p21l1107t666r1736b767],
4	lipoXygenase	NN	O	lipoxygenase	nn	5	SENT_351	[p21l1107t666r1736b767],
5	inhibitor	NN	O	inhibitor	nsubj	8	SENT_351	[p21l1773t666r2153b745],
6	might	MD	O	might	aux	8	SENT_351	[p21l10t794r264b896],
7	therefore	RB	O	therefore	advmod	8	SENT_351	[p21l296t793r670b873],
8	have	VB	O	have	_	0	SENT_351	[p21l707t794r892b874],
9	better	JJR	O	better	amod	10	SENT_351	[p21l929t794r1172b873],
10	efficacy	NN	O	efficacy	dobj	8	SENT_351	[p21l1206t793r1530b894],
11	than	IN	O	than	_	0	SENT_351	[p21l1562t794r1754b872],
12	a	DT	O	a	det	14	SENT_351	[p21l1789t820r1834b872],
13	CysLT1	NN	O	cyslt1	nn	14	SENT_351	[p21l1869t800r2150b898],
14	antagonist	NN	O	antagonist	prep_than	8	SENT_351	[p21l10t924r495b1024],
15	.	.	O	.	_	0	SENT_351	[p21l10t924r495b1024],

1	Although	IN	O	although	mark	4	SENT_352	[p21l539t923r950b1024],
2	retrospective	JJ	O	retrospective	amod	3	SENT_352	[p21l992t924r1549b1023],
3	data	NNS	O	datum	nsubj	4	SENT_352	[p21l1592t923r1777b1002],
4	support	VBP	O	support	advcl	21	SENT_352	[p21l1819t940r2154b1023],
5	the	DT	O	the	det	6	SENT_352	[p21l11t1050r144b1128],
6	possibility	NN	O	possibility	dobj	4	SENT_352	[p21l186t1050r641b1150],
7	that	IN	O	that	complm	11	SENT_352	[p21l679t1050r854b1128],
8	zileuton	NN	O	zileuton	nsubj	11	SENT_352	[p21l891t1050r1241b1130],
9	is	VBZ	O	be	cop	11	SENT_352	[p21l1284t1051r1351b1128],
10	more	RBR	O	more	advmod	11	SENT_352	[p21l1396t1076r1617b1129],
11	effective	JJ	O	effective	ccomp	4	SENT_352	[p21l1661t1049r2022b1130],
12	in	IN	O	in	_	0	SENT_352	[p21l2065t1051r2149b1128],
13	severe	JJ	O	severe	amod	14	SENT_352	[p21l11t1205r271b1259],
14	asthma	NN	O	asthma	prep_in	11	SENT_352	[p21l315t1179r637b1257],
15	than	IN	O	than	advmod	11	SENT_352	[p21l680t1179r878b1257],
16	in	IN	O	in	_	0	SENT_352	[p21l921t1180r1005b1257],
17	mild	JJ	O	mild	amod	18	SENT_352	[p21l1049t1179r1249b1258],
18	asthma	NN	O	asthma	prep_in	15	SENT_352	[p21l1292t1179r1712b1274],
19	,92	CD	NUMBER	,92	tmod	15	SENT_352	[p21l1292t1179r1712b1274],
20	there	EX	O	there	expl	21	SENT_352	[p21l1757t1179r1976b1258],
21	are	VBP	O	be	_	0	SENT_352	[p21l2019t1205r2149b1258],
22	no	DT	O	no	det	23	SENT_352	[p21l10t1334r114b1388],
23	data	NNS	O	datum	nsubj	21	SENT_352	[p21l149t1308r327b1388],
24	from	IN	O	from	_	0	SENT_352	[p21l358t1307r564b1388],
25	large	JJ	O	large	amod	27	SENT_352	[p21l596t1308r1063b1410],
26	—	NN	O	—	nn	27	SENT_352	[p21l596t1308r1063b1410],
27	scale	NN	O	scale	prep_from	23	SENT_352	[p21l596t1308r1063b1410],
28	,	,	O	,	_	0	SENT_352	[p21l596t1308r1063b1410],
29	prospective	JJ	O	prospective	amod	30	SENT_352	[p21l1101t1309r1573b1409],
30	comparisons	NNS	O	comparison	appos	27	SENT_352	[p21l1606t1309r2147b1409],
31	of	IN	O	of	_	0	SENT_352	[p21l11t1435r113b1515],
32	an	DT	O	a	det	33	SENT_352	[p21l140t1462r245b1514],
33	inhibitor	NN	O	inhibitor	prep_of	30	SENT_352	[p21l292t1436r686b1515],
34	of	IN	O	of	_	0	SENT_352	[p21l731t1435r833b1515],
35	leukotriene	NN	O	leukotriene	nn	36	SENT_352	[p21l860t1436r1361b1516],
36	synthesis	NN	O	synthesis	prep_of	33	SENT_352	[p21l1410t1436r1815b1536],
37	with	IN	O	with	_	0	SENT_352	[p21l1860t1436r2059b1516],
38	a	DT	O	a	det	40	SENT_352	[p21l2106t1462r2151b1514],
39	CysLT1	NN	O	cyslt1	nn	40	SENT_352	[p21l10t1571r303b1669],
40	antagonist	NN	O	antagonist	prep_with	36	SENT_352	[p21l341t1566r827b1667],
41	.	.	O	.	_	0	SENT_352	[p21l341t1566r827b1667],

1	CARDIOVASCULAR	JJ	O	cardiovascular	amod	2	SENT_353	[p21l11t1841r737b1892],
2	DISEASE	NN	O	disease	nsubj	13	SENT_353	[p21l775t1841r1104b1892],
3	The	DT	O	the	det	4	SENT_353	[p21l7t1942r169b2022],
4	role	NN	O	role	dep	2	SENT_353	[p21l198t1942r359b2022],
5	of	IN	O	of	_	0	SENT_353	[p21l389t1941r490b2022],
6	leukotrienes	NNS	O	leukotriene	prep_of	2	SENT_353	[p21l500t1942r1032b2022],
7	in	IN	O	in	_	0	SENT_353	[p21l1063t1943r1147b2021],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_353	[p21l1177t1942r1810b2022],
9	disease	NN	O	disease	prep_in	6	SENT_353	[p21l1837t1942r2149b2022],
10	has	VBZ	O	have	aux	13	SENT_353	[p21l10t2071r156b2150],
11	been	VBN	O	be	cop	13	SENT_353	[p21l192t2071r395b2151],
12	the	DT	O	the	det	13	SENT_353	[p21l428t2071r562b2150],
13	subject	NN	O	subject	_	0	SENT_353	[p21l597t2071r899b2172],
14	of	IN	O	of	_	0	SENT_353	[p21l928t2070r1028b2151],
15	intense	JJ	O	intense	amod	16	SENT_353	[p21l1043t2072r1355b2150],
16	investigation	NN	O	investigation	prep_of	13	SENT_353	[p21l1388t2072r1947b2173],
17	(	CD	NUMBER	(	num	18	SENT_353	[p21l1986t2078r2148b2163, p21l11t2200r174b2279],
18	Tables	NNS	O	table	dep	16	SENT_353	[p21l1986t2078r2148b2163, p21l11t2200r174b2279],
19	2	CD	NUMBER	2	num	22	SENT_353	[p21l214t2206r261b2278],
20	and	CC	O	and	_	0	SENT_353	[p21l299t2200r456b2279],
21	3	CD	NUMBER	3	num	22	SENT_353	[p21l495t2206r591b2291],
22	)	NN	O	)	dep	18	SENT_353	[p21l495t2206r591b2291],
23	.	.	O	.	_	0	SENT_353	[p21l495t2206r591b2291],

1	Atherosclerotic	JJ	MISC	atherosclerotic	amod	3	SENT_354	[p21l631t2200r1280b2279],
2	vascular	JJ	O	vascular	amod	3	SENT_354	[p21l1313t2200r1665b2280],
3	lesions	NNS	O	lesion	nsubj	4	SENT_354	[p21l1700t2200r1989b2279],
4	express	VBP	O	express	_	0	SENT_354	[p21l2030t2226r2148b2278, p21l8t2354r228b2428],
5	the	DT	O	the	det	7	SENT_354	[p21l259t2328r391b2406],
6	entire	JJ	O	entire	amod	7	SENT_354	[p21l420t2329r663b2406],
7	cassette	NN	O	cassette	nsubj	14	SENT_354	[p21l692t2345r1026b2406],
8	of	IN	O	of	_	0	SENT_354	[p21l1055t2327r1155b2407],
9	leukotriene	NN	O	leukotriene	nn	13	SENT_354	[p21l1163t2328r1643b2408],
10	biosynthet	NN	O	biosynthet	nn	13	SENT_354	[p21l1673t2328r2148b2428],
11	—	CD	NUMBER	—	num	13	SENT_354	[p21l1673t2328r2148b2428],
12	ic	JJ	O	ic	amod	13	SENT_354	[p21l10t2458r79b2536],
13	proteins	NNS	O	protein	prep_of	7	SENT_354	[p21l98t2458r455b2558],
14	(	VBP	O	(	dep	4	SENT_354	[p21l484t2457r1182b2559],
15	5	CD	NUMBER	5	num	17	SENT_354	[p21l484t2457r1182b2559],
16	—	CD	NUMBER	—	num	17	SENT_354	[p21l484t2457r1182b2559],
17	lipoxygenase	NN	O	lipoxygenase	dobj	14	SENT_354	[p21l484t2457r1182b2559],
18	,	,	O	,	_	0	SENT_354	[p21l484t2457r1182b2559],
19	FLAP	NN	O	flap	dobj	14	SENT_354	[p21l1207t2463r1451b2554],
20	,	,	O	,	_	0	SENT_354	[p21l1207t2463r1451b2554],
21	LTA4	NN	O	lta4	nn	22	SENT_354	[p21l1477t2463r1685b2563],
22	hydrolase	NN	O	hydrolase	dobj	14	SENT_354	[p21l1706t2457r2144b2558],
23	,	,	O	,	_	0	SENT_354	[p21l1706t2457r2144b2558],
24	and	CC	O	and	_	0	SENT_354	[p21l10t2586r166b2666],
25	LT	NN	O	lt	nn	26	SENT_354	[p21l193t2592r301b2664],
26	C	NN	O	c	dobj	14	SENT_354	[p21l302t2592r360b2666],
27	4	CD	NUMBER	4	num	29	SENT_354	[p21l365t2651r400b2693],
28	synthase	NN	O	synthase	nn	29	SENT_354	[p21l430t2586r823b2687],
29	)	NN	O	)	dep	26	SENT_354	[p21l430t2586r823b2687],
30	and	CC	O	and	_	0	SENT_354	[p21l855t2586r1011b2666],
31	receptors	NNS	O	receptor	nsubj	32	SENT_354	[p21l1039t2603r1430b2687],
32	(	VBP	O	(	conj_and	14	SENT_354	[p21l1465t2592r1799b2691],
33	CysLT1	NN	O	cyslt1	dobj	32	SENT_354	[p21l1465t2592r1799b2691],
34	,	,	O	,	_	0	SENT_354	[p21l1465t2592r1799b2691],
35	CysL	NN	O	cysl	dobj	32	SENT_354	[p21l1833t2592r2033b2687],
36	2	CD	NUMBER	2	num	35	SENT_354	[p21l2087t2651r2144b2691],
37	,	,	O	,	_	0	SENT_354	[p21l2087t2651r2144b2691],
38	BLT1	NN	O	blt1	dobj	32	SENT_354	[p21l9t2722r231b2819],
39	,	,	O	,	_	0	SENT_354	[p21l9t2722r231b2819],
40	and	CC	O	and	_	0	SENT_354	[p21l272t2715r431b2794],
41	BLT2	NN	O	blt2	nn	42	SENT_354	[p21l465t2721r716b2819],
42	)	NN	O	)	dobj	32	SENT_354	[p21l465t2721r716b2819],
43	.	.	O	.	_	0	SENT_354	[p21l465t2721r716b2819],

1	Moreover	RB	O	moreover	advmod	28	SENT_355	[p21l755t2723r1183b2811],
2	,	,	O	,	_	0	SENT_355	[p21l755t2723r1183b2811],
3	levels	NNS	O	level	nsubj	28	SENT_355	[p21l1223t2715r1456b2795],
4	of	IN	O	of	_	0	SENT_355	[p21l1494t2714r1595b2794],
5	5	CD	NUMBER	5	number	6	SENT_355	[p21l1614t2715r2148b2817],
6	—	CD	NUMBER	—	num	7	SENT_355	[p21l1614t2715r2148b2817],
7	lipoXygen	NN	O	lipoxygen	prep_of	3	SENT_355	[p21l1614t2715r2148b2817],
8	—	CD	NUMBER	—	num	9	SENT_355	[p21l1614t2715r2148b2817],
9	ase	NN	O	ase	nsubj	10	SENT_355	[p21l10t2869r144b2921],
10	correlate	VBP	O	correlate	rcmod	7	SENT_355	[p21l185t2843r563b2922],
11	with	IN	O	with	_	0	SENT_355	[p21l599t2843r795b2923],
12	the	DT	O	the	det	13	SENT_355	[p21l837t2843r971b2921],
13	severity	NN	O	severity	prep_with	10	SENT_355	[p21l1012t2844r1340b2943],
14	of	IN	O	of	_	0	SENT_355	[p21l1377t2842r1478b2922],
15	the	DT	O	the	det	17	SENT_355	[p21l1500t2843r1634b2921],
16	atherosclerotic	JJ	O	atherosclerotic	amod	17	SENT_355	[p21l1674t2843r2148b2922, p21l10t2973r208b3051],
17	lesion93	NN	O	lesion93	prep_of	13	SENT_355	[p21l246t2972r573b3051],
18	and	CC	O	and	_	0	SENT_355	[p21l614t2972r773b3051],
19	plaque	NN	O	plaque	nn	20	SENT_355	[p21l812t2972r1098b3072],
20	instability	NN	O	instability	prep_of	13	SENT_355	[p21l1138t2972r1672b3072],
21	.94	CD	NUMBER	.94	num	22	SENT_355	[p21l1138t2972r1672b3072],
22	Studies	NNS	O	study	dep	17	SENT_355	[p21l1714t2972r2024b3051],
23	in	IN	O	in	_	0	SENT_355	[p21l2065t2973r2149b3050],
24	animals	NNS	O	animal	prep_in	22	SENT_355	[p21l10t3101r356b3180],
25	and	CC	O	and	cc	22	SENT_355	[p21l395t3101r554b3181],
26	in	FW	O	in	nn	27	SENT_355	[p21l590t3102r673b3179],
27	vitro	FW	O	vitro	advmod	22	SENT_355	[p21l705t3102r905b3181],
28	suggest	VBP	O	suggest	_	0	SENT_355	[p21l945t3118r1275b3203],
29	that	IN	O	that	complm	37	SENT_355	[p21l1306t3101r1481b3180],
30	both	CC	O	both	dep	32	SENT_355	[p21l1513t3101r1712b3181],
31	LT	NN	O	lt	nn	32	SENT_355	[p21l1747t3107r1856b3179],
32	B	NN	O	b	nsubj	37	SENT_355	[p21l1857t3107r1914b3180],
33	4	CD	NUMBER	4	dep	32	SENT_355	[p21l1920t3166r1955b3208],
34	and	CC	O	and	_	0	SENT_355	[p21l1990t3101r2149b3181],
35	cysteinyl	NN	O	cysteinyl	nn	36	SENT_355	[p21l11t3230r382b3330],
36	leukotrienes	NNS	O	leukotriene	dep	32	SENT_355	[p21l418t3230r952b3310],
37	participate	VBP	O	participate	ccomp	28	SENT_355	[p21l990t3231r1455b3330],
38	in	IN	O	in	_	0	SENT_355	[p21l1492t3231r1577b3308],
39	the	DT	O	the	det	40	SENT_355	[p21l1615t3230r1749b3308],
40	development	NN	O	development	prep_in	37	SENT_355	[p21l1788t3230r2148b3330, p21l10t3376r233b3438],
41	of	IN	O	of	_	0	SENT_355	[p21l261t3358r361b3439],
42	atherosclerotic	JJ	O	atherosclerotic	amod	43	SENT_355	[p21l374t3359r1018b3439],
43	lesions	NNS	O	lesion	prep_of	40	SENT_355	[p21l1048t3359r1369b3439],
44	.	.	O	.	_	0	SENT_355	[p21l1048t3359r1369b3439],

1	LT	NN	O	lt	nn	2	SENT_356	[p21l1406t3366r1516b3437],
2	B	NN	O	b	nsubj	43	SENT_356	[p21l1516t3366r1572b3438],
3	4	CD	NUMBER	4	nsubj	13	SENT_356	[p21l1578t3424r1638b3466],
4	,	,	O	,	_	0	SENT_356	[p21l1578t3424r1638b3466],
5	by	IN	O	by	_	0	SENT_356	[p21l1677t3359r1774b3460],
6	promoting	VBG	O	promote	prepc_by	3	SENT_356	[p21l1800t3376r2148b3460, p21l10t3489r146b3590],
7	BLT1	NN	O	blt1	nn	8	SENT_356	[p21l177t3488r788b3592],
8	—	NN	O	—	dobj	6	SENT_356	[p21l177t3488r788b3592],
9	mediated	VBN	O	mediate	partmod	8	SENT_356	[p21l177t3488r788b3592],
10	intracellular	JJ	O	intracellular	amod	11	SENT_356	[p21l822t3488r1331b3568],
11	signaling	NN	O	signaling	dobj	9	SENT_356	[p21l1365t3488r1772b3590],
12	,	,	O	,	_	0	SENT_356	[p21l1365t3488r1772b3590],
13	contributes	VBZ	O	contribute	rcmod	2	SENT_356	[p21l1813t3488r2148b3567, p21l10t3633r179b3695],
14	to	TO	O	to	_	0	SENT_356	[p21l228t3633r309b3695],
15	recruitment	NN	O	recruitment	prep_to	13	SENT_356	[p21l357t3617r862b3696],
16	of	IN	O	of	_	0	SENT_356	[p21l904t3615r1004b3695],
17	monocytes	NNS	O	monocyte	prep_of	15	SENT_356	[p21l1032t3633r1491b3716],
18	and	CC	O	and	_	0	SENT_356	[p21l1539t3616r1695b3695],
19	foam	NN	O	foam	nn	20	SENT_356	[p21l1742t3615r2150b3695],
20	—	NN	O	—	conj_and	17	SENT_356	[p21l1742t3615r2150b3695],
21	cell	NN	O	cell	nn	22	SENT_356	[p21l1742t3615r2150b3695],
22	differentiation	NN	O	differentiation	dobj	13	SENT_356	[p22l11t20r740b117],
23	,95	CD	NUMBER	,95	nsubj	32	SENT_356	[p22l11t20r740b117],
24	as	RB	O	as	_	0	SENT_356	[p22l770t47r855b99],
25	well	RB	O	well	_	0	SENT_356	[p22l881t21r1060b101],
26	as	IN	O	as	_	0	SENT_356	[p22l1087t47r1173b99],
27	intimal	JJ	O	intimal	amod	28	SENT_356	[p22l1202t21r1520b99],
28	hyperplasia	NN	O	hyperplasium	nsubj	32	SENT_356	[p22l1547t21r2149b121],
29	.96	CD	NUMBER	.96	num	31	SENT_356	[p22l1547t21r2149b121],
30	Cysteinyl	NN	O	cysteinyl	nn	31	SENT_356	[p22l10t150r400b250],
31	leukotrienes	NNS	O	leukotriene	dep	28	SENT_356	[p22l437t150r970b229],
32	—	VBP	O	—	rcmod	22	SENT_356	[p22l1007t195r1115b203],
33	probably	RB	O	probably	advmod	32	SENT_356	[p22l1147t150r1527b250],
34	involving	VBG	O	involve	_	0	SENT_356	[p22l1560t150r1960b251],
35	signaling	NN	O	signaling	prep_involving	32	SENT_356	[p22l1997t151r2148b251, p22l10t278r291b380],
36	mediated	VBN	O	mediate	partmod	35	SENT_356	[p22l334t278r736b357],
37	by	IN	O	by	_	0	SENT_356	[p22l782t278r880b378],
38	both	CC	O	both	preconj	39	SENT_356	[p22l922t278r1122b357],
39	CysLT1	NN	O	cyslt1	agent	36	SENT_356	[p22l1168t284r1460b382],
40	and	CC	O	and	_	0	SENT_356	[p22l1505t278r1664b357],
41	CysLT2	NN	O	cyslt2	conj_and	39	SENT_356	[p22l1710t284r2003b382],
42	—	CD	NUMBER	—	num	41	SENT_356	[p22l2045t323r2154b331],
43	enhance	VBP	O	enhance	_	0	SENT_356	[p22l11t406r378b484],
44	the	DT	O	the	det	45	SENT_356	[p22l421t406r556b484],
45	recruitment	NN	O	recruitment	dobj	43	SENT_356	[p22l599t407r1126b486],
46	of	IN	O	of	_	0	SENT_356	[p22l1163t405r1265b485],
47	leukocytes	NNS	O	leukocyte	prep_of	45	SENT_356	[p22l1287t406r1752b506],
48	into	IN	O	into	_	0	SENT_356	[p22l1796t407r1969b485],
49	the	DT	O	the	det	51	SENT_356	[p22l2013t406r2149b484],
50	arterial	JJ	O	arterial	amod	51	SENT_356	[p22l10t536r317b614],
51	wall	NN	O	wall	prep_into	43	SENT_356	[p22l340t536r517b615],
52	and	CC	O	and	_	0	SENT_356	[p22l545t536r699b615],
53	contribute	VBP	O	contribute	conj_and	43	SENT_356	[p22l729t536r1154b615],
54	to	TO	O	to	_	0	SENT_356	[p22l1184t553r1264b615],
55	thrombosis	NN	O	thrombosis	prep_to	53	SENT_356	[p22l1294t536r1772b615],
56	and	CC	O	and	_	0	SENT_356	[p22l1802t536r1956b615],
57	vascular	JJ	O	vascular	conj_and	55	SENT_356	[p22l1981t562r2148b615, p22l11t664r231b743],

1	remodeling97	NN	O	remodeling97	_	0	SENT_357	[p22l262t664r925b765],
2	’98	CD	NUMBER	’98	number	3	SENT_357	[p22l262t664r925b765],
3	(	CD	NUMBER	(	dep	1	SENT_357	[p22l966t665r1148b765],
4	Fig	NN	O	fig	dep	3	SENT_357	[p22l966t665r1148b765],
5	.	.	O	.	_	0	SENT_357	[p22l966t665r1148b765],

1	2	CD	NUMBER	2	_	0	SENT_358	[p22l1188t670r1235b742],
2	and	CC	O	and	_	0	SENT_358	[p22l1271t664r1430b743],
3	Table	NNP	O	Table	conj_and	1	SENT_358	[p22l1461t664r1693b743],
4	2	CD	NUMBER	2	number	5	SENT_358	[p22l1729t670r1829b755],
5	)	CD	NUMBER	)	dep	3	SENT_358	[p22l1729t670r1829b755],
6	.	.	O	.	_	0	SENT_358	[p22l1729t670r1829b755],

1	The	DT	O	the	dep	129	SENT_359	[p22l136t791r295b869],
2	incidence	NN	O	incidence	dep	129	SENT_359	[p22l325t791r716b870],
3	of	IN	O	of	dep	129	SENT_359	[p22l748t790r846b870],
4	strokes	NNS	O	stroke	dep	129	SENT_359	[p22l860t791r1154b871],
5	and	CC	O	and	dep	129	SENT_359	[p22l1186t791r1340b870],
6	myocardial	JJ	O	myocardial	dep	129	SENT_359	[p22l1371t791r1836b891],
7	infarctions	NNS	O	infarction	dep	129	SENT_359	[p22l1865t790r2148b869, p22l11t921r219b999],
8	in	IN	O	in	dep	129	SENT_359	[p22l258t921r340b998],
9	European	JJ	MISC	european	dep	129	SENT_359	[p22l376t928r807b1020],
10	,	,	O	,	_	0	SENT_359	[p22l376t928r807b1020],
11	Japanese	JJ	MISC	japanese	dep	129	SENT_359	[p22l839t928r1237b1020],
12	,	,	O	,	_	0	SENT_359	[p22l839t928r1237b1020],
13	and	CC	O	and	dep	129	SENT_359	[p22l1280t920r1436b999],
14	American	JJ	LOCATION	american	dep	129	SENT_359	[p22l1470t921r1885b998],
15	black	JJ	O	black	dep	129	SENT_359	[p22l1923t920r2154b1000],
16	populations	NNS	O	population	dep	129	SENT_359	[p22l8t1048r539b1148],
17	has	VBZ	O	have	dep	129	SENT_359	[p22l586t1048r733b1126],
18	been	VBN	O	be	dep	129	SENT_359	[p22l781t1048r988b1127],
19	linked	VBN	O	link	dep	129	SENT_359	[p22l1032t1048r1312b1128],
20	to	TO	O	to	dep	129	SENT_359	[p22l1357t1065r1440b1127],
21	variants	NNS	O	variant	dep	129	SENT_359	[p22l1482t1049r1837b1127],
22	of	IN	O	of	dep	129	SENT_359	[p22l1885t1047r1986b1127],
23	the	DT	O	the	dep	129	SENT_359	[p22l2013t1048r2149b1126],
24	genes	NNS	O	gene	dep	129	SENT_359	[p22l10t1203r258b1279],
25	that	WDT	O	that	dep	129	SENT_359	[p22l320t1177r498b1256],
26	encode	VBP	O	encode	dep	129	SENT_359	[p22l552t1177r860b1257],
27	FLAP	NN	O	flap	dep	129	SENT_359	[p22l917t1183r1150b1255],
28	and	CC	O	and	dep	129	SENT_359	[p22l1207t1177r1369b1257],
29	LTA4	NN	O	lta4	dep	129	SENT_359	[p22l1426t1183r1638b1284],
30	hydrolase	NN	O	hydrolase	dep	129	SENT_359	[p22l1695t1177r2145b1278],
31	;	:	O	;	_	0	SENT_359	[p22l1695t1177r2145b1278],
32	these	DT	O	these	dep	129	SENT_359	[p22l11t1305r236b1383],
33	variants	NNS	O	variant	dep	129	SENT_359	[p22l270t1306r616b1384],
34	result	VBP	O	result	dep	129	SENT_359	[p22l656t1305r902b1385],
35	in	IN	O	in	dep	129	SENT_359	[p22l934t1306r1019b1383],
36	overproduction	NN	O	overproduction	dep	129	SENT_359	[p22l1058t1305r1719b1405],
37	of	IN	O	of	dep	129	SENT_359	[p22l1758t1304r1859b1384],
38	leukotrienes	NNS	O	leukotriene	dep	129	SENT_359	[p22l1877t1305r2148b1385, p22l11t1435r606b1513],
39	.14	CD	NUMBER	.14	dep	129	SENT_359	[p22l1877t1305r2148b1385, p22l11t1435r606b1513],
40	»	CD	NUMBER	»	dep	129	SENT_359	[p22l1877t1305r2148b1385, p22l11t1435r606b1513],
41	15	CD	NUMBER	15	dep	129	SENT_359	[p22l1877t1305r2148b1385, p22l11t1435r606b1513],
42	’99	CD	NUMBER	’99	dep	129	SENT_359	[p22l1877t1305r2148b1385, p22l11t1435r606b1513],
43	In	IN	O	in	dep	129	SENT_359	[p22l646t1442r736b1512],
44	a	DT	O	a	dep	129	SENT_359	[p22l777t1460r821b1512],
45	4-week	JJ	DURATION	4-week	dep	129	SENT_359	[p22l859t1434r1176b1514],
46	pilot	NN	O	pilot	dep	129	SENT_359	[p22l1211t1434r1418b1534],
47	study	NN	O	study	dep	129	SENT_359	[p22l1455t1434r1705b1534],
48	,	,	O	,	_	0	SENT_359	[p22l1455t1434r1705b1534],
49	Icelandic	JJ	MISC	icelandic	dep	129	SENT_359	[p22l1751t1434r2150b1513],
50	patients	NNS	O	patient	dep	129	SENT_359	[p22l8t1563r360b1662],
51	with	IN	O	with	dep	129	SENT_359	[p22l395t1562r595b1642],
52	a	DT	O	a	dep	129	SENT_359	[p22l631t1588r676b1640],
53	history	NN	O	history	dep	129	SENT_359	[p22l712t1562r1024b1662],
54	of	IN	O	of	dep	129	SENT_359	[p22l1058t1561r1160b1641],
55	myocardial	JJ	O	myocardial	dep	129	SENT_359	[p22l1178t1562r1672b1662],
56	infarction	NN	O	infarction	dep	129	SENT_359	[p22l1708t1561r2149b1641],
57	and	CC	O	and	dep	129	SENT_359	[p22l10t1691r169b1771],
58	one	CD	NUMBER	one	dep	129	SENT_359	[p22l206t1717r355b1771],
59	of	IN	O	of	dep	129	SENT_359	[p22l388t1690r486b1771],
60	the	DT	O	the	dep	129	SENT_359	[p22l501t1691r630b1770],
61	variant	JJ	O	variant	dep	129	SENT_359	[p22l659t1692r953b1771],
62	genes	NNS	O	gene	dep	129	SENT_359	[p22l980t1717r1214b1793],
63	that	WDT	O	that	dep	129	SENT_359	[p22l1250t1691r1417b1770],
64	encodes	VBZ	O	encode	dep	129	SENT_359	[p22l1445t1691r1777b1771],
65	FLAP	NN	O	flap	dep	129	SENT_359	[p22l1811t1698r2033b1769],
66	or	CC	O	or	dep	129	SENT_359	[p22l2065t1717r2153b1771],
67	LTA4	NN	O	lta4	dep	129	SENT_359	[p22l8t1826r210b1927],
68	hydrolase	NN	O	hydrolase	dep	129	SENT_359	[p22l240t1820r663b1921],
69	who	WP	O	who	dep	129	SENT_359	[p22l692t1820r879b1900],
70	were	VBD	O	be	dep	129	SENT_359	[p22l910t1846r1117b1900],
71	treated	VBN	O	treat	dep	129	SENT_359	[p22l1151t1820r1459b1900],
72	with	IN	O	with	dep	129	SENT_359	[p22l1488t1820r1689b1900],
73	the	DT	O	the	dep	129	SENT_359	[p22l1723t1820r1859b1899],
74	investigational	JJ	O	investigational	dep	129	SENT_359	[p22l1893t1821r2148b1900, p22l11t1949r439b2051],
75	FLAP	NN	O	flap	dep	129	SENT_359	[p22l506t1956r738b2027],
76	inhibitor	NN	O	inhibitor	dep	129	SENT_359	[p22l805t1949r1200b2029],
77	DGO31	NN	O	dgo31	dep	129	SENT_359	[p22l1264t1955r1569b2029],
78	(	CD	NUMBER	(	dep	129	SENT_359	[p22l1644t1948r2144b2050],
79	veliﬂapon	NN	O	veliﬂapon	dep	129	SENT_359	[p22l1644t1948r2144b2050],
80	)	NN	O	)	dep	129	SENT_359	[p22l1644t1948r2144b2050],
81	had	VBD	O	have	dep	129	SENT_359	[p22l10t2078r170b2158],
82	a	DT	O	a	dep	129	SENT_359	[p22l203t2105r248b2157],
83	significant	JJ	O	significant	dep	129	SENT_359	[p22l283t2077r755b2180],
84	reduction	NN	O	reduction	dep	129	SENT_359	[p22l782t2078r1195b2158],
85	in	IN	O	in	dep	129	SENT_359	[p22l1227t2079r1310b2156],
86	levels	NNS	O	level	dep	129	SENT_359	[p22l1341t2078r1574b2158],
87	of	IN	O	of	dep	129	SENT_359	[p22l1609t2077r1710b2158],
88	C	NN	O	c	dep	129	SENT_359	[p22l1723t2079r2149b2158],
89	—	CD	NUMBER	—	dep	129	SENT_359	[p22l1723t2079r2149b2158],
90	reactive	JJ	O	reactive	dep	129	SENT_359	[p22l1723t2079r2149b2158],
91	protein	NN	O	protein	dep	129	SENT_359	[p22l8t2207r346b2306],
92	,	,	O	,	_	0	SENT_359	[p22l8t2207r346b2306],
93	a	DT	O	a	dep	129	SENT_359	[p22l401t2232r446b2284],
94	biomarker	NN	O	biomarker	dep	129	SENT_359	[p22l494t2206r944b2286],
95	of	IN	O	of	dep	129	SENT_359	[p22l991t2205r1092b2285],
96	inflammation	NN	O	inflammation	dep	129	SENT_359	[p22l1122t2205r1734b2285],
97	that	IN	O	that	dep	129	SENT_359	[p22l1785t2206r1958b2284],
98	has	VBZ	O	have	dep	129	SENT_359	[p22l2002t2206r2148b2284],
99	been	VBN	O	be	dep	129	SENT_359	[p22l11t2336r214b2415],
100	linked	VBN	O	link	dep	129	SENT_359	[p22l274t2336r547b2415],
101	to	TO	O	to	dep	129	SENT_359	[p22l608t2353r690b2415],
102	cardiovascular	JJ	O	cardiovascular	dep	129	SENT_359	[p22l753t2336r1386b2415],
103	disease	NN	O	disease	dep	129	SENT_359	[p22l1444t2336r1897b2415],
104	.1	NN	NUMBER	.1	dep	129	SENT_359	[p22l1444t2336r1897b2415],
105	°	CD	NUMBER	°	dep	129	SENT_359	[p22l1444t2336r1897b2415],
106	°	CD	NUMBER	°	dep	129	SENT_359	[p22l1444t2336r1897b2415],
107	In	IN	O	in	dep	129	SENT_359	[p22l1956t2344r2046b2414],
108	a	DT	O	a	dep	129	SENT_359	[p22l2107t2362r2151b2414],
109	population	NN	O	population	dep	129	SENT_359	[p22l8t2463r477b2563],
110	of	IN	O	of	dep	129	SENT_359	[p22l521t2462r619b2542],
111	predominantly	RB	O	predominantly	dep	129	SENT_359	[p22l641t2463r1263b2563],
112	white	JJ	O	white	dep	129	SENT_359	[p22l1296t2463r1528b2543],
113	North	NNPS	MISC	North	dep	129	SENT_359	[p22l1569t2463r1820b2542],
114	Americans	NNPS	MISC	Americans	dep	129	SENT_359	[p22l1859t2464r2148b2541, p22l11t2618r219b2689],
115	,	,	O	,	_	0	SENT_359	[p22l1859t2464r2148b2541, p22l11t2618r219b2689],
116	the	DT	O	the	dep	129	SENT_359	[p22l259t2592r393b2671],
117	association	NN	O	association	dep	129	SENT_359	[p22l430t2593r907b2672],
118	of	IN	O	of	dep	129	SENT_359	[p22l943t2591r1043b2672],
119	variants	NNS	O	variant	dep	129	SENT_359	[p22l1055t2593r1394b2672],
120	of	IN	O	of	dep	129	SENT_359	[p22l1432t2591r1532b2672],
121	the	DT	O	the	dep	129	SENT_359	[p22l1549t2592r1681b2671],
122	FLAP	NN	O	flap	dep	129	SENT_359	[p22l1716t2598r1920b2670],
123	gene	NN	O	gene	dep	129	SENT_359	[p22l1952t2618r2149b2694],
124	with	IN	O	with	dep	129	SENT_359	[p22l6t2722r199b2801],
125	cardiovascular	JJ	O	cardiovascular	dep	129	SENT_359	[p22l234t2722r845b2801],
126	disease	NN	O	disease	dep	129	SENT_359	[p22l874t2722r1174b2801],
127	is	VBZ	O	be	dep	129	SENT_359	[p22l1205t2723r1269b2800],
128	less	RBR	O	less	dep	129	SENT_359	[p22l1301t2722r1452b2800],
129	clear	JJ	O	clear	_	0	SENT_359	[p22l1486t2722r1700b2801],
130	.	.	O	.	_	0	SENT_359	[p22l1486t2722r1700b2801],

1	Two	CD	NUMBER	two	num	2	SENT_360	[p22l1734t2728r1907b2801],
2	studies	NNS	O	study	_	0	SENT_360	[p22l1942t2722r2148b2801, p22l10t2852r122b2930],

1	in	IN	O	in	_	0	SENT_361	[p22l172t2852r256b2929],
2	the	DT	O	the	det	4	SENT_361	[p22l306t2851r439b2930],
3	United	NNP	LOCATION	United	nn	4	SENT_361	[p22l488t2851r778b2930],
4	States	NNPS	LOCATION	States	prep_in	5	SENT_361	[p22l829t2857r1079b2930],
5	showed	VBD	O	show	_	0	SENT_361	[p22l1132t2851r1457b2930],
6	no	DT	O	no	det	7	SENT_361	[p22l1506t2877r1612b2930],
7	association	NN	O	association	dobj	5	SENT_361	[p22l1662t2852r2150b2930],
8	between	IN	O	between	_	0	SENT_361	[p22l11t2980r365b3060],
9	variants	NNS	O	variant	prep_between	7	SENT_361	[p22l393t2981r732b3060],
10	of	IN	O	of	_	0	SENT_361	[p22l768t2979r867b3060],
11	FLAP	NN	O	flap	prep_of	9	SENT_361	[p22l880t2986r1085b3059],
12	and	CC	O	and	_	0	SENT_361	[p22l1113t2980r1270b3060],
13	the	DT	O	the	det	14	SENT_361	[p22l1303t2980r1435b3059],
14	risk	NN	O	risk	conj_and	9	SENT_361	[p22l1468t2980r1630b3060],
15	of	IN	O	of	_	0	SENT_361	[p22l1659t2979r1759b3060],
16	ischemic	JJ	O	ischemic	amod	19	SENT_361	[p22l1773t2980r2150b3059],
17	stroke	NN	O	stroke	nn	19	SENT_361	[p22l12t3110r546b3207],
18	,1	CD	NUMBER	,1	num	19	SENT_361	[p22l12t3110r546b3207],
19	°	NN	O	°	prep_of	14	SENT_361	[p22l12t3110r546b3207],
20	1	CD	NUMBER	1	num	21	SENT_361	[p22l12t3110r546b3207],
21	’	NN	O	’	nsubj	5	SENT_361	[p22l12t3110r546b3207],
22	1	CD	NUMBER	1	num	23	SENT_361	[p22l12t3110r546b3207],
23	°	NN	O	°	dep	21	SENT_361	[p22l12t3110r546b3207],
24	2	CD	NUMBER	2	nsubj	31	SENT_361	[p22l12t3110r546b3207],
25	and	CC	O	and	_	0	SENT_361	[p22l583t3110r742b3190],
26	one	CD	NUMBER	one	nsubj	31	SENT_361	[p22l781t3136r933b3190],
27	of	IN	O	of	_	0	SENT_361	[p22l973t3109r1074b3190],
28	the	DT	O	the	det	29	SENT_361	[p22l1094t3110r1228b3190],
29	studies	NNS	O	study	prep_of	24	SENT_361	[p22l1268t3110r1570b3190],
30	also	RB	O	also	advmod	31	SENT_361	[p22l1610t3110r1783b3190],
31	showed	VBD	O	show	rcmod	23	SENT_361	[p22l1825t3110r2150b3190],
32	no	DT	O	no	det	33	SENT_361	[p22l10t3265r115b3318],
33	association	NN	O	association	dobj	31	SENT_361	[p22l152t3240r629b3318],
34	between	IN	O	between	_	0	SENT_361	[p22l665t3239r1019b3318],
35	these	DT	O	these	det	36	SENT_361	[p22l1055t3239r1277b3317],
36	alleles	NNS	O	allele	prep_between	33	SENT_361	[p22l1312t3239r1573b3317],
37	and	CC	O	and	_	0	SENT_361	[p22l1611t3239r1768b3318],
38	myocardial	JJ	O	myocardial	amod	39	SENT_361	[p22l1803t3265r2148b3339, p22l11t3367r166b3446],
39	infarction	NN	O	infarction	dobj	31	SENT_361	[p22l189t3366r732b3446],
40	.1	CD	NUMBER	.1	num	41	SENT_361	[p22l189t3366r732b3446],
41	°	NN	O	°	dep	39	SENT_361	[p22l189t3366r732b3446],
42	2	CD	NUMBER	2	tmod	31	SENT_361	[p22l189t3366r732b3446],
43	Another	DT	O	another	det	44	SENT_361	[p22l752t3367r1098b3446],
44	U.S.	NNP	LOCATION	U.S.	dep	42	SENT_361	[p22l1119t3367r1555b3446],
45	.	.	O	.	_	0	SENT_361	[p22l1119t3367r1555b3446],

1	—	NN	O	—	_	0	SENT_362	[p22l1119t3367r1555b3446],
2	.	.	O	.	_	0	SENT_362	[p22l1119t3367r1555b3446],

1	based	VBN	O	base	_	0	SENT_363	[p22l1119t3367r1555b3446],
2	study	NN	O	study	nsubj	3	SENT_363	[p22l1580t3367r1803b3467],
3	showed	VBD	O	show	ccomp	1	SENT_363	[p22l1825t3367r2150b3447],
4	an	DT	O	a	det	5	SENT_363	[p22l10t3523r113b3575],
5	association	NN	O	association	dobj	3	SENT_363	[p22l159t3498r647b3576],
6	between	IN	O	between	_	0	SENT_363	[p22l694t3497r1054b3576],
7	FLAP	NN	O	flap	nn	8	SENT_363	[p22l1099t3503r1308b3575],
8	variants	NNS	O	variant	prep_between	5	SENT_363	[p22l1345t3498r1691b3576],
9	and	CC	O	and	_	0	SENT_363	[p22l1739t3497r1898b3576],
10	ischemic	JJ	O	ischemic	conj_and	1	SENT_363	[p22l1944t3497r2148b3575, p22l11t3626r216b3703],

1	strokes	NNS	O	stroke	_	0	SENT_364	[p22l256t3625r564b3704],
2	among	IN	O	among	_	0	SENT_364	[p22l605t3651r907b3726],
3	whites	NNS	O	whites	prep_among	1	SENT_364	[p22l939t3625r1223b3704],
4	but	CC	O	but	_	0	SENT_364	[p22l1266t3625r1407b3704],
5	not	RB	O	not	_	0	SENT_364	[p22l1441t3642r1585b3704],
6	blacks	NNS	O	black	conj_negcc	3	SENT_364	[p22l1621t3625r2027b3704],
7	.1	CD	NUMBER	.1	number	8	SENT_364	[p22l1621t3625r2027b3704],
8	°	CD	NUMBER	°	dep	1	SENT_364	[p22l1621t3625r2027b3704],
9	3	CD	NUMBER	3	dep	8	SENT_364	[p22l1621t3625r2027b3704],

1	Other	JJ	O	other	amod	2	SENT_365	[p23l140t20r390b99],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_365	[p23l428t20r1111b120],
3	involving	VBG	O	involve	dep	2	SENT_365	[p23l1155t20r1556b121],
4	the	DT	O	the	det	7	SENT_365	[p23l1595t20r1729b99],
5	5	CD	NUMBER	5	num	7	SENT_365	[p23l1773t20r2148b120],
6	—	NN	O	—	nn	7	SENT_365	[p23l1773t20r2148b120],
7	lipoXy	NN	O	lipoxy	pobj	3	SENT_365	[p23l1773t20r2148b120],
8	—	CD	NUMBER	—	num	10	SENT_365	[p23l1773t20r2148b120],
9	genase	NN	O	genase	nn	10	SENT_365	[p23l10t174r300b249],
10	pathway	NN	O	pathway	nsubjpass	13	SENT_365	[p23l332t148r690b248],
11	have	VBP	O	have	aux	13	SENT_365	[p23l718t148r907b227],
12	been	VBN	O	be	auxpass	13	SENT_365	[p23l941t148r1141b227],
13	linked	VBN	O	link	rcmod	7	SENT_365	[p23l1173t148r1442b227],
14	to	TO	O	to	_	0	SENT_365	[p23l1475t165r1556b227],
15	atheroscleroN	NN	O	atheroscleron	prep_to	13	SENT_365	[p23l1591t148r2148b227, p23l496t334r510b350],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_366	[p23l525t334r605b357],
2	MED	NNP	O	MED	_	0	SENT_366	[p23l620t334r673b350],
3	;	:	O	;	_	0	SENT_366	[p23l726t328r759b355],
4	18	CD	NUMBER	18	num	6	SENT_366	[p23l726t328r759b355],
5	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	6	SENT_366	[p23l792t334r999b357],
6	NOVEMBER	NNP	DATE	NOVEMBER	dep	2	SENT_366	[p23l1037t334r1176b350],
7	1	CD	DATE	1	num	6	SENT_366	[p23l1187t334r1203b355],
8	,	,	DATE	,	_	0	SENT_366	[p23l1187t334r1203b355],
9	2007	CD	DATE	2007	num	10	SENT_366	[p23l1215t334r1279b356],
10	1849	CD	DATE	1849	appos	6	SENT_366	[p23l1940t324r2016b347],

1	e	LS	O	e	dep	4	SENT_367	[p23l739t376r753b392],
2	New	NNP	O	New	nn	4	SENT_367	[p23l762t369r824b392],
3	England	NNP	O	England	nn	4	SENT_367	[p23l833t368r944b399],
4	Journal	NNP	O	Journal	_	0	SENT_367	[p23l952t368r1050b392],
5	of	IN	O	of	prep	4	SENT_367	[p23l1059t368r1088b392],
6	Medicine	NNP	O	Medicine	dep	4	SENT_367	[p23l1095t368r1220b392],

1	Downloaded	VBN	O	download	_	0	SENT_368	[p23l144t409r314b432],
2	from	IN	O	from	_	0	SENT_368	[p23l323t409r387b432],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_368	[p23l396t409r514b439],
4	at	IN	O	at	_	0	SENT_368	[p23l524t413r547b432],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_368	[p23l556t409r738b432],
6	on	IN	O	on	_	0	SENT_368	[p23l748t416r780b432],
7	January	NNP	DATE	January	prep_on	1	SENT_368	[p23l789t409r892b439],
8	5	CD	DATE	5	num	7	SENT_368	[p23l902t409r924b437],
9	,	,	DATE	,	_	0	SENT_368	[p23l902t409r924b437],
10	2014	CD	DATE	2014	num	7	SENT_368	[p23l935t409r1007b432],
11	.	.	O	.	_	0	SENT_368	[p23l935t409r1007b432],

1	For	IN	O	for	_	0	SENT_369	[p23l1018t409r1064b432],
2	personal	JJ	O	personal	amod	3	SENT_369	[p23l1072t409r1185b439],
3	use	NN	O	use	pobj	1	SENT_369	[p23l1194t416r1237b432],
4	only	RB	O	only	advmod	3	SENT_369	[p23l1247t409r1312b439],
5	.	.	O	.	_	0	SENT_369	[p23l1247t409r1312b439],

1	No	DT	O	no	det	3	SENT_370	[p23l1322t409r1362b432],
2	other	JJ	O	other	amod	3	SENT_370	[p23l1372t409r1440b432],
3	uses	NNS	O	use	_	0	SENT_370	[p23l1448t416r1504b432],
4	without	IN	O	without	_	0	SENT_370	[p23l1514t409r1616b432],
5	permission	NN	O	permission	prep_without	3	SENT_370	[p23l1624t409r1776b439],
6	.	.	O	.	_	0	SENT_370	[p23l1624t409r1776b439],

1	Copyright	NN	O	copyright	_	0	SENT_371	[p23l494t450r629b481],
2	©	CD	NUMBER	©	num	6	SENT_371	[p23l638t450r661b474],
3	2007	CD	DATE	2007	num	6	SENT_371	[p23l671t450r736b474],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_371	[p23l746t450r937b474],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_371	[p23l947t450r1055b474],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_371	[p23l1065t450r1170b481],
7	.	.	O	.	_	0	SENT_371	[p23l1065t450r1170b481],

1	All	DT	O	all	det	2	SENT_372	[p23l1181t450r1223b474],
2	rights	NNS	O	rights	nsubj	3	SENT_372	[p23l1232t450r1306b481],
3	reserved	VBN	O	reserve	_	0	SENT_372	[p23l1316t450r1435b474],
4	.	.	O	.	_	0	SENT_372	[p23l1316t450r1435b474],

1	The	DT	O	the	det	3	SENT_373	[p23l672t556r717b577],
2	NEW	NNP	O	NEW	nn	3	SENT_373	[p23l736t558r821b577],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_373	[p23l840t558r1029b577],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_373	[p23l1048t558r1228b584],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_373	[p23l1247t556r1487b583],

1	sis	NN	O	si	_	0	SENT_374	[p23l12t779r140b857],
2	.	.	O	.	_	0	SENT_374	[p23l12t779r140b857],

1	In	IN	O	in	dep	5	SENT_375	[p23l176t786r264b855],
2	women	NNS	O	woman	pobj	1	SENT_375	[p23l291t804r625b874],
3	,	,	O	,	_	0	SENT_375	[p23l291t804r625b874],
4	an	DT	O	a	det	5	SENT_375	[p23l662t804r764b856],
5	A	NN	O	a	_	0	SENT_375	[p23l792t784r1068b857],
6	.	.	O	.	_	0	SENT_375	[p23l792t784r1068b857],

1	—	NN	O	—	_	0	SENT_376	[p23l792t784r1068b857],
2	.	.	O	.	_	0	SENT_376	[p23l792t784r1068b857],

1	to	TO	O	to	_	0	SENT_377	[p23l792t784r1068b857],
2	.	.	O	.	_	0	SENT_377	[p23l792t784r1068b857],

1	—	NN	O	—	_	0	SENT_378	[p23l792t784r1068b857],
2	.	.	O	.	_	0	SENT_378	[p23l792t784r1068b857],

1	C	NN	O	c	nn	2	SENT_379	[p23l792t784r1068b857],
2	transversion	NN	O	transversion	nsubj	18	SENT_379	[p23l1103t779r1622b857],
3	in	IN	O	in	_	0	SENT_379	[p23l1652t779r1735b855],
4	the	DT	O	the	det	6	SENT_379	[p23l1767t778r1898b856],
5	LT	NN	O	lt	nn	6	SENT_379	[p23l1928t784r2036b855],
6	C	NN	O	c	prep_in	2	SENT_379	[p23l2037t784r2095b857],
7	4	CD	NUMBER	4	num	10	SENT_379	[p23l2100t843r2135b884],
8	synthase	NN	O	synthase	nn	10	SENT_379	[p23l12t906r393b1006],
9	promoter	NN	O	promoter	nn	10	SENT_379	[p23l441t923r854b1006],
10	region	NN	O	region	nsubjpass	13	SENT_379	[p23l899t907r1180b1007],
11	has	VBZ	O	have	aux	13	SENT_379	[p23l1229t906r1375b984],
12	been	VBN	O	be	auxpass	13	SENT_379	[p23l1426t906r1631b985],
13	associated	VBN	O	associate	rcmod	6	SENT_379	[p23l1679t906r2134b985],
14	with	IN	O	with	_	0	SENT_379	[p23l7t1034r205b1113],
15	an	DT	O	a	det	16	SENT_379	[p23l246t1060r351b1112],
16	age	NN	O	age	prep_with	13	SENT_379	[p23l392t1034r942b1135],
17	—	RB	O	—	advmod	18	SENT_379	[p23l392t1034r942b1135],
18	adjusted	VBN	O	adjust	_	0	SENT_379	[p23l392t1034r942b1135],
19	risk	NN	O	risk	nsubj	33	SENT_379	[p23l984t1034r1151b1113],
20	of	IN	O	of	_	0	SENT_379	[p23l1189t1033r1290b1113],
21	increased	VBN	O	increase	amod	22	SENT_379	[p23l1313t1034r1730b1113],
22	levels	NNS	O	level	prep_of	19	SENT_379	[p23l1771t1034r2007b1113],
23	of	IN	O	of	_	0	SENT_379	[p23l2051t1033r2153b1113],
24	coronary-artery	JJ	O	coronary-artery	amod	25	SENT_379	[p23l12t1179r699b1261],
25	calcium	NN	O	calcium	prep_of	22	SENT_379	[p23l731t1162r1073b1241],
26	and	CC	O	and	_	0	SENT_379	[p23l1108t1162r1268b1240],
27	an	DT	O	a	det	29	SENT_379	[p23l1303t1188r1406b1239],
28	increased	VBN	O	increase	amod	29	SENT_379	[p23l1441t1162r1859b1240],
29	mean	NN	O	mean	nsubj	33	SENT_379	[p23l1894t1188r2134b1240],
30	intimal	JJ	O	intimal	amod	33	SENT_379	[p23l11t1289r666b1368],
31	—	NN	O	—	nn	33	SENT_379	[p23l11t1289r666b1368],
32	medial	JJ	O	medial	amod	33	SENT_379	[p23l11t1289r666b1368],
33	thickness	NN	O	thickness	xcomp	18	SENT_379	[p23l703t1289r1102b1369],
34	of	IN	O	of	prep	33	SENT_379	[p23l1141t1288r1241b1368],
35	the	DT	O	the	det	37	SENT_379	[p23l1259t1289r1389b1367],
36	carotid	NN	O	carotid	nn	37	SENT_379	[p23l1427t1289r1723b1368],
37	artery	NN	O	artery	dep	43	SENT_379	[p23l1759t1294r2135b1389],
38	,1	CD	NUMBER	,1	dep	37	SENT_379	[p23l1759t1294r2135b1389],
39	°	NN	O	°	dep	43	SENT_379	[p23l1759t1294r2135b1389],
40	4	CD	NUMBER	4	num	39	SENT_379	[p23l1759t1294r2135b1389],
41	a	DT	O	a	det	43	SENT_379	[p23l10t1444r55b1496],
42	surrogate	JJ	O	surrogate	amod	43	SENT_379	[p23l94t1435r509b1519],
43	measure	NN	O	measure	dep	34	SENT_379	[p23l549t1444r917b1497],
44	of	IN	O	of	_	0	SENT_379	[p23l957t1417r1058b1497],
45	atherosclerosis	NN	O	atherosclerosis	prep_of	43	SENT_379	[p23l1078t1418r1762b1497],
46	.	.	O	.	_	0	SENT_379	[p23l1078t1418r1762b1497],

1	Carotid	NN	O	carotid	nn	2	SENT_380	[p23l1807t1418r2134b1497],
2	intimal	NN	O	intimal	dep	61	SENT_380	[p23l10t1547r680b1626],
3	—	CD	NUMBER	—	num	5	SENT_380	[p23l10t1547r680b1626],
4	medial	JJ	O	medial	amod	5	SENT_380	[p23l10t1547r680b1626],
5	thickness	NN	O	thickness	nsubjpass	8	SENT_380	[p23l721t1547r1130b1626],
6	was	VBD	O	be	auxpass	8	SENT_380	[p23l1168t1573r1331b1626],
7	also	RB	O	also	advmod	8	SENT_380	[p23l1374t1547r1545b1626],
8	shown	VBN	O	show	rcmod	2	SENT_380	[p23l1589t1547r1871b1626],
9	to	TO	O	to	aux	11	SENT_380	[p23l1913t1564r1994b1626],
10	be	VB	O	be	auxpass	11	SENT_380	[p23l2038t1547r2134b1626],
11	increased	VBN	O	increase	xcomp	8	SENT_380	[p23l11t1675r419b1754],
12	in	IN	O	in	_	0	SENT_380	[p23l455t1676r538b1753],
13	carriers	NNS	O	carrier	prep_in	11	SENT_380	[p23l574t1676r899b1754],
14	of	IN	O	of	_	0	SENT_380	[p23l938t1674r1037b1754],
15	two	CD	NUMBER	two	num	17	SENT_380	[p23l1055t1692r1213b1754],
16	variant	JJ	O	variant	amod	17	SENT_380	[p23l1246t1676r1549b1754],
17	alleles	NNS	O	allele	prep_of	13	SENT_380	[p23l1580t1675r1845b1754],
18	of	IN	O	of	_	0	SENT_380	[p23l1884t1674r1984b1754],
19	the	DT	O	the	det	21	SENT_380	[p23l2002t1675r2134b1754],
20	5-lipoxygenase	NN	O	5-lipoxygenase	nn	21	SENT_380	[p23l14t1803r666b1904],
21	promoter	NN	O	promoter	prep_of	17	SENT_380	[p23l714t1820r1127b1903],
22	in	IN	O	in	_	0	SENT_380	[p23l1173t1804r1258b1881],
23	a	DT	O	a	det	26	SENT_380	[p23l1307t1829r1351b1881],
24	North	JJ	MISC	north	amod	26	SENT_380	[p23l1397t1803r1660b1882],
25	American	JJ	MISC	american	amod	26	SENT_380	[p23l1706t1804r2134b1882],
26	population	NN	O	population	prep_in	11	SENT_380	[p23l10t1931r601b2031],
27	.1	CD	NUMBER	.1	num	28	SENT_380	[p23l10t1931r601b2031],
28	°	NN	O	°	nsubjpass	39	SENT_380	[p23l10t1931r601b2031],
29	5	CD	NUMBER	5	dep	28	SENT_380	[p23l10t1931r601b2031],
30	The	DT	O	the	det	34	SENT_380	[p23l633t1931r792b2009],
31	same	JJ	O	same	amod	34	SENT_380	[p23l827t1957r1044b2010],
32	5	CD	NUMBER	5	number	33	SENT_380	[p23l1079t1931r1704b2032],
33	—	CD	NUMBER	—	num	34	SENT_380	[p23l1079t1931r1704b2032],
34	lipoXygenase	NN	O	lipoxygenase	dep	28	SENT_380	[p23l1079t1931r1704b2032],
35	promoter	NN	O	promoter	nn	36	SENT_380	[p23l1735t1948r2137b2031],
36	polymorphisms	NNS	O	polymorphism	dep	34	SENT_380	[p23l10t2059r688b2158],
37	were	VBD	O	be	auxpass	39	SENT_380	[p23l728t2085r930b2138],
38	not	RB	O	not	neg	39	SENT_380	[p23l973t2076r1116b2137],
39	associated	VBN	O	associate	rcmod	26	SENT_380	[p23l1153t2059r1598b2137],
40	with	IN	O	with	_	0	SENT_380	[p23l1636t2059r1832b2138],
41	an	DT	O	a	det	45	SENT_380	[p23l1873t2085r1976b2137],
42	in	IN	O	in	quantmod	43	SENT_380	[p23l2019t2060r2133b2136],
43	—	CD	NUMBER	—	num	45	SENT_380	[p23l2019t2060r2133b2136],
44	creased	JJ	O	creased	amod	45	SENT_380	[p23l11t2186r326b2265],
45	risk	NN	O	risk	prep_with	39	SENT_380	[p23l357t2186r518b2266],
46	of	IN	O	of	_	0	SENT_380	[p23l546t2185r645b2265],
47	myocardial	JJ	O	myocardial	amod	48	SENT_380	[p23l659t2186r1130b2286],
48	infarction	NN	O	infarction	prep_of	45	SENT_380	[p23l1160t2185r1579b2265],
49	in	IN	O	in	_	0	SENT_380	[p23l1610t2187r1692b2264],
50	a	DT	O	a	det	54	SENT_380	[p23l1723t2212r1768b2264],
51	Spanish	JJ	LOCATION	spanish	amod	54	SENT_380	[p23l1801t2186r2134b2286],
52	population	NN	O	population	nn	54	SENT_380	[p23l10t2315r606b2415],
53	.1	CD	NUMBER	.1	num	54	SENT_380	[p23l10t2315r606b2415],
54	°	NN	O	°	prep_in	48	SENT_380	[p23l10t2315r606b2415],
55	6	CD	NUMBER	6	tmod	45	SENT_380	[p23l10t2315r606b2415],
56	Taken	VBN	O	take	partmod	55	SENT_380	[p23l638t2315r895b2394],
57	together	RB	O	together	advmod	56	SENT_380	[p23l931t2315r1304b2416],
58	,	,	O	,	_	0	SENT_380	[p23l931t2315r1304b2416],
59	these	DT	O	these	det	60	SENT_380	[p23l1345t2315r1564b2394],
60	data	NNS	O	datum	nsubj	61	SENT_380	[p23l1600t2315r1780b2394],
61	suggest	VBP	O	suggest	_	0	SENT_380	[p23l1815t2332r2139b2416],
62	a	DT	O	a	det	63	SENT_380	[p23l10t2468r55b2520],
63	role	NN	O	role	dobj	61	SENT_380	[p23l90t2442r250b2521],
64	of	IN	O	of	_	0	SENT_380	[p23l288t2441r388b2521],
65	leukotrienes	NNS	O	leukotriene	prep_of	63	SENT_380	[p23l406t2442r935b2522],
66	in	IN	O	in	_	0	SENT_380	[p23l974t2443r1057b2520],
67	the	DT	O	the	det	68	SENT_380	[p23l1095t2442r1228b2520],
68	development	NN	O	development	prep_in	65	SENT_380	[p23l1266t2442r1815b2542],
69	of	IN	O	of	_	0	SENT_380	[p23l1847t2441r1948b2521],
70	atherosclerotic	JJ	O	atherosclerotic	amod	72	SENT_380	[p23l1966t2442r2133b2520, p23l11t2571r509b2650],
71	vascular	JJ	O	vascular	amod	72	SENT_380	[p23l537t2571r895b2650],
72	disease	NN	O	disease	prep_of	68	SENT_380	[p23l926t2571r1260b2667],
73	,	,	O	,	_	0	SENT_380	[p23l926t2571r1260b2667],
74	and	CC	O	and	_	0	SENT_380	[p23l1299t2571r1456b2650],
75	genetic	JJ	O	genetic	amod	76	SENT_380	[p23l1489t2572r1797b2672],
76	studies	NNS	O	study	nsubj	77	SENT_380	[p23l1832t2571r2132b2650],
77	suggest	VBP	O	suggest	conj_and	61	SENT_380	[p23l12t2716r346b2800],
78	a	DT	O	a	det	82	SENT_380	[p23l377t2725r422b2777],
79	population	NN	O	population	nn	82	SENT_380	[p23l455t2698r1314b2799],
80	—	CD	NUMBER	—	num	82	SENT_380	[p23l455t2698r1314b2799],
81	specific	JJ	O	specific	amod	82	SENT_380	[p23l455t2698r1314b2799],
82	influence	NN	O	influence	nsubj	87	SENT_380	[p23l1349t2698r1762b2778],
83	of	IN	O	of	_	0	SENT_380	[p23l1800t2698r1901b2778],
84	polymorphisms	NNS	O	polymorphism	prep_of	82	SENT_380	[p23l1918t2699r2133b2799, p23l11t2827r485b2927],
85	in	IN	O	in	_	0	SENT_380	[p23l522t2828r604b2905],
86	genes	NNS	O	gene	prep_in	84	SENT_380	[p23l638t2853r871b2928],
87	encoding	VBG	O	encode	dep	77	SENT_380	[p23l909t2827r1295b2928],
88	leukotriene	NN	O	leukotriene	nn	90	SENT_380	[p23l1326t2827r1791b2906],
89	biosyn	NN	O	biosyn	nn	90	SENT_380	[p23l1827t2827r2132b2927],
90	—	NN	O	—	nsubj	92	SENT_380	[p23l1827t2827r2132b2927],
91	thetic	JJ	O	thetic	amod	92	SENT_380	[p23l11t2955r254b3033],
92	enzymes	NNS	O	enzyme	xcomp	87	SENT_380	[p23l294t2981r666b3054],
93	or	CC	O	or	_	0	SENT_380	[p23l708t2981r797b3033],
94	leukotriene	NN	O	leukotriene	nn	95	SENT_380	[p23l832t2955r1319b3034],
95	receptors	NNS	O	receptor	conj_or	92	SENT_380	[p23l1358t2972r1779b3054],
96	.	.	O	.	_	0	SENT_380	[p23l1358t2972r1779b3054],

1	CANCER	NNP	O	CANCER	nn	3	SENT_381	[p23l12t3229r326b3279],
2	Chronic	JJ	O	chronic	amod	3	SENT_381	[p23l11t3328r360b3407],
3	inﬂammation	NN	O	inﬂammation	nsubj	5	SENT_381	[p23l402t3327r1022b3407],
4	can	MD	O	can	aux	5	SENT_381	[p23l1066t3354r1218b3406],
5	increase	VB	O	increase	_	0	SENT_381	[p23l1260t3329r1620b3406],
6	the	DT	O	the	det	7	SENT_381	[p23l1665t3328r1800b3407],
7	risk	NN	O	risk	dobj	5	SENT_381	[p23l1844t3328r2011b3407],
8	of	IN	O	of	_	0	SENT_381	[p23l2051t3327r2152b3407],
9	cancer	NN	O	cancer	prep_of	7	SENT_381	[p23l12t3482r311b3535],
10	.	.	O	.	_	0	SENT_381	[p23l12t3482r311b3535],

1	Cysteinyl	NN	O	cysteinyl	nn	2	SENT_382	[p23l357t3456r744b3556],
2	leukotrienes	NNS	O	leukotriene	nsubj	23	SENT_382	[p23l784t3456r1312b3535],
3	and	CC	O	and	_	0	SENT_382	[p23l1354t3456r1512b3535],
4	LTB4	NN	O	ltb4	conj_and	2	SENT_382	[p23l1551t3462r1757b3562],
5	that	WDT	O	that	nsubjpass	7	SENT_382	[p23l1798t3456r1970b3534],
6	are	VBP	O	be	auxpass	7	SENT_382	[p23l2004t3482r2134b3534],
7	released	VBN	O	release	rcmod	2	SENT_382	[p23l11t3584r346b3663],
8	by	IN	O	by	_	0	SENT_382	[p23l376t3584r471b3684],
9	inﬂammatory	JJ	O	inﬂammatory	amod	10	SENT_382	[p23l496t3583r1082b3684],
10	cells	NNS	O	cell	agent	7	SENT_382	[p23l1108t3584r1287b3663],
11	infiltrating	VBG	O	infiltrate	partmod	10	SENT_382	[p23l1318t3583r1780b3685],
12	the	DT	O	the	det	13	SENT_382	[p23l1807t3584r1935b3662],
13	mucosa	NN	O	mucosa	dobj	11	SENT_382	[p23l1965t3610r2133b3663, p23l11t3738r204b3791],
14	of	IN	O	of	_	0	SENT_382	[p23l245t3711r346b3791],
15	the	DT	O	the	det	16	SENT_382	[p23l371t3712r505b3790],
16	gut	NN	O	gut	prep_of	13	SENT_382	[p23l548t3729r694b3813],
17	in	IN	O	in	_	0	SENT_382	[p23l730t3713r814b3790],
18	inﬂammatory	JJ	O	inﬂammatory	amod	20	SENT_382	[p23l856t3711r1478b3812],
19	bowel	NN	O	bowel	nn	20	SENT_382	[p23l1517t3712r1774b3791],
20	disease	NN	O	disease	prep_in	16	SENT_382	[p23l1817t3712r2134b3791],
21	may	MD	O	may	aux	23	SENT_382	[p24l11t49r190b123],
22	be	VB	O	be	cop	23	SENT_382	[p24l216t23r312b102],
23	mediators	NNS	O	mediator	_	0	SENT_382	[p24l342t23r773b102],
24	of	IN	O	of	_	0	SENT_382	[p24l806t22r906b102],
25	such	JJ	O	such	amod	27	SENT_382	[p24l918t23r1112b102],
26	malignant	JJ	O	malignant	amod	27	SENT_382	[p24l1142t23r1593b124],
27	transformation	NN	O	transformation	prep_of	23	SENT_382	[p24l1618t22r2133b102, p24l11t152r178b230],
28	(	CD	NUMBER	(	num	29	SENT_382	[p24l215t151r468b242],
29	Table	NNP	O	Table	dep	27	SENT_382	[p24l215t151r468b242],
30	2	CD	NUMBER	2	number	31	SENT_382	[p24l500t157r598b242],
31	)	CD	NUMBER	)	dep	29	SENT_382	[p24l500t157r598b242],
32	.	.	O	.	_	0	SENT_382	[p24l500t157r598b242],

1	LT	NN	O	lt	nsubj	22	SENT_383	[p24l635t157r743b228],
2	D	NN	O	d	amod	1	SENT_383	[p24l743t157r811b229],
3	4	CD	NUMBER	4	number	2	SENT_383	[p24l813t216r849b257],
4	activates	VBZ	O	activate	_	0	SENT_383	[p24l880t152r1236b230],
5	B-catenin	NN	MISC	b-catenin	nn	6	SENT_383	[p24l1265t152r1677b251],
6	signaling	NN	O	signaling	dobj	4	SENT_383	[p24l1711t151r2128b252],
7	,	,	O	,	_	0	SENT_383	[p24l1711t151r2128b252],
8	leading	VBG	O	lead	partmod	6	SENT_383	[p24l10t279r330b380],
9	to	TO	O	to	_	0	SENT_383	[p24l362t296r443b358],
10	the	DT	O	the	det	13	SENT_383	[p24l480t279r613b358],
11	up	RB	O	up	advmod	13	SENT_383	[p24l648t279r1237b380],
12	—	JJ	O	—	amod	13	SENT_383	[p24l648t279r1237b380],
13	regulation	NN	O	regulation	prep_to	8	SENT_383	[p24l648t279r1237b380],
14	of	IN	O	of	_	0	SENT_383	[p24l1273t278r1373b358],
15	the	DT	O	the	det	19	SENT_383	[p24l1390t279r1522b357],
16	antiapoptotic	JJ	O	antiapoptotic	amod	19	SENT_383	[p24l1557t280r2134b379],
17	protein	NN	O	protein	nn	19	SENT_383	[p24l10t408r308b506],
18	Bcl	NN	O	bcl	nn	19	SENT_383	[p24l332t407r531b485],
19	—	NN	O	—	prep_of	13	SENT_383	[p24l332t407r531b485],
20	2	CD	NUMBER	2	dep	19	SENT_383	[p24l332t407r531b485],
21	and	CC	O	and	_	0	SENT_383	[p24l557t407r711b485],
22	increased	VBD	O	increase	conj_and	4	SENT_383	[p24l735t407r1126b485],
23	cell	NN	O	cell	nn	24	SENT_383	[p24l1153t407r1292b485],
24	survival	NN	O	survival	dobj	22	SENT_383	[p24l1319t407r1765b486],
25	.1	CD	NUMBER	.1	num	24	SENT_383	[p24l1319t407r1765b486],
26	°	NN	O	°	dep	39	SENT_383	[p24l1319t407r1765b486],
27	7	CD	NUMBER	7	num	26	SENT_383	[p24l1319t407r1765b486],
28	As	IN	O	as	dep	39	SENT_383	[p24l1788t414r1891b485],
29	compared	VBN	O	compare	_	0	SENT_383	[p24l1920t433r2133b485, p24l10t535r257b634],
30	with	IN	O	with	prepc_compared_with	39	SENT_383	[p24l314t535r513b614],
31	normal	JJ	O	normal	amod	34	SENT_383	[p24l575t535r894b613],
32	intestinal	JJ	O	intestinal	amod	34	SENT_383	[p24l955t535r1374b613],
33	epithelial	JJ	O	epithelial	amod	34	SENT_383	[p24l1437t535r1848b634],
34	cells	NNS	O	cell	pobj	39	SENT_383	[p24l1910t535r2129b630],
35	,	,	O	,	_	0	SENT_383	[p24l1910t535r2129b630],
36	colorectal	JJ	O	colorectal	amod	37	SENT_383	[p24l11t664r413b743],
37	adenocarcinomas	NNS	O	adenocarcinoma	nsubj	39	SENT_383	[p24l439t664r1165b743],
38	have	VBP	O	have	aux	39	SENT_383	[p24l1195t664r1378b743],
39	increased	VBN	O	increase	advcl	64	SENT_383	[p24l1405t664r1797b743],
40	nuclear	JJ	O	nuclear	amod	41	SENT_383	[p24l1824t664r2137b743],
41	localization	NN	O	localization	dobj	39	SENT_383	[p24l10t792r518b871],
42	of	IN	O	of	_	0	SENT_383	[p24l558t791r658b871],
43	CysLT1	NN	O	cyslt1	prep_of	41	SENT_383	[p24l678t798r991b896],
44	,	,	O	,	_	0	SENT_383	[p24l678t798r991b896],
45	which	WDT	O	which	nsubj	47	SENT_383	[p24l1030t792r1293b872],
46	may	MD	O	may	aux	47	SENT_383	[p24l1331t818r1511b892],
47	facilitate	VB	O	facilitate	rcmod	43	SENT_383	[p24l1544t791r1917b871],
48	proliferation	NN	O	proliferation	dobj	47	SENT_383	[p24l1954t818r2133b893, p24l10t920r407b1000],
49	of	IN	O	of	_	0	SENT_383	[p24l438t920r538b1000],
50	the	DT	O	the	det	52	SENT_383	[p24l550t921r683b999],
51	malignant	JJ	O	malignant	amod	52	SENT_383	[p24l713t921r1164b1022],
52	cells	NNS	O	cell	prep_of	48	SENT_383	[p24l1190t921r1377b999],
53	by	IN	O	by	_	0	SENT_383	[p24l1410t921r1507b1021],
54	kinase	NN	O	kinase	nn	55	SENT_383	[p24l1532t921r1811b1000],
55	signaling	NN	O	signaling	prep_by	47	SENT_383	[p24l1843t921r2133b1022, p24l10t1050r289b1150],
56	.1	CD	NUMBER	.1	num	57	SENT_383	[p24l1843t921r2133b1022, p24l10t1050r289b1150],
57	°	NN	O	°	dep	55	SENT_383	[p24l1843t921r2133b1022, p24l10t1050r289b1150],
58	8	CD	NUMBER	8	num	60	SENT_383	[p24l1843t921r2133b1022, p24l10t1050r289b1150],
59	LTB4	NN	O	ltb4	nn	60	SENT_383	[p24l329t1055r539b1155],
60	signaling	NN	O	signaling	nsubjpass	64	SENT_383	[p24l579t1049r992b1150],
61	has	VBZ	O	have	aux	64	SENT_383	[p24l1029t1049r1175b1127],
62	also	RB	O	also	advmod	64	SENT_383	[p24l1217t1049r1392b1128],
63	been	VBN	O	be	auxpass	64	SENT_383	[p24l1434t1049r1640b1128],
64	associated	VBN	O	associate	dep	22	SENT_383	[p24l1679t1049r2134b1128],
65	with	IN	O	with	_	0	SENT_383	[p24l6t1176r198b1256],
66	cancer	NN	O	cancer	nn	69	SENT_383	[p24l232t1176r684b1254],
67	—	NN	O	—	nn	69	SENT_383	[p24l232t1176r684b1254],
68	cell	NN	O	cell	nn	69	SENT_383	[p24l232t1176r684b1254],
69	proliferation	NN	O	proliferation	prep_with	64	SENT_383	[p24l715t1175r1269b1276],
70	.	.	O	.	_	0	SENT_383	[p24l715t1175r1269b1276],

1	In	IN	O	in	_	0	SENT_384	[p24l1305t1184r1393b1254],
2	colon	NN	O	colon	nn	5	SENT_384	[p24l1427t1176r1968b1255],
3	—	NN	O	—	nn	5	SENT_384	[p24l1427t1176r1968b1255],
4	cancer	NN	O	cancer	nn	5	SENT_384	[p24l1427t1176r1968b1255],
5	tissue	NN	O	tissue	prep_in	11	SENT_384	[p24l1998t1177r2133b1254, p24l12t1330r147b1384],
6	and	CC	O	and	_	0	SENT_384	[p24l179t1304r334b1383],
7	cell	NN	O	cell	nn	8	SENT_384	[p24l366t1304r509b1382],
8	lines	NNS	O	line	prep_in	11	SENT_384	[p24l539t1304r761b1400],
9	,	,	O	,	_	0	SENT_384	[p24l539t1304r761b1400],
10	there	EX	O	there	expl	11	SENT_384	[p24l798t1304r1011b1382],
11	is	VBZ	O	be	_	0	SENT_384	[p24l1042t1305r1107b1382],
12	increased	VBN	O	increase	amod	13	SENT_384	[p24l1140t1304r1540b1383],
13	expression	NN	O	expression	nsubj	11	SENT_384	[p24l1573t1305r2020b1404],
14	of	IN	O	of	_	0	SENT_384	[p24l2053t1303r2153b1383],
15	BLT1	NN	O	blt1	prep_of	13	SENT_384	[p24l10t1439r223b1536],
16	,	,	O	,	_	0	SENT_384	[p24l10t1439r223b1536],
17	and	CC	O	and	_	0	SENT_384	[p24l253t1433r406b1512],
18	when	WRB	O	when	advmod	22	SENT_384	[p24l427t1433r654b1512],
19	BLT	NNP	O	BLT	nsubjpass	22	SENT_384	[p24l678t1439r870b1536],
20	,	,	O	,	_	0	SENT_384	[p24l678t1439r870b1536],
21	is	VBZ	O	be	auxpass	22	SENT_384	[p24l895t1434r958b1511],
22	suppressed	VBN	O	suppress	advcl	34	SENT_384	[p24l988t1433r1444b1533],
23	in	IN	O	in	_	0	SENT_384	[p24l1468t1434r1549b1510],
24	cultured	VBN	O	culture	prepc_in	22	SENT_384	[p24l1576t1433r1918b1512],
25	cells	NNS	O	cell	dobj	24	SENT_384	[p24l1944t1433r2132b1511],
26	by	IN	O	by	_	0	SENT_384	[p24l11t1561r108b1661],
27	a	DT	O	a	det	28	SENT_384	[p24l137t1587r182b1639],
28	small	JJ	O	small	prep_by	24	SENT_384	[p24l215t1561r449b1639],
29	interfering	VBG	O	interfere	partmod	28	SENT_384	[p24l481t1560r947b1662],
30	RNA	NN	MISC	rna	dobj	29	SENT_384	[p24l976t1568r1207b1657],
31	,	,	O	,	_	0	SENT_384	[p24l976t1568r1207b1657],
32	cell	NN	O	cell	nn	33	SENT_384	[p24l1247t1561r1393b1640],
33	proliferation	NN	O	proliferation	nsubj	34	SENT_384	[p24l1424t1560r1969b1661],
34	decreases	VBZ	O	decrease	conj_and	11	SENT_384	[p24l2003t1561r2133b1640, p24l11t1695r458b1769],
35	.1	CD	NUMBER	.1	number	36	SENT_384	[p24l2003t1561r2133b1640, p24l11t1695r458b1769],
36	°	CD	NUMBER	°	num	37	SENT_384	[p24l2003t1561r2133b1640, p24l11t1695r458b1769],
37	9	CD	NUMBER	9	dobj	34	SENT_384	[p24l2003t1561r2133b1640, p24l11t1695r458b1769],

1	Malignant	JJ	O	malignant	amod	2	SENT_385	[p24l137t1818r589b1919],
2	cells	NNS	O	cell	nsubj	21	SENT_385	[p24l617t1818r804b1896],
3	in	IN	O	in	_	0	SENT_385	[p24l838t1819r921b1896],
4	colorectal	JJ	O	colorectal	prep_in	2	SENT_385	[p24l954t1818r1397b1914],
5	,	,	O	,	_	0	SENT_385	[p24l954t1818r1397b1914],
6	esophageal	NN	O	esophageal	prep_in	2	SENT_385	[p24l1435t1818r1939b1919],
7	,	,	O	,	_	0	SENT_385	[p24l1435t1818r1939b1919],
8	and	CC	O	and	_	0	SENT_385	[p24l1976t1818r2134b1897],
9	pancreatic	JJ	O	pancreatic	amod	10	SENT_385	[p24l10t1947r446b2046],
10	adenocarcinomas	NNS	O	adenocarcinoma	conj_and	4	SENT_385	[p24l482t1946r1247b2042],
11	,	,	O	,	_	0	SENT_385	[p24l482t1946r1247b2042],
12	bronchogenic	JJ	O	bronchogenic	amod	13	SENT_385	[p24l1290t1946r1865b2047],
13	carcinoma	NN	O	carcinoma	prep_in	2	SENT_385	[p24l1902t1947r2132b2024, p24l11t2100r268b2169],
14	,	,	O	,	_	0	SENT_385	[p24l1902t1947r2132b2024, p24l11t2100r268b2169],
15	melanoma	NN	O	melanoma	prep_in	2	SENT_385	[p24l312t2074r774b2169],
16	,	,	O	,	_	0	SENT_385	[p24l312t2074r774b2169],
17	lymphomas	NNS	O	lymphoma	prep_in	2	SENT_385	[p24l816t2074r1322b2173],
18	,	,	O	,	_	0	SENT_385	[p24l816t2074r1322b2173],
19	and	CC	O	and	_	0	SENT_385	[p24l1366t2074r1520b2152],
20	leukemias	NNS	O	leukemia	prep_in	2	SENT_385	[p24l1557t2074r1975b2153],
21	express	VBP	O	express	_	0	SENT_385	[p24l2016t2100r2132b2152, p24l10t2228r227b2302],
22	large	JJ	O	large	amod	23	SENT_385	[p24l260t2202r470b2303],
23	amounts	NNS	O	amount	dobj	21	SENT_385	[p24l501t2219r871b2281],
24	of	IN	O	of	_	0	SENT_385	[p24l905t2201r1004b2281],
25	5	CD	NUMBER	5	number	26	SENT_385	[p24l1019t2202r1667b2303],
26	—	CD	NUMBER	—	num	27	SENT_385	[p24l1019t2202r1667b2303],
27	lipoxygenase	NN	O	lipoxygenase	prep_of	23	SENT_385	[p24l1019t2202r1667b2303],
28	,	,	O	,	_	0	SENT_385	[p24l1019t2202r1667b2303],
29	FLAP	NN	O	flap	dobj	21	SENT_385	[p24l1703t2209r1939b2298],
30	,	,	O	,	_	0	SENT_385	[p24l1703t2209r1939b2298],
31	and	CC	O	and	_	0	SENT_385	[p24l1976t2202r2134b2281],
32	other	JJ	O	other	amod	35	SENT_385	[p24l12t2330r240b2408],
33	leukotriene	NN	O	leukotriene	nn	35	SENT_385	[p24l274t2330r760b2409],
34	biosynthetic	JJ	O	biosynthetic	amod	35	SENT_385	[p24l799t2330r1326b2429],
35	enzymes	NNS	O	enzyme	dobj	21	SENT_385	[p24l1365t2335r2008b2429],
36	.11	CD	NUMBER	.11	number	37	SENT_385	[p24l1365t2335r2008b2429],
37	°	CD	NUMBER	°	num	38	SENT_385	[p24l1365t2335r2008b2429],
38	»	NN	O	»	nsubj	61	SENT_385	[p24l1365t2335r2008b2429],
39	111	CD	NUMBER	111	num	38	SENT_385	[p24l1365t2335r2008b2429],
40	In	IN	O	in	_	0	SENT_385	[p24l2045t2337r2134b2407],
41	one	CD	NUMBER	one	num	42	SENT_385	[p24l11t2484r158b2537],
42	study	NN	O	study	prep_in	38	SENT_385	[p24l194t2458r427b2558],
43	,	,	O	,	_	0	SENT_385	[p24l194t2458r427b2558],
44	treatment	NN	O	treatment	appos	42	SENT_385	[p24l466t2475r873b2537],
45	of	IN	O	of	_	0	SENT_385	[p24l903t2457r1001b2537],
46	5	CD	NUMBER	5	number	47	SENT_385	[p24l1019t2458r2137b2559],
47	—	CD	NUMBER	—	num	49	SENT_385	[p24l1019t2458r2137b2559],
48	lipoxygenase	NN	O	lipoxygenase	nn	49	SENT_385	[p24l1019t2458r2137b2559],
49	—	NN	O	—	prep_of	44	SENT_385	[p24l1019t2458r2137b2559],
50	expressing	VBG	O	express	partmod	38	SENT_385	[p24l1019t2458r2137b2559],
51	esophageal	NN	O	esophageal	nn	54	SENT_385	[p24l12t2586r484b2687],
52	cancer	NN	O	cancer	nn	54	SENT_385	[p24l513t2612r789b2664],
53	cell	NN	O	cell	nn	54	SENT_385	[p24l816t2586r959b2664],
54	lines	NNS	O	line	dobj	50	SENT_385	[p24l987t2586r1184b2664],
55	with	IN	O	with	_	0	SENT_385	[p24l1211t2586r1404b2665],
56	a	DT	O	a	det	60	SENT_385	[p24l1433t2612r1477b2664],
57	5	CD	NUMBER	5	num	60	SENT_385	[p24l1507t2586r2134b2687],
58	—	NN	O	—	nn	60	SENT_385	[p24l1507t2586r2134b2687],
59	lipoxygenase	NN	O	lipoxygenase	nn	60	SENT_385	[p24l1507t2586r2134b2687],
60	inhibitor	NN	O	inhibitor	prep_with	54	SENT_385	[p24l10t2714r393b2793],
61	decreased	VBD	O	decrease	rcmod	35	SENT_385	[p24l443t2714r866b2793],
62	cell	NN	O	cell	nn	63	SENT_385	[p24l918t2714r1064b2793],
63	survival	NN	O	survival	dobj	61	SENT_385	[p24l1117t2714r1588b2793],
64	.112	CD	NUMBER	.112	num	63	SENT_385	[p24l1117t2714r1588b2793],
65	The	DT	O	the	det	66	SENT_385	[p24l1637t2714r1797b2792],
66	effects	NNS	O	effect	nsubjpass	80	SENT_385	[p24l1850t2713r2132b2793],
67	of	IN	O	of	_	0	SENT_385	[p24l12t2841r113b2921],
68	the	DT	O	the	det	69	SENT_385	[p24l149t2842r284b2921],
69	inhibitor	NN	O	inhibitor	prep_of	66	SENT_385	[p24l339t2842r730b2921],
70	paralleled	VBD	O	parallel	dep	61	SENT_385	[p24l780t2842r1215b2942],
71	reductions	NNS	O	reduction	dobj	70	SENT_385	[p24l1270t2842r1731b2921],
72	in	IN	O	in	_	0	SENT_385	[p24l1788t2843r1872b2920],
73	LT	NN	O	lt	nn	74	SENT_385	[p24l1925t2849r2035b2920],
74	B	NN	O	b	prep_in	70	SENT_385	[p24l2037t2849r2093b2920],
75	4	CD	NUMBER	4	num	76	SENT_385	[p24l2100t2907r2135b2948],
76	production	NN	O	production	dep	74	SENT_385	[p24l10t2970r484b3070],
77	and	CC	O	and	_	0	SENT_385	[p24l526t2970r685b3049],
78	could	MD	O	could	aux	80	SENT_385	[p24l727t2970r962b3049],
79	be	VB	O	be	auxpass	80	SENT_385	[p24l1006t2970r1102b3049],
80	reversed	VBN	O	reverse	dep	61	SENT_385	[p24l1145t2970r1500b3049],
81	by	IN	O	by	_	0	SENT_385	[p24l1544t2970r1641b3070],
82	exogenous	JJ	O	exogenous	amod	83	SENT_385	[p24l1679t2996r2131b3071],
83	LTB4	NN	O	ltb4	agent	80	SENT_385	[p24l10t3104r232b3204],
84	,	,	O	,	_	0	SENT_385	[p24l10t3104r232b3204],
85	Which	WDT	O	which	nsubj	86	SENT_385	[p24l271t3098r525b3177],
86	indicated	VBD	O	indicate	rcmod	83	SENT_385	[p24l562t3098r943b3177],
87	that	IN	O	that	complm	93	SENT_385	[p24l981t3098r1147b3176],
88	the	DT	O	the	det	91	SENT_385	[p24l1180t3098r1309b3176],
89	decreased	VBN	O	decrease	amod	91	SENT_385	[p24l1348t3098r1753b3177],
90	cell	NN	O	cell	nn	91	SENT_385	[p24l1792t3098r1931b3176],
91	survival	NN	O	survival	nsubj	93	SENT_385	[p24l1971t3124r2132b3177, p24l6t3226r202b3305],
92	was	VBD	O	be	cop	93	SENT_385	[p24l240t3252r402b3305],
93	due	JJ	O	due	ccomp	86	SENT_385	[p24l448t3226r597b3305],
94	to	TO	O	to	_	0	SENT_385	[p24l641t3243r722b3305],
95	interruption	NN	O	interruption	prep_to	93	SENT_385	[p24l766t3227r1293b3326],
96	of	IN	O	of	_	0	SENT_385	[p24l1337t3225r1437b3305],
97	LTB4	NN	O	ltb4	nn	98	SENT_385	[p24l1460t3232r1667b3332],
98	synthesis	NN	O	synthesis	prep_of	95	SENT_385	[p24l1710t3226r2128b3326],
99	.	.	O	.	_	0	SENT_385	[p24l1710t3226r2128b3326],

1	Chronic	JJ	O	chronic	amod	4	SENT_386	[p24l11t3354r347b3433],
2	lymphocytic	JJ	O	lymphocytic	amod	4	SENT_386	[p24l381t3354r898b3454],
3	leukemia	NN	O	leukemia	nn	4	SENT_386	[p24l932t3354r1320b3433],
4	cells	NNS	O	cell	nsubj	5	SENT_386	[p24l1355t3354r1538b3432],
5	express	VBP	O	express	_	0	SENT_386	[p24l1577t3380r1886b3454],
6	large	JJ	O	large	amod	7	SENT_386	[p24l1923t3354r2134b3455],
7	amounts	NNS	O	amount	dobj	5	SENT_386	[p24l10t3499r392b3562],
8	of	IN	O	of	_	0	SENT_386	[p24l432t3481r533b3561],
9	5	CD	NUMBER	5	number	10	SENT_386	[p24l554t3482r1207b3584],
10	—	CD	NUMBER	—	num	11	SENT_386	[p24l554t3482r1207b3584],
11	lipoxygenase	NN	O	lipoxygenase	prep_of	7	SENT_386	[p24l554t3482r1207b3584],
12	and	CC	O	and	_	0	SENT_386	[p24l1243t3482r1404b3561],
13	BLT1	NN	O	blt1	conj_and	11	SENT_386	[p24l1439t3489r1664b3586],
14	,	,	O	,	_	0	SENT_386	[p24l1439t3489r1664b3586],
15	and	CC	O	and	_	0	SENT_386	[p24l1706t3482r1867b3561],
16	treatment	NN	O	treatment	conj_and	7	SENT_386	[p24l1904t3499r2133b3561, p24l12t3628r226b3689],
17	with	IN	O	with	_	0	SENT_386	[p24l253t3611r442b3690],
18	an	DT	O	a	det	20	SENT_386	[p24l477t3637r577b3689],
19	investigational	JJ	O	investigational	amod	20	SENT_386	[p24l613t3611r1218b3712],
20	inhibitor	NN	O	inhibitor	prep_with	16	SENT_386	[p24l1253t3611r1618b3690],
21	of	IN	O	of	_	0	SENT_386	[p24l1652t3610r1750b3690],
22	5	CD	NUMBER	5	number	23	SENT_386	[p24l1769t3611r2133b3711],
23	—	CD	NUMBER	—	num	25	SENT_386	[p24l1769t3611r2133b3711],
24	lipoxy	NN	O	lipoxy	nn	25	SENT_386	[p24l1769t3611r2133b3711],
25	—	NN	O	—	prep_of	20	SENT_386	[p24l1769t3611r2133b3711],

1	genase	NN	O	genase	nsubj	4	SENT_387	[p25l12t46r300b121],
2	or	CC	O	or	_	0	SENT_387	[p25l339t46r426b99],
3	FLAP	NN	O	flap	nsubj	4	SENT_387	[p25l461t26r684b98],
4	blocks	VBZ	O	block	_	0	SENT_387	[p25l722t20r990b99],
5	the	DT	O	the	det	9	SENT_387	[p25l1031t20r1162b98],
6	CD40	NN	O	cd40	nn	9	SENT_387	[p25l1200t20r1919b120],
7	—	NN	O	—	nn	9	SENT_387	[p25l1200t20r1919b120],
8	dependent	JJ	O	dependent	amod	9	SENT_387	[p25l1200t20r1919b120],
9	activation	NN	O	activation	dobj	4	SENT_387	[p25l1952t21r2133b98, p25l7t148r272b227],
10	of	IN	O	of	_	0	SENT_387	[p25l305t146r404b226],
11	these	DT	O	these	det	12	SENT_387	[p25l418t147r642b225],
12	cells	NNS	O	cell	prep_of	9	SENT_387	[p25l675t147r888b243],
13	;	:	O	;	_	0	SENT_387	[p25l675t147r888b243],
14	this	DT	O	this	det	15	SENT_387	[p25l924t147r1084b225],
15	effect	NN	O	effect	nsubjpass	17	SENT_387	[p25l1119t146r1361b225],
16	is	VBZ	O	be	auxpass	17	SENT_387	[p25l1388t148r1453b225],
17	reversed	VBN	O	reverse	parataxis	4	SENT_387	[p25l1488t147r1843b227],
18	by	IN	O	by	_	0	SENT_387	[p25l1876t147r1973b247],
19	the	DT	O	the	det	20	SENT_387	[p25l2001t147r2134b225],
20	addition	NN	O	addition	agent	17	SENT_387	[p25l11t276r367b355],
21	of	IN	O	of	_	0	SENT_387	[p25l408t275r508b355],
22	LTB4	NN	O	ltb4	prep_of	20	SENT_387	[p25l527t283r734b382],
23	to	TO	O	to	_	0	SENT_387	[p25l773t293r855b355],
24	the	DT	O	the	prep_to	17	SENT_387	[p25l896t276r1029b354],
25	cultured	VBN	O	culture	partmod	24	SENT_387	[p25l1069t276r1427b355],
26	cells	NNS	O	cell	dobj	25	SENT_387	[p25l1467t276r1794b355],
27	.113	CD	NUMBER	.113	dep	26	SENT_387	[p25l1467t276r1794b355],

1	In	IN	O	in	dep	127	SENT_388	[p25l140t412r227b482],
2	a	DT	O	a	dep	127	SENT_388	[p25l283t430r327b482],
3	mouse	NN	O	mouse	dep	127	SENT_388	[p25l382t430r668b483],
4	model	NN	O	model	dep	127	SENT_388	[p25l724t404r995b483],
5	of	IN	O	of	dep	127	SENT_388	[p25l1053t403r1154b483],
6	lung	NN	O	lung	dep	127	SENT_388	[p25l1190t404r1387b505],
7	cancer	NN	O	cancer	dep	127	SENT_388	[p25l1441t430r1746b500],
8	,	,	O	,	_	0	SENT_388	[p25l1441t430r1746b500],
9	a	DT	O	a	dep	127	SENT_388	[p25l1808t430r1852b482],
10	FLAP	NN	O	flap	dep	127	SENT_388	[p25l1905t411r2136b482],
11	inhibitor	NN	O	inhibitor	dep	127	SENT_388	[p25l12t532r403b610],
12	that	WDT	O	that	dep	127	SENT_388	[p25l443t532r619b610],
13	reduces	VBZ	O	reduce	dep	127	SENT_388	[p25l656t532r986b611],
14	leukotriene	NN	O	leukotriene	dep	127	SENT_388	[p25l1030t532r1527b611],
15	synthesis	NN	O	synthesis	dep	127	SENT_388	[p25l1571t532r1973b631],
16	reduced	VBD	O	reduce	dep	127	SENT_388	[p25l2018t558r2133b610, p25l12t660r268b739],
17	the	DT	O	the	dep	127	SENT_388	[p25l311t660r447b739],
18	Volume	NN	O	volume	dep	127	SENT_388	[p25l485t660r802b739],
19	of	IN	O	of	dep	127	SENT_388	[p25l846t659r947b739],
20	lung	NN	O	lung	dep	127	SENT_388	[p25l970t660r1168b761],
21	tumors	NNS	O	tumor	dep	127	SENT_388	[p25l1208t677r1521b739],
22	induced	VBN	O	induce	dep	127	SENT_388	[p25l1566t660r1912b739],
23	by	IN	O	by	dep	127	SENT_388	[p25l1956t660r2054b760],
24	a	DT	O	a	dep	127	SENT_388	[p25l2091t686r2136b738],
25	tobacco	NN	O	tobacco	dep	127	SENT_388	[p25l12t787r733b888],
26	—	NN	O	—	dep	127	SENT_388	[p25l12t787r733b888],
27	specific	JJ	O	specific	dep	127	SENT_388	[p25l12t787r733b888],
28	carcinogen	NN	O	carcinogen	dep	127	SENT_388	[p25l791t789r1418b889],
29	.114	CD	NUMBER	.114	dep	127	SENT_388	[p25l791t789r1418b889],
30	In	IN	O	in	dep	127	SENT_388	[p25l1473t796r1564b866],
31	rats	NNS	O	rat	dep	127	SENT_388	[p25l1620t805r1781b866],
32	with	IN	O	with	dep	127	SENT_388	[p25l1836t788r2035b867],
33	a	DT	O	a	dep	127	SENT_388	[p25l2091t814r2135b866],
34	gastroesophageal	NN	O	gastroesophageal	dep	127	SENT_388	[p25l12t916r785b1017],
35	reﬂux	NN	O	reﬂux	dep	127	SENT_388	[p25l824t915r1087b995],
36	disease	NN	O	disease	dep	127	SENT_388	[p25l1124t916r1440b995],
37	similar	JJ	O	similar	dep	127	SENT_388	[p25l1482t916r1795b994],
38	to	TO	O	to	dep	127	SENT_388	[p25l1831t933r1914b995],
39	Barrett	NNP	PERSON	Barrett	dep	127	SENT_388	[p25l1953t923r2133b994, p25l12t1050r224b1123],
40	’s	POS	O	’s	dep	127	SENT_388	[p25l1953t923r2133b994, p25l12t1050r224b1123],
41	esophagus	NN	O	esophagus	dep	127	SENT_388	[p25l258t1044r737b1145],
42	,	,	O	,	_	0	SENT_388	[p25l258t1044r737b1145],
43	an	DT	O	a	dep	127	SENT_388	[p25l773t1070r877b1122],
44	esophageal	NN	O	esophageal	dep	127	SENT_388	[p25l908t1044r1390b1145],
45	adenocarcinoma	NN	O	adenocarcinoma	dep	127	SENT_388	[p25l1419t1044r2136b1123],
46	that	WDT	O	that	dep	127	SENT_388	[p25l12t1172r181b1250],
47	overexpresses	VBZ	O	overexpress	dep	127	SENT_388	[p25l220t1198r794b1272],
48	LTA4	NN	O	lta4	dep	127	SENT_388	[p25l838t1178r1041b1278],
49	hydrolase	NN	O	hydrolase	dep	127	SENT_388	[p25l1083t1172r1485b1272],
50	developed	VBD	O	develop	dep	127	SENT_388	[p25l1529t1172r1970b1272],
51	;	:	O	;	_	0	SENT_388	[p25l1529t1172r1970b1272],
52	inhibition	NN	O	inhibition	dep	127	SENT_388	[p25l2016t1173r2133b1249, p25l12t1300r359b1379],
53	of	IN	O	of	dep	127	SENT_388	[p25l394t1299r494b1379],
54	LTB4	NN	O	ltb4	dep	127	SENT_388	[p25l508t1306r718b1406],
55	synthesis	NN	O	synthesis	dep	127	SENT_388	[p25l751t1300r1153b1400],
56	by	IN	O	by	dep	127	SENT_388	[p25l1190t1300r1288b1400],
57	the	DT	O	the	dep	127	SENT_388	[p25l1317t1300r1452b1379],
58	LTA4	NN	O	lta4	dep	127	SENT_388	[p25l1485t1306r1692b1406],
59	hydrolase	NN	O	hydrolase	dep	127	SENT_388	[p25l1723t1300r2134b1400],
60	inhibitor	NN	O	inhibitor	dep	127	SENT_388	[p25l11t1429r385b1508],
61	bestatin	NN	O	bestatin	dep	127	SENT_388	[p25l425t1429r763b1508],
62	reduced	VBD	O	reduce	dep	127	SENT_388	[p25l805t1429r1135b1508],
63	the	DT	O	the	dep	127	SENT_388	[p25l1177t1429r1307b1507],
64	incidence	NN	O	incidence	dep	127	SENT_388	[p25l1348t1429r1746b1508],
65	and	CC	O	and	dep	127	SENT_388	[p25l1787t1429r1942b1508],
66	volume	NN	O	volume	dep	127	SENT_388	[p25l1979t1429r2133b1508, p25l12t1583r198b1636],
67	of	IN	O	of	dep	127	SENT_388	[p25l239t1556r340b1636],
68	such	JJ	O	such	dep	127	SENT_388	[p25l362t1557r558b1636],
69	tumors	NNS	O	tumor	dep	127	SENT_388	[p25l598t1562r1052b1636],
70	.115	CD	NUMBER	.115	dep	127	SENT_388	[p25l598t1562r1052b1636],
71	Administration	NN	O	administration	dep	127	SENT_388	[p25l1090t1557r1771b1636],
72	of	IN	O	of	dep	127	SENT_388	[p25l1811t1556r1912b1636],
73	both	CC	O	both	dep	127	SENT_388	[p25l1933t1557r2134b1636],
74	zileuton	NN	O	zileuton	dep	127	SENT_388	[p25l11t1686r359b1765],
75	and	CC	O	and	dep	127	SENT_388	[p25l396t1686r554b1765],
76	bestatin	NN	O	bestatin	dep	127	SENT_388	[p25l591t1686r938b1765],
77	also	RB	O	also	dep	127	SENT_388	[p25l974t1686r1146b1765],
78	reduced	VBD	O	reduce	dep	127	SENT_388	[p25l1184t1686r1521b1765],
79	the	DT	O	the	dep	127	SENT_388	[p25l1559t1686r1692b1765],
80	incidence	NN	O	incidence	dep	127	SENT_388	[p25l1729t1686r2134b1765],
81	of	IN	O	of	dep	127	SENT_388	[p25l13t1813r113b1893],
82	carcinogen	NN	O	carcinogen	dep	127	SENT_388	[p25l136t1814r985b1915],
83	—	NN	O	—	dep	127	SENT_388	[p25l136t1814r985b1915],
84	induced	VBD	O	induce	dep	127	SENT_388	[p25l136t1814r985b1915],
85	oral	JJ	O	oral	dep	127	SENT_388	[p25l1026t1814r1192b1893],
86	squamous	JJ	O	squamous	dep	127	SENT_388	[p25l1234t1814r1858b1914],
87	—	NN	O	—	dep	127	SENT_388	[p25l1234t1814r1858b1914],
88	cell	NN	O	cell	dep	127	SENT_388	[p25l1234t1814r1858b1914],
89	carcinoma	NN	O	carcinoma	dep	127	SENT_388	[p25l1899t1815r2133b1892, p25l12t1969r256b2022],
90	in	IN	O	in	dep	127	SENT_388	[p25l289t1944r372b2021],
91	hamsters	NNS	O	hamster	dep	127	SENT_388	[p25l409t1943r942b2022],
92	.115	CD	NUMBER	.115	dep	127	SENT_388	[p25l409t1943r942b2022],
93	These	DT	O	these	dep	127	SENT_388	[p25l976t1943r1227b2022],
94	results	NNS	O	result	dep	127	SENT_388	[p25l1263t1943r1547b2022],
95	are	VBP	O	be	dep	127	SENT_388	[p25l1584t1969r1714b2021],
96	the	DT	O	the	dep	127	SENT_388	[p25l1751t1943r1883b2022],
97	basis	NN	O	basis	dep	127	SENT_388	[p25l1921t1943r2132b2022],
98	of	IN	O	of	dep	127	SENT_388	[p25l12t2070r113b2150],
99	an	DT	O	a	dep	127	SENT_388	[p25l150t2097r254b2149],
100	ongoing	JJ	O	ongoing	dep	127	SENT_388	[p25l310t2072r674b2172],
101	clinical	JJ	O	clinical	dep	127	SENT_388	[p25l727t2071r1048b2149],
102	trial	NN	O	trial	dep	127	SENT_388	[p25l1103t2071r1285b2149],
103	sponsored	VBN	O	sponsor	dep	127	SENT_388	[p25l1342t2071r1794b2171],
104	by	IN	O	by	dep	127	SENT_388	[p25l1849t2071r1948b2171],
105	the	DT	O	the	dep	127	SENT_388	[p25l1999t2071r2134b2150],
106	National	NNP	ORGANIZATION	National	dep	127	SENT_388	[p25l9t2200r390b2279],
107	Cancer	NNP	ORGANIZATION	Cancer	dep	127	SENT_388	[p25l440t2206r745b2279],
108	Institute	NNP	ORGANIZATION	Institute	dep	127	SENT_388	[p25l790t2201r1163b2279],
109	to	TO	O	to	dep	127	SENT_388	[p25l1214t2217r1297b2279],
110	test	VB	O	test	dep	127	SENT_388	[p25l1348t2217r1506b2278],
111	the	DT	O	the	dep	127	SENT_388	[p25l1552t2200r1686b2278],
112	idea	NN	O	idea	dep	127	SENT_388	[p25l1736t2200r1914b2279],
113	that	IN	O	that	dep	127	SENT_388	[p25l1963t2200r2139b2278],
114	interruption	NN	O	interruption	dep	127	SENT_388	[p25l11t2328r550b2427],
115	of	IN	O	of	dep	127	SENT_388	[p25l600t2326r701b2406],
116	leukotriene	NN	O	leukotriene	dep	127	SENT_388	[p25l732t2327r1229b2407],
117	synthetic	JJ	O	synthetic	dep	127	SENT_388	[p25l1280t2327r1678b2427],
118	pathways	NNS	O	pathway	dep	127	SENT_388	[p25l1725t2327r2132b2427],
119	or	CC	O	or	dep	127	SENT_388	[p25l12t2482r102b2535],
120	leukotriene	NN	O	leukotriene	dep	127	SENT_388	[p25l141t2456r640b2535],
121	receptors	NNS	O	receptor	dep	127	SENT_388	[p25l683t2473r1089b2556],
122	reduces	VBZ	O	reduce	dep	127	SENT_388	[p25l1133t2456r1463b2535],
123	the	DT	O	the	dep	127	SENT_388	[p25l1509t2456r1644b2534],
124	growth	NN	O	growth	dep	127	SENT_388	[p25l1686t2456r2008b2557],
125	of	IN	O	of	dep	127	SENT_388	[p25l2051t2455r2152b2535],
126	cancer	NN	O	cancer	dep	127	SENT_388	[p25l12t2590r426b2664],
127	.114	CD	NUMBER	.114	_	0	SENT_388	[p25l12t2590r426b2664],

1	LEUKOTRIENES	NNP	O	LEUKOTRIENES	_	0	SENT_389	[p25l57t2910r926b2971],
2	IN	IN	O	in	dep	1	SENT_389	[p25l982t2911r1106b2970],
3	ANTIMICROBIAL	NNP	MISC	ANTIMICROBIAL	pobj	2	SENT_389	[p25l1157t2910r2094b2971],

1	DEFENSE	NN	O	defense	_	0	SENT_390	[p25l826t3018r1323b3077],

1	Leukotrienes	NNS	O	leukotriene	nsubj	13	SENT_391	[p25l11t3213r567b3292],
2	that	WDT	O	that	nsubjpass	4	SENT_391	[p25l606t3213r779b3291],
3	are	VBP	O	be	auxpass	4	SENT_391	[p25l808t3239r937b3291],
4	synthesized	VBN	O	synthesize	rcmod	1	SENT_391	[p25l975t3213r1480b3312],
5	in	IN	O	in	_	0	SENT_391	[p25l1515t3214r1598b3290],
6	response	NN	O	response	prep_in	4	SENT_391	[p25l1634t3239r2014b3312],
7	to	TO	O	to	_	0	SENT_391	[p25l2051t3230r2133b3291],
8	a	DT	O	a	det	9	SENT_391	[p25l11t3367r55b3419],
9	spectrum	NN	O	spectrum	prep_to	4	SENT_391	[p25l94t3358r500b3441],
10	of	IN	O	of	_	0	SENT_391	[p25l540t3340r639b3420],
11	infectious	JJ	O	infectious	amod	12	SENT_391	[p25l659t3340r1085b3420],
12	agents	NNS	O	agent	prep_of	9	SENT_391	[p25l1126t3358r1402b3442],
13	enhance	VBP	O	enhance	_	0	SENT_391	[p25l1444t3341r1801b3420],
14	the	DT	O	the	det	15	SENT_391	[p25l1841t3341r1973b3420],
15	capacities	NNS	O	capacity	nsubj	23	SENT_391	[p25l2013t3367r2133b3419, p25l11t3470r327b3569],
16	of	IN	O	of	_	0	SENT_391	[p25l360t3468r459b3548],
17	macrophages	NNS	O	macrophage	prep_of	15	SENT_391	[p25l471t3469r1032b3570],
18	and	CC	O	and	_	0	SENT_391	[p25l1063t3469r1219b3548],
19	neutrophils	NNS	O	neutrophil	conj_and	17	SENT_391	[p25l1249t3469r1734b3569],
20	to	TO	O	to	aux	21	SENT_391	[p25l1766t3486r1847b3548],
21	ingest	VB	O	ingest	ccomp	13	SENT_391	[p25l1878t3470r2139b3570],
22	and	CC	O	and	_	0	SENT_391	[p25l12t3597r171b3675],
23	kill	VB	O	kill	conj_and	21	SENT_391	[p25l208t3597r353b3676],
24	microbes	NNS	O	microbe	dobj	21	SENT_391	[p25l390t3597r791b3675],
25	and	CC	O	and	_	0	SENT_391	[p25l830t3597r990b3675],
26	to	TO	O	to	aux	27	SENT_391	[p25l1028t3614r1110b3675],
27	produce	VB	O	produce	conj_and	21	SENT_391	[p25l1148t3597r1500b3696],
28	antimicrobial	JJ	O	antimicrobial	amod	29	SENT_391	[p25l1538t3597r2135b3675],
29	mediators	NNS	O	mediator	iobj	27	SENT_391	[p26l12t21r581b100],
30	.117	CD	NUMBER	.117	num	31	SENT_391	[p26l12t21r581b100],
31	LTB4	NN	O	ltb4	dobj	27	SENT_391	[p26l607t27r1070b127],
32	.	.	O	.	_	0	SENT_391	[p26l607t27r1070b127],

1	—	NN	O	—	_	0	SENT_392	[p26l607t27r1070b127],
2	.	.	O	.	_	0	SENT_392	[p26l607t27r1070b127],

1	BLT1	NN	O	blt1	nn	2	SENT_393	[p26l607t27r1070b127],
2	signaling	NN	O	signaling	nsubj	3	SENT_393	[p26l1098t21r1502b122],
3	exerts	VBZ	O	exert	_	0	SENT_393	[p26l1527t38r1777b99],
4	broader	JJR	O	broader	amod	8	SENT_393	[p26l1807t21r2137b100],
5	and	CC	O	and	_	0	SENT_393	[p26l11t149r169b228],
6	more	JJR	O	more	amod	8	SENT_393	[p26l203t175r422b228],
7	potent	JJ	O	potent	amod	8	SENT_393	[p26l455t166r736b249],
8	effects	NNS	O	effect	dobj	3	SENT_393	[p26l765t148r1047b227],
9	in	IN	O	in	_	0	SENT_393	[p26l1082t150r1165b227],
10	this	DT	O	this	det	11	SENT_393	[p26l1200t149r1359b227],
11	regard	NN	O	regard	prep_in	3	SENT_393	[p26l1396t149r1673b250],
12	than	IN	O	than	mark	13	SENT_393	[p26l1707t149r1904b227],
13	does	VBZ	O	do	advcl	3	SENT_393	[p26l1939t149r2132b228],
14	signaling	NN	O	signaling	dobj	13	SENT_393	[p26l13t277r426b378],
15	between	IN	O	between	_	0	SENT_393	[p26l491t277r855b356],
16	cysteinyl	NN	O	cysteinyl	nn	17	SENT_393	[p26l923t277r1300b377],
17	leukotrienes	NNS	O	leukotriene	prep_between	14	SENT_393	[p26l1365t277r1906b356],
18	and	CC	O	and	_	0	SENT_393	[p26l1974t277r2134b356],
19	CysLT1	NN	O	cyslt1	prep_between	14	SENT_393	[p26l12t410r331b507],
20	.	.	O	.	_	0	SENT_393	[p26l12t410r331b507],

1	In	IN	O	in	_	0	SENT_394	[p26l365t412r455b481],
2	animal	NN	O	animal	nn	3	SENT_394	[p26l483t404r786b482],
3	models	NNS	O	model	prep_in	16	SENT_394	[p26l814t404r1124b483],
4	of	IN	O	of	_	0	SENT_394	[p26l1156t403r1256b483],
5	infection	NN	O	infection	prep_of	3	SENT_394	[p26l1266t403r1676b499],
6	,	,	O	,	_	0	SENT_394	[p26l1266t403r1676b499],
7	genetic	JJ	O	genetic	amod	10	SENT_394	[p26l1711t405r2019b505],
8	or	CC	O	or	_	0	SENT_394	[p26l2049t430r2137b483],
9	pharmacologic	JJ	O	pharmacologic	conj_or	7	SENT_394	[p26l11t532r644b633],
10	interruption	NN	O	interruption	nsubj	16	SENT_394	[p26l670t533r1185b632],
11	of	IN	O	of	_	0	SENT_394	[p26l1213t531r1311b611],
12	leukotriene	NN	O	leukotriene	nn	13	SENT_394	[p26l1319t532r1794b611],
13	synthesis	NN	O	synthesis	prep_of	10	SENT_394	[p26l1823t532r2133b632, p26l13t661r116b738],
14	or	CC	O	or	_	0	SENT_394	[p26l140t686r226b739],
15	signaling	NN	O	signaling	prep_of	10	SENT_394	[p26l245t660r633b761],
16	impairs	VBZ	O	impair	_	0	SENT_394	[p26l649t661r964b760],
17	local	JJ	O	local	amod	20	SENT_394	[p26l987t660r1183b739],
18	microbial	JJ	O	microbial	amod	20	SENT_394	[p26l1204t660r1598b739],
19	clearance	NN	O	clearance	nn	20	SENT_394	[p26l1619t660r2134b739],
20	.117	NN	NUMBER	.117	dobj	16	SENT_394	[p26l1619t660r2134b739],
21	For	IN	O	for	_	0	SENT_394	[p26l11t796r153b867],
22	example	NN	O	example	prep_for	32	SENT_394	[p26l193t788r571b888],
23	,	,	O	,	_	0	SENT_394	[p26l193t788r571b888],
24	lungs	NNS	O	lung	appos	22	SENT_394	[p26l618t788r851b889],
25	of	IN	O	of	_	0	SENT_394	[p26l896t787r996b867],
26	5	CD	NUMBER	5	number	27	SENT_394	[p26l1021t788r1889b889],
27	—	CD	NUMBER	—	num	28	SENT_394	[p26l1021t788r1889b889],
28	lipoXygenase	NN	O	lipoxygenase	prep_of	24	SENT_394	[p26l1021t788r1889b889],
29	—	CD	NUMBER	—	num	31	SENT_394	[p26l1021t788r1889b889],
30	null	JJ	O	null	amod	31	SENT_394	[p26l1021t788r1889b889],
31	mice	NNS	O	mouse	nsubj	32	SENT_394	[p26l1931t789r2134b866],
32	contain	VBP	O	contain	rcmod	20	SENT_394	[p26l13t917r337b994],
33	almost	RB	O	almost	quantmod	35	SENT_394	[p26l370t916r668b994],
34	100	CD	NUMBER	100	number	35	SENT_394	[p26l699t922r847b994],
35	times	NNS	O	time	num	38	SENT_394	[p26l883t917r1118b994],
36	as	RB	O	as	quantmod	35	SENT_394	[p26l1153t942r1239b994],
37	much	JJ	O	much	quantmod	35	SENT_394	[p26l1275t916r1513b995],
38	Klebsiella	NN	O	klebsiellum	dobj	32	SENT_394	[p26l1545t916r1899b994],
39	pneumoniae	FW	O	pneumoniae	rcmod	38	SENT_394	[p26l1921t942r2133b1015, p26l15t1047r287b1122],
40	as	IN	O	as	mark	41	SENT_394	[p26l314t1070r399b1122],
41	do	VBP	O	do	dep	39	SENT_394	[p26l433t1044r536b1123],
42	lungs	NNS	O	lung	dobj	41	SENT_394	[p26l567t1044r800b1145],
43	of	IN	O	of	_	0	SENT_394	[p26l834t1043r934b1123],
44	wild	JJ	O	wild	amod	47	SENT_394	[p26l942t1044r1348b1144],
45	—	NN	O	—	nn	47	SENT_394	[p26l942t1044r1348b1144],
46	type	NN	O	type	nn	47	SENT_394	[p26l942t1044r1348b1144],
47	animals	NNS	O	animal	prep_of	42	SENT_394	[p26l1378t1044r1723b1122],
48	48	CD	DURATION	48	num	49	SENT_394	[p26l1754t1050r1856b1123],
49	hours	NNS	NUMBER	hour	npadvmod	41	SENT_394	[p26l1889t1044r2132b1123],
50	after	IN	O	after	_	0	SENT_394	[p26l11t1170r213b1249],
51	intrapulmonary	JJ	O	intrapulmonary	amod	53	SENT_394	[p26l244t1171r930b1271],
52	bacterial	JJ	O	bacterial	amod	53	SENT_394	[p26l961t1171r1331b1250],
53	inoculation	NN	O	inoculation	prep_after	41	SENT_394	[p26l1365t1171r1881b1251],
54	.	.	O	.	_	0	SENT_394	[p26l1365t1171r1881b1251],

1	In	IN	O	in	_	0	SENT_395	[p26l139t1307r229b1377],
2	humans	NNS	O	human	prep_in	11	SENT_395	[p26l292t1299r670b1395],
3	,	,	O	,	_	0	SENT_395	[p26l292t1299r670b1395],
4	acquired	VBN	O	acquire	amod	5	SENT_395	[p26l738t1299r1115b1399],
5	states	NNS	O	state	nsubjpass	11	SENT_395	[p26l1180t1316r1426b1377],
6	of	IN	O	of	_	0	SENT_395	[p26l1492t1298r1593b1378],
7	leukotriene	NN	O	leukotriene	nn	8	SENT_395	[p26l1637t1299r2134b1379],
8	deficiency	NN	O	deficiency	prep_of	5	SENT_395	[p26l12t1426r439b1527],
9	have	VBP	O	have	aux	11	SENT_395	[p26l475t1427r661b1507],
10	been	VBN	O	be	auxpass	11	SENT_395	[p26l703t1427r901b1506],
11	described	VBN	O	describe	_	0	SENT_395	[p26l942t1427r1345b1506],
12	in	IN	O	in	_	0	SENT_395	[p26l1385t1428r1467b1505],
13	human	JJ	O	human	amod	19	SENT_395	[p26l1508t1427r1808b1507],
14	immunodeﬁciency	NN	O	immunodeﬁciency	nn	19	SENT_395	[p26l1848t1428r2133b1507, p26l12t1554r549b1655],
15	virus	NN	O	virus	nn	19	SENT_395	[p26l573t1556r781b1635],
16	(	CD	NUMBER	(	num	19	SENT_395	[p26l820t1562r1049b1646],
17	HIV	NN	MISC	hiv	nn	19	SENT_395	[p26l820t1562r1049b1646],
18	)	NN	O	)	nn	19	SENT_395	[p26l820t1562r1049b1646],
19	infection118	NN	O	infection118	prep_in	11	SENT_395	[p26l1086t1554r1574b1634],
20	and	CC	O	and	_	0	SENT_395	[p26l1606t1555r1763b1634],
21	proteincalorie	NN	O	proteincalorie	nn	22	SENT_395	[p26l1793t1556r2133b1655, p26l12t1683r299b1762],
22	malnutrition	NN	O	malnutrition	prep_in	11	SENT_395	[p26l341t1683r1026b1762],
23	.119	CD	NUMBER	.119	dobj	11	SENT_395	[p26l341t1683r1026b1762],
24	In	IN	O	in	_	0	SENT_395	[p26l1067t1691r1155b1761],
25	HIV	NN	MISC	hiv	nn	26	SENT_395	[p26l1196t1691r1371b1762],
26	infection	NN	O	infection	prep_in	32	SENT_395	[p26l1409t1682r1818b1779],
27	,	,	O	,	_	0	SENT_395	[p26l1409t1682r1818b1779],
28	leukotriene	NN	O	leukotriene	nn	29	SENT_395	[p26l1864t1683r2133b1762, p26l12t1812r254b1889],
29	deficiency	NN	O	deficiency	nsubj	32	SENT_395	[p26l277t1810r704b1911],
30	is	VBZ	O	be	cop	32	SENT_395	[p26l721t1812r785b1889],
31	the	DT	O	the	det	32	SENT_395	[p26l811t1811r942b1889],
32	result	NN	O	result	rcmod	23	SENT_395	[p26l964t1811r1203b1891],
33	of	IN	O	of	_	0	SENT_395	[p26l1221t1810r1320b1890],
34	reduced	VBN	O	reduce	amod	35	SENT_395	[p26l1324t1811r1654b1891],
35	expression	NN	O	expression	prep_of	32	SENT_395	[p26l1678t1812r2134b1911],
36	of	IN	O	of	_	0	SENT_395	[p26l13t1939r113b2019],
37	5	CD	NUMBER	5	number	38	SENT_395	[p26l129t1940r768b2041],
38	—	CD	NUMBER	—	num	39	SENT_395	[p26l129t1940r768b2041],
39	lipoxygenase	NN	O	lipoxygenase	prep_of	35	SENT_395	[p26l129t1940r768b2041],
40	and	CC	O	and	_	0	SENT_395	[p26l801t1940r982b2036],
41	,	,	O	,	_	0	SENT_395	[p26l801t1940r982b2036],
42	especially	RB	O	especially	dobj	11	SENT_395	[p26l1021t1940r1454b2040],
43	,	,	O	,	_	0	SENT_395	[p26l1021t1940r1454b2040],
44	of	IN	O	of	_	0	SENT_395	[p26l1493t1939r1593b2019],
45	FLAP	NN	O	flap	prep_of	42	SENT_395	[p26l1606t1947r1848b2019],
46	.	.	O	.	_	0	SENT_395	[p26l1606t1947r1848b2019],

1	These	DT	O	these	det	2	SENT_396	[p26l1882t1940r2134b2018],
2	reductions	NNS	O	reduction	_	0	SENT_396	[p26l12t2067r464b2147],
3	are	VBP	O	be	cop	5	SENT_396	[p26l510t2093r639b2145],
4	a	DT	O	a	det	5	SENT_396	[p26l683t2093r727b2145],
5	consequence	NN	O	consequence	rcmod	2	SENT_396	[p26l770t2093r1318b2167],
6	of	IN	O	of	_	0	SENT_396	[p26l1363t2066r1463b2146],
7	a	DT	O	a	det	8	SENT_396	[p26l1489t2093r1533b2145],
8	deficiency	NN	O	deficiency	prep_of	5	SENT_396	[p26l1576t2066r2012b2167],
9	of	IN	O	of	_	0	SENT_396	[p26l2053t2066r2152b2146],
10	CD4	NN	O	cd4	nn	14	SENT_396	[p26l12t2202r198b2274],
11	T	NN	O	t	nn	14	SENT_396	[p26l238t2196r844b2275],
12	—	NN	O	—	nn	14	SENT_396	[p26l238t2196r844b2275],
13	cell	NN	O	cell	nn	14	SENT_396	[p26l238t2196r844b2275],
14	—	NN	O	—	prep_of	8	SENT_396	[p26l238t2196r844b2275],
15	derived	VBN	O	derive	partmod	14	SENT_396	[p26l238t2196r844b2275],
16	cytokines	NNS	O	cytokine	dobj	15	SENT_396	[p26l889t2196r1297b2295],
17	that	WDT	O	that	nsubj	18	SENT_396	[p26l1343t2196r1516b2274],
18	stimulate	VBP	O	stimulate	rcmod	16	SENT_396	[p26l1556t2196r1957b2275],
19	the	DT	O	the	det	20	SENT_396	[p26l2001t2196r2134b2274],
20	production	NN	O	production	dobj	18	SENT_396	[p26l10t2323r484b2423],
21	of	IN	O	of	_	0	SENT_396	[p26l528t2322r629b2402],
22	these	DT	O	these	det	23	SENT_396	[p26l653t2323r877b2401],
23	elements	NNS	O	element	prep_of	20	SENT_396	[p26l921t2323r1301b2401],
24	in	IN	O	in	_	0	SENT_396	[p26l1345t2324r1429b2401],
25	the	DT	O	the	det	26	SENT_396	[p26l1472t2323r1605b2401],
26	leukotriene	NN	O	leukotriene	prep_in	23	SENT_396	[p26l1647t2323r2133b2403],
27	pathway	NN	O	pathway	dep	2	SENT_396	[p26l11t2452r499b2552],
28	.113	CD	NUMBER	.113	num	27	SENT_396	[p26l11t2452r499b2552],
29	Although	IN	O	although	mark	41	SENT_396	[p26l537t2452r944b2553],
30	patients	NNS	O	patient	nsubj	41	SENT_396	[p26l982t2453r1324b2552],
31	with	IN	O	with	_	0	SENT_396	[p26l1362t2452r1557b2531],
32	asthma	NN	O	asthma	prep_with	30	SENT_396	[p26l1596t2452r1916b2530],
33	who	WP	O	who	nsubjpass	35	SENT_396	[p26l1950t2452r2133b2531],
34	are	VBP	O	be	auxpass	35	SENT_396	[p26l11t2606r136b2658],
35	treated	VBN	O	treat	rcmod	32	SENT_396	[p26l167t2580r452b2659],
36	with	IN	O	with	_	0	SENT_396	[p26l477t2580r666b2659],
37	antileukotriene	JJ	O	antileukotriene	amod	38	SENT_396	[p26l695t2580r1323b2659],
38	agents	NNS	O	agent	prep_with	35	SENT_396	[p26l1352t2597r1617b2681],
39	do	VBP	O	do	aux	41	SENT_396	[p26l1650t2580r1750b2659],
40	not	RB	O	not	neg	41	SENT_396	[p26l1782t2597r1920b2659],
41	have	VB	O	have	dep	27	SENT_396	[p26l1944t2580r2134b2659],
42	an	DT	O	a	det	44	SENT_396	[p26l12t2734r116b2786],
43	increased	VBN	O	increase	amod	44	SENT_396	[p26l157t2708r575b2787],
44	risk	NN	O	risk	dobj	41	SENT_396	[p26l617t2708r784b2787],
45	of	IN	O	of	_	0	SENT_396	[p26l822t2707r923b2787],
46	infection	NN	O	infection	prep_of	44	SENT_396	[p26l947t2707r1367b2804],
47	,	,	O	,	_	0	SENT_396	[p26l947t2707r1367b2804],
48	a	DT	O	a	det	50	SENT_396	[p26l1414t2734r1458b2786],
49	significant	JJ	O	significant	amod	50	SENT_396	[p26l1500t2707r1979b2809],
50	in1350	NN	O	in1350	appos	46	SENT_396	[p26l2016t2709r2133b2786, p26l149t2884r225b2907],

1	N	NN	O	n	nn	3	SENT_397	[p26l897t2894r911b2909],
2	ENGLJ	NN	O	englj	nn	3	SENT_397	[p26l926t2894r1004b2916],
3	MED	NN	O	med	_	0	SENT_397	[p26l1018t2894r1070b2909],
4	;	:	O	;	_	0	SENT_397	[p26l1122t2888r1154b2914],
5	18	CD	NUMBER	18	num	6	SENT_397	[p26l1122t2888r1154b2914],
6	www	NN	O	www	dep	3	SENT_397	[p26l1187t2894r1388b2916],
7	,	,	O	,	_	0	SENT_397	[p26l1187t2894r1388b2916],
8	NEJM.oRG	NN	O	nejm.org	nn	9	SENT_397	[p26l1187t2894r1388b2916],
9	NovEMBER1	NN	O	november1	appos	6	SENT_397	[p26l1425t2894r1661b2915],
10	,2	CD	NUMBER	,2	num	11	SENT_397	[p26l1425t2894r1661b2915],
11	oo7	NN	O	oo7	dep	9	SENT_397	[p26l1425t2894r1661b2915],

1	The	DT	O	the	det	2	SENT_398	[p26l935t2927r986b2951],
2	New	NNP	O	New	_	0	SENT_398	[p26l995t2928r1057b2951],
3	n	NN	O	n	dep	2	SENT_398	[p26l1087t2935r1103b2951],
4	and	CC	O	and	_	0	SENT_398	[p26l1130t2927r1177b2951],
5	Joumal	NN	O	joumal	dep	2	SENT_398	[p26l1186t2927r1283b2951],
6	of	IN	O	of	_	0	SENT_398	[p26l1293t2927r1322b2951],
7	Medicine	NN	O	medicine	prep_of	3	SENT_398	[p26l1329t2927r1454b2951],

1	Downloaded	VBN	O	download	_	0	SENT_399	[p26l377t2968r547b2991],
2	from	IN	O	from	_	0	SENT_399	[p26l556t2968r621b2991],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_399	[p26l629t2968r748b2998],
4	at	IN	O	at	_	0	SENT_399	[p26l758t2972r781b2991],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_399	[p26l789t2968r972b2991],
6	on	IN	O	on	_	0	SENT_399	[p26l981t2975r1014b2991],
7	January	NNP	DATE	January	prep_on	1	SENT_399	[p26l1022t2968r1125b2998],
8	5	CD	DATE	5	num	7	SENT_399	[p26l1135t2968r1158b2995],
9	,	,	DATE	,	_	0	SENT_399	[p26l1135t2968r1158b2995],
10	2014	CD	DATE	2014	num	7	SENT_399	[p26l1168t2968r1241b2991],
11	.	.	O	.	_	0	SENT_399	[p26l1168t2968r1241b2991],

1	For	IN	O	for	_	0	SENT_400	[p26l1251t2968r1298b2991],
2	personal	JJ	O	personal	amod	3	SENT_400	[p26l1306t2968r1418b2998],
3	use	NN	O	use	pobj	1	SENT_400	[p26l1427t2975r1471b2991],
4	only	RB	O	only	advmod	3	SENT_400	[p26l1480t2968r1545b2998],
5	.	.	O	.	_	0	SENT_400	[p26l1480t2968r1545b2998],

1	No	DT	O	no	det	3	SENT_401	[p26l1556t2968r1595b2991],
2	other	JJ	O	other	amod	3	SENT_401	[p26l1605t2968r1673b2991],
3	uses	NNS	O	use	_	0	SENT_401	[p26l1682t2975r1738b2991],
4	without	IN	O	without	_	0	SENT_401	[p26l1748t2968r1849b2991],
5	permission	NN	O	permission	prep_without	3	SENT_401	[p26l1857t2968r2010b2998],
6	.	.	O	.	_	0	SENT_401	[p26l1857t2968r2010b2998],

1	Copyright	NN	O	copyright	_	0	SENT_402	[p26l728t3009r862b3040],
2	©	CD	NUMBER	©	num	6	SENT_402	[p26l871t3009r895b3033],
3	2007	CD	DATE	2007	num	6	SENT_402	[p26l905t3009r969b3033],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_402	[p26l979t3009r1170b3033],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_402	[p26l1180t3009r1288b3033],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_402	[p26l1299t3009r1404b3040],
7	.	.	O	.	_	0	SENT_402	[p26l1299t3009r1404b3040],

1	All	DT	O	all	det	2	SENT_403	[p26l1415t3009r1456b3033],
2	rights	NNS	O	rights	nsubj	3	SENT_403	[p26l1465t3009r1540b3040],
3	reserved	VBN	O	reserve	_	0	SENT_403	[p26l1550t3009r1668b3033],
4	.	.	O	.	_	0	SENT_403	[p26l1550t3009r1668b3033],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_404	[p26l866t3115r1091b3134],
2	OF	IN	O	of	_	0	SENT_404	[p26l1106t3115r1146b3134],
3	DISEASE	NN	O	disease	prep_of	1	SENT_404	[p26l1160t3115r1294b3134],

1	crease	NN	O	crease	nsubjpass	10	SENT_405	[p26l11t3356r277b3408],
2	in	IN	O	in	_	0	SENT_405	[p26l317t3331r401b3408],
3	the	DT	O	the	det	4	SENT_405	[p26l442t3330r576b3408],
4	risk	NN	O	risk	prep_in	1	SENT_405	[p26l616t3330r781b3410],
5	of	IN	O	of	_	0	SENT_405	[p26l818t3329r919b3409],
6	infectious	JJ	O	infectious	amod	8	SENT_405	[p26l940t3329r1370b3410],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_405	[p26l1411t3330r1894b3430],
8	exacerbations	NNS	O	exacerbation	prep_of	4	SENT_405	[p26l1931t3356r2148b3408, p26l11t3458r403b3537],
9	was	VBD	O	be	auxpass	10	SENT_405	[p26l441t3484r603b3538],
10	reported	VBN	O	report	_	0	SENT_405	[p26l645t3458r1007b3558],
11	in	IN	O	in	_	0	SENT_405	[p26l1047t3459r1130b3536],
12	patients	NNS	O	patient	prep_in	10	SENT_405	[p26l1168t3459r1505b3558],
13	with	IN	O	with	_	0	SENT_405	[p26l1544t3458r1737b3538],
14	cystic	JJ	O	cystic	amod	15	SENT_405	[p26l1778t3459r2012b3558],
15	fibrosis	NN	O	fibrosis	prep_with	10	SENT_405	[p26l2052t3457r2148b3536, p26l11t3587r268b3666],
16	who	WP	O	who	nsubjpass	18	SENT_405	[p26l309t3587r494b3666],
17	were	VBD	O	be	auxpass	18	SENT_405	[p26l534t3613r738b3666],
18	treated	VBN	O	treat	rcmod	15	SENT_405	[p26l782t3587r1083b3666],
19	with	IN	O	with	_	0	SENT_405	[p26l1123t3587r1319b3666],
20	an	DT	O	a	det	21	SENT_405	[p26l1362t3613r1466b3665],
21	investigational	JJ	O	investigational	prep_with	18	SENT_405	[p26l1509t3587r2150b3688],

1	BLT1	NN	O	blt1	nn	2	SENT_406	[p27l9t26r212b124],
2	antagonist	NN	O	antagonist	_	0	SENT_406	[p27l259t21r733b122],
3	(	CD	NUMBER	(	num	4	SENT_406	[p27l782t26r998b111],
4	BIIL	NN	O	biil	dep	2	SENT_406	[p27l782t26r998b111],
5	284	CD	NUMBER	284	num	6	SENT_406	[p27l1045t26r1257b116],
6	)	NN	O	)	dep	2	SENT_406	[p27l1045t26r1257b116],
7	,	,	O	,	_	0	SENT_406	[p27l1045t26r1257b116],
8	necessitating	VBG	O	necessitate	amod	10	SENT_406	[p27l1310t21r1896b122],
9	early	JJ	O	early	amod	10	SENT_406	[p27l1942t20r2154b120],
10	termination	NN	O	termination	appos	2	SENT_406	[p27l11t151r529b230],
11	of	IN	O	of	_	0	SENT_406	[p27l570t149r671b230],
12	the	DT	O	the	det	16	SENT_406	[p27l692t150r826b229],
13	clinical	JJ	O	clinical	amod	16	SENT_406	[p27l867t150r1183b229],
14	trial	NN	O	trial	nn	16	SENT_406	[p27l1223t150r1543b230],
15	.12	CD	NUMBER	.12	num	16	SENT_406	[p27l1223t150r1543b230],
16	°	NN	O	°	prep_of	10	SENT_406	[p27l1223t150r1543b230],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_407	[p27l679t448r1479b508],

1	Today	NN	DATE	today	tmod	36	SENT_408	[p27l6t668r270b768],
2	,	,	O	,	_	0	SENT_408	[p27l6t668r270b768],
3	nearly	RB	DURATION	nearly	quantmod	4	SENT_408	[p27l304t668r558b768],
4	three	CD	DURATION	three	num	5	SENT_408	[p27l581t668r794b746],
5	decades	NNS	DURATION	decade	dep	9	SENT_408	[p27l822t668r1146b747],
6	since	IN	O	since	dep	9	SENT_408	[p27l1177t669r1385b746],
7	leukotrienes	NNS	O	leukotriene	nsubjpass	9	SENT_408	[p27l1411t668r1920b748],
8	were	VBD	O	be	auxpass	9	SENT_408	[p27l1946t694r2149b747],
9	discovered	VBN	O	discover	dep	36	SENT_408	[p27l11t797r468b876],
10	and	CC	O	and	_	0	SENT_408	[p27l502t797r661b876],
11	one	CD	DURATION	one	num	12	SENT_408	[p27l696t823r849b876],
12	decade	NN	DURATION	decade	nsubj	25	SENT_408	[p27l885t797r1178b876],
13	since	IN	O	since	_	0	SENT_408	[p27l1214t798r1431b875],
14	drugs	NNS	O	drug	prep_since	12	SENT_408	[p27l1467t797r1712b898],
15	targeting	VBG	O	target	partmod	14	SENT_408	[p27l1750t798r2152b898],
16	this	DT	O	this	det	17	SENT_408	[p27l10t924r167b1002],
17	pathway	NN	O	pathway	dobj	15	SENT_408	[p27l200t924r557b1024],
18	became	VBD	O	become	cop	25	SENT_408	[p27l584t924r908b1003],
19	available	JJ	O	available	amod	25	SENT_408	[p27l938t924r1327b1020],
20	,	,	O	,	_	0	SENT_408	[p27l938t924r1327b1020],
21	new	JJ	O	new	amod	25	SENT_408	[p27l1363t950r1541b1004],
22	and	CC	O	and	_	0	SENT_408	[p27l1566t924r1724b1003],
23	often	RB	O	often	advmod	24	SENT_408	[p27l1755t923r1975b1003],
24	unexpected	JJ	O	unexpected	amod	25	SENT_408	[p27l2006t950r2148b1004, p27l11t1053r382b1153],
25	insights	NNS	O	insight	conj_and	9	SENT_408	[p27l411t1053r748b1154],
26	into	IN	O	into	_	0	SENT_408	[p27l779t1054r946b1132],
27	the	DT	O	the	det	31	SENT_408	[p27l977t1053r1109b1132],
28	biology	NN	O	biology	nn	31	SENT_408	[p27l1140t1053r1455b1154],
29	and	CC	O	and	_	0	SENT_408	[p27l1479t1053r1636b1132],
30	clinical	JJ	O	clinical	conj_and	28	SENT_408	[p27l1666t1053r1974b1131],
31	importance	NN	O	importance	prep_into	25	SENT_408	[p27l2003t1054r2148b1131, p27l8t1197r401b1280],
32	of	IN	O	of	_	0	SENT_408	[p27l456t1179r558b1259],
33	these	DT	O	these	det	34	SENT_408	[p27l594t1180r823b1258],
34	lipid	NN	O	lipid	prep_of	31	SENT_408	[p27l876t1180r1074b1280],
35	mediators	NNS	O	mediator	nsubj	36	SENT_408	[p27l1128t1180r1570b1259],
36	continue	VBP	O	continue	_	0	SENT_408	[p27l1627t1181r2011b1260],
37	to	TO	O	to	aux	38	SENT_408	[p27l2065t1197r2148b1259],
38	emerge	VB	O	emerge	xcomp	36	SENT_408	[p27l11t1335r336b1410],
39	.	.	O	.	_	0	SENT_408	[p27l11t1335r336b1410],

1	Beyond	IN	O	beyond	_	0	SENT_409	[p27l367t1309r673b1409],
2	the	DT	O	the	det	12	SENT_409	[p27l701t1309r830b1387],
3	classically	RB	O	classically	advmod	4	SENT_409	[p27l859t1309r1276b1409],
4	recognized	VBN	O	recognize	amod	12	SENT_409	[p27l1298t1309r1762b1410],
5	and	CC	O	and	_	0	SENT_409	[p27l1788t1309r1942b1388],
6	validated	VBN	O	validate	conj_and	4	SENT_409	[p27l1965t1309r2148b1388, p27l11t1436r251b1515],
7	participation	NN	O	participation	dobj	6	SENT_409	[p27l296t1437r870b1536],
8	of	IN	O	of	_	0	SENT_409	[p27l916t1435r1019b1515],
9	cysteinyl	NN	O	cysteinyl	nn	10	SENT_409	[p27l1047t1436r1427b1536],
10	leukotrienes	NNS	O	leukotriene	prep_of	7	SENT_409	[p27l1471t1436r2016b1516],
11	in	IN	O	in	prep	6	SENT_409	[p27l2064t1437r2149b1514],
12	asthma	NN	O	asthma	prep_beyond	17	SENT_409	[p27l15t1575r364b1671],
13	,	,	O	,	_	0	SENT_409	[p27l15t1575r364b1671],
14	it	PRP	O	it	nsubj	17	SENT_409	[p27l414t1576r474b1653],
15	is	VBZ	O	be	cop	17	SENT_409	[p27l513t1576r580b1653],
16	now	RB	DATE	now	advmod	17	SENT_409	[p27l627t1601r814b1654],
17	evident	JJ	O	evident	_	0	SENT_409	[p27l855t1575r1173b1654],
18	that	IN	O	that	complm	22	SENT_409	[p27l1213t1575r1389b1653],
19	leukotrienes	NNS	O	leukotriene	nsubj	22	SENT_409	[p27l1427t1575r1970b1654],
20	are	VBP	O	be	cop	22	SENT_409	[p27l2017t1601r2148b1653],
21	multifunctional	JJ	O	multifunctional	amod	22	SENT_409	[p27l15t1714r671b1795],
22	mediators	NNS	O	mediator	ccomp	17	SENT_409	[p27l705t1715r1120b1794],
23	that	WDT	O	that	nsubj	30	SENT_409	[p27l1157t1715r1323b1793],
24	influence	VBP	O	influence	rcmod	22	SENT_409	[p27l1352t1714r1741b1795],
25	many	JJ	O	many	amod	27	SENT_409	[p27l1775t1741r2008b1815],
26	biologic	JJ	O	biologic	amod	27	SENT_409	[p27l2039t1715r2147b1794, p27l16t1855r277b1956],
27	responses	NNS	O	response	dobj	24	SENT_409	[p27l304t1881r730b1955],
28	and	CC	O	and	_	0	SENT_409	[p27l760t1855r919b1934],
29	probably	RB	O	probably	advmod	24	SENT_409	[p27l946t1855r1325b1955],
30	play	VB	O	play	rcmod	22	SENT_409	[p27l1348t1855r1525b1955],
31	a	DT	O	a	det	32	SENT_409	[p27l1549t1881r1593b1933],
32	role	NN	O	role	dobj	30	SENT_409	[p27l1620t1855r1781b1934],
33	in	IN	O	in	_	0	SENT_409	[p27l1809t1856r1893b1933],
34	other	JJ	O	other	amod	35	SENT_409	[p27l1922t1855r2152b1934],
35	diseases	NNS	O	disease	prep_in	32	SENT_409	[p27l16t1994r395b2073],
36	.	.	O	.	_	0	SENT_409	[p27l16t1994r395b2073],

1	Dr.	NNP	O	Dr.	nn	2	SENT_410	[p27l99t2113r197b2168],
2	Peters	NNP	PERSON	Peters	_	0	SENT_410	[p27l251t2108r720b2168],
3	.	.	O	.	_	0	SENT_410	[p27l251t2108r720b2168],

1	—	NN	O	—	_	0	SENT_411	[p27l251t2108r720b2168],
2	.	.	O	.	_	0	SENT_411	[p27l251t2108r720b2168],

1	Golden	NNP	O	Golden	nn	2	SENT_412	[p27l251t2108r720b2168],
2	reports	NNS	O	report	nsubj	25	SENT_412	[p27l771t2121r1007b2184],
3	receiving	VBG	O	receive	_	0	SENT_412	[p27l1058t2109r1360b2185],
4	consulting	NN	O	consulting	nn	5	SENT_412	[p27l1408t2108r1763b2185],
5	fees	NNS	O	fee	dobj	3	SENT_412	[p27l1810t2108r1937b2168],
6	from	IN	O	from	_	0	SENT_412	[p27l1988t2108r2149b2168],
7	Critical	JJ	O	critical	amod	8	SENT_412	[p27l14t2203r257b2262],
8	Therapeutics	NNS	O	therapeutics	prep_from	3	SENT_412	[p27l276t2203r724b2279],
9	,	,	O	,	_	0	SENT_412	[p27l276t2203r724b2279],
10	Pfizer	NNP	ORGANIZATION	Pfizer	prep_from	3	SENT_412	[p27l749t2202r963b2275],
11	,	,	O	,	_	0	SENT_412	[p27l749t2202r963b2275],
12	Wyeth	NN	PERSON	wyeth	prep_from	3	SENT_412	[p27l986t2203r1214b2279],
13	,	,	O	,	_	0	SENT_412	[p27l986t2203r1214b2279],
14	and	CC	O	and	_	0	SENT_412	[p27l1240t2203r1361b2262],
15	Efficas	NNP	PERSON	Efficas	prep_from	3	SENT_412	[p27l1381t2202r1609b2262],
16	and	CC	O	and	_	0	SENT_412	[p27l1632t2202r1753b2262],
17	lecture	NN	O	lecture	nn	18	SENT_412	[p27l1773t2202r1999b2262],
18	fees	NNS	O	fee	prep_from	3	SENT_412	[p27l2021t2202r2148b2262],
19	from	IN	O	from	_	0	SENT_412	[p27l14t2294r175b2354],
20	Merck	NNP	LOCATION	Merck	prep_from	3	SENT_412	[p27l201t2295r409b2355],
21	and	CC	O	and	_	0	SENT_412	[p27l434t2295r554b2354],
22	Critical	JJ	ORGANIZATION	critical	amod	23	SENT_412	[p27l583t2295r825b2354],
23	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_from	3	SENT_412	[p27l851t2295r1279b2371],
24	and	CC	O	and	_	0	SENT_412	[p27l1309t2295r1429b2354],
25	serving	VBG	O	serve	conj_and	3	SENT_412	[p27l1458t2296r1702b2371],
26	on	IN	O	on	_	0	SENT_412	[p27l1728t2315r1808b2354],
27	a	DT	O	a	det	30	SENT_412	[p27l1836t2315r1869b2354],
28	respiratory	JJ	O	respiratory	amod	30	SENT_412	[p27l1896t2296r2148b2371, p27l15t2402r147b2464],
29	advisory	JJ	O	advisory	amod	30	SENT_412	[p27l170t2389r447b2464],
30	board	NN	O	board	prep_on	25	SENT_412	[p27l471t2389r662b2449],
31	for	IN	O	for	_	0	SENT_412	[p27l689t2389r784b2449],
32	Merck	NNP	ORGANIZATION	Merck	prep_for	30	SENT_412	[p27l806t2389r1029b2449],
33	.	.	O	.	_	0	SENT_412	[p27l806t2389r1029b2449],

1	He	PRP	O	he	nsubj	2	SENT_413	[p27l1060t2395r1149b2448],
2	shares	VBZ	O	share	_	0	SENT_413	[p27l1178t2389r1386b2448],
3	a	DT	O	a	det	4	SENT_413	[p27l1414t2409r1448b2448],
4	patent	NN	O	patent	dobj	2	SENT_413	[p27l1472t2402r1682b2464],
5	with	IN	O	with	_	0	SENT_413	[p27l1702t2389r1851b2449],
6	the	DT	O	the	det	7	SENT_413	[p27l1878t2389r1981b2448],
7	University	NNP	ORGANIZATION	University	prep_with	4	SENT_413	[p27l2007t2390r2148b2449, p27l11t2484r228b2560],
8	of	IN	ORGANIZATION	of	_	0	SENT_413	[p27l261t2483r337b2543],
9	Michigan	NNP	ORGANIZATION	Michigan	prep_of	7	SENT_413	[p27l357t2484r671b2560],
10	for	IN	O	for	_	0	SENT_413	[p27l707t2483r802b2543],
11	intrapulmonary	JJ	O	intrapulmonary	amod	12	SENT_413	[p27l835t2483r1362b2560],
12	administration	NN	O	administration	prep_for	9	SENT_413	[p27l1395t2483r1893b2543],
13	of	IN	O	of	_	0	SENT_413	[p27l1930t2483r2006b2543],
14	leukotriene	NN	O	leukotriene	nn	15	SENT_413	[p27l2027t2483r2148b2543, p27l14t2577r287b2637],
15	B	NN	O	b	prep_of	12	SENT_413	[p27l353t2582r396b2636],
16	4	CD	NUMBER	4	num	15	SENT_413	[p27l401t2628r431b2663],
17	as	IN	O	as	_	0	SENT_413	[p27l498t2597r563b2636],
18	a	DT	O	a	det	20	SENT_413	[p27l632t2597r665b2636],
19	local	JJ	O	local	amod	20	SENT_413	[p27l730t2577r888b2636],
20	immunostimulant	NN	O	immunostimulant	prep_as	2	SENT_413	[p27l955t2577r1566b2637],
21	for	IN	O	for	_	0	SENT_413	[p27l1629t2576r1724b2636],
22	respiratory	JJ	O	respiratory	amod	23	SENT_413	[p27l1789t2578r2153b2653],
23	infections	NNS	O	infection	prep_for	20	SENT_413	[p27l13t2671r364b2731],
24	.	.	O	.	_	0	SENT_413	[p27l13t2671r364b2731],

1	Dr.	NNP	O	Dr.	nn	2	SENT_414	[p27l409t2676r506b2731],
2	Henderson	NNP	PERSON	Henderson	nsubj	3	SENT_414	[p27l552t2671r914b2731],
3	reports	VBZ	O	report	_	0	SENT_414	[p27l955t2684r1191b2747],
4	receiving	VBG	O	receive	ccomp	3	SENT_414	[p27l1235t2672r1536b2748],
5	research	NN	O	research	nn	6	SENT_414	[p27l1576t2671r1854b2731],
6	support	NN	O	support	dobj	4	SENT_414	[p27l1897t2684r2153b2747],
7	from	IN	O	from	_	0	SENT_414	[p27l15t2765r176b2825],
8	Merck	NNP	PERSON	Merck	prep_from	4	SENT_414	[p27l196t2766r405b2826],
9	and	CC	O	and	_	0	SENT_414	[p27l423t2766r544b2825],
10	Sepracor	NNP	O	Sepracor	prep_from	4	SENT_414	[p27l568t2770r871b2842],
11	,	,	O	,	_	0	SENT_414	[p27l568t2770r871b2842],
12	consulting	VBG	O	consult	conj_and	4	SENT_414	[p27l898t2766r1252b2842],
13	fees	NNS	O	fee	dobj	12	SENT_414	[p27l1272t2765r1400b2825],
14	from	IN	O	from	_	0	SENT_414	[p27l1424t2765r1585b2825],
15	Alza	NNP	ORGANIZATION	Alza	nn	17	SENT_414	[p27l1605t2766r1754b2825],
16	(	NNP	O	(	nn	17	SENT_414	[p27l1780t2766r2077b2834],
17	Johnson	NNP	ORGANIZATION	Johnson	prep_from	13	SENT_414	[p27l1780t2766r2077b2834],
18	&	CC	ORGANIZATION	&	_	0	SENT_414	[p27l2100t2770r2149b2827],
19	Johnson	NNP	ORGANIZATION	Johnson	nn	20	SENT_414	[p27l7t2858r324b2930],
20	)	NNP	O	)	prep_from	13	SENT_414	[p27l7t2858r324b2930],
21	,	,	O	,	_	0	SENT_414	[p27l7t2858r324b2930],
22	Amgen	NNP	ORGANIZATION	Amgen	prep_from	13	SENT_414	[p27l365t2863r621b2934],
23	,	,	O	,	_	0	SENT_414	[p27l365t2863r621b2934],
24	and	CC	O	and	_	0	SENT_414	[p27l664t2858r785b2917],
25	Critical	JJ	O	critical	amod	26	SENT_414	[p27l825t2858r1068b2917],
26	Therapeutics	NNS	O	therapeutics	prep_from	13	SENT_414	[p27l1104t2858r1553b2934],
27	,	,	O	,	_	0	SENT_414	[p27l1104t2858r1553b2934],
28	and	CC	O	and	_	0	SENT_414	[p27l1596t2858r1716b2917],
29	lecture	NN	O	lecture	nn	30	SENT_414	[p27l1756t2858r1981b2918],
30	fees	NNS	O	fee	conj_and	13	SENT_414	[p27l2021t2857r2148b2917],
31	from	IN	O	from	_	0	SENT_414	[p27l14t2952r176b3012],
32	Critical	JJ	ORGANIZATION	critical	amod	33	SENT_414	[p27l198t2952r441b3012],
33	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_from	30	SENT_414	[p27l460t2952r889b3028],
34	and	CC	O	and	_	0	SENT_414	[p27l912t2952r1033b3012],
35	Merck	NNP	PERSON	Merck	prep_from	30	SENT_414	[p27l1053t2952r1261b3012],
36	and	CC	O	and	_	0	SENT_414	[p27l1280t2952r1401b3012],
37	serving	VBG	O	serve	conj_and	4	SENT_414	[p27l1424t2953r1667b3029],
38	on	IN	O	on	_	0	SENT_414	[p27l1687t2972r1768b3012],
39	a	DT	O	a	det	42	SENT_414	[p27l1790t2972r1824b3011],
40	scientific	JJ	O	scientific	amod	42	SENT_414	[p27l1846t2952r2150b3011],
41	advisory	JJ	O	advisory	amod	42	SENT_414	[p27l14t3047r291b3124],
42	board	NN	O	board	prep_on	37	SENT_414	[p27l318t3048r509b3107],
43	for	IN	O	for	_	0	SENT_414	[p27l539t3047r634b3107],
44	Gilead	NNP	ORGANIZATION	Gilead	prep_for	42	SENT_414	[p27l661t3047r875b3107],
45	and	CC	O	and	_	0	SENT_414	[p27l904t3048r1025b3107],
46	Icos	NNP	ORGANIZATION	Icos	prep_for	42	SENT_414	[p27l1053t3053r1204b3107],
47	.	.	O	.	_	0	SENT_414	[p27l1053t3053r1204b3107],

1	No	DT	O	no	det	4	SENT_415	[p27l1236t3053r1331b3107],
2	other	JJ	O	other	amod	4	SENT_415	[p27l1363t3048r1538b3107],
3	potential	JJ	O	potential	amod	4	SENT_415	[p27l1564t3048r1864b3124],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_415	[p27l1894t3047r2153b3107],
5	of	IN	O	of	_	0	SENT_415	[p27l15t3141r91b3201],
6	interest	NN	O	interest	prep_of	4	SENT_415	[p27l103t3142r355b3201],
7	relevant	JJ	O	relevant	amod	6	SENT_415	[p27l376t3142r639b3202],
8	to	TO	O	to	_	0	SENT_415	[p27l662t3154r724b3201],
9	this	DT	O	this	det	10	SENT_415	[p27l751t3142r873b3201],
10	article	NN	O	article	prep_to	7	SENT_415	[p27l900t3142r1107b3201],
11	was	VBD	O	be	auxpass	12	SENT_415	[p27l1130t3162r1253b3202],
12	reported	VBN	O	report	_	0	SENT_415	[p27l1281t3142r1582b3218],
13	.	.	O	.	_	0	SENT_415	[p27l1281t3142r1582b3218],

1	We	PRP	O	we	nsubj	2	SENT_416	[p27l99t3240r199b3294],
2	thank	VBP	O	thank	_	0	SENT_416	[p27l234t3235r431b3295],
3	Christine	NNP	PERSON	Christine	nn	4	SENT_416	[p27l461t3235r768b3295],
4	Abrass	NNP	PERSON	Abrass	dobj	2	SENT_416	[p27l799t3235r1042b3308],
5	,	,	O	,	_	0	SENT_416	[p27l799t3235r1042b3308],
6	David	NNP	PERSON	David	nn	7	SENT_416	[p27l1079t3235r1268b3295],
7	Fox	NNP	PERSON	Fox	conj_and	4	SENT_416	[p27l1300t3240r1434b3307],
8	,	,	O	,	_	0	SENT_416	[p27l1300t3240r1434b3307],
9	and	CC	O	and	_	0	SENT_416	[p27l1471t3235r1592b3295],
10	Teal	NNP	PERSON	Teal	nn	11	SENT_416	[p27l1623t3235r1760b3294],
11	Hallstrand	NNP	PERSON	Hallstrand	conj_and	4	SENT_416	[p27l1793t3235r2150b3295],
12	for	IN	O	for	_	0	SENT_416	[p27l15t3328r110b3388],
13	their	PRP$	O	they	poss	15	SENT_416	[p27l137t3328r294b3387],
14	helpful	JJ	O	helpful	amod	15	SENT_416	[p27l322t3328r556b3403],
15	comments	NNS	O	comment	prep_for	11	SENT_416	[p27l586t3341r930b3388],
16	and	CC	O	and	_	0	SENT_416	[p27l961t3328r1082b3388],
17	Rachel	NNP	PERSON	Rachel	nn	18	SENT_416	[p27l1110t3328r1333b3391],
18	Norris	NNP	PERSON	Norris	prep_for	11	SENT_416	[p27l1361t3329r1572b3388],
19	and	CC	O	and	_	0	SENT_416	[p27l1603t3328r1724b3388],
20	Patty	NNP	PERSON	Patty	nn	21	SENT_416	[p27l1752t3333r1920b3403],
21	Urban	NNP	PERSON	Urban	prep_for	11	SENT_416	[p27l1945t3328r2149b3388],
22	for	IN	O	for	_	0	SENT_416	[p27l14t3422r109b3482],
23	their	PRP$	O	they	poss	24	SENT_416	[p27l133t3423r290b3482],
24	assistance	NN	O	assistance	prep_for	21	SENT_416	[p27l314t3423r650b3482],
25	in	IN	O	in	_	0	SENT_416	[p27l676t3423r740b3481],
26	the	DT	O	the	det	27	SENT_416	[p27l767t3423r868b3482],
27	preparation	NN	O	preparation	prep_in	24	SENT_416	[p27l893t3423r1282b3499],
28	of	IN	O	of	_	0	SENT_416	[p27l1307t3422r1384b3482],
29	the	DT	O	the	det	30	SENT_416	[p27l1397t3423r1498b3482],
30	manuscript	NN	O	manuscript	prep_of	27	SENT_416	[p27l1524t3423r1921b3499],
31	.	.	O	.	_	0	SENT_416	[p27l1524t3423r1921b3499],

1	REFERENCES	NNS	O	reference	_	0	SENT_417	[p27l15t3605r338b3636],

1	1	LS	NUMBER	1	_	0	SENT_418	[p28l14t29r50b67],
2	.	.	O	.	_	0	SENT_418	[p28l14t29r50b67],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_419	[p28l107t27r284b67],
2	JM	NN	PERSON	jm	_	0	SENT_419	[p28l320t27r403b77],
3	,	,	O	,	_	0	SENT_419	[p28l320t27r403b77],
4	Israel	NNP	LOCATION	Israel	nn	5	SENT_419	[p28l447t23r580b67],
5	E	NNP	O	E	appos	2	SENT_419	[p28l622t27r666b77],
6	,	,	O	,	_	0	SENT_419	[p28l622t27r666b77],
7	O’Byrne	NNP	O	O’Byrne	nn	8	SENT_419	[p28l711t27r905b79],
8	PM	NNP	O	PM	appos	5	SENT_419	[p28l947t27r1036b67],
9	.	.	O	.	_	0	SENT_419	[p28l947t27r1036b67],

1	Treatment	NN	O	treatment	_	0	SENT_420	[p28l10t97r266b137],
2	of	IN	O	of	_	0	SENT_420	[p28l285t93r342b137],
3	asthma	NN	O	asthma	prep_of	1	SENT_420	[p28l353t93r534b137],
4	with	IN	O	with	_	0	SENT_420	[p28l552t93r663b137],
5	drugs	NNS	O	drug	prep_with	3	SENT_420	[p28l685t93r824b149],
6	modifying	VBG	O	modify	partmod	1	SENT_420	[p28l846t93r1038b149, p28l12t164r91b220],
7	the	DT	O	the	det	9	SENT_420	[p28l106t163r181b207],
8	leukotriene	NN	O	leukotriene	nn	9	SENT_420	[p28l197t163r475b208],
9	pathway	NN	O	pathway	dobj	6	SENT_420	[p28l491t163r704b219],
10	.	.	O	.	_	0	SENT_420	[p28l491t163r704b219],

1	N	NN	O	n	nsubj	2	SENT_421	[p28l722t167r764b207],
2	EnglJMed	VBD	O	engljm	_	0	SENT_421	[p28l779t163r1040b220],
3	1999	CD	DATE	1999	dobj	2	SENT_421	[p28l14t238r456b288],
4	;	:	O	;	_	0	SENT_421	[p28l14t238r456b288],
5	340:197	CD	NUMBER	340:197	num	6	SENT_421	[p28l14t238r456b288],
6	—	NN	O	—	dep	3	SENT_421	[p28l14t238r456b288],
7	206	CD	NUMBER	206	dep	6	SENT_421	[p28l14t238r456b288],
8	.	.	O	.	_	0	SENT_421	[p28l14t238r456b288],

1	[	NN	O	[	nn	6	SENT_422	[p28l489t238r668b288],
2	Errata	NNP	O	Errata	nn	6	SENT_422	[p28l489t238r668b288],
3	,	,	O	,	_	0	SENT_422	[p28l489t238r668b288],
4	N	NNP	O	N	appos	6	SENT_422	[p28l695t238r737b279],
5	Engl	NNP	O	Engl	nn	6	SENT_422	[p28l761t234r871b291],
6	J	NNP	O	J	nsubj	7	SENT_422	[p28l891t238r912b285],
7	Med	VBD	O	med	_	0	SENT_422	[p28l934t234r1039b278],
8	1999	CD	DATE	1999	dobj	7	SENT_422	[p28l14t309r355b358],
9	;	:	O	;	_	0	SENT_422	[p28l14t309r355b358],
10	340:663	CD	NUMBER	340:663	dep	8	SENT_422	[p28l14t309r355b358],
11	,	,	O	,	_	0	SENT_422	[p28l14t309r355b358],
12	341:1632	CD	NUMBER	341:1632	dep	10	SENT_422	[p28l378t309r622b355],
13	.	.	O	.	_	0	SENT_422	[p28l378t309r622b355],
14	]	SYM	O	]	dep	8	SENT_422	[p28l378t309r622b355],

1	2	LS	NUMBER	2	_	0	SENT_423	[p28l12t382r50b420],
2	.	.	O	.	_	0	SENT_423	[p28l12t382r50b420],

1	Peters-Golden	JJ	O	peters-golden	amod	2	SENT_424	[p28l107t376r455b420],
2	M	NN	O	m	_	0	SENT_424	[p28l469t380r531b430],
3	,	,	O	,	_	0	SENT_424	[p28l469t380r531b430],
4	Brock	NNP	PERSON	Brock	nn	5	SENT_424	[p28l549t376r692b421],
5	TG	NN	PERSON	tg	appos	2	SENT_424	[p28l704t380r792b420],
6	.	.	O	.	_	0	SENT_424	[p28l704t380r792b420],

1	5Lipoxygenase	NN	O	5lipoxygenase	_	0	SENT_425	[p28l813t377r1038b432, p28l12t460r179b503],
2	and	CC	O	and	_	0	SENT_425	[p28l202t446r292b490],
3	FLAP	NN	O	flap	conj_and	1	SENT_425	[p28l314t450r451b490],
4	.	.	O	.	_	0	SENT_425	[p28l314t450r451b490],

1	Prostaglandins	NNP	O	Prostaglandins	nn	5	SENT_426	[p28l477t446r848b503],
2	Leukot	NNP	O	Leukot	nn	5	SENT_426	[p28l872t446r1042b491],
3	Essent	NNP	O	Essent	nn	5	SENT_426	[p28l12t522r171b562],
4	Fatty	NNP	O	Fatty	nn	5	SENT_426	[p28l187t522r308b574],
5	Acids	NNP	O	Acids	_	0	SENT_426	[p28l323t518r456b562],
6	2003	CD	DATE	2003	num	5	SENT_426	[p28l476t522r858b571],
7	;	:	O	;	_	0	SENT_426	[p28l476t522r858b571],
8	69:99	CD	NUMBER	69:99	number	9	SENT_426	[p28l476t522r858b571],
9	-109	CD	NUMBER	-109	dep	5	SENT_426	[p28l476t522r858b571],
10	.	.	O	.	_	0	SENT_426	[p28l476t522r858b571],

1	3	LS	NUMBER	3	_	0	SENT_427	[p28l12t595r50b633],
2	.	.	O	.	_	0	SENT_427	[p28l12t595r50b633],

1	Folco	NNP	PERSON	Folco	nn	2	SENT_428	[p28l107t589r237b633],
2	G	NNP	PERSON	G	_	0	SENT_428	[p28l250t593r302b643],
3	,	,	O	,	_	0	SENT_428	[p28l250t593r302b643],
4	Murphy	NNP	PERSON	Murphy	nn	5	SENT_428	[p28l316t589r509b645],
5	RC	NNP	O	RC	appos	2	SENT_428	[p28l518t593r601b636],
6	.	.	O	.	_	0	SENT_428	[p28l518t593r601b636],

1	Eicosanoid	NN	O	eicosanoid	nn	3	SENT_429	[p28l615t589r883b633],
2	transcellular	JJ	O	transcellular	amod	3	SENT_429	[p28l895t599r1038b633, p28l13t659r192b704],
3	biosynthesis	NN	O	biosynthesis	_	0	SENT_429	[p28l216t659r527b715],
4	:	:	O	:	_	0	SENT_429	[p28l216t659r527b715],
5	from	IN	O	from	_	0	SENT_429	[p28l555t659r672b704],
6	cell-cell	JJ	O	cell-cell	amod	7	SENT_429	[p28l699t659r883b703],
7	interactions	NNS	O	interaction	prep_from	3	SENT_429	[p28l908t660r1039b703, p28l12t731r186b775],
8	to	TO	O	to	aux	12	SENT_429	[p28l210t739r256b775],
9	in	FW	O	in	nn	10	SENT_429	[p28l279t731r326b774],
10	vivo	FW	O	vivo	advmod	12	SENT_429	[p28l346t731r442b775],
11	tissue	NN	O	tissue	nn	12	SENT_429	[p28l466t731r606b775],
12	responses	NNS	O	response	infmod	7	SENT_429	[p28l629t744r885b786],
13	.	.	O	.	_	0	SENT_429	[p28l629t744r885b786],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_430	[p28l910t730r1038b774, p28l12t801r159b845],
2	Rev	NN	O	rev	_	0	SENT_430	[p28l177t805r266b848],
3	2006	CD	DATE	2006	num	2	SENT_430	[p28l284t805r673b854],
4	;	:	O	;	_	0	SENT_430	[p28l284t805r673b854],
5	58:375	CD	NUMBER	58:375	number	6	SENT_430	[p28l284t805r673b854],
6	-88	CD	NUMBER	-88	dep	2	SENT_430	[p28l284t805r673b854],
7	.	.	O	.	_	0	SENT_430	[p28l284t805r673b854],

1	4	LS	NUMBER	4	_	0	SENT_431	[p28l11t878r50b916],
2	.	.	O	.	_	0	SENT_431	[p28l11t878r50b916],

1	Powell	NNP	PERSON	Powell	nn	2	SENT_432	[p28l107t872r268b917],
2	WS	NNP	O	WS	_	0	SENT_432	[p28l298t876r392b926],
3	,	,	O	,	_	0	SENT_432	[p28l298t876r392b926],
4	Rokach	NNP	PERSON	Rokach	nn	6	SENT_432	[p28l426t872r608b919],
5	J.	NNP	PERSON	J.	nn	6	SENT_432	[p28l635t876r667b923],
6	Biochemistry	NNP	PERSON	Biochemistry	appos	2	SENT_432	[p28l701t872r1036b928],
7	,	,	O	,	_	0	SENT_432	[p28l701t872r1036b928],
8	biology	NN	O	biology	appos	2	SENT_432	[p28l12t943r194b1000],
9	and	CC	O	and	_	0	SENT_432	[p28l209t943r299b987],
10	chemistry	NN	O	chemistry	appos	2	SENT_432	[p28l317t943r561b999],
11	of	IN	O	of	_	0	SENT_432	[p28l577t943r634b987],
12	the	DT	O	the	det	15	SENT_432	[p28l641t943r717b987],
13	5lipoxygenase	NN	O	5lipoxygenase	nn	15	SENT_432	[p28l736t943r1039b1000, p28l12t1029r89b1058],
14	product	NN	O	product	nn	15	SENT_432	[p28l120t1014r314b1070],
15	5-oxo-ETE	NN	O	5-oxo-ete	prep_of	8	SENT_432	[p28l344t1018r617b1059],
16	.	.	O	.	_	0	SENT_432	[p28l344t1018r617b1059],

1	Prog	NN	O	prog	nn	2	SENT_433	[p28l651t1018r767b1071],
2	Lipid	NN	O	lipid	_	0	SENT_433	[p28l796t1014r921b1070],
3	Res	NNP	O	Res	dep	2	SENT_433	[p28l952t1018r1038b1061],
4	2005	CD	DATE	2005	num	3	SENT_433	[p28l12t1089r403b1138],
5	;	:	O	;	_	0	SENT_433	[p28l12t1089r403b1138],
6	44:154	CD	NUMBER	44:154	num	7	SENT_433	[p28l12t1089r403b1138],
7	-83	CD	NUMBER	-83	dep	2	SENT_433	[p28l12t1089r403b1138],
8	.	.	O	.	_	0	SENT_433	[p28l12t1089r403b1138],

1	5	CD	NUMBER	5	_	0	SENT_434	[p28l13t1162r50b1200],
2	.	.	O	.	_	0	SENT_434	[p28l13t1162r50b1200],

1	Schwab	NNP	PERSON	Schwab	nn	2	SENT_435	[p28l109t1156r292b1201],
2	JM	NN	O	jm	_	0	SENT_435	[p28l309t1160r391b1210],
3	,	,	O	,	_	0	SENT_435	[p28l309t1160r391b1210],
4	Serhan	NNP	PERSON	Serhan	nn	5	SENT_435	[p28l417t1156r584b1201],
5	CN	NN	O	cn	appos	2	SENT_435	[p28l606t1160r694b1201],
6	.	.	O	.	_	0	SENT_435	[p28l606t1160r694b1201],

1	Lipoxins	NNS	PERSON	lipoxin	_	0	SENT_436	[p28l718t1157r928b1212],
2	and	CC	O	and	_	0	SENT_436	[p28l950t1156r1039b1200],
3	new	JJ	O	new	amod	4	SENT_436	[p28l12t1243r112b1273],
4	lipid	NN	O	lipid	conj_and	1	SENT_436	[p28l136t1228r245b1284],
5	mediators	NNS	O	mediator	dep	1	SENT_436	[p28l271t1228r517b1272],
6	in	IN	O	in	_	0	SENT_436	[p28l544t1229r591b1272],
7	the	DT	O	the	det	8	SENT_436	[p28l617t1228r692b1272],
8	resolution	NN	O	resolution	prep_in	5	SENT_436	[p28l719t1228r966b1273],
9	of	IN	O	of	_	0	SENT_436	[p28l993t1228r1050b1272],
10	inflammation	NN	O	inflammation	prep_of	8	SENT_436	[p28l12t1299r363b1343],
11	.	.	O	.	_	0	SENT_436	[p28l12t1299r363b1343],

1	Curr	NNP	O	Curr	nn	3	SENT_437	[p28l380t1303r489b1344],
2	Opin	NNP	O	Opin	nn	3	SENT_437	[p28l502t1300r620b1355],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_437	[p28l633t1299r891b1343],
4	2006	CD	DATE	2006	num	3	SENT_437	[p28l904t1303r1037b1352],
5	;	:	O	;	_	0	SENT_437	[p28l904t1303r1037b1352],
6	6:414	CD	NUMBER	6:414	number	7	SENT_437	[p28l13t1373r229b1413],
7	-20	CD	NUMBER	-20	dep	3	SENT_437	[p28l13t1373r229b1413],
8	.	.	O	.	_	0	SENT_437	[p28l13t1373r229b1413],

1	6	CD	NUMBER	6	_	0	SENT_438	[p28l12t1446r50b1485],
2	.	.	O	.	_	0	SENT_438	[p28l12t1446r50b1485],

1	Uozumi	NNP	ORGANIZATION	Uozumi	nn	2	SENT_439	[p28l108t1441r303b1485],
2	N	NNP	ORGANIZATION	N	_	0	SENT_439	[p28l325t1444r379b1494],
3	,	,	O	,	_	0	SENT_439	[p28l325t1444r379b1494],
4	Kume	NNP	PERSON	Kume	nn	5	SENT_439	[p28l405t1444r547b1486],
5	K	NNP	PERSON	K	appos	2	SENT_439	[p28l571t1444r620b1494],
6	,	,	O	,	_	0	SENT_439	[p28l571t1444r620b1494],
7	Nagase	NNP	ORGANIZATION	Nagase	nn	8	SENT_439	[p28l646t1444r823b1497],
8	T	NN	ORGANIZATION	t	appos	2	SENT_439	[p28l845t1444r889b1494],
9	,	,	O	,	_	0	SENT_439	[p28l845t1444r889b1494],
10	et	FW	O	et	nn	11	SENT_439	[p28l916t1449r960b1484],
11	al.	FW	O	al.	appos	2	SENT_439	[p28l981t1440r1036b1484],
12	.	.	O	.	_	0	SENT_439	[p28l981t1440r1036b1484],

1	Role	NN	O	role	_	0	SENT_440	[p28l12t1511r119b1557],
2	of	IN	O	of	_	0	SENT_440	[p28l143t1511r200b1555],
3	cytosolic	JJ	O	cytosolic	amod	5	SENT_440	[p28l213t1511r429b1566],
4	phospholipase	NN	O	phospholipase	nn	5	SENT_440	[p28l451t1511r807b1567],
5	A2	NN	O	a2	prep_of	1	SENT_440	[p28l828t1515r885b1570],
6	in	IN	O	in	_	0	SENT_440	[p28l908t1512r956b1554],
7	allergic	JJ	O	allergic	amod	8	SENT_440	[p28l979t1511r1038b1555, p28l12t1581r147b1638],
8	response	NN	O	response	prep_in	1	SENT_440	[p28l180t1595r397b1637],
9	and	CC	O	and	_	0	SENT_440	[p28l430t1581r519b1625],
10	parturition	NN	O	parturition	conj_and	8	SENT_440	[p28l551t1582r836b1637],
11	.	.	O	.	_	0	SENT_440	[p28l551t1582r836b1637],

1	Nature	NNP	O	Nature	_	0	SENT_441	[p28l872t1585r1039b1626],
2	1997	CD	DATE	1997	num	1	SENT_441	[p28l14t1657r423b1706],
3	;	:	O	;	_	0	SENT_441	[p28l14t1657r423b1706],
4	390:618	CD	NUMBER	390:618	number	5	SENT_441	[p28l14t1657r423b1706],
5	-22	CD	NUMBER	-22	dep	1	SENT_441	[p28l14t1657r423b1706],
6	.	.	O	.	_	0	SENT_441	[p28l14t1657r423b1706],

1	7	CD	NUMBER	7	_	0	SENT_442	[p28l13t1729r50b1767],
2	.	.	O	.	_	0	SENT_442	[p28l13t1729r50b1767],

1	Henderson	NNP	PERSON	Henderson	nn	3	SENT_443	[p28l108t1723r375b1767],
2	WR	NNP	PERSON	WR	nn	3	SENT_443	[p28l402t1727r498b1770],
3	Jr	NNP	PERSON	Jr	_	0	SENT_443	[p28l515t1727r568b1777],
4	,	,	O	,	_	0	SENT_443	[p28l515t1727r568b1777],
5	Chi	NNP	LOCATION	Chi	nn	6	SENT_443	[p28l599t1723r683b1768],
6	EY	NNP	LOCATION	EY	appos	3	SENT_443	[p28l710t1727r782b1777],
7	,	,	O	,	_	0	SENT_443	[p28l710t1727r782b1777],
8	Bollinger	NNP	PERSON	Bollinger	nn	9	SENT_443	[p28l813t1723r1041b1780],
9	JG	NNP	O	JG	appos	3	SENT_443	[p28l7t1798r81b1847],
10	,	,	O	,	_	0	SENT_443	[p28l7t1798r81b1847],
11	et	FW	O	et	nn	12	SENT_443	[p28l106t1803r150b1838],
12	al.	FW	O	al.	appos	3	SENT_443	[p28l169t1794r224b1838],
13	.	.	O	.	_	0	SENT_443	[p28l169t1794r224b1838],

1	Importance	NN	O	importance	_	0	SENT_444	[p28l248t1798r533b1850],
2	of	IN	O	of	_	0	SENT_444	[p28l555t1794r612b1838],
3	group	NN	O	group	nn	6	SENT_444	[p28l623t1808r766b1850],
4	X-secreted	JJ	O	x-secreted	amod	6	SENT_444	[p28l786t1794r1039b1838],
5	phospholipase	NN	O	phospholipase	nn	6	SENT_444	[p28l12t1865r367b1921],
6	A2	NN	O	a2	prep_of	1	SENT_444	[p28l384t1869r441b1928],
7	in	IN	O	in	_	0	SENT_444	[p28l460t1866r507b1908],
8	allergen-induced	JJ	O	allergen-induced	amod	10	SENT_444	[p28l526t1865r938b1921],
9	airway	NN	O	airway	nn	10	SENT_444	[p28l956t1866r1038b1909, p28l10t1950r104b1991],
10	inflammation	NN	O	inflammation	prep_in	1	SENT_444	[p28l132t1935r477b1979],
11	and	CC	O	and	_	0	SENT_444	[p28l507t1935r597b1979],
12	remodeling	NN	O	remodeling	conj_and	10	SENT_444	[p28l627t1935r910b1992],
13	in	IN	O	in	_	0	SENT_444	[p28l938t1936r985b1979],
14	a	DT	O	a	det	17	SENT_444	[p28l1015t1950r1040b1979],
15	mouse	NN	O	mouse	nn	17	SENT_444	[p28l12t2020r171b2051],
16	asthma	NN	O	asthma	nn	17	SENT_444	[p28l202t2006r383b2050],
17	model	NN	O	model	prep_in	1	SENT_444	[p28l413t2006r578b2051],
18	.	.	O	.	_	0	SENT_444	[p28l413t2006r578b2051],

1	J	NNP	O	J	nn	3	SENT_445	[p28l606t2010r627b2057],
2	Exp	NNP	O	Exp	nn	3	SENT_445	[p28l656t2010r745b2062],
3	Med	NNP	O	Med	_	0	SENT_445	[p28l775t2006r880b2050],
4	2007	CD	DATE	2007	num	3	SENT_445	[p28l910t2010r1037b2059],
5	;	:	O	;	_	0	SENT_445	[p28l910t2010r1037b2059],
6	204:865	CD	NUMBER	204:865	number	7	SENT_445	[p28l12t2082r288b2122],
7	—	CD	NUMBER	—	dep	3	SENT_445	[p28l12t2082r288b2122],
8	77	CD	NUMBER	77	dep	7	SENT_445	[p28l12t2082r288b2122],
9	.	.	O	.	_	0	SENT_445	[p28l12t2082r288b2122],

1	8	CD	NUMBER	8	_	0	SENT_446	[p28l12t2153r50b2193],
2	.	.	O	.	_	0	SENT_446	[p28l12t2153r50b2193],

1	Luo	NNP	PERSON	Luo	nn	2	SENT_447	[p28l107t2152r196b2193],
2	M	NNP	O	M	_	0	SENT_447	[p28l224t2152r285b2202],
3	,	,	O	,	_	0	SENT_447	[p28l224t2152r285b2202],
4	Jones	NNP	PERSON	Jones	nn	5	SENT_447	[p28l312t2152r444b2199],
5	SM	NNP	O	SM	appos	2	SENT_447	[p28l476t2152r563b2202],
6	,	,	O	,	_	0	SENT_447	[p28l476t2152r563b2202],
7	Phare	NNP	O	Phare	nn	8	SENT_447	[p28l595t2148r732b2192],
8	SM	NNP	O	SM	appos	5	SENT_447	[p28l762t2152r850b2202],
9	,	,	O	,	_	0	SENT_447	[p28l762t2152r850b2202],
10	Coffey	NNP	ORGANIZATION	Coffey	nn	11	SENT_447	[p28l882t2148r1042b2204],
11	MJ	NNP	ORGANIZATION	MJ	appos	5	SENT_447	[p28l11t2223r88b2273],
12	,	,	O	,	_	0	SENT_447	[p28l11t2223r88b2273],
13	Peters-Golden	NNP	O	Peters-Golden	nn	14	SENT_447	[p28l117t2219r464b2264],
14	M	NNP	O	M	appos	5	SENT_447	[p28l490t2223r551b2273],
15	,	,	O	,	_	0	SENT_447	[p28l490t2223r551b2273],
16	Brock	NNP	PERSON	Brock	nn	17	SENT_447	[p28l579t2219r722b2264],
17	TG	NN	PERSON	tg	appos	5	SENT_447	[p28l745t2223r833b2264],
18	.	.	O	.	_	0	SENT_447	[p28l745t2223r833b2264],

1	Protein	NN	O	protein	nn	3	SENT_448	[p28l862t2220r1039b2263],
2	kinase	NN	O	kinase	nn	3	SENT_448	[p28l12t2291r170b2336],
3	A	NN	O	a	nsubj	4	SENT_448	[p28l187t2295r223b2335],
4	inhibits	VBZ	O	inhibit	_	0	SENT_448	[p28l239t2291r428b2335],
5	leukotriene	NN	O	leukotriene	nn	6	SENT_448	[p28l447t2291r724b2336],
6	synthesis	NN	O	synthesis	dobj	4	SENT_448	[p28l743t2291r967b2347],
7	by	IN	O	by	_	0	SENT_448	[p28l987t2291r1042b2347],
8	phosphorylation	NN	O	phosphorylation	prep_by	4	SENT_448	[p28l11t2361r408b2417],
9	of	IN	O	of	_	0	SENT_448	[p28l428t2361r484b2405],
10	5-lipoxygenase	NN	O	5-lipoxygenase	prep_of	8	SENT_448	[p28l495t2361r851b2418],
11	on	IN	O	on	_	0	SENT_448	[p28l871t2375r931b2405],
12	serine	NN	O	serine	prep_on	10	SENT_448	[p28l951t2376r1039b2405, p28l12t2434r85b2477],
13	523	CD	NUMBER	523	num	12	SENT_448	[p28l106t2437r203b2478],
14	.	.	O	.	_	0	SENT_448	[p28l106t2437r203b2478],

1	J	NNP	O	J	nn	3	SENT_449	[p28l220t2437r241b2484],
2	Biol	NNP	O	Biol	nn	3	SENT_449	[p28l258t2433r352b2477],
3	Chem	NNP	O	Chem	_	0	SENT_449	[p28l371t2433r512b2477],
4	2004	CD	DATE	2004	num	3	SENT_449	[p28l531t2437r1002b2487],
5	;	:	O	;	_	0	SENT_449	[p28l531t2437r1002b2487],
6	279:4	CD	NUMBER	279:4	num	7	SENT_449	[p28l531t2437r1002b2487],
7	l512-20	NN	O	l512-20	dep	3	SENT_449	[p28l531t2437r1002b2487],
8	.	.	O	.	_	0	SENT_449	[p28l531t2437r1002b2487],

1	9	CD	NUMBER	9	_	0	SENT_450	[p28l12t2509r50b2548],
2	.	.	O	.	_	0	SENT_450	[p28l12t2509r50b2548],

1	Coffey	NNP	ORGANIZATION	Coffey	nn	2	SENT_451	[p28l108t2504r268b2560],
2	MJ	NNP	ORGANIZATION	MJ	nsubj	13	SENT_451	[p28l294t2508r371b2558],
3	,	,	O	,	_	0	SENT_451	[p28l294t2508r371b2558],
4	Phare	NNP	O	Phare	nn	5	SENT_451	[p28l404t2504r541b2548],
5	SM	NNP	O	SM	appos	2	SENT_451	[p28l572t2508r660b2558],
6	,	,	O	,	_	0	SENT_451	[p28l572t2508r660b2558],
7	Peters-Golden	NNP	PERSON	Peters-Golden	nn	10	SENT_451	[p28l691t2504r1039b2548],
8	M.	NNP	O	M.	nn	10	SENT_451	[p28l11t2578r72b2618],
9	Prolonged	JJ	O	prolonged	amod	10	SENT_451	[p28l91t2574r341b2631],
10	exposure	NN	O	exposure	appos	2	SENT_451	[p28l358t2588r577b2630],
11	to	TO	O	to	_	0	SENT_451	[p28l595t2583r641b2618],
12	lipopolysaccharide	NN	O	lipopolysaccharide	prep_to	10	SENT_451	[p28l658t2574r1038b2630, p28l12t2645r105b2689],
13	inhibits	VBZ	O	inhibit	_	0	SENT_451	[p28l131t2645r320b2689],
14	macrophage	NN	O	macrophage	nn	16	SENT_451	[p28l347t2645r647b2702],
15	5-lipoxygenase	NN	O	5-lipoxygenase	nn	16	SENT_451	[p28l675t2645r1039b2702],
16	metabolism	NN	O	metabolism	dobj	13	SENT_451	[p28l12t2717r302b2761],
17	via	IN	O	via	_	0	SENT_451	[p28l326t2718r395b2762],
18	induction	NN	O	induction	prep_via	16	SENT_451	[p28l420t2717r655b2762],
19	of	IN	O	of	_	0	SENT_451	[p28l681t2717r738b2761],
20	nitric	JJ	O	nitric	amod	22	SENT_451	[p28l753t2718r884b2761],
21	oxide	NN	O	oxide	nn	22	SENT_451	[p28l910t2717r1039b2761],
22	synthesis	NN	O	synthesis	prep_of	18	SENT_451	[p28l13t2788r252b2844],
23	.	.	O	.	_	0	SENT_451	[p28l13t2788r252b2844],

1	J	NNP	O	J	nn	2	SENT_452	[p28l268t2792r289b2839],
2	Immunol	NNP	O	Immunol	_	0	SENT_452	[p28l307t2788r535b2833],
3	2000	CD	DATE	2000	num	2	SENT_452	[p28l554t2792r966b2842],
4	;	:	O	;	_	0	SENT_452	[p28l554t2792r966b2842],
5	165:3592	CD	NUMBER	165:3592	number	6	SENT_452	[p28l554t2792r966b2842],
6	-8	CD	NUMBER	-8	dep	2	SENT_452	[p28l554t2792r966b2842],
7	.	.	O	.	_	0	SENT_452	[p28l554t2792r966b2842],

1	10	CD	NUMBER	10	_	0	SENT_453	[p28l14t2864r78b2903],
2	.	.	O	.	_	0	SENT_453	[p28l14t2864r78b2903],

1	Peters-Golden	JJ	O	peters-golden	amod	2	SENT_454	[p28l107t2859r455b2903],
2	M	NN	O	m	_	0	SENT_454	[p28l475t2863r536b2913],
3	,	,	O	,	_	0	SENT_454	[p28l475t2863r536b2913],
4	Brock	NNP	PERSON	Brock	nn	5	SENT_454	[p28l560t2859r703b2904],
5	TG	NN	PERSON	tg	appos	2	SENT_454	[p28l720t2863r808b2903],
6	.	.	O	.	_	0	SENT_454	[p28l720t2863r808b2903],

1	Intracellular	JJ	O	intracellular	amod	2	SENT_455	[p28l832t2859r1039b2903, p28l12t2930r126b2975],
2	compartmentalization	NN	O	compartmentalization	_	0	SENT_455	[p28l160t2930r712b2986],
3	of	IN	O	of	_	0	SENT_455	[p28l747t2930r804b2974],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_455	[p28l828t2930r1038b2975, p28l13t3015r94b3045],
5	synthesis	NN	O	synthesis	prep_of	2	SENT_455	[p28l110t3001r349b3057],
6	:	:	O	:	_	0	SENT_455	[p28l110t3001r349b3057],
7	unexpected	JJ	O	unexpected	amod	9	SENT_455	[p28l367t3001r646b3057],
8	nuclear	JJ	O	nuclear	amod	9	SENT_455	[p28l661t3001r842b3046],
9	secrets	NNS	O	secret	dep	2	SENT_455	[p28l856t3011r1036b3045],
10	.	.	O	.	_	0	SENT_455	[p28l856t3011r1036b3045],

1	FEBS	NNP	O	FEBS	nn	2	SENT_456	[p28l12t3075r133b3116],
2	Lett	NNP	O	Lett	_	0	SENT_456	[p28l154t3075r250b3115],
3	2001	CD	DATE	2001	num	2	SENT_456	[p28l267t3075r653b3124],
4	;	:	O	;	_	0	SENT_456	[p28l267t3075r653b3124],
5	487:323	CD	NUMBER	487:323	number	6	SENT_456	[p28l267t3075r653b3124],
6	-6	CD	NUMBER	-6	dep	2	SENT_456	[p28l267t3075r653b3124],
7	.	.	O	.	_	0	SENT_456	[p28l267t3075r653b3124],

1	11	CD	NUMBER	11	_	0	SENT_457	[p28l14t3148r78b3186],
2	.	.	O	.	_	0	SENT_457	[p28l14t3148r78b3186],

1	Luo	NNP	PERSON	Luo	nn	2	SENT_458	[p28l107t3146r196b3186],
2	M	NNP	O	M	_	0	SENT_458	[p28l225t3146r287b3195],
3	,	,	O	,	_	0	SENT_458	[p28l225t3146r287b3195],
4	Jones	NNP	PERSON	Jones	nn	5	SENT_458	[p28l314t3146r447b3193],
5	SM	NNP	O	SM	appos	2	SENT_458	[p28l479t3146r567b3195],
6	,	,	O	,	_	0	SENT_458	[p28l479t3146r567b3195],
7	Peters-Golden	NNP	O	Peters-Golden	nn	8	SENT_458	[p28l599t3142r947b3186],
8	M	NNP	O	M	appos	2	SENT_458	[p28l975t3146r1036b3195],
9	,	,	O	,	_	0	SENT_458	[p28l975t3146r1036b3195],
10	Brock	NNP	PERSON	Brock	nn	11	SENT_458	[p28l1114t23r1254b68],
11	TG	NN	PERSON	tg	appos	2	SENT_458	[p28l1265t27r1352b67],
12	.	.	O	.	_	0	SENT_458	[p28l1265t27r1352b67],

1	Nuclear	JJ	O	nuclear	amod	2	SENT_459	[p28l1369t23r1557b68],
2	localization	NN	O	localization	_	0	SENT_459	[p28l1570t23r1853b67],
3	of	IN	O	of	_	0	SENT_459	[p28l1869t23r1925b67],
4	5lipoxygenase	NN	O	5lipoxygenase	prep_of	2	SENT_459	[p28l1931t23r2141b79, p28l1114t107r1281b149],
5	as	IN	O	as	_	0	SENT_459	[p28l1299t108r1347b137],
6	a	DT	O	a	det	9	SENT_459	[p28l1366t108r1391b137],
7	determinant	NN	O	determinant	nn	9	SENT_459	[p28l1409t93r1714b137],
8	ofleukotriene	NN	O	ofleukotriene	nn	9	SENT_459	[p28l1730t93r2071b137],
9	B4	NN	O	b4	prep_as	2	SENT_459	[p28l2089t97r2142b152],
10	synthetic	JJ	O	synthetic	amod	11	SENT_459	[p28l1115t163r1327b219],
11	capacity	NN	O	capacity	dep	9	SENT_459	[p28l1344t164r1541b219],
12	.	.	O	.	_	0	SENT_459	[p28l1344t164r1541b219],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_460	[p28l1561t167r1665b207],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_460	[p28l1680t163r1780b208],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_460	[p28l1795t163r1912b207],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_460	[p28l1929t164r1995b208],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_460	[p28l2011t167r2049b207],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_460	[p28l2066t167r2090b207],
7	A	NNP	O	A	_	0	SENT_460	[p28l2107t167r2143b207],
8	2003	CD	DATE	2003	num	7	SENT_460	[p28l1115t238r1583b288],
9	;	:	O	;	_	0	SENT_460	[p28l1115t238r1583b288],
10	100:12165	CD	NUMBER	100:12165	number	11	SENT_460	[p28l1115t238r1583b288],
11	-70	CD	NUMBER	-70	dep	7	SENT_460	[p28l1115t238r1583b288],
12	.	.	O	.	_	0	SENT_460	[p28l1115t238r1583b288],

1	12	CD	NUMBER	12	_	0	SENT_461	[p28l1116t311r1180b349],
2	.	.	O	.	_	0	SENT_461	[p28l1116t311r1180b349],

1	Mayatepek	NNP	PERSON	Mayatepek	nn	2	SENT_462	[p28l1209t305r1468b361],
2	E.	NNP	PERSON	E.	_	0	SENT_462	[p28l1482t309r1525b349],
3	Leukotriene	NN	PERSON	leukotriene	nn	6	SENT_462	[p28l1544t305r1831b349],
4	C4	NN	O	c4	nn	6	SENT_462	[p28l1848t309r1902b364],
5	synthesis	NN	O	synthesis	nn	6	SENT_462	[p28l1920t305r2140b361],
6	deficiency	NN	O	deficiency	dep	2	SENT_462	[p28l1115t376r1374b432],
7	:	:	O	:	_	0	SENT_462	[p28l1115t376r1374b432],
8	a	DT	O	a	det	9	SENT_462	[p28l1393t391r1418b420],
9	member	NN	O	member	dep	2	SENT_462	[p28l1433t376r1636b420],
10	of	IN	O	of	_	0	SENT_462	[p28l1651t376r1708b420],
11	a	DT	O	a	det	15	SENT_462	[p28l1714t391r1738b420],
12	probably	RB	O	probably	advmod	13	SENT_462	[p28l1753t376r1968b432],
13	underdiagnosed	JJ	O	underdiagnosed	amod	15	SENT_462	[p28l1982t376r2141b421, p28l1115t446r1367b503],
14	new	JJ	O	new	amod	15	SENT_462	[p28l1392t461r1493b491],
15	group	NN	O	group	prep_of	9	SENT_462	[p28l1515t460r1659b503],
16	of	IN	O	of	_	0	SENT_462	[p28l1685t446r1742b491],
17	neurometabolic	JJ	O	neurometabolic	amod	18	SENT_462	[p28l1756t446r2142b491],
18	diseases	NNS	O	disease	prep_of	15	SENT_462	[p28l1115t518r1330b562],
19	.	.	O	.	_	0	SENT_462	[p28l1115t518r1330b562],

1	EurJ	NN	O	eurj	_	0	SENT_463	[p28l1352t522r1470b569],
2	Pediatr	NNP	O	Pediatr	dep	1	SENT_463	[p28l1487t518r1662b562],
3	2000	CD	DATE	2000	num	2	SENT_463	[p28l1680t522r2067b571],
4	;	:	O	;	_	0	SENT_463	[p28l1680t522r2067b571],
5	159:811	CD	NUMBER	159:811	num	6	SENT_463	[p28l1680t522r2067b571],
6	-8	CD	NUMBER	-8	dep	1	SENT_463	[p28l1680t522r2067b571],
7	.	.	O	.	_	0	SENT_463	[p28l1680t522r2067b571],

1	13	CD	NUMBER	13	_	0	SENT_464	[p28l1116t595r1180b633],
2	.	.	O	.	_	0	SENT_464	[p28l1116t595r1180b633],

1	In	IN	O	in	dep	5	SENT_465	[p28l1210t593r1260b633],
2	KH	NNP	O	KH	pobj	1	SENT_465	[p28l1281t593r1375b643],
3	,	,	O	,	_	0	SENT_465	[p28l1281t593r1375b643],
4	Asano	NNP	PERSON	Asano	nn	5	SENT_465	[p28l1398t593r1550b633],
5	K	NNP	PERSON	K	_	0	SENT_465	[p28l1572t593r1621b643],
6	,	,	O	,	_	0	SENT_465	[p28l1572t593r1621b643],
7	Beier	NNP	PERSON	Beier	nn	8	SENT_465	[p28l1645t590r1769b633],
8	D	NNP	O	D	appos	5	SENT_465	[p28l1788t593r1839b643],
9	,	,	O	,	_	0	SENT_465	[p28l1788t593r1839b643],
10	et	FW	O	et	nn	11	SENT_465	[p28l1863t598r1907b633],
11	al.	FW	O	al.	appos	5	SENT_465	[p28l1926t589r1981b633],
12	.	.	O	.	_	0	SENT_465	[p28l1926t589r1981b633],

1	Naturally	RB	O	naturally	advmod	2	SENT_466	[p28l2004t593r2141b634, p28l1114t659r1223b715],
2	occurring	VBG	O	occur	_	0	SENT_466	[p28l1249t660r1489b716],
3	mutations	NNS	O	mutation	dobj	2	SENT_466	[p28l1515t660r1762b704],
4	in	IN	O	in	_	0	SENT_466	[p28l1791t660r1838b703],
5	the	DT	O	the	det	9	SENT_466	[p28l1866t659r1941b703],
6	human	JJ	O	human	amod	9	SENT_466	[p28l1969t659r2142b704],
7	5-lipoxygenase	NN	O	5-lipoxygenase	nn	9	SENT_466	[p28l1116t730r1480b787],
8	gene	NN	O	gene	nn	9	SENT_466	[p28l1500t744r1613b787],
9	promoter	NN	O	promoter	prep_in	2	SENT_466	[p28l1632t739r1863b786],
10	that	WDT	O	that	nsubj	11	SENT_466	[p28l1881t730r1979b774],
11	modify	VBP	O	modify	rcmod	9	SENT_466	[p28l1997t730r2141b775, p28l1115t801r1160b857],
12	transcription	NN	O	transcription	nn	14	SENT_466	[p28l1193t802r1515b857],
13	factor	NN	O	factor	nn	14	SENT_466	[p28l1550t801r1693b846],
14	binding	NN	O	binding	dobj	11	SENT_466	[p28l1727t801r1919b858],
15	and	CC	O	and	_	0	SENT_466	[p28l1952t801r2041b845],
16	reporter	NN	O	reporter	nn	18	SENT_466	[p28l2076t816r2141b845, p28l1114t881r1266b928],
17	gene	NN	O	gene	nn	18	SENT_466	[p28l1298t886r1411b929],
18	transcription	NN	O	transcription	dobj	11	SENT_466	[p28l1445t873r1779b928],
19	.	.	O	.	_	0	SENT_466	[p28l1445t873r1779b928],

1	J	NNP	O	J	nn	3	SENT_467	[p28l1811t876r1832b923],
2	Clin	NNP	O	Clin	nn	3	SENT_467	[p28l1864t872r1965b917],
3	Invest	NNP	O	Invest	_	0	SENT_467	[p28l1998t876r2144b917],
4	1997	CD	DATE	1997	num	3	SENT_467	[p28l1116t947r1491b997],
5	;	:	O	;	_	0	SENT_467	[p28l1116t947r1491b997],
6	99:1130	CD	NUMBER	99:1130	number	7	SENT_467	[p28l1116t947r1491b997],
7	-7	CD	NUMBER	-7	dep	3	SENT_467	[p28l1116t947r1491b997],
8	.	.	O	.	_	0	SENT_467	[p28l1116t947r1491b997],

1	14	CD	NUMBER	14	_	0	SENT_468	[p28l1116t1020r1180b1058],
2	.	.	O	.	_	0	SENT_468	[p28l1116t1020r1180b1058],

1	Helgadottir	NNP	MISC	Helgadottir	nn	2	SENT_469	[p28l1210t1014r1494b1071],
2	A	NNP	MISC	A	_	0	SENT_469	[p28l1509t1018r1558b1068],
3	,	,	O	,	_	0	SENT_469	[p28l1509t1018r1558b1068],
4	Manolescu	NNP	PERSON	Manolescu	nn	5	SENT_469	[p28l1578t1014r1843b1059],
5	A	NNP	O	A	appos	2	SENT_469	[p28l1859t1018r1909b1068],
6	,	,	O	,	_	0	SENT_469	[p28l1859t1018r1909b1068],
7	Thorleifsson	NNP	O	Thorleifsson	nn	8	SENT_469	[p28l1928t1014r2141b1058, p28l1115t1099r1223b1129],
8	G	NNP	O	G	appos	2	SENT_469	[p28l1242t1089r1293b1139],
9	,	,	O	,	_	0	SENT_469	[p28l1242t1089r1293b1139],
10	et	FW	O	et	nn	11	SENT_469	[p28l1316t1094r1359b1129],
11	al.	FW	O	al.	appos	2	SENT_469	[p28l1375t1085r1429b1129],
12	.	.	O	.	_	0	SENT_469	[p28l1375t1085r1429b1129],

1	The	DT	O	the	det	4	SENT_470	[p28l1449t1085r1539b1129],
2	gene	NN	O	gene	nn	4	SENT_470	[p28l1558t1099r1669b1142],
3	encoding	VBG	O	encode	amod	4	SENT_470	[p28l1689t1085r1913b1142],
4	5lipoxygenase	NN	O	5lipoxygenase	nsubj	7	SENT_470	[p28l1931t1085r2141b1141, p28l1114t1171r1281b1213],
5	activating	VBG	O	activate	partmod	4	SENT_470	[p28l1306t1157r1547b1213],
6	protein	NN	O	protein	dobj	5	SENT_470	[p28l1570t1157r1748b1212],
7	confers	VBZ	O	confer	_	0	SENT_470	[p28l1773t1156r1952b1201],
8	risk	NN	O	risk	dobj	7	SENT_470	[p28l1979t1156r2072b1201],
9	of	IN	O	of	_	0	SENT_470	[p28l2095t1156r2152b1201],
10	myocardial	JJ	O	myocardial	amod	11	SENT_470	[p28l1115t1228r1377b1284],
11	infarction	NN	O	infarction	prep_of	8	SENT_470	[p28l1394t1228r1627b1272],
12	and	CC	O	and	_	0	SENT_470	[p28l1644t1228r1731b1272],
13	stroke	NN	O	stroke	prep_of	8	SENT_470	[p28l1749t1228r1905b1273],
14	.	.	O	.	_	0	SENT_470	[p28l1749t1228r1905b1273],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_471	[p28l1924t1232r2009b1272],
2	Genet	NNP	PERSON	Genet	_	0	SENT_471	[p28l2023t1232r2141b1272, p28l1115t1308r1159b1343],
3	2004	CD	DATE	2004	num	2	SENT_471	[p28l1175t1303r1534b1352],
4	;	:	O	;	_	0	SENT_471	[p28l1175t1303r1534b1352],
5	36:233	CD	NUMBER	36:233	number	6	SENT_471	[p28l1175t1303r1534b1352],
6	-9	CD	NUMBER	-9	dep	2	SENT_471	[p28l1175t1303r1534b1352],
7	.	.	O	.	_	0	SENT_471	[p28l1175t1303r1534b1352],

1	15	CD	NUMBER	15	_	0	SENT_472	[p28l1116t1375r1180b1413],
2	.	.	O	.	_	0	SENT_472	[p28l1116t1375r1180b1413],

1	Helgadottir	NNP	MISC	Helgadottir	nn	2	SENT_473	[p28l1210t1369r1494b1426],
2	A	NNP	MISC	A	_	0	SENT_473	[p28l1522t1373r1571b1423],
3	,	,	O	,	_	0	SENT_473	[p28l1522t1373r1571b1423],
4	Manolescu	NNP	PERSON	Manolescu	nn	5	SENT_473	[p28l1604t1369r1869b1414],
5	A	NNP	O	A	appos	2	SENT_473	[p28l1898t1373r1948b1423],
6	,	,	O	,	_	0	SENT_473	[p28l1898t1373r1948b1423],
7	Helgason	NNP	O	Helgason	nn	8	SENT_473	[p28l1982t1369r2141b1426, p28l1115t1454r1199b1485],
8	A	NNP	O	A	appos	2	SENT_473	[p28l1212t1444r1261b1494],
9	,	,	O	,	_	0	SENT_473	[p28l1212t1444r1261b1494],
10	et	FW	O	et	nn	11	SENT_473	[p28l1281t1450r1324b1484],
11	al.	FW	O	al.	appos	2	SENT_473	[p28l1337t1440r1391b1484],
12	.	.	O	.	_	0	SENT_473	[p28l1337t1440r1391b1484],

1	A	DT	O	a	det	2	SENT_474	[p28l1408t1444r1445b1484],
2	variant	NN	O	variant	nsubj	10	SENT_474	[p28l1456t1441r1626b1485],
3	of	IN	O	of	_	0	SENT_474	[p28l1639t1440r1695b1485],
4	the	DT	O	the	det	5	SENT_474	[p28l1701t1440r1775b1484],
5	gene	NN	O	gene	prep_of	2	SENT_474	[p28l1791t1454r1902b1497],
6	encoding	VBG	O	encode	partmod	5	SENT_474	[p28l1919t1440r2144b1497],
7	leukotriene	NN	O	leukotriene	nn	9	SENT_474	[p28l1114t1511r1391b1555],
8	A4	NN	O	a4	nn	9	SENT_474	[p28l1412t1515r1468b1570],
9	hydrolase	NN	O	hydrolase	dobj	6	SENT_474	[p28l1491t1511r1725b1567],
10	confers	VBZ	O	confer	_	0	SENT_474	[p28l1748t1511r1927b1555],
11	ethnicity-specific	JJ	O	ethnicity-specific	amod	12	SENT_474	[p28l1951t1511r2141b1555, p28l1115t1581r1374b1637],
12	risk	NN	O	risk	dobj	10	SENT_474	[p28l1396t1581r1491b1626],
13	of	IN	O	of	_	0	SENT_474	[p28l1511t1581r1568b1626],
14	myocardial	JJ	O	myocardial	amod	15	SENT_474	[p28l1580t1581r1859b1637],
15	infarction	NN	O	infarction	prep_of	12	SENT_474	[p28l1881t1581r2138b1625],
16	.	.	O	.	_	0	SENT_474	[p28l1881t1581r2138b1625],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_475	[p28l1113t1657r1201b1697],
2	Genet	NNP	PERSON	Genet	_	0	SENT_475	[p28l1217t1657r1363b1697],
3	2006	CD	DATE	2006	num	2	SENT_475	[p28l1380t1657r1734b1706],
4	;	:	O	;	_	0	SENT_475	[p28l1380t1657r1734b1706],
5	38:68	CD	NUMBER	38:68	number	6	SENT_475	[p28l1380t1657r1734b1706],
6	-74	CD	NUMBER	-74	dep	2	SENT_475	[p28l1380t1657r1734b1706],
7	.	.	O	.	_	0	SENT_475	[p28l1380t1657r1734b1706],

1	16	CD	NUMBER	16	_	0	SENT_476	[p28l1116t1729r1180b1767],
2	.	.	O	.	_	0	SENT_476	[p28l1116t1729r1180b1767],

1	Sanak	NNP	O	Sanak	nn	2	SENT_477	[p28l1212t1723r1360b1768],
2	M	NNP	O	M	_	0	SENT_477	[p28l1393t1727r1454b1777],
3	,	,	O	,	_	0	SENT_477	[p28l1393t1727r1454b1777],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_477	[p28l1496t1724r1650b1767],
5	HU	NNP	PERSON	HU	appos	2	SENT_477	[p28l1687t1727r1781b1777],
6	,	,	O	,	_	0	SENT_477	[p28l1687t1727r1781b1777],
7	Szczeklik	NNP	O	Szczeklik	nn	8	SENT_477	[p28l1822t1723r2056b1768],
8	A.	NNP	O	A.	appos	2	SENT_477	[p28l2089t1727r2138b1767],
9	Leukotriene	NN	O	leukotriene	nn	11	SENT_477	[p28l1114t1794r1407b1838],
10	C4	NN	O	c4	nn	11	SENT_477	[p28l1437t1798r1492b1853],
11	synthase	NN	O	synthase	dep	8	SENT_477	[p28l1522t1794r1734b1850],
12	promoter	NN	O	promoter	nn	13	SENT_477	[p28l1764t1803r1994b1850],
13	polymorphism	NN	O	polymorphism	dep	2	SENT_477	[p28l2021t1794r2141b1850, p28l1114t1865r1370b1921],
14	and	CC	O	and	_	0	SENT_477	[p28l1409t1865r1499b1909],
15	risk	NN	O	risk	dep	2	SENT_477	[p28l1539t1865r1633b1909],
16	of	IN	O	of	_	0	SENT_477	[p28l1671t1865r1727b1909],
17	aspirin-induced	JJ	O	aspirin-induced	amod	18	SENT_477	[p28l1757t1865r2142b1921],
18	asthma	NN	O	asthma	prep_of	13	SENT_477	[p28l1114t1935r1308b1979],
19	.	.	O	.	_	0	SENT_477	[p28l1114t1935r1308b1979],

1	Lancet	NNP	O	Lancet	_	0	SENT_478	[p28l1330t1939r1493b1979],
2	1997	CD	DATE	1997	num	1	SENT_478	[p28l1512t1939r1985b1989],
3	;	:	O	;	_	0	SENT_478	[p28l1512t1939r1985b1989],
4	350:1599	CD	NUMBER	350:1599	number	5	SENT_478	[p28l1512t1939r1985b1989],
5	-600	CD	NUMBER	-600	dep	1	SENT_478	[p28l1512t1939r1985b1989],
6	.	.	O	.	_	0	SENT_478	[p28l1512t1939r1985b1989],

1	17	CD	NUMBER	17	_	0	SENT_479	[p28l1116t2012r1180b2050],
2	.	.	O	.	_	0	SENT_479	[p28l1116t2012r1180b2050],

1	Cowburn	NNP	PERSON	Cowburn	nn	2	SENT_480	[p28l1210t2006r1436b2051],
2	AS	NNP	O	AS	_	0	SENT_480	[p28l1468t2010r1547b2060],
3	,	,	O	,	_	0	SENT_480	[p28l1468t2010r1547b2060],
4	Holgate	NNP	ORGANIZATION	Holgate	nn	8	SENT_480	[p28l1584t2006r1774b2063],
5	ST	JJ	ORGANIZATION	st	amod	8	SENT_480	[p28l1810t2010r1880b2060],
6	,	,	O	,	_	0	SENT_480	[p28l1810t2010r1880b2060],
7	Sampson	NNP	PERSON	Sampson	dep	8	SENT_480	[p28l1919t2010r2142b2062],
8	AP	NNP	O	AP	appos	2	SENT_480	[p28l1112t2082r1189b2122],
9	.	.	O	.	_	0	SENT_480	[p28l1112t2082r1189b2122],

1	IL-5	NN	MISC	il-5	nsubj	8	SENT_481	[p28l1213t2082r1307b2122],
2	increases	VBZ	O	increase	_	0	SENT_481	[p28l1329t2079r1555b2122],
3	expression	NN	O	expression	dobj	2	SENT_481	[p28l1578t2079r1838b2134],
4	of	IN	O	of	_	0	SENT_481	[p28l1860t2078r1916b2122],
5	5lipoxygenase-activating	JJ	O	5lipoxygenase-activating	amod	6	SENT_481	[p28l1928t2078r2141b2134, p28l1114t2149r1536b2205],
6	protein	NN	O	protein	prep_of	3	SENT_481	[p28l1551t2149r1725b2204],
7	and	CC	O	and	_	0	SENT_481	[p28l1743t2148r1831b2193],
8	translocates	VBZ	O	translocate	conj_and	2	SENT_481	[p28l1849t2148r2140b2193],
9	5-lipoxygenase	NN	O	5-lipoxygenase	dobj	8	SENT_481	[p28l1116t2219r1480b2276],
10	to	TO	O	to	_	0	SENT_481	[p28l1507t2229r1553b2263],
11	the	DT	O	the	det	12	SENT_481	[p28l1581t2219r1657b2263],
12	nucleus	NN	O	nucleus	prep_to	8	SENT_481	[p28l1683t2219r1867b2264],
13	in	IN	O	in	_	0	SENT_481	[p28l1895t2220r1942b2263],
14	human	JJ	O	human	amod	16	SENT_481	[p28l1969t2219r2142b2264],
15	blood	NN	O	blood	nn	16	SENT_481	[p28l1115t2291r1252b2335],
16	eosinophils	NNS	O	eosinophil	prep_in	12	SENT_481	[p28l1281t2291r1578b2347],
17	.	.	O	.	_	0	SENT_481	[p28l1281t2291r1578b2347],

1	J	NNP	O	J	nn	2	SENT_482	[p28l1604t2295r1625b2342],
2	Immunol	NNP	O	Immunol	_	0	SENT_482	[p28l1651t2291r1879b2336],
3	1999	CD	DATE	1999	num	2	SENT_482	[p28l1909t2295r2139b2344],
4	;	:	O	;	_	0	SENT_482	[p28l1909t2295r2139b2344],
5	163	CD	NUMBER	163	num	7	SENT_482	[p28l1909t2295r2139b2344],
6	:	:	O	:	_	0	SENT_482	[p28l1909t2295r2139b2344],
7	456-65	CD	NUMBER	456-65	dep	2	SENT_482	[p28l1114t2365r1292b2405],
8	.	.	O	.	_	0	SENT_482	[p28l1114t2365r1292b2405],

1	18	CD	NUMBER	18	_	0	SENT_483	[p28l1116t2438r1180b2478],
2	.	.	O	.	_	0	SENT_483	[p28l1116t2438r1180b2478],

1	Hsieh	NNP	PERSON	Hsieh	nn	2	SENT_484	[p28l1210t2433r1351b2477],
2	PH	NNP	O	PH	_	0	SENT_484	[p28l1366t2437r1450b2487],
3	,	,	O	,	_	0	SENT_484	[p28l1366t2437r1450b2487],
4	Lam	NNP	LOCATION	Lam	nn	5	SENT_484	[p28l1468t2437r1575b2477],
5	BK	NNP	LOCATION	BK	appos	2	SENT_484	[p28l1590t2437r1673b2487],
6	,	,	O	,	_	0	SENT_484	[p28l1590t2437r1673b2487],
7	Penrose	NNP	ORGANIZATION	Penrose	nn	8	SENT_484	[p28l1691t2437r1883b2477],
8	JF	NNP	ORGANIZATION	JF	appos	2	SENT_484	[p28l1894t2437r1955b2487],
9	,	,	O	,	_	0	SENT_484	[p28l1894t2437r1955b2487],
10	Austen	NNP	PERSON	Austen	nn	11	SENT_484	[p28l1972t2437r2142b2478],
11	KP	NNP	O	KP	appos	2	SENT_484	[p28l1114t2508r1192b2558],
12	,	,	O	,	_	0	SENT_484	[p28l1114t2508r1192b2558],
13	Boyce	NNP	PERSON	Boyce	nn	14	SENT_484	[p28l1222t2508r1362b2560],
14	JA	NNP	O	JA	appos	2	SENT_484	[p28l1385t2508r1454b2555],
15	.	.	O	.	_	0	SENT_484	[p28l1385t2508r1454b2555],

1	T	NN	O	t	nn	4	SENT_485	[p28l1484t2508r1518b2548],
2	helper	NN	O	helper	nn	4	SENT_485	[p28l1544t2504r1697b2560],
3	cell	NN	O	cell	nn	4	SENT_485	[p28l1724t2504r1807b2548],
4	type	NN	O	type	nsubj	8	SENT_485	[p28l1835t2514r1938b2560],
5	2	CD	NUMBER	2	num	6	SENT_485	[p28l1966t2508r1992b2548],
6	cytokines	NNS	O	cytokine	dep	4	SENT_485	[p28l2021t2513r2141b2560, p28l1114t2574r1243b2619],
7	coordinately	RB	O	coordinately	advmod	8	SENT_485	[p28l1263t2574r1569b2630],
8	regulate	VBP	O	regulate	_	0	SENT_485	[p28l1585t2574r1784b2631],
9	immunoglobulin	NN	O	immunoglobulin	dobj	8	SENT_485	[p28l1802t2574r2141b2631, p28l1115t2645r1211b2690],
10	E-dependent	JJ	O	e-dependent	amod	13	SENT_485	[p28l1256t2645r1566b2701],
11	cysteinyl	NN	O	cysteinyl	nn	13	SENT_485	[p28l1609t2645r1819b2701],
12	leukotriene	NN	O	leukotriene	nn	13	SENT_485	[p28l1864t2645r2141b2690],
13	production	NN	O	production	dep	9	SENT_485	[p28l1113t2717r1384b2773],
14	by	IN	O	by	_	0	SENT_485	[p28l1406t2717r1461b2773],
15	human	JJ	O	human	amod	19	SENT_485	[p28l1481t2717r1653b2762],
16	cord	NN	O	cord	nn	19	SENT_485	[p28l1676t2717r1782b2761],
17	blood-derived	JJ	O	blood-derived	amod	19	SENT_485	[p28l1805t2717r2142b2762],
18	mast	NN	O	mast	nn	19	SENT_485	[p28l1115t2798r1234b2832],
19	cells	NNS	O	cell	prep_by	13	SENT_485	[p28l1257t2788r1378b2832],
20	:	:	O	:	_	0	SENT_485	[p28l1257t2788r1378b2832],
21	profound	JJ	O	profound	amod	22	SENT_485	[p28l1404t2788r1633b2844],
22	induction	NN	O	induction	dep	9	SENT_485	[p28l1657t2788r1892b2833],
23	of	IN	O	of	_	0	SENT_485	[p28l1917t2788r1974b2832],
24	leukotriene	NN	O	leukotriene	nn	25	SENT_485	[p28l1988t2788r2141b2833, p28l1115t2860r1255b2903],
25	C	NN	O	c	prep_of	22	SENT_485	[p28l1281t2863r1377b2910],
26	(	CD	NUMBER	(	number	27	SENT_485	[p28l1281t2863r1377b2910],
27	4	CD	NUMBER	4	dep	22	SENT_485	[p28l1281t2863r1377b2910],
28	)	NN	O	)	nn	30	SENT_485	[p28l1281t2863r1377b2910],
29	synthase	NN	O	synthase	nn	30	SENT_485	[p28l1406t2859r1618b2915],
30	expression	NN	O	expression	dep	27	SENT_485	[p28l1645t2860r1905b2915],
31	by	IN	O	by	_	0	SENT_485	[p28l1931t2859r1986b2915],
32	interleukin	NN	O	interleukin	prep_by	8	SENT_485	[p28l2009t2860r2141b2903, p28l1114t2930r1268b2975],
33	4	CD	NUMBER	4	num	32	SENT_485	[p28l1286t2934r1327b2974],
34	.	.	O	.	_	0	SENT_485	[p28l1286t2934r1327b2974],

1	J	NNP	O	J	nn	3	SENT_486	[p28l1344t2934r1365b2981],
2	Exp	NNP	O	Exp	nn	3	SENT_486	[p28l1382t2934r1472b2986],
3	Med	NNP	O	Med	_	0	SENT_486	[p28l1490t2930r1595b2974],
4	2001	CD	DATE	2001	num	3	SENT_486	[p28l1614t2934r2028b2984],
5	;	:	O	;	_	0	SENT_486	[p28l1614t2934r2028b2984],
6	193:123	CD	NUMBER	193:123	number	7	SENT_486	[p28l1614t2934r2028b2984],
7	-33	CD	NUMBER	-33	dep	3	SENT_486	[p28l1614t2934r2028b2984],
8	.	.	O	.	_	0	SENT_486	[p28l1614t2934r2028b2984],

1	19	CD	NUMBER	19	_	0	SENT_487	[p28l1116t3006r1180b3045],
2	.	.	O	.	_	0	SENT_487	[p28l1116t3006r1180b3045],

1	Serio	NNP	ORGANIZATION	Serio	nn	2	SENT_488	[p28l1212t3002r1332b3045],
2	KJ	NNP	ORGANIZATION	KJ	_	0	SENT_488	[p28l1364t3005r1431b3055],
3	,	,	O	,	_	0	SENT_488	[p28l1364t3005r1431b3055],
4	Johns	NNP	PERSON	Johns	nn	5	SENT_488	[p28l1460t3001r1600b3052],
5	SC	NNP	PERSON	SC	appos	2	SENT_488	[p28l1634t3005r1709b3055],
6	,	,	O	,	_	0	SENT_488	[p28l1634t3005r1709b3055],
7	Luo	NNP	PERSON	Luo	nn	8	SENT_488	[p28l1744t3005r1832b3046],
8	L	NNP	PERSON	L	appos	2	SENT_488	[p28l1864t3005r1907b3055],
9	,	,	O	,	_	0	SENT_488	[p28l1864t3005r1907b3055],
10	Hodulik	NNP	PERSON	Hodulik	nn	11	SENT_488	[p28l1941t3001r2144b3046],
11	CR	NN	O	cr	appos	2	SENT_488	[p28l1115t3075r1199b3125],
12	,	,	O	,	_	0	SENT_488	[p28l1115t3075r1199b3125],
13	Bigby	NNP	O	Bigby	nn	14	SENT_488	[p28l1224t3071r1361b3128],
14	TD	NNP	O	TD	appos	2	SENT_488	[p28l1380t3075r1466b3115],
15	.	.	O	.	_	0	SENT_488	[p28l1380t3075r1466b3115],

1	Lipopolysaccharide	NN	O	lipopolysaccharide	nsubj	2	SENT_489	[p28l1491t3071r1965b3127],
2	downregulates	VBZ	O	downregulate	_	0	SENT_489	[p28l1988t3071r2141b3116, p28l1115t3142r1334b3198],
3	the	DT	O	the	det	7	SENT_489	[p28l1352t3142r1426b3186],
4	leukotriene	NN	O	leukotriene	nn	7	SENT_489	[p28l1443t3142r1714b3186],
5	C4	NN	O	c4	nn	7	SENT_489	[p28l1731t3146r1785b3201],
6	synthase	NN	O	synthase	nn	7	SENT_489	[p28l1803t3142r2011b3198],
7	gene	NN	O	gene	dobj	2	SENT_489	[p28l2028t3156r2141b3198],
8	in	IN	O	in	_	0	SENT_489	[p28l16t3499r113b3586],
9	the	DT	O	the	det	12	SENT_489	[p28l195t3497r350b3587],
10	monocyte-like	JJ	O	monocyte-like	amod	12	SENT_489	[p28l432t3497r1151b3611],
11	cell	NN	O	cell	nn	12	SENT_489	[p28l1233t3497r1405b3587],
12	line	NN	O	line	prep_in	7	SENT_489	[p28l1486t3497r1699b3607],
13	,	,	O	,	_	0	SENT_489	[p28l1486t3497r1699b3607],
14	THP-1	NN	O	thp-1	appos	12	SENT_489	[p28l1784t3505r2125b3587],
15	.	.	O	.	_	0	SENT_489	[p28l1784t3505r2125b3587],

1	J	NNP	O	J	nn	2	SENT_490	[p28l6t3652r49b3749],
2	Immunol	NNP	O	Immunol	_	0	SENT_490	[p28l85t3644r553b3735],
3	2003	CD	DATE	2003	num	2	SENT_490	[p28l592t3652r1443b3753],
4	;	:	O	;	_	0	SENT_490	[p28l592t3652r1443b3753],
5	170:2121	CD	NUMBER	170:2121	number	6	SENT_490	[p28l592t3652r1443b3753],
6	-8	CD	NUMBER	-8	dep	2	SENT_490	[p28l592t3652r1443b3753],
7	.	.	O	.	_	0	SENT_490	[p28l592t3652r1443b3753],

1	20	CD	NUMBER	20	_	0	SENT_491	[p29l16t35r152b116],
2	.	.	O	.	_	0	SENT_491	[p29l16t35r152b116],

1	Tager	NNP	ORGANIZATION	Tager	nn	2	SENT_492	[p29l211t33r495b141],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_492	[p29l523t33r728b135],
3	,	,	O	,	_	0	SENT_492	[p29l523t33r728b135],
4	Luster	NNP	O	Luster	nn	5	SENT_492	[p29l769t33r1084b116],
5	AD	NN	O	ad	appos	2	SENT_492	[p29l1111t33r1297b116],
6	.	.	O	.	_	0	SENT_492	[p29l1111t33r1297b116],

1	BLTI	NN	ORGANIZATION	bltus	_	0	SENT_493	[p29l1336t33r1591b115],
2	and	CC	O	and	_	0	SENT_493	[p29l1626t25r1810b116],
3	BLT2	NN	O	blt2	conj_and	1	SENT_493	[p29l1845t33r2127b116],
4	:	:	O	:	_	0	SENT_493	[p29l1845t33r2127b116],
5	the	DT	O	the	det	7	SENT_493	[p29l18t173r172b263],
6	leukotriene	NN	O	leukotriene	nn	7	SENT_493	[p29l221t173r792b264],
7	B	NN	O	b	dep	1	SENT_493	[p29l841t181r904b263],
8	4	CD	NUMBER	4	num	9	SENT_493	[p29l912t251r951b295],
9	receptors	NNS	O	receptor	dep	7	SENT_493	[p29l1000t192r1494b287],
10	.	.	O	.	_	0	SENT_493	[p29l1000t192r1494b287],

1	l	NN	O	l	dep	9	SENT_494	[p29l1549t173r2130b289],
2	>	JJR	O	>	amod	3	SENT_494	[p29l1549t173r2130b289],
3	rostaglan	NN	O	rostaglan	dep	1	SENT_494	[p29l1549t173r2130b289],
4	—	CD	NUMBER	—	num	5	SENT_494	[p29l1549t173r2130b289],
5	dins	NNS	O	din	dep	9	SENT_494	[p29l18t321r229b411],
6	Leukot	NNP	O	Leukot	nn	9	SENT_494	[p29l290t321r640b412],
7	Essent	NNP	O	Essent	nn	9	SENT_494	[p29l691t329r1020b411],
8	Fatty	NNP	O	Fatty	nn	9	SENT_494	[p29l1071t329r1322b435],
9	Acids	NNP	O	Acids	dep	14	SENT_494	[p29l1372t321r1644b412],
10	2003	CD	DATE	2003	dep	9	SENT_494	[p29l1705t329r2126b431],
11	;	:	O	;	_	0	SENT_494	[p29l1705t329r2126b431],
12	69	CD	NUMBER	69	num	14	SENT_494	[p29l1705t329r2126b431],
13	:	:	O	:	_	0	SENT_494	[p29l1705t329r2126b431],
14	123-34	CD	NUMBER	123-34	_	0	SENT_494	[p29l20t476r385b559],
15	.	.	O	.	_	0	SENT_494	[p29l20t476r385b559],

1	21	CD	NUMBER	21	_	0	SENT_495	[p29l16t628r152b706],
2	.	.	O	.	_	0	SENT_495	[p29l16t628r152b706],

1	Kanaoka	FW	O	kanaoka	_	0	SENT_496	[p29l213t616r655b709],
2	Y	NN	O	y	dep	1	SENT_496	[p29l714t624r798b726],
3	,	,	O	,	_	0	SENT_496	[p29l714t624r798b726],
4	Boyce	NNP	PERSON	Boyce	nn	5	SENT_496	[p29l868t624r1157b730],
5	IA	NNP	O	IA	appos	2	SENT_496	[p29l1212t624r1356b720],
6	.	.	O	.	_	0	SENT_496	[p29l1212t624r1356b720],

1	Cysteinyl	NN	O	cysteinyl	nn	2	SENT_497	[p29l1427t616r1883b730],
2	leukotrienes	NNS	O	leukotriene	_	0	SENT_497	[p29l1946t616r2130b707, p29l16t763r482b854],
3	and	CC	O	and	_	0	SENT_497	[p29l517t763r701b854],
4	their	PRP$	O	they	poss	5	SENT_497	[p29l736t763r975b853],
5	receptors	NNS	O	receptor	conj_and	2	SENT_497	[p29l1004t782r1498b877],
6	:	:	O	:	_	0	SENT_497	[p29l1004t782r1498b877],
7	cellular	JJ	O	cellular	amod	8	SENT_497	[p29l1539t763r1916b854],
8	distribution	NN	O	distribution	dep	2	SENT_497	[p29l1948t763r2130b853, p29l18t910r454b1001],
9	and	CC	O	and	_	0	SENT_497	[p29l497t910r677b1001],
10	function	NN	O	function	conj_and	8	SENT_497	[p29l720t910r1141b1001],
11	in	IN	O	in	_	0	SENT_497	[p29l1184t912r1279b999],
12	immune	JJ	O	immune	amod	15	SENT_497	[p29l1320t912r1735b1001],
13	and	CC	O	and	_	0	SENT_497	[p29l1776t910r1958b1001],
14	inﬂammatory	JJ	O	inﬂammatory	conj_and	12	SENT_497	[p29l1999t912r2130b999, p29l16t1058r614b1172],
15	responses	NNS	O	response	prep_in	8	SENT_497	[p29l667t1087r1182b1172],
16	.	.	O	.	_	0	SENT_497	[p29l667t1087r1182b1172],

1	}	NN	O	}	_	0	SENT_498	[p29l1235t1066r1279b1162],
2	Immunol	NNP	O	Immunol	dep	1	SENT_498	[p29l1334t1058r1796b1149],
3	2004	CD	DATE	2004	num	2	SENT_498	[p29l1855t1066r2127b1166],
4	;	:	O	;	_	0	SENT_498	[p29l1855t1066r2127b1166],
5	173:1	CD	NUMBER	173:1	number	6	SENT_498	[p29l20t1213r642b1296],
6	§	CD	NUMBER	§	dep	1	SENT_498	[p29l20t1213r642b1296],
7	03	CD	NUMBER	03	num	8	SENT_498	[p29l20t1213r642b1296],
8	—	NN	O	—	dep	6	SENT_498	[p29l20t1213r642b1296],
9	10	CD	NUMBER	10	dep	6	SENT_498	[p29l20t1213r642b1296],
10	.	.	O	.	_	0	SENT_498	[p29l20t1213r642b1296],

1	22	CD	NUMBER	22	_	0	SENT_499	[p29l16t1365r152b1443],
2	.	.	O	.	_	0	SENT_499	[p29l16t1365r152b1443],

1	Lynch	NNP	ORGANIZATION	Lynch	nn	2	SENT_500	[p29l213t1353r509b1467],
2	KR	NNP	ORGANIZATION	KR	_	0	SENT_500	[p29l570t1361r752b1463],
3	,	,	O	,	_	0	SENT_500	[p29l570t1361r752b1463],
4	O’Neill	NNP	O	O’Neill	nn	5	SENT_500	[p29l821t1353r1178b1444],
5	GP	NNP	O	GP	appos	2	SENT_500	[p29l1239t1361r1401b1463],
6	,	,	O	,	_	0	SENT_500	[p29l1239t1361r1401b1463],
7	Liu	NNP	O	Liu	nn	8	SENT_500	[p29l1468t1355r1624b1444],
8	Q	NNP	O	Q	appos	2	SENT_500	[p29l1685t1361r1796b1465],
9	,	,	O	,	_	0	SENT_500	[p29l1685t1361r1796b1465],
10	et	FW	O	et	nn	11	SENT_500	[p29l1867t1372r1956b1443],
11	al.	FW	O	al.	appos	2	SENT_500	[p29l2011t1353r2126b1443],
12	.	.	O	.	_	0	SENT_500	[p29l2011t1353r2126b1443],

1	Characterization	NN	O	characterization	_	0	SENT_501	[p29l18t1500r863b1590],
2	of	IN	O	of	_	0	SENT_501	[p29l921t1500r1036b1590],
3	the	DT	O	the	det	8	SENT_501	[p29l1073t1500r1229b1590],
4	human	JJ	O	human	amod	8	SENT_501	[p29l1287t1500r1640b1591],
5	cysteinyl	NN	O	cysteinyl	nn	8	SENT_501	[p29l1699t1500r2133b1614],
6	leukotriene	NN	O	leukotriene	nn	8	SENT_501	[p29l16t1647r587b1738],
7	CysLT1	NN	O	cyslt1	nn	8	SENT_501	[p29l617t1655r979b1761],
8	receptor	NN	O	receptor	prep_of	1	SENT_501	[p29l1010t1666r1450b1761],
9	.	.	O	.	_	0	SENT_501	[p29l1010t1666r1450b1761],

1	Nature	NNP	O	Nature	_	0	SENT_502	[p29l1484t1655r1828b1738],
2	1999	CD	DATE	1999	num	1	SENT_502	[p29l1861t1655r2127b1757],
3	;	:	O	;	_	0	SENT_502	[p29l1861t1655r2127b1757],
4	399789-93	CD	NUMBER	399789-93	dep	1	SENT_502	[p29l18t1802r592b1885],
5	.	.	O	.	_	0	SENT_502	[p29l18t1802r592b1885],

1	23	CD	NUMBER	23	_	0	SENT_503	[p29l16t1955r152b2034],
2	.	.	O	.	_	0	SENT_503	[p29l16t1955r152b2034],

1	Beller	NNP	PERSON	Beller	nn	2	SENT_504	[p29l213t1943r505b2034],
2	TC	NNP	O	TC	nsubj	18	SENT_504	[p29l576t1951r748b2054],
3	,	,	O	,	_	0	SENT_504	[p29l576t1951r748b2054],
4	Maekawa	NNP	PERSON	Maekawa	nn	5	SENT_504	[p29l831t1943r1301b2034],
5	A	NNP	O	A	appos	2	SENT_504	[p29l1373t1951r1476b2054],
6	,	,	O	,	_	0	SENT_504	[p29l1373t1951r1476b2054],
7	Friend	NN	O	friend	nn	8	SENT_504	[p29l1561t1943r1881b2034],
8	DS	NN	O	d	appos	2	SENT_504	[p29l1958t1951r2125b2054],
9	,	,	O	,	_	0	SENT_504	[p29l1958t1951r2125b2054],
10	Austen	NNP	PERSON	Austen	nn	11	SENT_504	[p29l12t2098r361b2181],
11	KF	NNP	O	KF	appos	2	SENT_504	[p29l397t2098r557b2200],
12	,	,	O	,	_	0	SENT_504	[p29l397t2098r557b2200],
13	Kanaoka	NNP	LOCATION	Kanaoka	nn	14	SENT_504	[p29l600t2090r1042b2183],
14	Y.	NNP	O	Y.	appos	2	SENT_504	[p29l1072t2098r1157b2181],
15	Targeted	VBN	O	target	partmod	2	SENT_504	[p29l1196t2090r1640b2206],
16	gene	NN	O	gene	nn	17	SENT_504	[p29l1677t2119r1909b2206],
17	disruption	NN	O	disruption	dobj	15	SENT_504	[p29l1947t2090r2130b2181, p29l16t2240r391b2352],
18	reveals	VBZ	O	reveal	_	0	SENT_504	[p29l454t2238r795b2329],
19	the	DT	O	the	det	20	SENT_504	[p29l860t2238r1015b2328],
20	role	NN	O	role	dobj	18	SENT_504	[p29l1075t2238r1263b2329],
21	of	IN	O	of	_	0	SENT_504	[p29l1326t2238r1441b2329],
22	the	DT	O	the	det	26	SENT_504	[p29l1482t2238r1636b2328],
23	cysteinyl	NN	O	cysteinyl	nn	26	SENT_504	[p29l1699t2238r2132b2352],
24	leukotriene	NN	O	leukotriene	nn	26	SENT_504	[p29l16t2385r586b2476],
25	2	CD	NUMBER	2	num	26	SENT_504	[p29l625t2393r679b2474],
26	receptor	NN	O	receptor	prep_of	20	SENT_504	[p29l718t2404r1137b2499],
27	in	IN	O	in	_	0	SENT_504	[p29l1170t2387r1267b2474],
28	increased	VBN	O	increase	amod	30	SENT_504	[p29l1304t2385r1784b2475],
29	Vascular	JJ	O	vascular	amod	30	SENT_504	[p29l1817t2416r2130b2476, p29l16t2532r148b2622],
30	permeability	NN	O	permeability	prep_in	18	SENT_504	[p29l179t2532r811b2646],
31	and	CC	O	and	_	0	SENT_504	[p29l841t2532r1022b2623],
32	in	IN	O	in	_	0	SENT_504	[p29l1058t2534r1153b2621],
33	bleomycin	NN	O	bleomycin	nn	34	SENT_504	[p29l1190t2532r2131b2646],
34	—	NN	O	—	prep_in	37	SENT_504	[p29l1190t2532r2131b2646],
35	induced	VBD	O	induce	amod	37	SENT_504	[p29l1190t2532r2131b2646],
36	pulmonary	JJ	O	pulmonary	amod	37	SENT_504	[p29l16t2679r574b2793],
37	fibrosis	NN	O	fibrosis	conj_and	30	SENT_504	[p29l619t2679r1001b2769],
38	in	IN	O	in	_	0	SENT_504	[p29l1052t2681r1149b2768],
39	mice	NNS	O	mouse	prep_in	37	SENT_504	[p29l1199t2681r1464b2769],
40	.	.	O	.	_	0	SENT_504	[p29l1199t2681r1464b2769],

1	J	NNP	O	J	nn	3	SENT_505	[p29l1509t2687r1553b2783],
2	Biol	NNP	O	Biol	nn	3	SENT_505	[p29l1598t2679r1792b2769],
3	Chem	NNP	O	Chem	_	0	SENT_505	[p29l1841t2679r2131b2769],
4	2004	CD	DATE	2004	num	3	SENT_505	[p29l18t2835r1003b2936],
5	;	:	O	;	_	0	SENT_505	[p29l18t2835r1003b2936],
6	279:46129	CD	NUMBER	279:46129	number	7	SENT_505	[p29l18t2835r1003b2936],
7	—	CD	NUMBER	—	dep	3	SENT_505	[p29l18t2835r1003b2936],
8	34	CD	NUMBER	34	dep	7	SENT_505	[p29l18t2835r1003b2936],
9	.	.	O	.	_	0	SENT_505	[p29l18t2835r1003b2936],

1	24	CD	NUMBER	24	_	0	SENT_506	[p29l16t2986r152b3064],
2	.	.	O	.	_	0	SENT_506	[p29l16t2986r152b3064],

1	Hui	NNP	PERSON	Hui	nn	2	SENT_507	[p29l213t2976r393b3065],
2	Y	NN	PERSON	y	_	0	SENT_507	[p29l444t2982r527b3084],
3	,	,	O	,	_	0	SENT_507	[p29l444t2982r527b3084],
4	Cheng	NNP	PERSON	Cheng	nn	5	SENT_507	[p29l590t2974r906b3090],
5	Y	NN	PERSON	y	appos	2	SENT_507	[p29l955t2982r1036b3084],
6	,	,	O	,	_	0	SENT_507	[p29l955t2982r1036b3084],
7	Smalera	NNP	O	Smalera	appos	2	SENT_507	[p29l1103t2974r1496b3065],
8	I	PRP	O	I	dep	7	SENT_507	[p29l1549t2982r1610b3084],
9	,	,	O	,	_	0	SENT_507	[p29l1549t2982r1610b3084],
10	et	FW	O	et	nn	13	SENT_507	[p29l1673t2993r1762b3064],
11	al.	FW	O	al.	nn	13	SENT_507	[p29l1811t2974r1922b3065],
12	lDi	FW	O	ldi	nn	13	SENT_507	[p29l1983t2976r2130b3063],
13	—	FW	O	—	appos	2	SENT_507	[p29l1983t2976r2130b3063],
14	rected	VBN	O	rect	partmod	13	SENT_507	[p29l16t3122r318b3212],
15	Vascular	JJ	O	vascular	amod	16	SENT_507	[p29l345t3122r756b3213],
16	expression	NN	O	expression	dobj	14	SENT_507	[p29l785t3124r1310b3236],
17	of	IN	O	of	_	0	SENT_507	[p29l1344t3122r1458b3213],
18	human	JJ	O	human	amod	20	SENT_507	[p29l1470t3122r1818b3213],
19	cysteinyl	NN	O	cysteinyl	nn	20	SENT_507	[p29l1851t3141r2130b3236, p29l16t3269r194b3383],
20	leukotriene	NN	O	leukotriene	prep_of	16	SENT_507	[p29l243t3269r801b3360],
21	2	CD	NUMBER	2	num	22	SENT_507	[p29l852t3277r906b3358],
22	receptor	NN	O	receptor	nsubj	23	SENT_507	[p29l957t3288r1366b3383],
23	modulates	VBZ	O	modulate	rcmod	20	SENT_507	[p29l1415t3269r1926b3360],
24	endothelial	JJ	O	endothelial	amod	25	SENT_507	[p29l1981t3298r2130b3359, p29l18t3416r456b3507],
25	permeability	NN	O	permeability	dobj	23	SENT_507	[p29l496t3416r1127b3530],
26	and	CC	O	and	_	0	SENT_507	[p29l1164t3416r1344b3507],
27	systemic	JJ	O	systemic	amod	29	SENT_507	[p29l1389t3418r1810b3530],
28	blood	NN	O	blood	nn	29	SENT_507	[p29l1853t3416r2131b3507],
29	pressure	NN	O	pressure	dobj	23	SENT_507	[p29l16t3592r460b3677],
30	.	.	O	.	_	0	SENT_507	[p29l16t3592r460b3677],

1	Circulation	NN	O	circulation	_	0	SENT_508	[p29l503t3563r1058b3654],
2	2004	CD	DATE	2004	num	1	SENT_508	[p29l1095t3571r1942b3673],
3	;	:	O	;	_	0	SENT_508	[p29l1095t3571r1942b3673],
4	110:3360	CD	NUMBER	110:3360	number	5	SENT_508	[p29l1095t3571r1942b3673],
5	—	CD	NUMBER	—	dep	1	SENT_508	[p29l1095t3571r1942b3673],
6	6	CD	NUMBER	6	dep	5	SENT_508	[p29l1095t3571r1942b3673],
7	.	.	O	.	_	0	SENT_508	[p29l1095t3571r1942b3673],

1	25	CD	NUMBER	25	_	0	SENT_509	[p30l16t35r152b113],
2	.	.	O	.	_	0	SENT_509	[p30l16t35r152b113],

1	Yoshisue	NN	O	yoshisue	nn	2	SENT_510	[p30l209t23r652b114],
2	H	NN	O	h	_	0	SENT_510	[p30l701t31r813b133],
3	,	,	O	,	_	0	SENT_510	[p30l701t31r813b133],
4	Kirl	NN	O	kirl	appos	2	SENT_510	[p30l868t23r1689b116],
5	<	JJR	O	<	amod	6	SENT_510	[p30l868t23r1689b116],
6	ham	NN	O	ham	dep	4	SENT_510	[p30l868t23r1689b116],
7	.	.	O	.	_	0	SENT_510	[p30l868t23r1689b116],

1	—	NN	O	—	_	0	SENT_511	[p30l868t23r1689b116],
2	.	.	O	.	_	0	SENT_511	[p30l868t23r1689b116],

1	BroWn	NN	O	brown	nn	2	SENT_512	[p30l868t23r1689b116],
2	J	NN	O	j	_	0	SENT_512	[p30l1728t31r1794b133],
3	,	,	O	,	_	0	SENT_512	[p30l1728t31r1794b133],
4	Healy	NNP	PERSON	Healy	nn	5	SENT_512	[p30l1849t23r2137b137],
5	E	NNP	O	E	appos	2	SENT_512	[p30l16t177r105b279],
6	,	,	O	,	_	0	SENT_512	[p30l16t177r105b279],
7	Holgate	NNP	ORGANIZATION	Holgate	nn	11	SENT_512	[p30l170t169r561b285],
8	ST	JJ	ORGANIZATION	st	amod	11	SENT_512	[p30l622t177r766b279],
9	,	,	O	,	_	0	SENT_512	[p30l622t177r766b279],
10	Sampson	NNP	ORGANIZATION	Sampson	dep	11	SENT_512	[p30l833t177r1293b283],
11	AP	NNP	ORGANIZATION	AP	appos	2	SENT_512	[p30l1346t177r1504b279],
12	,	,	O	,	_	0	SENT_512	[p30l1346t177r1504b279],
13	Davies	NNP	PERSON	Davies	nn	14	SENT_512	[p30l1567t171r1893b260],
14	DE	NN	O	de	appos	2	SENT_512	[p30l1952t177r2125b260],
15	.	.	O	.	_	0	SENT_512	[p30l1952t177r2125b260],

1	Cysteinyl	JJ	O	cysteinyl	amod	2	SENT_513	[p30l16t316r482b430],
2	leukotrienes	NNS	O	leukotriene	nsubj	3	SENT_513	[p30l578t316r1214b407],
3	synergize	VBP	O	synergize	_	0	SENT_513	[p30l1316t318r1806b432],
4	With	IN	O	with	_	0	SENT_513	[p30l1900t316r2131b407],
5	growth	NN	O	growth	nn	6	SENT_513	[p30l16t463r383b579],
6	factors	NNS	O	factor	prep_with	3	SENT_513	[p30l432t463r774b554],
7	to	TO	O	to	aux	8	SENT_513	[p30l825t482r920b554],
8	induce	VB	O	induce	xcomp	3	SENT_513	[p30l969t463r1300b554],
9	proliferation	NN	O	proliferation	dobj	8	SENT_513	[p30l1346t463r1987b577],
10	of	IN	O	of	_	0	SENT_513	[p30l2037t463r2153b554],
11	human	JJ	O	human	amod	13	SENT_513	[p30l18t610r371b701],
12	bronchial	JJ	O	bronchial	amod	13	SENT_513	[p30l450t610r932b701],
13	fibroblasts	NNS	O	fibroblast	prep_of	9	SENT_513	[p30l1008t610r1581b701],
14	.	.	O	.	_	0	SENT_513	[p30l1008t610r1581b701],

1	J	NN	O	j	nn	3	SENT_514	[p30l1653t618r1697b714],
2	Allergy	NN	O	allergy	nn	3	SENT_514	[p30l1766t610r2137b726],
3	Clin	NN	O	clin	_	0	SENT_514	[p30l16t759r223b850],
4	lmmunol	NN	O	lmmunol	dep	3	SENT_514	[p30l262t759r732b850],
5	2007	CD	DATE	2007	num	4	SENT_514	[p30l771t767r1620b868],
6	;	:	O	;	_	0	SENT_514	[p30l771t767r1620b868],
7	119:132	CD	NUMBER	119:132	number	8	SENT_514	[p30l771t767r1620b868],
8	—	CD	NUMBER	—	dep	3	SENT_514	[p30l771t767r1620b868],
9	40	CD	NUMBER	40	dep	8	SENT_514	[p30l771t767r1620b868],
10	.	.	O	.	_	0	SENT_514	[p30l771t767r1620b868],

1	26	CD	NUMBER	26	_	0	SENT_515	[p30l16t918r152b997],
2	.	.	O	.	_	0	SENT_515	[p30l16t918r152b997],

1	Ciana	NNP	O	Ciana	nn	2	SENT_516	[p30l215t908r502b997],
2	P	NN	O	p	_	0	SENT_516	[p30l537t914r614b1016],
3	,	,	O	,	_	0	SENT_516	[p30l537t914r614b1016],
4	Fumagalli	NNP	PERSON	Fumagalli	nn	5	SENT_516	[p30l655t906r1166b1022],
5	M	NNP	O	M	appos	2	SENT_516	[p30l1200t914r1326b1016],
6	,	,	O	,	_	0	SENT_516	[p30l1200t914r1326b1016],
7	Trincavelli	NNP	O	Trincavelli	nn	8	SENT_516	[p30l1365t906r1900b997],
8	ML	NNP	O	ML	appos	2	SENT_516	[p30l1934t914r2125b1016],
9	,	,	O	,	_	0	SENT_516	[p30l1934t914r2125b1016],
10	et	FW	O	et	nn	11	SENT_516	[p30l18t1073r109b1144],
11	al.	FW	O	al.	appos	2	SENT_516	[p30l150t1054r263b1144],
12	.	.	O	.	_	0	SENT_516	[p30l150t1054r263b1144],

1	The	DT	O	the	det	4	SENT_517	[p30l314t1054r500b1144],
2	orphan	NN	O	orphan	nn	4	SENT_517	[p30l549t1054r912b1168],
3	receptor	NN	O	receptor	nn	4	SENT_517	[p30l959t1073r1377b1168],
4	GPR17	NN	O	gpr17	nsubj	5	SENT_517	[p30l1421t1062r1758b1150],
5	identified	VBN	O	identify	_	0	SENT_517	[p30l1806t1054r2130b1145, p30l17t1201r211b1291],
6	as	IN	O	as	_	0	SENT_517	[p30l254t1232r354b1291],
7	a	DT	O	a	det	11	SENT_517	[p30l400t1232r452b1291],
8	new	JJ	O	new	amod	11	SENT_517	[p30l493t1230r701b1292],
9	dual	JJ	O	dual	amod	11	SENT_517	[p30l742t1201r957b1292],
10	uracil	NN	O	uracil	nn	11	SENT_517	[p30l1000t1201r1285b1292],
11	nucleotides/cysteinyl	NN	O	nucleotides/cysteinyl	prep_as	5	SENT_517	[p30l1328t1201r2130b1315, p30l18t1348r933b1462],
12	—	CD	NUMBER	—	num	14	SENT_517	[p30l1328t1201r2130b1315, p30l18t1348r933b1462],
13	leukotrienes	NN	O	leukotriene	nn	14	SENT_517	[p30l1328t1201r2130b1315, p30l18t1348r933b1462],
14	receptor	NN	O	receptor	dep	11	SENT_517	[p30l969t1367r1399b1462],
15	.	.	O	.	_	0	SENT_517	[p30l969t1367r1399b1462],

1	EMBOJ	NNP	O	EMBOJ	_	0	SENT_518	[p30l1438t1356r1822b1452],
2	2006	CD	DATE	2006	num	1	SENT_518	[p30l1853t1356r2127b1456],
3	;	:	O	;	_	0	SENT_518	[p30l1853t1356r2127b1456],
4	23461327	CD	NUMBER	23461327	dep	1	SENT_518	[p30l17t1503r579b1586],

1	27	CD	NUMBER	27	_	0	SENT_519	[p30l16t1655r152b1733],
2	.	.	O	.	_	0	SENT_519	[p30l16t1655r152b1733],

1	Espinosa	NNP	PERSON	Espinosa	nn	2	SENT_520	[p30l213t1645r667b1757],
2	K	NNP	PERSON	K	nsubjpass	24	SENT_520	[p30l699t1651r799b1753],
3	,	,	O	,	_	0	SENT_520	[p30l699t1651r799b1753],
4	Bossé	NNP	O	Bossé	nn	5	SENT_520	[p30l839t1641r1127b1733],
5	Y	NN	O	y	dep	16	SENT_520	[p30l1156t1651r1241b1753],
6	,	,	O	,	_	0	SENT_520	[p30l1156t1651r1241b1753],
7	Stankova	NN	PERSON	stankova	nn	8	SENT_520	[p30l1285t1643r1739b1734],
8	J	NN	PERSON	j	appos	5	SENT_520	[p30l1760t1652r1827b1753],
9	,	,	O	,	_	0	SENT_520	[p30l1760t1652r1827b1753],
10	RolaPleszczynski	NNP	O	RolaPleszczynski	nn	11	SENT_520	[p30l1867t1643r2130b1739, p30l16t1789r655b1903],
11	M.	NNP	O	M.	appos	5	SENT_520	[p30l695t1797r821b1880],
12	CysLT1	NN	O	cyslt1	nn	13	SENT_520	[p30l872t1797r1235b1903],
13	receptor	NN	O	receptor	dep	16	SENT_520	[p30l1281t1808r1699b1903],
14	upregu	NN	O	upregu	nn	16	SENT_520	[p30l1740t1819r2130b1905],
15	—	NN	O	—	nn	16	SENT_520	[p30l1740t1819r2130b1905],
16	lation	NN	O	lation	dep	24	SENT_520	[p30l16t1937r306b2027],
17	by	IN	O	by	_	0	SENT_520	[p30l341t1937r454b2051],
18	TGF	NN	O	tgf	nn	19	SENT_520	[p30l481t1937r955b2027],
19	—	NN	O	—	prep_by	16	SENT_520	[p30l481t1937r955b2027],
20	beta	NN	O	beta	nsubjpass	24	SENT_520	[p30l481t1937r955b2027],
21	and	CC	O	and	_	0	SENT_520	[p30l989t1937r1172b2027],
22	IL-13	NN	O	il-13	conj_and	20	SENT_520	[p30l1206t1945r1457b2028],
23	is	VBZ	O	be	auxpass	24	SENT_520	[p30l1496t1939r1573b2027],
24	associated	VBN	O	associate	_	0	SENT_520	[p30l1608t1937r2131b2027],
25	with	IN	O	with	_	0	SENT_520	[p30l12t2084r239b2175],
26	bronchial	JJ	O	bronchial	amod	30	SENT_520	[p30l278t2084r760b2175],
27	smooth	JJ	O	smooth	amod	30	SENT_520	[p30l801t2084r1180b2175],
28	muscle	NN	O	muscle	nn	30	SENT_520	[p30l1219t2084r1569b2175],
29	cell	NN	O	cell	nn	30	SENT_520	[p30l1608t2084r1780b2174],
30	proliferation	NN	O	proliferation	prep_with	24	SENT_520	[p30l1816t2084r2130b2198, p30l18t2233r371b2322],
31	in	IN	O	in	_	0	SENT_520	[p30l405t2233r501b2320],
32	response	NN	O	response	prep_in	24	SENT_520	[p30l537t2260r983b2345],
33	to	TO	O	to	_	0	SENT_520	[p30l1018t2250r1113b2322],
34	LTD	NN	ORGANIZATION	ltd	prep_to	24	SENT_520	[p30l1146t2239r1354b2320],
35	4	CD	NUMBER	4	num	34	SENT_520	[p30l1358t2304r1425b2353],
36	.	.	O	.	_	0	SENT_520	[p30l1358t2304r1425b2353],

1	J	NNP	O	J	nn	4	SENT_521	[p30l1455t2239r1498b2335],
2	Allergy	NNP	O	Allergy	nn	4	SENT_521	[p30l1525t2231r1895b2347],
3	Clin	NNP	O	Clin	nn	4	SENT_521	[p30l1924t2231r2131b2322],
4	Immunol	NNP	O	Immunol	_	0	SENT_521	[p30l16t2380r486b2471],
5	2003	CD	DATE	2003	num	4	SENT_521	[p30l525t2388r1431b2489],
6	;	:	O	;	_	0	SENT_521	[p30l525t2388r1431b2489],
7	111:1032	CD	NUMBER	111:1032	number	8	SENT_521	[p30l525t2388r1431b2489],
8	—	CD	NUMBER	—	dep	4	SENT_521	[p30l525t2388r1431b2489],
9	40	CD	NUMBER	40	dep	8	SENT_521	[p30l525t2388r1431b2489],
10	.	.	O	.	_	0	SENT_521	[p30l525t2388r1431b2489],

1	28	CD	NUMBER	28	_	0	SENT_522	[p30l16t2537r152b2618],
2	.	.	O	.	_	0	SENT_522	[p30l16t2537r152b2618],

1	Sousa	NNP	ORGANIZATION	Sousa	_	0	SENT_523	[p30l217t2535r506b2618],
2	AR	NNS	ORGANIZATION	ar	dep	1	SENT_523	[p30l537t2535r719b2637],
3	,	,	O	,	_	0	SENT_523	[p30l537t2535r719b2637],
4	Parikh	NNP	O	Parikh	nn	5	SENT_523	[p30l760t2527r1092b2618],
5	A	NNP	O	A	appos	2	SENT_523	[p30l1123t2535r1226b2637],
6	,	,	O	,	_	0	SENT_523	[p30l1123t2535r1226b2637],
7	Scadding	NNP	O	Scadding	nn	8	SENT_523	[p30l1271t2527r1735b2643],
8	G	NNP	O	G	appos	2	SENT_523	[p30l1766t2535r1873b2637],
9	,	,	O	,	_	0	SENT_523	[p30l1766t2535r1873b2637],
10	Corrigan	NNP	PERSON	Corrigan	appos	2	SENT_523	[p30l1916t2535r2130b2618, p30l11t3277r275b3392],

1	C	NN	O	c	nn	2	SENT_524	[p30l349t3281r480b3386],
2	]	NN	O	]	_	0	SENT_524	[p30l349t3281r480b3386],
3	,	,	O	,	_	0	SENT_524	[p30l349t3281r480b3386],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_524	[p30l559t3283r728b3366],
5	TH	NN	O	th	appos	2	SENT_524	[p30l799t3283r985b3366],
6	.	.	O	.	_	0	SENT_524	[p30l799t3283r985b3366],

1	Leul	NN	PERSON	leul	_	0	SENT_525	[p30l1066t3275r2135b3390],
2	<	JJR	O	<	dep	1	SENT_525	[p30l1066t3275r2135b3390],
3	otriene	CD	NUMBER	otriene	num	6	SENT_525	[p30l1066t3275r2135b3390],
4	—	NN	O	—	nn	6	SENT_525	[p30l1066t3275r2135b3390],
5	receptor	NN	O	receptor	nn	6	SENT_525	[p30l1066t3275r2135b3390],
6	expression	NN	O	expression	dep	1	SENT_525	[p30l13t3426r550b3539],
7	on	IN	O	on	_	0	SENT_525	[p30l607t3454r732b3515],
8	nasal	JJ	O	nasal	amod	11	SENT_525	[p30l789t3424r1053b3514],
9	mucosal	JJ	O	mucosal	amod	11	SENT_525	[p30l1109t3424r1532b3515],
10	inflammatory	JJ	O	inflammatory	amod	11	SENT_525	[p30l1587t3424r2131b3514, p30l11t3593r213b3688],
11	cells	NNS	O	cell	prep_on	6	SENT_525	[p30l270t3573r490b3664],
12	in	IN	O	in	_	0	SENT_525	[p30l553t3575r651b3662],
13	aspirin	NN	O	aspirin	nn	17	SENT_525	[p30l712t3575r1540b3688],
14	—	CD	NUMBER	—	num	17	SENT_525	[p30l712t3575r1540b3688],
15	sensitive	JJ	O	sensitive	amod	17	SENT_525	[p30l712t3575r1540b3688],
16	rhinosinu	NN	O	rhinosinu	nn	17	SENT_525	[p30l1601t3573r2131b3664],
17	—	NN	O	—	prep_in	11	SENT_525	[p30l1601t3573r2131b3664],

1	sitis	NN	O	sitis	_	0	SENT_526	[p31l13t26r243b115],
2	.	.	O	.	_	0	SENT_526	[p31l13t26r243b115],

1	N	NN	O	n	nn	3	SENT_527	[p31l286t32r373b115],
2	Engll	NNP	O	Engll	nn	3	SENT_527	[p31l409t24r708b141],
3	Med	NNP	O	Med	_	0	SENT_527	[p31l741t24r959b115],
4	2002	CD	DATE	2002	num	3	SENT_527	[p31l999t30r1840b133],
5	;	:	O	;	_	0	SENT_527	[p31l999t30r1840b133],
6	347:1493	CD	NUMBER	347:1493	number	7	SENT_527	[p31l999t30r1840b133],
7	-9	CD	NUMBER	-9	dep	3	SENT_527	[p31l999t30r1840b133],
8	.	.	O	.	_	0	SENT_527	[p31l999t30r1840b133],

1	29	CD	NUMBER	29	_	0	SENT_528	[p31l9t183r148b264],
2	.	.	O	.	_	0	SENT_528	[p31l9t183r148b264],

1	Ott	NNP	PERSON	Ott	nn	2	SENT_529	[p31l209t179r373b264],
2	VL	NNP	O	VL	_	0	SENT_529	[p31l421t181r585b282],
3	,	,	O	,	_	0	SENT_529	[p31l421t181r585b282],
4	Cambier	NNP	ORGANIZATION	Cambier	nn	5	SENT_529	[p31l648t173r1078b264],
5	JC	NNP	ORGANIZATION	JC	appos	2	SENT_529	[p31l1120t179r1264b282],
6	,	,	O	,	_	0	SENT_529	[p31l1120t179r1264b282],
7	Kappler	NNP	PERSON	Kappler	nn	8	SENT_529	[p31l1327t173r1722b288],
8	J	NNP	PERSON	J	appos	2	SENT_529	[p31l1765t181r1831b284],
9	,	,	O	,	_	0	SENT_529	[p31l1765t181r1831b284],
10	Marrack	NNP	PERSON	Marrack	nn	11	SENT_529	[p31l1892t181r2131b263, p31l11t322r227b413],
11	P	NN	PERSON	p	appos	2	SENT_529	[p31l274t330r350b431],
12	,	,	O	,	_	0	SENT_529	[p31l274t330r350b431],
13	Swanson	NNP	PERSON	Swanson	nn	14	SENT_529	[p31l413t328r860b413],
14	B	NNP	O	B	appos	2	SENT_529	[p31l911t330r1037b427],
15	]	NN	O	]	dep	14	SENT_529	[p31l911t330r1037b427],
16	.	.	O	.	_	0	SENT_529	[p31l911t330r1037b427],

1	Mast	NN	O	mast	nn	3	SENT_530	[p31l1094t330r1343b412],
2	cell-dependent	JJ	O	cell-dependent	amod	3	SENT_530	[p31l1391t322r2137b437],
3	migration	NN	O	migration	_	0	SENT_530	[p31l11t473r506b588],
4	of	IN	O	of	_	0	SENT_530	[p31l536t471r651b562],
5	effector	NN	O	effector	nn	6	SENT_530	[p31l660t471r1045b562],
6	CD8	NN	O	cd8	prep_of	3	SENT_530	[p31l1070t477r1351b562],
7	+	CC	O	+	_	0	SENT_530	[p31l1070t477r1351b562],
8	T	NN	O	t	nn	9	SENT_530	[p31l1377t479r1447b560],
9	cells	NNS	O	cell	prep_of	3	SENT_530	[p31l1474t471r1690b562],
10	through	IN	O	through	_	0	SENT_530	[p31l1723t471r2133b588],
11	production	NN	O	production	prep_through	3	SENT_530	[p31l9t620r567b735],
12	of	IN	O	of	_	0	SENT_530	[p31l616t620r732b711],
13	leukotriene	NN	O	leukotriene	nn	14	SENT_530	[p31l757t620r1330b711],
14	B4	NN	O	b4	prep_of	3	SENT_530	[p31l1377t628r1516b743],
15	.	.	O	.	_	0	SENT_530	[p31l1377t628r1516b743],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_531	[p31l1569t628r1749b711],
2	Immunol	NNP	PERSON	Immunol	_	0	SENT_531	[p31l1789t628r2131b711, p31l11t769r169b860],
3	2003	CD	DATE	2003	num	2	SENT_531	[p31l209t775r940b878],
4	;	:	O	;	_	0	SENT_531	[p31l209t775r940b878],
5	4:974	CD	NUMBER	4:974	number	6	SENT_531	[p31l209t775r940b878],
6	-81	CD	NUMBER	-81	dep	2	SENT_531	[p31l209t775r940b878],
7	.	.	O	.	_	0	SENT_531	[p31l209t775r940b878],

1	30	CD	NUMBER	30	_	0	SENT_532	[p31l11t928r148b1009],
2	.	.	O	.	_	0	SENT_532	[p31l11t928r148b1009],

1	Tager	NNP	ORGANIZATION	Tager	nn	2	SENT_533	[p31l205t926r490b1035],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_533	[p31l522t926r728b1029],
3	,	,	O	,	_	0	SENT_533	[p31l522t926r728b1029],
4	Bromley	NNP	PERSON	Bromley	nn	5	SENT_533	[p31l771t918r1193b1033],
5	SK	NNP	O	SK	appos	2	SENT_533	[p31l1230t926r1387b1027],
6	,	,	O	,	_	0	SENT_533	[p31l1230t926r1387b1027],
7	MedoffBD	NNP	O	MedoffBD	appos	2	SENT_533	[p31l1428t918r2003b1027],
8	,	,	O	,	_	0	SENT_533	[p31l1428t918r2003b1027],
9	et	FW	O	et	nn	10	SENT_533	[p31l2048t938r2139b1008],
10	al.	FW	O	al.	appos	2	SENT_533	[p31l11t1067r124b1158],
11	.	.	O	.	_	0	SENT_533	[p31l11t1067r124b1158],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_534	[p31l163t1067r767b1158],
2	B4	NN	O	b4	nsubj	5	SENT_534	[p31l800t1075r910b1190],
3	receptor	NN	O	receptor	nn	4	SENT_534	[p31l943t1087r1361b1182],
4	BLT1	NN	O	blt1	dep	2	SENT_534	[p31l1390t1073r1644b1157],
5	mediates	VBZ	O	mediate	_	0	SENT_534	[p31l1678t1067r2130b1158],
6	early	JJ	O	early	amod	10	SENT_534	[p31l13t1216r254b1331],
7	effector	NN	O	effector	nn	10	SENT_534	[p31l296t1216r688b1307],
8	T	NN	O	t	nn	10	SENT_534	[p31l727t1224r797b1305],
9	cell	NN	O	cell	nn	10	SENT_534	[p31l842t1216r1013b1306],
10	recruitment	NN	O	recruitment	dobj	5	SENT_534	[p31l1058t1218r1686b1307],
11	.	.	O	.	_	0	SENT_534	[p31l1058t1218r1686b1307],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_535	[p31l1737t1224r1918b1307],
2	Immunol	NNP	O	Immunol	_	0	SENT_535	[p31l1955t1224r2131b1305, p31l11t1365r336b1456],
3	2003	CD	DATE	2003	num	2	SENT_535	[p31l375t1371r1110b1474],
4	;	:	O	;	_	0	SENT_535	[p31l375t1371r1110b1474],
5	4:982	CD	NUMBER	4:982	number	6	SENT_535	[p31l375t1371r1110b1474],
6	—	CD	NUMBER	—	dep	2	SENT_535	[p31l375t1371r1110b1474],
7	90	CD	NUMBER	90	dep	6	SENT_535	[p31l375t1371r1110b1474],
8	.	.	O	.	_	0	SENT_535	[p31l375t1371r1110b1474],

1	31	CD	NUMBER	31	_	0	SENT_536	[p31l11t1526r148b1605],
2	.	.	O	.	_	0	SENT_536	[p31l11t1526r148b1605],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_537	[p31l207t1522r379b1605],
2	E	NNP	PERSON	E	_	0	SENT_537	[p31l426t1522r518b1625],
3	,	,	O	,	_	0	SENT_537	[p31l426t1522r518b1625],
4	Lindo	NNP	PERSON	Lindo	nn	5	SENT_537	[p31l571t1514r864b1605],
5	T	NN	PERSON	t	appos	2	SENT_537	[p31l910t1522r1001b1625],
6	,	,	O	,	_	0	SENT_537	[p31l910t1522r1001b1625],
7	Jackson	NNP	PERSON	Jackson	nn	8	SENT_537	[p31l1044t1514r1447b1619],
8	N	NNP	O	N	appos	2	SENT_537	[p31l1493t1522r1603b1623],
9	,	,	O	,	_	0	SENT_537	[p31l1493t1522r1603b1623],
10	et	FW	O	et	nn	11	SENT_537	[p31l1660t1534r1751b1604],
11	al.	FW	O	al.	appos	2	SENT_537	[p31l1792t1514r1909b1605],
12	.	.	O	.	_	0	SENT_537	[p31l1792t1514r1909b1605],

1	Reversal	NN	O	reversal	_	0	SENT_538	[p31l1963t1522r2131b1611, p31l7t1663r306b1754],
2	of	IN	O	of	_	0	SENT_538	[p31l369t1663r486b1754],
3	human	JJ	O	human	amod	5	SENT_538	[p31l528t1663r888b1754],
4	neutrophil	NN	O	neutrophil	nn	5	SENT_538	[p31l951t1663r1496b1778],
5	survival	NN	O	survival	prep_of	1	SENT_538	[p31l1561t1663r1961b1754],
6	by	IN	O	by	_	0	SENT_538	[p31l2024t1663r2137b1778],
7	leukotriene	NN	O	leukotriene	nn	10	SENT_538	[p31l11t1812r595b1903],
8	B4	NN	O	b4	nn	10	SENT_538	[p31l684t1820r797b1935],
9	receptor	NN	O	receptor	nn	10	SENT_538	[p31l886t1832r1314b1927],
10	blockade	NN	O	blockade	prep_by	1	SENT_538	[p31l1401t1812r1856b1903],
11	and	CC	O	and	_	0	SENT_538	[p31l1947t1812r2133b1903],
12	5-lipoxygenase	NN	O	5-lipoxygenase	conj_and	10	SENT_538	[p31l13t1961r781b2078],
13	and	CC	O	and	_	0	SENT_538	[p31l838t1961r1025b2052],
14	5-lipoxygenase	NN	O	5-lipoxygenase	nn	17	SENT_538	[p31l1086t1961r1852b2078],
15	activating	NN	O	activating	nn	17	SENT_538	[p31l1910t1963r2131b2051, p31l7t2112r330b2227],
16	protein	NN	O	protein	nn	17	SENT_538	[p31l359t2112r726b2225],
17	inhibitors	NNS	O	inhibitor	conj_and	10	SENT_538	[p31l757t2110r1286b2201],
18	.	.	O	.	_	0	SENT_538	[p31l757t2110r1286b2201],

1	Aml	NNP	O	Aml	nn	4	SENT_539	[p31l1321t2118r1563b2215],
2	Respir	NNP	O	Respir	nn	4	SENT_539	[p31l1593t2112r1919b2225],
3	Crit	NNP	O	Crit	nn	4	SENT_539	[p31l1949t2112r2139b2201],
4	Care	NNP	O	Care	nsubj	5	SENT_539	[p31l11t2265r239b2350],
5	Med	VBD	O	med	_	0	SENT_539	[p31l274t2259r492b2350],
6	1999	CD	DATE	1999	dobj	5	SENT_539	[p31l535t2265r1452b2368],
7	;	:	O	;	_	0	SENT_539	[p31l535t2265r1452b2368],
8	160:2079	CD	NUMBER	160:2079	num	9	SENT_539	[p31l535t2265r1452b2368],
9	-85	CD	NUMBER	-85	dep	6	SENT_539	[p31l535t2265r1452b2368],
10	.	.	O	.	_	0	SENT_539	[p31l535t2265r1452b2368],

1	32	CD	NUMBER	32	_	0	SENT_540	[p31l11t2420r148b2499],
2	.	.	O	.	_	0	SENT_540	[p31l11t2420r148b2499],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_541	[p31l209t2416r374b2499],
2	E	NNP	PERSON	E	_	0	SENT_541	[p31l407t2416r496b2517],
3	,	,	O	,	_	0	SENT_541	[p31l407t2416r496b2517],
4	Robertson	NNP	PERSON	Robertson	nn	5	SENT_541	[p31l536t2408r1054b2505],
5	T	NN	PERSON	t	appos	2	SENT_541	[p31l1084t2416r1171b2517],
6	,	,	O	,	_	0	SENT_541	[p31l1084t2416r1171b2517],
7	Smith	NNP	PERSON	Smith	nn	8	SENT_541	[p31l1215t2408r1595b2519],
8	]	NNP	O	]	appos	2	SENT_541	[p31l1215t2408r1595b2519],
9	,	,	O	,	_	0	SENT_541	[p31l1215t2408r1595b2519],
10	Kilfeather	NNP	PERSON	Kilfeather	nn	11	SENT_541	[p31l1634t2408r2137b2501],
11	S.	NNP	PERSON	S.	appos	2	SENT_541	[p31l15t2563r92b2648],
12	Leukotriene	NN	PERSON	leukotriene	nn	14	SENT_541	[p31l167t2557r759b2648],
13	receptor	NN	O	receptor	nn	14	SENT_541	[p31l828t2577r1239b2672],
14	antagonists	NNS	O	antagonist	dep	11	SENT_541	[p31l1304t2559r1880b2674],
15	and	CC	O	and	_	0	SENT_541	[p31l1951t2557r2133b2648],
16	synthesis	NN	O	synthesis	nn	17	SENT_541	[p31l13t2706r466b2821],
17	inhibitors	NNS	O	inhibitor	dep	11	SENT_541	[p31l508t2706r995b2797],
18	reverse	JJ	O	reverse	amod	19	SENT_541	[p31l1038t2736r1381b2797],
19	survival	NN	O	survival	dep	2	SENT_541	[p31l1423t2706r1805b2797],
20	in	IN	O	in	_	0	SENT_541	[p31l1844t2708r1941b2795],
21	eosinophils	NNS	O	eosinophil	prep_in	19	SENT_541	[p31l1981t2736r2131b2797, p31l13t2855r465b2970],
22	of	IN	O	of	_	0	SENT_541	[p31l529t2853r644b2946],
23	asthmatic	JJ	O	asthmatic	amod	24	SENT_541	[p31l682t2855r1173b2945],
24	individuals	NNS	O	individual	prep_of	21	SENT_541	[p31l1230t2855r1805b2946],
25	.	.	O	.	_	0	SENT_541	[p31l1230t2855r1805b2946],

1	Am	NNP	O	Am	nn	5	SENT_542	[p31l1868t2863r2044b2944],
2	J	NNP	O	J	nn	5	SENT_542	[p31l2092t2863r2135b2960],
3	Respir	NNP	O	Respir	nn	5	SENT_542	[p31l9t3006r330b3119],
4	Crit	NNP	O	Crit	nn	5	SENT_542	[p31l363t3006r550b3095],
5	Care	NNP	O	Care	nsubj	6	SENT_542	[p31l581t3010r805b3095],
6	Med	VBD	O	med	_	0	SENT_542	[p31l838t3004r1054b3095],
7	2000	CD	DATE	2000	dobj	6	SENT_542	[p31l1090t3010r1928b3113],
8	;	:	O	;	_	0	SENT_542	[p31l1090t3010r1928b3113],
9	161:1881	CD	NUMBER	161:1881	num	10	SENT_542	[p31l1090t3010r1928b3113],
10	-6	CD	NUMBER	-6	dep	7	SENT_542	[p31l1090t3010r1928b3113],
11	.	.	O	.	_	0	SENT_542	[p31l1090t3010r1928b3113],

1	33	CD	NUMBER	33	_	0	SENT_543	[p31l11t3165r148b3244],
2	.	.	O	.	_	0	SENT_543	[p31l11t3165r148b3244],

1	Robbiani	JJ	MISC	robbiani	amod	2	SENT_544	[p31l207t3153r670b3250],
2	DF	NN	MISC	df	_	0	SENT_544	[p31l702t3161r864b3264],
3	,	,	O	,	_	0	SENT_544	[p31l702t3161r864b3264],
4	Finch	NNP	PERSON	Finch	nn	5	SENT_544	[p31l904t3153r1183b3243],
5	RA	NN	O	ra	appos	2	SENT_544	[p31l1216t3161r1397b3264],
6	,	,	O	,	_	0	SENT_544	[p31l1216t3161r1397b3264],
7	Jéiger	NN	PERSON	jéiger	nn	8	SENT_544	[p31l1427t3161r1688b3270],
8	D	NN	PERSON	d	appos	2	SENT_544	[p31l1719t3161r1822b3264],
9	,	,	O	,	_	0	SENT_544	[p31l1719t3161r1822b3264],
10	Muller	NNP	ORGANIZATION	Muller	nn	11	SENT_544	[p31l1860t3153r2131b3244, p31l13t3332r106b3393],
11	WA	NNP	ORGANIZATION	WA	appos	2	SENT_544	[p31l158t3310r361b3411],
12	,	,	O	,	_	0	SENT_544	[p31l158t3310r361b3411],
13	Sartorelli	NNP	ORGANIZATION	Sartorelli	nn	14	SENT_544	[p31l429t3302r898b3393],
14	AC	NN	ORGANIZATION	ac	appos	2	SENT_544	[p31l951t3310r1126b3411],
15	,	,	O	,	_	0	SENT_544	[p31l951t3310r1126b3411],
16	Randolph	NNP	PERSON	Randolph	nn	17	SENT_544	[p31l1189t3302r1682b3417],
17	G	NNP	O	G	appos	2	SENT_544	[p31l1743t3310r1882b3407],
18	]	NN	O	]	dep	17	SENT_544	[p31l1743t3310r1882b3407],
19	.	.	O	.	_	0	SENT_544	[p31l1743t3310r1882b3407],

1	The	DT	O	the	det	5	SENT_545	[p31l1945t3302r2133b3392],
2	leukotriene	NN	O	leukotriene	nn	5	SENT_545	[p31l11t3451r571b3542],
3	C4	NN	O	c4	nn	5	SENT_545	[p31l603t3457r716b3574],
4	transporter	NN	O	transporter	nn	5	SENT_545	[p31l749t3471r1314b3566],
5	MRP1	NN	O	mrp1	_	0	SENT_545	[p31l1339t3457r1640b3547],
6	regulates	VBZ	O	regulate	dep	5	SENT_545	[p31l1672t3451r2129b3568],
7	CCL19	NN	O	ccl19	nn	8	SENT_545	[p31l11t3606r338b3691],
8	(	NN	O	(	dobj	6	SENT_545	[p31l405t3600r827b3709],
9	MIT	NNP	ORGANIZATION	MIT	dep	5	SENT_545	[p31l405t3600r827b3709],
10	)	CD	NUMBER	)	num	9	SENT_545	[p31l405t3600r827b3709],
11	-3	CD	NUMBER	-3	num	12	SENT_545	[p31l405t3600r827b3709],
12	b	NN	O	b	dep	9	SENT_545	[p31l405t3600r827b3709],
13	,	,	O	,	_	0	SENT_545	[p31l405t3600r827b3709],
14	ELC	NN	O	elc	nn	15	SENT_545	[p31l892t3600r1710b3715],
15	)	NN	O	)	appos	5	SENT_545	[p31l892t3600r1710b3715],
16	.	.	O	.	_	0	SENT_545	[p31l892t3600r1710b3715],

1	—	NN	O	—	_	0	SENT_546	[p31l892t3600r1710b3715],
2	.	.	O	.	_	0	SENT_546	[p31l892t3600r1710b3715],

1	dependent	JJ	O	dependent	amod	2	SENT_547	[p31l892t3600r1710b3715],
2	mobilization	NN	O	mobilization	_	0	SENT_547	[p31l1765t3600r2131b3691, p32l11t26r324b115],

1	of	IN	O	of	_	0	SENT_548	[p32l373t24r490b115],
2	dendritic	JJ	O	dendritic	amod	3	SENT_548	[p32l519t24r973b115],
3	cells	NNS	O	cell	pobj	1	SENT_548	[p32l1022t24r1242b114],
4	to	TO	O	to	_	0	SENT_548	[p32l1294t44r1389b115],
5	lymph	NN	O	lymph	nn	6	SENT_548	[p32l1438t24r1753b139],
6	nodes	NNS	O	node	prep_to	3	SENT_548	[p32l1802t24r2126b115],
7	.	.	O	.	_	0	SENT_548	[p32l1802t24r2126b115],

1	Cell	NN	O	cell	_	0	SENT_549	[p32l11t173r205b264],
2	2000	CD	DATE	2000	num	1	SENT_549	[p32l245t179r1098b282],
3	;	:	O	;	_	0	SENT_549	[p32l245t179r1098b282],
4	103:757	CD	NUMBER	103:757	number	5	SENT_549	[p32l245t179r1098b282],
5	—	CD	NUMBER	—	dep	1	SENT_549	[p32l245t179r1098b282],
6	68	CD	NUMBER	68	dep	5	SENT_549	[p32l245t179r1098b282],
7	.	.	O	.	_	0	SENT_549	[p32l245t179r1098b282],

1	34	CD	NUMBER	34	_	0	SENT_550	[p32l11t334r148b413],
2	.	.	O	.	_	0	SENT_550	[p32l11t334r148b413],

1	Okunishi	NNP	O	Okunishi	nn	2	SENT_551	[p32l209t322r682b413],
2	K	NNP	O	K	nsubj	30	SENT_551	[p32l745t330r845b431],
3	,	,	O	,	_	0	SENT_551	[p32l745t330r845b431],
4	Dohi	NNP	O	Dohi	nn	5	SENT_551	[p32l915t322r1163b413],
5	M	NNP	O	M	appos	2	SENT_551	[p32l1223t330r1349b433],
6	,	,	O	,	_	0	SENT_551	[p32l1223t330r1349b433],
7	Nakagome	NNP	PERSON	Nakagome	nn	8	SENT_551	[p32l1418t322r1961b439],
8	K	NNP	PERSON	K	appos	2	SENT_551	[p32l2026t330r2126b431],
9	,	,	O	,	_	0	SENT_551	[p32l2026t330r2126b431],
10	Tanaka	NNP	PERSON	Tanaka	nn	11	SENT_551	[p32l7t471r379b562],
11	R	NNP	PERSON	R	appos	2	SENT_551	[p32l430t479r532b580],
12	,	,	O	,	_	0	SENT_551	[p32l430t479r532b580],
13	Yamamoto	NNP	PERSON	Yamamoto	nn	17	SENT_551	[p32l589t479r1134b562],
14	K.	NNP	O	K.	nn	17	SENT_551	[p32l1191t479r1292b564],
15	A	NNP	O	A	nn	17	SENT_551	[p32l1349t479r1425b560],
16	novel	JJ	O	novel	amod	17	SENT_551	[p32l1476t471r1739b562],
17	role	NN	O	role	appos	2	SENT_551	[p32l1793t471r1981b562],
18	of	IN	O	of	_	0	SENT_551	[p32l2038t471r2153b562],
19	cysteinyl	NN	O	cysteinyl	nn	20	SENT_551	[p32l11t620r437b735],
20	leukotrienes	NNS	O	leukotriene	prep_of	17	SENT_551	[p32l464t620r1074b711],
21	to	TO	O	to	aux	22	SENT_551	[p32l1108t640r1201b711],
22	promote	VB	O	promote	infmod	2	SENT_551	[p32l1232t640r1652b735],
23	dendritic	JJ	O	dendritic	amod	25	SENT_551	[p32l1683t620r2133b711],
24	cell	NN	O	cell	nn	25	SENT_551	[p32l13t769r183b859],
25	activation	NN	O	activation	dobj	22	SENT_551	[p32l225t771r718b860],
26	in	IN	O	in	_	0	SENT_551	[p32l759t771r858b858],
27	the	DT	O	the	det	29	SENT_551	[p32l901t769r1056b859],
28	antigen	NN	O	antigen	nn	29	SENT_551	[p32l1099t769r1920b886],
29	—	NN	O	—	prep_in	25	SENT_551	[p32l1099t769r1920b886],
30	induced	VBD	O	induce	_	0	SENT_551	[p32l1099t769r1920b886],
31	immune	JJ	O	immune	amod	32	SENT_551	[p32l1963t771r2131b858, p32l11t948r292b1009],
32	responses	NNS	O	response	dobj	30	SENT_551	[p32l347t948r846b1033],
33	in	IN	O	in	_	0	SENT_551	[p32l904t920r1001b1007],
34	the	DT	O	the	det	35	SENT_551	[p32l1056t918r1213b1009],
35	lung	NN	O	lung	prep_in	30	SENT_551	[p32l1266t918r1517b1035],
36	.	.	O	.	_	0	SENT_551	[p32l1266t918r1517b1035],

1	J	NN	O	j	nn	2	SENT_552	[p32l1567t926r1611b1023],
2	lmmunol	NN	O	lmmunol	_	0	SENT_552	[p32l1662t918r2133b1009],
3	2004	CD	DATE	2004	dep	2	SENT_552	[p32l11t1073r997b1176],
4	;	:	O	;	_	0	SENT_552	[p32l11t1073r997b1176],
5	173:6393	CD	NUMBER	173:6393	num	6	SENT_552	[p32l11t1073r997b1176],
6	-402	CD	NUMBER	-402	dep	2	SENT_552	[p32l11t1073r997b1176],
7	.	.	O	.	_	0	SENT_552	[p32l11t1073r997b1176],

1	35	CD	NUMBER	35	_	0	SENT_553	[p32l11t1228r148b1307],
2	.	.	O	.	_	0	SENT_553	[p32l11t1228r148b1307],

1	Parameswaran	NNP	ORGANIZATION	Parameswaran	nn	2	SENT_554	[p32l207t1224r955b1307],
2	K	NNP	ORGANIZATION	K	_	0	SENT_554	[p32l1013t1224r1114b1325],
3	,	,	O	,	_	0	SENT_554	[p32l1013t1224r1114b1325],
4	Liang	NNP	PERSON	Liang	nn	5	SENT_554	[p32l1177t1218r1464b1333],
5	H	NNP	PERSON	H	appos	2	SENT_554	[p32l1518t1224r1630b1325],
6	,	,	O	,	_	0	SENT_554	[p32l1518t1224r1630b1325],
7	Fanat	NNP	O	Fanat	nn	8	SENT_554	[p32l1694t1224r1975b1306],
8	A	NNP	O	A	appos	5	SENT_554	[p32l2024t1224r2126b1325],
9	,	,	O	,	_	0	SENT_554	[p32l2024t1224r2126b1325],
10	Watson	NNP	PERSON	Watson	nn	11	SENT_554	[p32l7t1373r387b1456],
11	R	NNP	PERSON	R	appos	5	SENT_554	[p32l442t1373r544b1474],
12	,	,	O	,	_	0	SENT_554	[p32l442t1373r544b1474],
13	Snider	NNP	PERSON	Snider	nn	14	SENT_554	[p32l609t1365r930b1456],
14	DP	NN	O	dp	appos	5	SENT_554	[p32l983t1373r1142b1476],
15	,	,	O	,	_	0	SENT_554	[p32l983t1373r1142b1476],
16	O’Byrne	NN	O	o’byrne	nn	17	SENT_554	[p32l1206t1371r1607b1480],
17	PM	NN	O	pm	appos	5	SENT_554	[p32l1664t1373r1848b1456],
18	.	.	O	.	_	0	SENT_554	[p32l1664t1373r1848b1456],

1	Role	NN	O	role	_	0	SENT_555	[p32l1910t1365r2132b1462],
2	for	IN	O	for	_	0	SENT_555	[p32l11t1514r156b1605],
3	cysteinyl	NN	O	cysteinyl	nn	4	SENT_555	[p32l248t1514r682b1629],
4	leukotrienes	NNS	O	leukotriene	prep_for	1	SENT_555	[p32l775t1514r1399b1605],
5	in	IN	O	in	_	0	SENT_555	[p32l1494t1516r1591b1603],
6	allergeninduced	JJ	O	allergeninduced	amod	7	SENT_555	[p32l1686t1514r2131b1631, p32l11t1663r409b1754],
7	change	NN	O	change	prep_in	1	SENT_555	[p32l476t1663r835b1780],
8	in	IN	O	in	_	0	SENT_555	[p32l900t1665r997b1752],
9	circulating	VBG	O	circulate	prepc_in	1	SENT_555	[p32l1064t1663r1617b1780],
10	dendritic	JJ	O	dendritic	amod	12	SENT_555	[p32l1680t1663r2133b1754],
11	cell	NN	O	cell	nn	12	SENT_555	[p32l13t1812r183b1902],
12	number	NN	O	number	dobj	9	SENT_555	[p32l223t1812r619b1903],
13	in	IN	O	in	_	0	SENT_555	[p32l654t1814r752b1901],
14	asthma	NN	O	asthma	prep_in	9	SENT_555	[p32l791t1812r1193b1903],
15	.	.	O	.	_	0	SENT_555	[p32l791t1812r1193b1903],

1	J	NNP	O	J	nn	4	SENT_556	[p32l1228t1820r1270b1917],
2	Allergy	NNP	O	Allergy	nn	4	SENT_556	[p32l1304t1812r1674b1929],
3	Clin	NNP	O	Clin	nn	4	SENT_556	[p32l1709t1812r1918b1903],
4	Immunol	NNP	O	Immunol	_	0	SENT_556	[p32l1955t1820r2131b1901, p32l11t1961r336b2052],
5	2004	CD	DATE	2004	num	4	SENT_556	[p32l375t1967r1104b2070],
6	;	:	O	;	_	0	SENT_556	[p32l375t1967r1104b2070],
7	114:73	CD	NUMBER	114:73	number	8	SENT_556	[p32l375t1967r1104b2070],
8	—	CD	NUMBER	—	dep	4	SENT_556	[p32l375t1967r1104b2070],
9	9	CD	NUMBER	9	dep	8	SENT_556	[p32l375t1967r1104b2070],
10	.	.	O	.	_	0	SENT_556	[p32l375t1967r1104b2070],

1	36	CD	NUMBER	36	_	0	SENT_557	[p32l11t2120r148b2201],
2	.	.	O	.	_	0	SENT_557	[p32l11t2120r148b2201],

1	Stelmach	NNP	PERSON	Stelmach	nn	2	SENT_558	[p32l211t2110r672b2201],
2	I	NNP	O	I	_	0	SENT_558	[p32l708t2118r771b2219],
3	,	,	O	,	_	0	SENT_558	[p32l708t2118r771b2219],
4	BobroWsl	NNP	O	BobroWsl	appos	2	SENT_558	[p32l813t2110r2134b2203],
5	<	JJR	O	<	dep	4	SENT_558	[p32l813t2110r2134b2203],
6	a	DT	O	a	dep	5	SENT_558	[p32l813t2110r2134b2203],
7	.	.	O	.	_	0	SENT_558	[p32l813t2110r2134b2203],

1	—	NN	O	—	_	0	SENT_559	[p32l813t2110r2134b2203],
2	.	.	O	.	_	0	SENT_559	[p32l813t2110r2134b2203],

1	Korzeniowsl	NN	O	korzeniowsl	dep	2	SENT_560	[p32l813t2110r2134b2203],
2	<	JJR	O	<	_	0	SENT_560	[p32l813t2110r2134b2203],
3	a	DT	O	a	det	4	SENT_560	[p32l813t2110r2134b2203],
4	M	NN	O	m	dep	2	SENT_560	[p32l9t2267r134b2370],
5	,	,	O	,	_	0	SENT_560	[p32l9t2267r134b2370],
6	Majak	NNP	PERSON	Majak	nn	7	SENT_560	[p32l183t2259r494b2374],
7	P	NN	O	p	dep	2	SENT_560	[p32l532t2267r609b2370],
8	,	,	O	,	_	0	SENT_560	[p32l532t2267r609b2370],
9	Stelmach	NNP	PERSON	Stelmach	nn	10	SENT_560	[p32l664t2259r1126b2350],
10	W	NNP	O	W	conj_and	4	SENT_560	[p32l1167t2267r1292b2368],
11	,	,	O	,	_	0	SENT_560	[p32l1167t2267r1292b2368],
12	Kuna	NNP	O	Kuna	nn	13	SENT_560	[p32l1343t2267r1607b2352],
13	P.	NNP	O	P.	dep	2	SENT_560	[p32l1648t2267r1726b2350],
14	The	DT	O	the	det	15	SENT_560	[p32l1775t2259r1963b2350],
15	effect	NN	O	effect	dep	13	SENT_560	[p32l2009t2259r2131b2349, p32l11t2405r197b2496],
16	of	IN	O	of	_	0	SENT_560	[p32l229t2405r346b2498],
17	montelukast	NN	O	montelukast	prep_of	15	SENT_560	[p32l361t2407r993b2498],
18	and	CC	O	and	_	0	SENT_560	[p32l1024t2407r1207b2498],
19	different	JJ	O	different	amod	20	SENT_560	[p32l1244t2405r1690b2498],
20	doses	NNS	O	dose	conj_and	4	SENT_560	[p32l1721t2407r1999b2498],
21	of	IN	O	of	_	0	SENT_560	[p32l2038t2405r2153b2498],
22	budesonide	NN	O	budesonide	prep_of	20	SENT_560	[p32l13t2556r589b2647],
23	on	IN	O	on	_	0	SENT_560	[p32l628t2586r751b2647],
24	IgE	NN	O	ige	nn	26	SENT_560	[p32l787t2564r950b2673],
25	serum	NN	O	serum	nn	26	SENT_560	[p32l991t2586r1306b2647],
26	levels	NNS	O	level	prep_on	22	SENT_560	[p32l1341t2556r1613b2647],
27	and	CC	O	and	_	0	SENT_560	[p32l1652t2556r1835b2647],
28	clinical	JJ	O	clinical	amod	29	SENT_560	[p32l1873t2556r2131b2646, p32l13t2705r154b2795],
29	parameters	NNS	O	parameter	conj_and	4	SENT_560	[p32l193t2725r761b2820],
30	in	IN	O	in	_	0	SENT_560	[p32l805t2707r902b2794],
31	children	NNS	O	child	prep_in	29	SENT_560	[p32l945t2705r1363b2796],
32	with	IN	O	with	_	0	SENT_560	[p32l1400t2705r1629b2796],
33	newly	RB	O	newly	advmod	34	SENT_560	[p32l1670t2705r1963b2820],
34	diagnosed	VBN	O	diagnose	amod	35	SENT_560	[p32l2000t2705r2131b2796, p32l11t2854r431b2971],
35	asthma	NN	O	asthma	prep_with	31	SENT_560	[p32l496t2854r896b2945],
36	.	.	O	.	_	0	SENT_560	[p32l496t2854r896b2945],

1	Pulm	NNP	O	Pulm	nn	3	SENT_561	[p32l967t2854r1233b2945],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_561	[p32l1297t2854r1838b2945],
3	Ther	NNP	O	Ther	_	0	SENT_561	[p32l1899t2854r2137b2944],
4	2005	CD	DATE	2005	num	3	SENT_561	[p32l11t3009r805b3112],
5	;	:	O	;	_	0	SENT_561	[p32l11t3009r805b3112],
6	18:374	CD	NUMBER	18:374	number	7	SENT_561	[p32l11t3009r805b3112],
7	-80	CD	NUMBER	-80	dep	3	SENT_561	[p32l11t3009r805b3112],
8	.	.	O	.	_	0	SENT_561	[p32l11t3009r805b3112],

1	37	CD	NUMBER	37	_	0	SENT_562	[p32l11t3164r148b3243],
2	.	.	O	.	_	0	SENT_562	[p32l11t3164r148b3243],

1	Dworski	NNP	PERSON	Dworski	nn	2	SENT_563	[p32l207t3152r635b3243],
2	R	NNP	PERSON	R	_	0	SENT_563	[p32l682t3160r783b3261],
3	,	,	O	,	_	0	SENT_563	[p32l682t3160r783b3261],
4	FitzGerald	NNP	ORGANIZATION	FitzGerald	nn	5	SENT_563	[p32l837t3152r1369b3243],
5	GA	NNP	ORGANIZATION	GA	appos	2	SENT_563	[p32l1420t3160r1605b3261],
6	,	,	O	,	_	0	SENT_563	[p32l1420t3160r1605b3261],
7	Oates	NNP	PERSON	Oates	nn	8	SENT_563	[p32l1662t3158r1941b3243],
8	JA	NNP	O	JA	appos	2	SENT_563	[p32l1982t3160r2126b3261],
9	,	,	O	,	_	0	SENT_563	[p32l1982t3160r2126b3261],
10	Sheller	NNP	O	Sheller	nn	11	SENT_563	[p32l13t3301r357b3392],
11	JR.	NNP	O	JR.	appos	2	SENT_563	[p32l403t3309r552b3406],
12	.	.	O	.	_	0	SENT_563	[p32l403t3309r552b3406],

1	Effect	NN	O	effect	_	0	SENT_564	[p32l617t3301r916b3392],
2	of	IN	O	of	_	0	SENT_564	[p32l971t3301r1088b3392],
3	oral	JJ	O	oral	amod	4	SENT_564	[p32l1127t3301r1322b3392],
4	prednisone	NN	O	prednisone	prep_of	1	SENT_564	[p32l1381t3301r1947b3416],
5	on	IN	O	on	_	0	SENT_564	[p32l2009t3331r2133b3392],
6	airway	NN	O	airway	nn	8	SENT_564	[p32l11t3452r348b3565],
7	inflammatory	JJ	O	inflammatory	amod	8	SENT_564	[p32l385t3450r1100b3565],
8	mediators	NNS	O	mediator	prep_on	1	SENT_564	[p32l1137t3450r1644b3541],
9	in	IN	O	in	_	0	SENT_564	[p32l1689t3452r1787b3539],
10	atopic	JJ	O	atopic	amod	11	SENT_564	[p32l1830t3452r2133b3565],
11	asthma	NN	O	asthma	prep_in	1	SENT_564	[p32l11t3599r411b3690],
12	.	.	O	.	_	0	SENT_564	[p32l11t3599r411b3690],

1	Aml	NNP	O	Aml	nn	4	SENT_565	[p32l455t3607r706b3704],
2	Respir	NNP	O	Respir	nn	4	SENT_565	[p32l743t3601r1070b3714],
3	Crit	NNP	O	Crit	nn	4	SENT_565	[p32l1108t3601r1298b3690],
4	Care	NNP	O	Care	nsubj	5	SENT_565	[p32l1333t3605r1559b3690],
5	Med	VBD	O	med	_	0	SENT_565	[p32l1599t3599r1816b3690],
6	1994	CD	DATE	1994	dobj	5	SENT_565	[p32l1862t3605r2128b3708],
7	;	:	O	;	_	0	SENT_565	[p32l1862t3605r2128b3708],

1	38	CD	NUMBER	38	_	0	SENT_566	[p33l11t179r148b260],
2	.	.	O	.	_	0	SENT_566	[p33l11t179r148b260],

1	Gyllfors	NNP	O	Gyllfors	nn	2	SENT_567	[p33l209t169r613b284],
2	P	NN	O	p	nsubj	21	SENT_567	[p33l696t177r773b278],
3	,	,	O	,	_	0	SENT_567	[p33l696t177r773b278],
4	Dahlén	NNP	PERSON	Dahlén	nn	5	SENT_567	[p33l858t167r1223b260],
5	SE	NN	PERSON	se	appos	2	SENT_567	[p33l1307t175r1452b280],
6	,	,	O	,	_	0	SENT_567	[p33l1307t175r1452b280],
7	Kumlin	NN	O	kumlin	nn	8	SENT_567	[p33l1541t169r1921b262],
8	M	NN	O	m	appos	2	SENT_567	[p33l2000t177r2127b278],
9	,	,	O	,	_	0	SENT_567	[p33l2000t177r2127b278],
10	Larsson	NNP	PERSON	Larsson	nn	11	SENT_567	[p33l9t326r407b409],
11	K	NNP	PERSON	K	appos	2	SENT_567	[p33l464t326r565b429],
12	,	,	O	,	_	0	SENT_567	[p33l464t326r565b429],
13	Dahlén	NNP	PERSON	Dahlén	nn	16	SENT_567	[p33l628t316r991b408],
14	B.	NNP	PERSON	B.	nn	16	SENT_567	[p33l1048t326r1142b409],
15	Bronchial	JJ	PERSON	bronchial	amod	16	SENT_567	[p33l1204t318r1696b409],
16	responsiveness	NN	O	responsiveness	appos	2	SENT_567	[p33l1753t348r2131b433, p33l13t469r417b558],
17	to	TO	O	to	_	0	SENT_567	[p33l472t487r567b558],
18	leukotriene	NN	O	leukotriene	nn	19	SENT_567	[p33l621t467r1193b558],
19	D4	NN	O	d4	prep_to	16	SENT_567	[p33l1244t475r1365b590],
20	is	VBZ	O	be	cop	21	SENT_567	[p33l1417t469r1494b557],
21	resistant	JJ	O	resistant	_	0	SENT_567	[p33l1549t469r1989b557],
22	to	TO	O	to	aux	23	SENT_567	[p33l2036t487r2131b558],
23	inhaled	VBN	O	inhale	xcomp	21	SENT_567	[p33l11t616r391b707],
24	fluticasone	NN	O	fluticasone	nn	25	SENT_567	[p33l442t616r1007b707],
25	propionate	NN	O	propionate	dobj	23	SENT_567	[p33l1056t618r1632b731],
26	.	.	O	.	_	0	SENT_567	[p33l1056t618r1632b731],

1	J	NNP	O	J	nn	4	SENT_568	[p33l1680t624r1722b721],
2	Allergy	NNP	O	Allergy	nn	4	SENT_568	[p33l1767t616r2137b733],
3	Clin	NNP	O	Clin	nn	4	SENT_568	[p33l11t765r219b856],
4	Immunol	NNP	O	Immunol	_	0	SENT_568	[p33l258t765r728b856],
5	2006	CD	DATE	2006	num	4	SENT_568	[p33l767t771r1565b874],
6	;	:	O	;	_	0	SENT_568	[p33l767t771r1565b874],
7	118:78	CD	NUMBER	118:78	number	8	SENT_568	[p33l767t771r1565b874],
8	—	CD	NUMBER	—	dep	4	SENT_568	[p33l767t771r1565b874],
9	83	CD	NUMBER	83	dep	8	SENT_568	[p33l767t771r1565b874],
10	.	.	O	.	_	0	SENT_568	[p33l767t771r1565b874],

1	39	CD	NUMBER	39	_	0	SENT_569	[p33l11t924r148b1005],
2	.	.	O	.	_	0	SENT_569	[p33l11t924r148b1005],

1	Montuschi	NNP	PERSON	Montuschi	_	0	SENT_570	[p33l207t914r750b1005],

1	,	,	O	,	_	0	SENT_571	[p33l806t931r860b1025],
2	Macagno	NNP	O	Macagno	dep	3	SENT_571	[p33l900t922r1361b1031],
3	F	NN	O	f	_	0	SENT_571	[p33l1397t922r1476b1023],
4	,	,	O	,	_	0	SENT_571	[p33l1397t922r1476b1023],
5	Parente	NNP	PERSON	Parente	appos	3	SENT_571	[p33l1516t922r1894b1004],
6	P	NN	O	p	nn	5	SENT_571	[p33l1927t922r2005b1025],
7	,	,	O	,	_	0	SENT_571	[p33l1927t922r2005b1025],
8	et	FW	O	et	dep	5	SENT_571	[p33l2048t934r2139b1004],
9	al.	FW	O	al.	dep	3	SENT_571	[p33l11t1063r124b1154],
10	.	.	O	.	_	0	SENT_571	[p33l11t1063r124b1154],

1	Effects	NNS	O	effect	_	0	SENT_572	[p33l189t1061r534b1153],
2	of	IN	O	of	_	0	SENT_572	[p33l597t1061r712b1154],
3	cyclo	JJ	O	cyclo	amod	6	SENT_572	[p33l751t1063r1567b1180],
4	—	NN	O	—	nn	6	SENT_572	[p33l751t1063r1567b1180],
5	oxygenase	NN	O	oxygenase	nn	6	SENT_572	[p33l751t1063r1567b1180],
6	inhibition	NN	O	inhibition	prep_of	1	SENT_572	[p33l1626t1063r2133b1154],
7	on	IN	O	on	_	0	SENT_572	[p33l13t1242r136b1303],
8	exhaled	VBN	O	exhale	amod	9	SENT_572	[p33l195t1212r583b1303],
9	eicosanoids	NNS	O	eicosanoid	prep_on	6	SENT_572	[p33l643t1212r1231b1303],
10	in	IN	O	in	_	0	SENT_572	[p33l1292t1214r1389b1301],
11	patients	NNS	O	patient	prep_in	9	SENT_572	[p33l1446t1214r1848b1327],
12	with	IN	O	with	_	0	SENT_572	[p33l1904t1212r2133b1303],
13	COPD	NN	O	copd	prep_with	11	SENT_572	[p33l11t1367r334b1452],
14	.	.	O	.	_	0	SENT_572	[p33l11t1367r334b1452],

1	Thorax	NNP	O	Thorax	_	0	SENT_573	[p33l377t1361r739b1452],
2	2005	CD	DATE	2005	num	1	SENT_573	[p33l775t1367r1567b1470],
3	;	:	O	;	_	0	SENT_573	[p33l775t1367r1567b1470],
4	60:827	CD	NUMBER	60:827	number	5	SENT_573	[p33l775t1367r1567b1470],
5	—	CD	NUMBER	—	dep	1	SENT_573	[p33l775t1367r1567b1470],
6	33	CD	NUMBER	33	dep	5	SENT_573	[p33l775t1367r1567b1470],
7	.	.	O	.	_	0	SENT_573	[p33l775t1367r1567b1470],

1	40	CD	NUMBER	40	_	0	SENT_574	[p33l9t1520r148b1601],
2	.	.	O	.	_	0	SENT_574	[p33l9t1520r148b1601],

1	Stankova	FW	PERSON	stankova	_	0	SENT_575	[p33l213t1510r660b1601],
2	J	NN	PERSON	j	dep	1	SENT_575	[p33l694t1518r758b1619],
3	,	,	O	,	_	0	SENT_575	[p33l694t1518r758b1619],
4	Turcotte	NNP	PERSON	Turcotte	nn	5	SENT_575	[p33l807t1518r1223b1601],
5	S	NNP	O	S	appos	2	SENT_575	[p33l1272t1516r1351b1619],
6	,	,	O	,	_	0	SENT_575	[p33l1272t1516r1351b1619],
7	Harris	NNP	PERSON	Harris	nn	8	SENT_575	[p33l1403t1512r1821b1619],
8	]	NNP	O	]	appos	2	SENT_575	[p33l1403t1512r1821b1619],
9	,	,	O	,	_	0	SENT_575	[p33l1403t1512r1821b1619],
10	RolaPleszczynski	NNP	PERSON	RolaPleszczynski	appos	2	SENT_575	[p33l1872t1510r2131b1607, p33l11t1659r639b1774],

1	M.	NNP	O	M.	nn	2	SENT_576	[p33l668t1667r793b1750],
2	Modulation	NN	O	modulation	dep	10	SENT_576	[p33l830t1659r1409b1750],
3	of	IN	O	of	_	0	SENT_576	[p33l1444t1659r1561b1750],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_576	[p33l1573t1659r2133b1750],
5	B	NN	O	b	prep_of	2	SENT_576	[p33l9t1816r74b1898],
6	4	CD	NUMBER	4	num	7	SENT_576	[p33l84t1887r122b1931],
7	receptor	NN	O	receptor	dep	10	SENT_576	[p33l177t1814r696b1923],
8	—	NN	O	—	nn	10	SENT_576	[p33l177t1814r696b1923],
9	1	CD	NUMBER	1	num	10	SENT_576	[p33l177t1814r696b1923],
10	expression	NN	O	expression	dep	17	SENT_576	[p33l755t1810r1304b1923],
11	by	IN	O	by	_	0	SENT_576	[p33l1363t1808r1476b1923],
12	dexametha	NN	O	dexametha	nn	14	SENT_576	[p33l1529t1808r2131b1899],
13	—	CD	NUMBER	—	num	14	SENT_576	[p33l1529t1808r2131b1899],
14	sone	NN	O	sone	prep_by	10	SENT_576	[p33l13t1987r265b2048],
15	:	:	O	:	_	0	SENT_576	[p33l13t1987r265b2048],
16	potential	JJ	O	potential	amod	17	SENT_576	[p33l324t1957r771b2072],
17	mechanism	NN	O	mechanism	_	0	SENT_576	[p33l826t1957r1405b2048],
18	for	IN	O	for	_	0	SENT_576	[p33l1460t1957r1603b2048],
19	enhanced	VBN	O	enhance	amod	21	SENT_576	[p33l1656t1957r2133b2048],
20	neutrophil	NN	O	neutrophil	nn	21	SENT_576	[p33l11t2106r534b2221],
21	survival	NN	O	survival	prep_for	17	SENT_576	[p33l589t2106r999b2197],
22	.	.	O	.	_	0	SENT_576	[p33l589t2106r999b2197],

1	J	NNP	O	J	nn	2	SENT_577	[p33l1048t2114r1090b2211],
2	Immunol	NNP	O	Immunol	_	0	SENT_577	[p33l1141t2106r1605b2197],
3	2002	CD	DATE	2002	num	2	SENT_577	[p33l1658t2112r2129b2215],
4	;	:	O	;	_	0	SENT_577	[p33l1658t2112r2129b2215],
5	168	CD	NUMBER	168	dep	2	SENT_577	[p33l1658t2112r2129b2215],
6	:	:	O	:	_	0	SENT_577	[p33l1658t2112r2129b2215],

1	41	CD	NUMBER	41	_	0	SENT_578	[p33l8t2496r75b2534],
2	.	.	O	.	_	0	SENT_578	[p33l8t2496r75b2534],

1	Dubé	NNP	ORGANIZATION	Dubé	nn	2	SENT_579	[p33l104t2489r232b2535],
2	LM	NNP	ORGANIZATION	LM	_	0	SENT_579	[p33l250t2494r341b2543],
3	,	,	O	,	_	0	SENT_579	[p33l250t2494r341b2543],
4	Swanson	NNP	PERSON	Swanson	nn	6	SENT_579	[p33l364t2493r581b2535],
5	L	NNP	O	L	nn	6	SENT_579	[p33l598t2494r655b2543],
6	]	NN	O	]	appos	2	SENT_579	[p33l598t2494r655b2543],
7	,	,	O	,	_	0	SENT_579	[p33l598t2494r655b2543],
8	Awni	NNP	PERSON	Awni	nn	10	SENT_579	[p33l674t2491r801b2535],
9	W.	NNP	PERSON	W.	nn	10	SENT_579	[p33l816t2494r877b2534],
10	Zileuton	NNP	PERSON	Zileuton	appos	2	SENT_579	[p33l897t2490r1037b2535, p33l9t2569r102b2614],
11	,	,	O	,	_	0	SENT_579	[p33l897t2490r1037b2535, p33l9t2569r102b2614],
12	a	DT	O	a	det	15	SENT_579	[p33l133t2575r158b2604],
13	leukotriene	NN	O	leukotriene	nn	15	SENT_579	[p33l185t2560r463b2605],
14	synthesis	NN	O	synthesis	nn	15	SENT_579	[p33l492t2560r717b2616],
15	inhibitor	NN	O	inhibitor	appos	2	SENT_579	[p33l746t2560r964b2604],
16	in	IN	O	in	_	0	SENT_579	[p33l991t2561r1038b2604],
17	the	DT	O	the	det	18	SENT_579	[p33l9t2631r85b2675],
18	management	NN	O	management	prep_in	15	SENT_579	[p33l104t2640r426b2688],
19	of	IN	O	of	_	0	SENT_579	[p33l443t2631r500b2675],
20	chronic	JJ	O	chronic	amod	21	SENT_579	[p33l509t2631r694b2675],
21	asthma	NN	O	asthma	prep_of	18	SENT_579	[p33l712t2631r907b2675],
22	:	:	O	:	_	0	SENT_579	[p33l712t2631r907b2675],
23	clinical	JJ	O	clinical	amod	24	SENT_579	[p33l929t2631r1037b2675, p33l9t2703r94b2747],
24	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_579	[p33l131t2703r575b2759],
25	and	CC	O	and	_	0	SENT_579	[p33l614t2703r703b2747],
26	safety	NN	O	safety	conj_and	24	SENT_579	[p33l743t2703r895b2759],
27	.	.	O	.	_	0	SENT_579	[p33l743t2703r895b2759],

1	Clin	NNP	O	Clin	nn	4	SENT_580	[p33l937t2703r1038b2747],
2	Rev	NN	O	rev	nn	4	SENT_580	[p33l8t2777r97b2820],
3	Allergy	NNP	O	Allergy	nn	4	SENT_580	[p33l113t2773r292b2830],
4	Immunol	NNP	O	Immunol	_	0	SENT_580	[p33l308t2773r537b2818],
5	1999	CD	DATE	1999	num	4	SENT_580	[p33l558t2776r937b2826],
6	;	:	O	;	_	0	SENT_580	[p33l558t2776r937b2826],
7	17:213	CD	NUMBER	17:213	number	8	SENT_580	[p33l558t2776r937b2826],
8	—	CD	NUMBER	—	dep	4	SENT_580	[p33l558t2776r937b2826],
9	21	CD	NUMBER	21	dep	8	SENT_580	[p33l558t2776r937b2826],
10	.	.	O	.	_	0	SENT_580	[p33l558t2776r937b2826],

1	42	CD	NUMBER	42	_	0	SENT_581	[p33l8t2851r75b2889],
2	.	.	O	.	_	0	SENT_581	[p33l8t2851r75b2889],

1	Beierschmitt	NNP	O	Beierschmitt	nn	2	SENT_582	[p33l104t2845r407b2889],
2	WP	NNP	O	WP	_	0	SENT_582	[p33l414t2849r505b2898],
3	,	,	O	,	_	0	SENT_582	[p33l414t2849r505b2898],
4	McNeish	NNP	PERSON	McNeish	nn	5	SENT_582	[p33l519t2845r727b2889],
5	JD	NNP	O	JD	appos	2	SENT_582	[p33l734t2849r805b2899],
6	,	,	O	,	_	0	SENT_582	[p33l734t2849r805b2899],
7	Griffiths	NNP	PERSON	Griffiths	nn	9	SENT_582	[p33l820t2845r1037b2889],
8	R	NNP	O	R	nn	9	SENT_582	[p33l8t2920r77b2969],
9	]	NN	O	]	appos	5	SENT_582	[p33l8t2920r77b2969],
10	,	,	O	,	_	0	SENT_582	[p33l8t2920r77b2969],
11	Nagahisa	NN	MISC	nagahisa	nn	12	SENT_582	[p33l100t2916r330b2973],
12	A	NN	MISC	a	appos	5	SENT_582	[p33l349t2920r398b2970],
13	,	,	O	,	_	0	SENT_582	[p33l349t2920r398b2970],
14	Nakane	NN	PERSON	nakane	nn	15	SENT_582	[p33l421t2916r608b2961],
15	M	NN	O	m	appos	5	SENT_582	[p33l627t2920r689b2970],
16	,	,	O	,	_	0	SENT_582	[p33l627t2920r689b2970],
17	Amacher	NNP	PERSON	Amacher	nn	18	SENT_582	[p33l711t2916r932b2960],
18	DE	NN	O	de	appos	5	SENT_582	[p33l951t2920r1035b2960],
19	.	.	O	.	_	0	SENT_582	[p33l951t2920r1035b2960],

1	Induction	NN	O	induction	_	0	SENT_583	[p33l8t2988r251b3033],
2	of	IN	O	of	_	0	SENT_583	[p33l283t2988r340b3032],
3	hepatic	JJ	O	hepatic	amod	6	SENT_583	[p33l360t2988r542b3044],
4	microsomal	JJ	O	microsomal	amod	6	SENT_583	[p33l572t2988r871b3032],
5	drugmetabolizing	NN	O	drugmetabolizing	nn	6	SENT_583	[p33l902t2988r1037b3045, p33l9t3059r343b3116],
6	enzymes	NNS	O	enzyme	prep_of	1	SENT_583	[p33l375t3073r590b3115],
7	by	IN	O	by	_	0	SENT_583	[p33l624t3059r680b3115],
8	inhibitors	NNS	O	inhibitor	prep_by	6	SENT_583	[p33l710t3059r957b3103],
9	of	IN	O	of	_	0	SENT_583	[p33l991t3059r1048b3103],
10	5	CD	NUMBER	5	num	12	SENT_583	[p33l10t3130r376b3187],
11	—	NN	O	—	nn	12	SENT_583	[p33l10t3130r376b3187],
12	lipoxygenase	NN	O	lipoxygenase	prep_of	8	SENT_583	[p33l10t3130r376b3187],
13	(	CD	NUMBER	(	num	14	SENT_583	[p33l397t3133r562b3181],
14	5-LO	NN	O	5-lo	dep	12	SENT_583	[p33l397t3133r562b3181],
15	)	CD	NUMBER	)	dep	14	SENT_583	[p33l397t3133r562b3181],
16	:	:	O	:	_	0	SENT_583	[p33l397t3133r562b3181],
17	studies	NNS	O	study	dep	1	SENT_583	[p33l584t3130r755b3175],
18	in	IN	O	in	_	0	SENT_583	[p33l774t3131r821b3174],
19	rats	NNS	O	rat	prep_in	17	SENT_583	[p33l840t3139r929b3174],
20	and	CC	O	and	_	0	SENT_583	[p33l949t3130r1038b3174],
21	5-LO	NN	O	5-lo	nn	23	SENT_583	[p33l10t3205r127b3246],
22	knockout	NN	O	knockout	nn	23	SENT_583	[p33l161t3202r393b3247],
23	mice	NNS	O	mouse	conj_and	19	SENT_583	[p33l425t3203r554b3246],
24	.	.	O	.	_	0	SENT_583	[p33l425t3203r554b3246],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_584	[p33l590t3202r768b3246],
2	Sci	NNP	O	Sci	_	0	SENT_584	[p33l803t3203r871b3246],
3	2001	CD	DATE	2001	num	2	SENT_584	[p33l905t3205r1036b3255],
4	;	:	O	;	_	0	SENT_584	[p33l905t3205r1036b3255],
5	63:15	CD	NUMBER	63:15	number	6	SENT_584	[p33l9t3276r228b3317],
6	-21	CD	NUMBER	-21	dep	2	SENT_584	[p33l9t3276r228b3317],
7	.	.	O	.	_	0	SENT_584	[p33l9t3276r228b3317],

1	43	CD	NUMBER	43	_	0	SENT_585	[p33l8t3348r75b3387],
2	.	.	O	.	_	0	SENT_585	[p33l8t3348r75b3387],

1	Ferguson	NNP	PERSON	Ferguson	nn	2	SENT_586	[p33l104t3347r333b3400],
2	AD	NN	O	ad	_	0	SENT_586	[p33l353t3347r443b3397],
3	,	,	O	,	_	0	SENT_586	[p33l353t3347r443b3397],
4	McKeever	NNP	PERSON	McKeever	nn	5	SENT_586	[p33l468t3347r706b3388],
5	BM	NN	O	bm	appos	2	SENT_586	[p33l726t3347r821b3396],
6	,	,	O	,	_	0	SENT_586	[p33l726t3347r821b3396],
7	Xu	NN	O	xu	nn	8	SENT_586	[p33l845t3347r908b3388],
8	S	NN	O	s	appos	2	SENT_586	[p33l932t3346r970b3396],
9	,	,	O	,	_	0	SENT_586	[p33l932t3346r970b3396],
10	et	FW	O	et	nn	11	SENT_586	[p33l997t3352r1041b3387],
11	al.	FW	O	al.	appos	2	SENT_586	[p33l9t3414r64b3458],
12	.	.	O	.	_	0	SENT_586	[p33l9t3414r64b3458],

1	Crystal	NNP	O	Crystal	nn	2	SENT_587	[p33l101t3414r273b3470],
2	structure	NN	O	structure	nsubj	6	SENT_587	[p33l308t3423r530b3459],
3	of	IN	O	of	_	0	SENT_587	[p33l564t3414r621b3458],
4	inhibitor	NN	O	inhibitor	nn	5	SENT_587	[p33l643t3414r1038b3459],
5	—	NN	O	—	prep_of	2	SENT_587	[p33l643t3414r1038b3459],
6	bound	VBD	O	bind	_	0	SENT_587	[p33l643t3414r1038b3459],
7	human	JJ	O	human	amod	9	SENT_587	[p33l9t3485r181b3530],
8	5-lipoxygenase	NN	O	5-lipoxygenase	nn	9	SENT_587	[p33l199t3485r829b3542],
9	—	NN	O	—	dobj	6	SENT_587	[p33l199t3485r829b3542],
10	activating	VBG	O	activate	xcomp	6	SENT_587	[p33l199t3485r829b3542],
11	protein	NN	O	protein	dobj	10	SENT_587	[p33l843t3486r1035b3541],
12	.	.	O	.	_	0	SENT_587	[p33l843t3486r1035b3541],

1	Science	NNP	O	Science	_	0	SENT_588	[p33l10t3557r189b3600],
2	2007	CD	DATE	2007	num	1	SENT_588	[p33l208t3559r583b3609],
3	;	:	O	;	_	0	SENT_588	[p33l208t3559r583b3609],
4	317:510	CD	NUMBER	317:510	num	5	SENT_588	[p33l208t3559r583b3609],
5	—	NN	O	—	dep	1	SENT_588	[p33l208t3559r583b3609],
6	2	CD	NUMBER	2	dep	5	SENT_588	[p33l208t3559r583b3609],
7	.	.	O	.	_	0	SENT_588	[p33l208t3559r583b3609],

1	44	CD	NUMBER	44	_	0	SENT_589	[p33l8t3633r75b3671],
2	.	.	O	.	_	0	SENT_589	[p33l8t3633r75b3671],

1	Griffiths	NNP	PERSON	Griffiths	nn	3	SENT_590	[p33l105t3627r322b3671],
2	R	NNP	O	R	nn	3	SENT_590	[p33l342t3631r411b3680],
3	]	NN	O	]	_	0	SENT_590	[p33l342t3631r411b3680],
4	,	,	O	,	_	0	SENT_590	[p33l342t3631r411b3680],
5	Pettipher	JJ	O	pettipher	amod	6	SENT_590	[p33l433t3627r657b3683],
6	ER	NN	O	er	appos	3	SENT_590	[p33l675t3631r757b3681],
7	,	,	O	,	_	0	SENT_590	[p33l675t3631r757b3681],
8	Koch	NNP	PERSON	Koch	nn	9	SENT_590	[p33l780t3627r904b3672],
9	K	NNP	PERSON	K	appos	3	SENT_590	[p33l924t3631r973b3681],
10	,	,	O	,	_	0	SENT_590	[p33l924t3631r973b3681],
11	et	FW	O	et	nn	12	SENT_590	[p33l997t3636r1041b3671],
12	al.	FW	O	al.	appos	3	SENT_590	[p33l9t3698r64b3742],
13	.	.	O	.	_	0	SENT_590	[p33l9t3698r64b3742],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_591	[p33l91t3698r384b3742],
2	B	NN	O	b	nsubj	4	SENT_591	[p33l408t3702r439b3741],
3	4	CD	NUMBER	4	dep	2	SENT_591	[p33l444t3736r462b3757],
4	plays	VBZ	O	play	_	0	SENT_591	[p33l485t3698r608b3753],
5	a	DT	O	a	det	7	SENT_591	[p33l633t3712r658b3741],
6	critical	JJ	O	critical	amod	7	SENT_591	[p33l682t3698r851b3741],
7	role	NN	O	role	dobj	4	SENT_591	[p33l875t3698r967b3742],
8	in	IN	O	in	_	0	SENT_591	[p33l991t3699r1038b3741],
9	the	DT	O	the	det	10	SENT_591	[p33l9t3769r82b3813],
10	progression	NN	O	progression	prep_in	7	SENT_591	[p33l99t3770r380b3826],
11	of	IN	O	of	_	0	SENT_591	[p33l398t3769r453b3813],
12	collagen-induced	JJ	O	collagen-induced	amod	13	SENT_591	[p33l461t3769r863b3826],
13	arthriblind	NN	O	arthriblind	prep_of	10	SENT_591	[p33l880t3769r1037b3813, p33l1114t2490r1254b2543],
14	,	,	O	,	_	0	SENT_591	[p33l880t3769r1037b3813, p33l1114t2490r1254b2543],
15	placebo-controlled	JJ	O	placebo-controlled	amod	16	SENT_591	[p33l1277t2490r1740b2546],
16	trial	NN	O	trial	appos	13	SENT_591	[p33l1761t2490r1863b2534],
17	performed	VBN	O	perform	partmod	16	SENT_591	[p33l1882t2490r2142b2546],
18	in	IN	O	in	_	0	SENT_591	[p33l1113t2561r1160b2604],
19	the	DT	O	the	det	20	SENT_591	[p33l1187t2560r1263b2604],
20	spring	NN	DATE	spring	prep_in	17	SENT_591	[p33l1291t2561r1459b2617],
21	.	.	O	.	_	0	SENT_591	[p33l1291t2561r1459b2617],

1	Clin	NNP	O	Clin	nn	3	SENT_592	[p33l1489t2560r1590b2604],
2	Exp	NNP	O	Exp	nn	3	SENT_592	[p33l1616t2564r1706b2616],
3	Allergy	NNP	O	Allergy	_	0	SENT_592	[p33l1731t2560r1911b2617],
4	2002	CD	DATE	2002	num	3	SENT_592	[p33l1936t2563r2140b2613],
5	;	:	O	;	_	0	SENT_592	[p33l1936t2563r2140b2613],
6	32	CD	NUMBER	32	num	8	SENT_592	[p33l1936t2563r2140b2613],
7	:	:	O	:	_	0	SENT_592	[p33l1936t2563r2140b2613],
8	1020-8	CD	NUMBER	1020-8	dep	3	SENT_592	[p33l1115t2634r1291b2675],
9	.	.	O	.	_	0	SENT_592	[p33l1115t2634r1291b2675],

1	55	CD	NUMBER	55	_	0	SENT_593	[p33l1114t2709r1179b2747],
2	.	.	O	.	_	0	SENT_593	[p33l1114t2709r1179b2747],

1	Peters	NNP	PERSON	Peters	_	0	SENT_594	[p33l1208t2703r1557b2747],
2	.	.	O	.	_	0	SENT_594	[p33l1208t2703r1557b2747],

1	—	NN	O	—	_	0	SENT_595	[p33l1208t2703r1557b2747],
2	.	.	O	.	_	0	SENT_595	[p33l1208t2703r1557b2747],

1	Golden	NNP	O	Golden	nn	2	SENT_596	[p33l1208t2703r1557b2747],
2	M	NNP	O	M	_	0	SENT_596	[p33l1584t2707r1645b2756],
3	,	,	O	,	_	0	SENT_596	[p33l1584t2707r1645b2756],
4	Henderson	NNP	PERSON	Henderson	nn	6	SENT_596	[p33l1678t2703r1945b2747],
5	WR	NNP	O	WR	nn	6	SENT_596	[p33l1972t2707r2069b2750],
6	Jr.	NNP	O	Jr.	appos	2	SENT_596	[p33l2087t2707r2139b2754],
7	.	.	O	.	_	0	SENT_596	[p33l2087t2707r2139b2754],

1	The	DT	O	the	det	2	SENT_597	[p33l1111t2773r1203b2817],
2	role	NN	O	role	_	0	SENT_597	[p33l1225t2773r1316b2817],
3	of	IN	O	of	_	0	SENT_597	[p33l1339t2773r1395b2817],
4	leukotrienes	NNS	O	leukotriene	prep_of	2	SENT_597	[p33l1406t2773r1708b2818],
5	in	IN	O	in	_	0	SENT_597	[p33l1731t2774r1779b2817],
6	allergic	JJ	O	allergic	amod	7	SENT_597	[p33l1800t2773r1982b2830],
7	rhinitis	NN	O	rhinitis	prep_in	2	SENT_597	[p33l2004t2773r2142b2817, p33l1113t2846r1185b2889],
8	.	.	O	.	_	0	SENT_597	[p33l2004t2773r2142b2817, p33l1113t2846r1185b2889],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_598	[p33l1212t2849r1315b2889],
2	Allergy	NNP	O	Allergy	nn	4	SENT_598	[p33l1339t2845r1518b2902],
3	Asthma	NNP	O	Asthma	nn	4	SENT_598	[p33l1539t2845r1732b2889],
4	Immunol	NNP	O	Immunol	_	0	SENT_598	[p33l1756t2845r1984b2890],
5	2005	CD	DATE	2005	num	4	SENT_598	[p33l2010t2848r2140b2898],
6	;	:	O	;	_	0	SENT_598	[p33l2010t2848r2140b2898],
7	94:609	CD	NUMBER	94:609	number	8	SENT_598	[p33l1113t2919r1367b2960],
8	—	CD	NUMBER	—	dep	4	SENT_598	[p33l1113t2919r1367b2960],
9	18	CD	NUMBER	18	dep	8	SENT_598	[p33l1113t2919r1367b2960],
10	.	.	O	.	_	0	SENT_598	[p33l1113t2919r1367b2960],

1	56	CD	NUMBER	56	_	0	SENT_599	[p33l1114t2993r1179b3032],
2	.	.	O	.	_	0	SENT_599	[p33l1114t2993r1179b3032],

1	Nayak	NNP	PERSON	Nayak	nn	2	SENT_600	[p33l1208t2988r1362b3044],
2	A	NNP	O	A	_	0	SENT_600	[p33l1373t2992r1422b3041],
3	,	,	O	,	_	0	SENT_600	[p33l1373t2992r1422b3041],
4	Langdon	NNP	PERSON	Langdon	nn	5	SENT_600	[p33l1440t2988r1656b3045],
5	RB	NN	O	rb	appos	2	SENT_600	[p33l1671t2992r1757b3035],
6	.	.	O	.	_	0	SENT_600	[p33l1671t2992r1757b3035],

1	Montelukast	NNP	O	Montelukast	_	0	SENT_601	[p33l1774t2988r2082b3033],
2	in	IN	O	in	_	0	SENT_601	[p33l2095t2989r2142b3032],
3	the	DT	O	the	det	4	SENT_601	[p33l1114t3059r1189b3103],
4	treatment	NN	O	treatment	prep_in	1	SENT_601	[p33l1214t3068r1455b3103],
5	of	IN	O	of	_	0	SENT_601	[p33l1478t3059r1534b3103],
6	allergic	JJ	O	allergic	amod	7	SENT_601	[p33l1548t3059r1730b3116],
7	rhinitis	NN	O	rhinitis	prep_of	4	SENT_601	[p33l1753t3059r1948b3103],
8	:	:	O	:	_	0	SENT_601	[p33l1753t3059r1948b3103],
9	an	DT	O	a	det	11	SENT_601	[p33l1974t3073r2032b3103],
10	evidence-based	JJ	O	evidence-based	amod	11	SENT_601	[p33l2057t3060r2142b3104, p33l1114t3130r1415b3174],
11	review	NN	O	review	dep	1	SENT_601	[p33l1449t3131r1616b3175],
12	.	.	O	.	_	0	SENT_601	[p33l1449t3131r1616b3175],

1	Drugs	NNS	O	drug	_	0	SENT_602	[p33l1653t3134r1801b3187],
2	2007	CD	DATE	2007	num	1	SENT_602	[p33l1835t3133r2142b3183, p33l1113t3205r1213b3246],
3	;	:	O	;	_	0	SENT_602	[p33l1835t3133r2142b3183, p33l1113t3205r1213b3246],
4	67:887901	CD	NUMBER	67:887901	dep	1	SENT_602	[p33l1835t3133r2142b3183, p33l1113t3205r1213b3246],
5	.	.	O	.	_	0	SENT_602	[p33l1835t3133r2142b3183, p33l1113t3205r1213b3246],

1	57	CD	NUMBER	57	_	0	SENT_603	[p33l1114t3279r1179b3317],
2	.	.	O	.	_	0	SENT_603	[p33l1114t3279r1179b3317],

1	Price	NN	O	price	nn	2	SENT_604	[p33l1208t3274r1328b3317],
2	DB	NN	O	db	_	0	SENT_604	[p33l1355t3277r1441b3327],
3	,	,	O	,	_	0	SENT_604	[p33l1355t3277r1441b3327],
4	Swern	NNP	PERSON	Swern	nn	5	SENT_604	[p33l1472t3276r1621b3318],
5	A	NNP	O	A	appos	2	SENT_604	[p33l1646t3277r1696b3327],
6	,	,	O	,	_	0	SENT_604	[p33l1646t3277r1696b3327],
7	Tozzi	NNP	PERSON	Tozzi	nn	8	SENT_604	[p33l1725t3274r1857b3317],
8	CA	NNP	O	CA	appos	2	SENT_604	[p33l1884t3276r1968b3326],
9	,	,	O	,	_	0	SENT_604	[p33l1884t3276r1968b3326],
10	Philip	NNP	PERSON	Philip	nn	11	SENT_604	[p33l1998t3273r2141b3329],
11	G	NNP	PERSON	G	appos	2	SENT_604	[p33l1113t3346r1165b3397],
12	,	,	O	,	_	0	SENT_604	[p33l1113t3346r1165b3397],
13	Polos	NNP	O	Polos	nn	15	SENT_604	[p33l1188t3343r1318b3387],
14	P.	NNP	O	P.	nn	15	SENT_604	[p33l1339t3347r1376b3387],
15	Effect	NN	O	effect	appos	2	SENT_604	[p33l1399t3343r1544b3387],
16	of	IN	O	of	_	0	SENT_604	[p33l1562t3343r1618b3387],
17	montelukast	NN	O	montelukast	prep_of	15	SENT_604	[p33l1629t3343r1936b3388],
18	on	IN	O	on	_	0	SENT_604	[p33l1954t3357r2014b3387],
19	lung	NN	O	lung	nn	20	SENT_604	[p33l2034t3343r2144b3400],
20	function	NN	O	function	prep_on	2	SENT_604	[p33l1113t3414r1322b3459],
21	in	IN	O	in	_	0	SENT_604	[p33l1343t3415r1391b3458],
22	asthma	NN	O	asthma	nn	23	SENT_604	[p33l1412t3414r1593b3458],
23	patients	NNS	O	patient	prep_in	20	SENT_604	[p33l1613t3415r1808b3470],
24	with	IN	O	with	_	0	SENT_604	[p33l1828t3414r1939b3459],
25	allergic	JJ	O	allergic	amod	26	SENT_604	[p33l1961t3414r2142b3471],
26	rhinitis	NN	O	rhinitis	prep_with	23	SENT_604	[p33l1113t3485r1307b3529],
27	:	:	O	:	_	0	SENT_604	[p33l1113t3485r1307b3529],
28	analysis	NN	O	analysis	dep	2	SENT_604	[p33l1331t3485r1525b3541],
29	from	IN	O	from	_	0	SENT_604	[p33l1549t3485r1668b3529],
30	the	DT	O	the	det	32	SENT_604	[p33l1690t3485r1766b3529],
31	COMPACT	NNP	O	COMPACT	nn	32	SENT_604	[p33l1788t3488r2047b3529],
32	trial	NN	O	trial	prep_from	28	SENT_604	[p33l2067t3486r2142b3529, p33l1113t3556r1168b3600],
33	.	.	O	.	_	0	SENT_604	[p33l2067t3486r2142b3529, p33l1113t3556r1168b3600],

1	Allergy	NNP	O	Allergy	_	0	SENT_605	[p33l1194t3556r1373b3613],
2	2006	CD	DATE	2006	num	1	SENT_605	[p33l1395t3559r1779b3609],
3	;	:	O	;	_	0	SENT_605	[p33l1395t3559r1779b3609],
4	61:737	CD	NUMBER	61:737	number	5	SENT_605	[p33l1395t3559r1779b3609],
5	—	CD	NUMBER	—	dep	1	SENT_605	[p33l1395t3559r1779b3609],
6	42	CD	NUMBER	42	dep	5	SENT_605	[p33l1395t3559r1779b3609],
7	.	.	O	.	_	0	SENT_605	[p33l1395t3559r1779b3609],

1	[	NN	O	[	_	0	SENT_606	[p33l1811t3560r2045b3610],
2	Erratum	NN	O	erratum	dep	1	SENT_606	[p33l1811t3560r2045b3610],
3	,	,	O	,	_	0	SENT_606	[p33l1811t3560r2045b3610],
4	Allergy	NNP	O	Allergy	appos	2	SENT_606	[p33l2070t3556r2142b3600, p33l1113t3627r1235b3684],
5	2006	CD	DATE	2006	rcmod	4	SENT_606	[p33l1252t3630r1607b3680],
6	;	:	O	;	_	0	SENT_606	[p33l1252t3630r1607b3680],
7	61:1153	CD	NUMBER	61:1153	dep	5	SENT_606	[p33l1252t3630r1607b3680],
8	.	.	O	.	_	0	SENT_606	[p33l1252t3630r1607b3680],
9	]	SYM	O	]	dep	5	SENT_606	[p33l1252t3630r1607b3680],

1	58	CD	NUMBER	58	_	0	SENT_607	[p33l1114t3702r1179b3742],
2	.	.	O	.	_	0	SENT_607	[p33l1114t3702r1179b3742],

1	Virchow	NNP	ORGANIZATION	Virchow	nn	2	SENT_608	[p33l1207t3698r1413b3742],
2	JC	NNP	ORGANIZATION	JC	_	0	SENT_608	[p33l1434t3701r1504b3751],
3	,	,	O	,	_	0	SENT_608	[p33l1434t3701r1504b3751],
4	Bachert	NNP	PERSON	Bachert	nn	6	SENT_608	[p33l1535t3698r1724b3741],
5	C.	NNP	PERSON	C.	nn	6	SENT_608	[p33l1750t3701r1797b3742],
6	Efficacy	NNP	PERSON	Efficacy	appos	2	SENT_608	[p33l1828t3698r2027b3753],
7	and	CC	O	and	_	0	SENT_608	[p33l2053t3698r2143b3742],
8	safety	NN	O	safety	appos	2	SENT_608	[p33l1114t3769r1258b3825],
9	of	IN	O	of	_	0	SENT_608	[p33l1275t3769r1331b3813],
10	montelukast	NN	O	montelukast	prep_of	8	SENT_608	[p33l1340t3769r1647b3814],
11	in	IN	O	in	_	0	SENT_608	[p33l1662t3770r1710b3813],
12	adults	NNS	O	adult	prep_in	10	SENT_608	[p33l1728t3769r1875b3814],
13	with	IN	O	with	_	0	SENT_608	[p33l1892t3769r2003b3814],
14	asthtis	NN	O	asthti	prep_with	12	SENT_608	[p33l2021t3769r2142b3813, p34l9t18r81b61],
15	.	.	O	.	_	0	SENT_608	[p33l2021t3769r2142b3813, p34l9t18r81b61],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_609	[p34l103t21r211b61],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_609	[p34l228t17r332b61],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_609	[p34l349t17r469b61],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_609	[p34l489t18r557b61],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_609	[p34l575t21r614b61],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_609	[p34l634t20r657b61],
7	A	NNP	O	A	_	0	SENT_609	[p34l676t21r713b61],
8	1995	CD	DATE	1995	num	7	SENT_609	[p34l732t20r1037b70, p34l9t92r78b133],
9	;	:	O	;	_	0	SENT_609	[p34l732t20r1037b70, p34l9t92r78b133],
10	92:51721	CD	NUMBER	92:51721	dep	7	SENT_609	[p34l732t20r1037b70, p34l9t92r78b133],
11	.	.	O	.	_	0	SENT_609	[p34l732t20r1037b70, p34l9t92r78b133],

1	45	CD	NUMBER	45	_	0	SENT_610	[p34l8t166r75b204],
2	.	.	O	.	_	0	SENT_610	[p34l8t166r75b204],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_611	[p34l104t160r238b204],
2	E	NNP	O	E	_	0	SENT_611	[p34l263t164r307b214],
3	,	,	O	,	_	0	SENT_611	[p34l263t164r307b214],
4	Rubin	NNP	PERSON	Rubin	nn	5	SENT_611	[p34l335t160r482b207],
5	P	NN	PERSON	p	appos	2	SENT_611	[p34l507t164r545b214],
6	,	,	O	,	_	0	SENT_611	[p34l507t164r545b214],
7	Kemp	NNP	PERSON	Kemp	nn	8	SENT_611	[p34l574t164r715b216],
8	J	NNP	O	J	appos	2	SENT_611	[p34l736t164r768b214],
9	,	,	O	,	_	0	SENT_611	[p34l736t164r768b214],
10	et	FW	O	et	nn	11	SENT_611	[p34l797t169r841b204],
11	al.	FW	O	al.	appos	2	SENT_611	[p34l864t160r919b204],
12	.	.	O	.	_	0	SENT_611	[p34l864t160r919b204],

1	The	DT	O	the	det	2	SENT_612	[p34l946t160r1038b204],
2	effect	NN	O	effect	_	0	SENT_612	[p34l9t230r147b274],
3	of	IN	O	of	_	0	SENT_612	[p34l172t230r229b274],
4	inhibition	NN	O	inhibition	prep_of	2	SENT_612	[p34l245t230r491b274],
5	of	IN	O	of	_	0	SENT_612	[p34l519t230r575b274],
6	5-lipoxygenase	NN	O	5-lipoxygenase	prep_of	2	SENT_612	[p34l593t230r958b287],
7	by	IN	O	by	_	0	SENT_612	[p34l985t230r1040b286],
8	zileuton	NN	O	zileuton	prep_by	2	SENT_612	[p34l9t302r203b346],
9	in	IN	O	in	_	0	SENT_612	[p34l220t303r267b345],
10	mild-to-moderate	JJ	O	mild-to-moderate	amod	11	SENT_612	[p34l284t302r708b346],
11	asthma	NN	O	asthma	prep_in	8	SENT_612	[p34l725t302r916b346],
12	.	.	O	.	_	0	SENT_612	[p34l725t302r916b346],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_613	[p34l934t306r1038b345],
2	Intern	NNP	O	Intern	nn	3	SENT_613	[p34l8t376r160b416],
3	Med	NNP	O	Med	_	0	SENT_613	[p34l177t372r283b416],
4	1993	CD	DATE	1993	num	3	SENT_613	[p34l303t375r747b425],
5	;	:	O	;	_	0	SENT_613	[p34l303t375r747b425],
6	119:1059	CD	NUMBER	119:1059	number	7	SENT_613	[p34l303t375r747b425],
7	-66	CD	NUMBER	-66	dep	3	SENT_613	[p34l303t375r747b425],
8	.	.	O	.	_	0	SENT_613	[p34l303t375r747b425],

1	46	CD	NUMBER	46	_	0	SENT_614	[p34l8t449r75b488],
2	.	.	O	.	_	0	SENT_614	[p34l8t449r75b488],

1	Knorr	NN	PERSON	knorr	nn	2	SENT_615	[p34l105t448r251b489],
2	B	NN	PERSON	b	_	0	SENT_615	[p34l275t448r321b498],
3	,	,	O	,	_	0	SENT_615	[p34l275t448r321b498],
4	Matz	NNP	PERSON	Matz	nn	5	SENT_615	[p34l349t448r472b488],
5	J	NNP	PERSON	J	appos	2	SENT_615	[p34l493t448r526b498],
6	,	,	O	,	_	0	SENT_615	[p34l493t448r526b498],
7	Bernstein	NNP	PERSON	Bernstein	nn	8	SENT_615	[p34l555t445r790b488],
8	JA	NNP	O	JA	appos	2	SENT_615	[p34l811t448r881b498],
9	,	,	O	,	_	0	SENT_615	[p34l811t448r881b498],
10	et	FW	O	et	nn	11	SENT_615	[p34l911t453r955b488],
11	al.	FW	O	al.	appos	2	SENT_615	[p34l979t444r1035b488],
12	.	.	O	.	_	0	SENT_615	[p34l979t444r1035b488],

1	Montelukast	NNP	O	Montelukast	_	0	SENT_616	[p34l7t515r315b560],
2	for	IN	O	for	_	0	SENT_616	[p34l338t515r408b559],
3	chronic	JJ	O	chronic	amod	4	SENT_616	[p34l432t515r616b559],
4	asthma	NN	O	asthma	prep_for	1	SENT_616	[p34l640t515r822b559],
5	in	IN	O	in	_	0	SENT_616	[p34l845t516r893b558],
6	6	CD	NUMBER	6	prep_in	4	SENT_616	[p34l918t518r965b559],
7	-	:	O	-	_	0	SENT_616	[p34l918t518r965b559],
8	to	TO	O	to	_	0	SENT_616	[p34l991t524r1037b559],
9	14-year-old	JJ	DURATION	14-year-old	amod	10	SENT_616	[p34l11t586r282b642],
10	children	NNS	O	child	prep_to	1	SENT_616	[p34l305t586r522b630],
11	:	:	O	:	_	0	SENT_616	[p34l305t586r522b630],
12	a	DT	O	a	dep	1	SENT_616	[p34l546t601r571b630],
13	randomized	VBN	O	randomize	partmod	12	SENT_616	[p34l593t586r903b640],
14	,	,	O	,	_	0	SENT_616	[p34l593t586r903b640],
15	double-blind	JJ	O	double-blind	amod	16	SENT_616	[p34l929t586r1037b631, p34l9t656r229b700],
16	trial	NN	O	trial	dobj	13	SENT_616	[p34l248t656r363b700],
17	.	.	O	.	_	0	SENT_616	[p34l248t656r363b700],

1	JAMA	NN	O	jama	_	0	SENT_617	[p34l380t660r526b707],
2	1998	CD	DATE	1998	num	1	SENT_617	[p34l545t659r959b709],
3	;	:	O	;	_	0	SENT_617	[p34l545t659r959b709],
4	279:1181	CD	NUMBER	279:1181	number	5	SENT_617	[p34l545t659r959b709],
5	-6	CD	NUMBER	-6	dep	1	SENT_617	[p34l545t659r959b709],
6	.	.	O	.	_	0	SENT_617	[p34l545t659r959b709],

1	47	CD	NUMBER	47	_	0	SENT_618	[p34l8t733r75b771],
2	.	.	O	.	_	0	SENT_618	[p34l8t733r75b771],

1	Suissa	NNP	PERSON	Suissa	nn	2	SENT_619	[p34l106t728r258b772],
2	S	NNP	PERSON	S	_	0	SENT_619	[p34l276t730r315b780],
3	,	,	O	,	_	0	SENT_619	[p34l276t730r315b780],
4	Dennis	NNP	PERSON	Dennis	nn	5	SENT_619	[p34l335t728r508b771],
5	R	NNP	PERSON	R	appos	2	SENT_619	[p34l526t731r575b780],
6	,	,	O	,	_	0	SENT_619	[p34l526t731r575b780],
7	Ernst	NNP	ORGANIZATION	Ernst	nn	8	SENT_619	[p34l595t731r726b771],
8	P	NN	ORGANIZATION	p	appos	2	SENT_619	[p34l740t731r777b780],
9	,	,	O	,	_	0	SENT_619	[p34l740t731r777b780],
10	Sheehy	NNP	PERSON	Sheehy	nn	11	SENT_619	[p34l799t727r969b783],
11	O	NNP	O	O	appos	2	SENT_619	[p34l984t730r1035b781],
12	,	,	O	,	_	0	SENT_619	[p34l984t730r1035b781],
13	Wood-Dauphinee	NNP	O	Wood-Dauphinee	nn	15	SENT_619	[p34l7t799r434b855],
14	S.	NNP	O	S.	nn	15	SENT_619	[p34l465t802r504b843],
15	Effectiveness	NNP	O	Effectiveness	appos	2	SENT_619	[p34l536t799r856b843],
16	of	IN	O	of	_	0	SENT_619	[p34l886t799r943b843],
17	the	DT	O	the	det	21	SENT_619	[p34l962t799r1037b843],
18	leukotriene	NN	O	leukotriene	nn	21	SENT_619	[p34l8t870r286b915],
19	receptor	NN	O	receptor	nn	21	SENT_619	[p34l322t879r526b926],
20	antagonist	NN	O	antagonist	nn	21	SENT_619	[p34l560t871r823b927],
21	zafirlukast	NN	O	zafirlukast	prep_of	15	SENT_619	[p34l856t870r1037b915, p34l9t942r110b987],
22	for	IN	O	for	_	0	SENT_619	[p34l129t942r199b986],
23	mild-to-moderate	JJ	O	mild-to-moderate	amod	24	SENT_619	[p34l220t942r652b986],
24	asthma	NN	O	asthma	prep_for	2	SENT_619	[p34l674t942r869b986],
25	:	:	O	:	_	0	SENT_619	[p34l674t942r869b986],
26	a	DT	O	a	dep	2	SENT_619	[p34l893t957r918b986],
27	randomized	VBN	O	randomize	partmod	26	SENT_619	[p34l939t956r1037b986, p34l9t1013r232b1067],
28	,	,	O	,	_	0	SENT_619	[p34l939t956r1037b986, p34l9t1013r232b1067],
29	double-blind	JJ	O	double-blind	amod	32	SENT_619	[p34l248t1013r567b1067],
30	,	,	O	,	_	0	SENT_619	[p34l248t1013r567b1067],
31	placebo-controlled	JJ	O	placebo-controlled	amod	32	SENT_619	[p34l581t1013r1038b1069],
32	trial	NN	O	trial	appos	26	SENT_619	[p34l9t1084r124b1128],
33	.	.	O	.	_	0	SENT_619	[p34l9t1084r124b1128],

1	Ann	NNP	O	Ann	nn	3	SENT_620	[p34l145t1088r248b1128],
2	Intern	NNP	O	Intern	nn	3	SENT_620	[p34l266t1088r418b1128],
3	Med	NNP	O	Med	_	0	SENT_620	[p34l435t1084r541b1128],
4	1997	CD	DATE	1997	num	3	SENT_620	[p34l562t1087r969b1137],
5	;	:	O	;	_	0	SENT_620	[p34l562t1087r969b1137],
6	126:177	CD	NUMBER	126:177	number	7	SENT_620	[p34l562t1087r969b1137],
7	-83	CD	NUMBER	-83	dep	3	SENT_620	[p34l562t1087r969b1137],
8	.	.	O	.	_	0	SENT_620	[p34l562t1087r969b1137],

1	48	CD	NUMBER	48	_	0	SENT_621	[p34l8t1159r75b1199],
2	.	.	O	.	_	0	SENT_621	[p34l8t1159r75b1199],

1	Ducharme	NNP	O	Ducharme	nn	2	SENT_622	[p34l104t1155r360b1199],
2	FM	NNP	O	FM	_	0	SENT_622	[p34l394t1159r483b1208],
3	,	,	O	,	_	0	SENT_622	[p34l394t1159r483b1208],
4	Hicks	NNP	PERSON	Hicks	nn	5	SENT_622	[p34l521t1155r659b1200],
5	GC	NN	O	gc	appos	2	SENT_622	[p34l695t1158r786b1199],
6	.	.	O	.	_	0	SENT_622	[p34l695t1158r786b1199],

1	Antileukotriene	JJ	O	antileukotriene	amod	2	SENT_623	[p34l821t1155r1037b1199, p34l9t1225r211b1270],
2	agents	NNS	O	agent	nsubj	5	SENT_623	[p34l231t1234r388b1282],
3	compared	VBN	O	compare	_	0	SENT_623	[p34l410t1225r652b1281],
4	to	TO	O	to	prepc_compared_to	2	SENT_623	[p34l673t1234r719b1269],
5	inhaled	VBN	O	inhale	_	0	SENT_623	[p34l739t1225r924b1269],
6	corticosteroids	NNS	O	corticosteroid	dobj	5	SENT_623	[p34l944t1239r1037b1269, p34l9t1296r294b1340],
7	in	IN	O	in	_	0	SENT_623	[p34l317t1297r364b1340],
8	the	DT	O	the	det	9	SENT_623	[p34l386t1296r462b1340],
9	management	NN	O	management	prep_in	6	SENT_623	[p34l484t1305r806b1353],
10	of	IN	O	of	_	0	SENT_623	[p34l825t1296r882b1340],
11	recurrent	JJ	O	recurrent	amod	14	SENT_623	[p34l893t1311r1037b1341, p34l9t1377r109b1412],
12	and/or	JJ	O	and/or	amod	14	SENT_623	[p34l142t1368r304b1418],
13	chronic	JJ	O	chronic	amod	14	SENT_623	[p34l339t1368r527b1412],
14	asthma	NN	O	asthma	prep_of	9	SENT_623	[p34l562t1368r760b1412],
15	.	.	O	.	_	0	SENT_623	[p34l562t1368r760b1412],

1	Cochrane	NNP	ORGANIZATION	Cochrane	nn	4	SENT_624	[p34l799t1368r1038b1412],
2	Database	NNP	ORGANIZATION	Database	nn	4	SENT_624	[p34l8t1439r232b1483],
3	Syst	NNP	ORGANIZATION	Syst	nn	4	SENT_624	[p34l253t1442r349b1495],
4	Rev	NN	O	rev	_	0	SENT_624	[p34l365t1443r454b1486],
5	2000	CD	DATE	2000	num	4	SENT_624	[p34l471t1442r918b1492],
6	;	:	O	;	_	0	SENT_624	[p34l471t1442r918b1492],
7	3	CD	NUMBER	3	dep	4	SENT_624	[p34l471t1442r918b1492],
8	:	:	O	:	_	0	SENT_624	[p34l471t1442r918b1492],
9	CD002314	NN	O	cd002314	dep	7	SENT_624	[p34l471t1442r918b1492],
10	.	.	O	.	_	0	SENT_624	[p34l471t1442r918b1492],

1	49	CD	NUMBER	49	_	0	SENT_625	[p34l8t1515r75b1554],
2	.	.	O	.	_	0	SENT_625	[p34l8t1515r75b1554],

1	Peters	NNP	ORGANIZATION	Peters	nn	2	SENT_626	[p34l104t1514r251b1554],
2	SP	NN	ORGANIZATION	sp	_	0	SENT_626	[p34l272t1513r336b1564],
3	,	,	O	,	_	0	SENT_626	[p34l272t1513r336b1564],
4	Anthonisen	JJ	PERSON	anthonisen	amod	5	SENT_626	[p34l356t1510r644b1554],
5	N	NN	O	n	appos	2	SENT_626	[p34l662t1514r715b1564],
6	,	,	O	,	_	0	SENT_626	[p34l662t1514r715b1564],
7	Castro	NNP	PERSON	Castro	nn	8	SENT_626	[p34l737t1513r895b1554],
8	M	NNP	O	M	appos	2	SENT_626	[p34l913t1514r974b1564],
9	,	,	O	,	_	0	SENT_626	[p34l913t1514r974b1564],
10	et	FW	O	et	nn	11	SENT_626	[p34l997t1519r1041b1554],
11	al.	FW	O	al.	appos	2	SENT_626	[p34l9t1581r64b1625],
12	.	.	O	.	_	0	SENT_626	[p34l9t1581r64b1625],

1	Randomized	VBN	O	randomize	_	0	SENT_627	[p34l87t1581r401b1628],
2	comparison	NN	O	comparison	dobj	1	SENT_627	[p34l423t1582r713b1637],
3	of	IN	O	of	_	0	SENT_627	[p34l734t1581r791b1625],
4	strategies	NNS	O	strategy	prep_of	2	SENT_627	[p34l802t1582r1037b1638],
5	for	IN	O	for	_	0	SENT_627	[p34l9t1652r79b1696],
6	reducing	VBG	O	reduce	prepc_for	1	SENT_627	[p34l99t1652r315b1709],
7	treatment	NN	O	treatment	dobj	6	SENT_627	[p34l335t1661r577b1696],
8	in	IN	O	in	_	0	SENT_627	[p34l595t1653r642b1696],
9	mild	JJ	O	mild	amod	11	SENT_627	[p34l664t1652r776b1696],
10	persistent	JJ	O	persistent	amod	11	SENT_627	[p34l797t1653r1040b1708],
11	asthma	NN	O	asthma	prep_in	6	SENT_627	[p34l9t1723r203b1767],
12	.	.	O	.	_	0	SENT_627	[p34l9t1723r203b1767],

1	N	NN	O	n	nn	3	SENT_628	[p34l230t1727r272b1767],
2	Engl	NNP	O	Engl	nn	3	SENT_628	[p34l296t1723r407b1780],
3	J	NNP	O	J	nsubj	4	SENT_628	[p34l426t1727r447b1774],
4	Med	VBD	O	med	_	0	SENT_628	[p34l469t1723r575b1767],
5	2007	CD	DATE	2007	dobj	4	SENT_628	[p34l600t1726r1035b1776],
6	;	:	O	;	_	0	SENT_628	[p34l600t1726r1035b1776],
7	356:2027	CD	NUMBER	356:2027	num	8	SENT_628	[p34l600t1726r1035b1776],
8	-39	CD	NUMBER	-39	dep	5	SENT_628	[p34l600t1726r1035b1776],
9	.	.	O	.	_	0	SENT_628	[p34l600t1726r1035b1776],

1	[	NN	O	[	nn	2	SENT_629	[p34l14t1799r247b1848],
2	Erratum	NN	O	erratum	nsubj	7	SENT_629	[p34l14t1799r247b1848],
3	,	,	O	,	_	0	SENT_629	[p34l14t1799r247b1848],
4	N	NN	O	n	appos	2	SENT_629	[p34l269t1799r311b1839],
5	Engl	NNP	O	Engl	nn	6	SENT_629	[p34l328t1795r473b1852],
6	]	NNP	O	]	dep	4	SENT_629	[p34l328t1795r473b1852],
7	Med	VBD	O	med	_	0	SENT_629	[p34l490t1795r595b1839],
8	2007	CD	DATE	2007	dobj	7	SENT_629	[p34l614t1798r959b1848],
9	;	:	O	;	_	0	SENT_629	[p34l614t1798r959b1848],
10	357:728	CD	NUMBER	357:728	dep	8	SENT_629	[p34l614t1798r959b1848],
11	.	.	O	.	_	0	SENT_629	[p34l614t1798r959b1848],
12	]	SYM	O	]	dep	8	SENT_629	[p34l614t1798r959b1848],

1	50	CD	NUMBER	50	_	0	SENT_630	[p34l10t1871r75b1911],
2	.	.	O	.	_	0	SENT_630	[p34l10t1871r75b1911],

1	Laviolette	NNP	PERSON	Laviolette	nn	2	SENT_631	[p34l104t1867r341b1912],
2	M	NNP	O	M	_	0	SENT_631	[p34l365t1871r426b1921],
3	,	,	O	,	_	0	SENT_631	[p34l365t1871r426b1921],
4	Malmstrom	NNP	ORGANIZATION	Malmstrom	nn	5	SENT_631	[p34l453t1867r743b1911],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_631	[p34l768t1871r817b1921],
6	,	,	O	,	_	0	SENT_631	[p34l768t1871r817b1921],
7	Lu	NNP	PERSON	Lu	nn	8	SENT_631	[p34l844t1871r904b1912],
8	S	NNP	PERSON	S	appos	2	SENT_631	[p34l930t1870r968b1921],
9	,	,	O	,	_	0	SENT_631	[p34l930t1870r968b1921],
10	et	FW	O	et	nn	11	SENT_631	[p34l997t1876r1041b1911],
11	al.	FW	O	al.	appos	2	SENT_631	[p34l9t1938r64b1982],
12	.	.	O	.	_	0	SENT_631	[p34l9t1938r64b1982],

1	Montelukast	NNP	O	Montelukast	nsubj	2	SENT_632	[p34l94t1938r402b1983],
2	added	VBD	O	add	_	0	SENT_632	[p34l427t1938r573b1982],
3	to	TO	O	to	aux	4	SENT_632	[p34l601t1947r647b1982],
4	inhaled	VBN	O	inhale	xcomp	2	SENT_632	[p34l676t1938r861b1982],
5	beclomethasone	NN	O	beclomethasone	dobj	4	SENT_632	[p34l889t1938r1037b1982, p34l9t2008r278b2052],
6	in	IN	O	in	_	0	SENT_632	[p34l299t2009r346b2052],
7	treatment	NN	O	treatment	prep_in	4	SENT_632	[p34l369t2017r610b2052],
8	of	IN	O	of	_	0	SENT_632	[p34l630t2008r687b2052],
9	asthma	NN	O	asthma	prep_of	7	SENT_632	[p34l698t2008r893b2052],
10	.	.	O	.	_	0	SENT_632	[p34l698t2008r893b2052],

1	Am	VBP	O	be	cop	2	SENT_633	[p34l916t2012r1039b2059],
2	]	CD	NUMBER	]	dep	6	SENT_633	[p34l916t2012r1039b2059],
3	Respir	NNP	O	Respir	nn	5	SENT_633	[p34l9t2081r167b2136],
4	Crit	NNP	O	Crit	nn	5	SENT_633	[p34l184t2081r277b2124],
5	Care	NNP	O	Care	nsubj	6	SENT_633	[p34l293t2083r403b2124],
6	Med	VBD	O	med	_	0	SENT_633	[p34l421t2080r526b2124],
7	1999	CD	DATE	1999	dobj	6	SENT_633	[p34l547t2083r961b2133],
8	;	:	O	;	_	0	SENT_633	[p34l547t2083r961b2133],
9	160:1862	CD	NUMBER	160:1862	num	10	SENT_633	[p34l547t2083r961b2133],
10	-8	CD	NUMBER	-8	dep	7	SENT_633	[p34l547t2083r961b2133],
11	.	.	O	.	_	0	SENT_633	[p34l547t2083r961b2133],

1	51	CD	NUMBER	51	_	0	SENT_634	[p34l10t2157r75b2195],
2	.	.	O	.	_	0	SENT_634	[p34l10t2157r75b2195],

1	Ducharme	NNP	O	Ducharme	nn	2	SENT_635	[p34l105t2151r352b2195],
2	FM	NNP	O	FM	_	0	SENT_635	[p34l373t2155r460b2204],
3	,	,	O	,	_	0	SENT_635	[p34l373t2155r460b2204],
4	Lasserson	NNP	PERSON	Lasserson	nn	6	SENT_635	[p34l484t2155r719b2195],
5	T	NN	O	t	nn	6	SENT_635	[p34l739t2155r800b2204],
6	]	NN	O	]	appos	2	SENT_635	[p34l739t2155r800b2204],
7	,	,	O	,	_	0	SENT_635	[p34l739t2155r800b2204],
8	Cates	NNP	PERSON	Cates	nn	9	SENT_635	[p34l826t2154r951b2195],
9	CJ	NNP	O	CJ	appos	6	SENT_635	[p34l974t2154r1035b2202],
10	.	.	O	.	_	0	SENT_635	[p34l974t2154r1035b2202],

1	Long-acting	JJ	O	long-acting	amod	2	SENT_636	[p34l8t2222r294b2278],
2	beta2-agonists	NNS	O	beta2-agonist	_	0	SENT_636	[p34l313t2221r656b2278],
3	versus	CC	O	versus	prep	2	SENT_636	[p34l676t2235r821b2266],
4	antileukotrienes	NNS	O	antileukotriene	dep	3	SENT_636	[p34l843t2221r1037b2266, p34l9t2293r226b2338],
5	as	IN	O	as	_	0	SENT_636	[p34l245t2308r293b2337],
6	add-on	JJ	O	add-on	amod	7	SENT_636	[p34l312t2293r476b2337],
7	therapy	NN	O	therapy	prep_as	4	SENT_636	[p34l494t2293r671b2349],
8	to	TO	O	to	aux	9	SENT_636	[p34l687t2302r732b2337],
9	inhaled	VBN	O	inhale	infmod	2	SENT_636	[p34l751t2293r929b2337],
10	corticosteroids	NNS	O	corticosteroid	dobj	9	SENT_636	[p34l948t2307r1037b2337, p34l9t2364r281b2408],
11	for	IN	O	for	_	0	SENT_636	[p34l306t2364r374b2408],
12	chronic	JJ	O	chronic	amod	13	SENT_636	[p34l397t2364r574b2408],
13	asthma	NN	O	asthma	prep_for	10	SENT_636	[p34l597t2364r785b2408],
14	.	.	O	.	_	0	SENT_636	[p34l597t2364r785b2408],

1	Cochrane	NNP	ORGANIZATION	Cochrane	nn	4	SENT_637	[p34l812t2364r1038b2408],
2	Database	NNP	ORGANIZATION	Database	nn	4	SENT_637	[p34l8t2435r224b2479],
3	Syst	NNP	ORGANIZATION	Syst	nn	4	SENT_637	[p34l242t2438r335b2491],
4	Rev	NN	O	rev	_	0	SENT_637	[p34l348t2439r435b2482],
5	2006	CD	DATE	2006	num	4	SENT_637	[p34l449t2438r875b2488],
6	;	:	O	;	_	0	SENT_637	[p34l449t2438r875b2488],
7	4	CD	NUMBER	4	num	9	SENT_637	[p34l449t2438r875b2488],
8	:	:	O	:	_	0	SENT_637	[p34l449t2438r875b2488],
9	CDO03137	CD	NUMBER	cdo03137	dep	4	SENT_637	[p34l449t2438r875b2488],
10	.	.	O	.	_	0	SENT_637	[p34l449t2438r875b2488],

1	52	CD	NUMBER	52	_	0	SENT_638	[p34l10t2511r75b2549],
2	.	.	O	.	_	0	SENT_638	[p34l10t2511r75b2549],

1	Ilowite	NN	O	ilowite	nn	2	SENT_639	[p34l104t2505r273b2550],
2	J	NN	O	j	_	0	SENT_639	[p34l292t2509r324b2559],
3	,	,	O	,	_	0	SENT_639	[p34l292t2509r324b2559],
4	Webb	NNP	PERSON	Webb	nn	5	SENT_639	[p34l349t2505r485b2549],
5	R	NNP	O	R	appos	2	SENT_639	[p34l509t2509r558b2559],
6	,	,	O	,	_	0	SENT_639	[p34l509t2509r558b2559],
7	Friedman	NNP	PERSON	Friedman	nn	8	SENT_639	[p34l584t2505r820b2549],
8	B	NNP	O	B	appos	2	SENT_639	[p34l843t2509r888b2558],
9	,	,	O	,	_	0	SENT_639	[p34l843t2509r888b2558],
10	et	FW	O	et	nn	11	SENT_639	[p34l915t2514r959b2549],
11	al.	FW	O	al.	appos	2	SENT_639	[p34l979t2505r1035b2549],
12	.	.	O	.	_	0	SENT_639	[p34l979t2505r1035b2549],

1	Addition	NN	O	addition	_	0	SENT_640	[p34l7t2577r222b2621],
2	of	IN	O	of	_	0	SENT_640	[p34l245t2577r301b2621],
3	montelukast	NN	O	montelukast	prep_of	1	SENT_640	[p34l313t2577r620b2622],
4	or	CC	O	or	_	0	SENT_640	[p34l640t2591r690b2621],
5	salmeterol	NN	O	salmeterol	prep_of	1	SENT_640	[p34l712t2577r969b2621],
6	to	TO	O	to	_	0	SENT_640	[p34l991t2586r1037b2621],
7	fluticasone	NN	O	fluticasone	prep_to	1	SENT_640	[p34l9t2647r283b2692],
8	for	IN	O	for	_	0	SENT_640	[p34l302t2647r372b2691],
9	protection	NN	O	protection	prep_for	7	SENT_640	[p34l388t2648r643b2703],
10	against	IN	O	against	_	0	SENT_640	[p34l662t2648r842b2704],
11	asthma	NN	O	asthma	nn	12	SENT_640	[p34l857t2647r1039b2691],
12	attacks	NNS	O	attack	prep_against	9	SENT_640	[p34l9t2719r191b2764],
13	:	:	O	:	_	0	SENT_640	[p34l9t2719r191b2764],
14	a	DT	O	a	dep	1	SENT_640	[p34l212t2734r237b2763],
15	randomized	VBN	O	randomize	partmod	14	SENT_640	[p34l256t2719r560b2772],
16	,	,	O	,	_	0	SENT_640	[p34l256t2719r560b2772],
17	double-blind	JJ	O	double-blind	amod	20	SENT_640	[p34l583t2719r902b2772],
18	,	,	O	,	_	0	SENT_640	[p34l583t2719r902b2772],
19	multicenter	JJ	O	multicenter	amod	20	SENT_640	[p34l925t2719r1037b2764, p34l9t2790r196b2833],
20	study	NN	O	study	appos	14	SENT_640	[p34l225t2789r364b2845],
21	.	.	O	.	_	0	SENT_640	[p34l225t2789r364b2845],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_641	[p34l395t2793r498b2833],
2	Allergy	NNP	O	Allergy	nn	4	SENT_641	[p34l526t2789r706b2846],
3	Asthma	NNP	O	Asthma	nn	4	SENT_641	[p34l731t2789r924b2833],
4	Immunol	NNP	O	Immunol	_	0	SENT_641	[p34l952t2793r1037b2833, p34l9t2861r166b2906],
5	2004	CD	DATE	2004	num	4	SENT_641	[p34l185t2864r543b2914],
6	;	:	O	;	_	0	SENT_641	[p34l185t2864r543b2914],
7	92:641	CD	NUMBER	92:641	number	8	SENT_641	[p34l185t2864r543b2914],
8	-8	CD	NUMBER	-8	dep	4	SENT_641	[p34l185t2864r543b2914],
9	.	.	O	.	_	0	SENT_641	[p34l185t2864r543b2914],

1	53	CD	NUMBER	53	_	0	SENT_642	[p34l10t2937r75b2976],
2	.	.	O	.	_	0	SENT_642	[p34l10t2937r75b2976],

1	Bjermer	NNP	O	Bjermer	nn	2	SENT_643	[p34l104t2933r298b2988],
2	L	NNP	O	L	_	0	SENT_643	[p34l318t2936r360b2985],
3	,	,	O	,	_	0	SENT_643	[p34l318t2936r360b2985],
4	Bisgaard	NNP	PERSON	Bisgaard	nn	5	SENT_643	[p34l384t2932r598b2989],
5	H	NNP	PERSON	H	appos	2	SENT_643	[p34l619t2936r673b2986],
6	,	,	O	,	_	0	SENT_643	[p34l619t2936r673b2986],
7	Bousquet	NNP	PERSON	Bousquet	nn	8	SENT_643	[p34l697t2936r926b2988],
8	J	NNP	PERSON	J	appos	2	SENT_643	[p34l940t2936r972b2986],
9	,	,	O	,	_	0	SENT_643	[p34l940t2936r972b2986],
10	et	FW	O	et	nn	11	SENT_643	[p34l997t2941r1041b2976],
11	al.	FW	O	al.	appos	2	SENT_643	[p34l9t3003r64b3047],
12	.	.	O	.	_	0	SENT_643	[p34l9t3003r64b3047],

1	Montelukast	NNP	O	Montelukast	_	0	SENT_644	[p34l81t3003r389b3048],
2	and	CC	O	and	_	0	SENT_644	[p34l402t3003r491b3047],
3	fluticasone	NN	O	fluticasone	conj_and	1	SENT_644	[p34l506t3003r780b3048],
4	compared	VBN	O	compare	_	0	SENT_644	[p34l795t3003r1038b3059],
5	with	IN	O	with	prepc_compared_with	3	SENT_644	[p34l7t3075r116b3120],
6	salmeterol	NN	O	salmeterol	pobj	3	SENT_644	[p34l133t3075r385b3119],
7	and	CC	O	and	_	0	SENT_644	[p34l400t3075r489b3119],
8	ﬂuticasone	NN	O	ﬂuticasone	pobj	3	SENT_644	[p34l504t3075r772b3120],
9	in	IN	O	in	_	0	SENT_644	[p34l788t3076r835b3119],
10	protecting	VBG	O	protect	prepc_in	6	SENT_644	[p34l850t3084r1037b3131, p34l9t3146r88b3202],
11	against	IN	O	against	_	0	SENT_644	[p34l101t3146r281b3202],
12	asthma	NN	O	asthma	nn	13	SENT_644	[p34l292t3145r474b3189],
13	exacerbation	NN	O	exacerbation	prep_against	10	SENT_644	[p34l488t3145r799b3189],
14	in	IN	O	in	_	0	SENT_644	[p34l813t3146r860b3189],
15	adults	NNS	O	adult	prep_in	13	SENT_644	[p34l875t3145r1036b3190],
16	:	:	O	:	_	0	SENT_644	[p34l875t3145r1036b3190],
17	one	CD	DURATION	one	num	18	SENT_644	[p34l10t3231r95b3261],
18	year	NN	NUMBER	year	dep	1	SENT_644	[p34l111t3231r224b3273],
19	,	,	O	,	_	0	SENT_644	[p34l111t3231r224b3273],
20	double	JJ	O	double	amod	26	SENT_644	[p34l246t3217r409b3262],
21	blind	JJ	O	blind	amod	26	SENT_644	[p34l427t3217r568b3271],
22	,	,	O	,	_	0	SENT_644	[p34l427t3217r568b3271],
23	randomised	JJ	O	randomised	amod	26	SENT_644	[p34l589t3217r895b3270],
24	,	,	O	,	_	0	SENT_644	[p34l589t3217r895b3270],
25	comparative	JJ	O	comparative	amod	26	SENT_644	[p34l917t3231r1037b3261, p34l8t3289r203b3344],
26	trial	NN	O	trial	appos	18	SENT_644	[p34l223t3288r338b3332],
27	.	.	O	.	_	0	SENT_644	[p34l223t3288r338b3332],

1	BMJ	NNP	O	BMJ	_	0	SENT_645	[p34l359t3292r459b3339],
2	2003	CD	DATE	2003	num	1	SENT_645	[p34l477t3291r811b3341],
3	;	:	O	;	_	0	SENT_645	[p34l477t3291r811b3341],
4	327:891	CD	NUMBER	327:891	dep	1	SENT_645	[p34l477t3291r811b3341],
5	.	.	O	.	_	0	SENT_645	[p34l477t3291r811b3341],

1	54	CD	NUMBER	54	_	0	SENT_646	[p34l10t3365r75b3403],
2	.	.	O	.	_	0	SENT_646	[p34l10t3365r75b3403],

1	Philip	NNP	PERSON	Philip	nn	2	SENT_647	[p34l104t3359r247b3415],
2	G	NNP	PERSON	G	_	0	SENT_647	[p34l273t3362r325b3413],
3	,	,	O	,	_	0	SENT_647	[p34l273t3362r325b3413],
4	Malmstrom	NNP	ORGANIZATION	Malmstrom	nn	5	SENT_647	[p34l350t3359r641b3403],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_647	[p34l664t3363r713b3413],
6	,	,	O	,	_	0	SENT_647	[p34l664t3363r713b3413],
7	Hampel	NNP	ORGANIZATION	Hampel	nn	8	SENT_647	[p34l740t3359r934b3415],
8	FC	NNP	ORGANIZATION	FC	appos	2	SENT_647	[p34l957t3362r1035b3412],
9	,	,	O	,	_	0	SENT_647	[p34l957t3362r1035b3412],
10	et	FW	O	et	nn	11	SENT_647	[p34l10t3438r53b3473],
11	al.	FW	O	al.	appos	2	SENT_647	[p34l81t3429r136b3473],
12	.	.	O	.	_	0	SENT_647	[p34l81t3429r136b3473],

1	Montelukast	NNP	O	Montelukast	_	0	SENT_648	[p34l168t3429r476b3474],
2	for	IN	O	for	dep	1	SENT_648	[p34l504t3429r574b3473],
3	treating	VBG	O	treat	pcomp	2	SENT_648	[p34l603t3430r798b3486],
4	seasonal	JJ	O	seasonal	amod	6	SENT_648	[p34l828t3429r1038b3473],
5	allergic	JJ	O	allergic	amod	6	SENT_648	[p34l9t3500r191b3557],
6	rhinitis	NN	O	rhinitis	dobj	3	SENT_648	[p34l223t3500r417b3544],
7	:	:	O	:	_	0	SENT_648	[p34l223t3500r417b3544],
8	a	DT	O	a	dep	6	SENT_648	[p34l452t3515r477b3544],
9	randomized	VBN	O	randomize	partmod	8	SENT_648	[p34l508t3500r818b3554],
10	,	,	O	,	_	0	SENT_648	[p34l508t3500r818b3554],
11	doublema	NN	O	doublema	appos	8	SENT_648	[p34l855t3500r1037b3545, p34l1113t31r1188b61],

1	and	CC	O	and	dep	3	SENT_649	[p34l1202t17r1292b61],
2	allergic	JJ	O	allergic	amod	3	SENT_649	[p34l1307t17r1489b74],
3	rhinitis	NN	O	rhinitis	_	0	SENT_649	[p34l1503t17r1698b61],
4	.	.	O	.	_	0	SENT_649	[p34l1503t17r1698b61],

1	Respir	NNP	O	Respir	nn	2	SENT_650	[p34l1716t18r1874b73],
2	Med	NNP	O	Med	_	0	SENT_650	[p34l1886t17r1992b61],
3	2006	CD	DATE	2006	num	2	SENT_650	[p34l2007t20r2140b70],
4	;	:	O	;	_	0	SENT_650	[p34l2007t20r2140b70],
5	100:1952	CD	NUMBER	100:1952	number	6	SENT_650	[p34l1115t92r1391b133],
6	-9	CD	NUMBER	-9	dep	2	SENT_650	[p34l1115t92r1391b133],
7	.	.	O	.	_	0	SENT_650	[p34l1115t92r1391b133],

1	59	CD	NUMBER	59	_	0	SENT_651	[p34l1114t165r1179b204],
2	.	.	O	.	_	0	SENT_651	[p34l1114t165r1179b204],

1	Stempel	NNP	PERSON	Stempel	nn	2	SENT_652	[p34l1211t160r1405b216],
2	DA	NNP	PERSON	DA	_	0	SENT_652	[p34l1433t164r1520b213],
3	,	,	O	,	_	0	SENT_652	[p34l1433t164r1520b213],
4	Stanford	NNP	ORGANIZATION	Stanford	nn	5	SENT_652	[p34l1554t160r1764b204],
5	RH	NNP	O	RH	appos	2	SENT_652	[p34l1792t164r1886b213],
6	,	,	O	,	_	0	SENT_652	[p34l1792t164r1886b213],
7	Carranza	NNP	PERSON	Carranza	nn	9	SENT_652	[p34l1918t163r2143b204],
8	Rosenzweig	NNP	PERSON	Rosenzweig	nn	9	SENT_652	[p34l1112t231r1410b287],
9	JR	NNP	O	JR	appos	2	SENT_652	[p34l1428t234r1500b284],
10	,	,	O	,	_	0	SENT_652	[p34l1428t234r1500b284],
11	McLaughlin	NNP	PERSON	McLaughlin	nn	12	SENT_652	[p34l1527t230r1822b287],
12	TP	NNP	O	TP	appos	2	SENT_652	[p34l1846t234r1919b274],
13	.	.	O	.	_	0	SENT_652	[p34l1846t234r1919b274],

1	The	DT	O	the	det	2	SENT_653	[p34l1946t230r2037b274],
2	use	NN	O	use	_	0	SENT_653	[p34l2063t245r2142b275],
3	of	IN	O	of	_	0	SENT_653	[p34l1114t302r1170b346],
4	rhinitis	NN	O	rhinitis	nn	5	SENT_653	[p34l1178t302r1358b345],
5	medications	NNS	O	medication	prep_of	2	SENT_653	[p34l1378t302r1677b346],
6	in	IN	O	in	_	0	SENT_653	[p34l1696t303r1743b345],
7	children	NNS	O	child	prep_in	5	SENT_653	[p34l1762t302r1965b346],
8	receiving	VBG	O	receive	partmod	2	SENT_653	[p34l1984t303r2141b346, p34l1113t373r1192b429],
9	initial	JJ	O	initial	amod	11	SENT_653	[p34l1214t372r1361b416],
10	controller	NN	O	controller	nn	11	SENT_653	[p34l1385t372r1626b416],
11	therapy	NN	O	therapy	dobj	8	SENT_653	[p34l1648t372r1832b428],
12	for	IN	O	for	_	0	SENT_653	[p34l1853t372r1923b416],
13	asthma	NN	O	asthma	prep_for	11	SENT_653	[p34l1945t372r2139b416],
14	.	.	O	.	_	0	SENT_653	[p34l1945t372r2139b416],

1	Curr	NNP	O	Curr	nn	4	SENT_654	[p34l1113t447r1225b489],
2	Med	NNP	O	Med	nn	4	SENT_654	[p34l1241t444r1346b488],
3	Res	NNP	O	Res	nn	4	SENT_654	[p34l1365t448r1450b491],
4	Opin	NNP	O	Opin	_	0	SENT_654	[p34l1470t445r1591b500],
5	2006	CD	DATE	2006	num	4	SENT_654	[p34l1610t447r2032b497],
6	;	:	O	;	_	0	SENT_654	[p34l1610t447r2032b497],
7	22:2279	CD	NUMBER	22:2279	number	8	SENT_654	[p34l1610t447r2032b497],
8	-85	CD	NUMBER	-85	dep	4	SENT_654	[p34l1610t447r2032b497],
9	.	.	O	.	_	0	SENT_654	[p34l1610t447r2032b497],

1	60	CD	NUMBER	60	_	0	SENT_655	[p34l1113t520r1179b559],
2	.	.	O	.	_	0	SENT_655	[p34l1113t520r1179b559],

1	Coreno	NNP	MISC	Coreno	nn	2	SENT_656	[p34l1209t518r1385b559],
2	A	NNP	MISC	A	_	0	SENT_656	[p34l1411t519r1460b569],
3	,	,	O	,	_	0	SENT_656	[p34l1411t519r1460b569],
4	Skowronski	NNP	PERSON	Skowronski	nn	5	SENT_656	[p34l1492t515r1780b560],
5	M	NNP	O	M	appos	2	SENT_656	[p34l1805t519r1866b569],
6	,	,	O	,	_	0	SENT_656	[p34l1805t519r1866b569],
7	Kotaru	NNP	PERSON	Kotaru	nn	8	SENT_656	[p34l1896t519r2065b560],
8	C	NNP	PERSON	C	appos	2	SENT_656	[p34l2092t518r2139b568],
9	,	,	O	,	_	0	SENT_656	[p34l2092t518r2139b568],
10	McFadden	NNP	PERSON	McFadden	nn	12	SENT_656	[p34l1112t586r1363b630],
11	ER	NN	O	er	nn	12	SENT_656	[p34l1390t590r1464b633],
12	Jr.	NNP	O	Jr.	appos	2	SENT_656	[p34l1481t590r1533b637],
13	.	.	O	.	_	0	SENT_656	[p34l1481t590r1533b637],

1	Comparative	JJ	O	comparative	amod	2	SENT_657	[p34l1565t587r1876b642],
2	effects	NNS	O	effect	_	0	SENT_657	[p34l1905t586r2065b630],
3	of	IN	O	of	_	0	SENT_657	[p34l2096t586r2152b630],
4	long-acting	JJ	O	long-acting	amod	5	SENT_657	[p34l1113t656r1389b713],
5	beta2-agonists	NNS	O	beta2-agonist	prep_of	2	SENT_657	[p34l1404t656r1769b713],
6	,	,	O	,	_	0	SENT_657	[p34l1404t656r1769b713],
7	leukotriene	NN	O	leukotriene	nn	9	SENT_657	[p34l1788t656r2060b701],
8	receptor	NN	O	receptor	nn	9	SENT_657	[p34l2077t670r2142b700, p34l1114t736r1268b783],
9	antagonists	NNS	O	antagonist	conj_and	5	SENT_657	[p34l1290t728r1590b784],
10	,	,	O	,	_	0	SENT_657	[p34l1290t728r1590b784],
11	and	CC	O	and	_	0	SENT_657	[p34l1616t727r1706b771],
12	a	DT	O	a	det	14	SENT_657	[p34l1728t742r1753b771],
13	5-lipoxygenase	NN	O	5-lipoxygenase	nn	14	SENT_657	[p34l1777t727r2142b784],
14	inhibitor	NN	O	inhibitor	conj_and	5	SENT_657	[p34l1113t799r1336b843],
15	on	IN	O	on	_	0	SENT_657	[p34l1378t813r1439b843],
16	exercise-induced	JJ	O	exercise-induced	amod	17	SENT_657	[p34l1482t799r1899b844],
17	asthma	NN	O	asthma	prep_on	2	SENT_657	[p34l1941t799r2139b843],
18	.	.	O	.	_	0	SENT_657	[p34l1941t799r2139b843],

1	J	NNP	O	J	nn	4	SENT_658	[p34l1108t874r1129b921],
2	Allergy	NNP	O	Allergy	nn	4	SENT_658	[p34l1146t870r1327b927],
3	Clin	NNP	O	Clin	nn	4	SENT_658	[p34l1343t870r1444b914],
4	Immunol	NNP	O	Immunol	_	0	SENT_658	[p34l1463t870r1691b915],
5	2000	CD	DATE	2000	num	4	SENT_658	[p34l1711t873r2106b923],
6	;	:	O	;	_	0	SENT_658	[p34l1711t873r2106b923],
7	106:500	CD	NUMBER	106:500	number	8	SENT_658	[p34l1711t873r2106b923],
8	-6	CD	NUMBER	-6	dep	4	SENT_658	[p34l1711t873r2106b923],
9	.	.	O	.	_	0	SENT_658	[p34l1711t873r2106b923],

1	61	CD	NUMBER	61	_	0	SENT_659	[p34l1113t947r1179b986],
2	.	.	O	.	_	0	SENT_659	[p34l1113t947r1179b986],

1	Edelman	NNP	PERSON	Edelman	nn	2	SENT_660	[p34l1209t942r1425b986],
2	JM	NN	O	jm	_	0	SENT_660	[p34l1444t946r1527b996],
3	,	,	O	,	_	0	SENT_660	[p34l1444t946r1527b996],
4	Turpin	NNP	PERSON	Turpin	nn	5	SENT_660	[p34l1553t943r1719b998],
5	JA	NNP	O	JA	appos	2	SENT_660	[p34l1738t946r1807b995],
6	,	,	O	,	_	0	SENT_660	[p34l1738t946r1807b995],
7	Bronsky	NNP	ORGANIZATION	Bronsky	nn	8	SENT_660	[p34l1834t942r2036b998],
8	EA	NN	ORGANIZATION	ea	appos	2	SENT_660	[p34l2058t946r2139b995],
9	,	,	O	,	_	0	SENT_660	[p34l2058t946r2139b995],
10	et	FW	O	et	nn	11	SENT_660	[p34l1114t1022r1158b1057],
11	al.	FW	O	al.	appos	2	SENT_660	[p34l1188t1013r1244b1057],
12	.	.	O	.	_	0	SENT_660	[p34l1188t1013r1244b1057],

1	Oral	JJ	O	oral	amod	2	SENT_661	[p34l1280t1013r1386b1057],
2	montelukast	NN	O	montelukast	nsubj	5	SENT_661	[p34l1419t1013r1727b1058],
3	compared	VBN	O	compare	_	0	SENT_661	[p34l1758t1013r2000b1069],
4	with	IN	O	with	prepc_compared_with	2	SENT_661	[p34l2031t1013r2142b1058],
5	inhaled	VBN	O	inhale	_	0	SENT_661	[p34l1113t1084r1298b1128],
6	salmeterol	NN	O	salmeterol	nsubj	8	SENT_661	[p34l1336t1084r1593b1128],
7	to	TO	O	to	aux	8	SENT_661	[p34l1630t1093r1676b1128],
8	prevent	VB	O	prevent	xcomp	5	SENT_661	[p34l1713t1093r1895b1140],
9	exerciseinduced	JJ	O	exerciseinduced	amod	10	SENT_661	[p34l1930t1085r2142b1128, p34l1113t1155r1306b1200],
10	bronchoconstriction	NN	O	bronchoconstriction	dobj	8	SENT_661	[p34l1334t1155r1851b1199],
11	:	:	O	:	_	0	SENT_661	[p34l1334t1155r1851b1199],
12	a	DT	O	a	dep	10	SENT_661	[p34l1880t1170r1905b1199],
13	randomized	VBN	O	randomize	partmod	12	SENT_661	[p34l1932t1155r2142b1199, p34l1113t1225r1228b1279],
14	,	,	O	,	_	0	SENT_661	[p34l1932t1155r2142b1199, p34l1113t1225r1228b1279],
15	double-blind	JJ	O	double-blind	amod	16	SENT_661	[p34l1256t1225r1568b1270],
16	trial	NN	O	trial	dobj	13	SENT_661	[p34l1594t1225r1709b1269],
17	.	.	O	.	_	0	SENT_661	[p34l1594t1225r1709b1269],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_662	[p34l1735t1229r1838b1269],
2	Intern	NNP	O	Intern	nn	3	SENT_662	[p34l1862t1229r2014b1269],
3	Med	NNP	O	Med	_	0	SENT_662	[p34l2037t1225r2142b1269],
4	2000	CD	DATE	2000	num	3	SENT_662	[p34l1113t1299r1524b1349],
5	;	:	O	;	_	0	SENT_662	[p34l1113t1299r1524b1349],
6	132:97	CD	NUMBER	132:97	number	7	SENT_662	[p34l1113t1299r1524b1349],
7	-104	CD	NUMBER	-104	dep	3	SENT_662	[p34l1113t1299r1524b1349],
8	.	.	O	.	_	0	SENT_662	[p34l1113t1299r1524b1349],

1	62	CD	NUMBER	62	_	0	SENT_663	[p34l1113t1373r1179b1412],
2	.	.	O	.	_	0	SENT_663	[p34l1113t1373r1179b1412],

1	Dahlén	NN	PERSON	dahlén	nn	2	SENT_664	[p34l1208t1367r1385b1412],
2	B	NN	PERSON	b	_	0	SENT_664	[p34l1408t1372r1454b1421],
3	,	,	O	,	_	0	SENT_664	[p34l1408t1372r1454b1421],
4	Nizankowska	FW	ORGANIZATION	nizankowska	appos	2	SENT_664	[p34l1480t1368r1815b1413],
5	E	NN	ORGANIZATION	e	dep	4	SENT_664	[p34l1838t1372r1882b1421],
6	,	,	O	,	_	0	SENT_664	[p34l1838t1372r1882b1421],
7	Szczeklik	NNP	O	Szczeklik	nn	8	SENT_664	[p34l1911t1368r2144b1413],
8	A	NNP	O	A	appos	2	SENT_664	[p34l1111t1443r1161b1492],
9	,	,	O	,	_	0	SENT_664	[p34l1111t1443r1161b1492],
10	et	FW	O	et	nn	11	SENT_664	[p34l1183t1448r1227b1483],
11	al.	FW	O	al.	appos	2	SENT_664	[p34l1242t1439r1297b1483],
12	.	.	O	.	_	0	SENT_664	[p34l1242t1439r1297b1483],

1	Benefits	NNS	O	benefit	_	0	SENT_665	[p34l1318t1439r1518b1483],
2	from	IN	O	from	_	0	SENT_665	[p34l1538t1439r1657b1483],
3	adding	VBG	O	add	prepc_from	1	SENT_665	[p34l1675t1439r1846b1496],
4	the	DT	O	the	det	7	SENT_665	[p34l1862t1439r1938b1483],
5	5lipoxygenase	NN	O	5lipoxygenase	nn	7	SENT_665	[p34l1957t1439r2141b1495, p34l1111t1524r1304b1567],
6	inhibitor	NN	O	inhibitor	nn	7	SENT_665	[p34l1319t1510r1538b1554],
7	zileuton	NN	O	zileuton	dobj	3	SENT_665	[p34l1551t1510r1750b1555],
8	to	TO	O	to	_	0	SENT_665	[p34l1765t1519r1811b1554],
9	conventional	JJ	O	conventional	amod	10	SENT_665	[p34l1827t1510r2142b1555],
10	therapy	NN	O	therapy	prep_to	3	SENT_665	[p34l1113t1581r1297b1637],
11	in	IN	O	in	_	0	SENT_665	[p34l1322t1582r1370b1625],
12	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	13	SENT_665	[p34l1398t1581r1832b1637],
13	asthmatics	NNS	O	asthmatic	prep_in	10	SENT_665	[p34l1857t1581r2139b1625],
14	.	.	O	.	_	0	SENT_665	[p34l1857t1581r2139b1625],

1	Am	NNP	O	Am	nn	5	SENT_666	[p34l1111t1656r1198b1696],
2	J	NNP	O	J	nn	5	SENT_666	[p34l1230t1656r1251b1703],
3	Respir	NNP	O	Respir	nn	5	SENT_666	[p34l1286t1653r1447b1708],
4	Crit	NNP	O	Crit	nn	5	SENT_666	[p34l1483t1653r1577b1696],
5	Care	NNP	O	Care	nsubj	6	SENT_666	[p34l1612t1655r1724b1696],
6	Med	VBD	O	med	_	0	SENT_666	[p34l1759t1652r1866b1696],
7	1998	CD	DATE	1998	dobj	6	SENT_666	[p34l1905t1655r2140b1705],
8	;	:	O	;	_	0	SENT_666	[p34l1905t1655r2140b1705],
9	157	CD	NUMBER	157	num	11	SENT_666	[p34l1905t1655r2140b1705],
10	:	:	O	:	_	0	SENT_666	[p34l1905t1655r2140b1705],
11	1187-94	CD	NUMBER	1187-94	dep	7	SENT_666	[p34l1115t1726r1317b1767],
12	.	.	O	.	_	0	SENT_666	[p34l1115t1726r1317b1767],

1	63	CD	NUMBER	63	_	0	SENT_667	[p34l1113t1800r1179b1839],
2	.	.	O	.	_	0	SENT_667	[p34l1113t1800r1179b1839],

1	Dahlén	NNP	O	Dahlén	nn	2	SENT_668	[p34l1208t1794r1377b1839],
2	SE	NN	O	se	_	0	SENT_668	[p34l1406t1798r1473b1848],
3	,	,	O	,	_	0	SENT_668	[p34l1406t1798r1473b1848],
4	Malmstrom	NNP	ORGANIZATION	Malmstrom	nn	5	SENT_668	[p34l1502t1795r1781b1839],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_668	[p34l1807t1799r1854b1848],
6	,	,	O	,	_	0	SENT_668	[p34l1807t1799r1854b1848],
7	Nizankowska	NNP	O	Nizankowska	nn	8	SENT_668	[p34l1883t1795r2142b1840, p34l1114t1867r1192b1912],
8	E	NNP	O	E	appos	2	SENT_668	[p34l1205t1871r1248b1921],
9	,	,	O	,	_	0	SENT_668	[p34l1205t1871r1248b1921],
10	et	FW	O	et	nn	11	SENT_668	[p34l1266t1876r1309b1911],
11	al.	FW	O	al.	appos	2	SENT_668	[p34l1320t1867r1374b1911],
12	.	.	O	.	_	0	SENT_668	[p34l1320t1867r1374b1911],

1	Improvement	NN	O	improvement	_	0	SENT_669	[p34l1391t1871r1712b1923],
2	of	IN	O	of	_	0	SENT_669	[p34l1725t1867r1780b1911],
3	aspirinintolerant	JJ	O	aspirinintolerant	amod	4	SENT_669	[p34l1784t1867r2142b1923, p34l1113t1947r1190b1982],
4	asthma	NN	O	asthma	prep_of	1	SENT_669	[p34l1210t1938r1388b1982],
5	by	IN	O	by	_	0	SENT_669	[p34l1411t1938r1465b1994],
6	montelukast	NN	O	montelukast	prep_by	4	SENT_669	[p34l1485t1938r1798b1992],
7	,	,	O	,	_	0	SENT_669	[p34l1485t1938r1798b1992],
8	a	DT	O	a	det	10	SENT_669	[p34l1824t1953r1849b1982],
9	leukotriene	NN	O	leukotriene	nn	10	SENT_669	[p34l1870t1938r2142b1983],
10	antagonist	NN	O	antagonist	appos	6	SENT_669	[p34l1113t2009r1382b2065],
11	:	:	O	:	_	0	SENT_669	[p34l1113t2009r1382b2065],
12	a	DT	O	a	dep	1	SENT_669	[p34l1419t2023r1444b2052],
13	randomized	VBN	O	randomize	partmod	12	SENT_669	[p34l1478t2008r1782b2062],
14	,	,	O	,	_	0	SENT_669	[p34l1478t2008r1782b2062],
15	double-blind	JJ	O	double-blind	amod	18	SENT_669	[p34l1820t2008r2139b2062],
16	,	,	O	,	_	0	SENT_669	[p34l1820t2008r2139b2062],
17	placebo-controlled	JJ	O	placebo-controlled	amod	18	SENT_669	[p34l1112t2080r1565b2136],
18	trial	NN	O	trial	appos	12	SENT_669	[p34l1590t2080r1702b2124],
19	.	.	O	.	_	0	SENT_669	[p34l1590t2080r1702b2124],

1	Am	NNP	O	Am	nn	5	SENT_670	[p34l1728t2084r1814b2124],
2	J	NNP	O	J	nn	5	SENT_670	[p34l1833t2084r1854b2131],
3	Respir	NNP	O	Respir	nn	5	SENT_670	[p34l1876t2081r2032b2136],
4	Crit	NNP	O	Crit	nn	5	SENT_670	[p34l2055t2081r2145b2124],
5	Care	NNP	O	Care	nsubj	6	SENT_670	[p34l1113t2154r1222b2195],
6	Med	VBD	O	med	_	0	SENT_670	[p34l1238t2151r1342b2195],
7	2002	CD	DATE	2002	dobj	6	SENT_670	[p34l1361t2154r1702b2204],
8	;	:	O	;	_	0	SENT_670	[p34l1361t2154r1702b2204],
9	165:9	CD	NUMBER	165:9	num	10	SENT_670	[p34l1361t2154r1702b2204],
10	-14	CD	NUMBER	-14	dep	7	SENT_670	[p34l1361t2154r1702b2204],
11	.	.	O	.	_	0	SENT_670	[p34l1361t2154r1702b2204],

1	64	CD	NUMBER	64	_	0	SENT_671	[p34l1113t2226r1179b2265],
2	.	.	O	.	_	0	SENT_671	[p34l1113t2226r1179b2265],

1	Volkman	NNP	PERSON	Volkman	nn	2	SENT_672	[p34l1207t2221r1429b2266],
2	JA	NNP	O	JA	_	0	SENT_672	[p34l1444t2225r1514b2275],
3	,	,	O	,	_	0	SENT_672	[p34l1444t2225r1514b2275],
4	Pontikes	NNP	PERSON	Pontikes	nn	6	SENT_672	[p34l1537t2221r1747b2266],
5	P	NN	O	p	nn	6	SENT_672	[p34l1768t2225r1826b2272],
6	]	NN	O	]	appos	2	SENT_672	[p34l1768t2225r1826b2272],
7	.	.	O	.	_	0	SENT_672	[p34l1768t2225r1826b2272],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_673	[p34l1849t2221r2142b2266],
2	modifiers	NNS	O	modifier	nsubj	4	SENT_673	[p34l1113t2293r1353b2337],
3	to	TO	O	to	aux	4	SENT_673	[p34l1374t2302r1421b2337],
4	prevent	VB	O	prevent	_	0	SENT_673	[p34l1441t2302r1623b2349],
5	aspirin-provoked	JJ	O	aspirin-provoked	amod	7	SENT_673	[p34l1640t2293r2057b2349],
6	respiratory	JJ	O	respiratory	amod	7	SENT_673	[p34l2077t2307r2142b2337, p34l1114t2365r1334b2420],
7	reactions	NNS	O	reaction	dobj	4	SENT_673	[p34l1370t2365r1593b2408],
8	in	IN	O	in	_	0	SENT_673	[p34l1632t2365r1680b2408],
9	asthmatics	NNS	O	asthmatic	prep_in	4	SENT_673	[p34l1718t2364r1999b2408],
10	.	.	O	.	_	0	SENT_673	[p34l1718t2364r1999b2408],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_674	[p34l2039t2368r2142b2408],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_674	[p34l1113t2435r1462b2479],
3	2002	CD	DATE	2002	num	2	SENT_674	[p34l1479t2438r1889b2488],
4	;	:	O	;	_	0	SENT_674	[p34l1479t2438r1889b2488],
5	36:1457	CD	NUMBER	36:1457	number	6	SENT_674	[p34l1479t2438r1889b2488],
6	-61	CD	NUMBER	-61	dep	2	SENT_674	[p34l1479t2438r1889b2488],
7	.	.	O	.	_	0	SENT_674	[p34l1479t2438r1889b2488],

1	65	CD	NUMBER	65	_	0	SENT_675	[p34l1113t2510r1179b2549],
2	.	.	O	.	_	0	SENT_675	[p34l1113t2510r1179b2549],

1	Bisgaard	NNP	PERSON	Bisgaard	nn	3	SENT_676	[p34l1209t2505r1422b2562],
2	H.	NNP	O	H.	nn	3	SENT_676	[p34l1459t2509r1513b2549],
3	A	NNP	O	A	nsubj	4	SENT_676	[p34l1551t2509r1588b2549],
4	randomized	VBD	O	randomize	_	0	SENT_676	[p34l1623t2505r1920b2549],
5	trial	NN	O	trial	dobj	4	SENT_676	[p34l1957t2505r2059b2549],
6	of	IN	O	of	_	0	SENT_676	[p34l2096t2505r2152b2549],
7	montelukast	NN	O	montelukast	prep_of	5	SENT_676	[p34l1113t2577r1420b2622],
8	in	IN	O	in	_	0	SENT_676	[p34l1436t2578r1483b2621],
9	respiratory	JJ	O	respiratory	amod	12	SENT_676	[p34l1501t2578r1771b2633],
10	syncytial	NN	O	syncytial	nn	12	SENT_676	[p34l1788t2577r2004b2633],
11	virus	NN	O	virus	nn	12	SENT_676	[p34l2020t2578r2141b2622],
12	postbronchiolitis	NN	O	postbronchiolitis	prep_in	4	SENT_676	[p34l1112t2647r1549b2703],
13	.	.	O	.	_	0	SENT_676	[p34l1112t2647r1549b2703],

1	Am	NNP	O	Am	nn	5	SENT_677	[p34l1578t2651r1664b2691],
2	J	NNP	O	J	nn	5	SENT_677	[p34l1685t2651r1707b2698],
3	Respir	NNP	O	Respir	nn	5	SENT_677	[p34l1732t2648r1890b2703],
4	Crit	NNP	O	Crit	nn	5	SENT_677	[p34l1916t2648r2008b2691],
5	Care	NNP	O	Care	nsubj	6	SENT_677	[p34l2032t2650r2142b2691],
6	Med	VBD	O	med	_	0	SENT_677	[p34l1112t2719r1217b2763],
7	2003	CD	DATE	2003	dobj	6	SENT_677	[p34l1236t2722r1647b2772],
8	;	:	O	;	_	0	SENT_677	[p34l1236t2722r1647b2772],
9	167:379	CD	NUMBER	167:379	num	10	SENT_677	[p34l1236t2722r1647b2772],
10	-83	CD	NUMBER	-83	dep	7	SENT_677	[p34l1236t2722r1647b2772],
11	.	.	O	.	_	0	SENT_677	[p34l1236t2722r1647b2772],

1	66	CD	NUMBER	66	_	0	SENT_678	[p34l1113t2794r1179b2833],
2	.	.	O	.	_	0	SENT_678	[p34l1113t2794r1179b2833],

1	Harmanci	NNP	PERSON	Harmanci	nn	2	SENT_679	[p34l1209t2790r1455b2833],
2	K	NNP	PERSON	K	_	0	SENT_679	[p34l1487t2793r1536b2843],
3	,	,	O	,	_	0	SENT_679	[p34l1487t2793r1536b2843],
4	Bakirtas	NNP	O	Bakirtas	nn	5	SENT_679	[p34l1570t2789r1776b2834],
5	A	NNP	O	A	appos	2	SENT_679	[p34l1806t2793r1856b2842],
6	,	,	O	,	_	0	SENT_679	[p34l1806t2793r1856b2842],
7	Turktas	NNP	O	Turktas	appos	2	SENT_679	[p34l1890t2789r2076b2834],
8	I	PRP	O	I	dep	7	SENT_679	[p34l2109t2793r2139b2843],
9	,	,	O	,	_	0	SENT_679	[p34l2109t2793r2139b2843],
10	Degim	NNP	O	Degim	nn	14	SENT_679	[p34l1113t2862r1277b2918],
11	T.	NNP	O	T.	nn	14	SENT_679	[p34l1300t2864r1344b2905],
12	Oral	NNP	O	Oral	nn	14	SENT_679	[p34l1372t2861r1478b2905],
13	montelukast	NN	O	montelukast	nn	14	SENT_679	[p34l1502t2861r1809b2906],
14	treatment	NN	O	treatment	appos	2	SENT_679	[p34l1832t2870r2074b2905],
15	of	IN	O	of	_	0	SENT_679	[p34l2096t2861r2153b2905],
16	preschool-aged	JJ	O	preschool-aged	amod	17	SENT_679	[p34l1113t2932r1472b2989],
17	children	NNS	O	child	prep_of	14	SENT_679	[p34l1487t2932r1682b2976],
18	with	IN	O	with	_	0	SENT_679	[p34l1694t2932r1801b2977],
19	acute	JJ	O	acute	amod	20	SENT_679	[p34l1816t2941r1937b2977],
20	asthma	NN	O	asthma	prep_with	17	SENT_679	[p34l1952t2932r2139b2976],
21	.	.	O	.	_	0	SENT_679	[p34l1952t2932r2139b2976],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_680	[p34l1111t3007r1216b3047],
2	Allergy	NNP	O	Allergy	nn	4	SENT_680	[p34l1241t3003r1424b3060],
3	Asthma	NNP	O	Asthma	nn	4	SENT_680	[p34l1447t3003r1643b3047],
4	Immunol	NNP	O	Immunol	_	0	SENT_680	[p34l1668t3003r1900b3048],
5	2006	CD	DATE	2006	num	4	SENT_680	[p34l1927t3006r2140b3056],
6	;	:	O	;	_	0	SENT_680	[p34l1927t3006r2140b3056],
7	96	CD	NUMBER	96	num	9	SENT_680	[p34l1927t3006r2140b3056],
8	:	:	O	:	_	0	SENT_680	[p34l1927t3006r2140b3056],
9	731-5	CD	NUMBER	731-5	dep	4	SENT_680	[p34l1114t3078r1255b3119],
10	.	.	O	.	_	0	SENT_680	[p34l1114t3078r1255b3119],

1	67	CD	NUMBER	67	_	0	SENT_681	[p34l1113t3150r1179b3189],
2	.	.	O	.	_	0	SENT_681	[p34l1113t3150r1179b3189],

1	Camargo	NNP	PERSON	Camargo	nn	3	SENT_682	[p34l1209t3148r1433b3202],
2	CA	NNP	PERSON	CA	nn	3	SENT_682	[p34l1452t3148r1524b3189],
3	Jr	NNP	PERSON	Jr	_	0	SENT_682	[p34l1535t3149r1587b3198],
4	,	,	O	,	_	0	SENT_682	[p34l1535t3149r1587b3198],
5	Smithline	NNP	ORGANIZATION	Smithline	nn	6	SENT_682	[p34l1610t3145r1848b3189],
6	HA	NNP	ORGANIZATION	HA	appos	3	SENT_682	[p34l1866t3149r1960b3199],
7	,	,	O	,	_	0	SENT_682	[p34l1866t3149r1960b3199],
8	Malice	NNP	O	Malice	nn	9	SENT_682	[p34l1980t3145r2142b3189],
9	MP	NNP	O	MP	appos	3	SENT_682	[p34l1112t3221r1200b3271],
10	,	,	O	,	_	0	SENT_682	[p34l1112t3221r1200b3271],
11	Green	NNP	ORGANIZATION	Green	nn	12	SENT_682	[p34l1233t3220r1380b3261],
12	SA	NNP	ORGANIZATION	SA	appos	3	SENT_682	[p34l1411t3220r1487b3271],
13	,	,	O	,	_	0	SENT_682	[p34l1411t3220r1487b3271],
14	Reiss	NNP	PERSON	Reiss	nn	15	SENT_682	[p34l1519t3218r1646b3264],
15	TF	NN	O	tf	appos	3	SENT_682	[p34l1675t3221r1749b3261],
16	.	.	O	.	_	0	SENT_682	[p34l1675t3221r1749b3261],

1	A	DT	O	a	det	4	SENT_683	[p34l1780t3221r1817b3261],
2	randomized	VBN	O	randomize	amod	4	SENT_683	[p34l1846t3217r2142b3261],
3	controlled	JJ	O	controlled	amod	4	SENT_683	[p34l1113t3288r1364b3332],
4	trial	NN	O	trial	_	0	SENT_683	[p34l1394t3288r1496b3332],
5	of	IN	O	of	_	0	SENT_683	[p34l1527t3288r1584b3332],
6	intravenous	JJ	O	intravenous	amod	7	SENT_683	[p34l1604t3289r1889b3333],
7	montelukast	NN	O	montelukast	prep_of	4	SENT_683	[p34l1921t3288r2142b3333, p34l1113t3359r1214b3404],
8	in	IN	O	in	_	0	SENT_683	[p34l1242t3360r1289b3403],
9	acute	JJ	O	acute	amod	10	SENT_683	[p34l1320t3368r1446b3404],
10	asthma	NN	O	asthma	prep_in	7	SENT_683	[p34l1477t3359r1672b3403],
11	.	.	O	.	_	0	SENT_683	[p34l1477t3359r1672b3403],

1	Am	NNP	O	Am	nn	5	SENT_684	[p34l1704t3363r1790b3403],
2	J	NNP	O	J	nn	5	SENT_684	[p34l1815t3363r1836b3410],
3	Respir	NNP	O	Respir	nn	5	SENT_684	[p34l1865t3360r2023b3415],
4	Crit	NNP	O	Crit	nn	5	SENT_684	[p34l2053t3360r2145b3403],
5	Care	NNP	O	Care	nsubj	6	SENT_684	[p34l1113t3432r1223b3473],
6	Med	VBD	O	med	_	0	SENT_684	[p34l1241t3429r1346b3473],
7	2003	CD	DATE	2003	dobj	6	SENT_684	[p34l1365t3432r1773b3482],
8	;	:	O	;	_	0	SENT_684	[p34l1365t3432r1773b3482],
9	167:528	CD	NUMBER	167:528	num	10	SENT_684	[p34l1365t3432r1773b3482],
10	-33	CD	NUMBER	-33	dep	7	SENT_684	[p34l1365t3432r1773b3482],
11	.	.	O	.	_	0	SENT_684	[p34l1365t3432r1773b3482],

1	68	CD	NUMBER	68	_	0	SENT_685	[p34l1113t3504r1179b3545],
2	.	.	O	.	_	0	SENT_685	[p34l1113t3504r1179b3545],

1	Bergeron	NNP	PERSON	Bergeron	nn	2	SENT_686	[p34l1208t3504r1424b3557],
2	C	NNP	O	C	_	0	SENT_686	[p34l1477t3503r1523b3554],
3	,	,	O	,	_	0	SENT_686	[p34l1477t3503r1523b3554],
4	Boulet	NNP	PERSON	Boulet	nn	5	SENT_686	[p34l1580t3500r1733b3545],
5	LP	NN	O	lp	appos	2	SENT_686	[p34l1783t3504r1849b3544],
6	.	.	O	.	_	0	SENT_686	[p34l1783t3504r1849b3544],

1	Structural	JJ	O	structural	_	0	SENT_687	[p34l1908t3500r2142b3545],

1	N	NN	O	n	nn	3	SENT_688	[p34l897t3642r911b3657],
2	ENGLJ	NN	O	englj	nn	3	SENT_688	[p34l926t3642r1004b3664],
3	MED357	NN	O	med357	_	0	SENT_688	[p34l1018t3636r1154b3664],
4	;	:	O	;	_	0	SENT_688	[p34l1018t3636r1154b3664],
5	'	''	O	'	_	0	SENT_688	[p34l1018t3636r1154b3664],
6	|	SYM	O	|	dep	7	SENT_688	[p34l1018t3636r1154b3664],
7	8	CD	NUMBER	8	rcmod	5	SENT_688	[p34l1018t3636r1154b3664],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	dep	16	SENT_688	[p34l1187t3642r1388b3664],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_688	[p34l1425t3642r1661b3663],
10	'	POS	O	'	_	0	SENT_688	[p34l1425t3642r1661b3663],
11	|	JJ	O	|	dep	9	SENT_688	[p34l1425t3642r1661b3663],
12	,2007	CD	NUMBER	,2007	dep	16	SENT_688	[p34l1425t3642r1661b3663],
13	The	DT	O	the	det	16	SENT_688	[p34l935t3675r986b3699],
14	New	NNP	O	New	nn	16	SENT_688	[p34l995t3676r1057b3699],
15	England	NNP	O	England	nn	16	SENT_688	[p34l1066t3675r1177b3706],
16	Joumal	NNP	O	Joumal	dep	3	SENT_688	[p34l1186t3675r1283b3699],
17	of	IN	O	of	_	0	SENT_688	[p34l1293t3675r1322b3699],
18	Medicine	NNP	O	Medicine	prep_of	16	SENT_688	[p34l1329t3675r1454b3699],

1	Downloaded	VBN	O	download	_	0	SENT_689	[p34l377t3716r547b3739],
2	from	IN	O	from	_	0	SENT_689	[p34l556t3716r621b3739],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_689	[p34l629t3716r748b3746],
4	at	IN	O	at	_	0	SENT_689	[p34l758t3720r781b3739],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_689	[p34l789t3716r972b3739],
6	on	IN	O	on	_	0	SENT_689	[p34l981t3723r1014b3739],
7	January	NNP	DATE	January	prep_on	1	SENT_689	[p34l1022t3716r1125b3746],
8	5	CD	DATE	5	num	7	SENT_689	[p34l1135t3716r1158b3743],
9	,	,	DATE	,	_	0	SENT_689	[p34l1135t3716r1158b3743],
10	2014	CD	DATE	2014	num	7	SENT_689	[p34l1168t3716r1241b3739],
11	.	.	O	.	_	0	SENT_689	[p34l1168t3716r1241b3739],

1	For	IN	O	for	_	0	SENT_690	[p34l1251t3716r1298b3739],
2	personal	JJ	O	personal	amod	3	SENT_690	[p34l1306t3716r1418b3746],
3	use	NN	O	use	pobj	1	SENT_690	[p34l1427t3723r1471b3739],
4	only	RB	O	only	advmod	3	SENT_690	[p34l1480t3716r1545b3746],
5	.	.	O	.	_	0	SENT_690	[p34l1480t3716r1545b3746],

1	No	DT	O	no	det	3	SENT_691	[p34l1556t3716r1595b3739],
2	other	JJ	O	other	amod	3	SENT_691	[p34l1605t3716r1673b3739],
3	uses	NNS	O	use	_	0	SENT_691	[p34l1682t3723r1738b3739],
4	without	IN	O	without	_	0	SENT_691	[p34l1748t3716r1849b3739],
5	permission	NN	O	permission	prep_without	3	SENT_691	[p34l1857t3716r2010b3746],
6	.	.	O	.	_	0	SENT_691	[p34l1857t3716r2010b3746],

1	Copyright	NN	O	copyright	_	0	SENT_692	[p34l728t3757r862b3788],
2	©	CD	NUMBER	©	num	6	SENT_692	[p34l871t3757r895b3781],
3	2007	CD	DATE	2007	num	6	SENT_692	[p34l905t3757r969b3781],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_692	[p34l979t3757r1170b3781],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_692	[p34l1180t3757r1288b3781],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_692	[p34l1299t3757r1404b3788],
7	.	.	O	.	_	0	SENT_692	[p34l1299t3757r1404b3788],

1	All	DT	O	all	det	2	SENT_693	[p34l1415t3757r1456b3781],
2	rights	NNS	O	rights	nsubj	3	SENT_693	[p34l1465t3757r1540b3788],
3	reserved	VBN	O	reserve	_	0	SENT_693	[p34l1550t3757r1668b3781],
4	.	.	O	.	_	0	SENT_693	[p34l1550t3757r1668b3781],

1	changes	NNS	O	change	_	0	SENT_694	[p35l10t308r201b365],
2	in	IN	O	in	_	0	SENT_694	[p35l219t309r265b352],
3	airway	NN	O	airway	nn	4	SENT_694	[p35l283t309r440b364],
4	diseases	NNS	O	disease	prep_in	1	SENT_694	[p35l456t308r662b352],
5	:	:	O	:	_	0	SENT_694	[p35l456t308r662b352],
6	characteristics	NNS	O	characteristic	dep	1	SENT_694	[p35l683t308r1035b361],
7	,	,	O	,	_	0	SENT_694	[p35l683t308r1035b361],
8	mechanisms	NNS	O	mechanism	dep	1	SENT_694	[p35l9t380r333b434],
9	,	,	O	,	_	0	SENT_694	[p35l9t380r333b434],
10	consequences	NNS	O	consequence	conj_and	6	SENT_694	[p35l353t394r704b436],
11	,	,	O	,	_	0	SENT_694	[p35l353t394r704b436],
12	and	CC	O	and	_	0	SENT_694	[p35l723t380r813b424],
13	pharmacologic	JJ	O	pharmacologic	amod	14	SENT_694	[p35l828t380r1038b436, p35l10t451r177b508],
14	modulation	NN	O	modulation	conj_and	6	SENT_694	[p35l203t451r489b496],
15	.	.	O	.	_	0	SENT_694	[p35l203t451r489b496],

1	Chest	NN	O	chest	_	0	SENT_695	[p35l519t451r652b495],
2	2006	CD	DATE	2006	num	1	SENT_695	[p35l676t454r1037b504, p35l10t526r71b567],
3	;	:	O	;	_	0	SENT_695	[p35l676t454r1037b504, p35l10t526r71b567],
4	129:106887	CD	NUMBER	129:106887	dep	1	SENT_695	[p35l676t454r1037b504, p35l10t526r71b567],
5	.	.	O	.	_	0	SENT_695	[p35l676t454r1037b504, p35l10t526r71b567],

1	69	CD	NUMBER	69	_	0	SENT_696	[p35l9t600r75b639],
2	.	.	O	.	_	0	SENT_696	[p35l9t600r75b639],

1	Covar	JJ	O	covar	amod	2	SENT_697	[p35l105t598r246b640],
2	RA	NN	O	ra	_	0	SENT_697	[p35l261t599r349b649],
3	,	,	O	,	_	0	SENT_697	[p35l261t599r349b649],
4	Spahn	NNP	PERSON	Spahn	nn	10	SENT_697	[p35l371t595r522b651],
5	JD	NNP	O	JD	nn	10	SENT_697	[p35l533t599r607b648],
6	,	,	O	,	_	0	SENT_697	[p35l533t599r607b648],
7	MurphyJR	NNP	O	MurphyJR	appos	10	SENT_697	[p35l626t595r900b651],
8	,	,	O	,	_	0	SENT_697	[p35l626t595r900b651],
9	Szefler	NNP	O	Szefler	appos	10	SENT_697	[p35l922t595r1037b639, p35l9t665r72b709],
10	SJ	NNP	O	SJ	appos	2	SENT_697	[p35l88t668r143b716],
11	.	.	O	.	_	0	SENT_697	[p35l88t668r143b716],

1	Progression	NN	O	progression	nsubj	4	SENT_698	[p35l162t666r454b722],
2	of	IN	O	of	_	0	SENT_698	[p35l471t665r528b709],
3	asthma	NN	O	asthma	prep_of	1	SENT_698	[p35l533t665r715b709],
4	measured	VBN	O	measure	_	0	SENT_698	[p35l731t665r969b710],
5	by	IN	O	by	_	0	SENT_698	[p35l986t665r1041b721],
6	lung	NN	O	lung	nn	7	SENT_698	[p35l9t736r119b793],
7	function	NN	O	function	prep_by	4	SENT_698	[p35l145t736r354b781],
8	in	IN	O	in	_	0	SENT_698	[p35l382t737r429b780],
9	the	DT	O	the	det	13	SENT_698	[p35l457t736r532b780],
10	Childhood	NNP	O	Childhood	nn	13	SENT_698	[p35l560t736r820b780],
11	Asthma	NNP	O	Asthma	nn	13	SENT_698	[p35l846t736r1039b780],
12	Management	NNP	O	Management	nn	13	SENT_698	[p35l8t811r331b864],
13	Program	NNP	O	Program	prep_in	7	SENT_698	[p35l354t811r582b864],
14	.	.	O	.	_	0	SENT_698	[p35l354t811r582b864],

1	Am	NNP	O	Am	nn	5	SENT_699	[p35l611t811r697b851],
2	J	NNP	O	J	nn	5	SENT_699	[p35l718t811r740b858],
3	Respir	NNP	O	Respir	nn	5	SENT_699	[p35l765t808r923b863],
4	Crit	NNP	O	Crit	nn	5	SENT_699	[p35l949t808r1041b851],
5	Care	NNP	O	Care	nsubj	6	SENT_699	[p35l9t882r119b923],
6	Med	VBD	O	med	_	0	SENT_699	[p35l137t879r242b923],
7	2004	CD	DATE	2004	dobj	6	SENT_699	[p35l261t882r682b933],
8	;	:	O	;	_	0	SENT_699	[p35l261t882r682b933],
9	170:234	CD	NUMBER	170:234	num	10	SENT_699	[p35l261t882r682b933],
10	-41	CD	NUMBER	-41	dep	7	SENT_699	[p35l261t882r682b933],
11	.	.	O	.	_	0	SENT_699	[p35l261t882r682b933],

1	70	CD	NUMBER	70	_	0	SENT_700	[p35l11t955r75b994],
2	.	.	O	.	_	0	SENT_700	[p35l11t955r75b994],

1	Henderson	NNP	PERSON	Henderson	nn	3	SENT_701	[p35l105t950r373b994],
2	WR	NNP	PERSON	WR	nn	3	SENT_701	[p35l401t954r498b997],
3	Jr	NNP	PERSON	Jr	_	0	SENT_701	[p35l517t954r569b1004],
4	,	,	O	,	_	0	SENT_701	[p35l517t954r569b1004],
5	Chiang	NNP	PERSON	Chiang	nn	6	SENT_701	[p35l602t950r780b1007],
6	GK	NNP	PERSON	GK	appos	3	SENT_701	[p35l809t953r899b1004],
7	,	,	O	,	_	0	SENT_701	[p35l809t953r899b1004],
8	Tien	NNP	PERSON	Tien	nn	9	SENT_701	[p35l930t951r1038b994],
9	YT	NNP	PERSON	YT	appos	3	SENT_701	[p35l7t1025r83b1075],
10	,	,	O	,	_	0	SENT_701	[p35l7t1025r83b1075],
11	Chi	NNP	O	Chi	nn	12	SENT_701	[p35l112t1021r196b1065],
12	EY	NNP	O	EY	appos	3	SENT_701	[p35l221t1025r293b1065],
13	.	.	O	.	_	0	SENT_701	[p35l221t1025r293b1065],

1	Reversal	NN	O	reversal	_	0	SENT_702	[p35l322t1021r528b1068],
2	of	IN	O	of	_	0	SENT_702	[p35l554t1021r610b1065],
3	allergen-induced	JJ	O	allergen-induced	amod	5	SENT_702	[p35l626t1021r1038b1078],
4	airway	NN	O	airway	nn	5	SENT_702	[p35l9t1093r172b1148],
5	remodeling	NN	O	remodeling	prep_of	1	SENT_702	[p35l208t1092r492b1149],
6	by	IN	O	by	_	0	SENT_702	[p35l529t1092r584b1148],
7	CysLT1	NN	O	cyslt1	nn	9	SENT_702	[p35l621t1095r797b1148],
8	receptor	NN	O	receptor	nn	9	SENT_702	[p35l836t1101r1040b1148],
9	blockade	NN	O	blockade	prep_by	1	SENT_702	[p35l10t1164r235b1209],
10	.	.	O	.	_	0	SENT_702	[p35l10t1164r235b1209],

1	AmJ	NN	O	amj	nn	4	SENT_703	[p35l252t1168r370b1215],
2	Respir	NN	O	respir	nn	4	SENT_703	[p35l384t1165r540b1220],
3	Crit	NNP	O	Crit	nn	4	SENT_703	[p35l555t1165r645b1208],
4	Care	NNP	O	Care	nsubj	5	SENT_703	[p35l659t1167r767b1208],
5	Med	VBD	O	med	_	0	SENT_703	[p35l782t1164r886b1208],
6	2006	CD	DATE	2006	dobj	5	SENT_703	[p35l903t1167r1036b1217],
7	;	:	O	;	_	0	SENT_703	[p35l903t1167r1036b1217],
8	173:718	CD	NUMBER	173:718	num	9	SENT_703	[p35l11t1237r285b1279],
9	-28	CD	NUMBER	-28	dep	6	SENT_703	[p35l11t1237r285b1279],
10	.	.	O	.	_	0	SENT_703	[p35l11t1237r285b1279],

1	71	CD	NUMBER	71	_	0	SENT_704	[p35l11t1311r75b1349],
2	.	.	O	.	_	0	SENT_704	[p35l11t1311r75b1349],

1	Kelly	NNP	PERSON	Kelly	nn	2	SENT_705	[p35l105t1305r227b1361],
2	MM	NN	O	mm	_	0	SENT_705	[p35l242t1309r354b1359],
3	,	,	O	,	_	0	SENT_705	[p35l242t1309r354b1359],
4	Chakir	NNP	PERSON	Chakir	nn	5	SENT_705	[p35l375t1305r543b1350],
5	J	NNP	PERSON	J	appos	2	SENT_705	[p35l554t1309r586b1359],
6	,	,	O	,	_	0	SENT_705	[p35l554t1309r586b1359],
7	Vethanayagam	NNP	O	Vethanayagam	nn	8	SENT_705	[p35l606t1305r967b1362],
8	D	NNP	O	D	appos	2	SENT_705	[p35l985t1309r1035b1358],
9	,	,	O	,	_	0	SENT_705	[p35l985t1309r1035b1358],
10	et	FW	O	et	nn	11	SENT_705	[p35l10t1385r54b1420],
11	al.	FW	O	al.	appos	2	SENT_705	[p35l84t1376r140b1420],
12	.	.	O	.	_	0	SENT_705	[p35l84t1376r140b1420],

1	Montelukast	NN	O	montelukast	nn	2	SENT_706	[p35l175t1376r483b1421],
2	treatment	NN	O	treatment	nsubj	3	SENT_706	[p35l515t1385r756b1420],
3	attenuates	VBZ	O	attenuate	_	0	SENT_706	[p35l787t1385r1037b1421],
4	the	DT	O	the	det	5	SENT_706	[p35l10t1447r85b1491],
5	increase	NN	O	increase	dobj	3	SENT_706	[p35l110t1448r311b1491],
6	in	IN	O	in	_	0	SENT_706	[p35l336t1448r384b1491],
7	myofibroblasts	NNS	O	myofibroblast	prep_in	5	SENT_706	[p35l408t1447r777b1503],
8	following	VBG	O	follow	_	0	SENT_706	[p35l803t1447r1040b1504],
9	low-dose	JJ	O	low-dose	amod	11	SENT_706	[p35l9t1518r228b1563],
10	allergen	NN	O	allergen	nn	11	SENT_706	[p35l251t1518r449b1575],
11	challenge	NN	O	challenge	prep_following	7	SENT_706	[p35l472t1518r720b1575],
12	.	.	O	.	_	0	SENT_706	[p35l472t1518r720b1575],

1	Chest	NN	O	chest	_	0	SENT_707	[p35l746t1518r883b1562],
2	2006	CD	DATE	2006	num	1	SENT_707	[p35l903t1521r1036b1571],
3	;	:	O	;	_	0	SENT_707	[p35l903t1521r1036b1571],
4	130:741	CD	NUMBER	130:741	number	5	SENT_707	[p35l11t1593r281b1634],
5	-53	CD	NUMBER	-53	dep	1	SENT_707	[p35l11t1593r281b1634],
6	.	.	O	.	_	0	SENT_707	[p35l11t1593r281b1634],

1	72	CD	NUMBER	72	_	0	SENT_708	[p35l11t1666r75b1704],
2	.	.	O	.	_	0	SENT_708	[p35l11t1666r75b1704],

1	Malmstrom	NNP	ORGANIZATION	Malmstrom	nn	2	SENT_709	[p35l104t1660r394b1704],
2	K	NNP	ORGANIZATION	K	_	0	SENT_709	[p35l422t1664r471b1714],
3	,	,	O	,	_	0	SENT_709	[p35l422t1664r471b1714],
4	Rodriguez-Gomez	NNP	O	Rodriguez-Gomez	nn	5	SENT_709	[p35l501t1660r954b1717],
5	G	NNP	O	G	appos	2	SENT_709	[p35l983t1663r1035b1713],
6	,	,	O	,	_	0	SENT_709	[p35l983t1663r1035b1713],
7	Guerra	NNP	PERSON	Guerra	nn	8	SENT_709	[p35l9t1735r179b1777],
8	J	NNP	PERSON	J	appos	2	SENT_709	[p35l192t1736r224b1786],
9	,	,	O	,	_	0	SENT_709	[p35l192t1736r224b1786],
10	et	FW	O	et	nn	11	SENT_709	[p35l248t1741r291b1776],
11	al.	FW	O	al.	appos	2	SENT_709	[p35l308t1732r363b1776],
12	.	.	O	.	_	0	SENT_709	[p35l308t1732r363b1776],

1	Oral	JJ	O	oral	amod	2	SENT_710	[p35l386t1732r492b1776],
2	montelukast	NN	O	montelukast	_	0	SENT_710	[p35l512t1732r831b1786],
3	,	,	O	,	_	0	SENT_710	[p35l512t1732r831b1786],
4	inhaled	VBN	O	inhale	partmod	2	SENT_710	[p35l854t1732r1038b1776],
5	beclomethasone	NN	O	beclomethasone	dobj	4	SENT_710	[p35l10t1803r423b1857],
6	,	,	O	,	_	0	SENT_710	[p35l10t1803r423b1857],
7	and	CC	O	and	_	0	SENT_710	[p35l447t1803r536b1847],
8	placebo	NN	O	placebo	dobj	4	SENT_710	[p35l556t1803r744b1859],
9	for	IN	O	for	_	0	SENT_710	[p35l765t1803r835b1847],
10	chronic	JJ	O	chronic	amod	11	SENT_710	[p35l854t1803r1039b1847],
11	asthma	NN	O	asthma	prep_for	8	SENT_710	[p35l9t1874r200b1918],
12	.	.	O	.	_	0	SENT_710	[p35l9t1874r200b1918],

1	Ann	NNP	O	Ann	nn	3	SENT_711	[p35l219t1878r321b1918],
2	Intern	NNP	O	Intern	nn	3	SENT_711	[p35l338t1878r487b1918],
3	Med	NNP	O	Med	_	0	SENT_711	[p35l503t1874r607b1918],
4	1999	CD	DATE	1999	num	3	SENT_711	[p35l627t1877r1033b1927],
5	;	:	O	;	_	0	SENT_711	[p35l627t1877r1033b1927],
6	130:487	CD	NUMBER	130:487	number	7	SENT_711	[p35l627t1877r1033b1927],
7	-95	CD	NUMBER	-95	dep	3	SENT_711	[p35l627t1877r1033b1927],
8	.	.	O	.	_	0	SENT_711	[p35l627t1877r1033b1927],

1	73	CD	NUMBER	73	_	0	SENT_712	[p35l11t1949r75b1988],
2	.	.	O	.	_	0	SENT_712	[p35l11t1949r75b1988],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_713	[p35l105t1944r238b1988],
2	E	NNP	O	E	_	0	SENT_713	[p35l261t1948r306b1998],
3	,	,	O	,	_	0	SENT_713	[p35l261t1948r306b1998],
4	Chervinsky	NNP	PERSON	Chervinsky	nn	5	SENT_713	[p35l333t1944r611b2000],
5	PS	NNP	O	PS	appos	2	SENT_713	[p35l632t1947r703b1998],
6	,	,	O	,	_	0	SENT_713	[p35l632t1947r703b1998],
7	Friedman	NNP	PERSON	Friedman	nn	8	SENT_713	[p35l730t1944r966b1988],
8	B	NNP	O	B	appos	2	SENT_713	[p35l989t1948r1035b1997],
9	,	,	O	,	_	0	SENT_713	[p35l989t1948r1035b1997],
10	et	FW	O	et	nn	11	SENT_713	[p35l10t2025r53b2060],
11	al.	FW	O	al.	appos	2	SENT_713	[p35l79t2016r135b2060],
12	.	.	O	.	_	0	SENT_713	[p35l79t2016r135b2060],

1	Effects	NNS	O	effect	_	0	SENT_714	[p35l166t2016r333b2060],
2	of	IN	O	of	_	0	SENT_714	[p35l363t2016r420b2060],
3	montelukast	NN	O	montelukast	prep_of	1	SENT_714	[p35l438t2016r745b2060],
4	and	CC	O	and	_	0	SENT_714	[p35l771t2016r861b2060],
5	beclomethasone	NN	O	beclomethasone	prep_of	1	SENT_714	[p35l889t2016r1038b2060, p35l9t2087r278b2131],
6	on	IN	O	on	_	0	SENT_714	[p35l303t2101r362b2131],
7	airway	NN	O	airway	nn	8	SENT_714	[p35l386t2088r549b2143],
8	function	NN	O	function	prep_on	1	SENT_714	[p35l571t2087r780b2132],
9	and	CC	O	and	_	0	SENT_714	[p35l804t2087r893b2131],
10	asthma	NN	O	asthma	nn	11	SENT_714	[p35l917t2087r1037b2131, p35l9t2171r84b2201],
11	control	NN	O	control	conj_and	8	SENT_714	[p35l103t2157r290b2201],
12	.	.	O	.	_	0	SENT_714	[p35l103t2157r290b2201],

1	J	NNP	O	J	nn	4	SENT_715	[p35l307t2161r328b2208],
2	Allergy	NNP	O	Allergy	nn	4	SENT_715	[p35l344t2157r524b2214],
3	Clin	NNP	O	Clin	nn	4	SENT_715	[p35l540t2157r641b2201],
4	Immunol	NNP	O	Immunol	_	0	SENT_715	[p35l659t2157r888b2202],
5	2002	CD	DATE	2002	num	4	SENT_715	[p35l906t2160r1036b2210],
6	;	:	O	;	_	0	SENT_715	[p35l906t2160r1036b2210],
7	110:847	CD	NUMBER	110:847	number	8	SENT_715	[p35l11t2232r286b2273],
8	—	CD	NUMBER	—	dep	4	SENT_715	[p35l11t2232r286b2273],
9	54	CD	NUMBER	54	dep	8	SENT_715	[p35l11t2232r286b2273],
10	.	.	O	.	_	0	SENT_715	[p35l11t2232r286b2273],

1	74	CD	NUMBER	74	_	0	SENT_716	[p35l11t2305r75b2343],
2	.	.	O	.	_	0	SENT_716	[p35l11t2305r75b2343],

1	Wenzel	NNP	PERSON	Wenzel	nn	2	SENT_717	[p35l103t2299r284b2343],
2	SE	NN	PERSON	se	_	0	SENT_717	[p35l326t2302r397b2353],
3	,	,	O	,	_	0	SENT_717	[p35l326t2302r397b2353],
4	Trudeau	NNP	PERSON	Trudeau	nn	5	SENT_717	[p35l439t2299r641b2344],
5	JB	NNP	O	JB	appos	2	SENT_717	[p35l677t2303r746b2353],
6	,	,	O	,	_	0	SENT_717	[p35l677t2303r746b2353],
7	Kaminsky	NNP	PERSON	Kaminsky	nn	8	SENT_717	[p35l790t2299r1041b2355],
8	DA	NNP	PERSON	DA	appos	5	SENT_717	[p35l9t2375r96b2424],
9	,	,	O	,	_	0	SENT_717	[p35l9t2375r96b2424],
10	Cohn	NNP	PERSON	Cohn	nn	11	SENT_717	[p35l117t2371r247b2415],
11	J	NNP	PERSON	J	appos	5	SENT_717	[p35l260t2375r292b2424],
12	,	,	O	,	_	0	SENT_717	[p35l260t2375r292b2424],
13	Martin	NNP	PERSON	Martin	nn	14	SENT_717	[p35l311t2372r481b2415],
14	RJ	NN	PERSON	rj	appos	5	SENT_717	[p35l498t2375r566b2424],
15	,	,	O	,	_	0	SENT_717	[p35l498t2375r566b2424],
16	Westcott	NNP	PERSON	Westcott	nn	17	SENT_717	[p35l585t2375r803b2415],
17	JY	NN	O	jy	appos	5	SENT_717	[p35l812t2375r876b2422],
18	.	.	O	.	_	0	SENT_717	[p35l812t2375r876b2422],

1	Effect	NN	O	effect	_	0	SENT_718	[p35l896t2371r1041b2415],
2	of	IN	O	of	_	0	SENT_718	[p35l10t2442r66b2486],
3	5-lipoxygenase	NN	O	5-lipoxygenase	nn	4	SENT_718	[p35l79t2442r444b2499],
4	inhibition	NN	O	inhibition	prep_of	1	SENT_718	[p35l466t2442r711b2486],
5	on	IN	O	on	_	0	SENT_718	[p35l734t2456r794b2486],
6	bronchoconstriction	NN	O	bronchoconstriction	nn	9	SENT_718	[p35l816t2442r1038b2486, p35l10t2515r306b2558],
7	and	CC	O	and	_	0	SENT_718	[p35l328t2514r418b2558],
8	airway	NN	O	airway	nn	9	SENT_718	[p35l440t2515r603b2570],
9	inflammation	NN	O	inflammation	prep_on	1	SENT_718	[p35l623t2514r969b2558],
10	in	IN	O	in	_	0	SENT_718	[p35l991t2515r1038b2558],
11	nocturnal	JJ	O	nocturnal	amod	12	SENT_718	[p35l9t2586r251b2631],
12	asthma	NN	O	asthma	prep_in	1	SENT_718	[p35l273t2586r467b2630],
13	.	.	O	.	_	0	SENT_718	[p35l273t2586r467b2630],

1	AmJ	NN	O	amj	nn	4	SENT_719	[p35l492t2590r616b2637],
2	Respir	NN	O	respir	nn	4	SENT_719	[p35l637t2587r795b2642],
3	Crit	NNP	O	Crit	nn	4	SENT_719	[p35l816t2587r908b2630],
4	Care	NNP	O	Care	nsubj	5	SENT_719	[p35l929t2589r1038b2630],
5	Med	VBD	O	med	_	0	SENT_719	[p35l8t2656r113b2700],
6	1995	CD	DATE	1995	dobj	5	SENT_719	[p35l134t2659r574b2709],
7	;	:	O	;	_	0	SENT_719	[p35l134t2659r574b2709],
8	152:897	CD	NUMBER	152:897	num	9	SENT_719	[p35l134t2659r574b2709],
9	-905	CD	NUMBER	-905	dep	6	SENT_719	[p35l134t2659r574b2709],
10	.	.	O	.	_	0	SENT_719	[p35l134t2659r574b2709],

1	75	CD	NUMBER	75	_	0	SENT_720	[p35l11t2734r75b2772],
2	.	.	O	.	_	0	SENT_720	[p35l11t2734r75b2772],

1	Hallstrand	NNP	O	Hallstrand	nn	2	SENT_721	[p35l105t2728r369b2772],
2	TS	NN	O	t	_	0	SENT_721	[p35l406t2731r482b2781],
3	,	,	O	,	_	0	SENT_721	[p35l406t2731r482b2781],
4	Moody	NNP	ORGANIZATION	Moody	nn	5	SENT_721	[p35l522t2728r691b2784],
5	MW	NNP	ORGANIZATION	MW	appos	2	SENT_721	[p35l726t2732r836b2782],
6	,	,	O	,	_	0	SENT_721	[p35l726t2732r836b2782],
7	Aitken	NNP	PERSON	Aitken	nn	8	SENT_721	[p35l876t2728r1038b2773],
8	ML	NNP	O	ML	appos	2	SENT_721	[p35l8t2803r101b2853],
9	,	,	O	,	_	0	SENT_721	[p35l8t2803r101b2853],
10	Henderson	NNP	PERSON	Henderson	nn	12	SENT_721	[p35l130t2799r398b2843],
11	WR	NNP	O	WR	nn	12	SENT_721	[p35l421t2803r518b2846],
12	Jr.	NNP	O	Jr.	appos	2	SENT_721	[p35l532t2803r584b2850],
13	.	.	O	.	_	0	SENT_721	[p35l532t2803r584b2850],

1	Airway	NN	O	airway	nn	2	SENT_722	[p35l611t2800r786b2855],
2	immunopathology	NN	O	immunopathology	_	0	SENT_722	[p35l809t2800r1037b2844, p35l9t2870r251b2927],
3	of	IN	O	of	_	0	SENT_722	[p35l264t2870r320b2914],
4	asthma	NN	O	asthma	prep_of	2	SENT_722	[p35l323t2870r502b2914],
5	with	IN	O	with	_	0	SENT_722	[p35l513t2870r622b2915],
6	exercise-induced	JJ	O	exercise-induced	amod	7	SENT_722	[p35l637t2870r1038b2915],
7	bronchoconstriction	NN	O	bronchoconstriction	prep_with	2	SENT_722	[p35l10t2941r514b2985],
8	.	.	O	.	_	0	SENT_722	[p35l10t2941r514b2985],

1	J	NNP	O	J	nn	4	SENT_723	[p35l530t2945r551b2992],
2	Allergy	NNP	O	Allergy	nn	4	SENT_723	[p35l565t2941r741b2998],
3	Clin	NNP	O	Clin	nn	4	SENT_723	[p35l757t2941r856b2985],
4	Immunol	NNP	O	Immunol	_	0	SENT_723	[p35l873t2945r1037b2986, p35l9t3012r86b3056],
5	2005	CD	DATE	2005	num	4	SENT_723	[p35l105t3015r521b3065],
6	;	:	O	;	_	0	SENT_723	[p35l105t3015r521b3065],
7	116:586	CD	NUMBER	116:586	number	8	SENT_723	[p35l105t3015r521b3065],
8	-93	CD	NUMBER	-93	dep	4	SENT_723	[p35l105t3015r521b3065],
9	.	.	O	.	_	0	SENT_723	[p35l105t3015r521b3065],

1	76	CD	NUMBER	76	_	0	SENT_724	[p35l11t3089r75b3128],
2	.	.	O	.	_	0	SENT_724	[p35l11t3089r75b3128],

1	Frolich	NNP	ORGANIZATION	Frolich	nn	2	SENT_725	[p35l105t3084r276b3128],
2	JC	NNP	ORGANIZATION	JC	_	0	SENT_725	[p35l292t3087r362b3137],
3	,	,	O	,	_	0	SENT_725	[p35l292t3087r362b3137],
4	Fauler	NNP	PERSON	Fauler	nn	5	SENT_725	[p35l385t3084r537b3129],
5	J	NNP	PERSON	J	appos	2	SENT_725	[p35l551t3088r583b3137],
6	,	,	O	,	_	0	SENT_725	[p35l551t3088r583b3137],
7	Tsikas	NNP	O	Tsikas	nn	9	SENT_725	[p35l606t3084r761b3129],
8	D.	NNP	O	D.	nn	9	SENT_725	[p35l783t3088r833b3128],
9	Assessment	NNP	O	Assessment	appos	2	SENT_725	[p35l856t3088r1038b3128, p35l9t3164r135b3199],
10	of	IN	O	of	_	0	SENT_725	[p35l152t3155r209b3199],
11	cysteinyl	NN	O	cysteinyl	nn	13	SENT_725	[p35l218t3155r429b3211],
12	leukotriene	NN	O	leukotriene	nn	13	SENT_725	[p35l448t3155r725b3200],
13	synthesis	NN	O	synthesis	prep_of	9	SENT_725	[p35l746t3155r971b3211],
14	in	IN	O	in	_	0	SENT_725	[p35l991t3156r1038b3199],
15	man	NN	O	man	prep_in	13	SENT_725	[p35l10t3239r131b3269],
16	.	.	O	.	_	0	SENT_725	[p35l10t3239r131b3269],

1	J	NN	O	j	nn	5	SENT_726	[p35l158t3229r179b3276],
2	Lipid	NN	O	lipid	nn	5	SENT_726	[p35l206t3225r329b3281],
3	Mediat	NN	O	mediat	nn	5	SENT_726	[p35l357t3225r528b3269],
4	Cell	NN	O	cell	nn	5	SENT_726	[p35l555t3225r649b3269],
5	Signal	NN	O	signal	_	0	SENT_726	[p35l679t3225r831b3282],
6	1994	CD	DATE	1994	dep	5	SENT_726	[p35l861t3228r1036b3278],
7	;	:	O	;	_	0	SENT_726	[p35l861t3228r1036b3278],
8	9	CD	NUMBER	9	num	10	SENT_726	[p35l861t3228r1036b3278],
9	:	:	O	:	_	0	SENT_726	[p35l861t3228r1036b3278],
10	75-8	CD	NUMBER	75-8	dep	5	SENT_726	[p35l10t3300r129b3341],
11	.	.	O	.	_	0	SENT_726	[p35l10t3300r129b3341],

1	77	CD	NUMBER	77	_	0	SENT_727	[p35l11t3373r75b3411],
2	.	.	O	.	_	0	SENT_727	[p35l11t3373r75b3411],

1	Cai	NN	PERSON	caus	nn	2	SENT_728	[p35l105t3368r184b3411],
2	C	NN	O	c	_	0	SENT_728	[p35l205t3370r252b3421],
3	,	,	O	,	_	0	SENT_728	[p35l205t3370r252b3421],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_728	[p35l275t3371r397b3424],
5	J	NNP	PERSON	J	appos	2	SENT_728	[p35l411t3371r443b3421],
6	,	,	O	,	_	0	SENT_728	[p35l411t3371r443b3421],
7	Hu	NNP	O	Hu	nn	8	SENT_728	[p35l467t3371r539b3412],
8	S	NNP	O	S	appos	2	SENT_728	[p35l561t3370r600b3421],
9	,	,	O	,	_	0	SENT_728	[p35l561t3370r600b3421],
10	Zhou	NNP	O	Zhou	nn	11	SENT_728	[p35l623t3367r748b3412],
11	M	NNP	O	M	appos	2	SENT_728	[p35l768t3371r829b3421],
12	,	,	O	,	_	0	SENT_728	[p35l768t3371r829b3421],
13	Guo	NNP	O	Guo	nn	15	SENT_728	[p35l854t3370r954b3412],
14	W.	NNP	O	W.	nn	15	SENT_728	[p35l975t3371r1035b3411],
15	Relationship	NN	O	relationship	appos	2	SENT_728	[p35l9t3439r320b3495],
16	between	IN	O	between	_	0	SENT_728	[p35l362t3439r565b3484],
17	urinary	JJ	O	urinary	amod	20	SENT_728	[p35l606t3440r789b3495],
18	cysteinyl	NN	O	cysteinyl	nn	20	SENT_728	[p35l828t3439r1039b3495],
19	leukotriene	NN	O	leukotriene	nn	20	SENT_728	[p35l9t3510r287b3555],
20	E	NN	O	e	prep_between	15	SENT_728	[p35l303t3514r332b3554],
21	4	CD	NUMBER	4	num	22	SENT_728	[p35l335t3548r354b3570],
22	levels	NNS	O	level	dep	2	SENT_728	[p35l370t3510r502b3555],
23	and	CC	O	and	_	0	SENT_728	[p35l519t3510r608b3554],
24	clinical	JJ	O	clinical	amod	25	SENT_728	[p35l625t3510r804b3554],
25	response	NN	O	response	conj_and	22	SENT_728	[p35l821t3524r1038b3566],
26	to	TO	O	to	_	0	SENT_728	[p35l10t3591r56b3626],
27	antileukotriene	JJ	O	antileukotriene	amod	28	SENT_728	[p35l87t3582r463b3627],
28	treatment	NN	O	treatment	prep_to	25	SENT_728	[p35l495t3591r737b3626],
29	in	IN	O	in	_	0	SENT_728	[p35l764t3583r812b3626],
30	patients	NNS	O	patient	prep_in	28	SENT_728	[p35l842t3583r1037b3638],
31	with	IN	O	with	_	0	SENT_728	[p35l7t3652r118b3697],
32	asthma	NN	O	asthma	prep_with	30	SENT_728	[p35l137t3652r331b3696],
33	.	.	O	.	_	0	SENT_728	[p35l137t3652r331b3696],

1	Lung	NN	O	lung	_	0	SENT_729	[p35l353t3656r478b3709],
2	2007	CD	DATE	2007	num	1	SENT_729	[p35l495t3655r903b3705],
3	;	:	O	;	_	0	SENT_729	[p35l495t3655r903b3705],
4	185:105	CD	NUMBER	185:105	number	5	SENT_729	[p35l495t3655r903b3705],
5	-12	CD	NUMBER	-12	dep	1	SENT_729	[p35l495t3655r903b3705],
6	.	.	O	.	_	0	SENT_729	[p35l495t3655r903b3705],

1	78	CD	NUMBER	78	_	0	SENT_730	[p35l11t3728r75b3768],
2	.	.	O	.	_	0	SENT_730	[p35l11t3728r75b3768],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_731	[p35l104t3724r284b3769],
2	H	NNP	PERSON	H	_	0	SENT_731	[p35l302t3728r356b3778],
3	,	,	O	,	_	0	SENT_731	[p35l302t3728r356b3778],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_731	[p35l380t3725r499b3768],
5	T	NN	O	t	appos	2	SENT_731	[p35l517t3728r560b3777],
6	,	,	O	,	_	0	SENT_731	[p35l517t3728r560b3777],
7	Kurokawa	NNP	PERSON	Kurokawa	nn	8	SENT_731	[p35l583t3724r830b3769],
8	K	NNP	PERSON	K	appos	2	SENT_731	[p35l848t3728r897b3777],
9	,	,	O	,	_	0	SENT_731	[p35l848t3728r897b3777],
10	et	FW	O	et	nn	11	SENT_731	[p35l920t3733r963b3768],
11	al.	FW	O	al.	appos	2	SENT_731	[p35l980t3724r1035b3768],
12	.	.	O	.	_	0	SENT_731	[p35l980t3724r1035b3768],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_732	[p35l1217t129r1650b164],
2	OF	IN	O	of	_	0	SENT_732	[p35l1678t128r1754b164],
3	DISEASE	NN	O	disease	prep_of	1	SENT_732	[p35l1782t129r2040b164],

1	82	CD	NUMBER	82	_	0	SENT_733	[p35l1113t313r1179b353],
2	.	.	O	.	_	0	SENT_733	[p35l1113t313r1179b353],

1	Asano	NNP	PERSON	Asano	nn	2	SENT_734	[p35l1208t312r1360b352],
2	K	NNP	PERSON	K	_	0	SENT_734	[p35l1376t312r1425b362],
3	,	,	O	,	_	0	SENT_734	[p35l1376t312r1425b362],
4	Shiomi	NNP	ORGANIZATION	Shiomi	nn	5	SENT_734	[p35l1445t308r1617b352],
5	T	NN	ORGANIZATION	t	appos	2	SENT_734	[p35l1631t312r1674b362],
6	,	,	O	,	_	0	SENT_734	[p35l1631t312r1674b362],
7	Hasegawa	NNP	PERSON	Hasegawa	nn	8	SENT_734	[p35l1693t312r1941b365],
8	N	NNP	O	N	appos	2	SENT_734	[p35l1955t312r2008b362],
9	,	,	O	,	_	0	SENT_734	[p35l1955t312r2008b362],
10	et	FW	O	et	nn	11	SENT_734	[p35l2027t317r2071b352],
11	al.	FW	O	al.	appos	2	SENT_734	[p35l2084t308r2139b352],
12	.	.	O	.	_	0	SENT_734	[p35l2084t308r2139b352],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_735	[p35l1113t380r1406b425],
2	C	NN	O	c	_	0	SENT_735	[p35l1441t383r1473b424],
3	4	CD	NUMBER	4	num	4	SENT_735	[p35l1477t418r1496b440],
4	synthase	NN	O	synthase	dep	2	SENT_735	[p35l1530t380r1743b436],
5	gene	NN	O	gene	nn	7	SENT_735	[p35l1777t394r1890b437],
6	A	NN	O	a	nn	7	SENT_735	[p35l1923t383r2141b431],
7	(	NN	O	(	dep	4	SENT_735	[p35l1923t383r2141b431],
8	.	.	O	.	_	0	SENT_735	[p35l1923t383r2141b431],

1	—	NN	O	—	_	0	SENT_736	[p35l1923t383r2141b431],
2	.	.	O	.	_	0	SENT_736	[p35l1923t383r2141b431],

1	444	CD	NUMBER	444	num	2	SENT_737	[p35l1923t383r2141b431],
2	)	NN	O	)	nsubj	3	SENT_737	[p35l1923t383r2141b431],
3	C	NN	O	c	_	0	SENT_737	[p35l1923t383r2141b431],
4	polymorphism	NN	O	polymorphism	nn	7	SENT_737	[p35l1113t451r1475b507],
5	and	CC	O	and	_	0	SENT_737	[p35l1497t451r1586b495],
6	clinical	JJ	O	clinical	nn	7	SENT_737	[p35l1609t451r1788b495],
7	response	NN	O	response	dobj	3	SENT_737	[p35l1810t465r2027b507],
8	to	TO	O	to	_	0	SENT_737	[p35l2050t460r2096b495],
9	a	DT	O	a	det	11	SENT_737	[p35l2118t466r2143b495],
10	Cys-LT1	NN	O	cys-lt1	nn	11	SENT_737	[p35l1114t526r1289b582],
11	antagonist	NN	O	antagonist	prep_to	7	SENT_737	[p35l1306t524r1569b580],
12	,	,	O	,	_	0	SENT_737	[p35l1306t524r1569b580],
13	pranlukast	NN	O	pranlukast	appos	11	SENT_737	[p35l1588t523r1854b579],
14	,	,	O	,	_	0	SENT_737	[p35l1588t523r1854b579],
15	in	IN	O	in	_	0	SENT_737	[p35l1874t524r1920b567],
16	Japanese	JJ	MISC	japanese	amod	17	SENT_737	[p35l1931t527r2142b579],
17	patients	NNS	O	patient	prep_in	3	SENT_737	[p35l1113t596r1308b651],
18	with	IN	O	with	_	0	SENT_737	[p35l1329t595r1440b640],
19	moderate	JJ	O	moderate	amod	20	SENT_737	[p35l1463t595r1692b639],
20	asthma	NN	O	asthma	prep_with	17	SENT_737	[p35l1715t595r1909b639],
21	.	.	O	.	_	0	SENT_737	[p35l1715t595r1909b639],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_738	[p35l1934t595r2142b639, p35l1114t666r1371b722],
2	2002	CD	DATE	2002	num	1	SENT_738	[p35l1391t668r1774b718],
3	;	:	O	;	_	0	SENT_738	[p35l1391t668r1774b718],
4	12:565	CD	NUMBER	12:565	number	5	SENT_738	[p35l1391t668r1774b718],
5	—	CD	NUMBER	—	dep	1	SENT_738	[p35l1391t668r1774b718],
6	70	CD	NUMBER	70	dep	5	SENT_738	[p35l1391t668r1774b718],
7	.	.	O	.	_	0	SENT_738	[p35l1391t668r1774b718],

1	83	CD	NUMBER	83	_	0	SENT_739	[p35l1113t741r1179b781],
2	.	.	O	.	_	0	SENT_739	[p35l1113t741r1179b781],

1	Currie	NNP	PERSON	Currie	nn	2	SENT_740	[p35l1210t737r1363b781],
2	GP	NNP	O	GP	_	0	SENT_740	[p35l1391t739r1470b789],
3	,	,	O	,	_	0	SENT_740	[p35l1391t739r1470b789],
4	Lima	NNP	LOCATION	Lima	nn	7	SENT_740	[p35l1501t737r1624b780],
5	IL	NN	ORGANIZATION	il	nn	7	SENT_740	[p35l1646t740r1698b790],
6	Sylvester	NNP	ORGANIZATION	Sylvester	nn	7	SENT_740	[p35l1730t736r1942b792],
7	JE	NNP	ORGANIZATION	JE	appos	2	SENT_740	[p35l1963t740r2030b790],
8	,	,	O	,	_	0	SENT_740	[p35l1963t740r2030b790],
9	Lee	NNP	PERSON	Lee	nn	10	SENT_740	[p35l2061t740r2142b780],
10	DK	NNP	O	DK	appos	2	SENT_740	[p35l1113t811r1202b860],
11	,	,	O	,	_	0	SENT_740	[p35l1113t811r1202b860],
12	Cockburn	NNP	ORGANIZATION	Cockburn	nn	13	SENT_740	[p35l1225t807r1466b852],
13	WJ	NNP	ORGANIZATION	WJ	appos	2	SENT_740	[p35l1484t811r1568b861],
14	,	,	O	,	_	0	SENT_740	[p35l1484t811r1568b861],
15	Lipworth	NNP	ORGANIZATION	Lipworth	nn	16	SENT_740	[p35l1589t807r1814b863],
16	BJ	NNP	ORGANIZATION	BJ	appos	2	SENT_740	[p35l1832t811r1893b858],
17	.	.	O	.	_	0	SENT_740	[p35l1832t811r1893b858],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_741	[p35l1915t807r2142b852, p35l1114t893r1195b923],
2	C	NN	O	c	_	0	SENT_741	[p35l1223t882r1255b923],
3	4	CD	NUMBER	4	num	5	SENT_741	[p35l1259t917r1278b939],
4	synthase	NN	O	synthase	nn	5	SENT_741	[p35l1306t879r1519b935],
5	polymorphisms	NNS	O	polymorphism	dep	2	SENT_741	[p35l1546t879r1932b935],
6	and	CC	O	and	_	0	SENT_741	[p35l1961t879r2050b923],
7	responsiveness	NN	O	responsiveness	conj_and	5	SENT_741	[p35l2077t894r2142b923, p35l1114t951r1431b1006],
8	to	TO	O	to	_	0	SENT_741	[p35l1465t959r1512b994],
9	leukotriene	NN	O	leukotriene	nn	10	SENT_741	[p35l1545t950r1823b995],
10	antagonists	NNS	O	antagonist	prep_to	5	SENT_741	[p35l1856t951r2141b1007],
11	in	IN	O	in	_	0	SENT_741	[p35l1113t1022r1160b1065],
12	asthma	NN	O	asthma	prep_in	10	SENT_741	[p35l1185t1021r1379b1065],
13	.	.	O	.	_	0	SENT_741	[p35l1185t1021r1379b1065],

1	BrJ	NN	O	brj	nn	2	SENT_742	[p35l1407t1025r1500b1072],
2	Clin	NN	O	clin	_	0	SENT_742	[p35l1523t1021r1624b1065],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_742	[p35l1648t1021r1911b1065],
4	2003	CD	DATE	2003	num	3	SENT_742	[p35l1936t1024r2140b1074],
5	;	:	O	;	_	0	SENT_742	[p35l1936t1024r2140b1074],
6	56	CD	NUMBER	56	num	8	SENT_742	[p35l1936t1024r2140b1074],
7	:	:	O	:	_	0	SENT_742	[p35l1936t1024r2140b1074],
8	422-6	CD	NUMBER	422-6	dep	2	SENT_742	[p35l1113t1095r1262b1136],
9	.	.	O	.	_	0	SENT_742	[p35l1113t1095r1262b1136],

1	84	CD	NUMBER	84	_	0	SENT_743	[p35l1113t1168r1179b1209],
2	.	.	O	.	_	0	SENT_743	[p35l1113t1168r1179b1209],

1	Klotsman	NN	O	klotsman	nn	2	SENT_744	[p35l1209t1164r1449b1209],
2	M	NN	O	m	_	0	SENT_744	[p35l1467t1168r1529b1218],
3	,	,	O	,	_	0	SENT_744	[p35l1467t1168r1529b1218],
4	York	NNP	ORGANIZATION	York	nn	5	SENT_744	[p35l1550t1164r1662b1209],
5	TP	NN	ORGANIZATION	tp	appos	2	SENT_744	[p35l1677t1168r1750b1217],
6	,	,	O	,	_	0	SENT_744	[p35l1677t1168r1750b1217],
7	Pillai	NNP	PERSON	Pillai	nn	8	SENT_744	[p35l1773t1164r1899b1208],
8	SG	NNP	O	SG	appos	2	SENT_744	[p35l1920t1167r2000b1217],
9	,	,	O	,	_	0	SENT_744	[p35l1920t1167r2000b1217],
10	et	FW	O	et	nn	11	SENT_744	[p35l2023t1173r2067b1208],
11	al.	FW	O	al.	appos	2	SENT_744	[p35l2084t1164r2140b1208],
12	.	.	O	.	_	0	SENT_744	[p35l2084t1164r2140b1208],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_745	[p35l1113t1234r1563b1291],
2	of	IN	O	of	_	0	SENT_745	[p35l1594t1234r1651b1278],
3	the	DT	O	the	det	6	SENT_745	[p35l1671t1234r1746b1278],
4	5-lipoxygenase	NN	O	5-lipoxygenase	nn	6	SENT_745	[p35l1778t1234r2143b1291],
5	biosynthetic	JJ	O	biosynthetic	amod	6	SENT_745	[p35l1114t1305r1416b1361],
6	pathway	NN	O	pathway	prep_of	1	SENT_745	[p35l1431t1305r1636b1361],
7	and	CC	O	and	_	0	SENT_745	[p35l1650t1305r1740b1349],
8	variable	JJ	O	variable	amod	10	SENT_745	[p35l1754t1305r1946b1350],
9	clinical	JJ	O	clinical	amod	10	SENT_745	[p35l1964t1305r2143b1349],
10	response	NN	O	response	prep_of	1	SENT_745	[p35l1114t1390r1331b1432],
11	to	TO	O	to	_	0	SENT_745	[p35l1352t1385r1398b1420],
12	montelukast	NN	O	montelukast	prep_to	1	SENT_745	[p35l1419t1376r1738b1421],
13	.	.	O	.	_	0	SENT_745	[p35l1419t1376r1738b1421],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_746	[p35l1761t1376r2146b1433],
2	Genomics	NNP	O	Genomics	_	0	SENT_746	[p35l1114t1448r1360b1491],
3	2007	CD	DATE	2007	num	2	SENT_746	[p35l1380t1450r1761b1500],
4	;	:	O	;	_	0	SENT_746	[p35l1380t1450r1761b1500],
5	17:189	CD	NUMBER	17:189	number	6	SENT_746	[p35l1380t1450r1761b1500],
6	-96	CD	NUMBER	-96	dep	2	SENT_746	[p35l1380t1450r1761b1500],
7	.	.	O	.	_	0	SENT_746	[p35l1380t1450r1761b1500],

1	85	CD	NUMBER	85	_	0	SENT_747	[p35l1113t1522r1179b1563],
2	.	.	O	.	_	0	SENT_747	[p35l1113t1522r1179b1563],

1	Barnes	NNP	PERSON	Barnes	nn	2	SENT_748	[p35l1209t1522r1376b1562],
2	N	NNP	O	N	_	0	SENT_748	[p35l1393t1522r1446b1571],
3	,	,	O	,	_	0	SENT_748	[p35l1393t1522r1446b1571],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_748	[p35l1464t1518r1662b1562],
5	M	NNP	PERSON	M	appos	2	SENT_748	[p35l1679t1522r1740b1572],
6	,	,	O	,	_	0	SENT_748	[p35l1679t1522r1740b1572],
7	Price	NNP	O	Price	nn	8	SENT_748	[p35l1760t1519r1880b1562],
8	D	NNP	O	D	appos	2	SENT_748	[p35l1896t1522r1947b1572],
9	,	,	O	,	_	0	SENT_748	[p35l1896t1522r1947b1572],
10	Tate	NNP	O	Tate	nn	12	SENT_748	[p35l1965t1522r2068b1562],
11	H.	NNP	O	H.	nn	12	SENT_748	[p35l2085t1522r2140b1562],
12	The	NNP	O	The	appos	2	SENT_748	[p35l1112t1590r1203b1634],
13	national	JJ	O	national	amod	15	SENT_748	[p35l1226t1590r1429b1634],
14	montelukast	NN	O	montelukast	nn	15	SENT_748	[p35l1452t1590r1759b1635],
15	survey	NN	O	survey	dep	12	SENT_748	[p35l1780t1605r1944b1646],
16	.	.	O	.	_	0	SENT_748	[p35l1780t1605r1944b1646],

1	J	NNP	O	J	nn	4	SENT_749	[p35l1965t1594r1986b1641],
2	Allergy	NNP	O	Allergy	nn	4	SENT_749	[p35l2005t1590r2142b1634, p35l1113t1675r1171b1717],
3	Clin	NNP	O	Clin	nn	4	SENT_749	[p35l1188t1660r1289b1704],
4	Immunol	NNP	O	Immunol	_	0	SENT_749	[p35l1307t1660r1536b1705],
5	2005	CD	DATE	2005	num	4	SENT_749	[p35l1555t1663r1937b1713],
6	;	:	O	;	_	0	SENT_749	[p35l1555t1663r1937b1713],
7	115:47	CD	NUMBER	115:47	number	8	SENT_749	[p35l1555t1663r1937b1713],
8	-54	CD	NUMBER	-54	dep	4	SENT_749	[p35l1555t1663r1937b1713],
9	.	.	O	.	_	0	SENT_749	[p35l1555t1663r1937b1713],

1	86	CD	NUMBER	86	_	0	SENT_750	[p35l1113t1736r1179b1777],
2	.	.	O	.	_	0	SENT_750	[p35l1113t1736r1179b1777],

1	Szefler	NNP	O	Szefler	nn	2	SENT_751	[p35l1211t1732r1380b1776],
2	SJ	NNP	O	SJ	_	0	SENT_751	[p35l1405t1735r1461b1786],
3	,	,	O	,	_	0	SENT_751	[p35l1405t1735r1461b1786],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_751	[p35l1488t1732r1674b1788],
5	BR	NNP	O	BR	appos	2	SENT_751	[p35l1700t1736r1783b1785],
6	,	,	O	,	_	0	SENT_751	[p35l1700t1736r1783b1785],
7	Martinez	NNP	PERSON	Martinez	nn	8	SENT_751	[p35l1810t1733r2034b1776],
8	FD	NNP	O	FD	appos	2	SENT_751	[p35l2059t1736r2139b1785],
9	,	,	O	,	_	0	SENT_751	[p35l2059t1736r2139b1785],
10	et	FW	O	et	nn	11	SENT_751	[p35l1114t1812r1158b1847],
11	al.	FW	O	al.	appos	2	SENT_751	[p35l1185t1803r1240b1847],
12	.	.	O	.	_	0	SENT_751	[p35l1185t1803r1240b1847],

1	Characterization	NN	O	characterization	_	0	SENT_752	[p35l1273t1803r1685b1847],
2	of	IN	O	of	_	0	SENT_752	[p35l1715t1803r1772b1847],
3	within-subject	JJ	O	within-subject	amod	4	SENT_752	[p35l1789t1803r2145b1859],
4	responses	NNS	O	response	prep_of	1	SENT_752	[p35l1114t1888r1355b1930],
5	to	TO	O	to	_	0	SENT_752	[p35l1375t1883r1421b1918],
6	fluticasone	NN	O	fluticasone	prep_to	1	SENT_752	[p35l1439t1874r1713b1919],
7	and	CC	O	and	_	0	SENT_752	[p35l1731t1874r1820b1918],
8	montelukast	NN	O	montelukast	prep_to	1	SENT_752	[p35l1838t1874r2145b1919],
9	in	IN	O	in	_	0	SENT_752	[p35l1113t1945r1160b1988],
10	childhood	NN	O	childhood	nn	11	SENT_752	[p35l1188t1944r1437b1988],
11	asthma	NN	O	asthma	prep_in	1	SENT_752	[p35l1463t1944r1658b1988],
12	.	.	O	.	_	0	SENT_752	[p35l1463t1944r1658b1988],

1	J	NNP	O	J	nn	4	SENT_753	[p35l1682t1948r1703b1995],
2	Allergy	NNP	O	Allergy	nn	4	SENT_753	[p35l1726t1944r1906b2001],
3	Clin	NNP	O	Clin	nn	4	SENT_753	[p35l1930t1944r2031b1988],
4	Immunol	NNP	O	Immunol	_	0	SENT_753	[p35l2057t1948r2142b1988, p35l1114t2016r1271b2060],
5	2005	CD	DATE	2005	num	4	SENT_753	[p35l1290t2019r1709b2069],
6	;	:	O	;	_	0	SENT_753	[p35l1290t2019r1709b2069],
7	115:233	CD	NUMBER	115:233	number	8	SENT_753	[p35l1290t2019r1709b2069],
8	-42	CD	NUMBER	-42	dep	4	SENT_753	[p35l1290t2019r1709b2069],
9	.	.	O	.	_	0	SENT_753	[p35l1290t2019r1709b2069],

1	87	CD	NUMBER	87	_	0	SENT_754	[p35l1113t2091r1179b2131],
2	.	.	O	.	_	0	SENT_754	[p35l1113t2091r1179b2131],

1	Peters-Golden	JJ	O	peters-golden	amod	2	SENT_755	[p35l1209t2087r1557b2131],
2	M	NN	O	m	_	0	SENT_755	[p35l1585t2091r1646b2141],
3	,	,	O	,	_	0	SENT_755	[p35l1585t2091r1646b2141],
4	Swern	NNP	PERSON	Swern	nn	5	SENT_755	[p35l1680t2090r1829b2132],
5	A	NNP	O	A	appos	2	SENT_755	[p35l1857t2091r1906b2140],
6	,	,	O	,	_	0	SENT_755	[p35l1857t2091r1906b2140],
7	Bird	NNP	O	Bird	nn	8	SENT_755	[p35l1939t2087r2041b2131],
8	SS	NNP	O	SS	appos	5	SENT_755	[p35l2071t2090r2139b2140],
9	,	,	O	,	_	0	SENT_755	[p35l2071t2090r2139b2140],
10	Hustad	NNP	ORGANIZATION	Hustad	nn	11	SENT_755	[p35l1113t2157r1288b2202],
11	CM	NN	ORGANIZATION	cm	appos	5	SENT_755	[p35l1310t2160r1406b2211],
12	,	,	O	,	_	0	SENT_755	[p35l1310t2160r1406b2211],
13	Grant	NNP	PERSON	Grant	nn	14	SENT_755	[p35l1432t2160r1574b2201],
14	E	NNP	O	E	appos	5	SENT_755	[p35l1592t2161r1637b2211],
15	,	,	O	,	_	0	SENT_755	[p35l1592t2161r1637b2211],
16	Edelman	NNP	PERSON	Edelman	nn	17	SENT_755	[p35l1661t2157r1878b2201],
17	JM	NN	O	jm	appos	5	SENT_755	[p35l1894t2161r1977b2208],
18	.	.	O	.	_	0	SENT_755	[p35l1894t2161r1977b2208],

1	Influence	NN	O	influence	_	0	SENT_756	[p35l2001t2157r2142b2202, p35l1114t2243r1222b2273],
2	of	IN	O	of	_	0	SENT_756	[p35l1243t2229r1300b2273],
3	body	NN	O	body	nn	5	SENT_756	[p35l1311t2229r1430b2285],
4	mass	NN	O	mass	nn	5	SENT_756	[p35l1448t2243r1572b2273],
5	index	NN	O	index	prep_of	1	SENT_756	[p35l1594t2229r1727b2273],
6	on	IN	O	on	_	0	SENT_756	[p35l1748t2243r1807b2273],
7	the	DT	O	the	det	8	SENT_756	[p35l1828t2229r1904b2273],
8	response	NN	O	response	prep_on	5	SENT_756	[p35l1925t2243r2143b2285],
9	to	TO	O	to	_	0	SENT_756	[p35l1114t2308r1160b2343],
10	asthma	NN	O	asthma	nn	12	SENT_756	[p35l1183t2299r1364b2343],
11	controller	NN	O	controller	nn	12	SENT_756	[p35l1386t2299r1628b2343],
12	agents	NNS	O	agent	prep_to	1	SENT_756	[p35l1648t2308r1820b2356],
13	.	.	O	.	_	0	SENT_756	[p35l1648t2308r1820b2356],

1	Eur	NNP	MISC	Eur	nn	2	SENT_757	[p35l1845t2303r1929b2344],
2	RespirJ	NNP	O	RespirJ	_	0	SENT_757	[p35l1949t2300r2144b2355],
3	2006	CD	DATE	2006	num	2	SENT_757	[p35l1114t2374r1527b2424],
4	;	:	O	;	_	0	SENT_757	[p35l1114t2374r1527b2424],
5	27:495	CD	NUMBER	27:495	number	6	SENT_757	[p35l1114t2374r1527b2424],
6	-503	CD	NUMBER	-503	dep	2	SENT_757	[p35l1114t2374r1527b2424],
7	.	.	O	.	_	0	SENT_757	[p35l1114t2374r1527b2424],

1	88	CD	NUMBER	88	_	0	SENT_758	[p35l1113t2446r1179b2487],
2	.	.	O	.	_	0	SENT_758	[p35l1113t2446r1179b2487],

1	Lazarus	NNP	ORGANIZATION	Lazarus	nn	2	SENT_759	[p35l1209t2446r1402b2487],
2	SC	NNP	ORGANIZATION	SC	_	0	SENT_759	[p35l1432t2445r1507b2496],
3	,	,	O	,	_	0	SENT_759	[p35l1432t2445r1507b2496],
4	Chinchilli	NNP	PERSON	Chinchilli	nn	5	SENT_759	[p35l1538t2442r1784b2486],
5	VM	NNP	O	VM	appos	2	SENT_759	[p35l1809t2446r1905b2495],
6	,	,	O	,	_	0	SENT_759	[p35l1809t2446r1905b2495],
7	Rollings	NNP	PERSON	Rollings	nn	8	SENT_759	[p35l1935t2442r2141b2499],
8	NJ	NNP	O	NJ	appos	2	SENT_759	[p35l1112t2518r1185b2568],
9	,	,	O	,	_	0	SENT_759	[p35l1112t2518r1185b2568],
10	et	FW	O	et	nn	11	SENT_759	[p35l1209t2523r1253b2558],
11	al.	FW	O	al.	appos	2	SENT_759	[p35l1270t2514r1325b2558],
12	.	.	O	.	_	0	SENT_759	[p35l1270t2514r1325b2558],

1	Smoking	NN	O	smoking	nsubj	2	SENT_760	[p35l1350t2514r1569b2571],
2	affects	VBZ	O	affect	_	0	SENT_760	[p35l1587t2514r1750b2558],
3	response	NN	O	response	dobj	2	SENT_760	[p35l1772t2528r1989b2570],
4	to	TO	O	to	aux	5	SENT_760	[p35l2010t2523r2055b2558],
5	inhaled	VBN	O	inhale	xcomp	2	SENT_760	[p35l2076t2515r2142b2558, p35l1114t2586r1247b2630],
6	corticosteroids	NNS	O	corticosteroid	dobj	5	SENT_760	[p35l1282t2586r1646b2630],
7	or	CC	O	or	_	0	SENT_760	[p35l1682t2600r1733b2630],
8	leukotriene	NN	O	leukotriene	nn	10	SENT_760	[p35l1765t2586r2043b2631],
9	receptor	NN	O	receptor	nn	10	SENT_760	[p35l2078t2601r2142b2630, p35l1114t2665r1268b2712],
10	antagonists	NNS	O	antagonist	conj_or	6	SENT_760	[p35l1281t2657r1567b2713],
11	in	IN	O	in	_	0	SENT_760	[p35l1583t2657r1630b2700],
12	asthma	NN	O	asthma	prep_in	5	SENT_760	[p35l1645t2656r1840b2700],
13	.	.	O	.	_	0	SENT_760	[p35l1645t2656r1840b2700],

1	Am	VBP	O	be	cop	2	SENT_761	[p35l1856t2660r1973b2707],
2	]	CD	NUMBER	]	dep	6	SENT_761	[p35l1856t2660r1973b2707],
3	Respir	NNP	O	Respir	nn	5	SENT_761	[p35l1986t2657r2144b2712],
4	Crit	NNP	O	Crit	nn	5	SENT_761	[p35l1114t2729r1206b2772],
5	Care	NNP	O	Care	nsubj	6	SENT_761	[p35l1222t2731r1332b2772],
6	Med	VBD	O	med	_	0	SENT_761	[p35l1350t2728r1455b2772],
7	2007	CD	DATE	2007	dobj	6	SENT_761	[p35l1475t2731r1884b2781],
8	;	:	O	;	_	0	SENT_761	[p35l1475t2731r1884b2781],
9	175:783	CD	NUMBER	175:783	num	10	SENT_761	[p35l1475t2731r1884b2781],
10	-90	CD	NUMBER	-90	dep	7	SENT_761	[p35l1475t2731r1884b2781],
11	.	.	O	.	_	0	SENT_761	[p35l1475t2731r1884b2781],

1	89	CD	NUMBER	89	_	0	SENT_762	[p35l1113t2803r1179b2843],
2	.	.	O	.	_	0	SENT_762	[p35l1113t2803r1179b2843],

1	Reiss	NNP	PERSON	Reiss	nn	2	SENT_763	[p35l1209t2800r1336b2846],
2	TF	NN	O	tf	_	0	SENT_763	[p35l1355t2802r1428b2853],
3	,	,	O	,	_	0	SENT_763	[p35l1355t2802r1428b2853],
4	Chervinsky	NNP	PERSON	Chervinsky	nn	5	SENT_763	[p35l1451t2799r1729b2855],
5	P	NN	PERSON	p	appos	2	SENT_763	[p35l1745t2803r1783b2852],
6	,	,	O	,	_	0	SENT_763	[p35l1745t2803r1783b2852],
7	Dockhorn	NNP	O	Dockhorn	nn	8	SENT_763	[p35l1805t2799r2052b2844],
8	RJ	NN	O	rj	appos	5	SENT_763	[p35l2071t2803r2139b2852],
9	,	,	O	,	_	0	SENT_763	[p35l2071t2803r2139b2852],
10	Shingo	NNP	PERSON	Shingo	nn	11	SENT_763	[p35l1115t2870r1284b2927],
11	S	NNP	PERSON	S	appos	5	SENT_763	[p35l1327t2873r1365b2924],
12	,	,	O	,	_	0	SENT_763	[p35l1327t2873r1365b2924],
13	Seidenberg	NNP	PERSON	Seidenberg	nn	14	SENT_763	[p35l1411t2870r1682b2927],
14	B	NNP	O	B	appos	5	SENT_763	[p35l1720t2874r1766b2924],
15	,	,	O	,	_	0	SENT_763	[p35l1720t2874r1766b2924],
16	Edwards	NNP	PERSON	Edwards	nn	17	SENT_763	[p35l1809t2870r2018b2915],
17	TB	NN	O	tb	appos	5	SENT_763	[p35l2058t2873r2139b2914],
18	.	.	O	.	_	0	SENT_763	[p35l2058t2873r2139b2914],

1	Montelukast	NNP	O	Montelukast	_	0	SENT_764	[p35l1112t2941r1432b2995],
2	,	,	O	,	_	0	SENT_764	[p35l1112t2941r1432b2995],
3	a	DT	O	a	det	7	SENT_764	[p35l1457t2956r1482b2985],
4	once-daily	JJ	O	once-daily	amod	7	SENT_764	[p35l1504t2941r1758b2997],
5	leukotriene	NN	O	leukotriene	nn	7	SENT_764	[p35l1777t2941r2055b2986],
6	receptor	NN	O	receptor	nn	7	SENT_764	[p35l2077t2956r2142b2985, p35l1114t3021r1271b3068],
7	antagonist	NN	O	antagonist	appos	1	SENT_764	[p35l1304t3013r1585b3069],
8	,	,	O	,	_	0	SENT_764	[p35l1304t3013r1585b3069],
9	in	IN	O	in	_	0	SENT_764	[p35l1623t3013r1670b3056],
10	the	DT	O	the	det	11	SENT_764	[p35l1705t3012r1782b3056],
11	treatment	NN	O	treatment	prep_in	1	SENT_764	[p35l1817t3021r2064b3056],
12	of	IN	O	of	_	0	SENT_764	[p35l2096t3012r2153b3056],
13	chronic	JJ	O	chronic	amod	14	SENT_764	[p35l1114t3084r1299b3128],
14	asthma	NN	O	asthma	prep_of	11	SENT_764	[p35l1327t3084r1521b3128],
15	:	:	O	:	_	0	SENT_764	[p35l1327t3084r1521b3128],
16	a	DT	O	a	det	17	SENT_764	[p35l1553t3099r1577b3128],
17	multicenter	NN	O	multicenter	dep	1	SENT_764	[p35l1606t3084r1900b3137],
18	,	,	O	,	_	0	SENT_764	[p35l1606t3084r1900b3137],
19	randomized	VBN	O	randomize	partmod	17	SENT_764	[p35l1932t3084r2142b3128, p35l1113t3155r1228b3209],
20	,	,	O	,	_	0	SENT_764	[p35l1932t3084r2142b3128, p35l1113t3155r1228b3209],
21	double-blind	JJ	O	double-blind	amod	22	SENT_764	[p35l1254t3155r1566b3200],
22	trial	NN	O	trial	appos	17	SENT_764	[p35l1588t3155r1704b3199],
23	.	.	O	.	_	0	SENT_764	[p35l1588t3155r1704b3199],

1	Arch	NNP	O	Arch	nn	3	SENT_765	[p35l1727t3155r1844b3199],
2	Intern	NNP	O	Intern	nn	3	SENT_765	[p35l1865t3159r2017b3199],
3	Med	NNP	O	Med	_	0	SENT_765	[p35l2037t3155r2143b3199],
4	1998	CD	DATE	1998	num	3	SENT_765	[p35l1116t3228r1558b3278],
5	;	:	O	;	_	0	SENT_765	[p35l1116t3228r1558b3278],
6	158:1213	CD	NUMBER	158:1213	number	7	SENT_765	[p35l1116t3228r1558b3278],
7	-20	CD	NUMBER	-20	dep	3	SENT_765	[p35l1116t3228r1558b3278],
8	.	.	O	.	_	0	SENT_765	[p35l1116t3228r1558b3278],

1	90	CD	NUMBER	90	_	0	SENT_766	[p35l1113t3302r1179b3341],
2	.	.	O	.	_	0	SENT_766	[p35l1113t3302r1179b3341],

1	Sandrini	NNP	MISC	Sandrini	nn	2	SENT_767	[p35l1211t3297r1420b3341],
2	A	NNP	MISC	A	_	0	SENT_767	[p35l1441t3301r1491b3350],
3	,	,	O	,	_	0	SENT_767	[p35l1441t3301r1491b3350],
4	Ferreira	NNP	PERSON	Ferreira	nn	5	SENT_767	[p35l1516t3298r1708b3341],
5	IM	NNP	O	IM	appos	2	SENT_767	[p35l1730t3301r1811b3350],
6	,	,	O	,	_	0	SENT_767	[p35l1730t3301r1811b3350],
7	Gutierrez	NNP	PERSON	Gutierrez	nn	8	SENT_767	[p35l1837t3298r2069b3341],
8	C	NNP	O	C	appos	5	SENT_767	[p35l2092t3300r2139b3350],
9	,	,	O	,	_	0	SENT_767	[p35l2092t3300r2139b3350],
10	Jardim	NNP	PERSON	Jardim	nn	11	SENT_767	[p35l1108t3367r1277b3418],
11	JR	NNP	O	JR	appos	5	SENT_767	[p35l1291t3371r1364b3421],
12	,	,	O	,	_	0	SENT_767	[p35l1291t3371r1364b3421],
13	Zamel	NNP	PERSON	Zamel	nn	14	SENT_767	[p35l1386t3367r1538b3411],
14	N	NNP	PERSON	N	appos	5	SENT_767	[p35l1556t3371r1610b3421],
15	,	,	O	,	_	0	SENT_767	[p35l1556t3371r1610b3421],
16	Chapman	NNP	PERSON	Chapman	nn	17	SENT_767	[p35l1633t3367r1869b3423],
17	KR	NNP	O	KR	appos	5	SENT_767	[p35l1889t3371r1978b3414],
18	.	.	O	.	_	0	SENT_767	[p35l1889t3371r1978b3414],

1	Effect	NN	O	effect	_	0	SENT_768	[p35l2000t3367r2145b3411],
2	of	IN	O	of	_	0	SENT_768	[p35l1114t3439r1171b3483],
3	montelukast	NN	O	montelukast	prep_of	1	SENT_768	[p35l1194t3439r1501b3484],
4	on	IN	O	on	_	0	SENT_768	[p35l1532t3453r1592b3483],
5	exhaled	VBN	O	exhale	amod	7	SENT_768	[p35l1626t3439r1815b3483],
6	nitric	JJ	O	nitric	amod	7	SENT_768	[p35l1848t3440r1979b3483],
7	oxide	NN	O	oxide	prep_on	3	SENT_768	[p35l2013t3439r2142b3483],
8	and	CC	O	and	_	0	SENT_768	[p35l1113t3510r1203b3554],
9	nonvolatile	JJ	O	nonvolatile	amod	10	SENT_768	[p35l1221t3510r1493b3555],
10	markers	NNS	O	marker	prep_on	3	SENT_768	[p35l1512t3510r1712b3555],
11	of	IN	O	of	_	0	SENT_768	[p35l1732t3510r1789b3554],
12	inflammation	NN	O	inflammation	prep_of	10	SENT_768	[p35l1797t3510r2143b3554],
13	in	IN	O	in	_	0	SENT_768	[p35l1113t3583r1160b3626],
14	mild	JJ	O	mild	amod	15	SENT_768	[p35l1179t3582r1292b3626],
15	asthma	NN	O	asthma	prep_in	12	SENT_768	[p35l1311t3582r1505b3626],
16	.	.	O	.	_	0	SENT_768	[p35l1311t3582r1505b3626],

1	Chest	NN	O	chest	_	0	SENT_769	[p35l1528t3582r1665b3626],
2	2003	CD	DATE	2003	num	1	SENT_769	[p35l1682t3585r2131b3635],
3	;	:	O	;	_	0	SENT_769	[p35l1682t3585r2131b3635],
4	124:1334	CD	NUMBER	124:1334	number	5	SENT_769	[p35l1682t3585r2131b3635],
5	-40	CD	NUMBER	-40	dep	1	SENT_769	[p35l1682t3585r2131b3635],
6	.	.	O	.	_	0	SENT_769	[p35l1682t3585r2131b3635],

1	91	CD	NUMBER	91	_	0	SENT_770	[p35l1113t3657r1179b3696],
2	.	.	O	.	_	0	SENT_770	[p35l1113t3657r1179b3696],

1	Dempsey	NNP	ORGANIZATION	Dempsey	nn	2	SENT_771	[p35l1209t3656r1435b3708],
2	OJ	NNP	ORGANIZATION	OJ	_	0	SENT_771	[p35l1450t3655r1518b3706],
3	,	,	O	,	_	0	SENT_771	[p35l1450t3655r1518b3706],
4	Kennedy	NNP	PERSON	Kennedy	nn	5	SENT_771	[p35l1538t3652r1751b3708],
5	G	NNP	PERSON	G	appos	2	SENT_771	[p35l1766t3655r1818b3706],
6	,	,	O	,	_	0	SENT_771	[p35l1766t3655r1818b3706],
7	Lipworth	NNP	ORGANIZATION	Lipworth	nn	8	SENT_771	[p35l1838t3652r2062b3708],
8	BJ	NNP	ORGANIZATION	BJ	appos	5	SENT_771	[p35l2078t3656r2140b3703],
9	.	.	O	.	_	0	SENT_771	[p35l2078t3656r2140b3703],

1	Comparative	JJ	O	comparative	amod	2	SENT_772	[p35l1114t3725r1424b3780],
2	efficacy	NN	O	efficacy	_	0	SENT_772	[p35l1444t3724r1636b3780],
3	and	CC	O	and	_	0	SENT_772	[p35l1654t3724r1743b3768],
4	antiinflammaLeukotriene	NN	O	antiinflammaleukotriene	conj_and	2	SENT_772	[p35l1763t3724r2142b3768, p36l9t15r308b60],

1	(	NN	O	(	nn	2	SENT_773	[p36l343t18r672b71],
2	LT	NN	O	lt	_	0	SENT_773	[p36l343t18r672b71],
3	)	SYM	O	)	dep	6	SENT_773	[p36l343t18r672b71],
4	-	:	O	-	_	0	SENT_773	[p36l343t18r672b71],
5	receptor	NN	O	receptor	nn	6	SENT_773	[p36l343t18r672b71],
6	antagonist	NN	O	antagonist	dep	2	SENT_773	[p36l702t16r970b72],
7	is	VBZ	O	be	cop	9	SENT_773	[p36l999t16r1037b59],
8	more	RBR	O	more	advmod	9	SENT_773	[p36l9t101r134b131],
9	effective	JJ	O	effective	rcmod	6	SENT_773	[p36l156t87r360b132],
10	in	IN	O	in	_	0	SENT_773	[p36l381t88r429b131],
11	asthmatic	JJ	O	asthmatic	amod	12	SENT_773	[p36l449t87r692b131],
12	patients	NNS	O	patient	prep_in	9	SENT_773	[p36l712t88r907b143],
13	with	IN	O	with	_	0	SENT_773	[p36l927t87r1038b132],
14	a	DT	O	a	det	17	SENT_773	[p36l9t174r34b203],
15	low	JJ	O	low	amod	17	SENT_773	[p36l49t159r137b204],
16	baseline	NN	O	baseline	nn	17	SENT_773	[p36l152t159r349b203],
17	ratio	NN	O	ratio	prep_with	12	SENT_773	[p36l366t160r476b203],
18	of	IN	O	of	_	0	SENT_773	[p36l495t159r551b203],
19	urinary	JJ	O	urinary	amod	20	SENT_773	[p36l557t160r736b215],
20	LTE	NN	O	lte	prep_of	17	SENT_773	[p36l750t162r841b203],
21	4	CD	NUMBER	4	num	20	SENT_773	[p36l844t197r863b219],
22	to	TO	O	to	_	0	SENT_773	[p36l880t168r926b203],
23	2,3dinor-6-keto-prostaglandin	JJ	O	2,3dinor-6-keto-prostaglandin	amod	27	SENT_773	[p36l944t162r1037b213, p36l10t231r702b288],
24	(	NN	O	(	nn	27	SENT_773	[p36l723t231r1035b290],
25	PG	NN	O	pg	nn	27	SENT_773	[p36l723t231r1035b290],
26	)	CD	NUMBER	)	num	27	SENT_773	[p36l723t231r1035b290],
27	F1alpha	NN	O	f1alpha	prep_to	20	SENT_773	[p36l723t231r1035b290],
28	.	.	O	.	_	0	SENT_773	[p36l723t231r1035b290],

1	Allergy	NN	O	allergy	_	0	SENT_774	[p36l7t302r187b359],
2	1999	CD	DATE	1999	num	1	SENT_774	[p36l206t305r596b355],
3	;	:	O	;	_	0	SENT_774	[p36l206t305r596b355],
4	54:489	CD	NUMBER	54:489	number	5	SENT_774	[p36l206t305r596b355],
5	—	CD	NUMBER	—	dep	1	SENT_774	[p36l206t305r596b355],
6	94	CD	NUMBER	94	dep	5	SENT_774	[p36l206t305r596b355],
7	.	.	O	.	_	0	SENT_774	[p36l206t305r596b355],

1	79	CD	NUMBER	79	_	0	SENT_775	[p36l11t378r75b417],
2	.	.	O	.	_	0	SENT_775	[p36l11t378r75b417],

1	Terashima	NNP	PERSON	Terashima	nn	2	SENT_776	[p36l104t373r363b417],
2	T	NN	O	t	_	0	SENT_776	[p36l383t377r427b427],
3	,	,	O	,	_	0	SENT_776	[p36l383t377r427b427],
4	Amakawa	NNP	PERSON	Amakawa	nn	5	SENT_776	[p36l451t373r695b418],
5	K	NNP	PERSON	K	appos	2	SENT_776	[p36l717t377r766b427],
6	,	,	O	,	_	0	SENT_776	[p36l717t377r766b427],
7	Matsuma	NNP	O	Matsuma	appos	2	SENT_776	[p36l791t377r1037b418],
8	—	CD	NUMBER	—	num	10	SENT_776	[p36l791t377r1037b418],
9	ru	NN	O	ru	nn	10	SENT_776	[p36l9t459r61b489],
10	A	NN	O	a	dep	7	SENT_776	[p36l83t448r132b498],
11	,	,	O	,	_	0	SENT_776	[p36l83t448r132b498],
12	Yamaguchi	NNP	PERSON	Yamaguchi	nn	14	SENT_776	[p36l157t444r431b501],
13	K.	NNP	O	K.	nn	14	SENT_776	[p36l454t448r504b489],
14	Correlation	NN	O	correlation	appos	2	SENT_776	[p36l530t444r811b488],
15	between	IN	O	between	_	0	SENT_776	[p36l835t444r1038b489],
16	cysteinyl	NN	O	cysteinyl	nn	18	SENT_776	[p36l10t515r220b571],
17	leukotriene	NN	O	leukotriene	nn	18	SENT_776	[p36l245t515r523b560],
18	release	NN	O	release	prep_between	14	SENT_776	[p36l548t515r715b559],
19	from	IN	O	from	_	0	SENT_776	[p36l740t515r860b559],
20	leukocytes	NNS	O	leukocyte	prep_from	18	SENT_776	[p36l884t515r1038b560, p36l10t596r130b643],
21	and	CC	O	and	_	0	SENT_776	[p36l154t587r243b631],
22	clinical	JJ	O	clinical	amod	23	SENT_776	[p36l267t587r446b631],
23	response	NN	O	response	conj_and	18	SENT_776	[p36l469t601r686b643],
24	to	TO	O	to	_	0	SENT_776	[p36l710t596r756b631],
25	a	DT	O	a	det	27	SENT_776	[p36l780t602r805b631],
26	leukotriene	NN	O	leukotriene	nn	27	SENT_776	[p36l827t587r1037b632, p36l10t672r91b702],
27	inhibitor	NN	O	inhibitor	prep_to	23	SENT_776	[p36l110t658r340b702],
28	.	.	O	.	_	0	SENT_776	[p36l110t658r340b702],

1	Chest	NN	O	chest	_	0	SENT_777	[p36l362t658r500b702],
2	2002	CD	DATE	2002	num	1	SENT_777	[p36l516t661r962b711],
3	;	:	O	;	_	0	SENT_777	[p36l516t661r962b711],
4	122:1566	CD	NUMBER	122:1566	number	5	SENT_777	[p36l516t661r962b711],
5	-70	CD	NUMBER	-70	dep	1	SENT_777	[p36l516t661r962b711],
6	.	.	O	.	_	0	SENT_777	[p36l516t661r962b711],

1	80	CD	NUMBER	80	_	0	SENT_778	[p36l9t733r75b773],
2	.	.	O	.	_	0	SENT_778	[p36l9t733r75b773],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_779	[p36l105t733r281b773],
2	JM	NN	PERSON	jm	_	0	SENT_779	[p36l305t733r387b782],
3	,	,	O	,	_	0	SENT_779	[p36l305t733r387b782],
4	Yandava	NNP	O	Yandava	nn	5	SENT_779	[p36l417t729r618b774],
5	CN	NN	O	cn	appos	2	SENT_779	[p36l646t732r735b783],
6	,	,	O	,	_	0	SENT_779	[p36l646t732r735b783],
7	Dubé	NN	O	dubé	nn	8	SENT_779	[p36l766t728r894b774],
8	L	NN	O	l	appos	2	SENT_779	[p36l923t733r965b782],
9	,	,	O	,	_	0	SENT_779	[p36l923t733r965b782],
10	et	FW	O	et	nn	11	SENT_779	[p36l997t738r1041b773],
11	al.	FW	O	al.	appos	2	SENT_779	[p36l9t800r65b844],
12	.	.	O	.	_	0	SENT_779	[p36l9t800r65b844],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_780	[p36l82t800r516b857],
2	association	NN	O	association	_	0	SENT_780	[p36l532t801r815b844],
3	between	IN	O	between	_	0	SENT_780	[p36l831t800r1038b845],
4	ALOX5	NN	O	alox5	nn	6	SENT_780	[p36l7t874r180b915],
5	promoter	NN	O	promoter	nn	6	SENT_780	[p36l214t880r449b927],
6	genotype	NN	O	genotype	prep_between	2	SENT_780	[p36l479t880r708b928],
7	and	CC	O	and	_	0	SENT_780	[p36l740t871r831b915],
8	the	DT	O	the	det	9	SENT_780	[p36l863t871r940b915],
9	response	NN	O	response	prep_between	2	SENT_780	[p36l972t886r1038b915, p36l10t957r172b999],
10	to	TO	O	to	_	0	SENT_780	[p36l185t952r230b987],
11	anti-asthma	JJ	O	anti-asthma	amod	12	SENT_780	[p36l243t943r529b987],
12	treatment	NN	O	treatment	prep_to	2	SENT_780	[p36l541t952r784b987],
13	.	.	O	.	_	0	SENT_780	[p36l541t952r784b987],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_781	[p36l799t947r885b987],
2	Genet	NNP	PERSON	Genet	_	0	SENT_781	[p36l895t946r1041b987],
3	1999	CD	DATE	1999	num	2	SENT_781	[p36l11t1016r393b1066],
4	;	:	O	;	_	0	SENT_781	[p36l11t1016r393b1066],
5	22:168	CD	NUMBER	22:168	number	6	SENT_781	[p36l11t1016r393b1066],
6	-70	CD	NUMBER	-70	dep	2	SENT_781	[p36l11t1016r393b1066],
7	.	.	O	.	_	0	SENT_781	[p36l11t1016r393b1066],

1	81	CD	NUMBER	81	_	0	SENT_782	[p36l9t1088r75b1129],
2	.	.	O	.	_	0	SENT_782	[p36l9t1088r75b1129],

1	Sampson	NNP	PERSON	Sampson	nn	2	SENT_783	[p36l107t1087r330b1140],
2	AP	NNP	O	AP	_	0	SENT_783	[p36l345t1088r423b1138],
3	,	,	O	,	_	0	SENT_783	[p36l345t1088r423b1138],
4	Siddiqui	NNP	PERSON	Siddiqui	nn	5	SENT_783	[p36l445t1084r645b1140],
5	S	NNP	O	S	appos	2	SENT_783	[p36l664t1087r702b1138],
6	,	,	O	,	_	0	SENT_783	[p36l664t1087r702b1138],
7	Buchanan	NNP	PERSON	Buchanan	nn	8	SENT_783	[p36l722t1084r967b1129],
8	D	NNP	O	D	appos	2	SENT_783	[p36l984t1088r1035b1138],
9	,	,	O	,	_	0	SENT_783	[p36l984t1088r1035b1138],
10	et	FW	O	et	nn	11	SENT_783	[p36l10t1165r53b1200],
11	al.	FW	O	al.	appos	2	SENT_783	[p36l75t1156r131b1200],
12	.	.	O	.	_	0	SENT_783	[p36l75t1156r131b1200],

1	Variant	JJ	O	variant	amod	2	SENT_784	[p36l157t1157r337b1200],
2	LTC	NN	ORGANIZATION	ltc	nsubj	9	SENT_784	[p36l359t1159r454b1200],
3	4	CD	NUMBER	4	num	6	SENT_784	[p36l458t1194r477b1216],
4	synthase	NN	O	synthase	nn	6	SENT_784	[p36l502t1156r715b1212],
5	allele	NN	O	allele	nn	6	SENT_784	[p36l740t1156r868b1200],
6	modiﬁes	NNS	O	modiﬁes	dep	2	SENT_784	[p36l893t1156r1038b1200, p36l9t1228r96b1272],
7	cysteinyl	NN	O	cysteinyl	nn	9	SENT_784	[p36l118t1228r329b1284],
8	leukotriene	NN	O	leukotriene	nn	9	SENT_784	[p36l349t1228r627b1273],
9	synthesis	NN	O	synthesis	_	0	SENT_784	[p36l649t1228r873b1284],
10	in	IN	O	in	_	0	SENT_784	[p36l895t1229r942b1272],
11	eosinophils	NNS	O	eosinophil	prep_in	9	SENT_784	[p36l963t1242r1038b1272, p36l10t1299r235b1355],
12	and	CC	O	and	_	0	SENT_784	[p36l265t1299r355b1343],
13	predicts	VBZ	O	predict	conj_and	9	SENT_784	[p36l384t1299r580b1355],
14	clinical	JJ	O	clinical	amod	15	SENT_784	[p36l612t1299r791b1343],
15	response	NN	O	response	dobj	13	SENT_784	[p36l821t1313r1038b1355],
16	to	TO	O	to	_	0	SENT_784	[p36l10t1379r56b1414],
17	zafirlukast	NN	O	zafirlukast	prep_to	13	SENT_784	[p36l90t1370r371b1415],
18	.	.	O	.	_	0	SENT_784	[p36l90t1370r371b1415],

1	Thorax	NNP	O	Thorax	_	0	SENT_785	[p36l406t1370r582b1414],
2	2000	CD	DATE	2000	num	1	SENT_785	[p36l615t1370r962b1426],
3	;	:	O	;	_	0	SENT_785	[p36l615t1370r962b1426],
4	55	CD	NUMBER	55	dep	1	SENT_785	[p36l615t1370r962b1426],
5	:	:	O	:	_	0	SENT_785	[p36l615t1370r962b1426],
6	Suppl	NN	O	suppl	dep	1	SENT_785	[p36l615t1370r962b1426],
7	2	CD	NUMBER	2	num	6	SENT_785	[p36l996t1373r1036b1414],
8	:	:	O	:	_	0	SENT_785	[p36l996t1373r1036b1414],
9	S28	CD	NUMBER	s28	dep	6	SENT_785	[p36l11t1444r214b1485],
10	.	.	O	.	_	0	SENT_785	[p36l11t1444r214b1485],

1	—	NN	O	—	_	0	SENT_786	[p36l11t1444r214b1485],
2	.	.	O	.	_	0	SENT_786	[p36l11t1444r214b1485],

1	S31	NN	O	s31	_	0	SENT_787	[p36l11t1444r214b1485],
2	.	.	O	.	_	0	SENT_787	[p36l11t1444r214b1485],

1	tory	JJ	O	tory	amod	2	SENT_788	[p36l1114t24r1210b71],
2	profile	NN	O	profile	nsubj	11	SENT_788	[p36l1224t15r1386b71],
3	of	IN	O	of	_	0	SENT_788	[p36l1404t15r1460b59],
4	once-daily	JJ	O	once-daily	amod	5	SENT_788	[p36l1468t15r1717b71],
5	therapy	NN	O	therapy	prep_of	2	SENT_788	[p36l1733t15r1913b71],
6	with	IN	O	with	_	0	SENT_788	[p36l1926t15r2035b60],
7	leukotriene	NN	O	leukotriene	nn	8	SENT_788	[p36l2052t15r2142b60, p36l1113t87r1316b132],
8	antagonist	NN	O	antagonist	prep_with	5	SENT_788	[p36l1344t88r1607b144],
9	or	CC	O	or	_	0	SENT_788	[p36l1633t101r1684b131],
10	low-dose	JJ	O	low-dose	prep_with	5	SENT_788	[p36l1710t87r1929b132],
11	inhaled	VBN	O	inhale	_	0	SENT_788	[p36l1958t87r2143b131],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_788	[p36l1114t159r1455b203],
13	in	IN	O	in	_	0	SENT_788	[p36l1480t160r1527b203],
14	patients	NNS	O	patient	prep_in	11	SENT_788	[p36l1552t160r1748b215],
15	with	IN	O	with	_	0	SENT_788	[p36l1772t159r1883b204],
16	mild	JJ	O	mild	amod	18	SENT_788	[p36l1909t159r2021b203],
17	persistent	JJ	O	persistent	amod	18	SENT_788	[p36l2045t173r2142b215, p36l1114t232r1275b275],
18	asthma	NN	O	asthma	prep_with	11	SENT_788	[p36l1303t231r1497b275],
19	.	.	O	.	_	0	SENT_788	[p36l1303t231r1497b275],

1	}	RB	O	}	advmod	4	SENT_789	[p36l1526t235r1547b282],
2	Allergy	NNP	O	Allergy	nn	4	SENT_789	[p36l1575t231r1755b288],
3	Clin	NNP	O	Clin	nn	4	SENT_789	[p36l1783t231r1884b275],
4	Immunol	NNP	O	Immunol	_	0	SENT_789	[p36l1914t231r2143b276],
5	2002	CD	DATE	2002	amod	4	SENT_789	[p36l1114t305r1494b355],
6	;	:	O	;	_	0	SENT_789	[p36l1114t305r1494b355],
7	109:68	CD	NUMBER	109:68	number	8	SENT_789	[p36l1114t305r1494b355],
8	—	CD	NUMBER	—	dep	4	SENT_789	[p36l1114t305r1494b355],
9	74	CD	NUMBER	74	dep	8	SENT_789	[p36l1114t305r1494b355],
10	.	.	O	.	_	0	SENT_789	[p36l1114t305r1494b355],

1	92	CD	NUMBER	92	_	0	SENT_790	[p36l1113t378r1179b417],
2	.	.	O	.	_	0	SENT_790	[p36l1113t378r1179b417],

1	Berger	NNP	PERSON	Berger	nn	2	SENT_791	[p36l1209t377r1370b430],
2	W	NNP	O	W	_	0	SENT_791	[p36l1389t377r1449b426],
3	,	,	O	,	_	0	SENT_791	[p36l1389t377r1449b426],
4	De	NNP	PERSON	De	nn	6	SENT_791	[p36l1474t377r1539b417],
5	Chandt	NNP	PERSON	Chandt	nn	6	SENT_791	[p36l1561t373r1740b417],
6	MT	NNP	O	MT	appos	2	SENT_791	[p36l1758t376r1850b426],
7	,	,	O	,	_	0	SENT_791	[p36l1758t376r1850b426],
8	Cairns	NNP	ORGANIZATION	Cairns	nn	9	SENT_791	[p36l1875t374r2035b417],
9	CB	NNP	ORGANIZATION	CB	appos	6	SENT_791	[p36l2058t376r2139b417],
10	.	.	O	.	_	0	SENT_791	[p36l2058t376r2139b417],

1	Zileuton	NNP	O	Zileuton	_	0	SENT_792	[p36l1112t444r1326b489],
2	:	:	O	:	_	0	SENT_792	[p36l1112t444r1326b489],
3	clinical	JJ	O	clinical	amod	4	SENT_792	[p36l1349t444r1524b488],
4	implications	NNS	O	implication	dep	1	SENT_792	[p36l1544t444r1844b500],
5	of	IN	O	of	_	0	SENT_792	[p36l1866t444r1922b488],
6	5	CD	NUMBER	5	number	7	SENT_792	[p36l1933t444r2142b500],
7	—	CD	NUMBER	—	num	11	SENT_792	[p36l1933t444r2142b500],
8	lipoxy	NN	O	lipoxy	nn	11	SENT_792	[p36l1933t444r2142b500],
9	—	NN	O	—	nn	11	SENT_792	[p36l1933t444r2142b500],
10	genase	NN	O	genase	nn	11	SENT_792	[p36l1113t529r1277b572],
11	inhibition	NN	O	inhibition	prep_of	4	SENT_792	[p36l1294t515r1534b559],
12	in	IN	O	in	_	0	SENT_792	[p36l1551t516r1597b559],
13	severe	JJ	O	severe	amod	15	SENT_792	[p36l1615t529r1759b560],
14	airway	NN	O	airway	nn	15	SENT_792	[p36l1776t516r1936b571],
15	disease	NN	O	disease	prep_in	11	SENT_792	[p36l1950t515r2140b559],
16	.	.	O	.	_	0	SENT_792	[p36l1950t515r2140b559],

1	Int	NN	O	int	nn	4	SENT_793	[p36l1113t591r1215b638],
2	]	CD	NUMBER	]	num	4	SENT_793	[p36l1113t591r1215b638],
3	Clin	NNP	O	Clin	nn	4	SENT_793	[p36l1233t587r1334b631],
4	Pract	NNP	O	Pract	_	0	SENT_793	[p36l1353t591r1478b631],
5	2007	CD	DATE	2007	dep	4	SENT_793	[p36l1494t590r1875b640],
6	;	:	O	;	_	0	SENT_793	[p36l1494t590r1875b640],
7	61:663	CD	NUMBER	61:663	number	8	SENT_793	[p36l1494t590r1875b640],
8	—	CD	NUMBER	—	dep	4	SENT_793	[p36l1494t590r1875b640],
9	76	CD	NUMBER	76	dep	8	SENT_793	[p36l1494t590r1875b640],
10	.	.	O	.	_	0	SENT_793	[p36l1494t590r1875b640],

1	93	CD	NUMBER	93	_	0	SENT_794	[p36l1113t663r1179b702],
2	.	.	O	.	_	0	SENT_794	[p36l1113t663r1179b702],

1	Spanbroek	JJ	PERSON	spanbroek	amod	2	SENT_795	[p36l1211t658r1472b714],
2	R	NN	PERSON	r	_	0	SENT_795	[p36l1489t662r1539b712],
3	,	,	O	,	_	0	SENT_795	[p36l1489t662r1539b712],
4	Grabner	NNP	PERSON	Grabner	nn	5	SENT_795	[p36l1562t658r1763b702],
5	R	NNP	PERSON	R	appos	2	SENT_795	[p36l1781t662r1830b711],
6	,	,	O	,	_	0	SENT_795	[p36l1781t662r1830b711],
7	Lotzer	NNP	PERSON	Lotzer	nn	8	SENT_795	[p36l1853t662r2011b702],
8	K	NNP	PERSON	K	appos	2	SENT_795	[p36l2029t662r2078b711],
9	,	,	O	,	_	0	SENT_795	[p36l2029t662r2078b711],
10	et	FW	O	et	nn	11	SENT_795	[p36l2102t667r2146b702],
11	al.	FW	O	al.	appos	2	SENT_795	[p36l1113t729r1169b773],
12	.	.	O	.	_	0	SENT_795	[p36l1113t729r1169b773],

1	Expanding	VBG	O	expand	_	0	SENT_796	[p36l1193t729r1460b786],
2	expression	NN	O	expression	dobj	1	SENT_796	[p36l1480t730r1740b785],
3	of	IN	O	of	_	0	SENT_796	[p36l1762t729r1819b773],
4	the	DT	O	the	det	10	SENT_796	[p36l1831t729r1906b773],
5	5	CD	NUMBER	5	amod	10	SENT_796	[p36l1929t729r2142b785],
6	—	NN	O	—	nn	10	SENT_796	[p36l1929t729r2142b785],
7	lipoxy	NN	O	lipoxy	nn	10	SENT_796	[p36l1929t729r2142b785],
8	—	NN	O	—	nn	10	SENT_796	[p36l1929t729r2142b785],
9	genase	NN	O	genase	nn	10	SENT_796	[p36l1113t814r1280b857],
10	pathway	NN	O	pathway	prep_of	2	SENT_796	[p36l1309t800r1514b856],
11	within	IN	O	within	_	0	SENT_796	[p36l1538t800r1700b845],
12	the	DT	O	the	det	14	SENT_796	[p36l1730t800r1805b844],
13	arterial	JJ	O	arterial	amod	14	SENT_796	[p36l1834t800r2013b844],
14	wall	NN	O	wall	prep_within	1	SENT_796	[p36l2039t800r2143b845],
15	during	IN	O	during	_	0	SENT_796	[p36l1114t871r1279b928],
16	human	JJ	O	human	amod	17	SENT_796	[p36l1309t871r1481b916],
17	atherogenesis	NN	O	atherogenesis	prep_during	1	SENT_796	[p36l1513t871r1865b928],
18	.	.	O	.	_	0	SENT_796	[p36l1513t871r1865b928],

1	Proc	NNP	O	Proc	nn	7	SENT_797	[p36l1900t875r2008b915],
2	Natl	NNP	O	Natl	nn	7	SENT_797	[p36l2039t871r2143b915],
3	Acad	NNP	O	Acad	nn	7	SENT_797	[p36l1112t943r1232b987],
4	Sci	NNP	O	Sci	nn	7	SENT_797	[p36l1252t944r1320b987],
5	U	NNP	O	U	nn	7	SENT_797	[p36l1339t947r1377b987],
6	S	NNP	O	S	nn	7	SENT_797	[p36l1397t946r1420b987],
7	A	NNP	O	A	_	0	SENT_797	[p36l1439t947r1476b987],
8	2003	CD	DATE	2003	num	7	SENT_797	[p36l1494t946r1942b996],
9	;	:	O	;	_	0	SENT_797	[p36l1494t946r1942b996],
10	100:1238	CD	NUMBER	100:1238	number	11	SENT_797	[p36l1494t946r1942b996],
11	—	CD	NUMBER	—	dep	7	SENT_797	[p36l1494t946r1942b996],
12	43	CD	NUMBER	43	dep	11	SENT_797	[p36l1494t946r1942b996],
13	.	.	O	.	_	0	SENT_797	[p36l1494t946r1942b996],

1	94	CD	NUMBER	94	_	0	SENT_798	[p36l1113t1018r1179b1057],
2	.	.	O	.	_	0	SENT_798	[p36l1113t1018r1179b1057],

1	Qiu	NN	PERSON	qiu	nn	2	SENT_799	[p36l1210t1014r1295b1068],
2	H	NN	PERSON	h	_	0	SENT_799	[p36l1321t1017r1376b1067],
3	,	,	O	,	_	0	SENT_799	[p36l1321t1017r1376b1067],
4	Gabrielsen	NNP	PERSON	Gabrielsen	nn	5	SENT_799	[p36l1406t1013r1671b1057],
5	A	NNP	O	A	appos	2	SENT_799	[p36l1696t1017r1745b1067],
6	,	,	O	,	_	0	SENT_799	[p36l1696t1017r1745b1067],
7	Agardh	NNP	O	Agardh	appos	2	SENT_799	[p36l1774t1013r1956b1070],
8	HE	PRP	O	he	dep	7	SENT_799	[p36l1982t1017r2071b1067],
9	,	,	O	,	_	0	SENT_799	[p36l1982t1017r2071b1067],
10	et	FW	O	et	nn	11	SENT_799	[p36l2101t1022r2145b1057],
11	al.	FW	O	al.	appos	2	SENT_799	[p36l1113t1084r1169b1128],
12	.	.	O	.	_	0	SENT_799	[p36l1113t1084r1169b1128],

1	Expression	NN	O	expression	nsubj	14	SENT_800	[p36l1193t1085r1461b1140],
2	of	IN	O	of	_	0	SENT_800	[p36l1484t1084r1541b1128],
3	5	CD	NUMBER	5	number	4	SENT_800	[p36l1554t1084r1919b1141],
4	—	CD	NUMBER	—	num	5	SENT_800	[p36l1554t1084r1919b1141],
5	lipoxygenase	NN	O	lipoxygenase	prep_of	1	SENT_800	[p36l1554t1084r1919b1141],
6	and	CC	O	and	_	0	SENT_800	[p36l1941t1084r2030b1128],
7	leukotriene	NN	O	leukotriene	nn	9	SENT_800	[p36l2052t1084r2142b1129, p36l1113t1156r1316b1201],
8	A4	NN	O	a4	nn	9	SENT_800	[p36l1342t1160r1399b1216],
9	hydrolase	NN	O	hydrolase	conj_and	5	SENT_800	[p36l1427t1156r1662b1212],
10	in	IN	O	in	_	0	SENT_800	[p36l1690t1157r1737b1200],
11	human	JJ	O	human	amod	13	SENT_800	[p36l1766t1156r1938b1201],
12	atherosclerotic	JJ	O	atherosclerotic	amod	13	SENT_800	[p36l1966t1156r2142b1200, p36l1115t1228r1319b1272],
13	lesions	NNS	O	lesion	prep_in	9	SENT_800	[p36l1357t1228r1525b1272],
14	correlates	VBZ	O	correlate	_	0	SENT_800	[p36l1566t1228r1805b1272],
15	with	IN	O	with	_	0	SENT_800	[p36l1843t1228r1954b1272],
16	symptoms	NNS	O	symptom	prep_with	14	SENT_800	[p36l1994t1242r2142b1284, p36l1114t1308r1234b1343],
17	of	IN	O	of	_	0	SENT_800	[p36l1254t1299r1310b1343],
18	plaque	NN	O	plaque	nn	19	SENT_800	[p36l1317t1299r1479b1355],
19	instability	NN	O	instability	prep_of	16	SENT_800	[p36l1497t1299r1756b1355],
20	.	.	O	.	_	0	SENT_800	[p36l1497t1299r1756b1355],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_801	[p36l1777t1303r1885b1343],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_801	[p36l1902t1299r2006b1344],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_801	[p36l2022t1299r2142b1343],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_801	[p36l1115t1371r1182b1414],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_801	[p36l1201t1374r1239b1414],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_801	[p36l1259t1373r1283b1414],
7	A	NNP	O	A	_	0	SENT_801	[p36l1302t1374r1339b1413],
8	2006	CD	DATE	2006	num	7	SENT_801	[p36l1356t1373r1768b1423],
9	;	:	O	;	_	0	SENT_801	[p36l1356t1373r1768b1423],
10	103:8161	CD	NUMBER	103:8161	number	11	SENT_801	[p36l1356t1373r1768b1423],
11	—	CD	NUMBER	—	dep	7	SENT_801	[p36l1356t1373r1768b1423],
12	6	CD	NUMBER	6	dep	11	SENT_801	[p36l1356t1373r1768b1423],
13	.	.	O	.	_	0	SENT_801	[p36l1356t1373r1768b1423],

1	95	CD	NUMBER	95	_	0	SENT_802	[p36l1113t1446r1179b1485],
2	.	.	O	.	_	0	SENT_802	[p36l1113t1446r1179b1485],

1	Aiello	NNP	O	Aiello	nn	2	SENT_803	[p36l1207t1441r1351b1485],
2	RJ	NN	O	rj	_	0	SENT_803	[p36l1389t1445r1457b1495],
3	,	,	O	,	_	0	SENT_803	[p36l1389t1445r1457b1495],
4	Bourassa	NNP	ORGANIZATION	Bourassa	nn	5	SENT_803	[p36l1497t1445r1721b1486],
5	PA	NN	ORGANIZATION	pa	dep	2	SENT_803	[p36l1757t1445r1833b1494],
6	,	,	O	,	_	0	SENT_803	[p36l1757t1445r1833b1494],
7	Lindsey	NNP	PERSON	Lindsey	nn	8	SENT_803	[p36l1874t1441r2064b1497],
8	S	NNP	PERSON	S	appos	5	SENT_803	[p36l2100t1444r2139b1495],
9	,	,	O	,	_	0	SENT_803	[p36l2100t1444r2139b1495],

1	Weng	NNP	PERSON	Weng	nn	2	SENT_804	[p36l12t1803r306b1912],
2	W	NNP	PERSON	W	_	0	SENT_804	[p36l362t1803r489b1904],
3	,	,	O	,	_	0	SENT_804	[p36l362t1803r489b1904],
4	Freeman	NNP	PERSON	Freeman	nn	5	SENT_804	[p36l557t1803r1006b1885],
5	A	NNP	O	A	appos	2	SENT_804	[p36l1065t1803r1169b1906],
6	,	,	O	,	_	0	SENT_804	[p36l1065t1803r1169b1906],
7	Showell	NNP	O	Showell	nn	8	SENT_804	[p36l1242t1795r1642b1886],
8	HI	NNP	O	HI	appos	5	SENT_804	[p36l1704t1803r1855b1900],
9	.	.	O	.	_	0	SENT_804	[p36l1704t1803r1855b1900],

1	Leukotriene	NN	O	leukotriene	_	0	SENT_805	[p36l1924t1803r2145b1886, p36l16t1944r444b2035],

1	B4	NN	O	b4	nn	3	SENT_806	[p36l483t1952r597b2067],
2	receptor	NN	O	receptor	nn	3	SENT_806	[p36l634t1964r1064b2059],
3	antagonism	NN	O	antagonism	nsubj	4	SENT_806	[p36l1101t1946r1716b2061],
4	reduces	VBZ	O	reduce	_	0	SENT_806	[p36l1755t1944r2145b2035],
5	monocytic	JJ	O	monocytic	amod	7	SENT_806	[p36l18t2095r539b2208],
6	foam	NN	O	foam	nn	7	SENT_806	[p36l574t2091r829b2184],
7	cells	NNS	O	cell	dobj	4	SENT_806	[p36l866t2093r1082b2184],
8	in	IN	O	in	_	0	SENT_806	[p36l1121t2095r1217b2182],
9	mice	NNS	O	mouse	prep_in	4	SENT_806	[p36l1252t2095r1515b2184],
10	.	.	O	.	_	0	SENT_806	[p36l1252t2095r1515b2184],

1	Arterioscler	NN	O	arterioscler	_	0	SENT_807	[p36l1553t2093r2149b2184],

1	Thromb	NNP	O	Thromb	nn	3	SENT_808	[p36l12t2242r424b2333],
2	Vasc	NNP	O	Vasc	nn	3	SENT_808	[p36l461t2250r688b2332],
3	Biol	NNP	O	Biol	_	0	SENT_808	[p36l725t2242r921b2333],
4	2002	CD	DATE	2002	num	3	SENT_808	[p36l960t2248r1702b2351],
5	;	:	O	;	_	0	SENT_808	[p36l960t2248r1702b2351],
6	22:443	CD	NUMBER	22:443	number	7	SENT_808	[p36l960t2248r1702b2351],
7	—	CD	NUMBER	—	dep	3	SENT_808	[p36l960t2248r1702b2351],
8	9	CD	NUMBER	9	dep	7	SENT_808	[p36l960t2248r1702b2351],
9	.	.	O	.	_	0	SENT_808	[p36l960t2248r1702b2351],

1	95	CD	NUMBER	95	_	0	SENT_809	[p36l16t2401r153b2482],
2	.	.	O	.	_	0	SENT_809	[p36l16t2401r153b2482],

1	Back	RB	O	back	advmod	2	SENT_810	[p36l214t2391r459b2482],
2	M	NN	O	m	_	0	SENT_810	[p36l511t2399r636b2502],
3	,	,	O	,	_	0	SENT_810	[p36l511t2399r636b2502],
4	Bu	NNP	O	Bu	nn	5	SENT_810	[p36l702t2399r831b2482],
5	DX	NNP	O	DX	appos	2	SENT_810	[p36l890t2399r1066b2500],
6	,	,	O	,	_	0	SENT_810	[p36l890t2399r1066b2500],

1	Branstrom	NN	O	branstrom	nn	2	SENT_811	[p36l1131t2399r1672b2482],
2	R	NN	O	r	_	0	SENT_811	[p36l1731t2399r1833b2500],
3	,	,	O	,	_	0	SENT_811	[p36l1731t2399r1833b2500],
4	Sheikine	NN	O	sheikine	appos	2	SENT_811	[p36l1902t2391r2145b2482, p36l16t2540r233b2631],

1	Y	NN	O	y	_	0	SENT_812	[p36l265t2548r350b2649],
2	,	,	O	,	_	0	SENT_812	[p36l265t2548r350b2649],
3	Yan	NNP	PERSON	Yan	nn	4	SENT_812	[p36l387t2548r572b2630],
4	ZQ	NNP	O	ZQ	appos	1	SENT_812	[p36l604t2548r786b2653],
5	,	,	O	,	_	0	SENT_812	[p36l604t2548r786b2653],
6	Hansson	NNP	PERSON	Hansson	nn	7	SENT_812	[p36l827t2548r1276b2631],
7	GK	NNP	PERSON	GK	appos	4	SENT_812	[p36l1312t2546r1499b2633],
8	.	.	O	.	_	0	SENT_812	[p36l1312t2546r1499b2633],

1	Leukotriene	NN	O	leukotriene	_	0	SENT_813	[p36l1539t2540r2147b2631],

1	B4	NN	O	b4	nn	2	SENT_814	[p36l16t2697r128b2812],
2	signaling	NN	O	signaling	dep	15	SENT_814	[p36l175t2689r662b2806],
3	through	IN	O	through	_	0	SENT_814	[p36l706t2689r1125b2806],
4	N	NN	O	n	nn	5	SENT_814	[p36l1169t2697r1255b2780],
5	F	NN	O	f	prep_through	2	SENT_814	[p36l1262t2689r2145b2804],
6	—	CD	NUMBER	—	num	7	SENT_814	[p36l1262t2689r2145b2804],
7	l	NN	O	l	tmod	5	SENT_814	[p36l1262t2689r2145b2804],
8	<	JJR	O	<	amod	9	SENT_814	[p36l1262t2689r2145b2804],
9	appaB	NN	O	appab	dep	15	SENT_814	[p36l1262t2689r2145b2804],
10	—	CD	NUMBER	—	num	15	SENT_814	[p36l1262t2689r2145b2804],
11	depen	NN	O	depen	nn	15	SENT_814	[p36l1262t2689r2145b2804],
12	—	NN	O	—	nn	15	SENT_814	[p36l1262t2689r2145b2804],
13	dent	NN	O	dent	nn	15	SENT_814	[p36l18t2838r240b2929],
14	BLT1	NN	O	blt1	nn	15	SENT_814	[p36l286t2846r541b2928],
15	receptors	NNS	O	receptor	_	0	SENT_814	[p36l594t2858r1064b2953],
16	on	IN	O	on	_	0	SENT_814	[p36l1119t2868r1243b2929],
17	Vascular	JJ	O	vascular	amod	20	SENT_814	[p36l1290t2838r1714b2929],
18	smooth	JJ	O	smooth	amod	20	SENT_814	[p36l1765t2838r2147b2929],
19	muscle	NN	O	muscle	nn	20	SENT_814	[p36l18t2986r370b3077],
20	cells	NNS	O	cell	prep_on	15	SENT_814	[p36l430t2986r652b3077],
21	in	IN	O	in	_	0	SENT_814	[p36l713t2988r811b3075],
22	atherosclerosis	NN	O	atherosclerosis	prep_in	20	SENT_814	[p36l869t2986r1630b3077],
23	and	CC	O	and	_	0	SENT_814	[p36l1692t2986r1877b3077],
24	intimal	NN	O	intimal	prep_in	20	SENT_814	[p36l1936t2988r2145b3075, p36l18t3135r207b3225],

1	hyperplasia	NN	O	hyperplasium	_	0	SENT_815	[p36l244t3135r859b3250],
2	.	.	O	.	_	0	SENT_815	[p36l244t3135r859b3250],

1	Proc	NNP	O	Proc	nn	7	SENT_816	[p36l901t3143r1125b3226],
2	Natl	NNP	O	Natl	nn	7	SENT_816	[p36l1159t3135r1374b3226],
3	Acad	NNP	O	Acad	nn	7	SENT_816	[p36l1407t3135r1656b3226],
4	Sci	NNP	O	Sci	nn	7	SENT_816	[p36l1696t3137r1835b3226],
5	U	NNP	O	U	nn	7	SENT_816	[p36l1871t3143r1951b3226],
6	S	NNP	O	S	nn	7	SENT_816	[p36l1990t3141r2038b3226],
7	A	NNP	O	A	_	0	SENT_816	[p36l2075t3143r2151b3224],

1	97	CD	NUMBER	97	_	0	SENT_817	[p36l16t3443r153b3524],
2	.	.	O	.	_	0	SENT_817	[p36l16t3443r153b3524],

1	Zhao	NNP	PERSON	Zhao	nn	2	SENT_818	[p36l213t3433r460b3524],
2	L	NNP	PERSON	L	_	0	SENT_818	[p36l491t3441r577b3544],
3	,	,	O	,	_	0	SENT_818	[p36l491t3441r577b3544],
4	Moos	NNP	PERSON	Moos	nn	5	SENT_818	[p36l610t3441r883b3524],
5	MP	NNP	O	MP	appos	2	SENT_818	[p36l913t3441r1093b3542],
6	,	,	O	,	_	0	SENT_818	[p36l913t3441r1093b3542],
7	Grabner	NNP	PERSON	Grabner	nn	8	SENT_818	[p36l1129t3433r1539b3524],
8	R	NNP	O	R	appos	2	SENT_818	[p36l1565t3441r1664b3542],
9	,	,	O	,	_	0	SENT_818	[p36l1565t3441r1664b3542],
10	et	FW	O	et	nn	11	SENT_818	[p36l1702t3453r1791b3524],
11	al.	FW	O	al.	appos	2	SENT_818	[p36l1815t3433r1928b3524],
12	.	.	O	.	_	0	SENT_818	[p36l1815t3433r1928b3524],

1	The	DT	O	the	_	0	SENT_819	[p36l1960t3433r2147b3523],

1	5-lipoxygenase	NN	O	5-lipoxygenase	nn	2	SENT_820	[p36l20t3582r758b3699],
2	pathway	NN	O	pathway	nsubj	3	SENT_820	[p36l817t3582r1235b3697],
3	promotes	VBZ	O	promote	_	0	SENT_820	[p36l1288t3602r1760b3697],
4	pathogenesis	NN	O	pathogenesis	dobj	3	SENT_820	[p36l1821t3582r2145b3697, p37l16t26r380b141],

1	of	IN	O	of	dep	6	SENT_821	[p37l439t24r555b115],
2	hyperlipidemia	NN	O	hyperlipidemia	nn	3	SENT_821	[p37l588t24r1905b139],
3	—	NN	O	—	pobj	1	SENT_821	[p37l588t24r1905b139],
4	dependent	JJ	O	dependent	amod	3	SENT_821	[p37l588t24r1905b139],
5	aortic	JJ	O	aortic	amod	6	SENT_821	[p37l1954t54r2145b115, p37l18t175r137b263],
6	aneurysm	NN	O	aneurysm	_	0	SENT_821	[p37l173t203r688b288],
7	.	.	O	.	_	0	SENT_821	[p37l173t203r688b288],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_822	[p37l730t181r909b264],
2	Med	NNP	O	Med	_	0	SENT_822	[p37l938t173r1153b264],
3	2004	CD	DATE	2004	num	2	SENT_822	[p37l1191t179r1974b282],
4	;	:	O	;	_	0	SENT_822	[p37l1191t179r1974b282],
5	10:966	CD	NUMBER	10:966	number	6	SENT_822	[p37l1191t179r1974b282],
6	-73	CD	NUMBER	-73	dep	2	SENT_822	[p37l1191t179r1974b282],
7	.	.	O	.	_	0	SENT_822	[p37l1191t179r1974b282],

1	98	CD	NUMBER	98	_	0	SENT_823	[p37l16t332r153b413],
2	.	.	O	.	_	0	SENT_823	[p37l16t332r153b413],

1	Uzonyi	NNP	PERSON	Uzonyi	nn	2	SENT_824	[p37l215t324r569b437],
2	B	NNP	O	B	_	0	SENT_824	[p37l606t330r700b433],
3	,	,	O	,	_	0	SENT_824	[p37l606t330r700b433],
4	Lotzer	NNP	PERSON	Lotzer	nn	5	SENT_824	[p37l745t330r1072b413],
5	K	NNP	PERSON	K	appos	2	SENT_824	[p37l1107t330r1209b431],
6	,	,	O	,	_	0	SENT_824	[p37l1107t330r1209b431],
7	Jahn	NNP	PERSON	Jahn	nn	8	SENT_824	[p37l1243t322r1479b427],
8	S	NNP	O	S	appos	2	SENT_824	[p37l1521t328r1601b433],
9	,	,	O	,	_	0	SENT_824	[p37l1521t328r1601b433],
10	et	FW	O	et	nn	11	SENT_824	[p37l1648t342r1739b413],
11	al.	FW	O	al.	appos	2	SENT_824	[p37l1771t322r1887b413],
12	.	.	O	.	_	0	SENT_824	[p37l1771t322r1887b413],

1	Cysteinyl	NN	O	cysteinyl	nn	2	SENT_825	[p37l1932t328r2145b437, p37l18t471r294b586],
2	leukotriene	NN	O	leukotriene	nsubj	11	SENT_825	[p37l356t471r931b562],
3	2	CD	NUMBER	2	num	4	SENT_825	[p37l996t477r1050b560],
4	receptor	NN	O	receptor	dep	2	SENT_825	[p37l1115t491r1535b586],
5	and	CC	O	and	_	0	SENT_825	[p37l1594t471r1779b562],
6	protease	NN	O	protease	nn	7	SENT_825	[p37l1841t491r2145b586, p37l16t620r668b711],
7	—	NN	O	—	conj_and	2	SENT_825	[p37l1841t491r2145b586, p37l16t620r668b711],
8	activated	VBN	O	activate	partmod	7	SENT_825	[p37l1841t491r2145b586, p37l16t620r668b711],
9	receptor	NN	O	receptor	dobj	8	SENT_825	[p37l722t640r1143b735],
10	1	CD	NUMBER	1	num	9	SENT_825	[p37l1195t628r1247b709],
11	activate	VBP	O	activate	_	0	SENT_825	[p37l1300t622r1680b711],
12	strongly	RB	O	strongly	advmod	11	SENT_825	[p37l1735t620r2153b737],
13	correlated	VBN	O	correlate	dep	11	SENT_825	[p37l18t769r527b860],
14	early	JJ	O	early	amod	15	SENT_825	[p37l567t769r809b884],
15	genes	NNS	O	gene	dobj	13	SENT_825	[p37l843t799r1127b886],
16	in	IN	O	in	_	0	SENT_825	[p37l1167t771r1264b858],
17	human	JJ	O	human	amod	19	SENT_825	[p37l1302t769r1658b860],
18	endothelial	JJ	O	endothelial	amod	19	SENT_825	[p37l1698t769r2145b860, p37l16t918r175b1008],
19	cells	NNS	O	cell	prep_in	13	SENT_825	[p37l221t918r473b1009],
20	.	.	O	.	_	0	SENT_825	[p37l221t918r473b1009],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_826	[p37l525t926r748b1009],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_826	[p37l791t918r1006b1009],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_826	[p37l1046t918r1296b1009],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_826	[p37l1344t920r1485b1009],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_826	[p37l1529t926r1608b1009],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_826	[p37l1654t924r1704b1009],
7	A	NNP	O	A	_	0	SENT_826	[p37l1749t926r1825b1007],
8	2006	CD	DATE	2006	num	7	SENT_826	[p37l1867t924r2143b1027],
9	;	:	O	;	_	0	SENT_826	[p37l1867t924r2143b1027],
10	103:6326	CD	NUMBER	103:6326	number	11	SENT_826	[p37l20t1072r652b1157],
11	-31	CD	NUMBER	-31	dep	7	SENT_826	[p37l20t1072r652b1157],
12	.	.	O	.	_	0	SENT_826	[p37l20t1072r652b1157],

1	99	CD	NUMBER	99	_	0	SENT_827	[p37l16t1225r153b1306],
2	.	.	O	.	_	0	SENT_827	[p37l16t1225r153b1306],

1	Kajimoto	NNP	PERSON	Kajimoto	nn	2	SENT_828	[p37l215t1217r662b1330],
2	K	NNP	PERSON	K	_	0	SENT_828	[p37l721t1223r819b1326],
3	,	,	O	,	_	0	SENT_828	[p37l721t1223r819b1326],
4	Shioji	NNP	PERSON	Shioji	nn	5	SENT_828	[p37l887t1215r1155b1330],
5	K	NNP	PERSON	K	appos	2	SENT_828	[p37l1212t1223r1310b1326],
6	,	,	O	,	_	0	SENT_828	[p37l1212t1223r1310b1326],
7	Ishida	NNP	PERSON	Ishida	nn	8	SENT_828	[p37l1374t1215r1674b1306],
8	C	NNP	O	C	appos	2	SENT_828	[p37l1731t1223r1825b1326],
9	,	,	O	,	_	0	SENT_828	[p37l1731t1223r1825b1326],
10	et	FW	O	et	nn	11	SENT_828	[p37l1891t1235r1980b1305],
11	al.	FW	O	al.	appos	2	SENT_828	[p37l2030t1215r2141b1306],
12	.	.	O	.	_	0	SENT_828	[p37l2030t1215r2141b1306],

1	Validation	NN	O	validation	_	0	SENT_829	[p37l12t1363r533b1454],
2	of	IN	O	of	_	0	SENT_829	[p37l576t1363r694b1454],
3	the	DT	O	the	det	4	SENT_829	[p37l714t1363r871b1452],
4	association	NN	O	association	prep_of	1	SENT_829	[p37l912t1365r1485b1454],
5	between	IN	O	between	_	0	SENT_829	[p37l1527t1363r1948b1454],
6	the	DT	O	the	det	9	SENT_829	[p37l1990t1363r2147b1454],
7	gene	NN	O	gene	nn	9	SENT_829	[p37l16t1542r251b1629],
8	encoding	VBG	O	encode	amod	9	SENT_829	[p37l314t1512r787b1629],
9	5-lipoxygenase	NN	O	5-lipoxygenase	prep_between	4	SENT_829	[p37l847t1512r2151b1629],
10	—	CD	NUMBER	—	num	12	SENT_829	[p37l847t1512r2151b1629],
11	activating	VBG	O	activate	amod	12	SENT_829	[p37l847t1512r2151b1629],
12	protein	NN	O	protein	dep	1	SENT_829	[p37l14t1663r368b1776],
13	and	CC	O	and	_	0	SENT_829	[p37l400t1661r580b1752],
14	myocardial	JJ	O	myocardial	amod	15	SENT_829	[p37l612t1661r1157b1776],
15	infarction	NN	O	infarction	conj_and	12	SENT_829	[p37l1187t1661r1672b1752],
16	in	IN	O	in	_	0	SENT_829	[p37l1704t1663r1799b1750],
17	aJapanese	JJ	O	ajapanese	amod	18	SENT_829	[p37l1831t1669r2145b1776, p37l16t1840r231b1901],
18	population	NN	O	population	prep_in	15	SENT_829	[p37l264t1810r825b1925],
19	.	.	O	.	_	0	SENT_829	[p37l264t1810r825b1925],

1	CircJ	NNP	O	CircJ	_	0	SENT_830	[p37l867t1812r1129b1915],
2	2005	CD	DATE	2005	num	1	SENT_830	[p37l1161t1816r1982b1919],
3	;	:	O	;	_	0	SENT_830	[p37l1161t1816r1982b1919],
4	69:1029	CD	NUMBER	69:1029	number	5	SENT_830	[p37l1161t1816r1982b1919],
5	—	CD	NUMBER	—	dep	1	SENT_830	[p37l1161t1816r1982b1919],
6	34	CD	NUMBER	34	dep	5	SENT_830	[p37l1161t1816r1982b1919],
7	.	.	O	.	_	0	SENT_830	[p37l1161t1816r1982b1919],

1	100	CD	NUMBER	100	_	0	SENT_831	[p37l22t1969r211b2050],
2	.	.	O	.	_	0	SENT_831	[p37l22t1969r211b2050],

1	I-lakonarson	NN	O	i-lakonarson	nn	2	SENT_832	[p37l274t1959r903b2050],
2	H	NN	O	h	_	0	SENT_832	[p37l936t1967r1048b2068],
3	,	,	O	,	_	0	SENT_832	[p37l936t1967r1048b2068],
4	Thorvaldsson	NNP	PERSON	Thorvaldsson	nn	5	SENT_832	[p37l1085t1959r1779b2050],
5	S	NNP	PERSON	S	appos	2	SENT_832	[p37l1817t1965r1897b2068],
6	,	,	O	,	_	0	SENT_832	[p37l1817t1965r1897b2068],
7	Helgadottir	NNP	O	Helgadottir	nn	8	SENT_832	[p37l1936t1959r2145b2050, p37l16t2108r428b2225],
8	A	NNP	O	A	appos	2	SENT_832	[p37l461t2116r565b2217],
9	,	,	O	,	_	0	SENT_832	[p37l461t2116r565b2217],
10	et	FW	O	et	nn	11	SENT_832	[p37l612t2127r704b2199],
11	al.	FW	O	al.	appos	2	SENT_832	[p37l737t2108r853b2199],
12	.	.	O	.	_	0	SENT_832	[p37l737t2108r853b2199],

1	Effects	NNS	O	effect	_	0	SENT_833	[p37l898t2106r1245b2198],
2	of	IN	O	of	_	0	SENT_833	[p37l1290t2106r1406b2199],
3	a	DT	O	a	det	5	SENT_833	[p37l1425t2138r1477b2198],
4	5lipoxygenase	JJ	O	5lipoxygenase	amod	5	SENT_833	[p37l1517t2108r2145b2225, p37l16t2259r688b2374],
5	—	NN	O	—	prep_of	1	SENT_833	[p37l1517t2108r2145b2225, p37l16t2259r688b2374],
6	activating	VBG	O	activate	partmod	5	SENT_833	[p37l1517t2108r2145b2225, p37l16t2259r688b2374],
7	protein	NN	O	protein	nn	8	SENT_833	[p37l710t2259r1064b2372],
8	inhibitor	NN	O	inhibitor	dobj	6	SENT_833	[p37l1089t2257r1523b2348],
9	on	IN	O	on	_	0	SENT_833	[p37l1548t2287r1668b2348],
10	biomarl	NN	O	biomarl	prep_on	1	SENT_833	[p37l1696t2257r2145b2348],
11	<	JJR	O	<	amod	12	SENT_833	[p37l1696t2257r2145b2348],
12	ers	NNPS	O	ers	dobj	13	SENT_833	[p37l18t2436r163b2496],
13	associated	VBN	O	associate	partmod	1	SENT_833	[p37l234t2406r772b2497],
14	with	IN	O	with	_	0	SENT_833	[p37l837t2406r1070b2497],
15	risk	NN	O	risk	prep_with	13	SENT_833	[p37l1139t2406r1336b2497],
16	of	IN	O	of	_	0	SENT_833	[p37l1403t2406r1521b2497],
17	myocardial	JJ	O	myocardial	amod	18	SENT_833	[p37l1569t2406r2147b2521],
18	infarction	NN	O	infarction	prep_of	15	SENT_833	[p37l16t2555r539b2646],
19	:	:	O	:	_	0	SENT_833	[p37l16t2555r539b2646],
20	a	DT	O	a	det	22	SENT_833	[p37l574t2585r626b2645],
21	randomized	JJ	O	randomized	amod	22	SENT_833	[p37l656t2555r1258b2646],
22	trial	NN	O	trial	dep	15	SENT_833	[p37l1288t2555r1521b2646],
23	.	.	O	.	_	0	SENT_833	[p37l1288t2555r1521b2646],

1	JAMA	NNP	O	JAMA	_	0	SENT_834	[p37l1547t2563r1845b2660],
2	2005	CD	DATE	2005	num	1	SENT_834	[p37l1873t2561r2143b2664],
3	;	:	O	;	_	0	SENT_834	[p37l1873t2561r2143b2664],
4	293:2245	CD	NUMBER	293:2245	number	5	SENT_834	[p37l18t2709r656b2794],
5	—	CD	NUMBER	—	dep	1	SENT_834	[p37l18t2709r656b2794],
6	56	CD	NUMBER	56	dep	5	SENT_834	[p37l18t2709r656b2794],
7	.	.	O	.	_	0	SENT_834	[p37l18t2709r656b2794],

1	101	CD	NUMBER	101	_	0	SENT_835	[p37l22t2862r211b2943],
2	.	.	O	.	_	0	SENT_835	[p37l22t2862r211b2943],

1	Meschia	NNP	O	Meschia	_	0	SENT_836	[p37l294t2852r716b2942],
2	IF	IN	O	if	prep	1	SENT_836	[p37l749t2860r877b2961],
3	,	,	O	,	_	0	SENT_836	[p37l749t2860r877b2961],
4	Brott	NNP	PERSON	Brott	nn	5	SENT_836	[p37l928t2860r1187b2943],
5	TG	NN	O	tg	appos	1	SENT_836	[p37l1223t2858r1406b2961],
6	,	,	O	,	_	0	SENT_836	[p37l1223t2858r1406b2961],
7	Brown	NNP	PERSON	Brown	nn	9	SENT_836	[p37l1457t2860r1789b2943],
8	RD	NNP	PERSON	RD	nn	9	SENT_836	[p37l1835t2860r1996b2949],
9	Jr	NNP	PERSON	Jr	appos	1	SENT_836	[p37l2032t2860r2141b2961],
10	,	,	O	,	_	0	SENT_836	[p37l2032t2860r2141b2961],
11	et	FW	O	et	nn	12	SENT_836	[p37l18t3021r108b3091],
12	al.	FW	O	al.	appos	1	SENT_836	[p37l153t3001r265b3092],
13	.	.	O	.	_	0	SENT_836	[p37l153t3001r265b3092],

1	Phosphodiesterase	NN	O	phosphodiesterase	nn	2	SENT_837	[p37l318t3001r1247b3116],
2	4D	NN	O	4d	_	0	SENT_837	[p37l1294t3009r1433b3092],
3	and	CC	O	and	_	0	SENT_837	[p37l1481t3001r1664b3092],
4	5	CD	NUMBER	5	num	5	SENT_837	[p37l1714t3001r2145b3116],
5	—	NN	O	—	conj_and	2	SENT_837	[p37l1714t3001r2145b3116],
6	lipoxy	NN	O	lipoxy	nn	8	SENT_837	[p37l1714t3001r2145b3116],
7	—	NN	O	—	nn	8	SENT_837	[p37l1714t3001r2145b3116],
8	genase	NN	O	genase	dep	5	SENT_837	[p37l16t3180r362b3267],
9	activating	VBG	O	activate	partmod	2	SENT_837	[p37l457t3152r957b3267],
10	protein	NN	O	protein	dobj	9	SENT_837	[p37l1046t3152r1414b3265],
11	in	IN	O	in	_	0	SENT_837	[p37l1509t3152r1606b3239],
12	ischemic	JJ	O	ischemic	amod	13	SENT_837	[p37l1700t3150r2147b3241],
13	stroke	NN	O	stroke	prep_in	10	SENT_837	[p37l18t3299r358b3390],
14	.	.	O	.	_	0	SENT_837	[p37l18t3299r358b3390],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_838	[p37l399t3307r614b3388],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_838	[p37l652t3299r998b3390],
3	2005	CD	DATE	2005	num	2	SENT_838	[p37l1038t3305r1829b3408],
4	;	:	O	;	_	0	SENT_838	[p37l1038t3305r1829b3408],
5	58:351	CD	NUMBER	58:351	number	6	SENT_838	[p37l1038t3305r1829b3408],
6	-61	CD	NUMBER	-61	dep	2	SENT_838	[p37l1038t3305r1829b3408],
7	.	.	O	.	_	0	SENT_838	[p37l1038t3305r1829b3408],

1	102	CD	NUMBER	102	_	0	SENT_839	[p37l22t3458r211b3539],
2	.	.	O	.	_	0	SENT_839	[p37l22t3458r211b3539],

1	Zee	NN	O	zee	nn	2	SENT_840	[p37l270t3456r444b3538],
2	RY	NN	O	ry	_	0	SENT_840	[p37l477t3456r634b3559],
3	,	,	O	,	_	0	SENT_840	[p37l477t3456r634b3559],
4	Cheng	NNP	PERSON	Cheng	nn	5	SENT_840	[p37l674t3448r1000b3565],
5	S	NNP	PERSON	S	appos	2	SENT_840	[p37l1032t3456r1111b3559],
6	,	,	O	,	_	0	SENT_840	[p37l1032t3456r1111b3559],
7	Hegener	NNP	PERSON	Hegener	nn	8	SENT_840	[p37l1151t3456r1579b3565],
8	HH	NNP	O	HH	appos	2	SENT_840	[p37l1608t3456r1811b3557],
9	,	,	O	,	_	0	SENT_840	[p37l1608t3456r1811b3557],
10	Erlich	NNP	ORGANIZATION	Erlich	nn	11	SENT_840	[p37l1851t3448r2147b3538],
11	HA	NNP	ORGANIZATION	HA	appos	2	SENT_840	[p37l16t3605r209b3706],
12	,	,	O	,	_	0	SENT_840	[p37l16t3605r209b3706],
13	Ridker	NNP	PERSON	Ridker	nn	14	SENT_840	[p37l268t3597r610b3694],
14	PM	NNP	O	PM	appos	2	SENT_840	[p37l658t3605r843b3688],
15	.	.	O	.	_	0	SENT_840	[p37l658t3605r843b3688],

1	Genetic	JJ	O	genetic	amod	2	SENT_841	[p37l904t3599r1294b3688],
2	variants	NNS	O	variant	_	0	SENT_841	[p37l1342t3599r1748b3688],
3	of	IN	O	of	_	0	SENT_841	[p37l1805t3597r1923b3688],
4	arachidonate	NN	O	arachidonate	prep_of	2	SENT_841	[p37l1954t3627r2145b3687, p38l18t27r515b118],

1	5	CD	NUMBER	5	number	2	SENT_842	[p38l578t27r1881b144],
2	—	CD	NUMBER	—	_	0	SENT_842	[p38l578t27r1881b144],
3	lipoXygenase	NN	O	lipoxygenase	dep	2	SENT_842	[p38l578t27r1881b144],
4	—	CD	NUMBER	—	num	3	SENT_842	[p38l578t27r1881b144],
5	activating	VBG	O	activate	partmod	2	SENT_842	[p38l578t27r1881b144],
6	protein	NN	O	protein	dobj	5	SENT_842	[p38l1936t57r2145b142, p38l18t178r237b287],
7	,	,	O	,	_	0	SENT_842	[p38l1936t57r2145b142, p38l18t178r237b287],
8	and	CC	O	and	_	0	SENT_842	[p38l296t176r481b267],
9	risk	NN	O	risk	conj_and	2	SENT_842	[p38l535t176r730b267],
10	of	IN	O	of	_	0	SENT_842	[p38l779t176r897b267],
11	incident	NN	O	incident	nn	13	SENT_842	[p38l928t176r1342b267],
12	myocardial	JJ	O	myocardial	amod	13	SENT_842	[p38l1390t176r1958b291],
13	infarction	NN	O	infarction	prep_of	9	SENT_842	[p38l2010t178r2145b265, p38l16t322r426b415],
14	and	CC	O	and	_	0	SENT_842	[p38l493t324r682b415],
15	ischemic	JJ	O	ischemic	amod	16	SENT_842	[p38l749t324r1205b413],
16	stroke	NN	O	stroke	conj_and	13	SENT_842	[p38l1275t324r1622b415],
17	:	:	O	:	_	0	SENT_842	[p38l1275t324r1622b415],
18	a	DT	O	a	det	20	SENT_842	[p38l1695t354r1746b413],
19	nested	JJ	O	nested	amod	20	SENT_842	[p38l1813t324r2147b415],
20	case	NN	O	case	dep	2	SENT_842	[p38l18t473r642b564],
21	—	CD	NUMBER	—	num	23	SENT_842	[p38l18t473r642b564],
22	control	NN	O	control	nn	23	SENT_842	[p38l18t473r642b564],
23	approach	NN	O	approach	dep	20	SENT_842	[p38l727t473r1221b588],
24	.	.	O	.	_	0	SENT_842	[p38l727t473r1221b588],

1	Stroke	NNP	O	Stroke	_	0	SENT_843	[p38l1316t473r1634b564],
2	2006	CD	DATE	2006	num	1	SENT_843	[p38l1721t479r2143b582],
3	;	:	O	;	_	0	SENT_843	[p38l1721t479r2143b582],
4	37	CD	NUMBER	37	num	6	SENT_843	[p38l1721t479r2143b582],
5	:	:	O	:	_	0	SENT_843	[p38l1721t479r2143b582],
6	2007-11	CD	DATE	2007-11	dep	1	SENT_843	[p38l18t627r434b712],
7	.	.	O	.	_	0	SENT_843	[p38l18t627r434b712],

1	103	CD	NUMBER	103	_	0	SENT_844	[p38l22t780r211b861],
2	.	.	O	.	_	0	SENT_844	[p38l22t780r211b861],

1	Kaushal	JJ	PERSON	kaushal	amod	2	SENT_845	[p38l284t770r694b863],
2	R	NN	PERSON	r	_	0	SENT_845	[p38l731t778r833b879],
3	,	,	O	,	_	0	SENT_845	[p38l731t778r833b879],
4	Pal	NN	O	pal	nn	5	SENT_845	[p38l879t770r1030b860],
5	P	NN	O	p	appos	2	SENT_845	[p38l1069t778r1147b879],
6	,	,	O	,	_	0	SENT_845	[p38l1069t778r1147b879],
7	Alwell	NNP	PERSON	Alwell	nn	8	SENT_845	[p38l1189t770r1511b861],
8	K	NNP	PERSON	K	appos	2	SENT_845	[p38l1550t778r1652b879],
9	,	,	O	,	_	0	SENT_845	[p38l1550t778r1652b879],
10	et	FW	O	et	nn	11	SENT_845	[p38l1700t790r1790b860],
11	al.	FW	O	al.	appos	2	SENT_845	[p38l1823t770r1938b861],
12	.	.	O	.	_	0	SENT_845	[p38l1823t770r1938b861],

1	Association	NNP	O	Association	_	0	SENT_846	[p38l1980t778r2145b860, p38l18t920r460b1009],
2	of	IN	O	of	_	0	SENT_846	[p38l485t918r600b1009],
3	ALOXSAP	NNP	O	ALOXSAP	prep_of	1	SENT_846	[p38l599t924r1084b1009],
4	with	IN	O	with	_	0	SENT_846	[p38l1101t918r1324b1009],
5	ischemic	JJ	O	ischemic	amod	6	SENT_846	[p38l1348t918r1777b1009],
6	stroke	NN	O	stroke	prep_with	3	SENT_846	[p38l1803t918r2143b1009],
7	:	:	O	:	_	0	SENT_846	[p38l1803t918r2143b1009],
8	a	DT	O	a	det	10	SENT_846	[p38l16t1097r68b1157],
9	population	NN	O	population	nn	10	SENT_846	[p38l143t1067r1050b1182],
10	—	NN	O	—	dep	1	SENT_846	[p38l143t1067r1050b1182],
11	based	VBN	O	base	partmod	10	SENT_846	[p38l143t1067r1050b1182],
12	case	NN	O	case	nsubj	15	SENT_846	[p38l1129t1067r1767b1158],
13	—	CD	NUMBER	—	num	15	SENT_846	[p38l1129t1067r1767b1158],
14	control	NN	O	control	nn	15	SENT_846	[p38l1129t1067r1767b1158],
15	study	NN	O	study	xcomp	11	SENT_846	[p38l1847t1067r2141b1182],
16	.	.	O	.	_	0	SENT_846	[p38l1847t1067r2141b1182],

1	Hum	NNP	O	Hum	nn	2	SENT_847	[p38l16t1224r268b1307],
2	Genet	NNP	O	Genet	_	0	SENT_847	[p38l308t1222r611b1307],
3	2007	CD	DATE	2007	num	2	SENT_847	[p38l644t1224r1419b1325],
4	;	:	O	;	_	0	SENT_847	[p38l644t1224r1419b1325],
5	121:601	CD	NUMBER	121:601	num	6	SENT_847	[p38l644t1224r1419b1325],
6	—	NN	O	—	dep	2	SENT_847	[p38l644t1224r1419b1325],
7	7	CD	NUMBER	7	dep	6	SENT_847	[p38l644t1224r1419b1325],
8	.	.	O	.	_	0	SENT_847	[p38l644t1224r1419b1325],

1	104	CD	NUMBER	104	_	0	SENT_848	[p38l22t1375r211b1456],
2	.	.	O	.	_	0	SENT_848	[p38l22t1375r211b1456],

1	lovannisci	NN	O	lovanniscus	nn	2	SENT_849	[p38l306t1367r827b1456],
2	DM	NN	O	dm	_	0	SENT_849	[p38l877t1373r1084b1474],
3	,	,	O	,	_	0	SENT_849	[p38l877t1373r1084b1474],
4	Lammer	NN	PERSON	lammer	nn	5	SENT_849	[p38l1141t1373r1569b1456],
5	E	NN	O	e	appos	2	SENT_849	[p38l1614t1373r1738b1474],
6	]	CD	NUMBER	]	dep	5	SENT_849	[p38l1614t1373r1738b1474],
7	,	,	O	,	_	0	SENT_849	[p38l1614t1373r1738b1474],
8	Steiner	NNP	PERSON	Steiner	nn	9	SENT_849	[p38l1799t1367r2151b1456],
9	L	NNP	O	L	appos	2	SENT_849	[p38l16t1522r104b1623],
10	,	,	O	,	_	0	SENT_849	[p38l16t1522r104b1623],
11	et	FW	O	et	nn	12	SENT_849	[p38l165t1534r257b1605],
12	al.	FW	O	al.	appos	2	SENT_849	[p38l306t1514r420b1605],
13	.	.	O	.	_	0	SENT_849	[p38l306t1514r420b1605],

1	Association	NNP	O	Association	dep	12	SENT_850	[p38l477t1516r1074b1605],
2	between	IN	O	between	_	0	SENT_850	[p38l1129t1514r1551b1605],
3	a	DT	O	a	det	6	SENT_850	[p38l1604t1544r1656b1604],
4	leukotri	NN	O	leukotrus	nn	6	SENT_850	[p38l1708t1514r2145b1605],
5	—	NN	O	—	nn	6	SENT_850	[p38l1708t1514r2145b1605],
6	ene	NN	O	ene	prep_between	1	SENT_850	[p38l18t1693r187b1753],
7	C	NN	O	c	dep	12	SENT_850	[p38l234t1669r301b1754],
8	4	CD	NUMBER	4	num	7	SENT_850	[p38l308t1742r348b1786],
9	synthase	NN	O	synthase	nn	12	SENT_850	[p38l396t1663r837b1778],
10	gene	NN	O	gene	nn	12	SENT_850	[p38l884t1693r1118b1780],
11	promoter	NN	O	promoter	nn	12	SENT_850	[p38l1165t1683r1642b1778],
12	polymorphism	NN	O	polymorphism	dep	23	SENT_850	[p38l1684t1663r2145b1778, p38l16t1812r332b1927],
13	and	CC	O	and	_	0	SENT_850	[p38l410t1812r595b1903],
14	coronary	JJ	O	coronary	amod	16	SENT_850	[p38l674t1842r1129b1927],
15	artery	NN	O	artery	nn	16	SENT_850	[p38l1201t1832r1501b1927],
16	calcium	NN	O	calcium	dep	23	SENT_850	[p38l1576t1812r1972b1903],
17	in	IN	O	in	_	0	SENT_850	[p38l2049t1814r2147b1901],
18	young	JJ	O	young	amod	19	SENT_850	[p38l12t1991r326b2078],
19	women	NNS	O	woman	prep_in	12	SENT_850	[p38l354t1991r754b2052],
20	:	:	O	:	_	0	SENT_850	[p38l354t1991r754b2052],
21	the	DT	O	the	det	23	SENT_850	[p38l795t1961r952b2051],
22	Muscatine	NNP	ORGANIZATION	Muscatine	nn	23	SENT_850	[p38l986t1963r1511b2052],
23	Study	NNP	ORGANIZATION	Study	_	0	SENT_850	[p38l1551t1961r1847b2076],
24	.	.	O	.	_	0	SENT_850	[p38l1551t1961r1847b2076],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_851	[p38l1886t1969r2145b2052, p38l16t2110r398b2201],
2	Thromb	NNP	O	Thromb	nn	4	SENT_851	[p38l429t2110r841b2201],
3	Vasc	NNP	O	Vasc	nn	4	SENT_851	[p38l878t2118r1104b2200],
4	Biol	NNP	O	Biol	_	0	SENT_851	[p38l1141t2110r1338b2201],
5	2007	CD	DATE	2007	num	4	SENT_851	[p38l1377t2116r2105b2219],
6	;	:	O	;	_	0	SENT_851	[p38l1377t2116r2105b2219],
7	27:394	CD	NUMBER	27:394	number	8	SENT_851	[p38l1377t2116r2105b2219],
8	—	CD	NUMBER	—	dep	4	SENT_851	[p38l1377t2116r2105b2219],
9	9	CD	NUMBER	9	dep	8	SENT_851	[p38l1377t2116r2105b2219],
10	.	.	O	.	_	0	SENT_851	[p38l1377t2116r2105b2219],

1	105	CD	NUMBER	105	_	0	SENT_852	[p38l22t2269r211b2350],
2	.	.	O	.	_	0	SENT_852	[p38l22t2269r211b2350],

1	Dwyer	NNP	PERSON	Dwyer	nn	2	SENT_853	[p38l294t2267r622b2374],
2	JH	NNP	O	JH	_	0	SENT_853	[p38l652t2267r813b2368],
3	,	,	O	,	_	0	SENT_853	[p38l652t2267r813b2368],
4	Allayee	NNP	PERSON	Allayee	nn	5	SENT_853	[p38l861t2259r1225b2374],
5	H	NNP	PERSON	H	appos	2	SENT_853	[p38l1270t2267r1382b2370],
6	,	,	O	,	_	0	SENT_853	[p38l1270t2267r1382b2370],
7	Dwyer	NNP	PERSON	Dwyer	nn	8	SENT_853	[p38l1433t2267r1760b2374],
8	KM	NNP	O	KM	appos	2	SENT_853	[p38l1801t2267r2010b2368],
9	,	,	O	,	_	0	SENT_853	[p38l1801t2267r2010b2368],
10	et	FW	O	et	nn	11	SENT_853	[p38l2062t2279r2153b2349],
11	al.	FW	O	al.	appos	2	SENT_853	[p38l16t2408r131b2499],
12	.	.	O	.	_	0	SENT_853	[p38l16t2408r131b2499],

1	Arachidonate	NN	O	arachidonate	nn	2	SENT_854	[p38l167t2408r849b2499],
2	5-lipoxygenase	NN	O	5-lipoxygenase	_	0	SENT_854	[p38l885t2408r1640b2525],
3	promoter	NN	O	promoter	nn	4	SENT_854	[p38l1674t2428r2151b2523],
4	genotype	NN	O	genotype	dep	2	SENT_854	[p38l16t2577r489b2674],
5	,	,	O	,	_	0	SENT_854	[p38l16t2577r489b2674],
6	dietary	JJ	O	dietary	amod	8	SENT_854	[p38l525t2557r865b2672],
7	arachidonic	JJ	O	arachidonic	amod	8	SENT_854	[p38l888t2557r1461b2648],
8	acid	NN	O	acid	dep	2	SENT_854	[p38l1487t2557r1706b2666],
9	,	,	O	,	_	0	SENT_854	[p38l1487t2557r1706b2666],
10	and	CC	O	and	_	0	SENT_854	[p38l1741t2557r1921b2648],
11	atherosclerosis	NN	O	atherosclerosis	conj_and	4	SENT_854	[p38l1948t2557r2145b2647, p38l18t2706r644b2797],
12	.	.	O	.	_	0	SENT_854	[p38l1948t2557r2145b2647, p38l18t2706r644b2797],

1	N	NN	O	n	nn	3	SENT_855	[p38l704t2714r791b2797],
2	Engll	NNP	O	Engll	nn	3	SENT_855	[p38l845t2706r1161b2823],
3	Med	NNP	O	Med	_	0	SENT_855	[p38l1213t2706r1431b2797],
4	2004	CD	DATE	2004	num	3	SENT_855	[p38l1487t2712r2145b2815, p38l18t2860r147b2945],
5	;	:	O	;	_	0	SENT_855	[p38l1487t2712r2145b2815, p38l18t2860r147b2945],
6	350:2937	CD	NUMBER	350:2937	dep	3	SENT_855	[p38l1487t2712r2145b2815, p38l18t2860r147b2945],
7	.	.	O	.	_	0	SENT_855	[p38l1487t2712r2145b2815, p38l18t2860r147b2945],

1	106	CD	NUMBER	106	_	0	SENT_856	[p38l22t3013r211b3094],
2	.	.	O	.	_	0	SENT_856	[p38l22t3013r211b3094],

1	Gonzalez	NNP	PERSON	Gonzalez	nn	2	SENT_857	[p38l312t3001r791b3094],
2	P	NN	PERSON	p	dep	18	SENT_857	[p38l843t3011r921b3114],
3	,	,	O	,	_	0	SENT_857	[p38l843t3011r921b3114],
4	Reguero	NN	O	reguero	nn	5	SENT_857	[p38l980t3011r1402b3120],
5	JR	NN	O	jr	appos	2	SENT_857	[p38l1445t3011r1595b3114],
6	,	,	O	,	_	0	SENT_857	[p38l1445t3011r1595b3114],
7	Lozano	NNP	PERSON	Lozano	nn	8	SENT_857	[p38l1654t3011r2024b3094],
8	I	NNP	O	I	appos	2	SENT_857	[p38l2079t3011r2141b3112],
9	,	,	O	,	_	0	SENT_857	[p38l2079t3011r2141b3112],
10	Moris	NNP	PERSON	Moris	nn	11	SENT_857	[p38l14t3154r310b3243],
11	C	NNP	O	C	appos	2	SENT_857	[p38l407t3160r505b3263],
12	,	,	O	,	_	0	SENT_857	[p38l407t3160r505b3263],
13	Coto	NNP	O	Coto	nn	15	SENT_857	[p38l606t3158r847b3243],
14	E.	NNP	O	E.	nn	15	SENT_857	[p38l942t3160r1034b3243],
15	A	NNP	O	A	appos	2	SENT_857	[p38l1131t3160r1207b3241],
16	functional	JJ	O	functional	amod	17	SENT_857	[p38l1298t3152r1837b3243],
17	Spll	NNP	O	Spll	dep	18	SENT_857	[p38l1934t3158r2145b3267],
18	Egr1	NN	O	egr1	dep	31	SENT_857	[p38l16t3301r672b3418],
19	—	CD	NUMBER	—	num	22	SENT_857	[p38l16t3301r672b3418],
20	tandem	JJ	O	tandem	amod	22	SENT_857	[p38l16t3301r672b3418],
21	repeat	NN	O	repeat	nn	22	SENT_857	[p38l712t3321r1028b3416],
22	polymorphism	NN	O	polymorphism	dep	18	SENT_857	[p38l1061t3301r1811b3416],
23	in	IN	O	in	_	0	SENT_857	[p38l1851t3303r1948b3390],
24	the	DT	O	the	det	28	SENT_857	[p38l1988t3301r2147b3391],
25	5	CD	NUMBER	5	num	28	SENT_857	[p38l20t3450r758b3567],
26	—	NN	O	—	nn	28	SENT_857	[p38l20t3450r758b3567],
27	lipoxygenase	NN	O	lipoxygenase	nn	28	SENT_857	[p38l20t3450r758b3567],
28	gene	NN	O	gene	prep_in	22	SENT_857	[p38l795t3480r1026b3567],
29	is	VBZ	O	be	auxpass	31	SENT_857	[p38l1061t3452r1137b3540],
30	not	RB	O	not	neg	31	SENT_857	[p38l1177t3470r1342b3541],
31	associated	VBN	O	associate	_	0	SENT_857	[p38l1372t3450r1887b3541],
32	with	IN	O	with	_	0	SENT_857	[p38l1918t3450r2147b3541],
33	myocardial	JJ	O	myocardial	amod	34	SENT_857	[p38l18t3599r584b3714],
34	infarction	NN	O	infarction	prep_with	31	SENT_857	[p38l618t3599r1151b3690],
35	.	.	O	.	_	0	SENT_857	[p38l618t3599r1151b3690],

1	Int	NN	O	int	_	0	SENT_858	[p38l1191t3607r1398b3704],
2	]	CD	NUMBER	]	num	3	SENT_858	[p38l1191t3607r1398b3704],
3	Immunogenet	NN	O	immunogenet	dep	1	SENT_858	[p38l1429t3607r2153b3716],

1	2007	CD	DATE	2007	_	0	SENT_859	[p39l18t26r805b129],
2	;	:	O	;	_	0	SENT_859	[p39l18t26r805b129],
3	34:127	CD	NUMBER	34:127	number	4	SENT_859	[p39l18t26r805b129],
4	—	CD	NUMBER	—	dep	1	SENT_859	[p39l18t26r805b129],
5	30	CD	NUMBER	30	dep	4	SENT_859	[p39l18t26r805b129],
6	.	.	O	.	_	0	SENT_859	[p39l18t26r805b129],

1	107	CD	NUMBER	107	_	0	SENT_860	[p39l22t179r211b260],
2	.	.	O	.	_	0	SENT_860	[p39l22t179r211b260],

1	Mezhybovska	FW	O	mezhybovska	_	0	SENT_861	[p39l304t169r988b284],
2	M	NN	O	m	nsubj	18	SENT_861	[p39l1034t177r1161b280],
3	,	,	O	,	_	0	SENT_861	[p39l1034t177r1161b280],
4	Wikstrém	NNP	PERSON	Wikstrém	nn	5	SENT_861	[p39l1215t169r1726b260],
5	K	NNP	PERSON	K	appos	2	SENT_861	[p39l1777t177r1879b278],
6	,	,	O	,	_	0	SENT_861	[p39l1777t177r1879b278],
7	Ohd	NNP	ORGANIZATION	Ohd	nn	8	SENT_861	[p39l1936t169r2147b260],
8	JF	NNP	O	JF	appos	2	SENT_861	[p39l6t326r132b427],
9	,	,	O	,	_	0	SENT_861	[p39l6t326r132b427],
10	Sjolander	NNP	O	Sjolander	nn	15	SENT_861	[p39l179t318r652b433],
11	A.	NNP	O	A.	nn	15	SENT_861	[p39l680t326r783b409],
12	The	NNP	O	The	nn	15	SENT_861	[p39l823t318r1012b409],
13	inﬂammatory	JJ	O	inﬂammatory	amod	15	SENT_861	[p39l1048t318r1767b433],
14	mediator	NN	O	mediator	nn	15	SENT_861	[p39l1799t318r2145b409, p39l18t487r157b558],
15	leukotriene	NN	O	leukotriene	appos	2	SENT_861	[p39l185t467r736b558],
16	D	NN	O	d	dep	15	SENT_861	[p39l767t475r847b556],
17	4	CD	NUMBER	4	num	16	SENT_861	[p39l849t546r887b590],
18	induces	VBZ	O	induce	dep	1	SENT_861	[p39l922t467r1290b558],
19	beta	NN	O	beta	nn	22	SENT_861	[p39l1328t467r1932b558],
20	—	CD	NUMBER	—	num	22	SENT_861	[p39l1328t467r1932b558],
21	catenin	NN	O	catenin	nn	22	SENT_861	[p39l1328t467r1932b558],
22	signaling	NN	O	signaling	dobj	18	SENT_861	[p39l1968t469r2145b584, p39l16t616r346b733],
23	and	CC	O	and	_	0	SENT_861	[p39l384t616r569b707],
24	its	PRP$	O	its	poss	25	SENT_861	[p39l612t618r728b706],
25	association	NN	O	association	dobj	18	SENT_861	[p39l773t618r1346b707],
26	with	IN	O	with	_	0	SENT_861	[p39l1384t616r1614b707],
27	antiapop	JJ	O	antiapop	amod	28	SENT_861	[p39l1656t618r2145b731],
28	—	NN	O	—	prep_with	18	SENT_861	[p39l1656t618r2145b731],
29	totic	JJ	O	totic	amod	31	SENT_861	[p39l18t767r244b856],
30	Bcl	NN	O	bcl	nn	31	SENT_861	[p39l310t765r555b855],
31	—	NN	O	—	tmod	18	SENT_861	[p39l310t765r555b855],
32	2	CD	NUMBER	2	dep	31	SENT_861	[p39l310t765r555b855],
33	in	IN	O	in	_	0	SENT_861	[p39l624t767r722b854],
34	intestinal	JJ	O	intestinal	amod	36	SENT_861	[p39l791t765r1275b855],
35	epithelial	JJ	O	epithelial	amod	36	SENT_861	[p39l1344t765r1819b880],
36	cells	NNS	O	cell	prep_in	18	SENT_861	[p39l1889t765r2141b856],
37	.	.	O	.	_	0	SENT_861	[p39l1889t765r2141b856],

1	J	NNP	O	J	nn	3	SENT_862	[p39l6t922r48b1019],
2	Biol	NNP	O	Biol	nn	3	SENT_862	[p39l85t914r280b1005],
3	Chem	NNP	O	Chem	_	0	SENT_862	[p39l320t914r612b1005],
4	2006	CD	DATE	2006	num	3	SENT_862	[p39l652t920r1587b1021],
5	;	:	O	;	_	0	SENT_862	[p39l652t920r1587b1021],
6	281:6776	CD	NUMBER	281:6776	number	7	SENT_862	[p39l652t920r1587b1021],
7	—	CD	NUMBER	—	dep	3	SENT_862	[p39l652t920r1587b1021],
8	84	CD	NUMBER	84	dep	7	SENT_862	[p39l652t920r1587b1021],
9	.	.	O	.	_	0	SENT_862	[p39l652t920r1587b1021],

1	ov	NN	O	ov	nn	5	SENT_863	[p39l1057t1106r1090b1122],
2	E	NN	O	e	nn	5	SENT_863	[p39l1095t1106r1105b1122],
3	M	NN	O	m	nn	5	SENT_863	[p39l1110t1106r1127b1122],
4	B	NN	O	b	nn	5	SENT_863	[p39l1133t1106r1144b1122],
5	E	NN	O	e	nsubj	11	SENT_863	[p39l1149t1106r1159b1122],
6	,	,	O	,	_	0	SENT_863	[p39l1200t1118r1203b1127],
7	and	CC	O	and	_	0	SENT_863	[p39l897t1140r944b1164],
8	Journal	NNP	O	Journal	conj_and	5	SENT_863	[p39l952t1140r1050b1164],
9	of	IN	O	of	_	0	SENT_863	[p39l1059t1140r1088b1164],
10	Medicine	NNP	O	Medicine	prep_of	8	SENT_863	[p39l1095t1140r1220b1164],
11	ed	VBD	O	ed	_	0	SENT_863	[p39l283t1181r314b1204],
12	from	IN	O	from	_	0	SENT_863	[p39l323t1181r387b1204],
13	nejm.org	NN	O	nejm.org	prep_from	11	SENT_863	[p39l396t1181r514b1211],
14	at	IN	O	at	_	0	SENT_863	[p39l524t1185r547b1204],
15	UW-Madison	NN	O	uw-madison	prep_at	11	SENT_863	[p39l556t1181r738b1204],
16	on	IN	O	on	_	0	SENT_863	[p39l748t1188r780b1204],
17	January	NNP	DATE	January	prep_on	15	SENT_863	[p39l789t1181r892b1211],
18	5	CD	DATE	5	num	17	SENT_863	[p39l902t1181r924b1209],
19	,	,	DATE	,	_	0	SENT_863	[p39l902t1181r924b1209],
20	2014	CD	DATE	2014	num	17	SENT_863	[p39l935t1181r1007b1204],
21	.	.	O	.	_	0	SENT_863	[p39l935t1181r1007b1204],

1	For	IN	O	for	_	0	SENT_864	[p39l1018t1181r1064b1204],
2	personal	JJ	O	personal	amod	3	SENT_864	[p39l1072t1181r1185b1211],
3	use	NN	O	use	pobj	1	SENT_864	[p39l1194t1188r1237b1204],
4	only	RB	O	only	advmod	3	SENT_864	[p39l1247t1181r1312b1211],
5	.	.	O	.	_	0	SENT_864	[p39l1247t1181r1312b1211],

1	No	DT	O	no	det	3	SENT_865	[p39l1322t1181r1362b1204],
2	other	JJ	O	other	amod	3	SENT_865	[p39l1372t1181r1440b1204],
3	uses	NNS	O	use	_	0	SENT_865	[p39l1448t1188r1504b1204],
4	without	IN	O	without	_	0	SENT_865	[p39l1514t1181r1616b1204],
5	permission	NN	O	permission	prep_without	3	SENT_865	[p39l1624t1181r1776b1211],
6	.	.	O	.	_	0	SENT_865	[p39l1624t1181r1776b1211],
7	'	''	O	'	_	0	SENT_865	[p39l579t1222r583b1226],

1	©	RB	O	©	advmod	2	SENT_866	[p39l638t1222r661b1246],
2	2007	CD	DATE	2007	_	0	SENT_866	[p39l671t1222r736b1246],
3	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_866	[p39l746t1222r937b1246],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_866	[p39l947t1222r1055b1246],
5	Society	NNP	ORGANIZATION	Society	dep	2	SENT_866	[p39l1065t1222r1170b1253],
6	.	.	O	.	_	0	SENT_866	[p39l1065t1222r1170b1253],

1	All	DT	O	all	det	2	SENT_867	[p39l1181t1222r1223b1246],
2	rights	NNS	O	rights	nsubj	3	SENT_867	[p39l1232t1222r1306b1253],
3	reserved	VBN	O	reserve	_	0	SENT_867	[p39l1316t1222r1435b1246],
4	.	.	O	.	_	0	SENT_867	[p39l1316t1222r1435b1246],

1	108	CD	NUMBER	108	_	0	SENT_868	[p39l20t1559r209b1640],
2	.	.	O	.	_	0	SENT_868	[p39l20t1559r209b1640],

1	Nielsen	NNP	O	Nielsen	nn	2	SENT_869	[p39l292t1549r671b1639],
2	CK	NNP	O	CK	_	0	SENT_869	[p39l716t1555r890b1657],
3	,	,	O	,	_	0	SENT_869	[p39l716t1555r890b1657],
4	Campbell	NNP	ORGANIZATION	Campbell	nn	5	SENT_869	[p39l943t1549r1427b1663],
5	JI	NNP	ORGANIZATION	JI	appos	2	SENT_869	[p39l1460t1557r1571b1657],
6	,	,	O	,	_	0	SENT_869	[p39l1460t1557r1571b1657],
7	Ohd	NNP	ORGANIZATION	Ohd	nn	8	SENT_869	[p39l1622t1549r1833b1639],
8	JF	NNP	O	JF	appos	2	SENT_869	[p39l1867t1557r1993b1659],
9	,	,	O	,	_	0	SENT_869	[p39l1867t1557r1993b1659],
10	et	FW	O	et	nn	11	SENT_869	[p39l2046t1568r2137b1638],
11	al.	FW	O	al.	appos	2	SENT_869	[p39l16t1696r129b1786],
12	.	.	O	.	_	0	SENT_869	[p39l16t1696r129b1786],

1	A	DT	O	a	det	3	SENT_870	[p39l179t1704r255b1785],
2	novel	JJ	O	novel	amod	3	SENT_870	[p39l300t1696r563b1787],
3	localization	NN	O	localization	nsubj	10	SENT_870	[p39l608t1696r1206b1786],
4	of	IN	O	of	_	0	SENT_870	[p39l1255t1696r1370b1786],
5	the	DT	O	the	det	8	SENT_870	[p39l1397t1696r1553b1785],
6	G	NN	O	g	nn	8	SENT_870	[p39l1601t1698r2128b1810],
7	—	NN	O	—	nn	8	SENT_870	[p39l1601t1698r2128b1810],
8	protein	NN	O	protein	prep_of	3	SENT_870	[p39l1601t1698r2128b1810],
9	—	CD	NUMBER	—	dep	8	SENT_870	[p39l1601t1698r2128b1810],
10	coupled	VBN	O	couple	_	0	SENT_870	[p39l16t1843r407b1957],
11	CysLT1	NN	O	cyslt1	nn	12	SENT_870	[p39l442t1849r805b1957],
12	receptor	NN	O	receptor	dobj	10	SENT_870	[p39l842t1862r1259b1957],
13	in	IN	O	in	_	0	SENT_870	[p39l1292t1845r1389b1932],
14	the	DT	O	the	det	15	SENT_870	[p39l1426t1843r1581b1932],
15	nucleus	NN	O	nucleus	prep_in	12	SENT_870	[p39l1618t1843r1995b1934],
16	of	IN	O	of	_	0	SENT_870	[p39l2035t1843r2151b1933],
17	colorectal	JJ	O	colorectal	amod	19	SENT_870	[p39l16t1990r511b2081],
18	adenocarcinoma	NN	O	adenocarcinoma	nn	19	SENT_870	[p39l570t1990r1407b2081],
19	cells	NNS	O	cell	prep_of	15	SENT_870	[p39l1466t1990r1717b2081],
20	.	.	O	.	_	0	SENT_870	[p39l1466t1990r1717b2081],

1	Cancer	NN	O	cancer	_	0	SENT_871	[p39l1784t1996r2133b2081],

1	Res	NNP	O	Res	_	0	SENT_872	[p39l14t2147r190b2236],
2	2005	CD	DATE	2005	num	1	SENT_872	[p39l231t2147r1019b2248],
3	;	:	O	;	_	0	SENT_872	[p39l231t2147r1019b2248],
4	65:732	CD	NUMBER	65:732	number	5	SENT_872	[p39l231t2147r1019b2248],
5	—	CD	NUMBER	—	dep	1	SENT_872	[p39l231t2147r1019b2248],
6	42	CD	NUMBER	42	dep	5	SENT_872	[p39l231t2147r1019b2248],
7	.	.	O	.	_	0	SENT_872	[p39l231t2147r1019b2248],

1	109	CD	NUMBER	109	_	0	SENT_873	[p39l20t2297r209b2377],
2	.	.	O	.	_	0	SENT_873	[p39l20t2297r209b2377],

1	Ihara	NNP	PERSON	Ihara	nn	2	SENT_874	[p39l266t2287r533b2376],
2	A	NNP	O	A	nsubj	25	SENT_874	[p39l560t2295r661b2397],
3	,	,	O	,	_	0	SENT_874	[p39l560t2295r661b2397],
4	Wada	NNP	PERSON	Wada	nn	5	SENT_874	[p39l697t2287r977b2377],
5	K	NNP	PERSON	K	appos	2	SENT_874	[p39l1006t2295r1107b2397],
6	,	,	O	,	_	0	SENT_874	[p39l1006t2295r1107b2397],
7	Yoneda	NNP	PERSON	Yoneda	nn	8	SENT_874	[p39l1142t2287r1506b2377],
8	M	NNP	O	M	appos	2	SENT_874	[p39l1535t2295r1660b2397],
9	,	,	O	,	_	0	SENT_874	[p39l1535t2295r1660b2397],
10	Fujisawa	NNP	ORGANIZATION	Fujisawa	nn	11	SENT_874	[p39l1699t2289r2132b2401],
11	N	NNP	ORGANIZATION	N	appos	2	SENT_874	[p39l14t2442r123b2544],
12	,	,	O	,	_	0	SENT_874	[p39l14t2442r123b2544],
13	Takahashi	NNP	PERSON	Takahashi	nn	14	SENT_874	[p39l164t2434r687b2525],
14	H	NNP	O	H	appos	2	SENT_874	[p39l724t2442r837b2542],
15	,	,	O	,	_	0	SENT_874	[p39l724t2442r837b2542],
16	Nakajima	NNP	PERSON	Nakajima	nn	18	SENT_874	[p39l878t2434r1364b2548],
17	A.	NNP	PERSON	A.	nn	18	SENT_874	[p39l1397t2442r1500b2524],
18	Blockade	NN	PERSON	blockade	appos	2	SENT_874	[p39l1543t2434r1995b2525],
19	of	IN	O	of	_	0	SENT_874	[p39l2035t2434r2151b2524],
20	leukotriene	NN	O	leukotriene	nn	21	SENT_874	[p39l14t2581r586b2672],
21	B	NN	O	b	prep_of	18	SENT_874	[p39l625t2589r689b2670],
22	4	CD	NUMBER	4	num	24	SENT_874	[p39l698t2659r736b2703],
23	signaling	NN	O	signaling	nn	24	SENT_874	[p39l779t2581r1253b2697],
24	pathway	NN	O	pathway	dep	2	SENT_874	[p39l1289t2581r1711b2695],
25	induces	VBZ	O	induce	_	0	SENT_874	[p39l1746t2581r2128b2672],
26	apoptosis	NN	O	apoptosis	dobj	25	SENT_874	[p39l16t2731r487b2843],
27	and	CC	O	and	_	0	SENT_874	[p39l521t2729r703b2819],
28	suppresses	VBZ	O	suppress	conj_and	25	SENT_874	[p39l736t2758r1267b2843],
29	cell	NN	O	cell	nn	30	SENT_874	[p39l1303t2729r1470b2818],
30	proliferation	NN	O	proliferation	dobj	28	SENT_874	[p39l1501t2729r2131b2843],
31	in	IN	O	in	_	0	SENT_874	[p39l16t2879r113b2966],
32	colon	NN	O	colon	nn	33	SENT_874	[p39l182t2877r454b2968],
33	cancer	NN	O	cancer	prep_in	28	SENT_874	[p39l525t2907r875b2968],
34	.	.	O	.	_	0	SENT_874	[p39l525t2907r875b2968],

1	J	NNP	O	J	nn	3	SENT_875	[p39l939t2885r983b2982],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_875	[p39l1048t2877r1587b2968],
3	Sci	NNP	O	Sci	_	0	SENT_875	[p39l1658t2879r1798b2968],
4	2007	CD	DATE	2007	num	3	SENT_875	[p39l1865t2883r2126b2986],
5	;	:	O	;	_	0	SENT_875	[p39l1865t2883r2126b2986],
6	103:24	CD	NUMBER	103:24	number	7	SENT_875	[p39l20t3031r527b3116],
7	-32	CD	NUMBER	-32	dep	3	SENT_875	[p39l20t3031r527b3116],
8	.	.	O	.	_	0	SENT_875	[p39l20t3031r527b3116],

1	110	CD	NUMBER	110	_	0	SENT_876	[p39l20t3183r209b3263],
2	.	.	O	.	_	0	SENT_876	[p39l20t3183r209b3263],

1	Avis	NNP	ORGANIZATION	Avis	nn	2	SENT_877	[p39l261t3175r466b3264],
2	IM	NNP	O	IM	_	0	SENT_877	[p39l499t3181r665b3283],
3	,	,	O	,	_	0	SENT_877	[p39l499t3181r665b3283],
4	Jett	NNP	PERSON	Jett	nn	5	SENT_877	[p39l691t3181r870b3277],
5	M	NNP	O	M	appos	2	SENT_877	[p39l892t3181r1018b3283],
6	,	,	O	,	_	0	SENT_877	[p39l892t3181r1018b3283],
7	Boyle	NNP	PERSON	Boyle	nn	8	SENT_877	[p39l1054t3173r1322b3287],
8	T	NN	O	t	appos	2	SENT_877	[p39l1350t3180r1439b3283],
9	,	,	O	,	_	0	SENT_877	[p39l1350t3180r1439b3283],
10	et	FW	O	et	nn	11	SENT_877	[p39l1478t3192r1567b3262],
11	al.	FW	O	al.	appos	2	SENT_877	[p39l1592t3173r1707b3263],
12	.	.	O	.	_	0	SENT_877	[p39l1592t3173r1707b3263],

1	Growth	NN	O	growth	nn	2	SENT_878	[p39l1744t3173r2131b3264],
2	control	NN	O	control	_	0	SENT_878	[p39l18t3320r375b3410],
3	of	IN	O	of	_	0	SENT_878	[p39l424t3318r541b3410],
4	lung	NN	O	lung	nn	5	SENT_878	[p39l566t3320r793b3436],
5	cancer	NN	O	cancer	prep_of	2	SENT_878	[p39l839t3349r1168b3409],
6	by	IN	O	by	_	0	SENT_878	[p39l1213t3320r1326b3434],
7	interruption	NN	O	interruption	prep_by	2	SENT_878	[p39l1369t3322r1987b3434],
8	of	IN	O	of	_	0	SENT_878	[p39l2036t3318r2153b3410],
9	5	CD	NUMBER	5	number	10	SENT_878	[p39l20t3467r1281b3583],
10	—	CD	NUMBER	—	num	12	SENT_878	[p39l20t3467r1281b3583],
11	lipoxygenase	NN	O	lipoxygenase	nn	12	SENT_878	[p39l20t3467r1281b3583],
12	—	NN	O	—	prep_of	2	SENT_878	[p39l20t3467r1281b3583],
13	mediated	VBN	O	mediate	partmod	2	SENT_878	[p39l20t3467r1281b3583],
14	growth	NN	O	growth	nn	16	SENT_878	[p39l1377t3467r1745b3583],
15	factor	NN	O	factor	nn	16	SENT_878	[p39l1841t3467r2135b3557],
16	signaling	NN	O	signaling	dobj	13	SENT_878	[p39l18t3614r515b3730],
17	.	.	O	.	_	0	SENT_878	[p39l18t3614r515b3730],

1	J	NNP	O	J	nn	3	SENT_879	[p39l551t3622r594b3718],
2	Clin	NNP	O	Clin	nn	3	SENT_879	[p39l631t3614r837b3704],
3	Invest	NNP	O	Invest	_	0	SENT_879	[p39l876t3622r1178b3705],
4	1996	CD	DATE	1996	num	3	SENT_879	[p39l1215t3620r2003b3722],
5	;	:	O	;	_	0	SENT_879	[p39l1215t3620r2003b3722],
6	97:806	CD	NUMBER	97:806	number	7	SENT_879	[p39l1215t3620r2003b3722],
7	-13	CD	NUMBER	-13	dep	3	SENT_879	[p39l1215t3620r2003b3722],
8	.	.	O	.	_	0	SENT_879	[p39l1215t3620r2003b3722],

1	111	CD	NUMBER	111	_	0	SENT_880	[p40l20t35r209b114],
2	.	.	O	.	_	0	SENT_880	[p40l20t35r209b114],

1	Romano	NNP	PERSON	Romano	nn	2	SENT_881	[p40l298t31r730b120],
2	M	NNP	PERSON	M	nsubj	13	SENT_881	[p40l777t31r904b134],
3	,	,	O	,	_	0	SENT_881	[p40l777t31r904b134],
4	Catalano	NNP	PERSON	Catalano	nn	5	SENT_881	[p40l961t23r1417b114],
5	A	NNP	O	A	appos	2	SENT_881	[p40l1462t31r1567b132],
6	,	,	O	,	_	0	SENT_881	[p40l1462t31r1567b132],
7	Nutini	NNP	PERSON	Nutini	nn	8	SENT_881	[p40l1620t25r1952b114],
8	M	NNP	O	M	appos	2	SENT_881	[p40l1999t31r2125b132],
9	,	,	O	,	_	0	SENT_881	[p40l1999t31r2125b132],
10	et	FW	O	et	nn	12	SENT_881	[p40l18t189r108b259],
11	al.	FW	O	al.	nn	12	SENT_881	[p40l138t170r251b260],
12	5-Lipoxygenase	NN	O	5-lipoxygenase	appos	2	SENT_881	[p40l296t172r1074b286],
13	regulates	VBZ	O	regulate	_	0	SENT_881	[p40l1111t170r1571b286],
14	malignant	JJ	O	malignant	amod	17	SENT_881	[p40l1610t170r2137b286],
15	mesothelial	JJ	O	mesothelial	amod	17	SENT_881	[p40l16t318r608b409],
16	cell	NN	O	cell	nn	17	SENT_881	[p40l665t318r837b409],
17	survival	NN	O	survival	dobj	13	SENT_881	[p40l894t318r1312b409],
18	:	:	O	:	_	0	SENT_881	[p40l894t318r1312b409],
19	involvement	NN	O	involvement	dep	17	SENT_881	[p40l1373t318r1985b409],
20	of	IN	O	of	_	0	SENT_881	[p40l2036t316r2153b409],
21	vascular	JJ	O	vascular	amod	24	SENT_881	[p40l12t465r431b556],
22	endothelial	JJ	O	endothelial	amod	24	SENT_881	[p40l459t465r1028b555],
23	growth	NN	O	growth	nn	24	SENT_881	[p40l1058t465r1425b581],
24	factor	NN	O	factor	prep_of	19	SENT_881	[p40l1456t465r1772b555],
25	.	.	O	.	_	0	SENT_881	[p40l1456t465r1772b555],

1	FASEB	NN	O	faseb	_	0	SENT_882	[p40l1807t471r2129b555],

1	J	NNP	O	J	_	0	SENT_883	[p40l6t622r48b719],
2	2001	CD	DATE	2001	num	1	SENT_883	[p40l85t620r943b723],
3	;	:	O	;	_	0	SENT_883	[p40l85t620r943b723],
4	15:2326	CD	NUMBER	15:2326	number	5	SENT_883	[p40l85t620r943b723],
5	—	CD	NUMBER	—	dep	1	SENT_883	[p40l85t620r943b723],
6	36	CD	NUMBER	36	dep	5	SENT_883	[p40l85t620r943b723],
7	.	.	O	.	_	0	SENT_883	[p40l85t620r943b723],

1	112	CD	NUMBER	112	_	0	SENT_884	[p40l20t774r209b852],
2	.	.	O	.	_	0	SENT_884	[p40l20t774r209b852],

1	Hoque	NNP	O	Hoque	nn	2	SENT_885	[p40l288t770r608b876],
2	A	NNP	O	A	_	0	SENT_885	[p40l645t770r744b872],
3	,	,	O	,	_	0	SENT_885	[p40l645t770r744b872],
4	Lippman	NNP	PERSON	Lippman	nn	5	SENT_885	[p40l789t764r1225b876],
5	SM	NNP	O	SM	appos	2	SENT_885	[p40l1269t768r1443b872],
6	,	,	O	,	_	0	SENT_885	[p40l1269t768r1443b872],
7	Wu	NNP	O	Wu	nn	8	SENT_885	[p40l1486t770r1652b853],
8	TT	NN	O	tt	appos	2	SENT_885	[p40l1687t769r1847b870],
9	,	,	O	,	_	0	SENT_885	[p40l1687t769r1847b870],
10	et	FW	O	et	nn	11	SENT_885	[p40l1894t781r1982b851],
11	al.	FW	O	al.	appos	2	SENT_885	[p40l2017t762r2125b852],
12	.	.	O	.	_	0	SENT_885	[p40l2017t762r2125b852],

1	Increased	VBN	O	increase	_	0	SENT_886	[p40l16t908r482b998],
2	5-lipoxygenase	NN	O	5-lipoxygenase	nn	3	SENT_886	[p40l562t908r1281b1024],
3	expression	NN	O	expression	dobj	1	SENT_886	[p40l1361t910r1875b1022],
4	and	CC	O	and	advmod	1	SENT_886	[p40l1953t908r2132b998],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_887	[p40l143t1167r572b1202],
2	OF	IN	O	of	_	0	SENT_887	[p40l600t1166r675b1202],
3	DISEASE	NN	O	disease	prep_of	1	SENT_887	[p40l703t1167r957b1202],

1	induction	NN	O	induction	_	0	SENT_888	[p40l41t1346r264b1390],
2	of	IN	O	of	_	0	SENT_888	[p40l289t1346r344b1389],
3	apoptosis	NN	O	apoptosis	prep_of	1	SENT_888	[p40l358t1347r580b1401],
4	by	IN	O	by	_	0	SENT_888	[p40l606t1346r660b1401],
5	its	PRP$	O	its	poss	6	SENT_888	[p40l681t1347r735b1389],
6	inhibitors	NNS	O	inhibitor	prep_by	3	SENT_888	[p40l760t1346r988b1389],
7	in	IN	O	in	_	0	SENT_888	[p40l1014t1347r1060b1389],
8	esophageal	NN	O	esophageal	nn	9	SENT_888	[p40l42t1416r303b1472],
9	cancer	NN	O	cancer	prep_in	6	SENT_888	[p40l334t1430r498b1459],
10	:	:	O	:	_	0	SENT_888	[p40l334t1430r498b1459],
11	a	DT	O	a	det	13	SENT_888	[p40l531t1430r556b1459],
12	potential	JJ	O	potential	amod	13	SENT_888	[p40l585t1416r796b1471],
13	target	NN	O	target	dep	1	SENT_888	[p40l827t1425r966b1472],
14	for	IN	O	for	_	0	SENT_888	[p40l994t1416r1061b1459],
15	prevention	NN	O	prevention	prep_for	13	SENT_888	[p40l41t1487r301b1541],
16	.	.	O	.	_	0	SENT_888	[p40l41t1487r301b1541],

1	Carcinogenesis	NN	O	carcinogenesis	_	0	SENT_889	[p40l321t1487r674b1542],
2	2005	CD	DATE	2005	num	1	SENT_889	[p40l692t1489r1056b1538],
3	;	:	O	;	_	0	SENT_889	[p40l692t1489r1056b1538],
4	26:785	CD	NUMBER	26:785	number	5	SENT_889	[p40l692t1489r1056b1538],
5	-91	CD	NUMBER	-91	dep	1	SENT_889	[p40l692t1489r1056b1538],
6	.	.	O	.	_	0	SENT_889	[p40l692t1489r1056b1538],

1	113	CD	NUMBER	113	_	0	SENT_890	[p40l43t1561r134b1599],
2	.	.	O	.	_	0	SENT_890	[p40l43t1561r134b1599],

1	Runarsson	NN	MISC	runarsson	nn	2	SENT_891	[p40l179t1560r441b1602],
2	G	NN	O	g	_	0	SENT_891	[p40l466t1559r517b1608],
3	,	,	O	,	_	0	SENT_891	[p40l466t1559r517b1608],
4	Liu	NNP	O	Liu	nn	5	SENT_891	[p40l544t1557r619b1600],
5	A	NNP	O	A	appos	2	SENT_891	[p40l641t1560r690b1609],
6	,	,	O	,	_	0	SENT_891	[p40l641t1560r690b1609],
7	Mahshid	NNP	O	Mahshid	nn	8	SENT_891	[p40l716t1556r929b1599],
8	Y	NN	O	y	appos	2	SENT_891	[p40l951t1560r991b1608],
9	,	,	O	,	_	0	SENT_891	[p40l951t1560r991b1608],
10	et	FW	O	et	nn	11	SENT_891	[p40l1019t1565r1063b1599],
11	al.	FW	O	al.	appos	2	SENT_891	[p40l41t1626r96b1669],
12	.	.	O	.	_	0	SENT_891	[p40l41t1626r96b1669],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_892	[p40l120t1626r417b1670],
2	B	NN	O	b	nsubj	4	SENT_892	[p40l439t1630r470b1669],
3	4	CD	NUMBER	4	dep	2	SENT_892	[p40l474t1664r492b1685],
4	plays	VBZ	O	play	_	0	SENT_892	[p40l513t1626r637b1681],
5	a	DT	O	a	det	7	SENT_892	[p40l660t1640r685b1669],
6	pivotal	JJ	O	pivotal	amod	7	SENT_892	[p40l706t1626r875b1681],
7	role	NN	O	role	dobj	4	SENT_892	[p40l897t1626r989b1670],
8	in	IN	O	in	_	0	SENT_892	[p40l1012t1627r1060b1669],
9	CD40-dependent	JJ	O	cd40-dependent	amod	10	SENT_892	[p40l41t1696r454b1751],
10	activation	NN	O	activation	prep_in	7	SENT_892	[p40l479t1697r716b1740],
11	of	IN	O	of	_	0	SENT_892	[p40l744t1696r800b1739],
12	chronic	JJ	O	chronic	amod	16	SENT_892	[p40l818t1696r1000b1739],
13	B	NN	O	b	nn	16	SENT_892	[p40l1027t1700r1058b1739],
14	lymphocytic	JJ	O	lymphocytic	amod	16	SENT_892	[p40l41t1766r338b1821],
15	leukemia	NN	O	leukemia	nn	16	SENT_892	[p40l363t1766r586b1810],
16	cells	NNS	O	cell	prep_of	10	SENT_892	[p40l612t1766r732b1809],
17	.	.	O	.	_	0	SENT_892	[p40l612t1766r732b1809],

1	Blood	NN	O	blood	_	0	SENT_893	[p40l761t1766r902b1809],
2	2005	CD	DATE	2005	num	1	SENT_893	[p40l928t1769r1057b1818],
3	;	:	O	;	_	0	SENT_893	[p40l928t1769r1057b1818],
4	105:1274	CD	NUMBER	105:1274	number	5	SENT_893	[p40l43t1839r315b1880],
5	-9	CD	NUMBER	-9	dep	1	SENT_893	[p40l43t1839r315b1880],
6	.	.	O	.	_	0	SENT_893	[p40l43t1839r315b1880],

1	114	CD	NUMBER	114	_	0	SENT_894	[p40l43t1911r134b1949],
2	.	.	O	.	_	0	SENT_894	[p40l43t1911r134b1949],

1	Rioux	NNP	PERSON	Rioux	nn	6	SENT_895	[p40l162t1907r306b1952],
2	N	NNP	O	N	nn	6	SENT_895	[p40l318t1910r371b1959],
3	,	,	O	,	_	0	SENT_895	[p40l318t1910r371b1959],
4	Castonguay	NNP	PERSON	Castonguay	appos	6	SENT_895	[p40l390t1909r675b1962],
5	A.	NNP	O	A.	nn	6	SENT_895	[p40l686t1910r736b1949],
6	Inhibitors	NNS	O	inhibitor	_	0	SENT_895	[p40l754t1906r996b1950],
7	of	IN	O	of	_	0	SENT_895	[p40l1014t1906r1069b1949],
8	lipoxygenase	NN	O	lipoxygenase	prep_of	6	SENT_895	[p40l41t1976r355b2032],
9	:	:	O	:	_	0	SENT_895	[p40l41t1976r355b2032],
10	a	DT	O	a	det	12	SENT_895	[p40l373t1990r398b2019],
11	new	JJ	O	new	amod	12	SENT_895	[p40l413t1990r511b2020],
12	class	NN	O	class	dep	6	SENT_895	[p40l525t1976r635b2019],
13	of	IN	O	of	_	0	SENT_895	[p40l654t1976r708b2019],
14	cancer	NN	O	cancer	nn	16	SENT_895	[p40l715t1990r868b2019],
15	chemopreventive	JJ	O	chemopreventive	amod	16	SENT_895	[p40l883t1976r1059b2019, p40l40t2047r282b2101],
16	agents	NNS	O	agent	prep_of	12	SENT_895	[p40l295t2055r461b2102],
17	.	.	O	.	_	0	SENT_895	[p40l295t2055r461b2102],

1	Carcinogenesis	NN	O	carcinogenesis	_	0	SENT_896	[p40l478t2047r839b2102],
2	1998	CD	DATE	1998	num	1	SENT_896	[p40l856t2049r1057b2098],
3	;	:	O	;	_	0	SENT_896	[p40l856t2049r1057b2098],
4	19	CD	NUMBER	19	num	6	SENT_896	[p40l856t2049r1057b2098],
5	:	:	O	:	_	0	SENT_896	[p40l856t2049r1057b2098],
6	1393-400	CD	NUMBER	1393-400	dep	1	SENT_896	[p40l43t2119r280b2160],
7	.	.	O	.	_	0	SENT_896	[p40l43t2119r280b2160],

1	115	CD	NUMBER	115	_	0	SENT_897	[p40l43t2191r134b2229],
2	.	.	O	.	_	0	SENT_897	[p40l43t2191r134b2229],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_898	[p40l174t2186r297b2230],
2	X	NNP	PERSON	X	_	0	SENT_898	[p40l316t2190r363b2239],
3	,	,	O	,	_	0	SENT_898	[p40l316t2190r363b2239],
4	Li	NNP	PERSON	Li	nn	5	SENT_898	[p40l386t2187r431b2229],
5	N	NNP	PERSON	N	appos	2	SENT_898	[p40l451t2190r504b2239],
6	,	,	O	,	_	0	SENT_898	[p40l451t2190r504b2239],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_898	[p40l526t2190r667b2242],
8	S	NNP	O	S	appos	2	SENT_898	[p40l688t2189r726b2239],
9	,	,	O	,	_	0	SENT_898	[p40l688t2189r726b2239],
10	et	FW	O	et	nn	11	SENT_898	[p40l751t2195r795b2229],
11	al.	FW	O	al.	appos	2	SENT_898	[p40l812t2186r868b2230],
12	.	.	O	.	_	0	SENT_898	[p40l812t2186r868b2230],

1	Leukotriene	NN	O	leukotriene	nn	3	SENT_899	[p40l891t2186r1058b2230, p40l41t2257r181b2299],
2	A4	NN	O	a4	nn	3	SENT_899	[p40l216t2260r272b2315],
3	hydrolase	NN	O	hydrolase	_	0	SENT_899	[p40l309t2256r541b2311],
4	in	IN	O	in	_	0	SENT_899	[p40l578t2257r625b2299],
5	rat	NN	O	rat	nn	9	SENT_899	[p40l662t2265r729b2299],
6	and	CC	O	and	_	0	SENT_899	[p40l763t2256r852b2300],
7	human	JJ	O	human	conj_and	5	SENT_899	[p40l889t2256r1060b2300],
8	esophageal	NN	O	esophageal	nn	9	SENT_899	[p40l42t2326r311b2382],
9	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	3	SENT_899	[p40l338t2326r757b2370],
10	and	CC	O	and	_	0	SENT_899	[p40l785t2326r873b2369],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_899	[p40l900t2326r1059b2370, p40l41t2405r137b2451],
12	effects	NNS	O	effect	prep_in	3	SENT_899	[p40l152t2395r311b2439],
13	of	IN	O	of	_	0	SENT_899	[p40l332t2396r388b2439],
14	bestatin	NN	O	bestatin	prep_of	3	SENT_899	[p40l397t2396r606b2439],
15	.	.	O	.	_	0	SENT_899	[p40l397t2396r606b2439],

1	J	NNP	O	J	nn	4	SENT_900	[p40l623t2400r644b2446],
2	Natl	NNP	O	Natl	nn	4	SENT_900	[p40l660t2396r763b2440],
3	Cancer	NNP	O	Cancer	nn	4	SENT_900	[p40l782t2399r950b2439],
4	Inst	NNP	O	Inst	_	0	SENT_900	[p40l967t2400r1062b2439],
5	2003	CD	DATE	2003	num	4	SENT_900	[p40l41t2469r450b2518],
6	;	:	O	;	_	0	SENT_900	[p40l41t2469r450b2518],
7	95:1053	CD	NUMBER	95:1053	number	8	SENT_900	[p40l41t2469r450b2518],
8	-61	CD	NUMBER	-61	dep	4	SENT_900	[p40l41t2469r450b2518],
9	.	.	O	.	_	0	SENT_900	[p40l41t2469r450b2518],

1	116	CD	NUMBER	116	_	0	SENT_901	[p40l43t2541r134b2579],
2	.	.	O	.	_	0	SENT_901	[p40l43t2541r134b2579],

1	Sun	NNP	O	Sun	nn	2	SENT_902	[p40l181t2539r270b2580],
2	Z	NN	O	z	_	0	SENT_902	[p40l293t2540r337b2589],
3	,	,	O	,	_	0	SENT_902	[p40l293t2540r337b2589],
4	Sood	NNP	PERSON	Sood	nn	5	SENT_902	[p40l366t2536r484b2579],
5	S	NNP	O	S	appos	2	SENT_902	[p40l510t2539r548b2589],
6	,	,	O	,	_	0	SENT_902	[p40l510t2539r548b2589],
7	Li	NNP	PERSON	Li	nn	8	SENT_902	[p40l575t2537r620b2579],
8	N	NNP	PERSON	N	appos	2	SENT_902	[p40l642t2540r695b2589],
9	,	,	O	,	_	0	SENT_902	[p40l642t2540r695b2589],
10	et	FW	O	et	nn	11	SENT_902	[p40l723t2545r766b2579],
11	al.	FW	O	al.	appos	2	SENT_902	[p40l787t2536r842b2579],
12	.	.	O	.	_	0	SENT_902	[p40l787t2536r842b2579],

1	Involvement	NN	O	involvement	dep	13	SENT_903	[p40l869t2536r1059b2580, p40l41t2615r167b2649],
2	of	IN	O	of	_	0	SENT_903	[p40l198t2606r255b2650],
3	the	DT	O	the	det	7	SENT_903	[p40l278t2606r354b2649],
4	5-lipoxygenase/leukotriene	JJ	O	5-lipoxygenase/leukotriene	amod	7	SENT_903	[p40l389t2606r1059b2662],
5	A4	NN	O	a4	nn	7	SENT_903	[p40l39t2680r95b2735],
6	hydrolase	NN	O	hydrolase	nn	7	SENT_903	[p40l128t2676r361b2731],
7	pathway	NN	O	pathway	prep_of	1	SENT_903	[p40l394t2676r597b2731],
8	in	IN	O	in	_	0	SENT_903	[p40l629t2677r675b2719],
9	7,12	CD	NUMBER	7,12	prep_in	7	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
10	dimethylbenz	NN	O	dimethylbenz	dep	13	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
11	[	CD	NUMBER	[	num	10	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
12	a	DT	O	a	det	13	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
13	]	NN	O	]	dep	16	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
14	anthracene	NN	O	anthracene	dep	13	SENT_903	[p40l710t2676r1059b2731, p40l42t2746r482b2796],
15	(	CD	NUMBER	(	num	16	SENT_903	[p40l528t2746r924b2796],
16	DMBA	NN	O	dmba	_	0	SENT_903	[p40l528t2746r924b2796],
17	)	SYM	O	)	dep	19	SENT_903	[p40l528t2746r924b2796],
18	-	:	O	-	_	0	SENT_903	[p40l528t2746r924b2796],
19	induced	VBN	O	induce	rcmod	16	SENT_903	[p40l528t2746r924b2796],
20	oral	JJ	O	oral	amod	21	SENT_903	[p40l968t2746r1060b2789],
21	carcinogenesis	NN	O	carcinogenesis	dobj	19	SENT_903	[p40l42t2817r400b2872],
22	in	IN	O	in	_	0	SENT_903	[p40l429t2817r476b2859],
23	hamster	NN	O	hamster	nn	25	SENT_903	[p40l503t2816r703b2859],
24	cheek	NN	O	cheek	nn	25	SENT_903	[p40l730t2816r869b2860],
25	pouch	NN	O	pouch	prep_in	19	SENT_903	[p40l894t2816r1056b2871],
26	,	,	O	,	_	0	SENT_903	[p40l894t2816r1056b2871],

1	RECEIVE	VB	O	receive	_	0	SENT_904	[p40l1040t3064r1128b3081],
2	IMMEDIATE	JJ	O	immediate	amod	3	SENT_904	[p40l1141t3064r1267b3080],
3	NOTIFICATION	NN	O	notification	dobj	1	SENT_904	[p40l1280t3064r1441b3080],
4	WHEN	WRB	O	when	advmod	8	SENT_904	[p40l1453t3064r1522b3080],
5	AJOURNAL	NNP	O	AJOURNAL	nn	6	SENT_904	[p40l1054t3102r1179b3123],
6	ARTICLE	NN	O	article	nsubjpass	8	SENT_904	[p40l1190t3102r1279b3118],
7	IS	VBZ	O	be	auxpass	8	SENT_904	[p40l1292t3102r1309b3118],
8	RELEASED	VBN	O	release	advcl	1	SENT_904	[p40l1323t3102r1431b3118],
9	EARLY	NN	O	early	dobj	8	SENT_904	[p40l1444t3102r1509b3118],

1	To	TO	O	to	aux	3	SENT_905	[p40l989t3151r1022b3172],
2	be	VB	O	be	auxpass	3	SENT_905	[p40l1031t3149r1059b3172],
3	notiﬁed	VBN	O	notiﬁed	_	0	SENT_905	[p40l1068t3149r1166b3172],
4	when	WRB	O	when	advmod	8	SENT_905	[p40l1173t3149r1242b3172],
5	an	DT	O	a	det	6	SENT_905	[p40l1251t3157r1280b3172],
6	article	NN	O	article	nsubjpass	8	SENT_905	[p40l1289t3149r1366b3172],
7	is	VBZ	O	be	auxpass	8	SENT_905	[p40l1374t3150r1394b3172],
8	released	VBN	O	release	advcl	3	SENT_905	[p40l1403t3149r1505b3172],
9	early	RB	O	early	advmod	8	SENT_905	[p40l1514t3149r1573b3179],
10	on	IN	O	on	_	0	SENT_905	[p40l986t3194r1018b3210],
11	the	DT	O	the	det	12	SENT_905	[p40l1027t3187r1065b3210],
12	Web	NN	MISC	web	prep_on	8	SENT_905	[p40l1073t3187r1129b3210],
13	and	CC	O	and	dep	3	SENT_905	[p40l1138t3187r1184b3210],
14	to	TO	O	to	dep	3	SENT_905	[p40l1193t3192r1217b3210],
15	receive	VB	O	receive	dep	14	SENT_905	[p40l1226t3187r1311b3210],
16	the	DT	O	the	det	17	SENT_905	[p40l1319t3187r1358b3210],
17	table	NN	O	table	dobj	15	SENT_905	[p40l1367t3187r1427b3210],
18	of	IN	O	of	_	0	SENT_905	[p40l1436t3187r1465b3210],
19	contents	NNS	O	contents	prep_of	17	SENT_905	[p40l1469t3192r1575b3210],
20	of	IN	O	of	_	0	SENT_905	[p40l970t3224r1000b3247],
21	thejoumal	JJ	O	thejoumal	amod	26	SENT_905	[p40l1004t3224r1132b3254],
22	by	IN	O	by	_	0	SENT_905	[p40l1140t3224r1169b3254],
23	e-mail	JJ	O	e-mail	amod	24	SENT_905	[p40l1176t3224r1255b3247],
24	every	DT	SET	every	prep_by	21	SENT_905	[p40l1264t3232r1327b3254],
25	Wednesday	NNP	DATE	Wednesday	tmod	24	SENT_905	[p40l1334t3224r1479b3254],
26	evening	NN	TIME	evening	prep_of	19	SENT_905	[p40l1486t3225r1590b3254],
27	,	,	O	,	_	0	SENT_905	[p40l1486t3225r1590b3254],

1	sign	NN	O	sign	_	0	SENT_906	[p40l1081t3262r1134b3291],
2	up	IN	O	up	dep	1	SENT_906	[p40l1142t3269r1173b3291],
3	through	IN	O	through	_	0	SENT_906	[p40l1182t3262r1284b3291],
4	our	PRP$	O	we	poss	6	SENT_906	[p40l1293t3269r1335b3285],
5	Web	NN	O	web	nn	6	SENT_906	[p40l1342t3262r1399b3285],
6	site	NN	O	site	prep_through	2	SENT_906	[p40l1408t3262r1451b3285],
7	at	IN	O	at	prep	6	SENT_906	[p40l1459t3267r1483b3285],
8	and	CC	O	and	_	0	SENT_906	[p40l1133t1346r1222b1389],
9	inhibition	NN	O	inhibition	prep_through	2	SENT_906	[p40l1239t1346r1482b1390],
10	of	IN	O	of	_	0	SENT_906	[p40l1501t1346r1557b1389],
11	carcinogenesis	NN	O	carcinogenesis	prep_of	9	SENT_906	[p40l1565t1347r1923b1402],
12	by	IN	O	by	_	0	SENT_906	[p40l1942t1346r1997b1401],
13	its	PRP$	O	its	poss	14	SENT_906	[p40l2012t1347r2068b1389],
14	inhibitors	NNS	O	inhibitor	prep_by	11	SENT_906	[p40l2086t1347r2151b1389, p40l1134t1416r1336b1460],
15	.	.	O	.	_	0	SENT_906	[p40l2086t1347r2151b1389, p40l1134t1416r1336b1460],

1	Carcinogenesis	NN	O	carcinogenesis	_	0	SENT_907	[p40l1358t1417r1727b1472],
2	2006	CD	DATE	2006	num	1	SENT_907	[p40l1747t1419r2129b1468],
3	;	:	O	;	_	0	SENT_907	[p40l1747t1419r2129b1468],
4	27:1902	CD	NUMBER	27:1902	number	5	SENT_907	[p40l1747t1419r2129b1468],
5	-8	CD	NUMBER	-8	dep	1	SENT_907	[p40l1747t1419r2129b1468],
6	.	.	O	.	_	0	SENT_907	[p40l1747t1419r2129b1468],

1	117	CD	NUMBER	117	_	0	SENT_908	[p40l1135t1491r1227b1529],
2	.	.	O	.	_	0	SENT_908	[p40l1135t1491r1227b1529],

1	Peters-Golden	JJ	O	peters-golden	amod	2	SENT_909	[p40l1254t1486r1592b1529],
2	M	NN	O	m	_	0	SENT_909	[p40l1605t1490r1666b1539],
3	,	,	O	,	_	0	SENT_909	[p40l1605t1490r1666b1539],
4	Canetti	NN	PERSON	canettus	nn	5	SENT_909	[p40l1684t1487r1857b1530],
5	C	NN	O	c	appos	2	SENT_909	[p40l1871t1489r1918b1539],
6	,	,	O	,	_	0	SENT_909	[p40l1871t1489r1918b1539],
7	Mancuso	NNP	PERSON	Mancuso	nn	8	SENT_909	[p40l1934t1490r2151b1530],
8	P	NN	PERSON	p	appos	2	SENT_909	[p40l1133t1560r1170b1609],
9	,	,	O	,	_	0	SENT_909	[p40l1133t1560r1170b1609],
10	Coffey	NNP	PERSON	Coffey	nn	11	SENT_909	[p40l1192t1556r1351b1611],
11	M	NNP	O	M	appos	2	SENT_909	[p40l1366t1560r1443b1606],
12	]	NN	O	]	dep	11	SENT_909	[p40l1366t1560r1443b1606],
13	.	.	O	.	_	0	SENT_909	[p40l1366t1560r1443b1606],

1	Leukotrienes	NNPS	O	Leukotrienes	_	0	SENT_910	[p40l1464t1556r1793b1600],
2	:	:	O	:	_	0	SENT_910	[p40l1464t1556r1793b1600],
3	underappreciated	JJ	O	underappreciated	amod	4	SENT_910	[p40l1814t1556r2151b1611, p40l1133t1626r1232b1670],
4	mediators	NNS	O	mediator	dep	1	SENT_910	[p40l1248t1626r1486b1670],
5	of	IN	O	of	_	0	SENT_910	[p40l1504t1626r1559b1670],
6	innate	JJ	O	innate	amod	8	SENT_910	[p40l1564t1627r1714b1669],
7	immune	JJ	O	immune	amod	8	SENT_910	[p40l1729t1627r1929b1670],
8	responses	NNS	O	response	prep_of	4	SENT_910	[p40l1945t1640r2151b1681, p40l1134t1710r1195b1739],
9	.	.	O	.	_	0	SENT_910	[p40l1945t1640r2151b1681, p40l1134t1710r1195b1739],

1	J	NNP	O	J	nn	2	SENT_911	[p40l1211t1700r1232b1746],
2	Immunol	NNP	O	Immunol	_	0	SENT_911	[p40l1249t1696r1476b1740],
3	2005	CD	DATE	2005	num	2	SENT_911	[p40l1494t1699r1904b1748],
4	;	:	O	;	_	0	SENT_911	[p40l1494t1699r1904b1748],
5	174:589	CD	NUMBER	174:589	number	6	SENT_911	[p40l1494t1699r1904b1748],
6	-94	CD	NUMBER	-94	dep	2	SENT_911	[p40l1494t1699r1904b1748],
7	.	.	O	.	_	0	SENT_911	[p40l1494t1699r1904b1748],

1	118	CD	NUMBER	118	_	0	SENT_912	[p40l1135t1770r1227b1810],
2	.	.	O	.	_	0	SENT_912	[p40l1135t1770r1227b1810],

1	Coffey	NNP	PERSON	Coffey	nn	3	SENT_913	[p40l1268t1766r1424b1821],
2	M	NNP	O	M	nn	3	SENT_913	[p40l1441t1770r1517b1819],
3	]	NN	O	]	_	0	SENT_913	[p40l1441t1770r1517b1819],
4	,	,	O	,	_	0	SENT_913	[p40l1441t1770r1517b1819],
5	Phare	NNP	O	Phare	nn	6	SENT_913	[p40l1541t1766r1675b1809],
6	MS	NN	O	m	appos	3	SENT_913	[p40l1695t1769r1783b1819],
7	,	,	O	,	_	0	SENT_913	[p40l1695t1769r1783b1819],
8	Kazanjian	NNP	PERSON	Kazanjian	nn	9	SENT_913	[p40l1807t1767r2046b1821],
9	PH	NNP	O	PH	appos	3	SENT_913	[p40l2067t1770r2149b1819],
10	,	,	O	,	_	0	SENT_913	[p40l2067t1770r2149b1819],
11	Peters-Golden	NNP	PERSON	Peters-Golden	nn	13	SENT_913	[p40l1133t1836r1471b1880],
12	M.	NNP	O	M.	nn	13	SENT_913	[p40l1487t1840r1547b1879],
13	5-Lipoxygenase	NNP	O	5-Lipoxygenase	appos	9	SENT_913	[p40l1569t1837r1936b1892],
14	metabolism	NN	O	metabolism	dep	3	SENT_913	[p40l1954t1836r2151b1879, p40l1133t1906r1236b1949],
15	in	IN	O	in	_	0	SENT_913	[p40l1265t1907r1312b1949],
16	alveolar	JJ	O	alveolar	amod	17	SENT_913	[p40l1341t1906r1528b1950],
17	macrophages	NNS	O	macrophage	prep_in	14	SENT_913	[p40l1556t1906r1873b1962],
18	from	IN	O	from	_	0	SENT_913	[p40l1904t1906r2020b1949],
19	subjects	NNS	O	subject	prep_from	17	SENT_913	[p40l2051t1906r2151b1950, p40l1126t1977r1238b2031],
20	infected	JJ	O	infected	dep	3	SENT_913	[p40l1257t1976r1450b2020],
21	with	IN	O	with	_	0	SENT_913	[p40l1466t1976r1574b2020],
22	the	DT	O	the	det	25	SENT_913	[p40l1593t1976r1667b2019],
23	human	JJ	O	human	amod	25	SENT_913	[p40l1685t1976r1853b2020],
24	immunodeficiency	NN	O	immunodeficiency	nn	25	SENT_913	[p40l1872t1976r2151b2020, p40l1134t2046r1319b2101],
25	virus	NN	O	virus	prep_with	20	SENT_913	[p40l1332t2047r1463b2090],
26	.	.	O	.	_	0	SENT_913	[p40l1332t2047r1463b2090],

1	J	NNP	O	J	nn	2	SENT_914	[p40l1479t2050r1499b2096],
2	Immunol	NNP	O	Immunol	_	0	SENT_914	[p40l1515t2046r1738b2090],
3	1996	CD	DATE	1996	num	2	SENT_914	[p40l1757t2049r2126b2098],
4	;	:	O	;	_	0	SENT_914	[p40l1757t2049r2126b2098],
5	157:393	CD	NUMBER	157:393	number	6	SENT_914	[p40l1757t2049r2126b2098],
6	-9	CD	NUMBER	-9	dep	2	SENT_914	[p40l1757t2049r2126b2098],
7	.	.	O	.	_	0	SENT_914	[p40l1757t2049r2126b2098],

1	119	CD	NUMBER	119	_	0	SENT_915	[p40l1136t2121r1227b2159],
2	.	.	O	.	_	0	SENT_915	[p40l1136t2121r1227b2159],

1	Cederholm	NNP	ORGANIZATION	Cederholm	nn	2	SENT_916	[p40l1258t2116r1525b2160],
2	T	NN	ORGANIZATION	t	_	0	SENT_916	[p40l1540t2119r1583b2169],
3	,	,	O	,	_	0	SENT_916	[p40l1540t2119r1583b2169],
4	Lindgren	NNP	ORGANIZATION	Lindgren	nn	5	SENT_916	[p40l1603t2116r1824b2172],
5	IA	NNP	ORGANIZATION	IA	appos	2	SENT_916	[p40l1836t2120r1904b2169],
6	,	,	O	,	_	0	SENT_916	[p40l1836t2120r1904b2169],
7	Palmblad	NNP	O	Palmblad	nn	8	SENT_916	[p40l1924t2116r2152b2160],
8	J.	NNP	O	J.	appos	2	SENT_916	[p40l1129t2190r1160b2237],
9	Impaired	JJ	O	impaired	amod	11	SENT_916	[p40l1189t2186r1411b2241],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_916	[p40l1437t2186r1712b2230],
11	C	NN	O	c	dep	8	SENT_916	[p40l1739t2189r1771b2230],
12	4	CD	NUMBER	4	num	13	SENT_916	[p40l1774t2224r1793b2245],
13	generation	NN	O	generation	dep	2	SENT_916	[p40l1819t2187r2079b2242],
14	in	IN	O	in	_	0	SENT_916	[p40l2105t2187r2152b2229],
15	granulocytes	NNS	O	granulocyte	prep_in	13	SENT_916	[p40l1134t2256r1452b2312],
16	from	IN	O	from	_	0	SENT_916	[p40l1487t2256r1607b2300],
17	protein-energy	JJ	O	protein-energy	prep_from	15	SENT_916	[p40l1640t2257r2010b2312],
18	malnourished	JJ	O	malnourished	dep	2	SENT_916	[p40l2041t2256r2151b2299, p40l1134t2326r1378b2370],
19	chronically	RB	O	chronically	advmod	20	SENT_916	[p40l1403t2326r1675b2381],
20	ill	JJ	O	ill	dep	18	SENT_916	[p40l1696t2326r1745b2369],
21	elderly	JJ	O	elderly	amod	20	SENT_916	[p40l1769t2326r1937b2381],
22	.	.	O	.	_	0	SENT_916	[p40l1769t2326r1937b2381],

1	J	NNP	O	J	nn	3	SENT_917	[p40l1959t2330r1980b2376],
2	Intern	NNP	O	Intern	nn	3	SENT_917	[p40l2002t2330r2152b2369],
3	Med	NNP	O	Med	_	0	SENT_917	[p40l1132t2396r1236b2439],
4	2000	CD	DATE	2000	num	3	SENT_917	[p40l1255t2399r1662b2448],
5	;	:	O	;	_	0	SENT_917	[p40l1255t2399r1662b2448],
6	247:715	CD	NUMBER	247:715	number	7	SENT_917	[p40l1255t2399r1662b2448],
7	-22	CD	NUMBER	-22	dep	3	SENT_917	[p40l1255t2399r1662b2448],
8	.	.	O	.	_	0	SENT_917	[p40l1255t2399r1662b2448],

1	120	CD	NUMBER	120	_	0	SENT_918	[p40l1135t2470r1227b2509],
2	.	.	O	.	_	0	SENT_918	[p40l1135t2470r1227b2509],

1	Konstan	NNP	O	Konstan	nn	2	SENT_919	[p40l1270t2470r1473b2511],
2	MW	NNP	O	MW	_	0	SENT_919	[p40l1495t2470r1604b2519],
3	,	,	O	,	_	0	SENT_919	[p40l1495t2470r1604b2519],
4	Doring	NNP	O	Doring	nn	5	SENT_919	[p40l1630t2467r1804b2522],
5	G	NNP	O	G	appos	2	SENT_919	[p40l1825t2469r1877b2519],
6	,	,	O	,	_	0	SENT_919	[p40l1825t2469r1877b2519],
7	Lands	NNP	O	Lands	nn	8	SENT_919	[p40l1903t2466r2047b2509],
8	LC	NNP	O	LC	appos	5	SENT_919	[p40l2071t2469r2149b2509],
9	.	.	O	.	_	0	SENT_919	[p40l2071t2469r2149b2509],

1	Results	NNS	O	result	_	0	SENT_920	[p40l1133t2536r1310b2582],
2	of	IN	O	of	_	0	SENT_920	[p40l1332t2536r1388b2579],
3	a	DT	O	a	det	7	SENT_920	[p40l1399t2550r1424b2579],
4	phase	NN	O	phase	nn	7	SENT_920	[p40l1444t2536r1584b2591],
5	II	CD	NUMBER	ii	num	7	SENT_920	[p40l1605t2540r1642b2579],
6	clinical	JJ	O	clinical	amod	7	SENT_920	[p40l1663t2536r1841b2579],
7	trial	NN	O	trial	prep_of	1	SENT_920	[p40l1862t2536r1963b2579],
8	of	IN	O	of	_	0	SENT_920	[p40l1985t2536r2040b2579],
9	BIIL	NN	O	biil	nn	11	SENT_920	[p40l2051t2540r2153b2579],
10	284	CD	NUMBER	284	num	11	SENT_920	[p40l1133t2609r1220b2650],
11	BS	NN	O	b	prep_of	7	SENT_920	[p40l1243t2609r1302b2650],
12	(	CD	NUMBER	(	num	11	SENT_920	[p40l1329t2610r1402b2656],
13	an	DT	O	a	det	17	SENT_920	[p40l1329t2610r1402b2656],
14	LTB4	NN	O	ltb4	nn	17	SENT_920	[p40l1424t2609r1539b2665],
15	receptor	NN	O	receptor	nn	17	SENT_920	[p40l1562t2615r1763b2661],
16	antagonist	NN	O	antagonist	nn	17	SENT_920	[p40l1784t2607r2058b2662],
17	)	NN	O	)	dep	1	SENT_920	[p40l1784t2607r2058b2662],
18	for	IN	O	for	_	0	SENT_920	[p40l2084t2606r2153b2650],
19	the	DT	O	the	det	20	SENT_920	[p40l1134t2676r1209b2719],
20	treatment	NN	O	treatment	prep_for	17	SENT_920	[p40l1230t2685r1470b2719],
21	of	IN	O	of	_	0	SENT_920	[p40l1489t2676r1544b2720],
22	CF	NN	O	cf	nn	24	SENT_920	[p40l1555t2679r1617b2720],
23	lung	NN	O	lung	nn	24	SENT_920	[p40l1639t2676r1748b2732],
24	disease	NN	O	disease	prep_of	20	SENT_920	[p40l1768t2676r1957b2720],
25	.	.	O	.	_	0	SENT_920	[p40l1768t2676r1957b2720],

1	Pediatr	NNP	O	Pediatr	nn	2	SENT_921	[p40l1980t2676r2153b2720],
2	Pulmonol	NNP	O	Pulmonol	_	0	SENT_921	[p40l1133t2746r1369b2790],
3	2005	CD	DATE	2005	num	2	SENT_921	[p40l1388t2749r1748b2798],
4	;	:	O	;	_	0	SENT_921	[p40l1388t2749r1748b2798],
5	40:125	CD	NUMBER	40:125	number	6	SENT_921	[p40l1388t2749r1748b2798],
6	-6	CD	NUMBER	-6	dep	2	SENT_921	[p40l1388t2749r1748b2798],
7	.	.	O	.	_	0	SENT_921	[p40l1388t2749r1748b2798],

1	abstract	JJ	O	abstract	_	0	SENT_922	[p40l1770t2746r1977b2789],
2	.	.	O	.	_	0	SENT_922	[p40l1770t2746r1977b2789],

1	Copyright	NN	O	copyright	_	0	SENT_923	[p40l1135t2823r1312b2871],
2	©	CD	NUMBER	©	num	6	SENT_923	[p40l1330t2827r1369b2867],
3	2007	CD	DATE	2007	num	6	SENT_923	[p40l1389t2826r1485b2859],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_923	[p40l1499t2823r1765b2859],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_923	[p40l1782t2823r1928b2859],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_923	[p40l1943t2825r2080b2870],
7	.	.	O	.	_	0	SENT_923	[p40l1943t2825r2080b2870],

1	www.nejm.org	NN	O	www.nejm.org	_	0	SENT_924	[p40l1183t3299r1379b3329],

1	N	NN	O	n	nn	3	SENT_925	[p40l897t3463r911b3478],
2	ENGLJ	NN	O	englj	nn	3	SENT_925	[p40l926t3463r1004b3485],
3	MED357	NN	O	med357	_	0	SENT_925	[p40l1018t3457r1154b3485],
4	;	:	O	;	_	0	SENT_925	[p40l1018t3457r1154b3485],
5	'	''	O	'	_	0	SENT_925	[p40l1018t3457r1154b3485],
6	|	SYM	O	|	dep	7	SENT_925	[p40l1018t3457r1154b3485],
7	8	CD	NUMBER	8	rcmod	5	SENT_925	[p40l1018t3457r1154b3485],
8	WWW	NNP	O	WWW	nn	10	SENT_925	[p40l1187t3463r1388b3485],
9	,	,	O	,	_	0	SENT_925	[p40l1187t3463r1388b3485],
10	NEJM.ORG	NNP	O	NEJM.ORG	dep	18	SENT_925	[p40l1187t3463r1388b3485],
11	NOVEMBER	NNP	DATE	NOVEMBER	dep	10	SENT_925	[p40l1425t3463r1661b3484],
12	'	POS	O	'	_	0	SENT_925	[p40l1425t3463r1661b3484],
13	|	JJ	O	|	dep	11	SENT_925	[p40l1425t3463r1661b3484],
14	,2007	CD	NUMBER	,2007	dep	18	SENT_925	[p40l1425t3463r1661b3484],
15	The	DT	O	the	det	18	SENT_925	[p40l935t3496r986b3520],
16	New	NNP	O	New	nn	18	SENT_925	[p40l995t3497r1057b3520],
17	England	NNP	O	England	nn	18	SENT_925	[p40l1066t3496r1177b3527],
18	Journal	NNP	O	Journal	dep	3	SENT_925	[p40l1186t3496r1283b3520],
19	of	IN	O	of	_	0	SENT_925	[p40l1293t3496r1322b3520],
20	Medicine	NNP	O	Medicine	prep_of	18	SENT_925	[p40l1329t3496r1454b3520],

1	Downloaded	VBN	O	download	_	0	SENT_926	[p40l377t3537r547b3560],
2	from	IN	O	from	_	0	SENT_926	[p40l556t3537r621b3560],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_926	[p40l629t3537r748b3567],
4	at	IN	O	at	_	0	SENT_926	[p40l758t3541r781b3560],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_926	[p40l789t3537r972b3560],
6	on	IN	O	on	_	0	SENT_926	[p40l981t3544r1014b3560],
7	January	NNP	DATE	January	prep_on	1	SENT_926	[p40l1022t3537r1125b3567],
8	5	CD	DATE	5	num	7	SENT_926	[p40l1135t3537r1158b3564],
9	,	,	DATE	,	_	0	SENT_926	[p40l1135t3537r1158b3564],
10	2014	CD	DATE	2014	num	7	SENT_926	[p40l1168t3537r1241b3560],
11	.	.	O	.	_	0	SENT_926	[p40l1168t3537r1241b3560],

1	For	IN	O	for	_	0	SENT_927	[p40l1251t3537r1298b3560],
2	personal	JJ	O	personal	amod	3	SENT_927	[p40l1306t3537r1418b3567],
3	use	NN	O	use	pobj	1	SENT_927	[p40l1427t3544r1471b3560],
4	only	RB	O	only	advmod	3	SENT_927	[p40l1480t3537r1545b3567],
5	.	.	O	.	_	0	SENT_927	[p40l1480t3537r1545b3567],

1	No	DT	O	no	det	3	SENT_928	[p40l1556t3537r1595b3560],
2	other	JJ	O	other	amod	3	SENT_928	[p40l1605t3537r1673b3560],
3	uses	NNS	O	use	_	0	SENT_928	[p40l1682t3544r1738b3560],
4	without	IN	O	without	_	0	SENT_928	[p40l1748t3537r1849b3560],
5	permission	NN	O	permission	prep_without	3	SENT_928	[p40l1857t3537r2010b3567],
6	.	.	O	.	_	0	SENT_928	[p40l1857t3537r2010b3567],

1	Copyright	NN	O	copyright	_	0	SENT_929	[p40l728t3578r862b3609],
2	©	CD	NUMBER	©	num	6	SENT_929	[p40l871t3578r895b3602],
3	2007	CD	DATE	2007	num	6	SENT_929	[p40l905t3578r969b3602],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_929	[p40l979t3578r1170b3602],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_929	[p40l1180t3578r1288b3602],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_929	[p40l1299t3578r1404b3609],
7	.	.	O	.	_	0	SENT_929	[p40l1299t3578r1404b3609],

1	All	DT	O	all	det	2	SENT_930	[p40l1415t3578r1456b3602],
2	rights	NNS	O	rights	nsubj	3	SENT_930	[p40l1465t3578r1540b3609],
3	reserved	VBN	O	reserve	_	0	SENT_930	[p40l1550t3578r1668b3602],
4	.	.	O	.	_	0	SENT_930	[p40l1550t3578r1668b3602],

